Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Endometrium,-0.8579159121418494,-1.9650677431113586,0.0,0.0,0.0,8/37,4.38%,CD74;PARP14;DDX60;SAMD9L;SAT1;GBP1;DDX60L;LGALS3
prerank,CellMarker_Augmented_2021__M1 macrophage:Lung,-0.9196363526597185,-1.7874835528268938,0.0,0.1384826099832187,0.16,12/19,4.49%,EPSTI1;RSAD2;MX1;SAMD9L;GBP1;IFIH1;PSMB9;APOL3;IRF2;IRF1;TNFSF10;TAP1
prerank,CellMarker_Augmented_2021__Muller Glia Precursor cell:Retina,-0.8392011300743984,-1.7841406071534904,0.0,0.03077391332960416,0.16,21/47,10.07%,PARP14;DDX60;SAMD9L;GBP1;IFIH1;PARP12;PSMB9;DDX60L;HLA-B;IRF1;SP100;LGALS3;TAP1;NLRC5;SLFN5;OAS3;B2M;NFKB1;S100A6;HLA-E;PARP9
prerank,CellMarker_Augmented_2021__Serous Acinar cell:Salivary Gland,-0.8392011300743984,-1.7841406071534904,0.0,0.03077391332960416,0.16,21/47,10.07%,PARP14;DDX60;SAMD9L;GBP1;IFIH1;PARP12;PSMB9;DDX60L;HLA-B;IRF1;SP100;LGALS3;TAP1;NLRC5;SLFN5;OAS3;B2M;NFKB1;S100A6;HLA-E;PARP9
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Oral Cavity,-0.8392011300743984,-1.7841406071534904,0.0,0.03077391332960416,0.16,21/47,10.07%,PARP14;DDX60;SAMD9L;GBP1;IFIH1;PARP12;PSMB9;DDX60L;HLA-B;IRF1;SP100;LGALS3;TAP1;NLRC5;SLFN5;OAS3;B2M;NFKB1;S100A6;HLA-E;PARP9
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Myometrium,-0.8392011300743984,-1.7841406071534904,0.0,0.03077391332960416,0.16,21/47,10.07%,PARP14;DDX60;SAMD9L;GBP1;IFIH1;PARP12;PSMB9;DDX60L;HLA-B;IRF1;SP100;LGALS3;TAP1;NLRC5;SLFN5;OAS3;B2M;NFKB1;S100A6;HLA-E;PARP9
prerank,CellMarker_Augmented_2021__Myometrial Stem cell:Myometrium,-0.8392011300743984,-1.7841406071534904,0.0,0.03077391332960416,0.16,21/47,10.07%,PARP14;DDX60;SAMD9L;GBP1;IFIH1;PARP12;PSMB9;DDX60L;HLA-B;IRF1;SP100;LGALS3;TAP1;NLRC5;SLFN5;OAS3;B2M;NFKB1;S100A6;HLA-E;PARP9
prerank,CellMarker_Augmented_2021__Prostate Stem cell:Prostate,-0.8392011300743984,-1.7841406071534904,0.0,0.03077391332960416,0.16,21/47,10.07%,PARP14;DDX60;SAMD9L;GBP1;IFIH1;PARP12;PSMB9;DDX60L;HLA-B;IRF1;SP100;LGALS3;TAP1;NLRC5;SLFN5;OAS3;B2M;NFKB1;S100A6;HLA-E;PARP9
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Fluid,-0.8392011300743984,-1.7841406071534904,0.0,0.03077391332960416,0.16,21/47,10.07%,PARP14;DDX60;SAMD9L;GBP1;IFIH1;PARP12;PSMB9;DDX60L;HLA-B;IRF1;SP100;LGALS3;TAP1;NLRC5;SLFN5;OAS3;B2M;NFKB1;S100A6;HLA-E;PARP9
prerank,CellMarker_Augmented_2021__Epithelial cell:Corneal Epithelium,-0.8284181192760433,-1.7810092534317934,0.0,0.03282550755157777,0.2,19/46,9.19%,EPSTI1;SAMD9L;SAT1;GBP1;PSMB9;DDX60L;APOL3;HLA-F;HLA-B;IRF1;HLA-C;SP100;NLRC5;NFKBIA;B2M;LRRFIP1;FOS;TANK;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.848857650161472,-1.7342545561413143,0.0,0.11283768220854858,0.52,2/17,1.12%,CX3CL1;GBP1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.7293026646047662,1.7263358279987495,0.02564102564102564,1.0,0.55,8/43,8.90%,GRIK2;NOVA1;SLC12A6;GRM5;GRIA2;SNAP25;NRXN1;HOMER1
prerank,CellMarker_Augmented_2021__Hair Follicle cell:Hair Follicle,-0.7974322985584368,-1.724070735232141,0.0,0.1196763296151273,0.6,13/46,6.99%,SAMD9L;GBP1;XAF1;DDX60L;APOL3;IRF1;SP100;TNFSF10;TIE1;CPQ;NLRC5;GBP4;LCP2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.9487557485427037,-1.7211872396566703,0.0,0.11520490631082583,0.61,2/7,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Decidual cell:Blood,-0.7825156588636171,-1.7190461044689018,0.0,0.11430310665281546,0.62,20/46,10.07%,SAMD9L;SAT1;GBP1;IFIH1;PARP12;APOL3;HLA-F;NDRG1;TNIP1;SP100;LGALS3;TNFSF10;TAP1;OAS3;NFKBIA;NFKB1;BHLHE40;S100A6;HLA-E;PARP9
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.7370990735627456,1.7160747059675483,0.0,0.6805106715437338,0.65,6/49,8.87%,TRIM5;AFF3;NOVA1;UTY;NOVA2;REST
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,-0.840319135545135,-1.7153189716999757,0.0,0.1189924648744694,0.66,13/27,6.91%,RSAD2;MX1;XAF1;ISG15;STAT1;IRF2;IFI27;HLA-F;HLA-B;IRF1;HLA-C;OAS3;SAMHD1
prerank,CellMarker_Augmented_2021__Endothelial Stem cell:Blood Vessel,-0.9564829014907941,-1.7102699092392861,0.0,0.12309565331841664,0.7,1/9,0.08%,VCAM1
prerank,KEGG_2021_Human__Ribosome,-0.738133872736892,-1.7053566812880967,0.0,0.1303365741018529,0.74,21/52,14.63%,RPS12;RPL31;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood,-0.7961612245843085,-1.7044961640821805,0.0,0.12993430072499534,0.75,9/35,6.99%,CD74;CYLD;SAMD9L;GBP1;XAF1;APOL3;NLRC5;GBP4;LCP2
prerank,CellMarker_Augmented_2021__Theca Interna cell:Ovarian Follicle,-0.8868836293680111,-1.6978875734852517,0.0,0.1441514887544616,0.78,5/24,4.04%,VCAM1;OMD;ITIH5;CXCL12;LAMA4
prerank,KEGG_2021_Human__Insulin secretion,0.8096165203017861,1.6926048019999278,0.0,0.7193969956319473,0.76,4/24,6.85%,CREB5;ITPR3;SNAP25;PLCB1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7257964706315925,-1.6905931151487343,0.0,0.16566623342436906,0.82,26/67,14.87%,RPS12;RPL31;TNIP1;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;WARS1;RPL23;RPL30;LARS1;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;EEF1A1;RPL24;RPL37;PPA2
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.9668377800120097,-1.6898278254847836,0.0,0.15875431479557703,0.83,2/11,0.21%,CD74;RSAD2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Oral Mucosa,-0.8465379946299957,-1.6896624426207147,0.0,0.15200448099168115,0.83,4/31,4.86%,VCAM1;CXCL12;LAMA4;TIE1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.8565989400926449,-1.6843399162437955,0.0,0.16591153273351808,0.85,8/16,6.29%,CD74;CX3CL1;GBP1;STAT1;SP100;NUB1;CALCOCO2;GBP4
prerank,KEGG_2021_Human__Long-term potentiation,0.7652356393530434,1.6828194946632917,0.0,0.6586371142441139,0.8,14/30,18.67%,ITPR3;GRM5;GRIA2;KRAS;PLCB1;PPP1CB;CACNA1C;ITPR2;PPP3CA;PPP3CB;CALM1;CREBBP;EP300;PRKCA
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8606616133245956,-1.681922251897089,0.01639344262295082,0.15920371162515218,0.85,14/23,6.91%,RSAD2;MX1;XAF1;ISG15;STAT1;IRF2;IFI27;HLA-F;HLA-B;IRF1;HLA-C;SP100;OAS3;SAMHD1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8606616133245956,-1.681922251897089,0.01639344262295082,0.15920371162515218,0.85,14/23,6.91%,RSAD2;MX1;XAF1;ISG15;STAT1;IRF2;IFI27;HLA-F;HLA-B;IRF1;HLA-C;SP100;OAS3;SAMHD1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.8641935084559358,-1.678054418364095,0.0,0.16452207510826838,0.86,6/17,6.99%,MX1;GBP1;FN1;TNFSF10;LY6E;LCP2
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,-0.732765673408107,-1.6761725980760207,0.0,0.165647237181573,0.87,18/48,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.7277896884326331,-1.6745298131599358,0.0,0.16595931831322244,0.88,20/55,14.63%,RPS12;RPL31;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;UPF3A;RPL28;RPL9;RPL37
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.8721182014523325,-1.6723995471379822,0.022222222222222223,0.16660359974992597,0.89,5/18,6.99%,CD74;HLA-B;HLA-C;LGALS3;LCP2
prerank,CellMarker_Augmented_2021__Stromal cell:Undefined,-0.9661022175738535,-1.6718929775547995,0.0,0.1617340111655863,0.89,1/7,0.08%,VCAM1
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.7251029423037995,-1.6696797600124855,0.0,0.16148031940695515,0.91,29/49,22.68%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37;SRP14;RPL11;RPS27;RPL27A;RPLP1;TRAM1;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,-0.7358262503238095,-1.6685885915583123,0.0,0.1575997379607001,0.92,19/48,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;EEF1A1;RPL37
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,-0.7358262503238095,-1.6685885915583123,0.0,0.1575997379607001,0.92,19/48,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;EEF1A1;RPL37
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Chorionic Villus,-0.8521878321691841,-1.665317718192328,0.0,0.16684288305167747,0.92,8/25,6.99%,CD74;SAMD9L;XAF1;APOL3;SP100;NLRC5;GBP4;LCP2
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.730952933736166,-1.6647131454972173,0.0,0.16324828309132874,0.92,18/48,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37
prerank,CellMarker_Augmented_2021__Exhausted CD8+ T cell:Liver,-0.6748373389778316,-1.6635126195230252,0.0,0.16184798862236263,0.92,24/98,10.78%,VCAM1;EPSTI1;MX1;PARP14;DDX60;SAMD9L;GBP1;IRF2;RNF19A;GABARAPL1;ACSL4;LY6E;CALCOCO2;OAS3;GBP4;GPD2;WARS1;EWSR1;TFRC;ITM2A;BST2;AHI1;AFAP1L2;PHTF2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord Blood,-0.8382488549586243,-1.663031654719968,0.0,0.15913717343416925,0.92,11/34,9.19%,CD74;SAMD9L;GBP1;APOL3;HLA-B;SP100;CPQ;NLRC5;LCP2;B2M;HLA-E
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.720756789156382,-1.659623252983723,0.0,0.1649373775823521,0.92,23/60,14.63%,RPS12;RPL31;RPS18;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;UPF3A;RPL28;RPL10;RPL9;RPL24;RPL37
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7182546918738105,-1.6552163306641827,0.0,0.17570063336902203,0.94,32/54,22.68%,RPS12;RPL31;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37;SRP14;RPL11;RPS27;RPL27A;RPLP1;TRAM1;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.8829974491208292,-1.6541997354621059,0.0,0.1748984074232503,0.94,8/20,6.19%,RSAD2;MX1;IFIH1;ISG15;TNIP1;ZC3HAV1;EIF2AK2;OAS3
prerank,CellMarker_Augmented_2021__Preadipocyte Progenitor cell:Adipose Tissue,-0.8115462692255103,-1.653568849610907,0.0,0.17188356469461835,0.94,4/33,4.04%,VCAM1;ITIH5;CXCL12;LAMA4
prerank,KEGG_2021_Human__Thyroid hormone synthesis,0.8146183156751307,1.6524108414407392,0.0,0.9449376753435847,0.91,4/21,6.85%,CREB5;ITPR3;HSP90B1;PLCB1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.8787266720755866,-1.6514374837234753,0.0,0.17707212034891281,0.95,1/14,0.13%,CD74
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.7291683028120104,-1.651229996366081,0.0,0.1734312789970715,0.95,28/47,22.68%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37;RPL11;GSPT1;RPS27;RPL27A;RPLP1;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Adipose Tissue,-0.9126355402416627,-1.6505509565876246,0.025,0.17182101609028988,0.95,1/9,0.08%,VCAM1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7343513823327633,-1.650147162726173,0.0,0.1684586811153887,0.95,25/60,14.63%,RPS12;RPL31;TNIP1;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;WARS1;DMD;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;EEF1A1;RPL24;RPL37
prerank,Reactome_2022__rRNA Processing R-HSA-72312,-0.696709780723737,-1.649511934139191,0.0,0.1681415264530546,0.95,22/56,14.63%,RPS12;RPL31;MTERF4;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;SPPL2A;RPS14;RPP38;RPS15;RPL28;RPL9;RIOK3;RPL37
prerank,CellMarker_Augmented_2021__Endothelial cell:Brain,-0.9923558244837755,-1.6476354650779925,0.0,0.171329943005243,0.97,1/8,0.08%,VCAM1
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.7323629273065237,-1.6464183143415645,0.0,0.17331697021047898,0.98,29/48,22.68%,RPS12;RPL31;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37;RPL11;GSPT1;RPS27;RPL27A;RPLP1;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.9612042115927966,-1.6430460967398357,0.0,0.17787321904511205,0.98,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.9612042115927966,-1.6430460967398357,0.0,0.17787321904511205,0.98,1/5,0.13%,CD74
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Germ,-0.8448004916732186,-1.6416485721395921,0.0,0.18021847283219167,0.98,8/23,9.27%,SAMD9L;CLEC1A;XAF1;APOL3;TNFSF10;GBP4;LCP2;SCARF1
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,-0.7260057222535775,-1.6398223715688462,0.0,0.18582709202876357,0.99,18/48,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8996740447304685,-1.6373690857110654,0.0,0.19335307808977706,0.99,2/12,2.79%,CD74;CXCL12
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood,-0.7755902855933801,-1.6362621793689538,0.017241379310344827,0.19338175166380886,0.99,6/42,6.56%,VCAM1;CD74;ITIH5;CLIC5;TIE1;SLCO2B1
prerank,CellMarker_Augmented_2021__Responder T cell:Blood,-0.9019865022833754,-1.6346771071283888,0.0,0.19434192539059109,0.99,1/10,0.13%,CD74
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.7127903738414014,-1.634275150169755,0.015151515151515152,0.19160424608789256,0.99,19/53,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;LARS1;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,0.9198697064953016,1.6342025610847855,0.0,1.0,0.95,1/13,0.03%,CREB5
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7247602707790639,-1.6338175973822255,0.0,0.19040234095158595,0.99,22/51,15.88%,RPS12;RPL31;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37;SRP14
prerank,CellMarker_Augmented_2021__Lymphocyte:Blood,-0.8529424322021713,-1.6326475660214705,0.0,0.1890650192491198,0.99,7/19,9.19%,GBP1;HLA-B;HLA-C;CPQ;SAMHD1;B2M;HLA-E
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Blood,-0.9048010769054434,-1.6310080976950598,0.018518518518518517,0.19090258099381563,0.99,1/14,0.08%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.9836900924269338,-1.6295206111344331,0.0,0.19148212738420367,1.0,2/5,1.30%,CD74;IFIH1
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.6721676896546435,1.6286148205689706,0.0,1.0,0.97,15/49,17.18%,CREB5;ITPR3;PRKG1;ATP2A2;PLCB1;PPP1CB;CACNA1C;GTF2I;ITPR2;PPP3CA;PPP3CB;SLC8A1;CALM1;ATP2B4;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.8435029501364766,-1.6281297023951773,0.021739130434782608,0.19338797994013543,1.0,6/15,6.91%,PARP14;PPARG;ISG15;NLRC5;OAS3;SAMHD1
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Endometrium,-0.9378655888230332,-1.6260503232919319,0.02127659574468085,0.1987068274669602,1.0,1/9,0.08%,VCAM1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.907040509934207,-1.6227501550620487,0.0,0.20841592096239853,1.0,2/16,0.27%,HES1;TBX3
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.6868492939469668,-1.622263241915536,0.0,0.20326564291553925,1.0,21/55,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;SPPL2A;RPS14;RPP38;RPS15;RPL28;RPL9;RIOK3;RPL37
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.6868492939469668,-1.622263241915536,0.0,0.20326564291553925,1.0,21/55,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;SPPL2A;RPS14;RPP38;RPS15;RPL28;RPL9;RIOK3;RPL37
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.720048993688792,-1.6188331221613015,0.0,0.21075467916638,1.0,21/51,14.63%,RPS12;RPL31;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Peripheral Blood,-0.7964273948871741,-1.6177895751528042,0.0,0.2115897921468306,1.0,5/40,6.56%,VCAM1;CX3CL1;ITIH5;TIE1;SLCO2B1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Ligament,-0.9658208906760797,-1.617783533271909,0.0,0.20847817755643602,1.0,2/9,0.13%,VCAM1;CD74
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.7629018591440193,-1.6176665296408266,0.02040816326530612,0.2062000859331448,1.0,11/30,8.63%,SAT1;IFIH1;PARP12;IRF2;HLA-C;TNIP1;LGALS3;TNFSF10;OAS3;NFKBIA;BHLHE40
prerank,KEGG_2021_Human__Alcoholism,0.7835885905428954,1.6175035263229527,0.0,1.0,0.98,6/31,11.18%,CREB5;HDAC9;KRAS;HDAC7;PPP1CB;GNB4
prerank,CellMarker_Augmented_2021__Myeloid cell:Bone Marrow,-0.9379315363834039,-1.6173433253883995,0.0,0.20457325241965432,1.0,1/9,0.08%,VCAM1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.8457212424171522,-1.6166205547649484,0.019230769230769232,0.20443702986568021,1.0,3/13,7.28%,CD74;TNFSF10;DSP
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9656746309255211,-1.6150499764520594,0.0,0.20672661222803534,1.0,1/7,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.8105183500423336,-1.6143895438022442,0.0,0.2058620229583109,1.0,2/28,0.32%,CD74;CX3CL1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.9771325150148912,-1.613796734775432,0.020833333333333332,0.20460493727250334,1.0,2/5,2.23%,CD74;PLCG2
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.7661191991388914,-1.6127527165468856,0.03508771929824561,0.20420201156044004,1.0,8/30,8.07%,CYLD;IFIH1;ISG15;IRF1;NLRC5;NFKB1;LRRFIP1;TRIM25
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6913039592588979,-1.6127037280724081,0.0,0.20178508959543076,1.0,31/89,14.63%,RPS12;RPL31;TNIP1;RPS18;RFC3;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;MEF2A;WARS1;RPL23;RPL30;TOPBP1;RPS28;RPS19;POLR2A;PTMA;RPS7;RPS14;RPS15;RPL28;RPL10;ATM;RPL9;EEF1A1;GCNT1;RPL24;RPL37
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.7890619326410696,-1.61204926252845,0.016666666666666666,0.20222857330882732,1.0,12/32,10.73%,VCAM1;RSAD2;HLA-F;HLA-B;IRF1;HLA-C;SAMHD1;B2M;ERAP1;HLA-E;SPPL2A;APPL2
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.8926361901263273,-1.6112451669164924,0.017241379310344827,0.20318673544546337,1.0,2/19,0.93%,HES1;KIAA1217
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.7078921390507165,-1.610265221731318,0.0,0.2029520106927059,1.0,18/50,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Cartilage,-0.8423861635706822,-1.6093165994491196,0.047619047619047616,0.2027231540587674,1.0,1/11,0.08%,VCAM1
prerank,CellMarker_Augmented_2021__Interstitial cell:Dorsolateral Prefrontal Cortex,-0.7982517382739579,-1.6077450374471138,0.0,0.2057926302905628,1.0,14/30,10.07%,SAMD9L;LAP3;IFIH1;PSMB9;APOL3;IRF2;SP100;TNFSF10;CPQ;CALCOCO2;B2M;TANK;MYL12A;PARP9
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.7606112464722504,-1.6070322528727652,0.02,0.20653549149258726,1.0,4/29,5.37%,CD74;CYLD;STAT1;CDC37
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.8309105728529528,-1.6068960857706347,0.0,0.20441788211712963,1.0,9/25,6.19%,RSAD2;MX1;IFIH1;ISG15;TNIP1;ZC3HAV1;PABPC1;EIF2AK2;OAS3
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Germ,-0.9734083968533664,-1.6064011954050688,0.0,0.20332764164202746,1.0,1/7,0.08%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.8895295586791514,-1.6062341987060147,0.0,0.20117691576647112,1.0,4/14,5.82%,CD74;PARP14;PRKN;NLRC5
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Germ,-0.8595968347172838,-1.6013258556525733,0.05555555555555555,0.21258760817347241,1.0,3/13,6.99%,CD74;GBP4;LCP2
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Germ,-0.8595968347172838,-1.6013258556525733,0.05555555555555555,0.21258760817347241,1.0,3/13,6.99%,CD74;GBP4;LCP2
prerank,KEGG_2021_Human__Fanconi anemia pathway,-0.9429116269492779,-1.5984222754026989,0.0,0.2207795145692056,1.0,1/8,0.24%,HES1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.9478351222522609,-1.597011711272548,0.0,0.22256339565342934,1.0,2/8,0.53%,CX3CL1;CEMIP
prerank,KEGG_2021_Human__Coronavirus disease,-0.6700264669864082,-1.5969351293104017,0.0,0.2202044464918342,1.0,33/87,14.63%,MX1;IFIH1;ISG15;RPS12;STAT1;PLCG2;RPL31;RPS18;RPL34;EIF2AK2;RPS8;RPL15;RPS6;RPL7A;RPL38;OAS3;NFKBIA;RPL23;NFKB1;FOS;RPL30;JUN;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;TBK1;RPL24;RPL37
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.8918198028409043,-1.596409523217385,0.02040816326530612,0.2200391165545323,1.0,1/17,0.27%,TBX3
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.7167733500996104,-1.593678266323287,0.0,0.22935485405433242,1.0,22/55,15.88%,RPS12;RPL31;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37;SRP14
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.8659753722197916,1.5935819890962892,0.0,1.0,0.99,3/12,5.95%,CRY1;CALR;CNOT2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Adipose Tissue,-0.8420413979622517,-1.593333757901344,0.09302325581395349,0.22766077818029745,1.0,1/11,0.08%,VCAM1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.7355585285972914,1.5909106204361962,0.0,1.0,0.99,7/29,8.37%,RBM20;NOVA1;PTBP3;MBNL1;YTHDF2;NOVA2;HNRNPLL
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.7776240019421166,1.5908148939757685,0.0,1.0,0.99,1/22,0.08%,PDK4
prerank,CellMarker_Augmented_2021__Astrocyte:Embryonic Prefrontal Cortex,-0.6550504659444788,-1.590316522368041,0.0,0.23560595347026728,1.0,18/87,14.02%,VCAM1;HES1;HLA-B;DOK5;HLA-C;LGALS3;SLC38A3;GRB14;B2M;JUN;CST3;PTMA;VIM;CLU;ITGAV;HLA-A;SYPL1;ELOVL5
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Bone Marrow,-0.8917565188818378,-1.5901688951544661,0.041666666666666664,0.23388174130499162,1.0,1/17,0.08%,VCAM1
prerank,KEGG_2021_Human__Glucagon signaling pathway,0.6935203257924101,1.5898248833470592,0.0,1.0,0.99,10/37,17.42%,CREB5;ITPR3;PKM;PLCB1;ITPR2;PPP3CA;PPP3CB;CALM1;CREBBP;EP300
prerank,CellMarker_Augmented_2021__Endothelial cell:Undefined,-0.960224095728236,-1.589634662565891,0.0,0.23294142728658704,1.0,1/11,0.08%,VCAM1
prerank,KEGG_2021_Human__Cocaine addiction,0.8252376129814384,1.5886702355599653,0.05555555555555555,1.0,1.0,2/13,3.43%,CREB5;GRIA2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.9300745659939915,-1.5879093477218373,0.02040816326530612,0.2345585558936839,1.0,2/8,4.01%,CD74;PRKN
prerank,CellMarker_Augmented_2021__Secretory cell:Lung,-0.8226672967730232,-1.5878656499373285,0.017857142857142856,0.23226977441629804,1.0,3/17,2.26%,CD74;CX3CL1;PLK2
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,0.9155990911675909,1.5867670334464774,0.043478260869565216,0.9721581022053339,1.0,2/6,1.49%,PDK4;GLO1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.8971276184762785,-1.5853664648333599,0.0,0.23831650053228812,1.0,7/15,6.99%,CD74;PARP14;PPARG;LGALS3;CPM;SLCO2B1;LCP2
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Blood,-0.7473269037684639,-1.5852416875452757,0.016129032258064516,0.23430831040064948,1.0,5/45,4.86%,VCAM1;CX3CL1;ITIH5;CXCL12;TIE1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood Vessel,-0.7473269037684639,-1.5852416875452757,0.016129032258064516,0.23430831040064948,1.0,5/45,4.86%,VCAM1;CX3CL1;ITIH5;CXCL12;TIE1
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Undefined,-0.7765613360391043,-1.5835727121813048,0.03125,0.23643617724803717,1.0,5/25,6.99%,CD74;XAF1;APOL3;GBP4;LCP2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tendon,-0.8425904747767976,-1.5822740591669016,0.09302325581395349,0.23349096145318712,1.0,1/10,0.08%,VCAM1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Muscle,-0.8425904747767976,-1.5822740591669016,0.09302325581395349,0.23349096145318712,1.0,1/10,0.08%,VCAM1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone,-0.8425904747767976,-1.5822740591669016,0.09302325581395349,0.23349096145318712,1.0,1/10,0.08%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.9291499112227286,-1.5822041478429143,0.020833333333333332,0.23148176315853192,1.0,1/6,1.01%,PPARG
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,0.7785752173878391,1.582078123101572,0.023809523809523808,0.9766948400156256,1.0,5/23,8.45%,PDK4;GLO1;NDUFAF2;CCNI;SLC16A1
prerank,KEGG_2021_Human__Dopaminergic synapse,0.6979758683668301,1.5795662329558446,0.021739130434782608,0.9545377366028623,1.0,13/47,13.39%,CREB5;ITPR3;GRIA2;MAPK10;PLCB1;PPP1CB;CACNA1C;GNB4;PPP2CB;ITPR2;PPP3CA;PPP3CB;PPP2R2B
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.702411824535029,-1.5790264503428733,0.0,0.23995982885981063,1.0,19/53,14.63%,RPS12;RPL31;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.8959222603649183,-1.5787892395411491,0.018518518518518517,0.23640388466044543,1.0,1/8,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.8959222603649183,-1.5787892395411491,0.018518518518518517,0.23640388466044543,1.0,1/8,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.8336991132501248,-1.5784475349939568,0.021739130434782608,0.23537380983006334,1.0,1/15,0.24%,HES1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.7264780203797914,-1.5782701454012924,0.0,0.23399263828996314,1.0,5/47,3.53%,CD74;CX3CL1;GBP1;FN1;TNIP1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.962542244139416,-1.5780946510379912,0.0,0.23272771955513147,1.0,1/6,0.08%,VCAM1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.9623239545392904,-1.5775300901875031,0.0,0.2328468663434651,1.0,1/7,0.08%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.682596458151316,-1.577026429700974,0.0,0.23206410081008516,1.0,9/101,3.24%,CD74;HES1;TBX3;CX3CL1;STAT1;FN1;CNOT8;GRK5;UFL1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.9283448797123227,-1.5761524560062887,0.0196078431372549,0.23316814331473992,1.0,2/9,0.32%,HES1;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.9359033800743781,-1.576139885464531,0.0,0.2311580731137508,1.0,1/6,0.13%,CD74
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.8595204292981294,-1.5759358753708916,0.037037037037037035,0.23040981262165167,1.0,1/12,0.29%,SLC22A5
prerank,CellMarker_Augmented_2021__CD1C-CD141- Dendritic cell:Blood,-0.6460037526885747,-1.5751583923585997,0.0,0.23106514584770582,1.0,18/105,7.14%,NR4A1;DDX60;PSTPIP2;SAT1;GBP1;SOD2;DDX60L;ISG15;KLF3;DENND3;IRF1;LGALS3;TNFSF10;ARAP2;LY6E;GBP4;LCP2;WARS1
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Undefined,-0.8515282499941451,-1.5741492570514157,0.0,0.23248527801104318,1.0,7/17,8.63%,IFIH1;SP100;LGALS3;TNFSF10;OAS3;NFKBIA;BHLHE40
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Placenta,-0.9388596925945697,-1.573439013926768,0.044444444444444446,0.23294142728658704,1.0,1/5,0.08%,VCAM1
prerank,KEGG_2021_Human__Oocyte meiosis,0.6733093982815403,1.5732056503708804,0.023809523809523808,0.982451540934567,1.0,16/40,18.91%,ITPR3;YWHAB;BTRC;YWHAZ;PGR;CPEB3;PPP1CB;YWHAQ;PPP2CB;ITPR2;PPP3CA;PPP3CB;SMC1A;CALM1;CPEB4;YWHAG
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.6971273629596251,1.5722269772402375,0.020833333333333332,0.9413730956354985,1.0,2/36,1.38%,CREB5;ITPR3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.7841562857392874,-1.571417473897704,0.0392156862745098,0.23627244200993605,1.0,5/22,7.30%,CYLD;SP100;LGALS3;TNFSF10;BCL2L14
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.9148666453489722,-1.5712264886484932,0.0,0.23500843649246894,1.0,2/11,0.56%,CX3CL1;CYLD
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.8884576027333086,-1.571117353810858,0.0,0.23343139135382665,1.0,6/13,4.49%,IFIH1;PARP12;HLA-F;IRF1;HLA-C;TAP1
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.8788639272866574,-1.569005292778486,0.031746031746031744,0.2383323771574989,1.0,4/12,3.19%,VCAM1;HLA-F;HLA-B;HLA-C
prerank,CellMarker_Augmented_2021__Oviduct-derived Stem cell:Oviduct,-0.9389839274415167,-1.5682109849810606,0.023255813953488372,0.2388055674377283,1.0,1/8,0.08%,VCAM1
prerank,CellMarker_Augmented_2021__Periodontal Ligament Stem cell:Periodontal Ligament,-0.8284479547737551,-1.5682050230983828,0.05263157894736842,0.2369916976256024,1.0,3/15,6.99%,CD74;GBP4;LCP2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.8132579836411864,-1.5679072257787146,0.019230769230769232,0.2361756498051511,1.0,2/21,0.66%,NR4A1;BTG2
prerank,KEGG_2021_Human__Long-term depression,0.742431620937685,1.5662257725618771,0.05128205128205128,0.9767630616368329,1.0,7/22,12.11%,ITPR3;PRKG1;GRIA2;KRAS;PLCB1;PPP2CB;ITPR2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.9629407983614988,1.5659686427751511,0.0,0.9318135409638126,1.0,1/8,0.08%,PDK4
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.8256878413739492,-1.5641699147327779,0.0,0.24771397422345434,1.0,5/22,7.01%,CYLD;TMSB4X;UFL1;NLRC5;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.8723705158094482,-1.5641321159031298,0.0,0.24603226832505237,1.0,2/12,2.12%,PPARG;STAT1
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.8215444664578856,-1.563813043671807,0.03571428571428571,0.2454022319360742,1.0,9/18,11.58%,RPS12;RPS8;RPS6;GEMIN5;RPS28;RPS19;RPS7;RPS14;RPS15
prerank,KEGG_2021_Human__Insulin resistance,0.6883072963241625,1.5636905419225653,0.020833333333333332,0.9203096700877162,1.0,3/36,7.01%,CREB5;MAPK10;PIK3CA
prerank,KEGG_2021_Human__Prostate cancer,0.6944606859547934,1.5624625053005625,0.0,0.8912922237037084,1.0,6/44,7.54%,CREB5;HSP90B1;ZEB1;KRAS;PIK3CA;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.8623121920662927,-1.5624386916956334,0.0196078431372549,0.24924520643290085,1.0,1/10,0.21%,RSAD2
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.7149394501199614,-1.5619873104980562,0.018518518518518517,0.2486780875119528,1.0,11/35,13.49%,CYLD;IFIH1;ISG15;NLRC5;NFKBIA;NFKB1;TRIM25;TANK;UBC;UBE2D2;TBK1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.8997249741372162,-1.556789989650385,0.0,0.2661673556402605,1.0,2/10,2.39%,CD74;FN1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.8049294229608398,1.553706192223756,0.024390243902439025,0.9620138437475392,1.0,5/13,8.90%,GRIK2;GRM5;GRIA2;PLCB1;HOMER1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.9431846957882446,-1.5527992822630328,0.0,0.2798741968483403,1.0,2/7,2.34%,PLK2;CENATAC
prerank,KEGG_2021_Human__Rheumatoid arthritis,-0.8159914663882191,-1.5525964346806498,0.02,0.2784849193901216,1.0,4/11,8.92%,CXCL12;ATP6V1E1;FOS;JUN
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,-0.9449450276501363,-1.5523236440839714,0.037037037037037035,0.271577940174924,1.0,1/6,0.85%,OMD
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.9449450276501363,-1.5523236440839714,0.037037037037037035,0.271577940174924,1.0,1/6,0.85%,OMD
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,-0.9449450276501363,-1.5523236440839714,0.037037037037037035,0.271577940174924,1.0,1/6,0.85%,OMD
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.9449450276501363,-1.5523236440839714,0.037037037037037035,0.271577940174924,1.0,1/6,0.85%,OMD
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Vein,-0.7712606240574966,-1.55182142756161,0.03508771929824561,0.2711767934115833,1.0,4/37,4.86%,VCAM1;CXCL12;LAMA4;TIE1
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,-0.730053283413101,-1.551721199669973,0.01818181818181818,0.2693990568783078,1.0,6/50,5.39%,VCAM1;CD99L2;PLCG2;CXCL12;VAV3;CTNNA2
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Placenta,-0.7706011863445653,-1.5508638060864697,0.017241379310344827,0.27068040668081406,1.0,3/40,4.86%,VCAM1;APOL3;TIE1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6793251033904407,-1.5508196605438942,0.017241379310344827,0.26885927076773053,1.0,28/52,22.68%,RPL31;RPL34;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RIOK3;RPL24;RPL37;RPL11;RPS27;RPL27A;RPLP1;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.957221649247591,-1.550634920308747,0.0,0.26777578751384734,1.0,1/8,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.7699956469823828,-1.5504427617725751,0.0,0.2648102268020047,1.0,8/29,8.31%,SLC22A5;SLC6A6;SLC16A2;SLC5A6;SLC38A3;SLCO2B1;SLC2A3;TFRC
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.7699956469823828,-1.5504427617725751,0.0,0.2648102268020047,1.0,8/29,8.31%,SLC22A5;SLC6A6;SLC16A2;SLC5A6;SLC38A3;SLCO2B1;SLC2A3;TFRC
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.8407916664959011,-1.5501390340407746,0.038461538461538464,0.26384618208442934,1.0,6/20,8.74%,CX3CL1;OPTN;TNIP1;SERPINE1;NFKBIA;CD47
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.7923891502524631,-1.5495316434647282,0.05084745762711865,0.2645586197727457,1.0,7/23,8.07%,VCAM1;CYLD;PLCG2;CXCL12;NFKBIA;NFKB1;TRIM25
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.8289557837979686,1.549519667470018,0.02,0.9798543538477928,1.0,3/9,3.56%,PNP;BCL6;ZBTB1
prerank,CellMarker_Augmented_2021__Progenitor cell:Undefined,0.8646345204223648,1.5491176205231956,0.0,0.9468819915479953,1.0,4/13,6.43%,PDIA3;CALR;HSP90B1;ALCAM
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.8680980994386015,-1.548211613562114,0.0,0.2672580124060925,1.0,3/10,2.79%,CX3CL1;NR4A1;CXCL12
prerank,CellMarker_Augmented_2021__Abnormal Plasma cell:Peripheral Blood,-0.7773863897800536,-1.5479036702914137,0.0,0.26650208943437204,1.0,2/32,0.32%,VCAM1;CX3CL1
prerank,CellMarker_Augmented_2021__pro-Natural Killer Cell (pro-NK cell):Peripheral Blood,-0.8759023097609945,-1.547708677900717,0.01818181818181818,0.26541651076989725,1.0,2/11,7.01%,BTG2;NFKBIA
prerank,CellMarker_Augmented_2021__Stem cell:Muscle,-0.926434943669525,-1.5474533334008134,0.0,0.2644801893392954,1.0,1/7,0.08%,VCAM1
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,0.6684985547493765,1.546579317785951,0.02564102564102564,0.9355152198914406,1.0,5/36,7.01%,PDK4;ATP2A2;MAPK10;PLCB1;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.846139148529072,-1.5456610160601352,0.019230769230769232,0.2681152056755709,1.0,6/19,9.75%,CX3CL1;TNIP1;SERPINE1;NFKBIA;CD47;RPS19
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Undefined,-0.8956569418069968,-1.5453264592249096,0.03636363636363636,0.2674399610787028,1.0,2/12,2.79%,VCAM1;CXCL12
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Adipose Tissue,-0.8880390166470333,-1.543277771484917,0.0,0.27623723491993063,1.0,1/13,0.08%,VCAM1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.7514309086125452,-1.5430773697654137,0.058823529411764705,0.27558433924010906,1.0,3/33,2.55%,VCAM1;FN1;ITGB5
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.7542891393537096,-1.5425274090607208,0.037037037037037035,0.2763118460103949,1.0,5/36,2.79%,VCAM1;CX3CL1;SLC6A6;FN1;CXCL12
prerank,KEGG_2021_Human__Influenza A,-0.6994868767340376,-1.5421660055421282,0.016666666666666666,0.2759264380818939,1.0,11/46,8.07%,RSAD2;MX1;IFIH1;STAT1;TNFSF10;EIF2AK2;CALCOCO2;OAS3;NFKBIA;NFKB1;TRIM25
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9433912396405595,-1.5416407464750863,0.022222222222222223,0.2758039402181504,1.0,2/7,4.01%,CD74;PRKN
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.8997412647794684,-1.541177312983176,0.0,0.27619587213319735,1.0,2/13,0.27%,HES1;TBX3
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,0.8499646579053427,1.540895726738058,0.022222222222222223,0.96387675540877,1.0,2/10,1.49%,PDK4;GLO1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.8258223531245881,1.5366201724456843,0.02127659574468085,0.9853516764495492,1.0,3/13,3.13%,BMP6;PRKD1;IL6R
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.7576203519925264,-1.5363765653714627,0.03389830508474576,0.2932760311721903,1.0,9/27,13.23%,CX3CL1;IFIH1;PLCG2;OAS3;CD47;HLA-E;VSIR;CLU;JAK2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.9177925195266471,-1.5363466020773628,0.0425531914893617,0.2916556477287176,1.0,2/8,2.79%,CD74;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.8092764396076682,-1.5363076158106612,0.05263157894736842,0.2899922139525889,1.0,3/16,3.43%,VCAM1;CD74;VAV3
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.8747507667356356,-1.5362735677278032,0.016666666666666666,0.28822396874556094,1.0,4/11,4.01%,CX3CL1;SOD2;SNX6;PRKN
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.768257599415724,-1.5349401977286314,0.0425531914893617,0.2918859052171546,1.0,5/26,8.31%,CX3CL1;LGALS3;SMAD3;WARS1;TFRC
prerank,CellMarker_Augmented_2021__Circulating Stem Like cell:Peripheral Blood,-0.8210964857621466,-1.5334524077049456,0.03389830508474576,0.2952565419454793,1.0,5/17,3.61%,PARP14;SLFN12L;DDX60L;IRF1;SP100
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.9309252435641535,-1.533304848778625,0.0,0.2939799385139431,1.0,1/6,0.13%,CD74
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.9389296414704005,-1.5329233954677908,0.06976744186046512,0.29332912626075075,1.0,2/5,4.01%,IFI27;PRKN
prerank,KEGG_2021_Human__Chemical carcinogenesis,0.6610600217126641,1.5328912945155453,0.021739130434782608,1.0,1.0,9/55,11.13%,CREB5;KPNA3;BCL6;HSP90B1;KRAS;PIK3CA;HSP90AA1;PGR;CACNA1C
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.8378476645099073,-1.53277331595771,0.018867924528301886,0.2923218276042872,1.0,3/10,7.73%,CX3CL1;CXCL12;STK39
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.9165431575617295,-1.5310866117974375,0.0425531914893617,0.2971191161470017,1.0,3/7,4.01%,HES1;PPARG;PRKN
prerank,CellMarker_Augmented_2021__DCLK1+ Progenitor cell:Large Intestine,-0.8796602892149816,-1.5300191900789344,0.05660377358490566,0.2992208181053909,1.0,3/13,1.12%,VCAM1;MX1;GBP1
prerank,CellMarker_Augmented_2021__Myofibroblast:Liver,-0.8045319044359087,-1.5296327309426039,0.08196721311475409,0.29903178572603734,1.0,5/27,4.04%,VCAM1;FN1;CXCL12;DOK5;LAMA4
prerank,KEGG_2021_Human__Cholinergic synapse,0.7485656515524929,1.528682808435333,0.0,1.0,1.0,8/33,12.11%,CREB5;ITPR3;KRAS;PLCB1;PIK3CA;CACNA1C;GNB4;ITPR2
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.8709989642079766,-1.5279052795342347,0.0,0.3043000447158546,1.0,5/20,2.95%,CD74;CX3CL1;IFIH1;PLCG2;HLA-B
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.9251990311450431,-1.5271747316352797,0.023255813953488372,0.30502725587619145,1.0,1/6,0.13%,CD74
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.9007677799535504,-1.5271463564414496,0.10909090909090909,0.3034600939187823,1.0,2/7,2.12%,MX1;STAT1
prerank,CellMarker_Augmented_2021__T Helper cell:Eye,-0.9274138096866538,-1.5247370969751088,0.020833333333333332,0.3109845930822145,1.0,1/7,0.13%,CD74
prerank,CellMarker_Augmented_2021__T Helper cell:Salivary Gland,-0.9274138096866538,-1.5247370969751088,0.020833333333333332,0.3109845930822145,1.0,1/7,0.13%,CD74
prerank,KEGG_2021_Human__Estrogen signaling pathway,0.7061793528540203,1.5238802619801437,0.02,1.0,1.0,12/45,13.12%,CREB5;ITPR3;HSP90B1;KRAS;PLCB1;PIK3CA;HSP90AA1;PGR;NCOA3;NCOA2;ITPR2;HSPA8
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.8582231171594226,-1.5234602441135912,0.04,0.31298337695333367,1.0,2/9,4.75%,SLC6A6;SLC38A3
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.7317795111486743,1.5229390895719548,0.02127659574468085,1.0,1.0,8/18,17.18%,ITPR3;STIM1;ATP2A2;ITPR2;SLC8A1;ANK2;ATP2B4;ATP1A1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.7985522258069275,-1.5212800652947036,0.03773584905660377,0.32034669555398,1.0,3/17,4.75%,SLC6A6;SLC16A2;SLC38A3
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.8039429746200332,-1.52126840883063,0.019230769230769232,0.31856699168979125,1.0,2/17,0.32%,HES1;CX3CL1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.8375118815067955,-1.5212109755766017,0.018867924528301886,0.31714699630288185,1.0,1/8,0.08%,VCAM1
prerank,CellMarker_Augmented_2021__Mesoderm cell:Germ,-0.9602386237729974,-1.5205006144730668,0.022727272727272728,0.3186734541494174,1.0,1/6,0.08%,VCAM1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.8315113561375538,-1.5197916261815747,0.023809523809523808,0.31923030311857137,1.0,1/13,2.82%,OPTN
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.9500619855231086,1.519129542788546,0.0,1.0,1.0,2/7,2.02%,MMRN1;SLC26A3
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,-0.6363296595070609,-1.5188636838388478,0.0,0.3214535946711913,1.0,18/61,13.17%,RPS12;RPL31;ATP6V1E1;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Peripheral Blood,-0.7392702288435152,-1.518100822466064,0.04081632653061224,0.3228211232521719,1.0,9/28,10.07%,PARP14;DDX60;IFIH1;DDX60L;SP100;LGALS3;ERO1A;S100A6;PARP9
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.9608227440589907,-1.5179527877061265,0.0,0.3183244864626075,1.0,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.9608227440589907,-1.5179527877061265,0.0,0.3183244864626075,1.0,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.9608227440589907,-1.5179527877061265,0.0,0.3183244864626075,1.0,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.8738403950489623,-1.5174904402380622,0.0,0.31832275428241336,1.0,5/14,6.40%,CX3CL1;ULK4;CTNNA2;NTNG1;SRGAP2C
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Undefined,-0.8071622946306845,-1.5174726608753135,0.07692307692307693,0.31664737136513754,1.0,5/15,10.46%,XAF1;APOL3;GBP4;LCP2;ARHGAP15
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.7829805980562727,-1.5161568511653387,0.0,0.32025278391698003,1.0,8/22,13.49%,CYLD;IFIH1;ISG15;NLRC5;TRIM25;UBC;UBE2D2;TBK1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.9455915873942498,-1.5158199345735062,0.0,0.32018760865332935,1.0,2/11,0.27%,HES1;TBX3
prerank,KEGG_2021_Human__Prion disease,0.6377733656043749,1.5155956886099573,0.0,1.0,1.0,14/60,13.31%,CREB5;PSMD14;ITPR3;MAPK10;TUBB4B;NCAM2;NCAM1;PIK3CA;SEM1;CACNA1C;ITPR2;PPP3CA;HSPA8;PPP3CB
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.8418005150752377,-1.515275561327048,0.02040816326530612,0.320335709218522,1.0,2/13,2.44%,CYLD;ULK4
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.7049345135104967,-1.5133496053260909,0.0,0.32751480955939544,1.0,1/32,0.08%,VCAM1
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.8275369135143062,-1.5119328739880662,0.07547169811320754,0.33051708965795373,1.0,7/18,8.37%,HES1;KIAA1217;LGALS3;NR3C2;ARHGEF37;DSP;ACER2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.8370498377432164,-1.5119129448725417,0.0,0.32898778773791115,1.0,6/17,8.92%,HES1;PPARG;SP100;PRKN;NFKBIA;JUN
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Endometrium,-0.8885140681878628,-1.5111349640362917,0.0392156862745098,0.32851411519026935,1.0,7/12,10.07%,SAT1;HLA-F;IRF1;IL32;TNFSF10;GBP4;PARP9
prerank,CellMarker_Augmented_2021__Trophoblast cell:Endometrium,-0.8885140681878628,-1.5111349640362917,0.0392156862745098,0.32851411519026935,1.0,7/12,10.07%,SAT1;HLA-F;IRF1;IL32;TNFSF10;GBP4;PARP9
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6752462575135614,-1.510807076777381,0.017241379310344827,0.3276365043935746,1.0,27/49,22.68%,RPL31;RPL34;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37;RPL11;RPS27;RPL27A;RPLP1;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,CellMarker_Augmented_2021__Vascular Endothelial cell:Placenta,-0.7368724051564304,-1.5099071925696823,0.05172413793103448,0.3297937711822579,1.0,6/42,6.56%,VCAM1;CLEC1A;APOL3;TIE1;MMRN2;SLCO2B1
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,-0.6595253943192178,-1.508760773437915,0.0,0.3333585437296424,1.0,19/55,14.63%,RPS12;RPL31;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.7588467475123666,-1.5074028964443376,0.038461538461538464,0.33780209813288264,1.0,8/30,9.27%,CX3CL1;DDX60;OPTN;TNIP1;SERPINE1;NFKBIA;CD47;SCARF1
prerank,CellMarker_Augmented_2021__Lymphocyte:Undefined,-0.8174593776499338,-1.506911464114193,0.018518518518518517,0.3380077278517606,1.0,7/12,17.26%,APOL3;IRF1;LCP2;HLA-E;SRGN;IL18R1;GIMAP8
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex8:Brain,0.7820482592056615,1.5068954560498622,0.0,1.0,1.0,2/18,4.99%,CREB5;MGAT5
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.8842432418589662,-1.506456600066241,0.02040816326530612,0.3380102049045738,1.0,3/13,3.43%,CD74;SHLD1;VAV3
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.983603572645922,-1.5063466157930034,0.0,0.3369118023548371,1.0,1/5,0.08%,VCAM1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lymph Node,0.7784296970035455,1.505960136127671,0.047619047619047616,1.0,1.0,5/14,10.68%,BACH2;NCAM1;ZEB2;ELMO1;CELF2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.9390202508828793,1.5059586228714619,0.0,1.0,1.0,1/5,4.59%,NAA50
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.7730597653539706,-1.5058236208970652,0.05555555555555555,0.33846325064938426,1.0,1/20,0.32%,CX3CL1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Undefined,-0.860170047501443,-1.505679292384654,0.0392156862745098,0.3311234181483948,1.0,3/16,4.04%,VCAM1;CXCL12;LAMA4
prerank,CellMarker_Augmented_2021__Peritubular Myoid cell:Testis,-0.860170047501443,-1.505679292384654,0.0392156862745098,0.3311234181483948,1.0,3/16,4.04%,VCAM1;CXCL12;LAMA4
prerank,CellMarker_Augmented_2021__Fibroblast:Corneal Endothelium,-0.860170047501443,-1.505679292384654,0.0392156862745098,0.3311234181483948,1.0,3/16,4.04%,VCAM1;CXCL12;LAMA4
prerank,CellMarker_Augmented_2021__Myofibroblast:Undefined,-0.860170047501443,-1.505679292384654,0.0392156862745098,0.3311234181483948,1.0,3/16,4.04%,VCAM1;CXCL12;LAMA4
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Blood Vessel,-0.860170047501443,-1.505679292384654,0.0392156862745098,0.3311234181483948,1.0,3/16,4.04%,VCAM1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.6490690153825512,1.5055355929434333,0.04878048780487805,1.0,1.0,3/38,1.51%,PDK4;ABL2;INSIG1
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,0.9325309941426515,1.5050880445767454,0.0,1.0,1.0,3/6,3.03%,CALR;COL4A2;HSP90B1
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Dorsolateral Prefrontal Cortex,0.7230672636670324,1.5034389564048407,0.04878048780487805,1.0,1.0,13/26,15.88%,GRIK2;GRM5;GRIA2;TTLL7;SNAP25;NTM;NAV3;PEX5L;DGKI;RBFOX1;FGF14;ANK2;IL1RAPL1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.8266539214751476,-1.5029801959019002,0.0,0.33928723312450376,1.0,2/15,1.57%,MX1;RIMS1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.8924080286929665,-1.5026931551586542,0.04,0.3386575250919819,1.0,4/10,6.99%,EPSTI1;ITGB5;SP100;LCP2
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.8716021889988814,1.50240991818139,0.05357142857142857,1.0,1.0,1/9,0.08%,PDK4
prerank,CellMarker_Augmented_2021__Endothelial cell:Bone Marrow,-0.9494200235475652,-1.50116210474972,0.0,0.34297094995843885,1.0,1/7,0.08%,VCAM1
prerank,CellMarker_Augmented_2021__Induced Pluripotent Stem cell:Undefined,-0.8653607782191867,-1.5011048057290957,0.03508771929824561,0.3416142937053733,1.0,2/12,6.77%,TBX3;SMAD3
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Pluripotent Stem Cell,-0.9362459692357996,-1.501004592617949,0.041666666666666664,0.3388439489195124,1.0,1/6,0.13%,CD74
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Embryonic Stem Cell,-0.9362459692357996,-1.501004592617949,0.041666666666666664,0.3388439489195124,1.0,1/6,0.13%,CD74
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.7407127763817003,-1.500366434809402,0.0196078431372549,0.3380446461183458,1.0,13/37,6.91%,IFI44L;RSAD2;MX1;IFIH1;ISG15;STAT1;IRF2;IFI27;IRF1;EIF2AK2;NLRC5;OAS3;SAMHD1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.7407127763817003,-1.500366434809402,0.0196078431372549,0.3380446461183458,1.0,13/37,6.91%,IFI44L;RSAD2;MX1;IFIH1;ISG15;STAT1;IRF2;IFI27;IRF1;EIF2AK2;NLRC5;OAS3;SAMHD1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.8067938867135498,1.5003113872357632,0.0,1.0,1.0,2/13,2.12%,TEAD4;YWHAB
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.9460596706503005,-1.4996825345526743,0.0,0.3394455894538156,1.0,1/5,4.01%,PRKN
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.9705830043846827,-1.4993362943201956,0.0,0.339348537485273,1.0,1/7,0.24%,HES1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.9004935774031085,-1.4993212470960708,0.017543859649122806,0.3378199404695736,1.0,1/10,0.24%,HES1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.6641806468838364,-1.4989760906483856,0.0,0.33699505090086707,1.0,14/52,8.07%,CD74;MX1;CYLD;PPARG;IFIH1;ISG15;PLCG2;IFI27;SP100;NUB1;CALCOCO2;NLRC5;B2M;TRIM25
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Embryonic Stem Cell,-0.7129380757274266,-1.498284119853059,0.03571428571428571,0.3368261802653563,1.0,4/42,2.79%,VCAM1;FN1;CDK14;CXCL12
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Embryonic Stem Cell,-0.7129380757274266,-1.498284119853059,0.03571428571428571,0.3368261802653563,1.0,4/42,2.79%,VCAM1;FN1;CDK14;CXCL12
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.8758290097570353,-1.4979203855024754,0.041666666666666664,0.33687903352849863,1.0,5/10,8.71%,IFIH1;NFKBIA;NFKB1;TRIM25;TANK
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.9121284923184465,-1.4975524789071093,0.03571428571428571,0.3370217997242112,1.0,2/6,4.49%,SLC5A6;TAP1
prerank,CellMarker_Augmented_2021__Extravillous Trophoblast cell:Placenta,-0.8124782798200232,-1.497054524017443,0.10909090909090909,0.3370283402807964,1.0,5/17,3.90%,VCAM1;EPSTI1;GBP1;OPTN;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.8847975400046062,1.49610599960763,0.01694915254237288,1.0,1.0,3/9,9.83%,PDK4;PIK3CA;ITGA5
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.8447564536818462,-1.495980009069165,0.05660377358490566,0.3401256534376774,1.0,1/10,0.24%,HES1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.752757535638136,-1.495900637535163,0.0784313725490196,0.3389144454951623,1.0,5/23,3.61%,BTG2;PLK2;CNOT8;NDRG1;SP100
prerank,CellMarker_Augmented_2021__Neuronal Progenitor cell:Undefined,0.7088888353946866,1.495813562455607,0.047619047619047616,1.0,1.0,8/24,4.41%,ATRNL1;ERBB4;GRM5;CADM2;GRIA2;SNAP25;MAPK10;FGF12
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.763336187722397,-1.495612519259926,0.06,0.33851304662564574,1.0,3/15,12.32%,PSMB9;SERPINE1;VSIR
prerank,CellMarker_Augmented_2021__Activated B cell:Peripheral Blood,-0.9024686767943662,-1.49486081507926,0.0,0.33992793919252406,1.0,7/8,9.19%,PSMB9;IRF1;HLA-C;TAP1;NLRC5;B2M;HLA-E
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.7655769020898947,-1.4943604834251516,0.018867924528301886,0.3408464048609376,1.0,1/26,0.13%,CD74
prerank,CellMarker_Augmented_2021__Podocyte:Renal Glomerulus,0.8359197287840754,1.4930334119650213,0.08108108108108109,1.0,1.0,4/10,10.89%,ITPR3;CLIC1;TUBB4B;ANXA2
prerank,CellMarker_Augmented_2021__Glomerular Epithelial cell:Renal Glomerulus,0.8359197287840754,1.4930334119650213,0.08108108108108109,1.0,1.0,4/10,10.89%,ITPR3;CLIC1;TUBB4B;ANXA2
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.9441516086628806,-1.4921831619042025,0.021739130434782608,0.3478942680680037,1.0,2/6,3.53%,VCAM1;TNIP1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6454192686574373,-1.491748471858045,0.016129032258064516,0.34794164985854575,1.0,29/53,22.68%,RPL31;RPL34;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37;RPL11;DHX29;RPS27;RPL27A;RPLP1;CUL4A;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.686426400007833,1.4915436819258123,0.0,1.0,1.0,6/32,8.39%,CREB5;GRM5;GRIA2;ST18;PEX5L;NRXN1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6576297236578078,1.4912792626997788,0.022222222222222223,1.0,1.0,11/37,11.61%,ATRNL1;NOVA1;SOX5;CADM2;GRIA2;SNAP25;NOVA2;ROBO2;NRXN1;ADGRB3;RBFOX1
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,0.8214076111807636,1.4909927599630455,0.03773584905660377,1.0,1.0,2/13,1.25%,PDIA3;CALR
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.9024624974112331,-1.4907030768204745,0.08695652173913043,0.35033579298956147,1.0,2/6,6.27%,DOK5;ZDHHC17
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.8851626246714044,1.4906536114961324,0.017543859649122806,1.0,1.0,3/8,9.83%,PDK4;PIK3CA;ITGA5
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:White Adipose Tissue,-0.939634575309424,-1.4901969161296755,0.0,0.3503291905623292,1.0,3/8,5.02%,CLEC1A;ITIH5;CPM
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,-0.7538193732384865,-1.489425597978009,0.037037037037037035,0.3510553558398121,1.0,1/26,0.13%,CD74
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.6856368239645521,1.489411270319424,0.07142857142857142,1.0,1.0,13/27,12.06%,SMAD9;NOVA1;CADM2;GRIA2;SNAP25;MAPK10;FGF12;NOVA2;ROBO2;NRXN1;ADGRB3;RBFOX1;CNTN1
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.90951731505156,-1.4886282009584582,0.02040816326530612,0.3526338520446691,1.0,1/8,0.16%,DPH6
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.6417430077515192,-1.4883913940316182,0.0,0.3522330829850943,1.0,9/91,5.74%,CD74;HES1;CX3CL1;RIMS1;HGSNAT;FN1;CXCL12;SPG7;GEMIN5
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.6475941428732965,-1.4883119549347867,0.0,0.35098435590029864,1.0,18/54,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;RPL37
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.9344187177565042,-1.4880524538291993,0.0,0.35021222028813986,1.0,1/7,0.21%,RSAD2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.8873802062385018,-1.4878185193777622,0.021739130434782608,0.3497419368117564,1.0,1/11,0.24%,HES1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.781268908885403,1.487468922309859,0.05,1.0,1.0,6/15,13.31%,ITPR3;SNAP25;CHD7;CACNA1C;ITPR2;PPP3CB
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.829951248208982,-1.4874475691275248,0.07692307692307693,0.349569794174397,1.0,5/11,14.13%,PPARG;LCP2;NFKB1;RORA;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.8758381461791815,-1.4873284204859438,0.017857142857142856,0.3487710177355138,1.0,3/13,2.23%,CD74;IFIH1;PLCG2
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.9033459176697471,-1.4871808265768671,0.0425531914893617,0.3479787354140199,1.0,1/9,0.24%,HES1
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.8288007262418134,-1.4863457070137414,0.058823529411764705,0.35039069738444034,1.0,3/10,4.41%,CX3CL1;CXCL12;TNFSF10
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.8887685608017072,-1.485234979630693,0.017241379310344827,0.35208004067418097,1.0,2/10,1.30%,RSAD2;IFIH1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Oral Cavity,0.7544495160012048,1.484918007824701,0.043478260869565216,1.0,1.0,4/17,5.76%,PDK4;IL1R1;BACE2;IGFBP3
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,0.7819078406952809,1.4844039011729229,0.022727272727272728,1.0,1.0,6/13,17.66%,PIK3CA;PIGU;DOCK3;FRS2;GRB2;TIAM1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.6289865306144298,-1.4833952657724514,0.016666666666666666,0.35733992532929915,1.0,27/85,14.93%,RPS12;CNOT8;RPL31;RPS18;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;NBDY;RPS14;RPS15;UPF3A;RPL28;RPL10;ATM;RPL9;RPL24;RPL37;PARN
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.8315521187662593,-1.4832797829396096,0.09615384615384616,0.35664913954789246,1.0,1/12,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.8974539948753113,-1.483254930138737,0.037037037037037035,0.3552690950521234,1.0,1/8,0.53%,CEMIP
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.7022473119773311,-1.48317424987477,0.016666666666666666,0.35414424069782563,1.0,6/42,2.12%,CX3CL1;PSMA1;GBP1;PSMB9;TMSB4X;STAT1
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.7944083653848248,-1.4810685444278535,0.043478260869565216,0.3610968012034975,1.0,4/11,11.71%,VPS36;MVB12B;STAM2;UBC
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.9582017129685274,-1.4810593598060104,0.023255813953488372,0.35967516025387747,1.0,2/5,3.08%,IRF2;IRF1
prerank,KEGG_2021_Human__African trypanosomiasis,-0.9012501168020335,-1.4800452998747222,0.020833333333333332,0.36184490248338486,1.0,2/6,4.04%,VCAM1;LAMA4
prerank,CellMarker_Augmented_2021__Monocyte:Peripheral Blood,0.9335063051600403,1.4798324044978195,0.03636363636363636,1.0,1.0,4/5,6.75%,IL6R;ITGA2;ITGA1;NCAM1
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.8766016349731828,-1.4784831418574114,0.06382978723404255,0.3665221161795433,1.0,2/10,4.75%,SLC6A6;SLC38A3
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.8887157908962502,1.4783544861128257,0.020833333333333332,1.0,1.0,2/8,1.62%,ANO5;SLC12A6
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.7036537235562189,-1.4772523549271828,0.01818181818181818,0.36976593136894026,1.0,4/50,1.41%,HES1;TBX3;PPARG;ABCA5
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.6917859703319382,-1.4771864271286632,0.05172413793103448,0.36849176839634545,1.0,7/49,4.99%,VCAM1;NR4A1;FN1;ITIH5;CXCL12;LAMA4;COL8A1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.8903409093804955,1.4771735327511286,0.02040816326530612,1.0,1.0,1/7,0.48%,GRIK2
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,0.8447955313726905,1.4771039193084352,0.07017543859649122,0.9875506054902519,1.0,4/6,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,Reactome_2022__PI-3K cascade:FGFR3 R-HSA-5654710,0.8447955313726905,1.4771039193084352,0.07017543859649122,0.9875506054902519,1.0,4/6,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,0.8447955313726905,1.4771039193084352,0.07017543859649122,0.9875506054902519,1.0,4/6,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.7919237400620969,-1.4768608000706105,0.08333333333333333,0.3683364143697795,1.0,2/17,2.39%,CD74;FN1
prerank,KEGG_2021_Human__Ferroptosis,-0.7998621099385103,-1.4766835214762328,0.034482758620689655,0.3678666254938836,1.0,3/16,8.31%,SAT1;ACSL4;TFRC
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.6255284348605098,-1.476600601128735,0.029411764705882353,0.36692880567711933,1.0,21/67,11.98%,PSMA1;PSMB9;RPS12;RPL31;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;UBC;UPF3A;RPL28
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.7052152135281522,-1.4764222423378939,0.04838709677419355,0.36619390759769427,1.0,7/34,8.42%,KIAA1217;TMEM117;ARHGEF37;SUN1;DSP;TMEM50B;COL18A1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.9411323715214402,-1.4753313596843034,0.020833333333333332,0.36885791933848733,1.0,1/6,0.24%,HES1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.7925643820176193,-1.474426928813634,0.09615384615384616,0.3705303503928097,1.0,4/26,4.97%,VCAM1;CXCL12;LAMA4;MMRN2
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.7122548264993611,-1.4742184652997752,0.08771929824561403,0.36979018117950757,1.0,5/19,8.74%,CX3CL1;GBP1;NFKB1;TANK;CD47
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7306052747469973,1.4739020766955144,0.023809523809523808,1.0,1.0,15/34,12.03%,ZNF385D;NOVA1;NREP;PRKG1;CADM2;GRIA2;MAPK10;NTM;SGIP1;ROBO2;NRXN1;ADGRB3;CACNA1C;RBFOX1;FGF14
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.9412237374544292,-1.4736931230442833,0.02040816326530612,0.37032818258670264,1.0,2/7,0.53%,CX3CL1;CEMIP
prerank,CellMarker_Augmented_2021__Central Nervous System Stem cell:Fetal Brain,-0.7365965866209164,-1.4733159535113693,0.05454545454545454,0.3702858635090198,1.0,5/23,6.35%,CD74;CLIC5;VAV3;TNFSF10;MYO15B
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.9553031289915503,-1.4727425257763425,0.02127659574468085,0.3712773125586572,1.0,2/6,1.59%,SLC6A6;SLC16A2
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.7818512122711381,-1.4724341946817534,0.07017543859649122,0.3713080471999451,1.0,4/23,7.22%,HES1;STAT1;PLXND1;MAML3
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Embryonic Stem Cell,-0.7773982241179693,-1.4721746116298629,0.07547169811320754,0.3697790397501882,1.0,7/19,6.56%,XAF1;SOD2;DDX60L;SP100;CPM;CPQ;SLCO2B1
prerank,CellMarker_Augmented_2021__Anterior Foregut Endoderm cell:Lung,-0.7773982241179693,-1.4721746116298629,0.07547169811320754,0.3697790397501882,1.0,7/19,6.56%,XAF1;SOD2;DDX60L;SP100;CPM;CPQ;SLCO2B1
prerank,CellMarker_Augmented_2021__T cell:Skin,-0.8935732340826088,-1.4721404992987626,0.017241379310344827,0.36868354988996355,1.0,6/7,9.19%,PSMB9;IRF1;TAP1;NLRC5;B2M;HLA-E
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.7045155272331429,1.4716678872066482,0.021739130434782608,1.0,1.0,8/28,14.48%,PDK4;GRM5;GRIA2;NRXN1;RTN1;LRRK2;BAALC;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.8480344254199399,-1.4716503060975694,0.11363636363636363,0.36928695995524985,1.0,2/6,8.31%,SHLD1;TFRC
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.9022635094850535,-1.4708573675119652,0.04081632653061224,0.3707844739858876,1.0,1/9,0.13%,CD74
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.8479844045026109,1.4703663396098714,0.02,1.0,1.0,2/8,4.67%,CRY1;HECTD4
prerank,KEGG_2021_Human__Amphetamine addiction,0.711073862215595,1.4695167931396094,0.058823529411764705,1.0,1.0,6/21,13.31%,CREB5;GRIA2;PPP1CB;CACNA1C;PPP3CA;PPP3CB
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,-0.6186922218934806,-1.4691476294567096,0.058823529411764705,0.3762623803099602,1.0,20/74,8.07%,VCAM1;RSAD2;MX1;GBP1;XAF1;ISG15;STAT1;IRF2;IFI27;HLA-F;HLA-B;IRF1;HLA-C;SP100;EIF2AK2;OAS3;GBP4;SAMHD1;B2M;TRIM25
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.7704969987145829,-1.4687015689799885,0.06521739130434782,0.3767946054776896,1.0,5/13,13.09%,FOS;JUN;POLR2A;MSH2;ATM
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.8877782529417599,-1.4684719939799113,0.0392156862745098,0.3765082753575036,1.0,1/8,0.24%,HES1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.8714033471830881,-1.4681750002293859,0.08,0.37615020681293143,1.0,2/5,9.46%,PPARG;PMAIP1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.8910468831879386,-1.4676134763087962,0.07407407407407407,0.37682417887110276,1.0,2/9,4.38%,CX3CL1;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.8021802901370237,-1.467585440854985,0.03389830508474576,0.3755516494544907,1.0,1/12,0.32%,CX3CL1
prerank,KEGG_2021_Human__Relaxin signaling pathway,0.6639978122094471,1.4674817814102379,0.02127659574468085,1.0,1.0,6/46,7.01%,CREB5;COL4A2;MAPK10;KRAS;PLCB1;PIK3CA
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.8703469231762759,1.4658114308461743,0.0392156862745098,1.0,1.0,2/9,4.57%,DTWD1;TRMT9B
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.9628917128184479,-1.4653408508525858,0.03773584905660377,0.38250185512169915,1.0,3/5,3.61%,MX1;ISG15;SP100
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.924930761942867,-1.4649199254544598,0.04081632653061224,0.3828915032002522,1.0,2/7,1.59%,SLC6A6;SLC16A2
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.7092896119712162,-1.4643956508133285,0.08196721311475409,0.38356837556404144,1.0,8/34,12.24%,KIAA1217;SLC16A2;ITGB5;CHKA;SMARCA1;KCTD3;ADAMTS1;RORA
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.5631789620376437,1.463635197388184,0.0851063829787234,1.0,1.0,8/73,3.16%,PDK4;ABL2;INSIG1;SLC26A3;PRKD1;TAF1;HSP90B1;SLC38A9
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.6407411481657208,1.4636299446816563,0.024390243902439025,1.0,1.0,15/48,12.19%,ATRNL1;NOVA1;TAFA1;CADM2;GRIA2;SNAP25;MAPK10;FBXO7;PIK3CA;NRXN1;PARVA;ADGRB3;RBFOX1;CNTN1;GCNT2
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.8278119405621294,-1.4630240852229146,0.07692307692307693,0.38759960556335943,1.0,3/7,14.50%,TNIP1;ALG11;GCNT1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.8153152071357435,1.462266831478062,0.018518518518518517,1.0,1.0,4/12,8.61%,CRY1;MAPK10;UBE2B;ERCC6
prerank,CellMarker_Augmented_2021__Stromal cell:Embryoid Body,-0.7864578442244082,-1.461312084185968,0.0625,0.39246637537544293,1.0,4/19,4.04%,VCAM1;FN1;CXCL12;LAMA4
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.7016920441008412,-1.4608594746875851,0.04838709677419355,0.39310266910543307,1.0,3/41,2.15%,VCAM1;KIAA1217;IRF2
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.5997036379961975,-1.4605198695825974,0.016129032258064516,0.39301968754044986,1.0,10/135,3.24%,HES1;TBX3;CX3CL1;SLC6A6;TPM1;FN1;CNOT8;CXCL12;GRK5;UFL1
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.9162444718071501,-1.4604694063932309,0.0,0.3917975076685715,1.0,2/5,7.68%,NFKBIA;NFKB1
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone Marrow,-0.92767746015604,-1.4601845730245175,0.043478260869565216,0.39161313237084505,1.0,3/5,6.99%,CD74;TNFSF10;LCP2
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.7062728208801674,-1.460143943070051,0.0,0.39047497614425325,1.0,6/48,4.94%,HES1;CX3CL1;EML1;SMARCA1;GPM6A;ACSL4
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.7601905747635014,-1.4600128137650175,0.0625,0.3895208960963642,1.0,4/22,8.37%,CX3CL1;PLXND1;SERPINE1;ACER2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7923007792864909,-1.4594605379408279,0.075,0.3896975120608436,1.0,7/14,10.89%,PARP14;PPARG;STAT1;CDC37;NLRC5;PARP9;IFNGR2
prerank,Reactome_2022__Translation R-HSA-72766,-0.6401907135595762,-1.45920739681946,0.0,0.38934777035099866,1.0,36/73,22.68%,RPS12;RPL31;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;WARS1;RPL23;RPL30;LARS1;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL9;EEF1A1;RPL37;PPA2;SRP14;RPL11;GSPT1;MRPL33;RPS27;RPL27A;RPLP1;TRAM1;RPL37A;RPL36;RPL19;RPL27;RPL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.8737300593810133,-1.458848754300147,0.03389830508474576,0.38980290217498603,1.0,1/8,0.24%,HES1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.6859118542327991,-1.4585087315113896,0.06779661016949153,0.3896638110412929,1.0,8/39,8.63%,HES1;CYLD;TMSB4X;UFL1;SP100;NLRC5;NFKBIA;BHLHE40
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.6088701304750298,1.4581439450893992,0.05405405405405406,1.0,1.0,10/54,8.90%,GRIK2;NOVA1;SLC12A6;GRM5;GRIA2;SNAP25;DNAJC5;DLGAP2;NRXN1;HOMER1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.9432541601931127,1.458071470634861,0.037037037037037035,1.0,1.0,1/5,0.08%,PDK4
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.8596372503576117,-1.4574225209521128,0.06666666666666667,0.3925753267992747,1.0,3/6,13.49%,NFKBIA;NFKB1;TBK1
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.8395578526204857,1.4568796960884658,0.03636363636363636,1.0,1.0,4/8,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,0.8395578526204857,1.4568796960884658,0.03636363636363636,1.0,1.0,4/8,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.8395578526204857,1.4568796960884658,0.03636363636363636,1.0,1.0,4/8,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,-0.7712333758986274,-1.4559198381494953,0.07407407407407407,0.39802309451218665,1.0,7/20,8.71%,CYLD;IFIH1;ISG15;NFKBIA;NFKB1;TRIM25;TANK
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.8302495087624795,-1.454751346602316,0.057692307692307696,0.4007149049999128,1.0,1/13,0.53%,CEMIP
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.7910809147094902,-1.454300183566141,0.05555555555555555,0.40095287077266867,1.0,7/16,9.19%,SAMD9L;IFIH1;DDX60L;IRF1;SP100;NFKB1;HLA-E
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.6986481905926434,-1.4538203565364103,0.02,0.4015995689513343,1.0,5/40,5.74%,CD74;HES1;RIMS1;SPG7;GEMIN5
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.8480670327394964,-1.4538184437028066,0.11627906976744186,0.3989399691569546,1.0,2/5,8.31%,SHLD1;TFRC
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.8480670327394964,-1.4538184437028066,0.11627906976744186,0.3989399691569546,1.0,2/5,8.31%,SHLD1;TFRC
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.9696680470730493,-1.4534391212859556,0.0,0.3976988404635029,1.0,1/5,0.50%,DDX60
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.9696680470730493,-1.4534391212859556,0.0,0.3976988404635029,1.0,1/5,0.50%,DDX60
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.9631813493074233,-1.4525666442544511,0.0,0.399791811747546,1.0,1/7,0.27%,TBX3
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.8306704916238479,-1.452470670223405,0.023809523809523808,0.39871996202866217,1.0,2/10,9.88%,SERPINE1;CST3
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.7429513687529035,-1.4523981575289524,0.03508771929824561,0.3976216814574261,1.0,2/18,4.01%,CYLD;PRKN
prerank,CellMarker_Augmented_2021__Specialist Antigen Presenting cell:Undefined,-0.9226839283715956,-1.4509369288982097,0.020833333333333332,0.4016595181331452,1.0,1/5,0.08%,VCAM1
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.8740605383613181,-1.449935086960718,0.018518518518518517,0.40447611651337334,1.0,4/8,7.68%,PPARG;ABCA5;NFKBIA;NFKB1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.8944450790884565,-1.4499313295572824,0.04,0.4032044450765878,1.0,1/6,2.66%,CDK14
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.878353258336911,-1.4498211215109207,0.13953488372093023,0.402402725210258,1.0,2/8,2.23%,CX3CL1;PLCG2
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7910182754597985,-1.4498065020976652,0.03571428571428571,0.40124448533599266,1.0,7/12,14.26%,RPS6;RPS28;RPS19;RPS7;RPS14;RPS15;RIOK3
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.7489925342136989,-1.4497229567412682,0.06896551724137931,0.40022473863804686,1.0,8/22,11.58%,RPS12;RPS8;RPS6;RPS28;RPS19;RPS7;RPS14;RPS15
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.9133235041542038,1.448572128512494,0.0,1.0,1.0,2/6,4.62%,PRKD1;PHACTR4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.7262366274162813,-1.4484646928283766,0.05172413793103448,0.4034257491584732,1.0,3/25,4.38%,CX3CL1;PRKN;LGALS3
prerank,CellMarker_Augmented_2021__HES1High Progenitor cell:Stomach,-0.720029463407635,-1.4481559657745373,0.05357142857142857,0.40331737204989154,1.0,6/32,5.10%,OMD;KIAA1217;ITIH5;LAMA4;MMRN2;ARHGEF37
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.7887798607563645,-1.447779784091832,0.07692307692307693,0.4034044524757288,1.0,5/14,9.46%,SP100;LGALS3;TNFSF10;SERPINE1;PMAIP1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.9098032017870226,1.44776246997507,0.05660377358490566,1.0,1.0,4/8,4.94%,ERBB4;CDH2;PHACTR4;SEMA3F
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.8486309296117546,-1.4474916316183202,0.058823529411764705,0.40284379289194766,1.0,3/11,4.30%,PARP14;PARP12;ZC3HAV1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.735702681717193,-1.4474431711007358,0.037037037037037035,0.4017705351364987,1.0,1/28,0.13%,CD74
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,0.8245483690344638,1.4474121894496979,0.05555555555555555,1.0,1.0,5/12,7.54%,CALR;COL4A2;HSP90B1;HSPH1;HSP90AA1
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,-0.8871653786536008,-1.447175537693445,0.09090909090909091,0.40141145255323796,1.0,2/8,6.99%,PLCG2;LCP2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.7823902982576003,-1.4468842020416832,0.075,0.40137517583330595,1.0,1/10,0.08%,VCAM1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.8112538348289283,-1.4466206357915463,0.1346153846153846,0.40133912513655107,1.0,1/9,0.27%,TBX3
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.8067706440186868,-1.445529071938786,0.10204081632653061,0.40474386009588076,1.0,3/9,1.81%,CEMIP;OMD;HGSNAT
prerank,KEGG_2021_Human__Glutamatergic synapse,0.6286163733185252,1.445505784483699,0.05,1.0,1.0,11/41,13.31%,GRIK2;ITPR3;GRM5;GRIA2;PLCB1;HOMER1;CACNA1C;GNB4;ITPR2;PPP3CA;PPP3CB
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.8996794273474729,-1.4452791195950239,0.04,0.4049516706561224,1.0,2/6,4.30%,CNOT8;ZC3HAV1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.6983551196807305,-1.4450608290245408,0.06382978723404255,0.40509487762580787,1.0,9/21,15.46%,IRF1;CDC37;SAMHD1;ERAP1;HLA-E;PARP9;APPL2;RIOK3;N4BP1
prerank,Reactome_2022__Rap1 Signaling R-HSA-392517,0.8373474626534128,1.4441829141274576,0.06382978723404255,1.0,1.0,3/9,8.63%,YWHAB;PRKG1;YWHAZ
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.8773560393898432,-1.4437097263728433,0.02127659574468085,0.40886694694532544,1.0,1/6,0.24%,HES1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Undefined,-0.7274390640328495,-1.4433719220428363,0.08064516129032258,0.40906019763277507,1.0,7/35,5.21%,PARP14;SAMD9L;XAF1;SOD2;DDX60L;SP100;CPQ
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.9485178600758535,1.4433279485282895,0.0,1.0,1.0,2/5,4.57%,DTWD1;TRMT9B
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.8100621908997572,1.4425210317584705,0.018518518518518517,1.0,1.0,2/10,1.51%,HSD17B4;INSIG1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Endometrium,-0.764645432702203,-1.4420073292892457,0.02,0.41376953804024347,1.0,7/22,10.12%,CD74;BTG2;VAV3;LCP2;CCDC88C;ITM2A;INPP5D
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.8211006335749996,-1.441526313475189,0.14516129032258066,0.4141343092587584,1.0,2/9,4.91%,BTG2;PABPC1
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.6963479715260763,1.4410203765224927,0.10638297872340426,1.0,1.0,3/18,3.37%,VAPB;PRKD1;KDSR
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.822660607094223,-1.440883106103877,0.10416666666666667,0.41540106108441366,1.0,1/10,0.48%,NR4A1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.7735605519240106,-1.4395998712781968,0.06382978723404255,0.41861847556543347,1.0,10/17,19.07%,PPARG;STAT1;LGALS3;AHI1;JAK2;PGK1;PPP2R3A;MFSD2A;CD34;PKD2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.892584875707231,-1.4390629457733866,0.08771929824561403,0.4195541174785308,1.0,2/8,4.38%,CX3CL1;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.7801218932361512,-1.4387262012462678,0.07692307692307693,0.41961899290095794,1.0,5/15,8.07%,CYLD;IFIH1;ISG15;NLRC5;TRIM25
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,0.8844592860616318,1.438241788204912,0.07407407407407407,1.0,1.0,3/6,7.76%,CALR;HSP90B1;NFYC
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.8642449246010809,-1.4380187430481455,0.08333333333333333,0.421038886275305,1.0,2/6,2.23%,GBP1;PLCG2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.9007163897251341,1.4380141767984997,0.038461538461538464,1.0,1.0,1/6,0.27%,HDAC9
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,0.7328725391058992,1.4378137163927083,0.10869565217391304,1.0,1.0,3/12,12.46%,KDM4C;UTY;KDM5A
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.923866208415537,-1.4372554765563832,0.0,0.4229416771077633,1.0,1/5,2.28%,SHLD1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.7203097346504456,-1.4367755708513226,0.08695652173913043,0.42327144672151074,1.0,3/27,5.82%,CD74;TIE1;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.7216514192371221,-1.4366319480002652,0.08163265306122448,0.422439125735846,1.0,2/25,3.45%,CX3CL1;CARMIL1
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.7379123357734321,-1.4363423588348168,0.04838709677419355,0.42103205090887424,1.0,9/24,11.58%,RPS12;PABPC1;RPS8;RPS6;RPS28;RPS19;RPS7;RPS14;RPS15
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,-0.7379123357734321,-1.4363423588348168,0.04838709677419355,0.42103205090887424,1.0,9/24,11.58%,RPS12;PABPC1;RPS8;RPS6;RPS28;RPS19;RPS7;RPS14;RPS15
prerank,CellMarker_Augmented_2021__Paneth cell:Large Intestine,-0.7128072780971806,-1.4355153310648296,0.05357142857142857,0.42317913265930596,1.0,8/43,7.89%,CD74;RSAD2;SOD2;PLCG2;SLCO2B1;LCP2;LMO2;LPAR6
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,0.7333322034499142,1.4348333681500738,0.09302325581395349,1.0,1.0,7/15,14.98%,DSE;FUT8;CHSY1;CHST15;GLCE;EXT1;HS6ST3
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.670765881140879,-1.4347311647021654,0.07142857142857142,0.4248610269681233,1.0,5/46,6.40%,CD74;CX3CL1;TPM1;SERPINE1;SRGAP2C
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.7873799844736329,-1.4343711951316962,0.06896551724137931,0.4245777250577059,1.0,5/23,7.01%,CYLD;TMSB4X;NR3C2;EIF2AK2;NFKBIA
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.6936082105862453,-1.4333764820761423,0.07142857142857142,0.42714551630301445,1.0,10/42,8.74%,CX3CL1;CYLD;PPARG;TMSB4X;UFL1;TNIP1;SNX6;SERPINE1;NFKBIA;CD47
prerank,CellMarker_Augmented_2021__Circulating Precursor cell:Peripheral Blood,-0.7012059209341286,-1.4330124557523962,0.05454545454545454,0.42751515164887405,1.0,6/26,10.04%,CD74;TIE1;GBP4;LCP2;LPAR6;ITM2A
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Fetal Liver,-0.7726572658189919,-1.4325703742541152,0.1111111111111111,0.4281510151031555,1.0,4/20,4.04%,VCAM1;FN1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.6075607147082717,-1.4325500913681428,0.014705882352941176,0.42699919741685544,1.0,6/105,3.00%,CD74;TBX3;CX3CL1;KLHL20;PLK2;GRK5
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.8609406637257018,1.4322917663713848,0.06666666666666667,1.0,1.0,3/7,4.33%,AGTPBP1;TTLL7;TUBB4B
prerank,KEGG_2021_Human__Pyruvate metabolism,0.7951087048396708,1.4321591505636626,0.0847457627118644,1.0,1.0,3/9,7.89%,GLO1;PKM;ACAT1
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.8362929500318377,-1.4309737547979506,0.06,0.4316945587595049,1.0,3/9,2.42%,BTG2;PLK2;CNOT8
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8362174783767045,-1.4307873828619833,0.08928571428571429,0.43127821476041794,1.0,3/10,3.08%,XAF1;STAT1;IRF1
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,-0.8394293578097389,-1.4300753708322111,0.04878048780487805,0.43248549460914965,1.0,1/5,6.83%,TAF1D
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.782892653114035,-1.4298744065132403,0.0784313725490196,0.43227501751527064,1.0,2/19,3.93%,VCAM1;SNX6
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,0.6634277317184394,1.4293075067994891,0.08695652173913043,1.0,1.0,3/27,7.46%,HSD17B4;NUP58;RANBP2
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.7531143481303029,1.4291352849474162,0.0851063829787234,1.0,1.0,2/13,1.62%,ANO5;SLC12A6
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.8345555961572522,-1.4287528289920117,0.08163265306122448,0.43605169763604823,1.0,3/10,7.68%,MAP3K2;IRF1;NFKB1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.8784105731446236,-1.4282973046361827,0.09615384615384616,0.4363583095197718,1.0,1/6,0.27%,TBX3
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.8756206792757242,-1.4270952079487662,0.046511627906976744,0.43972308544545186,1.0,1/9,0.08%,VCAM1
prerank,CellMarker_Augmented_2021__FGFR1HighNME5- Epithelial cell:Esophagus,-0.7785953303843005,-1.4270411142328974,0.06896551724137931,0.4386517674318931,1.0,3/26,3.00%,VCAM1;SLC16A2;GRK5
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.6907521665965148,-1.42692896842068,0.07142857142857142,0.4379052525771921,1.0,2/30,2.26%,CYLD;PLK2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.7152335112939571,-1.4268224241176262,0.03773584905660377,0.43716294343998247,1.0,1/18,0.27%,TBX3
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.8897974528413937,1.4267542984427488,0.041666666666666664,1.0,1.0,1/6,0.05%,TRIM5
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.8714712821638557,-1.4267065449726597,0.10909090909090909,0.4361942883741084,1.0,2/9,4.38%,CX3CL1;LGALS3
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.6093168224679995,-1.4264939342301373,0.08064516129032258,0.43600687288834133,1.0,20/62,14.63%,RPS12;RPL31;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;POLR2A;RPS7;RPS14;RPS15;RPL28;RPL9;NUP54;RPL37
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.9604733786870674,-1.426351844554437,0.0,0.4351328192023918,1.0,2/6,0.53%,CX3CL1;CEMIP
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.7366355270193589,1.426199137763891,0.0625,1.0,1.0,7/19,15.43%,IL1R1;ITGA2;ITGA1;PGR;ITGA5;ITPR2;RAI14
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.7670945944834665,-1.4260442121447645,0.08888888888888889,0.43523514190949913,1.0,3/18,2.42%,BTG2;PLK2;CNOT8
prerank,CellMarker_Augmented_2021__Endoderm Progenitor cell:Adipose Tissue,-0.6959511272874773,-1.426000648320966,0.05263157894736842,0.43425411031774763,1.0,6/41,6.99%,CD74;CLEC1A;TIE1;GBP4;SLCO2B1;LCP2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.7272722389193265,-1.4256995362468483,0.03508771929824561,0.4343014693718098,1.0,2/29,2.63%,CD74;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.7014623631618991,-1.4241679913257295,0.10638297872340426,0.4390241613402921,1.0,7/27,7.81%,IFIH1;ISG15;STAT1;IRF1;OAS3;NFKB1;LRRFIP1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.7490671384735682,-1.4238690893693988,0.08620689655172414,0.43877553009069215,1.0,3/18,5.60%,CD74;TMSB4X;SERPINE1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.7087437405496783,-1.423569406086112,0.0392156862745098,0.437776482132643,1.0,2/17,9.85%,MLLT1;POLR2A
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.7087437405496783,-1.423569406086112,0.0392156862745098,0.437776482132643,1.0,2/17,9.85%,MLLT1;POLR2A
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.8586777637077224,-1.4234452097388024,0.0625,0.437056834664706,1.0,2/12,0.53%,CX3CL1;CEMIP
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.618457057531289,-1.4232604876351673,0.04838709677419355,0.4363690598562944,1.0,19/63,14.63%,RPL31;RPL34;RPL15;RPS6;RPL7A;RPL38;SMAD3;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;RPL10;RPL9;RPL24;RPL37
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.7864412593074479,-1.4232014965152855,0.061224489795918366,0.43540627373950813,1.0,4/12,6.19%,IFIH1;ISG15;IRF1;OAS3
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.7868439398653648,1.423116282950173,0.03571428571428571,1.0,1.0,4/9,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.8124873236565563,-1.4213329936758847,0.041666666666666664,0.44164874531835707,1.0,7/11,14.13%,STAT1;SMAD3;NFKB1;JUN;IFNGR2;RORA;IL18R1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.9173459221110045,-1.4206096411379225,0.020833333333333332,0.4422816869904296,1.0,1/8,0.27%,TBX3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.9173459221110045,-1.4206096411379225,0.020833333333333332,0.4422816869904296,1.0,1/8,0.27%,TBX3
prerank,CellMarker_Augmented_2021__Morula Cell (Blastomere):Embryo,-0.69352443850619,-1.420542674935409,0.020833333333333332,0.44145123520934854,1.0,6/29,7.54%,PSMA1;KLF3;LYPLA1;RPL34;DSP;RPL23
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.9210084301147244,-1.4196115647460503,0.022222222222222223,0.4442004004466188,1.0,1/6,1.41%,ABCA5
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.8518357290681418,1.4190811639232614,0.06779661016949153,1.0,1.0,3/7,11.85%,PEX14;PCM1;CLASP1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.9363180514005938,1.4190056870390564,0.017543859649122806,1.0,1.0,2/5,4.25%,MCPH1;TENT4A
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.850576352991308,1.4189815804537902,0.018867924528301886,1.0,1.0,1/11,0.03%,CREB5
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.6711807246028081,1.4188758758106093,0.06666666666666667,1.0,1.0,6/22,15.56%,ERBB4;NRG2;PIK3CA;PIGU;FRS2;GRB2
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.7765475575696191,1.4187088106344898,0.06976744186046512,1.0,1.0,4/9,18.27%,INPP5A;PPP3CA;PPP3CB;EDN1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.6345643130678962,-1.4186810201291102,0.06557377049180328,0.446386309660702,1.0,15/56,12.70%,VCAM1;TLL1;FN1;ITGB5;LAMA4;COL8A1;SERPINE1;COL18A1;CD47;ITGA10;RECK;NID1;ADAMTS1;LAMA2;ITGAV
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.860868851146305,-1.4186177511910143,0.058823529411764705,0.44541478288528397,1.0,3/6,7.73%,CX3CL1;CXCL12;STK39
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,0.7080396949063414,1.4180875902313277,0.05128205128205128,1.0,1.0,8/19,18.67%,ITPR3;STIM1;ATP2A2;ITPR2;SLC8A1;CALM1;ATP2B4;PRKCA
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.7144457120337008,-1.4177962798255106,0.1206896551724138,0.44755855334411015,1.0,2/24,2.23%,VCAM1;PLCG2
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,-0.9100974928483323,-1.4173134041557938,0.058823529411764705,0.44814001108627805,1.0,2/7,2.79%,CX3CL1;CXCL12
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,-0.8906204317399697,-1.4172597720207438,0.13636363636363635,0.4459104855806759,1.0,1/5,0.40%,PARP14
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,-0.8906204317399697,-1.4172597720207438,0.13636363636363635,0.4459104855806759,1.0,1/5,0.40%,PARP14
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Undefined,-0.7256853033253895,-1.4168399222215253,0.03333333333333333,0.4459517966711059,1.0,3/34,4.86%,VCAM1;CXCL12;TIE1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.6730506482495956,-1.416802835331325,0.1,0.4449697861753001,1.0,5/27,7.09%,HES1;PSMA1;PSMB9;EIF2AK2;LMO2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.8860775300739031,1.4162885048958143,0.0851063829787234,1.0,1.0,1/5,4.04%,ZEB1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.9377736483860178,-1.416205761647888,0.02,0.4457652367115436,1.0,1/7,0.13%,CD74
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.897467329286819,1.416197841882791,0.02040816326530612,1.0,1.0,2/8,4.99%,FUT8;MGAT5
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.8830245928143075,-1.4160662910145883,0.07272727272727272,0.44519058952539625,1.0,2/6,3.08%,STAT1;IRF1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.8706811857738329,1.4157108979869288,0.03773584905660377,1.0,1.0,1/6,0.74%,ABL2
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.6746173862823887,1.415037176441813,0.10638297872340426,1.0,1.0,10/24,16.33%,GRM5;CADM2;GRIA2;SNAP25;NRXN1;ADGRB3;RBFOX1;NEGR1;PLPPR4;MRTFB
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.576048337185485,-1.41500157441337,0.047619047619047616,0.4478779781980411,1.0,15/140,6.40%,CD74;CX3CL1;CEMIP;SOD2;TMSB4X;TPM1;ULK4;CXCL12;CARMIL1;CASS4;CTNNA2;NTNG1;PLXND1;SERPINE1;SRGAP2C
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,-0.7981267131390221,-1.413991325563743,0.09433962264150944,0.4507379149756828,1.0,3/12,11.71%,PARP14;PARP9;UBC
prerank,KEGG_2021_Human__Gastric acid secretion,0.7055065553004657,1.4138428465784167,0.046511627906976744,1.0,1.0,8/20,18.67%,ITPR3;ACTG1;PLCB1;ACTB;ITPR2;CALM1;ATP1A1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.6813799870656743,-1.4138295915619588,0.06,0.45036745181070953,1.0,3/29,6.99%,CD74;TIE1;LCP2
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.7930769941356253,-1.4132160485456866,0.06382978723404255,0.45174832461364656,1.0,2/11,1.65%,PPARG;RREB1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.848410350543034,-1.4126420660492063,0.13953488372093023,0.4533864602142455,1.0,1/9,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.8512154072032284,-1.4119018433107087,0.1320754716981132,0.4539283728566739,1.0,1/6,1.57%,RIMS1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.8512154072032284,-1.4119018433107087,0.1320754716981132,0.4539283728566739,1.0,1/6,1.57%,RIMS1
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.8012167511182597,1.4110966137187417,0.06,1.0,1.0,3/9,9.16%,YES1;CBFB;ABL1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.778257574149094,1.4109583523682858,0.07547169811320754,1.0,1.0,4/11,17.42%,NAA50;MORF4L1;CREBBP;EP300
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood Vessel,-0.7307864719175078,-1.4107937286161227,0.08333333333333333,0.4568076546420014,1.0,1/27,0.08%,VCAM1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.7619466840944136,1.4107134423762908,0.08333333333333333,1.0,1.0,1/14,0.08%,PDK4
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.8155060883852127,1.410520203561611,0.10638297872340426,1.0,1.0,6/11,17.18%,SLC12A6;SLC8A1;SLC24A2;ATP2B4;SLC39A10;ATP1A1
prerank,Reactome_2022__Protein Localization R-HSA-9609507,0.642293236639326,1.4100143038574804,0.06666666666666667,1.0,1.0,7/29,15.30%,HSD17B4;PEX14;CCNI;IDE;ACOX1;HSPD1;HSPA9
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5598933894541389,-1.409471160170492,0.012987012987012988,0.4608236511346337,1.0,22/165,3.61%,VCAM1;RSAD2;CX3CL1;MX1;PSMA1;GBP1;XAF1;PSMB9;SOD2;ISG15;TMSB4X;STAT1;IRF2;FN1;IFI27;HLA-F;CXCL12;HLA-B;IRF1;HLA-C;IL32;SP100
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.9350781857472537,-1.4087483539210381,0.08333333333333333,0.46257446312743417,1.0,1/6,1.41%,ABCA5
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.6179056387171398,1.408090574756669,0.11363636363636363,1.0,1.0,15/36,16.15%,NOVA1;GRM5;CADM2;GRIA2;SNAP25;MAPK10;PRKX;NRXN1;NKAIN2;ADGRB3;RBFOX1;GCNT2;CREBRF;ANK2;PLPPR4
prerank,KEGG_2021_Human__GnRH secretion,0.7383954280246092,1.408085115183296,0.07692307692307693,1.0,1.0,6/19,12.11%,ITPR3;KRAS;PLCB1;PIK3CA;CACNA1C;ITPR2
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.6774899617856702,1.4080076961044345,0.1568627450980392,1.0,1.0,3/16,10.60%,RBM20;HNRNPLL;SETX
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7745349604197522,1.4079564540882281,0.044444444444444446,1.0,1.0,3/10,8.42%,GRIK2;BCR;PXK
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.9244988886398888,1.4075658089831573,0.07407407407407407,1.0,1.0,2/5,3.03%,CALR;HSP90B1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.9161589020929648,-1.4072482307278917,0.04,0.4674406429100787,1.0,1/6,0.82%,SLC6A6
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.8276753061217429,-1.407032313380412,0.08333333333333333,0.464631829968885,1.0,1/8,1.12%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.8276753061217429,-1.407032313380412,0.08333333333333333,0.464631829968885,1.0,1/8,1.12%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.8276753061217429,-1.407032313380412,0.08333333333333333,0.464631829968885,1.0,1/8,1.12%,GBP1
prerank,CellMarker_Augmented_2021__Acinar cell:Salivary Gland,0.606508512103562,1.4069500367436054,0.06451612903225806,1.0,1.0,5/45,2.07%,PDK4;DSE;INPP5A;MMRN1;BMP6
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.8081602487671793,-1.4067667998487114,0.1111111111111111,0.4643922699939763,1.0,3/13,2.42%,BTG2;PLK2;CNOT8
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.7739977163877058,1.4066769227561435,0.10714285714285714,1.0,1.0,1/9,0.08%,PDK4
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.9230112657389038,-1.4066021647993252,0.057692307692307696,0.4627627216939225,1.0,1/5,1.12%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.9230112657389038,-1.4066021647993252,0.057692307692307696,0.4627627216939225,1.0,1/5,1.12%,GBP1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.6208854511954832,1.40637140877438,0.06818181818181818,1.0,1.0,8/45,8.15%,HDAC9;RBM20;ERBB4;HSPG2;FGF12;PIK3CA;UTY;TAB2
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.6449600897187993,-1.4062159119895923,0.07017543859649122,0.46296449163688785,1.0,11/54,6.77%,CD74;MX1;KLHL20;XAF1;ISG15;STAT1;SP100;NUB1;EIF2AK2;CALCOCO2;SMAD3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7672434248782843,1.4060378534544666,0.046511627906976744,1.0,1.0,7/13,16.44%,GRM5;CDH2;NRXN1;HOMER1;DGKI;LRRK2;NLGN1
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Brain,0.7561501833560748,1.4056776533791009,0.09090909090909091,1.0,1.0,7/10,11.61%,GRM5;CADM2;GRIA2;SNAP25;NRXN1;RALYL;RBFOX1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.7090055785182076,-1.4055323099012411,0.019230769230769232,0.46474733289558917,1.0,5/37,3.72%,CD74;HES1;PARP14;PLCG2;CASS4
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.7661979249511279,-1.4052842062008324,0.1320754716981132,0.4645868205888628,1.0,3/13,11.26%,SHLD1;POLR2A;MSH2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.6282033577000453,-1.4046719862555472,0.06779661016949153,0.4651888334254767,1.0,7/46,2.39%,CX3CL1;CYLD;GBP1;IFIH1;ISG15;TMSB4X;FN1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.888877645767876,-1.403882541313587,0.02127659574468085,0.466952976250685,1.0,3/6,7.01%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.8162826287677422,1.4038731195320082,0.0625,1.0,1.0,6/8,14.21%,RALA;FBXO7;DNAJC15;HSPD1;PINK1;MFF
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.8710835683734441,-1.4035830184898208,0.08695652173913043,0.46683874925377344,1.0,1/8,0.50%,DDX60
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.8029637656278782,-1.4035782365073468,0.17777777777777778,0.4657673368804953,1.0,2/12,6.99%,PPARG;LCP2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.8098562725123833,-1.4035720515276877,0.08,0.46462575027049413,1.0,3/13,2.12%,CX3CL1;PPARG;STAT1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.7660488550465587,-1.4027875784504853,0.07547169811320754,0.4660730492290417,1.0,3/14,4.75%,SLC6A6;SLC16A2;SLC38A3
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.718198642593041,-1.40272022255671,0.08620689655172414,0.4650613829029936,1.0,6/28,6.56%,SLC22A5;ABCA5;CHKA;SLCO1A2;TAP1;SLCO2B1
prerank,Reactome_2022__Role Of ABL In ROBO-SLIT Signaling R-HSA-428890,0.862990325262784,1.4026982673238757,0.07462686567164178,1.0,1.0,3/5,11.85%,ABL2;ABL1;CLASP1
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,0.6035646757954687,1.4024625314183559,0.09259259259259259,1.0,1.0,10/33,18.67%,ITPR3;PLCB1;PRKX;GNB4;PPP2CB;ITPR2;PPP3CA;PPP3CB;CALM1;PRKCA
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.9436597463847854,1.4024606503032686,0.020833333333333332,1.0,1.0,1/5,0.24%,HSD17B4
prerank,CellMarker_Augmented_2021__Neuron:Undefined,-0.7705713120183997,-1.4021398963124523,0.11764705882352941,0.4665255376779894,1.0,4/12,8.74%,VCAM1;MAP2;FOS;CD47
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.7066259678123269,1.4018690363917126,0.15217391304347827,1.0,1.0,4/15,10.92%,TEAD4;RARB;PBX3;TBC1D23
prerank,Reactome_2022__TNFR1-induced Proapoptotic Signaling R-HSA-5357786,-0.7871851057680128,-1.4018386600367192,0.22916666666666666,0.46653850159395044,1.0,2/5,8.71%,CYLD;TANK
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.8370575602610054,-1.4016593995333075,0.10909090909090909,0.4659304601695274,1.0,1/9,0.27%,TBX3
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.9427427289256108,-1.401299584710431,0.018518518518518517,0.46656424154303244,1.0,1/6,1.01%,PPARG
prerank,Reactome_2022__MET Activates PI3K/AKT Signaling R-HSA-8851907,0.8345444666432033,1.401163391402411,0.14285714285714285,1.0,1.0,3/6,15.56%,PIK3CA;PIGU;GRB2
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.8127902959696832,-1.4008511522230156,0.08163265306122448,0.4658746350450412,1.0,2/8,2.12%,IFIH1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.8127902959696832,-1.4008511522230156,0.08163265306122448,0.4658746350450412,1.0,2/8,2.12%,IFIH1;STAT1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.827221940343738,-1.4004122972402004,0.08163265306122448,0.466602388517931,1.0,2/10,4.01%,MX1;PRKN
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.8699149386453275,-1.4001275646040454,0.10204081632653061,0.46663952309603113,1.0,1/5,0.48%,NR4A1
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreatic Islet,-0.6774946310909593,-1.4000607225414503,0.07936507936507936,0.4657951272943904,1.0,2/31,1.25%,RSAD2;LRATD1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.8301406430516185,-1.399849445933658,0.06,0.46571188838800964,1.0,2/14,3.93%,VCAM1;SNX6
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7937688867008255,-1.3986236953418083,0.0392156862745098,0.46913770961852613,1.0,2/7,10.07%,SHLD1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.8174036049477924,1.398622889586983,0.05555555555555555,1.0,1.0,1/8,0.74%,ABL2
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.8477299260907101,-1.3979165044393622,0.05172413793103448,0.4703595757723858,1.0,1/10,0.24%,HES1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.7584719570583879,-1.3979074066455346,0.10909090909090909,0.4692476146003471,1.0,5/11,11.08%,SOD2;SAMHD1;B2M;APPL2;CBR4
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.7685823053699912,-1.3977876336278363,0.15217391304347827,0.468648958418052,1.0,3/16,2.42%,BTG2;PLK2;CNOT8
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.7817347970332611,-1.3976226463588535,0.09259259259259259,0.46810139224654357,1.0,2/12,5.37%,CYLD;CDC37
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.9134395145891192,-1.397463714093497,0.04,0.4666295804170423,1.0,1/5,0.37%,MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.9134395145891192,-1.397463714093497,0.04,0.4666295804170423,1.0,1/5,0.37%,MX1
prerank,KEGG_2021_Human__Cell adhesion molecules,-0.6378360224416725,-1.3974401676273358,0.05357142857142857,0.46558725883246915,1.0,6/40,5.55%,VCAM1;CD99L2;HLA-F;HLA-B;HLA-C;NTNG1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.6849479498555511,-1.3968567210066798,0.11475409836065574,0.46720395691308136,1.0,4/33,6.72%,SLC22A5;SLC6A6;SLC38A3;TMEM30A
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.8507810770443514,1.396465245102173,0.02127659574468085,1.0,1.0,2/8,1.51%,HSD17B4;INSIG1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.8757313974513556,-1.395913475735688,0.061224489795918366,0.4698866440722582,1.0,3/6,7.01%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.8613166401634789,-1.395234949585491,0.0851063829787234,0.47134306231978407,1.0,2/9,3.43%,CD74;VAV3
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.9164987839221739,1.3949660675516902,0.06451612903225806,1.0,1.0,1/5,0.27%,HDAC9
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.6229588139937899,1.3945011561786842,0.05,1.0,1.0,5/29,7.17%,NOVA1;PRPF8;MBNL1;PPIG;IVNS1ABP
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.8740669579920004,1.3939332713972283,0.125,1.0,1.0,4/6,11.29%,COL4A2;NCAM1;CACNA1C;ST8SIA4
prerank,Reactome_2022__CLEC7A (Dectin-1) Induces NFAT Activation R-HSA-5607763,0.8059785398491146,1.3934693767399473,0.019230769230769232,1.0,1.0,5/9,16.49%,ITPR3;ITPR2;PPP3CA;PPP3CB;CALM1
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,0.7915487526796727,1.3929354318026617,0.09090909090909091,1.0,1.0,4/7,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,-0.8317048607615228,-1.3925018380897178,0.057692307692307696,0.480486216222639,1.0,2/7,8.31%,ATP6V1E1;TFRC
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.7559673396282859,1.3924152709057391,0.1,1.0,1.0,3/10,9.16%,CRY1;WRNIP1;ABL1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Embryo,-0.7200021880988174,-1.3917245551105142,0.09836065573770492,0.4822430944860834,1.0,6/22,9.27%,CXCL12;TIE1;PLXND1;MYO15B;SLCO2B1;SCARF1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.7491913275956632,-1.3915321904789777,0.11764705882352941,0.48174646811366506,1.0,1/17,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.8420893702194636,-1.3914897008324318,0.08,0.48073333113970146,1.0,1/6,0.21%,RSAD2
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.6259358074499816,-1.3912050015672608,0.04,0.48066593985000994,1.0,9/76,8.92%,TBX3;NR4A1;CYLD;GRK5;IRF1;CDC14A;SMAD3;RPL23;JUN
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.8979466613443225,-1.3909457814641795,0.06521739130434782,0.4808570667863778,1.0,1/5,0.08%,VCAM1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.7820754693893781,-1.390724734762862,0.08695652173913043,0.48039156028678875,1.0,1/10,1.04%,KLHL20
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.7014196651351441,-1.3906043351786759,0.1111111111111111,0.47969450777786166,1.0,1/18,0.37%,MX1
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.7968118610263397,1.390536899762622,0.11904761904761904,1.0,1.0,1/11,0.58%,BTBD10
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.6497382678810188,1.3904088388224332,0.07142857142857142,1.0,1.0,10/25,11.61%,ITPR3;GRM5;PRKG1;CADM2;GRIA2;SNAP25;NRXN1;CNTNAP2;ADGRB3;RBFOX1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.7306759593268214,-1.3902842231100947,0.03571428571428571,0.4798165986640782,1.0,2/29,1.01%,TBX3;PPARG
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.9024906096379044,-1.3902155572702835,0.09803921568627451,0.4790077076315483,1.0,1/5,0.29%,SLC22A5
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.8925002902280574,1.3900842561156892,0.02,1.0,1.0,1/6,0.05%,TRIM5
prerank,CellMarker_Augmented_2021__Endothelial cell:Cornea,-0.8535968376031168,-1.389889263071506,0.10416666666666667,0.47862022216925076,1.0,1/7,0.08%,VCAM1
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.7275686483296285,-1.3889060953601924,0.10204081632653061,0.4811289474511025,1.0,5/12,12.56%,ISG15;RFC3;TRIM25;UBC;NPLOC4
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.8297935571919487,-1.388670494956981,0.047619047619047616,0.4809925687755473,1.0,2/10,1.30%,CYLD;IFIH1
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,0.7608531205105871,1.3884556902575165,0.09375,1.0,1.0,7/14,17.80%,SMAD9;SMAD6;SMAD1;SMAD5;SKI;SMURF2;ACVR2A
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.7352898056872266,-1.3883525852812497,0.05660377358490566,0.48094900951974623,1.0,5/13,18.65%,ATP6V1E1;TFRC;IREB2;LMTK2;FTH1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.7913909961252154,-1.3882075826830094,0.12,0.4804226469572284,1.0,1/13,0.32%,CX3CL1
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Embryonic Stem Cell,-0.7425980960902366,-1.3878228176468086,0.1320754716981132,0.48088542417737146,1.0,2/20,2.79%,VCAM1;CXCL12
prerank,KEGG_2021_Human__Type II diabetes mellitus,0.760778136604225,1.3876789256040152,0.13725490196078433,1.0,1.0,4/15,11.13%,MAPK10;PKM;PIK3CA;CACNA1C
prerank,Reactome_2022__Frs2-mediated Activation R-HSA-170968,0.8586736882342805,1.3874572304044652,0.08,1.0,1.0,2/7,10.81%,YWHAB;FRS2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.8130849138655845,1.3874340742124092,0.0425531914893617,1.0,1.0,1/7,1.94%,PRPF8
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.8661512163589085,-1.3871724923290283,0.0851063829787234,0.48230782021933183,1.0,1/5,2.36%,TPM1
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,0.839933608411969,1.3871533148828976,0.03773584905660377,1.0,1.0,4/7,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,Reactome_2022__Signaling By FGFR4 In Disease R-HSA-5655291,0.839933608411969,1.3871533148828976,0.03773584905660377,1.0,1.0,4/7,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.9464183688318207,-1.3869947866311063,0.02,0.4818504870339134,1.0,1/5,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.8906047818504488,-1.3869935465486614,0.0851063829787234,0.48077970817383797,1.0,3/7,9.46%,CYLD;TNFSF10;PMAIP1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.8645447350214892,-1.386900905543032,0.08695652173913043,0.4800775969312306,1.0,2/7,8.53%,LGALS3;CDA
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.8446042666211091,-1.3868337585614416,0.1509433962264151,0.47933320312283884,1.0,1/10,0.13%,CD74
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.6717993205943115,1.3865485218218816,0.11320754716981132,1.0,1.0,11/19,22.44%,UHRF2;PIAS1;MRTFA;NCOA2;PHC2;ZNF131;CREBBP;EP300;NCOA1;NCOR2;PHC3
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Undefined,-0.7010286592851049,-1.3860585708269912,0.10204081632653061,0.4816038180235624,1.0,1/21,0.08%,VCAM1
prerank,KEGG_2021_Human__Pancreatic secretion,0.6418731152458108,1.385988902183221,0.06521739130434782,1.0,1.0,9/26,18.67%,ITPR3;SLC26A3;ATP2A2;PLCB1;ITPR2;ATP2B4;ATP1A1;RAC1;PRKCA
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,0.6596783041269693,1.3855955215831817,0.08108108108108109,1.0,1.0,4/20,7.76%,CALR;HSP90B1;CTDSP2;NFYC
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,0.8861912115497994,1.3850456565542058,0.07407407407407407,1.0,1.0,3/5,7.76%,CALR;HSP90B1;NFYC
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.8258502584751855,-1.3849091068597945,0.06,0.48494897341651544,1.0,2/8,4.38%,GBP1;LGALS3
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.7753751317588127,-1.38427943401192,0.08771929824561403,0.48609256065904416,1.0,2/14,5.37%,CYLD;CDC37
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.9134970485204492,-1.3839974698273743,0.13043478260869565,0.4859488857793195,1.0,1/5,0.32%,CX3CL1
prerank,CellMarker_Augmented_2021__Neutrophil:Kidney,-0.748494558231283,-1.3835773440928085,0.11764705882352941,0.48668124639859767,1.0,4/14,8.53%,SAT1;SOD2;FOS;CDA
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.6366168036685395,1.382996878149725,0.13636363636363635,1.0,1.0,8/25,15.22%,NOVA1;MBNL1;NOVA2;REST;KHDRBS3;CELF2;RBFOX1;KHDRBS1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.6401459757424578,-1.3828913009232982,0.07142857142857142,0.48812712307524964,1.0,6/42,7.04%,CYLD;BTG2;PSMA1;PSMB9;SMAD3;ANAPC16
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.7810807084731655,-1.3826834742875882,0.09090909090909091,0.4878458635235506,1.0,2/12,9.85%,MLLT1;POLR2A
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,0.8337729951639565,1.3822893857200602,0.0784313725490196,1.0,1.0,1/6,0.24%,HSD17B4
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.730101432868642,1.3815462731947856,0.14285714285714285,1.0,1.0,3/12,12.46%,KDM4C;UTY;KDM5A
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.5895050597342842,-1.3815301730308747,0.01694915254237288,0.4903087191144975,1.0,11/89,8.42%,HES1;TBX3;BTG2;PPARG;SOD2;SLC16A2;IRF1;EIF2AK2;WARS1;B2M;COL18A1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.675448200035635,-1.380684842367175,0.09615384615384616,0.49242711640212583,1.0,16/32,9.19%,VCAM1;CX3CL1;GBP1;STAT1;IRF2;HLA-F;HLA-B;IRF1;HLA-C;SP100;OAS3;GBP4;B2M;TRIM25;CD47;HLA-E
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.8200691713307824,-1.3804877160817948,0.17307692307692307,0.4918719350582402,1.0,3/8,13.44%,HLA-F;B2M;HLA-A
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.7519746272392035,-1.3803476651791278,0.14285714285714285,0.4912748410155814,1.0,2/11,4.38%,VCAM1;LGALS3
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,0.7971584956432325,1.3802128583339601,0.061224489795918366,1.0,1.0,7/9,16.57%,ITPR3;STIM1;ATP2A2;ITPR2;SLC8A1;CALM1;ATP2B4
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.8360007011652804,1.3798724278202343,0.04,1.0,1.0,5/6,16.49%,ATP2A2;PACS2;PDZD8;VMP1;CALM1
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.770702301480157,-1.3794628385761403,0.1702127659574468,0.4936427519660426,1.0,4/8,15.46%,NLRC5;TANK;UBC;N4BP1
prerank,KEGG_2021_Human__cAMP signaling pathway,0.5688845880735772,1.3789749130751774,0.10256410256410256,1.0,1.0,19/63,18.78%,CREB5;RRAS2;GRIA2;ATP2A2;MAPK10;PIK3CA;PPP1CB;CACNA1C;ACOX1;ABCC4;CALM1;ATP2B4;ATP1A1;CREBBP;EP300;TIAM1;RAC1;EDN1;ROCK1
prerank,KEGG_2021_Human__Tuberculosis,-0.6543979244157491,-1.3787176424028205,0.1206896551724138,0.49577987682403146,1.0,2/34,2.12%,CD74;STAT1
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,0.6144270020797755,1.3782704383861053,0.07692307692307693,1.0,1.0,14/34,21.78%,HDAC9;TLE4;HDAC7;CCNC;CNTN1;ADAM10;MIB1;PSEN1;CREBBP;EP300;NCOR2;ADAM17;HDAC4;ITCH
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.7983534456752854,-1.3782503640331576,0.14583333333333334,0.4964769965921976,1.0,2/8,2.23%,ISG15;PLCG2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.6614141608885076,-1.3769099971916468,0.15217391304347827,0.4999388061254751,1.0,3/22,9.24%,MX1;TFRC;SNX25
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Liver,-0.552924383777122,-1.3768200185697526,0.04918032786885246,0.499155504455182,1.0,23/134,10.78%,CD74;EPSTI1;MX1;LAP3;SAT1;LRPAP1;ISG15;VAV3;TNIP1;IL32;GABARAPL1;LGALS3;ACSL4;OAS3;GBP4;ICA1;TFRC;DDX24;CBX5;PMAIP1;BST2;WSB1;PHTF2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6494753291508836,1.3767619520164338,0.11764705882352941,1.0,1.0,3/22,3.37%,VAPB;PRKD1;KDSR
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.8485682151717592,-1.3766459200798902,0.08333333333333333,0.498681751183351,1.0,2/8,3.93%,PPARG;SNX6
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.8408894128792406,-1.376399180118209,0.07547169811320754,0.4984937449986943,1.0,5/8,14.26%,RPS8;RPS28;RPS19;RPS14;RIOK3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Undefined,-0.6607368635734452,-1.3763238025640756,0.12,0.4977838379769516,1.0,3/31,2.55%,VCAM1;FN1;ITGB5
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.7896161853563146,-1.376163780473585,0.0,0.49738120089076326,1.0,1/16,0.37%,MX1
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.6213828987865754,1.375950842569892,0.0,1.0,1.0,13/46,17.18%,CREB5;ATP2A2;TPM4;PLCB1;PPP1CB;CACNA1C;PPP2CB;PPP2R2B;SLC8A1;RPS6KA5;CALM1;ATP2B4;ATP1A1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.9184702714852298,-1.3755894523874144,0.11904761904761904,0.4984332981355126,1.0,2/6,1.35%,PARP14;PARP12
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.660226275659621,1.3746822604380482,0.1320754716981132,1.0,1.0,13/26,19.95%,SMAD9;BMP6;SMAD6;ID3;SMAD1;SMAD5;PPP2CB;SMURF2;CREBBP;EP300;ACVR2A;ROCK1;ID1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.8239096411837554,-1.374482494966255,0.09523809523809523,0.50093092253189,1.0,3/7,7.14%,SP100;PLXND1;WARS1
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Peripheral Blood,-0.8605136312959785,-1.3742734693907748,0.09615384615384616,0.501020904734608,1.0,3/7,10.46%,CYLD;LCP2;ARHGAP15
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.6890939886556479,1.3742316079704553,0.14893617021276595,1.0,1.0,1/16,0.05%,TRIM5
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.8901202379244049,-1.3742125565720613,0.08,0.5001622930439656,1.0,2/7,3.43%,CD74;VAV3
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.7926801137916901,-1.3732086151105591,0.08333333333333333,0.5030706879940113,1.0,2/10,2.79%,STAT1;CXCL12
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.6678015218021813,-1.3731781500057632,0.0196078431372549,0.5022113805714062,1.0,5/22,11.71%,ANAPC16;NFKB1;FOS;JUN;UBC
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.7528022728103124,-1.3731473517581294,0.20408163265306123,0.5013128302941571,1.0,4/20,8.92%,SOD2;TPM1;FOS;JUN
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.6918680749605828,-1.37309477682211,0.14285714285714285,0.5004393947495421,1.0,1/24,0.32%,CX3CL1
prerank,KEGG_2021_Human__Serotonergic synapse,0.6304181966961621,1.372736245281882,0.14285714285714285,1.0,1.0,6/28,12.11%,ITPR3;KRAS;PLCB1;CACNA1C;GNB4;ITPR2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.9644660880400846,-1.372272360032421,0.023255813953488372,0.5023206892345782,1.0,1/5,0.21%,RSAD2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.7454997025620926,-1.3722658586727834,0.15384615384615385,0.501321094323759,1.0,1/15,0.56%,CYLD
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.6950083346184148,1.3720778558147533,0.058823529411764705,1.0,1.0,4/15,11.61%,ANO5;CADM2;CKMT2;RBFOX1
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.8478423349219667,1.3715968218074965,0.09803921568627451,1.0,1.0,2/6,9.16%,ABL2;ABL1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.7850558226838873,1.3712276195545627,0.10344827586206896,1.0,1.0,1/8,0.08%,PDK4
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.8389850810351593,-1.371046199048773,0.12962962962962962,0.5045520075717087,1.0,3/6,13.49%,NFKBIA;NFKB1;TBK1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6519417391986246,1.3709122825582598,0.14285714285714285,1.0,1.0,3/22,3.37%,VAPB;PRKD1;KDSR
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.8069393073625674,-1.3706057124429603,0.10344827586206896,0.505183883005816,1.0,3/10,7.89%,CX3CL1;CXCL12;LPAR6
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.8145979219183274,-1.370587967740759,0.22,0.5041422667521958,1.0,2/6,8.39%,WARS1;LARS1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.8071484809209318,1.3701463715764257,0.1346153846153846,1.0,1.0,1/7,0.96%,CRY1
prerank,CellMarker_Augmented_2021__Basal cell:Undefined,-0.6468316523845155,-1.3694967999952896,0.07272727272727272,0.5063976190698649,1.0,8/33,9.19%,SAT1;GBP1;PARP12;LGALS3;TAP1;B2M;S100A6;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.6955379555287569,1.3693017883059966,0.15789473684210525,1.0,1.0,9/18,18.78%,NRXN1;CNTNAP2;ABL1;PPM1F;NRP1;IL1RAPL1;NLGN1;RAC1;ROCK1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.7313936949182783,-1.3689743438250512,0.125,0.5074430842049924,1.0,1/20,0.24%,HES1
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryoid Body,-0.6687816391243847,-1.3678106988908183,0.11666666666666667,0.5106283487723663,1.0,5/46,4.97%,VCAM1;CXCL12;LAMA4;TIE1;MMRN2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.868747770622607,-1.3674107220817822,0.06666666666666667,0.5109056981203199,1.0,3/6,7.01%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.841547379713588,-1.3666218460904955,0.04081632653061224,0.5123123857156959,1.0,3/10,6.19%,CD74;EIF2AK2;OAS3
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.7906278218017854,-1.3664753759657897,0.19607843137254902,0.5118330635858603,1.0,2/6,7.04%,CDC14A;ANAPC16
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,-0.7019908549815536,-1.3651770986774596,0.1320754716981132,0.5159008885011689,1.0,4/16,11.71%,CYLD;TANK;SPPL2A;UBC
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.84029517077457,-1.3645032742513974,0.0425531914893617,0.5174761490921268,1.0,2/13,3.93%,VCAM1;SNX6
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.7818397250774823,-1.36326534821951,0.14545454545454545,0.5207893025009934,1.0,2/10,5.71%,FN1;RPS6
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.7052529943269253,-1.3630331688503086,0.06,0.5205868530323139,1.0,4/16,6.19%,IFIH1;ISG15;IRF1;OAS3
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.6224473455672395,-1.3623431437239113,0.08620689655172414,0.5219156430012706,1.0,12/69,9.08%,VCAM1;PPARG;SOD2;VAV3;TNFSF10;MAP3K5;NFKBIA;NFKB1;FOS;TANK;JUN;ERO1A
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.6405944030416326,-1.3623405049589825,0.0851063829787234,0.5208655109227972,1.0,3/37,4.86%,CD74;RFC3;TIE1
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovary,0.77508175181958,1.3623197758732668,0.0851063829787234,1.0,1.0,2/10,1.67%,TEAD4;COL4A2
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.7103090183287593,-1.36157169267632,0.07936507936507936,0.5228269532342789,1.0,5/25,6.56%,CD74;SOD2;PLA1A;CPM;SLCO2B1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.7999727965863626,-1.3611756534190163,0.11764705882352941,0.5233004259975975,1.0,6/12,12.70%,LRPAP1;OPTN;PRKN;NFKB1;MTMR2;ITGAV
prerank,CellMarker_Augmented_2021__Epithelial cell:Undefined,-0.8241398571530143,-1.361175544830531,0.15517241379310345,0.5222538251456023,1.0,1/7,0.08%,VCAM1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.5304719239044621,1.3611158263543632,0.022727272727272728,1.0,1.0,8/73,3.16%,TRIM5;ABL2;DEPP1;EIF4G3;UBQLN1;MTDH;PRKD1;SLC38A9
prerank,CellMarker_Augmented_2021__Basophil:Lung,-0.7496387283632099,-1.360518459104589,0.1016949152542373,0.523791251362564,1.0,3/11,7.89%,GBP1;TNFSF10;LPAR6
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.6849481595784533,1.3604021812631852,0.13725490196078433,1.0,1.0,3/17,8.87%,HDAC9;MORF4L1;REST
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,-0.7074046530244466,-1.3603244535555499,0.10204081632653061,0.5233608686572522,1.0,7/23,8.45%,CHKA;LYPLA1;PLA1A;AGPAT3;GPD2;GPCPD1;DGKG
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,-0.8167342859797171,-1.3599241804406972,0.10526315789473684,0.5237275468638597,1.0,2/7,10.81%,MYL12A;EFNB2
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,0.676857745894504,1.3598527639880706,0.15217391304347827,1.0,1.0,3/21,7.46%,HSD17B4;NUP58;RANBP2
prerank,PanglaoDB_Augmented_2021__B Cells,-0.7725520913272883,-1.3597216685041458,0.10526315789473684,0.5232582921896781,1.0,1/15,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.8366905693749807,-1.3593771406299073,0.10638297872340426,0.5235830956989286,1.0,3/7,10.73%,DDX60;RPS19;APPL2
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,0.8438783815595391,1.3592099183270112,0.14285714285714285,1.0,1.0,1/5,0.74%,ABL2
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.7811417615570103,-1.3590096417652184,0.14583333333333334,0.5239877060805525,1.0,2/11,0.40%,HES1;PARP14
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.6896085923781364,1.3588727512107268,0.16666666666666666,1.0,1.0,6/18,14.66%,GRIK2;GRM5;GRIA2;S1PR1;CALCRL;PARD3
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,0.8725639541051933,1.358631344904186,0.058823529411764705,1.0,1.0,1/5,0.53%,PNP
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.7596537838225992,-1.3584664703404044,0.25,0.5231565266032707,1.0,3/8,14.87%,WARS1;LARS1;PPA2
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.7596537838225992,-1.3584664703404044,0.25,0.5231565266032707,1.0,3/8,14.87%,WARS1;LARS1;PPA2
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.7596537838225992,-1.3584664703404044,0.25,0.5231565266032707,1.0,3/8,14.87%,WARS1;LARS1;PPA2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7782471625507006,-1.3581551941895742,0.10416666666666667,0.5233978906293852,1.0,6/12,14.63%,RPL23;PMAIP1;RPS7;RPS15;ATM;RPL37
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,0.6405165297523946,1.357574942741819,0.10638297872340426,1.0,1.0,10/27,18.67%,ITPR3;PRKG1;PLCB1;GNB4;NLK;ITPR2;PPP3CA;PPP3CB;CALM1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.7291487028187285,-1.3572807512274383,0.12962962962962962,0.5256457407277788,1.0,7/22,12.54%,SLC6A6;HEBP2;MAP3K5;FOS;ACER2;EFNB2;CLU
prerank,CellMarker_Augmented_2021__Epithelial Hair Follicle Stem cell:Hair Follicle,-0.8860589696352703,-1.357182810986676,0.10909090909090909,0.5249797206872512,1.0,2/5,7.28%,KIAA1217;DSP
prerank,CellMarker_Augmented_2021__Exhausted CD4+ T cell:Liver,-0.6164925789686961,-1.3565447511636357,0.10526315789473684,0.5262159214956875,1.0,12/44,11.47%,EPSTI1;LAP3;SLC6A6;RNF19A;GBP4;WARS1;LIMA1;ITM2A;BST2;AHI1;PHTF2;GNG4
prerank,CellMarker_Augmented_2021__FOXP3+ Natural Regulatory T (Treg) cell:Blood,-0.8677032378922855,-1.3563097852226822,0.14583333333333334,0.5261700550810724,1.0,2/5,10.46%,LCP2;ARHGAP15
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.7065373144776323,1.3562339553736982,0.10204081632653061,1.0,1.0,3/14,10.17%,HDAC9;MORF4L1;HDAC7
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.787970825048766,1.3560134576478737,0.1320754716981132,1.0,1.0,4/8,20.35%,NAA50;CREBBP;EP300;NAA25
prerank,Reactome_2022__Cytochrome C-Mediated Apoptotic Response R-HSA-111461,0.8629508823331756,1.3557958278458566,0.1111111111111111,1.0,1.0,1/5,1.59%,AVEN
prerank,Reactome_2022__Formation Of Apoptosome R-HSA-111458,0.8629508823331756,1.3557958278458566,0.1111111111111111,1.0,1.0,1/5,1.59%,AVEN
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,0.8629508823331756,1.3557958278458566,0.1111111111111111,1.0,1.0,1/5,1.59%,AVEN
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.8872122365918241,1.354918322887002,0.08163265306122448,1.0,1.0,4/5,10.94%,ZBTB1;CBFB;ABL1;ZMIZ1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.6616297329196604,-1.3538156430233586,0.0784313725490196,0.5327584646770426,1.0,14/43,12.70%,VCAM1;FN1;ITGB5;LAMA4;COL8A1;SERPINE1;COL18A1;CD47;ITGA10;RECK;NID1;ADAMTS1;LAMA2;ITGAV
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.6616297329196604,-1.3538156430233586,0.0784313725490196,0.5327584646770426,1.0,14/43,12.70%,VCAM1;FN1;ITGB5;LAMA4;COL8A1;SERPINE1;COL18A1;CD47;ITGA10;RECK;NID1;ADAMTS1;LAMA2;ITGAV
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,0.681208014264688,1.3536554468535191,0.19607843137254902,1.0,1.0,5/15,15.56%,PIK3CA;PIGU;FRS2;PPP2CB;GRB2
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,0.681208014264688,1.3536554468535191,0.19607843137254902,1.0,1.0,5/15,15.56%,PIK3CA;PIGU;FRS2;PPP2CB;GRB2
prerank,CellMarker_Augmented_2021__CD1C+ A Dendritic cell:Blood,0.8425784283035235,1.3535732892761805,0.09259259259259259,1.0,1.0,1/6,0.03%,CREB5
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,-0.8698145212247059,-1.3533428470775972,0.1875,0.5334343390499083,1.0,2/5,3.43%,GMPS;VAV3
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.7672070494365523,-1.3532734847663321,0.16363636363636364,0.5327015885240359,1.0,3/11,8.55%,CYLD;PRKN;TAOK3
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,0.6198672710443835,1.3529142311605924,0.0625,1.0,1.0,6/32,10.73%,MAPK10;KRAS;PIK3CA;HSP90AA1;PGR;CPEB3
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,0.6280229354505017,1.352355828519197,0.1276595744680851,1.0,1.0,10/26,24.89%,YWHAB;SLC38A9;YWHAZ;YWHAQ;PTEN;SESN1;YWHAG;AGO2;AKT3;YWHAE
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.7017774832125341,1.3519068736163076,0.04878048780487805,1.0,1.0,5/19,17.42%,NAA50;MORF4L1;ZZZ3;CREBBP;EP300
prerank,Reactome_2022__MET Activates RAP1 And RAC1 R-HSA-8875555,0.7360887133717853,1.3513826521485268,0.10869565217391304,1.0,1.0,3/10,18.99%,PIGU;GRB2;CRK
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.6175441018375674,1.3512508695157797,0.06521739130434782,1.0,1.0,14/28,27.99%,YWHAB;RALA;RALGAPB;YWHAZ;YWHAQ;CALM1;YWHAG;RALGAPA2;KIFAP3;MYO1E;YWHAE;MYH9;C2CD5;EXOC5
prerank,KEGG_2021_Human__Notch signaling pathway,-0.7351960966983718,-1.3508438942716705,0.11538461538461539,0.5405298533962842,1.0,1/19,0.24%,HES1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.6643156507868738,1.350772634815698,0.11627906976744186,1.0,1.0,6/23,11.29%,ABL2;YES1;CSNK1G3;ABL1;PPP4R2;ST8SIA4
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.9314618657467462,-1.3505463653752738,0.05128205128205128,0.5395771559806795,1.0,1/5,0.56%,CYLD
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.9314618657467462,-1.3505463653752738,0.05128205128205128,0.5395771559806795,1.0,1/5,0.56%,CYLD
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.7639998606386355,-1.3505459995082136,0.10714285714285714,0.5385631345537238,1.0,3/13,2.74%,NR4A1;PPARG;FAM120B
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.6267589665061499,1.3504295443432106,0.0,1.0,1.0,8/31,10.73%,SLC26A3;TAF1;HSP90B1;SLC38A9;DIAPH1;CAPN2;ACTB;CPEB3
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.5605039403057809,1.3502437673901104,0.024390243902439025,1.0,1.0,13/76,12.22%,PDK4;ERBB4;RARB;PIK3CA;YY1;HSP90AA1;CBFB;PGR;NCOA3;XPO1;GNB4;NCOA2;FOXO3
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.8249857482369894,-1.3501317512679862,0.0625,0.5391613151800437,1.0,2/7,9.30%,VPS36;MVB12B
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.5325056719641862,-1.3501077452602652,0.0,0.5381715339339364,1.0,21/180,8.98%,HES1;TBX3;CX3CL1;BTG2;SOD2;STAT1;FN1;CNOT8;GRK5;IRF1;UFL1;EIF2AK2;RPS6;WARS1;RPL23;TFRC;ACER2;COL18A1;CD47;JUN;STAT5B
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.8878649203557106,-1.3499088532370562,0.10638297872340426,0.537771693060759,1.0,1/6,0.56%,CYLD
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.7707564520381857,1.3495872087061156,0.06,1.0,1.0,5/12,11.34%,YES1;SMAD6;CBFB;ABL1;SMAD1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.7056849645339494,1.349389880505044,0.13636363636363635,1.0,1.0,5/19,7.01%,INPP5F;PITPNM2;PI4KA;PLCB1;PIK3CA
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.7877040382301458,-1.3493170848292904,0.15517241379310345,0.5393820626553814,1.0,1/10,2.42%,CNOT8
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.731289787971052,-1.3492443300018462,0.08163265306122448,0.5387478640966376,1.0,4/15,8.92%,PPARG;SMAD3;FOS;JUN
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.8703991623942606,1.3492215263074638,0.12962962962962962,1.0,1.0,2/6,4.25%,MCPH1;TENT4A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bone Marrow,-0.6984167197803411,-1.3488333151438132,0.14285714285714285,0.5394760260962426,1.0,5/27,5.21%,SOD2;DDX60L;MAP3K2;SP100;CPQ
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.758299061348646,1.3482449612225722,0.07692307692307693,1.0,1.0,5/10,14.21%,FBXO7;HSP90AA1;DNAJC15;HSPD1;MFF
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.8971937355048273,-1.3481668429490063,0.10344827586206896,0.540608651364861,1.0,2/6,2.07%,CYLD;TMSB4X
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.857033648501732,-1.3477863602618925,0.1320754716981132,0.5407499147898179,1.0,2/6,4.01%,ATP9A;PRKN
prerank,CellMarker_Augmented_2021__Megakaryocyte Erythroid cell:Undefined,0.7482271060261504,1.3471701197795345,0.18518518518518517,1.0,1.0,5/10,17.34%,IL6R;NCAM1;ENTPD1;NRP1;CD81
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.6904205733699701,1.3470556555972117,0.08,1.0,1.0,6/22,11.71%,SMAD9;BMP6;SMAD6;HIVEP1;SMAD1;SMAD5
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.6904205733699701,1.3470556555972117,0.08,1.0,1.0,6/22,11.71%,SMAD9;BMP6;SMAD6;HIVEP1;SMAD1;SMAD5
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.7532727358805295,-1.3469600882390167,0.125,0.5428417856634506,1.0,1/8,4.01%,PRKN
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,-0.7041643683125981,-1.3467229929574078,0.14545454545454545,0.5427662194956312,1.0,1/19,0.40%,PARP14
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,-0.8221608624274851,-1.3465398578894403,0.2,0.5425369710828901,1.0,3/8,13.23%,STAT1;STAT5B;JAK2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.8296490286401994,-1.346138982113825,0.14285714285714285,0.5430193395763111,1.0,4/7,14.26%,NLRC5;HLA-E;RPS19;RIOK3
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.79746827415599,1.3456122146415266,0.13333333333333333,1.0,1.0,2/6,8.15%,MAPK10;TAB2
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.7873137094427556,-1.3452385333602694,0.1346153846153846,0.5447845479339831,1.0,1/7,1.30%,IFIH1
prerank,KEGG_2021_Human__Renin secretion,0.6654688619069955,1.3448012676455297,0.10869565217391304,1.0,1.0,8/18,18.27%,ITPR3;PLCB1;CACNA1C;ITPR2;PPP3CA;PPP3CB;CALM1;EDN1
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.6727413432916989,-1.3446747327696218,0.06557377049180328,0.545777649461226,1.0,9/39,8.98%,VCAM1;STAT1;PLCG2;FN1;SERPINE1;SMAD3;NFKB1;JUN;STAT5B
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.7482458176659292,1.3444921432005303,0.09615384615384616,1.0,1.0,2/8,6.67%,VAPB;CTDSP2
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.7123360606831494,-1.3440145744110235,0.16666666666666666,0.547282816196871,1.0,2/15,2.23%,VCAM1;PLCG2
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.8234188867637893,1.3438856053400032,0.08333333333333333,1.0,1.0,2/6,12.48%,BACH2;DENND5B
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.8461159363664031,1.343499728336283,0.09259259259259259,1.0,1.0,2/6,11.93%,XPO1;PPP2CB
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.620819613184025,1.343189085148888,0.09523809523809523,1.0,1.0,9/22,17.74%,GRIA2;FGF12;LRRC7;HOMER1;FGF14;ANK2;NLGN1;CALM1;ANK3
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.7738817461358135,-1.342963148941353,0.1590909090909091,0.5501552014946706,1.0,2/10,4.01%,CX3CL1;PRKN
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6440523012468561,-1.3428133219735736,0.140625,0.5496673870040985,1.0,3/27,9.85%,NR4A1;CEP57;POLR2A
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.7459813376605252,-1.3427825698121119,0.06976744186046512,0.5487444656495527,1.0,2/11,10.94%,SERPINE1;RECK
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,-0.6280799468695444,-1.3426919822201253,0.11764705882352941,0.5480714508886064,1.0,14/33,9.19%,VCAM1;GBP1;STAT1;IRF2;HLA-F;HLA-B;IRF1;HLA-C;SP100;OAS3;GBP4;B2M;TRIM25;HLA-E
prerank,Reactome_2022__NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,-0.8782968921302712,-1.3425528831776377,0.08888888888888889,0.5476658856203909,1.0,2/6,8.07%,IFIH1;TRIM25
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,-0.8679730726326516,-1.3421618300643205,0.1111111111111111,0.5480174657940374,1.0,1/5,3.51%,ATP6V1E1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.7641144639208416,-1.3420442181279142,0.16666666666666666,0.5475192079892074,1.0,2/9,11.34%,VPS36;STAM2
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.6952390448952158,-1.3415786159173877,0.10638297872340426,0.5485473578458615,1.0,5/29,3.72%,CX3CL1;RREB1;FN1;CARMIL1;CASS4
prerank,CellMarker_Augmented_2021__CD1C+ B Dendritic cell:Blood,0.8581997918098211,1.341388159393142,0.05263157894736842,1.0,1.0,1/7,0.03%,CREB5
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.5758380239802072,-1.340944701688715,0.05172413793103448,0.5500414289077051,1.0,22/90,13.17%,PSMA1;PSMB9;RPS12;RPL31;TMLHE;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;LARS1;RPS28;RPS19;RPS7;RPS14;RPS15;RPL28;HIBCH;RPL9
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,0.745358389250898,1.3407263427969376,0.10416666666666667,1.0,1.0,2/10,2.20%,PSMD14;UIMC1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.8619743120707414,1.340708751554046,0.12244897959183673,1.0,1.0,1/6,0.96%,CRY1
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.7787635594122531,-1.340678827209313,0.1276595744680851,0.5498797602989964,1.0,1/12,0.48%,NR4A1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.7185707158817445,-1.3406581550479248,0.0851063829787234,0.5489324868556217,1.0,4/24,4.91%,BTG2;CNOT8;ZC3HAV1;PABPC1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.882256024856057,-1.3404813372003073,0.16666666666666666,0.5485678940156944,1.0,1/7,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.687951899260334,-1.3404629550699005,0.1111111111111111,0.54758914870132,1.0,5/20,8.74%,CX3CL1;TPM1;CARMIL1;LIMCH1;CD47
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.7592443983659811,-1.3401750077548322,0.19148936170212766,0.5475634233819223,1.0,4/8,6.91%,ISG15;NLRC5;OAS3;SAMHD1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.8334763071046712,-1.3397897515994988,0.18867924528301888,0.5480952897000876,1.0,1/8,1.01%,PPARG
prerank,CellMarker_Augmented_2021__Limbal Mesenchymal cell:Sclerocorneal Tissue,-0.6527281844822518,-1.3396474005421874,0.1016949152542373,0.5475493512135357,1.0,3/39,4.86%,VCAM1;LAMA4;TIE1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.5559265114121934,-1.3395502643749804,0.11475409836065574,0.5467091245306211,1.0,4/106,2.23%,CD74;CX3CL1;CEMIP;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.7168225448166358,-1.339548523675543,0.125,0.5457240630449803,1.0,5/13,9.75%,ISG15;NLRC5;OAS3;SAMHD1;RPS19
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,0.7930585531309563,1.3395057242573647,0.08928571428571429,1.0,1.0,4/7,18.67%,ITPR3;ITPR2;CALM1;PRKCA
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.8356008699318266,-1.3389997047438926,0.1,0.5464768062487262,1.0,2/12,0.82%,SLC22A5;SLC6A6
prerank,Reactome_2022__MET Receptor Recycling R-HSA-8875656,0.7961513084488954,1.3386976287743173,0.19298245614035087,1.0,1.0,3/5,18.99%,PIGU;GRB2;CRK
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.6283963373589116,1.3382640880263652,0.1,1.0,1.0,10/29,16.57%,ITPR3;STIM1;PRKG1;ATP2A2;GNB4;PPP2CB;ITPR2;SLC8A1;CALM1;ATP2B4
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.6564280357849634,-1.3380357241909995,0.12962962962962962,0.5489579943320412,1.0,3/34,3.88%,VCAM1;DOK5;MAP2
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.716052183589109,1.3379041630709934,0.09090909090909091,1.0,1.0,7/14,17.03%,ABL2;YWHAB;PHACTR4;ABL1;SSBP1;POT1;PSEN1
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.5862434641997514,-1.3375865638189144,0.11290322580645161,0.5495367928087557,1.0,24/69,13.49%,CD74;IFIH1;ZNF43;STAT1;HLA-F;HLA-B;HLA-C;SP100;TAP1;EIF2AK2;OAS3;NFKBIA;B2M;NFKB1;ZNF33B;HLA-E;BST2;ZNF248;IFNGR2;SRPK1;SRSF5;JAK2;HLA-A;TBK1
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,0.8740327830055931,1.3369758177967215,0.11764705882352941,1.0,1.0,1/5,2.12%,YWHAB
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.8513893578059903,-1.336944503268144,0.11538461538461539,0.5502419744711871,1.0,2/6,5.05%,CD74;EIF2AK2
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,-0.704579955596287,-1.3368870922622456,0.12244897959183673,0.5494425775723076,1.0,6/24,11.71%,IRF2;IRF1;TNFSF10;CDC37;TANK;UBC
prerank,CellMarker_Augmented_2021__Stem cell:Stomach,-0.6718653013035845,-1.3366653306313132,0.05454545454545454,0.54839989679001,1.0,7/37,5.60%,CEMIP;GBP1;NDRG1;LAMA4;LGALS3;CD109;SERPINE1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovarian Cortex,-0.6718653013035845,-1.3366653306313132,0.05454545454545454,0.54839989679001,1.0,7/37,5.60%,CEMIP;GBP1;NDRG1;LAMA4;LGALS3;CD109;SERPINE1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Prostate,-0.793235238814633,-1.3362905962479807,0.1276595744680851,0.5488287846739707,1.0,1/9,0.24%,HES1
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,-0.6149268139067747,-1.336124315437743,0.1111111111111111,0.5482194418327001,1.0,16/56,12.70%,VCAM1;TLL1;FN1;ITGB5;LAMA4;COL8A1;SERPINE1;DMD;COL18A1;CD47;ITGA10;ACTN1;NID1;ADAMTS1;LAMA2;ITGAV
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.6590683821704868,1.3357405796969821,0.075,1.0,1.0,9/18,12.75%,BTBD10;GRIA2;SNAP25;KCTD8;FGF12;ADGRB3;TOX2;RBFOX1;DPP10
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.7072614319146585,-1.3356871318846595,0.10526315789473684,0.5490102449403541,1.0,7/24,11.39%,SLC6A6;SLC5A6;SCN3A;SCN2A;TRPM6;TRPM3;NDFIP1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.8326886992064316,1.3350447374821628,0.16363636363636364,1.0,1.0,3/7,8.10%,ANGPT2;SEMA3F;ROBO2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.8110993263817089,1.334832300107411,0.16326530612244897,1.0,1.0,1/7,1.57%,ERBB4
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.8738001297424649,-1.3347759393827634,0.12244897959183673,0.5516649869492467,1.0,3/5,10.65%,RPS8;RPS19;RPS14
prerank,Reactome_2022__YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,0.8159749230732884,1.3336883533156816,0.10204081632653061,1.0,1.0,1/7,1.04%,TEAD4
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.8741134151358458,1.333565365312073,0.07407407407407407,1.0,1.0,1/6,0.24%,HSD17B4
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.8500438334255226,1.3327543822705092,0.09090909090909091,1.0,1.0,1/6,0.74%,ABL2
prerank,CellMarker_Augmented_2021__Macrophage:Eye,-0.8117083568904566,-1.3317296564918129,0.14285714285714285,0.5567639354492371,1.0,3/8,12.72%,SAMD9L;HLA-E;SRGN
prerank,CellMarker_Augmented_2021__Macrophage:Retinal Pigment Epithelium,-0.8117083568904566,-1.3317296564918129,0.14285714285714285,0.5567639354492371,1.0,3/8,12.72%,SAMD9L;HLA-E;SRGN
prerank,CellMarker_Augmented_2021__Macrophage:Visceral Adipose Tissue,-0.8117083568904566,-1.3317296564918129,0.14285714285714285,0.5567639354492371,1.0,3/8,12.72%,SAMD9L;HLA-E;SRGN
prerank,CellMarker_Augmented_2021__Monocyte:Kidney,-0.8117083568904566,-1.3317296564918129,0.14285714285714285,0.5567639354492371,1.0,3/8,12.72%,SAMD9L;HLA-E;SRGN
prerank,CellMarker_Augmented_2021__Macrophage:Lymph Node,-0.8117083568904566,-1.3317296564918129,0.14285714285714285,0.5567639354492371,1.0,3/8,12.72%,SAMD9L;HLA-E;SRGN
prerank,CellMarker_Augmented_2021__Macrophage:Artery,-0.8117083568904566,-1.3317296564918129,0.14285714285714285,0.5567639354492371,1.0,3/8,12.72%,SAMD9L;HLA-E;SRGN
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.8384897588003251,1.331613880289754,0.07547169811320754,1.0,1.0,3/5,13.86%,NRCAM;RTN4;EPHA4
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,0.6166364776054222,1.3314761254048453,0.18518518518518517,1.0,1.0,6/23,18.67%,ITPR3;PLCB1;PRKX;ITPR2;CALM1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.6817933191222497,-1.3314402452134873,0.1568627450980392,0.5568843059592766,1.0,1/16,0.08%,VCAM1
prerank,KEGG_2021_Human__Leishmaniasis,-0.7184709386927827,-1.3313507723001639,0.16326530612244897,0.5562179317483158,1.0,8/15,13.76%,STAT1;NFKBIA;NFKB1;FOS;JUN;IFNGR2;JAK2;EEF1A1
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.8059863227538446,-1.3310880269730503,0.14583333333333334,0.5564458728485121,1.0,5/12,13.23%,STAT1;STAT5B;UBC;UBE2D2;JAK2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Whartons Jelly,-0.684852584270319,-1.3308451981695906,0.1111111111111111,0.5553704670730816,1.0,4/24,5.58%,SAMD9L;APOL3;TIE1;PLXND1
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone,-0.684852584270319,-1.3308451981695906,0.1111111111111111,0.5553704670730816,1.0,4/24,5.58%,SAMD9L;APOL3;TIE1;PLXND1
prerank,Reactome_2022__CASP8 Activity Is Inhibited R-HSA-5218900,-0.8253279187352225,-1.330672350838397,0.11904761904761904,0.552975387450232,1.0,2/6,8.71%,TNFSF10;TANK
prerank,Reactome_2022__Dimerization Of Procaspase-8 R-HSA-69416,-0.8253279187352225,-1.330672350838397,0.11904761904761904,0.552975387450232,1.0,2/6,8.71%,TNFSF10;TANK
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.8253279187352225,-1.330672350838397,0.11904761904761904,0.552975387450232,1.0,2/6,8.71%,TNFSF10;TANK
prerank,KEGG_2021_Human__Measles,-0.626575880952415,-1.3304473213069767,0.13559322033898305,0.552694539799156,1.0,10/41,8.98%,MX1;IFIH1;STAT1;EIF2AK2;OAS3;NFKBIA;NFKB1;FOS;JUN;STAT5B
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.6627311019718929,1.3293948292567495,0.12244897959183673,1.0,1.0,5/20,20.82%,PIK3CA;GAREM1;RPS6KA5;GRB2;ADAM17
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,-0.7431926354012883,-1.328468241925577,0.1875,0.5583544102912543,1.0,4/7,13.49%,IFIH1;TRIM25;TANK;TBK1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.8089602217736926,1.3276159531177094,0.16666666666666666,1.0,1.0,3/6,18.33%,HSP90B1;URI1;PPP6R3
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.640972247777796,1.3275472113378604,0.09433962264150944,1.0,1.0,8/18,17.74%,UGCG;NRXN1;STX2;ANXA2;IL1RAPL1;NLGN1;PTEN;ANK3
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.6181534616492739,1.3275213762746865,0.07142857142857142,1.0,1.0,10/29,12.06%,NOVA1;GRIA2;SNAP25;NTM;NOVA2;ROBO2;NRXN1;ADGRB3;RBFOX1;CNTN1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.6536303799443983,1.3270325788377886,0.13043478260869565,1.0,1.0,6/24,7.01%,INPP5F;PITPNM2;PLEKHA1;PI4KA;PLCB1;PIK3CA
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.5929039516301333,1.326812784579313,0.08333333333333333,1.0,1.0,11/40,12.56%,ATRNL1;NOVA1;CADM2;GRIA2;SNAP25;RAB11FIP2;SLC25A46;CNTNAP2;ADGRB3;SMAD1;CHN1
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.7405300546262233,1.3266313391518214,0.08620689655172414,1.0,1.0,6/17,15.56%,COL4A2;NCAM1;CACNA1C;ST8SIA4;RPS6KA5;GRB2
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.5394965475837643,1.3266282679985666,0.07142857142857142,1.0,1.0,10/60,12.86%,NOVA1;PRPF8;TENT4A;MBNL1;PPIG;HNRNPR;IVNS1ABP;SETX;CELF2;DICER1
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,-0.6987502757018248,-1.326627083721059,0.1320754716981132,0.5639772692703271,1.0,3/15,4.83%,NR4A1;PPARG;NR3C2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.7023888767582687,-1.326530143091351,0.10909090909090909,0.5634858102817931,1.0,4/33,4.06%,KIAA1217;SLC16A2;ATP9A;SMARCA1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.7910160579741023,1.326427922514751,0.11320754716981132,1.0,1.0,3/8,11.29%,FUT8;MAN1A2;ST8SIA4
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.7201991240287915,1.32477661510053,0.13333333333333333,1.0,1.0,3/13,2.50%,ANO5;SLC12A6;CLIC1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.8590495104645065,1.32468762007013,0.061224489795918366,1.0,1.0,1/5,4.62%,PHACTR4
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.7912116647926897,-1.3244289884446578,0.10416666666666667,0.569922353868259,1.0,1/7,0.24%,HES1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.7306790530329668,-1.3240787825974019,0.16981132075471697,0.5702276602456515,1.0,5/12,20.85%,PABPC1;MAPK14;FUS;ZFP36;LARP1
prerank,CellMarker_Augmented_2021__CD14+ Endothelial Progenitor cell:Blood,0.6287941418388437,1.323612416036348,0.06976744186046512,1.0,1.0,1/33,0.08%,PDK4
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,0.6447382944061768,1.3235281538108956,0.1111111111111111,1.0,1.0,6/22,11.66%,YWHAB;KDM4C;YWHAZ;PPP1CB;NCOA2;YWHAQ
prerank,Reactome_2022__AKT Phosphorylates Targets In Nucleus R-HSA-198693,-0.8694296222867643,-1.323004636059039,0.11904761904761904,0.5733454414713134,1.0,1/5,0.48%,NR4A1
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,0.6138915218315946,1.3229136219406152,0.14285714285714285,1.0,1.0,7/26,8.02%,ERBB4;NRG2;YES1;PIK3CA;PIGU;HSP90AA1;DIAPH1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.7805934538228265,1.3224876697003352,0.1320754716981132,1.0,1.0,3/7,18.19%,YWHAZ;CDC42;UVRAG
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.7184946622536945,1.3222045967631566,0.10638297872340426,1.0,1.0,3/9,17.34%,RTN4;RAB7A;CD81
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.5890439225059034,1.322157967527899,0.14285714285714285,1.0,1.0,3/49,1.51%,PDK4;HDAC9;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.8631320136693527,1.321977191279125,0.05357142857142857,1.0,1.0,1/5,2.15%,UBQLN1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.8155349516013077,1.3216481763589045,0.08333333333333333,1.0,1.0,2/8,5.66%,PCM1;SYNE2
prerank,CellMarker_Augmented_2021__Bipolar cell:Retina,0.8455823548604251,1.3214488636238921,0.01818181818181818,1.0,1.0,1/5,1.04%,TEAD4
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,0.6193034575609525,1.3213040459892216,0.15,1.0,1.0,10/26,18.91%,BCL6;YWHAB;NFYC;YWHAZ;YWHAQ;FOXO3;PINK1;CREBBP;EP300;YWHAG
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.6272396498192951,1.3210335646373048,0.07142857142857142,1.0,1.0,14/28,18.27%,CALR;STIM1;VAPB;ATP2A2;MT2A;MT1M;MT1E;NPTN;SLC8A1;SLC24A2;ANK2;ATP2B4;SLC39A10;EDN1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.815672109832662,1.3209748711582976,0.1111111111111111,1.0,1.0,2/5,15.91%,YWHAZ;CDC42
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.6158787454606732,1.3208784515371919,0.1,1.0,1.0,8/27,15.33%,TMTC1;TRAK1;TET2;GXYLT1;TMTC2;TMTC4;GALNT2;GALNT10
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.7919492881016621,-1.3205864281684232,0.11538461538461539,0.5803778620460721,1.0,5/7,18.03%,FN1;SMAD3;ITGAV;LRRC32;CD34
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.8446454888830093,-1.320432543878711,0.10526315789473684,0.579862730225903,1.0,5/9,13.44%,PLCG2;HLA-F;B2M;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.8336313907857537,-1.3200890338985503,0.1320754716981132,0.5802708233760107,1.0,1/8,1.01%,PPARG
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.8497504576145506,1.3195377680673055,0.11764705882352941,1.0,1.0,1/7,0.24%,HSD17B4
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.8361884239948384,1.3194297136204194,0.109375,1.0,1.0,2/5,2.66%,UGP2;FUT8
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.7774267236419223,-1.319164270517386,0.1346153846153846,0.5824826607039967,1.0,1/11,0.27%,TBX3
prerank,KEGG_2021_Human__Endocytosis,-0.540665879735378,-1.3191039459903475,0.13846153846153847,0.5818452903686813,1.0,18/103,13.60%,HLA-F;HLA-B;GRK5;HLA-C;SNX6;SNX2;ARAP2;GIT2;IGF2R;SMAD3;TFRC;VPS36;HLA-E;MVB12B;STAM2;CLTA;HLA-A;DNM3
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Lung,0.819369556364193,1.3188332020302744,0.037037037037037035,1.0,1.0,2/9,8.95%,ITGA2;SLC52A3
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Liver,0.819369556364193,1.3188332020302744,0.037037037037037035,1.0,1.0,2/9,8.95%,ITGA2;SLC52A3
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.8423502665116323,-1.3187529490782997,0.16363636363636364,0.5817636195547597,1.0,2/6,4.01%,RSAD2;PRKN
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.7269788003396775,-1.3180653923679806,0.2222222222222222,0.5834609628249192,1.0,2/12,2.23%,VCAM1;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.794071943272461,-1.3179121550955901,0.1509433962264151,0.5829803245045181,1.0,4/8,13.44%,HLA-F;HLA-B;HLA-E;HLA-A
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,0.6851873018385877,1.3172457823250154,0.07142857142857142,1.0,1.0,5/17,18.67%,ITPR3;PRKX;ITPR2;CALM1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.7543284406554688,-1.3161454207193,0.15384615384615385,0.5887834458011346,1.0,3/11,7.22%,STAT1;PLXND1;MAML3
prerank,KEGG_2021_Human__Thermogenesis,0.5344654407710274,1.3159045077657947,0.10638297872340426,1.0,1.0,5/51,5.37%,CREB5;PRKG1;NDUFAF2;ACTG1;KRAS
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.5962323747894203,1.3153115551037329,0.17777777777777778,1.0,1.0,4/33,10.15%,PDK4;PIK3CA;IDE;GRB10
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Stomach,-0.7479596499558718,-1.3142252745550969,0.08,0.5942750231254548,1.0,1/9,0.74%,ANKRD37
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.7184939326195553,-1.3137838767951175,0.11904761904761904,0.5944991718305971,1.0,2/12,0.32%,HES1;CX3CL1
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,0.8150362115674283,1.3130955251464347,0.13725490196078433,1.0,1.0,5/6,18.57%,ANKRD28;SHQ1;POT1;PPP6R3;PPP6C
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Pancreas,-0.7466553315043917,-1.313071122246875,0.13725490196078433,0.5901639676383096,1.0,2/15,6.45%,CX3CL1;PPP1R9A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Larynx,-0.7466553315043917,-1.313071122246875,0.13725490196078433,0.5901639676383096,1.0,2/15,6.45%,CX3CL1;PPP1R9A
prerank,CellMarker_Augmented_2021__Ductal cell:Pancreas,-0.7466553315043917,-1.313071122246875,0.13725490196078433,0.5901639676383096,1.0,2/15,6.45%,CX3CL1;PPP1R9A
prerank,CellMarker_Augmented_2021__Progenitor cell:Embryonic Stem Cell,-0.7466553315043917,-1.313071122246875,0.13725490196078433,0.5901639676383096,1.0,2/15,6.45%,CX3CL1;PPP1R9A
prerank,CellMarker_Augmented_2021__Early Hematopoietic cell:Blood,-0.7466553315043917,-1.313071122246875,0.13725490196078433,0.5901639676383096,1.0,2/15,6.45%,CX3CL1;PPP1R9A
prerank,CellMarker_Augmented_2021__Neural Stem cell:Bone Marrow,-0.7466553315043917,-1.313071122246875,0.13725490196078433,0.5901639676383096,1.0,2/15,6.45%,CX3CL1;PPP1R9A
prerank,CellMarker_Augmented_2021__Dermal Papilla cell:Hair Follicle,-0.7466553315043917,-1.313071122246875,0.13725490196078433,0.5901639676383096,1.0,2/15,6.45%,CX3CL1;PPP1R9A
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5872667219933999,1.3127106087986582,0.06382978723404255,1.0,1.0,10/34,12.08%,GRIK2;GRM5;CDH2;BCR;DLGAP2;PXK;HOMER1;DGKI;USP46;LRRK2
prerank,CellMarker_Augmented_2021__Hepatoblast:Liver,-0.6830647546713209,-1.3126967147616804,0.12244897959183673,0.590154958373663,1.0,6/32,8.31%,VCAM1;ITIH5;CXCL12;TIE1;SLCO2B1;TFRC
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,-0.7912327874409347,-1.3119337038771073,0.17307692307692307,0.5918528240688615,1.0,7/15,9.19%,PLCG2;HLA-B;HLA-C;VAV3;LCP2;B2M;HLA-E
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.7510261192825534,-1.311639490869782,0.08,0.591773580063523,1.0,2/10,8.31%,ATP6V1E1;TFRC
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.8156545595678892,-1.3115307486941734,0.1320754716981132,0.5911219016908201,1.0,4/7,13.44%,HLA-F;HLA-B;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.8511640109960379,-1.3102071613109934,0.09302325581395349,0.594558732066385,1.0,3/6,9.19%,SHLD1;TFRC;HLA-E
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.587877902651796,1.3101025857741415,0.05555555555555555,1.0,1.0,14/34,18.27%,CALR;STIM1;VAPB;ATP2A2;PACS2;PDZD8;MICU3;NPTN;SLC8A1;SLC24A2;ANK2;ATP2B4;PSEN1;EDN1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5713362291508185,1.3097549485599713,0.14285714285714285,1.0,1.0,12/30,11.61%,GRM5;CADM2;GRIA2;SNAP25;FRMD3;NCAM1;SGIP1;NRXN1;CNTNAP2;ADGRB3;NLK;RBFOX1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.8796102871671078,1.3096459000902478,0.09259259259259259,1.0,1.0,1/5,0.05%,TRIM5
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.7385546680235395,1.3089790454746155,0.1346153846153846,1.0,1.0,6/12,19.34%,HSD17B4;ACAT1;ACOX1;ETFA;SCP2;HADHB
prerank,Reactome_2022__Endosomal/Vacuolar Pathway R-HSA-1236977,-0.8631785569254056,-1.3087226944639934,0.1111111111111111,0.5975938627126237,1.0,6/7,13.44%,HLA-F;HLA-B;HLA-C;B2M;HLA-E;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8631785569254056,-1.3087226944639934,0.1111111111111111,0.5975938627126237,1.0,6/7,13.44%,HLA-F;HLA-B;HLA-C;B2M;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.8148057598439469,-1.3084618148679337,0.1346153846153846,0.5974556974479921,1.0,1/7,2.26%,PLK2
prerank,Reactome_2022__Calcineurin Activates NFAT R-HSA-2025928,0.7943200657572995,1.3083628619932683,0.20833333333333334,1.0,1.0,3/5,16.49%,PPP3CA;PPP3CB;CALM1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.8006265864887694,-1.3079126514775448,0.17391304347826086,0.5974309092898438,1.0,1/9,2.55%,ITGB5
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.8006265864887694,-1.3079126514775448,0.17391304347826086,0.5974309092898438,1.0,1/9,2.55%,ITGB5
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.8573060951024127,-1.30789399185552,0.16,0.5965276641196321,1.0,2/5,7.01%,TMSB4X;NFKBIA
prerank,PanglaoDB_Augmented_2021__Basophils,0.6931754046628964,1.3077861828486284,0.08888888888888889,1.0,1.0,2/18,2.02%,JAZF1;SLC26A3
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.7617978496003054,-1.306908090689291,0.21739130434782608,0.5979998789242983,1.0,1/9,0.61%,TLL1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.7617978496003054,-1.306908090689291,0.21739130434782608,0.5979998789242983,1.0,1/9,0.61%,TLL1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.6924131442937628,1.3065630791427383,0.18867924528301888,1.0,1.0,3/12,7.78%,TRAK1;HSPB1;TRAK2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.8065381563858598,-1.3063841520215662,0.20930232558139536,0.5962322018248549,1.0,1/7,9.85%,POLR2A
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.8065381563858598,-1.3063841520215662,0.20930232558139536,0.5962322018248549,1.0,1/7,9.85%,POLR2A
prerank,Reactome_2022__mRNA Capping R-HSA-72086,-0.8065381563858598,-1.3063841520215662,0.20930232558139536,0.5962322018248549,1.0,1/7,9.85%,POLR2A
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.8065381563858598,-1.3063841520215662,0.20930232558139536,0.5962322018248549,1.0,1/7,9.85%,POLR2A
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.80076612627184,1.3062118428424339,0.10526315789473684,1.0,1.0,4/7,17.05%,MT2A;MT1M;MT1E;SLC39A10
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.7395285420001138,1.3058874229697846,0.12962962962962962,1.0,1.0,5/9,24.89%,ANO6;WNK1;NEDD4L;AKAP6;YWHAE
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.8496384429721232,-1.3055676802810756,0.16666666666666666,0.598337740227119,1.0,1/5,1.57%,RIMS1
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.8078267589683665,-1.305392325395542,0.16666666666666666,0.5979706716689911,1.0,6/8,13.44%,HLA-F;HLA-B;HLA-C;ICA1;HLA-E;HLA-A
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.7560671810545602,-1.3053844126019551,0.16666666666666666,0.5970303313480965,1.0,3/10,7.22%,STAT1;PLXND1;MAML3
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.794671492170913,-1.304983081383367,0.14814814814814814,0.5975677834881123,1.0,2/10,4.44%,UFL1;GPM6A
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.8827529951631229,-1.3047259270043483,0.16326530612244897,0.5977272320558682,1.0,1/5,0.32%,CX3CL1
prerank,PanglaoDB_Augmented_2021__T Cells,-0.714820562810917,-1.3041622028699353,0.1111111111111111,0.5988008963640971,1.0,4/16,14.13%,IL32;LCP2;RORA;IL18R1
prerank,CellMarker_Augmented_2021__Naive T cell:Bone Marrow,-0.7938490443875188,-1.303926855567748,0.19230769230769232,0.5989089523669227,1.0,1/6,6.99%,LCP2
prerank,KEGG_2021_Human__Calcium signaling pathway,0.5301338156365996,1.3038360928996655,0.08888888888888889,1.0,1.0,13/44,16.57%,ITPR3;ERBB4;GRM5;STIM1;ATP2A2;PLCB1;CACNA1C;ITPR2;PPP3CA;PPP3CB;SLC8A1;CALM1;ATP2B4
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.8253081477864255,-1.3036965295743612,0.21428571428571427,0.5988049929150914,1.0,1/6,3.24%,UFL1
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,0.6240584959983636,1.3034774320889209,0.11764705882352941,1.0,1.0,6/21,11.82%,GRM5;LRRTM4;DLGAP2;NRXN1;HOMER1;NRXN3
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.5843386150271281,-1.3034172587773347,0.11475409836065574,0.5986363362120145,1.0,16/74,8.71%,CD74;CX3CL1;APOL3;STAT1;PLCG2;PLK2;OPTN;UFL1;SHISA5;TNIP1;PRKN;TNFSF10;ZDHHC17;TRIM25;TFRC;TANK
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.6070927932271737,1.3031015351856843,0.06521739130434782,1.0,1.0,7/31,15.56%,ERBB4;NRG2;PIK3CA;PIGU;FRS2;PPP2CB;GRB2
prerank,CellMarker_Augmented_2021__Fibroblast:Pancreas,0.5549524082779929,1.303099624417032,0.1111111111111111,1.0,1.0,13/37,17.69%,COL4A2;PRKG1;CDH2;NTM;DGKI;MPDZ;CHN1;ADGRL2;PDZRN3;ANK2;PLPPR4;NLGN1;KCNT2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.7910801670834366,-1.3030553490255055,0.14583333333333334,0.5989064493402236,1.0,4/12,10.97%,CD74;SERPINE1;AFAP1L2;RAB1A
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.8203427961170596,1.3030066678208077,0.09803921568627451,1.0,1.0,1/7,4.57%,TRMT9B
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.5340007052990869,-1.3029191734872099,0.04838709677419355,0.5982844161219883,1.0,12/109,12.54%,CD74;PPARG;OPTN;ATP6V1E1;SNX6;ZDHHC17;TFRC;RAB1A;COPA;USO1;STX17;CLU
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,0.6594889767457708,1.3027644495580162,0.20454545454545456,1.0,1.0,7/21,25.82%,KRAS;PKM;PIK3CA;PTEN;HK1;AKT3;FGFR1
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",0.5711472407752173,1.3027154581286031,0.13953488372093023,1.0,1.0,7/53,7.01%,CREB5;ITPR3;MAPK10;KRAS;IGFBP3;PLCB1;PIK3CA
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Large Intestine,0.5627582199256809,1.3022498933762616,0.14583333333333334,1.0,1.0,5/42,7.73%,SRGAP1;LRRTM4;BRWD1;WDPCP;CEP112
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.7975059109163218,-1.3022242290463615,0.125,0.5997838943892883,1.0,3/8,9.08%,TMEM117;MAP3K5;ERO1A
prerank,CellMarker_Augmented_2021__Stromal cell:Bone Marrow,0.8049751428868979,1.301588911037735,0.13114754098360656,1.0,1.0,2/5,6.43%,ITGA1;ALCAM
prerank,CellMarker_Augmented_2021__Sertoli cell:Seminal Plasma,-0.7743492394173308,-1.3014454438004222,0.12244897959183673,0.6016501984502768,1.0,1/7,4.75%,SLC38A3
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,0.7942220422262798,1.3012656472014463,0.08888888888888889,1.0,1.0,3/9,15.30%,CCNI;HSPD1;HSPA9
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.8480533106168362,1.3010054308409134,0.03333333333333333,1.0,1.0,1/7,0.96%,CRY1
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6541250548764426,1.30033636576168,0.13953488372093023,1.0,1.0,7/20,17.69%,GRIA2;SNAP25;MAPK10;NRXN1;CNTN1;PLPPR4;KCNT2
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.8562147437668536,1.2999496143461977,0.14,1.0,1.0,1/6,0.24%,HSD17B4
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,-0.7884476282162156,-1.2990539960826015,0.22727272727272727,0.6084944592169687,1.0,1/7,2.39%,FN1
prerank,Reactome_2022__MET Activates PTPN11 R-HSA-8865999,0.8262771108889382,1.2988617123555113,0.1568627450980392,1.0,1.0,2/5,15.56%,PIGU;GRB2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.8164016900917351,-1.2987497538912358,0.14285714285714285,0.6082638693280001,1.0,1/5,7.52%,JCAD
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.7279353523691308,-1.298333921110805,0.17307692307692307,0.6088218401979055,1.0,5/15,13.23%,STAT1;STAT5B;UBC;UBE2D2;JAK2
prerank,KEGG_2021_Human__Hematopoietic cell lineage,0.7316148731192779,1.2980577069053714,0.1320754716981132,1.0,1.0,5/12,9.83%,IL1R1;IL6R;ITGA2;ITGA1;ITGA5
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.7254979661750219,-1.297767486793472,0.1702127659574468,0.6098596595678989,1.0,5/9,17.74%,RFC3;UBC;PRIMPOL;RFC1;POLK
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.5969228979533648,1.2971049442437694,0.10638297872340426,1.0,1.0,9/34,16.68%,ERBB4;NRG2;PIK3CA;PIGU;FRS2;PPP2CB;GRB2;PHLPP1;PTEN
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,-0.8210744865280974,-1.2970839144454136,0.16666666666666666,0.6112628815891218,1.0,1/7,2.39%,FN1
prerank,CellMarker_Augmented_2021__Epithelial cell:Epithelium,-0.5997897300991729,-1.297008084450359,0.15625,0.6105493194753292,1.0,8/37,9.27%,CLEC1A;IFI27;TNFSF10;TIE1;MMRN2;MYO15B;SLCO2B1;SCARF1
prerank,CellMarker_Augmented_2021__Oligodendrocyte Precursor cell:Brain,0.5649438325920213,1.297002274895719,0.1111111111111111,1.0,1.0,8/39,9.72%,NOVA1;GRM5;CADM2;GRIA2;MAPK10;ROBO2;NRXN1;ADGRB3
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.7850676615307559,1.2967302503225364,0.1276595744680851,1.0,1.0,1/7,0.24%,HSD17B4
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.7170224310290901,1.2961889829307551,0.10869565217391304,1.0,1.0,6/15,19.34%,HSD17B4;ACAT1;ACOX1;AIG1;SCP2;HADHB
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6996437069419458,1.2959486985181408,0.20833333333333334,1.0,1.0,4/13,10.36%,ANKH;SMAD6;CHSY1;S1PR1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.8044970881502241,1.2958289340172806,0.1346153846153846,1.0,1.0,1/7,7.62%,YTHDF2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.7926918647497297,-1.295331669042716,0.1951219512195122,0.6154942447402295,1.0,1/5,3.21%,CHKA
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.5986483194187296,1.2952477261427924,0.09090909090909091,1.0,1.0,11/27,21.73%,HDAC9;HDAC7;CCNC;ADAM10;MIB1;PSEN1;CREBBP;EP300;NCOR2;ADAM17;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.7732673512967211,-1.2951393966529834,0.17391304347826086,0.6152868270068291,1.0,3/15,9.46%,CYLD;TNFSF10;PMAIP1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.8595500093047048,-1.294983702824582,0.1875,0.6148570540559265,1.0,3/5,10.07%,PARP14;ZC3HAV1;PARP9
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.5232793863143723,-1.2948574358674239,0.07692307692307693,0.6144763252278634,1.0,16/128,8.98%,VCAM1;CX3CL1;GBP1;STAT1;FN1;CXCL12;IRF1;IL32;GBP4;SMAD3;NFKB1;STK39;FOS;TANK;CD47;STAT5B
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.8179212510238424,1.2943600269519075,0.09615384615384616,1.0,1.0,2/5,9.22%,BMP6;PPM1F
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.6898861701969266,1.2943142021154603,0.10714285714285714,1.0,1.0,8/15,24.01%,SEMA3F;ALCAM;HSP90AA1;PPP3CB;NRP1;CYFIP1;HSP90AB1;USP9X
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.7961488278489316,-1.294313047379496,0.15384615384615385,0.6151606823471957,1.0,2/8,4.38%,CXCL12;LGALS3
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,-0.6823019633803362,-1.294249338091838,0.11320754716981132,0.6142733117167354,1.0,11/20,27.65%,ATP6V1E1;TFRC;UBC;IREB2;ACO1;FTH1;ABCG2;ATP6V1A;ATP6V1C1;RPS27A;CUL1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.658331792654396,1.2938585150027544,0.1320754716981132,1.0,1.0,10/24,21.65%,EIF4G3;EIF5;HSPB1;YTHDF2;EIF3E;KHDRBS1;EIF4A2;EIF5B;AGO2;EIF2AK3
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.6309552065090598,-1.2930066635575725,0.14814814814814814,0.6179002875485797,1.0,3/36,2.39%,VCAM1;STAT1;FN1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.7428444747784264,-1.292362228415529,0.17777777777777778,0.6191610204728216,1.0,3/13,11.29%,LRPAP1;AHI1;MTMR2
prerank,Reactome_2022__RUNX3 Regulates YAP1-mediated Transcription R-HSA-8951671,0.8344922523787259,1.292318948249001,0.12,1.0,1.0,1/5,1.04%,TEAD4
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,0.623544105142598,1.292164838249447,0.2037037037037037,1.0,1.0,6/21,18.67%,ITPR3;PLCB1;PRKX;ITPR2;CALM1;PRKCA
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.7661116412578186,-1.2918642207566535,0.2708333333333333,0.6200864628445163,1.0,2/7,9.54%,RIMS1;ARHGAP17
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.6558893705237092,-1.2912194668159995,0.125,0.6212611781087062,1.0,9/22,6.19%,RSAD2;MX1;IFIH1;ISG15;STAT1;TNIP1;ZC3HAV1;EIF2AK2;OAS3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.8214471149937885,1.2905544367081727,0.057692307692307696,1.0,1.0,3/9,11.71%,SMAD9;SMAD1;SMAD5
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,0.8218423017672437,1.290377711024746,0.1346153846153846,1.0,1.0,3/6,15.56%,PIK3CA;PIGU;GRB2
prerank,KEGG_2021_Human__Basal transcription factors,0.7803772321840758,1.29017253234643,0.12244897959183673,1.0,1.0,4/8,19.50%,TAF1;TAF3;GTF2I;TAF2
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.850348501532635,1.2899685615097851,0.18518518518518517,1.0,1.0,1/5,1.62%,SLC12A6
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.850348501532635,1.2899685615097851,0.18518518518518517,1.0,1.0,1/5,1.62%,SLC12A6
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5542318586913179,1.2899667353431428,0.08888888888888889,1.0,1.0,9/46,12.08%,INSIG1;SLC26A3;TAF1;HSP90B1;DIAPH1;URI1;ACTB;NCOA3;LRRK2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7904428800614827,-1.2895846301987415,0.18181818181818182,0.6263970272519733,1.0,4/6,17.74%,RFC3;UBC;RFC1;POLK
prerank,KEGG_2021_Human__Ovarian steroidogenesis,0.7375464394301795,1.2893959277446145,0.1836734693877551,1.0,1.0,1/10,2.07%,BMP6
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,0.8054997800198936,1.2891565444637472,0.1320754716981132,1.0,1.0,3/7,7.86%,ERBB4;GRIA2;LRRC7
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.8355291364167884,-1.2890362025679365,0.1568627450980392,0.6271971738630809,1.0,1/6,2.34%,CENATAC
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6371238698122146,1.2889595420893576,0.09259259259259259,1.0,1.0,4/23,9.16%,ABL2;ERBB4;TPST2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.6661306643093556,-1.288929064708045,0.1346153846153846,0.6266930209400275,1.0,2/21,5.58%,CX3CL1;PLXND1
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,-0.7778619650253246,-1.2888758351366796,0.1590909090909091,0.6258458648741178,1.0,3/6,12.56%,RFC3;UBC;NPLOC4
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.8163715753242375,1.2888062334676824,0.1323529411764706,1.0,1.0,3/5,17.74%,SLC8A1;CALM1;ANK3
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.7630018177268509,1.288670387036989,0.09302325581395349,1.0,1.0,1/6,1.86%,RARB
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,-0.6905741579664023,-1.288420770093196,0.1,0.6264868209538927,1.0,3/19,2.55%,VCAM1;FN1;ITGB5
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.7281113472659608,-1.2881902846396116,0.29545454545454547,0.6263607717116845,1.0,3/11,8.55%,CYLD;PRKN;TAOK3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.8185834379729757,1.2875882816886428,0.1875,1.0,1.0,1/6,1.57%,ERBB4
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5551295310103919,1.287438657933868,0.15384615384615385,1.0,1.0,9/42,15.22%,NOVA1;MBNL1;NOVA2;REST;KHDRBS3;CELF2;RBFOX1;SFSWAP;KHDRBS1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.78038063547439,1.2872758372857118,0.14285714285714285,1.0,1.0,4/8,13.39%,PPM1F;PPP2CB;PPP3CA;PPP2R2B
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.6637698357241318,-1.2871224201444316,0.25,0.6288697516732027,1.0,1/16,0.24%,HES1
prerank,CellMarker_Augmented_2021__Basophil:Umbilical Cord Blood,-0.8451700584347845,-1.2868763857801286,0.14285714285714285,0.6276479504996992,1.0,2/5,10.46%,LCP2;ARHGAP15
prerank,CellMarker_Augmented_2021__T cell:Eye,-0.8451700584347845,-1.2868763857801286,0.14285714285714285,0.6276479504996992,1.0,2/5,10.46%,LCP2;ARHGAP15
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.8667553154281774,-1.2865738141970389,0.14814814814814814,0.6278623224856908,1.0,4/5,13.44%,HLA-F;HLA-B;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.7385005612236601,1.2865430278521193,0.12244897959183673,1.0,1.0,3/12,11.55%,HSD17B4;ACAT1;ACOX1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.8392562180883643,-1.286121663580894,0.1956521739130435,0.6284789278627468,1.0,1/5,2.26%,PLK2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5596851593839807,-1.2860678818927183,0.09375,0.6277785486921512,1.0,8/104,4.97%,VCAM1;IFI27;CXCL12;CAVIN2;LAMA4;GPM6A;TIE1;MMRN2
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.7400117597280025,1.2858873470458758,0.10909090909090909,1.0,1.0,3/10,8.45%,GLO1;PKM;SLC16A1
prerank,Reactome_2022__TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,0.7940657280409622,1.2858421736009582,0.20833333333333334,1.0,1.0,1/6,5.76%,IGFBP3
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,0.8337479930460316,1.2858388610692721,0.13793103448275862,1.0,1.0,2/5,15.56%,PIK3CA;GRB2
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.7160531356494045,1.2855799536125374,0.17777777777777778,1.0,1.0,1/11,0.74%,ABL2
prerank,CellMarker_Augmented_2021__Natural Killer cell:Breast,0.6472295055329396,1.2855244152807628,0.15217391304347827,1.0,1.0,9/21,11.61%,CADM2;GRIA2;NCAM1;NRXN1;TRIM9;ADGRB3;RTN1;CACNA1C;RBFOX1
prerank,CellMarker_Augmented_2021__Definitive Zone cell:Adrenal Gland,0.6472295055329396,1.2855244152807628,0.15217391304347827,1.0,1.0,9/21,11.61%,CADM2;GRIA2;NCAM1;NRXN1;TRIM9;ADGRB3;RTN1;CACNA1C;RBFOX1
prerank,CellMarker_Augmented_2021__Chromaffin cell:Adrenal Gland,0.6472295055329396,1.2855244152807628,0.15217391304347827,1.0,1.0,9/21,11.61%,CADM2;GRIA2;NCAM1;NRXN1;TRIM9;ADGRB3;RTN1;CACNA1C;RBFOX1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.7873309295566238,1.2854265833353296,0.17307692307692307,1.0,1.0,2/5,18.11%,CHPT1;AGPS
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.663268425682384,1.2851486007444077,0.2222222222222222,1.0,1.0,10/15,16.15%,GRM5;CADM2;GRIA2;SNAP25;NKAIN2;ADGRB3;RBFOX1;HS6ST3;ANK2;PLPPR4
prerank,CellMarker_Augmented_2021__Plasmablast:Blood,-0.8309709035889112,-1.2842973273320395,0.1346153846153846,0.6329817022358791,1.0,2/6,10.46%,LCP2;ARHGAP15
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7713377443004616,1.2841722093556422,0.16666666666666666,1.0,1.0,3/7,9.19%,DSE;CHSY1;CHST15
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.768706771470708,-1.283970504665536,0.22448979591836735,0.6332947427302751,1.0,1/10,0.21%,RSAD2
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.4778980411158214,-1.2839110522136354,0.0136986301369863,0.6325286780314585,1.0,32/334,8.98%,CD74;HES1;TBX3;CX3CL1;NR4A1;ZIC1;PPARG;RREB1;MAP3K2;STAT1;IRF2;HMGN1;IRF1;TNIP1;SP100;PRKN;SMARCA1;SERPINE1;NLRC5;MAP3K5;MEF2A;SMAD3;PAXBP1;NFKBIA;LMO2;MAML3;FOXK1;NFKB1;FOS;CEBPZ;JUN;STAT5B
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,-0.7068051569152887,-1.2834107902134564,0.22641509433962265,0.6333182163483755,1.0,4/13,17.58%,RHOBTB1;VIM;SRRM1;PDE5A
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.7665555979879709,-1.2833448773751488,0.14893617021276595,0.6327847537789413,1.0,4/9,11.71%,ISG15;RFC3;TRIM25;UBC
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.8096466574040151,-1.2831527830094995,0.11320754716981132,0.632467552077485,1.0,2/5,7.68%,NFKBIA;NFKB1
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.7563697379189133,1.2826440177224259,0.19607843137254902,1.0,1.0,4/10,9.19%,DSE;HSPG2;CHSY1;CHST15
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5752079385526504,1.2824441201789298,0.15,1.0,1.0,11/32,12.83%,GRM5;CADM2;GRIA2;SNAP25;NTM;SLC25A46;NRXN1;ADGRB3;S1PR1;RBFOX1;BAALC
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.8467483799788071,-1.282426884457854,0.12244897959183673,0.6340344770176952,1.0,2/5,6.43%,ACSL4;MYRIP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.8467296965204004,-1.2822154577417302,0.13636363636363635,0.6338386589958857,1.0,2/5,10.17%,PRKN;RPS7
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Undefined,0.788407522129168,1.282173590767852,0.10909090909090909,1.0,1.0,3/8,9.83%,ITGA2;ITGA1;ITGA5
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6887726440218914,-1.282130661753827,0.12,0.6332160083028967,1.0,2/25,2.23%,CD74;PLCG2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.5666763399912276,1.2816757657031213,0.15555555555555556,1.0,1.0,7/47,8.15%,HDAC9;RBM20;ERBB4;FGF12;CHD7;UTY;TAB2
prerank,Reactome_2022__Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.7765867417429821,1.281379483849196,0.20454545454545456,1.0,1.0,3/5,18.67%,GRIA2;AP2B1;PRKCA
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,0.7786198777125801,1.2811969811697803,0.1,1.0,1.0,4/8,7.44%,ERBB4;NRG2;PIK3CA;PIGU
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.6261824277684502,-1.2811216872311442,0.1,0.6357960607814653,1.0,5/44,2.44%,CD74;CX3CL1;PLCG2;FN1;ULK4
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.7399880510060896,1.2810587961602788,0.1509433962264151,1.0,1.0,3/11,16.49%,SNAP25;HSP90AA1;CALM1
prerank,KEGG_2021_Human__AMPK signaling pathway,0.5645285310632308,1.2807539119005231,0.15217391304347827,1.0,1.0,1/42,0.03%,CREB5
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.7318272404866124,1.2807235740175305,0.125,1.0,1.0,2/9,3.85%,ATP2A2;PACS2
prerank,CellMarker_Augmented_2021__Macrophage:Intervertebral Disc,-0.7437469359184411,-1.2801295151700072,0.24,0.638825043569142,1.0,2/7,17.26%,LCP2;GIMAP8
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.82115063743038,1.279208619595055,0.14035087719298245,1.0,1.0,4/5,17.74%,SLC12A6;TMTC2;SLC8A1;ANK3
prerank,CellMarker_Augmented_2021__Preadipocyte:Adipose Tissue,-0.726528671150541,-1.278970538590925,0.22,0.6411459898581087,1.0,2/8,17.26%,LCP2;GIMAP8
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8341758009230309,-1.2789222674900433,0.17391304347826086,0.6404251667468509,1.0,2/5,12.86%,RREB1;ENPP2
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,-0.5610871809372859,-1.2787726470076544,0.16666666666666666,0.6399640587834373,1.0,10/57,11.71%,CYLD;PSMA1;IFIH1;PSMB9;SMAD3;NFKBIA;ATXN7;TANK;STAM2;UBC
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.6545650153633497,1.2779893323365619,0.1956521739130435,1.0,1.0,4/13,15.91%,RALA;ANXA2;HSPA9;CDC42
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.8387159805047303,-1.2777329361327132,0.21568627450980393,0.6428328562183979,1.0,1/5,3.72%,CASS4
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,0.684041238257499,1.2775645176583685,0.1702127659574468,1.0,1.0,4/15,11.55%,HSD17B4;PEX14;IDE;ACOX1
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,0.5664785512210895,1.277527130850929,0.1568627450980392,1.0,1.0,3/31,2.79%,CREB5;ITPR3;PRKD1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.7759247279615812,1.2774861014502006,0.14,1.0,1.0,5/9,13.20%,FUT8;MCFD2;MGAT5;STT3B;UBE2J1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.7759247279615812,1.2774861014502006,0.14,1.0,1.0,5/9,13.20%,FUT8;MCFD2;MGAT5;STT3B;UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.8354737448396866,1.277380509890463,0.17647058823529413,1.0,1.0,1/6,5.29%,CCDC88A
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.7706429206228431,-1.2773651229219918,0.1509433962264151,0.643457298249632,1.0,3/9,2.36%,PPARG;SOD2;TPM1
prerank,KEGG_2021_Human__Autoimmune thyroid disease,-0.8670212765957447,-1.2771264800344972,0.12244897959183673,0.639683479123263,1.0,5/5,13.44%,HLA-F;HLA-B;HLA-C;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8670212765957447,-1.2771264800344972,0.12244897959183673,0.639683479123263,1.0,5/5,13.44%,HLA-F;HLA-B;HLA-C;HLA-E;HLA-A
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.8670212765957447,-1.2771264800344972,0.12244897959183673,0.639683479123263,1.0,5/5,13.44%,HLA-F;HLA-B;HLA-C;HLA-E;HLA-A
prerank,KEGG_2021_Human__Allograft rejection,-0.8670212765957447,-1.2771264800344972,0.12244897959183673,0.639683479123263,1.0,5/5,13.44%,HLA-F;HLA-B;HLA-C;HLA-E;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8670212765957447,-1.2771264800344972,0.12244897959183673,0.639683479123263,1.0,5/5,13.44%,HLA-F;HLA-B;HLA-C;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.6981581892044479,-1.2770129083654556,0.20833333333333334,0.6392887396792222,1.0,1/11,3.45%,CARMIL1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.7658611544203461,-1.2764397215435033,0.21568627450980393,0.6405549685618335,1.0,1/6,2.52%,IFI27
prerank,KEGG_2021_Human__Hepatitis C,-0.60773437419057,-1.2761737716128219,0.15,0.6405184668122414,1.0,7/53,7.68%,RSAD2;MX1;STAT1;EIF2AK2;OAS3;NFKBIA;NFKB1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.7498878541668649,1.2761388716286426,0.23076923076923078,1.0,1.0,1/10,0.08%,PDK4
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.7520727734879276,1.2759558744235486,0.1836734693877551,1.0,1.0,5/6,24.86%,CBFB;ELF1;SLC39A10;CD81;ELF2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.7888183111671073,1.2754353126842504,0.1568627450980392,1.0,1.0,2/7,11.13%,STIM1;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.6713135687649823,-1.2750857206892114,0.22807017543859648,0.6435534985686552,1.0,2/20,3.45%,CX3CL1;CARMIL1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.711536464949893,-1.274853714659662,0.1346153846153846,0.6433787569547722,1.0,4/14,10.94%,NR4A1;RNF213;EFNB2;RECK
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.8401762847629116,1.2746476798027224,0.10909090909090909,1.0,1.0,1/6,0.05%,TRIM5
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,0.8201145265333603,1.274318347480043,0.14,1.0,1.0,1/7,3.53%,ATP2A2
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.7664023028186585,-1.2742032288670473,0.17391304347826086,0.6449587835643562,1.0,2/9,4.01%,MX1;PRKN
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.593197706213949,1.2741750760047963,0.1509433962264151,1.0,1.0,4/27,5.21%,PDK4;CRY1;HECTD4;BACE2
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.7992268268863778,1.274013073081285,0.21052631578947367,1.0,1.0,2/6,12.08%,SLC26A3;LRRK2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.8047291961192365,-1.2734982158676318,0.2765957446808511,0.6466233076753005,1.0,1/5,6.99%,LCP2
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6861536603850181,-1.2734879957866034,0.2222222222222222,0.6457037045877783,1.0,10/20,13.44%,ISG15;OPTN;SERPINE1;OAS3;GBP4;RPL30;HLA-E;RPS19;RAB1A;HLA-A
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,0.7211535267570557,1.2732654297182115,0.23529411764705882,1.0,1.0,3/8,17.42%,PIK3CA;FRS2;EP300
prerank,CellMarker_Augmented_2021__Ciliated cell:Lung,-0.6399172040053731,-1.2726448327968864,0.1896551724137931,0.6477472089001818,1.0,5/32,6.00%,LAP3;ANKRD37;ULK4;IFI27;SPC25
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.6414790336936509,-1.2725906033251553,0.19607843137254902,0.6470060077698188,1.0,13/26,9.19%,VCAM1;GBP1;STAT1;IRF2;HLA-F;HLA-B;IRF1;HLA-C;SP100;OAS3;B2M;TRIM25;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.6485436501555378,-1.272324031799186,0.14035087719298245,0.6468278070774929,1.0,3/35,4.01%,HES1;PPARG;PRKN
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,-0.7159881102154706,-1.2722484606710722,0.16071428571428573,0.6460900568150659,1.0,4/9,18.91%,SMAD3;TBK1;IL18R1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.4853900243917701,-1.2718460733944743,0.04477611940298507,0.6462816145590184,1.0,26/264,8.98%,HES1;TBX3;CX3CL1;NR4A1;PPARG;RREB1;STAT1;IRF2;IRF1;TNIP1;PRKN;SMARCA1;PLXND1;SERPINE1;NLRC5;MEF2A;SMAD3;PAXBP1;NFKBIA;LMO2;MAML3;NFKB1;FOS;CEBPZ;JUN;STAT5B
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.8156968619805323,-1.2717487710672464,0.18867924528301888,0.64560554563969,1.0,4/6,13.44%,HLA-F;HLA-B;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.7270323108391821,1.2717273634456971,0.17307692307692307,1.0,1.0,7/12,22.55%,TRAK1;TRAK2;ERCC6;ANXA1;RYK;CDK5RAP2;CDK6
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.7070828052727656,-1.271494709238219,0.22,0.6447867554774205,1.0,6/17,13.23%,IFIH1;PLCG2;OAS3;HLA-E;CLU;JAK2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.7070828052727656,-1.271494709238219,0.22,0.6447867554774205,1.0,6/17,13.23%,IFIH1;PLCG2;OAS3;HLA-E;CLU;JAK2
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.7326751464964963,1.2711548001837563,0.1875,1.0,1.0,5/8,16.63%,KPNA3;RANBP2;KPNA1;CBLB;KPNA5
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.6745974528606579,1.2711326150155873,0.16666666666666666,1.0,1.0,5/17,13.44%,PSMD14;YY1;MORF4L1;SEM1;INO80
prerank,Reactome_2022__NF-kB Is Activated And Signals Survival R-HSA-209560,-0.808791357091031,-1.2710378339566988,0.14583333333333334,0.6453010128430262,1.0,3/7,11.71%,NFKBIA;NFKB1;UBC
prerank,CellMarker_Augmented_2021__Periosteum-derived Progenitor cell:Periosteum,-0.63230379546377,-1.2709501466377626,0.16363636363636364,0.6446448055312521,1.0,2/28,2.79%,VCAM1;CXCL12
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.45834118792051337,1.270708971849584,0.06060606060606061,1.0,1.0,41/179,20.74%,PDK4;ABL2;CRY1;ERBB4;PRKG1;PRKD1;TAF1;BCR;PRAG1;MORC3;MAPK10;IGFBP3;CSNK1G3;STK38L;PRKX;PXK;YWHAZ;ABL1;NLK;LRRK2;PPP3CB;EPHA4;FNIP2;PINK1;ADAM10;RPS6KA5;STK24;NEK7;OXSR1;BAZ1B;WNK1;ACVR2A;PRKCA;ROCK1;RYK;LIMK2;TOP1;FES;TAOK1;DYRK1A;CDK12
prerank,Reactome_2022__MECP2 Regulates Transcription Factors R-HSA-9022707,-0.8387011392051615,-1.2705963283376134,0.15217391304347827,0.6449389261522874,1.0,1/5,1.01%,PPARG
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.7898273219560219,-1.2705479359365344,0.16,0.6442122424850658,1.0,4/7,18.91%,NFKBIA;NFKB1;ITGAV;PTPN2
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.7996520760568091,1.2705471522325846,0.23404255319148937,1.0,1.0,2/7,9.19%,CRY1;CHST15
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.8125087152762409,1.2703070818861688,0.20833333333333334,1.0,1.0,1/5,7.92%,CA5B
prerank,KEGG_2021_Human__Circadian entrainment,0.5914614116236575,1.2702111573219859,0.20408163265306123,1.0,1.0,9/31,18.67%,ITPR3;PRKG1;GRIA2;PLCB1;CACNA1C;GNB4;RPS6KA5;CALM1;PRKCA
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.7608854985102846,-1.2698582977913406,0.24,0.6457720195718637,1.0,2/7,16.02%,NTNG1;MFSD2A
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.750999580707008,-1.2697339179568206,0.19230769230769232,0.6453368085620249,1.0,1/12,1.01%,PPARG
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.6482966906550435,-1.2694047577462224,0.22916666666666666,0.6454977039701836,1.0,3/15,11.26%,GMPS;RFC3;MSH2
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.788401322455116,-1.2693659087543399,0.17647058823529413,0.6447308706469187,1.0,3/5,18.03%,RAPGEF2;RIN2;CD34
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.852557630648499,-1.2692572272092204,0.15217391304347827,0.6441542873815874,1.0,2/5,12.54%,ABCA5;CLU
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.7529408991126363,1.268807547774071,0.17777777777777778,1.0,1.0,4/9,17.69%,SLC12A6;SLC24A2;ATP1A1;KCNT2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.595145879729162,-1.2685077538056122,0.21818181818181817,0.6460932536087175,1.0,5/36,8.55%,CYLD;ULK4;PRKN;MAP3K5;TAOK3
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.7494573377487243,-1.2682898544926644,0.19298245614035087,0.6460213395028999,1.0,4/14,6.80%,SLC6A6;SLC5A6;SCN3A;SCN2A
prerank,Reactome_2022__TRAIL Signaling R-HSA-75158,-0.8116218349343725,-1.2682693064000579,0.1590909090909091,0.645142820686491,1.0,1/6,4.41%,TNFSF10
prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.6183827128644177,-1.2682674160279146,0.16363636363636364,0.6442667661584871,1.0,7/40,8.92%,SLC22A5;CHKA;LYPLA1;GPCPD1;FOS;DGKG;JUN
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,0.6430583762763384,1.2680324384321402,0.2,1.0,1.0,5/18,15.56%,PIK3CA;PIGU;FRS2;PPP2CB;GRB2
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.7394589769277335,1.267917116863634,0.2631578947368421,1.0,1.0,4/9,17.42%,YY1;HSPD1;CREBBP;EP300
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5608607973571764,-1.2674556702163076,0.17647058823529413,0.6458786403574626,1.0,3/24,11.10%,ATP9A;RAB1A;COPA
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,0.6054589021727409,1.2673545372161834,0.14893617021276595,1.0,1.0,4/25,4.78%,VAPB;PRKD1;KDSR;UGCG
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,-0.4787374804561521,-1.2672631409706854,0.0641025641025641,0.6456496137865623,1.0,16/215,4.22%,VCAM1;CD74;KLHL20;PSMA1;PSMB9;PLCG2;ITGB5;HLA-F;HLA-B;HLA-C;UFL1;RNF213;RNF19A;ARIH2;PRKN;HERC6
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.6418444583006322,-1.2669102984491474,0.16666666666666666,0.6459083373146526,1.0,3/26,4.86%,NR4A1;STAT1;TIE1
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,0.49495287985702663,1.2664359181925635,0.025,1.0,1.0,23/79,19.92%,PDIA3;CALR;FUT8;COG6;MCFD2;MAN1A2;MGAT5;MLEC;ST8SIA4;BET1;ANKRD28;TFG;CD59;RAD23B;ANK2;CAPZB;COG5;ARF4;ANK3;PPP6R3;PPP6C;UGGT1;CANX
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.8174408771176433,-1.2663506066396837,0.22,0.6468816788461422,1.0,1/8,1.01%,PPARG
prerank,CellMarker_Augmented_2021__Keratinocyte Progenitor cell:Skin,-0.6192448743346608,-1.2663119976139936,0.1896551724137931,0.6461235981111179,1.0,6/39,6.56%,OMD;IFI27;TIE1;MMRN2;ARHGEF37;SLCO2B1
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,-0.7490620178323548,-1.2661967490488057,0.20408163265306123,0.6446137539805279,1.0,2/6,11.71%,RFC3;UBC
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,-0.7490620178323548,-1.2661967490488057,0.20408163265306123,0.6446137539805279,1.0,2/6,11.71%,RFC3;UBC
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.7034655617244857,-1.2661416133268901,0.15384615384615385,0.6439046553265027,1.0,4/16,6.56%,GMPS;VAV3;SLC38A3;SLCO2B1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.7351649478600001,-1.2661264492849595,0.24,0.6430838592049276,1.0,2/6,4.38%,CXCL12;LGALS3
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,-0.8207764856012639,-1.2657638452087525,0.12,0.6434287549550709,1.0,1/6,3.51%,ATP6V1E1
prerank,CellMarker_Augmented_2021__Leydig cell:Fetal Gonad,-0.5357535337571598,-1.2657490757028764,0.14516129032258066,0.6425542096735166,1.0,21/87,12.01%,EPSTI1;LAP3;PIGC;RPS12;STAT1;IFI27;LAMA4;RPS18;PABPC1;RPS8;RPL7A;NFKB1;PRSS23;S100A6;RPS7;NNT;RPS14;NDFIP1;TLN2;UPF3A;SULF2
prerank,Reactome_2022__Neuronal System R-HSA-112316,0.4884796984291627,1.2654572705898497,0.10638297872340426,1.0,1.0,21/83,16.49%,ERBB4;GRM5;GRIA2;SNAP25;LRRTM4;PLCB1;PRKX;DNAJC5;LRRC7;DLGAP2;NRXN1;HOMER1;PPM1F;GNB4;NRXN3;NPTN;AP2B1;HSPA8;IL1RAPL1;NLGN1;CALM1
prerank,CellMarker_Augmented_2021__Goblet cell:Large Intestine,-0.787316416391227,-1.2650205421323961,0.19148936170212766,0.6441722878483762,1.0,2/5,2.63%,IFI27;HLA-F
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.7770282857361995,-1.264884981564609,0.22,0.6436806224258251,1.0,1/8,0.56%,CYLD
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.6755966418809867,1.264841526929565,0.21568627450980393,1.0,1.0,1/13,0.16%,AFF3
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.7564457323806413,-1.2648037638749974,0.23529411764705882,0.6420954471230457,1.0,3/12,6.75%,CEMIP;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.7564457323806413,-1.2648037638749974,0.23529411764705882,0.6420954471230457,1.0,3/12,6.75%,CEMIP;CLIC5;CDC14A
prerank,Reactome_2022__PI3K Events In ERBB4 Signaling R-HSA-1250342,0.8288101357320276,1.2646419725339504,0.15217391304347827,1.0,1.0,3/5,7.01%,ERBB4;NRG2;PIK3CA
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.7879251201670444,-1.2644119581519848,0.22,0.6427624997635978,1.0,1/6,1.12%,GBP1
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,0.5685129692104314,1.2641731880490674,0.18181818181818182,1.0,1.0,3/35,7.46%,HSD17B4;NUP58;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.6953261753191151,-1.264091026635298,0.13636363636363635,0.642865644253909,1.0,1/11,0.50%,DDX60
prerank,CellMarker_Augmented_2021__White Blood cell:Blood,-0.8196125582240749,-1.2637715916688241,0.10869565217391304,0.6421181615099235,1.0,2/7,10.46%,LCP2;ARHGAP15
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Undefined,-0.8196125582240749,-1.2637715916688241,0.10869565217391304,0.6421181615099235,1.0,2/7,10.46%,LCP2;ARHGAP15
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.7509733111025447,-1.2635995658533754,0.1509433962264151,0.6417179607680757,1.0,1/9,0.56%,CYLD
prerank,CellMarker_Augmented_2021__Mesodermal Embryonic Stem cell:Germ,-0.6098262962478593,-1.2630892742702502,0.09836065573770492,0.6426884433644444,1.0,2/55,0.77%,VCAM1;CLEC1A
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.5818719317112053,-1.263019587056226,0.18333333333333332,0.6419536015518379,1.0,4/50,10.09%,CX3CL1;RGS6;LARS1;NET1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.49483267484015997,-1.262929348442419,0.0945945945945946,0.6414298185031896,1.0,31/123,14.63%,RPS12;RPL31;TNIP1;RPS18;RPL34;RPS8;RPL15;YTHDC1;RPS6;RPL7A;RPL38;MEF2A;WARS1;RPL23;RPL30;RPS28;RPS19;POLR2A;PTMA;RPS7;RPS14;RPS15;RPL28;RPL10;SRSF5;RPL9;SRRM1;EEF1A1;NUP54;RPL24;RPL37
prerank,KEGG_2021_Human__Cushing syndrome,0.5528191685820941,1.262908336279636,0.15217391304347827,1.0,1.0,2/45,1.38%,CREB5;ITPR3
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.8172969398346408,1.2628334404499748,0.1702127659574468,1.0,1.0,2/6,7.38%,TET2;WDR82
prerank,CellMarker_Augmented_2021__Thymic Emigrant cell:Blood,-0.7414355466978141,-1.2626829349899342,0.29411764705882354,0.6412971762376806,1.0,3/9,17.26%,LCP2;ARHGAP15;GIMAP8
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,0.6929368171910025,1.2625491724926752,0.13333333333333333,1.0,1.0,1/14,0.27%,HDAC9
prerank,CellMarker_Augmented_2021__Monocyte:Bone Marrow,-0.7438079288793018,-1.2622860061710302,0.25,0.6415957838216795,1.0,2/6,17.26%,LCP2;GIMAP8
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.7345203473519448,-1.2621151942963267,0.1794871794871795,0.6413383480233202,1.0,5/13,6.91%,ISG15;CDC37;NLRC5;OAS3;SAMHD1
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Corneal Endothelium,-0.6376463508125751,-1.2619576113762125,0.22413793103448276,0.6410677458742675,1.0,3/41,2.79%,CX3CL1;KIAA1217;CXCL12
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.6995548543781275,-1.2617771111835763,0.2916666666666667,0.6406179096899515,1.0,2/13,4.75%,SLC6A6;SLC38A3
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.5748937423430218,-1.2615320559997991,0.125,0.6405978535282425,1.0,5/58,6.40%,CD74;CX3CL1;TPM1;SERPINE1;SRGAP2C
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.7281382027626347,-1.2614496682851333,0.2127659574468085,0.6400532175686177,1.0,1/9,0.24%,HES1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.7709764903300181,1.2613372629688555,0.1276595744680851,1.0,1.0,1/6,2.44%,NDUFAF2
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.7709764903300181,1.2613372629688555,0.1276595744680851,1.0,1.0,1/6,2.44%,NDUFAF2
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,0.7709764903300181,1.2613372629688555,0.1276595744680851,1.0,1.0,1/6,2.44%,NDUFAF2
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.8402905929830156,-1.2613269208105993,0.2391304347826087,0.639523833279731,1.0,1/5,1.35%,PARP12
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.7876610669939212,-1.2612518710227696,0.25925925925925924,0.6389683319792442,1.0,1/6,1.01%,PPARG
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.8040372111283007,-1.2611283900092107,0.23529411764705882,0.6385930781680728,1.0,1/6,1.62%,ATP9A
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.7844951755007195,1.2610939038023812,0.23404255319148937,1.0,1.0,1/6,1.89%,AGTPBP1
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.702913374218276,1.2606267145612071,0.14285714285714285,1.0,1.0,8/13,24.01%,SEMA3F;ALCAM;HSP90AA1;PPP3CB;NRP1;CYFIP1;HSP90AB1;USP9X
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.8186875177339943,-1.2605035971173508,0.14545454545454545,0.6396469803181445,1.0,3/8,12.70%,PPARG;NFKBIA;ITGAV
prerank,CellMarker_Augmented_2021__Endocrine cell:Undefined,0.6938202812209262,1.260496059057076,0.21818181818181817,1.0,1.0,3/10,11.87%,CYYR1;SLC52A3;SHROOM4
prerank,CellMarker_Augmented_2021__Endocrine cell:Embryonic Stem Cell,0.6938202812209262,1.260496059057076,0.21818181818181817,1.0,1.0,3/10,11.87%,CYYR1;SLC52A3;SHROOM4
prerank,Reactome_2022__Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,-0.8158443728859569,-1.2598666571297643,0.24489795918367346,0.6407529200085094,1.0,1/6,4.38%,LGALS3
prerank,KEGG_2021_Human__Arginine and proline metabolism,-0.7799374575019766,-1.259707284965263,0.22448979591836735,0.6404452643668355,1.0,2/8,0.98%,LAP3;SAT1
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Germ,0.6658213641385654,1.2595915871567773,0.21568627450980393,1.0,1.0,6/13,9.64%,GRM5;GRIA2;PEX5L;DLGAP2;NRXN1;RALYL
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.5531779874476837,1.259373567443371,0.1951219512195122,1.0,1.0,9/43,12.70%,ERBB4;GRIA2;PLCB1;PRKX;LRRC7;PPM1F;GNB4;NPTN;AP2B1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.7271348385298281,-1.2589909887599064,0.2459016393442623,0.6417249953385322,1.0,3/12,6.80%,SLC6A6;SCN3A;SCN2A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colorectum,0.7888443465818538,1.2585897433110689,0.23214285714285715,1.0,1.0,2/6,6.43%,CD58;ALCAM
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.8195187195065364,-1.25836577143859,0.2,0.642796431997857,1.0,2/5,13.71%,JCAD;PPP1R16B
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5978818628727438,1.2579393856681318,0.14634146341463414,1.0,1.0,11/23,18.27%,CALR;STIM1;VAPB;ATP2A2;NPTN;TMTC2;SLC8A1;SLC24A2;ANK2;ATP2B4;EDN1
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.718249201505842,1.2576082635269477,0.24444444444444444,1.0,1.0,3/10,22.55%,CBFB;AGO2;CDK6
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.8331161920316352,-1.257352609810358,0.2708333333333333,0.6451745473183901,1.0,3/5,12.86%,PDXDC1;ACER2;ENPP2
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.8271444091294632,1.2572655458037025,0.21153846153846154,1.0,1.0,1/6,2.12%,YWHAB
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.7144981866487892,-1.2572510591334178,0.25925925925925924,0.644726425918626,1.0,3/12,12.54%,ABCA5;LIMA1;CLU
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.596833816533682,1.2568562545971382,0.20454545454545456,1.0,1.0,5/22,15.64%,CRY1;UBQLN1;LRRK2;PINK1;UBE3A
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.6374563165441669,1.2566057828945492,0.16981132075471697,1.0,1.0,8/20,18.27%,ABL2;ITPR3;ABL1;CACNA1C;NPTN;SLC8A1;ATP2B4;EDN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.7228553307919092,1.256502898377424,0.1702127659574468,1.0,1.0,5/10,21.25%,ATP2A2;SLC8A1;ANK2;CALM1;RYR2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.6935037987750104,1.2564016326348462,0.2,1.0,1.0,6/17,14.48%,ABL2;ITPR3;ABL1;CACNA1C;NPTN;SLC8A1
prerank,KEGG_2021_Human__Gap junction,0.5514942719894028,1.2563213247990723,0.09803921568627451,1.0,1.0,6/34,6.85%,ITPR3;GRM5;PRKG1;TUBB4B;KRAS;PLCB1
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.7297327908529823,-1.2561808297368886,0.12244897959183673,0.6472453256657462,1.0,3/7,13.49%,TANK;UBC;TBK1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.8112461177360201,-1.2561752293551407,0.2,0.6464288072388109,1.0,2/5,5.60%,CXCL12;SERPINE1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.7147343717393309,-1.255508290885868,0.19148936170212766,0.6475276419379936,1.0,2/13,0.40%,HES1;PARP14
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.7074847458538036,1.254204822686467,0.16666666666666666,1.0,1.0,1/9,3.16%,SLC38A9
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.8725632328894453,-1.2540480327047399,0.1956521739130435,0.6517267113990806,1.0,1/5,2.82%,OPTN
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.8247158909402584,1.2536074795315142,0.1590909090909091,1.0,1.0,1/5,1.89%,AGTPBP1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.7793025746410343,1.2534966062693635,0.18181818181818182,1.0,1.0,2/6,3.93%,PNP;HSPH1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.6403016959568473,-1.253019250575693,0.16,0.6535870352535454,1.0,3/30,8.50%,CX3CL1;ACER2;LIMCH1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.5415851587501264,-1.2527410005294775,0.11290322580645161,0.6538071283412081,1.0,5/86,5.74%,CD74;HES1;RIMS1;SPG7;GEMIN5
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.5335709289281425,-1.252388245826172,0.109375,0.6540266422365347,1.0,8/90,3.72%,CEMIP;SOD2;RREB1;PLCG2;FN1;CXCL12;CARMIL1;CASS4
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,0.6374964876154366,1.2523875155881974,0.19230769230769232,1.0,1.0,6/15,18.99%,YWHAB;RALA;FRS2;RALB;GRB2;CRK
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.5932968663323855,1.252091865159431,0.18181818181818182,1.0,1.0,4/25,11.79%,HDAC9;TLE4;HDAC7;CCNC
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.6529874719798093,-1.2517258337090182,0.20754716981132076,0.6554452630976796,1.0,2/12,6.72%,ATP9A;TMEM30A
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.6602698254341747,-1.2514087406701289,0.2727272727272727,0.6554870463014374,1.0,1/6,7.04%,ANAPC16
prerank,KEGG_2021_Human__ABC transporters,-0.8261579744897307,-1.2513864157927808,0.21951219512195122,0.6547623971072005,1.0,2/8,4.49%,ABCA5;TAP1
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.6227523258118481,-1.2509947533097097,0.08928571428571429,0.6550600713458672,1.0,9/58,8.98%,CX3CL1;STAT1;PLCG2;CXCL12;GRK5;VAV3;NFKBIA;NFKB1;STAT5B
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.6506235887014806,1.2507351972356473,0.15384615384615385,1.0,1.0,8/25,22.50%,TRAM2;VAPB;RTN4;LRRK2;TOR1AIP2;ATL2;EIF2AK3;RTN3
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.5779700845641118,1.250696862761656,0.15555555555555556,1.0,1.0,10/38,10.12%,ABL2;ERBB4;INPP5F;PRAG1;NRG2;PRKX;DIAPH1;FRMD5;ABL1;HACE1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.7901593704811035,-1.2506073045875046,0.24489795918367346,0.6553837855763541,1.0,1/5,4.01%,PRKN
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.7973626397499376,-1.2505859455206243,0.2916666666666667,0.6546085428101438,1.0,3/6,18.35%,RAB1A;SEC23A;SEC24D
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.5143422138978809,-1.2504599674456178,0.08064516129032258,0.6540894303393961,1.0,19/149,8.39%,CD74;CX3CL1;DDX60;APOL3;PLCG2;PLK2;FN1;SHISA5;CASS4;PRKN;TNFSF10;NR3C2;EIF2AK2;ZDHHC17;JCAD;RPL23;TRIM25;TFRC;LARS1
prerank,CellMarker_Augmented_2021__Effector CD8+ Memory T (Tem) cell:Peripheral Blood,0.594888359510827,1.2504405119051192,0.175,1.0,1.0,8/24,21.70%,AGTPBP1;TPST2;CAPN2;ZEB2;SH3BP5;PXN;DSTN;ADGRG1
prerank,CellMarker_Augmented_2021__Purkinje cell:Undefined,0.7328468111692588,1.250189739146861,0.18867924528301888,1.0,1.0,2/8,2.18%,ITPR3;PRKG1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.8579748914006863,-1.2497086904742456,0.2926829268292683,0.6554148989078455,1.0,2/5,4.01%,ATP9A;PRKN
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.5349362145585375,-1.2497020408695405,0.09230769230769231,0.6546026219435046,1.0,10/129,4.01%,CD74;TBX3;CX3CL1;KLHL20;SOD2;PLK2;GRK5;RNF213;SNX6;PRKN
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.8577123033796911,-1.2496943888439103,0.2127659574468085,0.6529444749518607,1.0,1/6,0.53%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.8577123033796911,-1.2496943888439103,0.2127659574468085,0.6529444749518607,1.0,1/6,0.53%,CEMIP
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.7685530803646672,1.249605474912595,0.23076923076923078,1.0,1.0,4/7,14.50%,FUT8;MBNL1;CHD7;ADAM10
prerank,CellMarker_Augmented_2021__Macrophage:Subcutaneous Adipose Tissue,-0.7604978361713521,-1.2493013272254063,0.19230769230769232,0.6508715759440666,1.0,2/6,17.26%,LCP2;GIMAP8
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Peripheral Blood,-0.7604978361713521,-1.2493013272254063,0.19230769230769232,0.6508715759440666,1.0,2/6,17.26%,LCP2;GIMAP8
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Brain,-0.7604978361713521,-1.2493013272254063,0.19230769230769232,0.6508715759440666,1.0,2/6,17.26%,LCP2;GIMAP8
prerank,CellMarker_Augmented_2021__Monocyte:Subcutaneous Adipose Tissue,-0.7604978361713521,-1.2493013272254063,0.19230769230769232,0.6508715759440666,1.0,2/6,17.26%,LCP2;GIMAP8
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.7048523818250592,-1.2486016199638124,0.24242424242424243,0.6520288981884559,1.0,2/10,11.34%,VPS36;STAM2
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,0.5671690019689156,1.2484967595422711,0.1702127659574468,1.0,1.0,8/30,16.44%,GRM5;LRRTM4;DLGAP2;NRXN1;HOMER1;NRXN3;IL1RAPL1;NLGN1
prerank,CellMarker_Augmented_2021__Astrocyte:Brain,-0.5911041111799552,-1.248407771727683,0.1509433962264151,0.6517574231042034,1.0,14/50,18.65%,BTG2;DOK5;NFKBIA;FOS;DGKG;JUN;HLA-E;CST3;CLU;NFIA;EEPD1;HIF3A;EPAS1;FTH1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7337511893920464,1.2484057584933943,0.17073170731707318,1.0,1.0,1/9,0.27%,HDAC9
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.8682051414088758,1.2483607931290677,0.1111111111111111,1.0,1.0,3/5,12.78%,TMTC1;TMTC2;TMTC4
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.7701139428774161,1.2481335418138693,0.2,1.0,1.0,6/7,17.42%,BCL6;NFYC;FOXO3;PINK1;CREBBP;EP300
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7656411998364826,1.247707727375224,0.19230769230769232,1.0,1.0,2/6,6.06%,SOX5;TRPS1
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.7622895575679014,-1.2475697834519717,0.23255813953488372,0.6532798130856459,1.0,4/7,10.65%,RPS6;RPS7;SPPL2A;RPS14
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.5486320680072091,-1.2475525616352845,0.12307692307692308,0.6524938722273067,1.0,8/65,11.39%,PARP14;LRPAP1;OPTN;PRKN;NFKB1;PARP9;MTMR2;NDFIP1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.5805361110685454,1.2474665361169386,0.18,1.0,1.0,11/29,24.36%,BCR;EVI5;RALGAPB;TIAM2;TBC1D5;TIAM1;RALGAPA2;RABGAP1L;RALGAPA1;TBC1D9;TBC1D22A
prerank,CellMarker_Augmented_2021__Microglial cell:Embryonic Prefrontal Cortex,-0.5118733538206488,-1.247418862679778,0.11428571428571428,0.6519992739922159,1.0,21/131,10.73%,CD74;NR4A1;BTG2;SAT1;HLA-B;HLA-C;RNF213;SP100;GPM6A;SLCO2B1;MEF2A;NFKBIA;B2M;LPAR6;FOS;JUN;HLA-E;MYL12A;INPP5D;BST2;APPL2
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.6997258182909104,-1.2473579576544824,0.2553191489361702,0.651348329461545,1.0,4/14,11.18%,NDRG1;ACER2;PMAIP1;FHIT
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,0.7065648315125157,1.2472506792095046,0.21739130434782608,1.0,1.0,5/11,22.82%,PLCB1;PIK3CA;ATP1A1;HK1;AKT3
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.6282632633368767,1.2469723472393484,0.17391304347826086,1.0,1.0,6/23,13.65%,MCPH1;TENT4A;NAA50;DIS3L2;INO80;SMC1A
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.6243660686712671,1.2467640993749656,0.23529411764705882,1.0,1.0,7/14,25.18%,IFNAR1;SMAD6;TAB2;GCH1;ADAM17;CYRIB;NOS3
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.7698367726307771,1.2463655932108153,0.19230769230769232,1.0,1.0,5/7,21.25%,ITPR3;CACNA1C;SLC8A1;ATP2B4;RYR2
prerank,KEGG_2021_Human__Salivary secretion,0.6237828298393767,1.2456103963604084,0.1891891891891892,1.0,1.0,8/21,18.67%,ITPR3;PRKG1;PLCB1;ITPR2;CALM1;ATP2B4;ATP1A1;PRKCA
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7242203891211599,1.2455156628542559,0.20408163265306123,1.0,1.0,4/10,14.26%,SMAD6;ROBO2;PARVA;NRP1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.7396496256692481,-1.2453915587583873,0.2708333333333333,0.6563789749304062,1.0,4/11,13.23%,SP100;NFKBIA;JUN;JAK2
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.7851840277899336,1.2450794006453219,0.20754716981132076,1.0,1.0,2/6,10.60%,ABL2;SETX
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.5665218646564727,1.2448504252477788,0.1951219512195122,1.0,1.0,9/32,15.33%,FUT8;MGAT5;TRAK1;TET2;STT3B;ST8SIA4;GCNT2;GALNT2;GALNT10
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,0.7314444990759535,1.2445868696802673,0.1836734693877551,1.0,1.0,5/11,17.42%,HSPH1;HSP90AA1;HSPA8;CREBBP;EP300
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.751269226891421,1.2438934485768558,0.18181818181818182,1.0,1.0,1/7,1.99%,TRAM2
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.7704953133670152,-1.2436649080099074,0.2765957446808511,0.6610954510168092,1.0,2/7,4.38%,CX3CL1;LGALS3
prerank,CellMarker_Augmented_2021__Neural Crest cell:Germ,0.5994701352907182,1.242221283025015,0.2,1.0,1.0,7/29,13.39%,BACH2;NCAM1;ZEB2;ELMO1;S1PR1;CELF2;PPP2R2B
prerank,CellMarker_Augmented_2021__Macrophage:Brain,-0.7100361101848205,-1.2421696230923003,0.23636363636363636,0.6652634452566851,1.0,1/13,0.13%,CD74
prerank,KEGG_2021_Human__Bladder cancer,0.7249794540516807,1.2419723594951129,0.16981132075471697,1.0,1.0,2/11,14.61%,KRAS;RPS6KA5
prerank,KEGG_2021_Human__Thyroid cancer,-0.6401473534849773,-1.2415082050188053,0.22807017543859648,0.6664022327260396,1.0,1/15,1.01%,PPARG
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.7222787146262204,-1.2405435071026165,0.2,0.6684647331392388,1.0,4/11,12.32%,ISG15;PLCG2;CD47;VSIR
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.6609496813000111,-1.2402523641915517,0.19230769230769232,0.6684495430730283,1.0,5/14,11.08%,SOD2;SAMHD1;B2M;APPL2;CBR4
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7609780251466083,-1.2397750865962671,0.1875,0.6689290652940099,1.0,3/8,20.27%,MMRN2;RHOA;MAP2K5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6060601062105779,1.2396443937236692,0.18181818181818182,1.0,1.0,2/24,1.57%,ABL2;ERBB4
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.4952796871866977,1.2396408354470552,0.15789473684210525,1.0,1.0,8/54,15.78%,NOVA1;FASTKD1;HNRNPR;SETX;CELF2;DICER1;SND1;RBPMS
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.5364559242132418,1.2387734351743107,0.1875,1.0,1.0,6/41,10.60%,RBM20;PTBP3;MBNL1;HNRNPLL;KHDRBS3;SETX
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.5747208728424247,-1.2379605932870241,0.2,0.6744518495507162,1.0,3/38,2.79%,TBX3;ITGB5;CXCL12
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,-0.7918368012345254,-1.2369424451801962,0.18,0.6768053521008259,1.0,1/9,0.56%,CYLD
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6663915705397526,-1.2368184962282058,0.2549019607843137,0.6755625190904139,1.0,4/11,13.49%,TANK;UBC;UBE2D2;TBK1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6663915705397526,-1.2368184962282058,0.2549019607843137,0.6755625190904139,1.0,4/11,13.49%,TANK;UBC;UBE2D2;TBK1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.4927389231644831,-1.2366715890836033,0.0821917808219178,0.6752280377856273,1.0,33/209,13.23%,CD74;TBX3;CX3CL1;KLHL20;STAT1;PLK2;GRK5;NDRG1;VAV3;PRKN;TNFSF10;RASGRF2;RPS6;MAP3K5;NFKBIA;BCL2L14;NFKB1;TFRC;ACER2;JUN;BABAM2;PMAIP1;PTMA;NET1;AHI1;ACTN1;ARHGEF11;UBC;RPL10;MCF2L;CLU;ATM;JAK2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7630440509769287,1.2366656618065228,0.2,1.0,1.0,2/6,6.06%,SOX5;TRPS1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.7392651791108231,1.2366608875329312,0.15384615384615385,1.0,1.0,2/8,3.13%,BCL6;IL6R
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.7607236615077715,1.236541761002811,0.21818181818181817,1.0,1.0,3/6,14.61%,PRKD1;CRTC3;RPS6KA5
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.5597057121112392,-1.236504491155394,0.19642857142857142,0.6748685602848584,1.0,9/42,9.19%,IFIH1;ISG15;STAT1;HLA-F;HLA-B;HLA-C;B2M;TRIM25;HLA-E
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.6799690241707512,-1.236496742675977,0.22916666666666666,0.6731857975342805,1.0,1/5,7.04%,ANAPC16
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,-0.6799690241707512,-1.236496742675977,0.22916666666666666,0.6731857975342805,1.0,1/5,7.04%,ANAPC16
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.6343967385709238,1.2363985765981733,0.2,1.0,1.0,3/14,8.21%,GRIA2;LRRC7;DLGAP2
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.6453130938761686,-1.236217308876728,0.17857142857142858,0.67325496961868,1.0,8/24,11.58%,RPS12;RPS8;RPS6;RPS28;RPS19;RPS7;RPS14;RPS15
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.698346450462061,1.2359971452414125,0.2826086956521739,1.0,1.0,1/8,1.57%,ERBB4
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,-0.5420468545218503,-1.2354948839136486,0.16393442622950818,0.6745708645771251,1.0,22/73,14.16%,IFIH1;ISG15;RPS12;STAT1;HLA-F;HLA-B;HLA-C;PATJ;RPS8;RPS6;GEMIN5;B2M;TRIM25;HLA-E;RPS28;RPS19;RPS7;RPS14;RPS15;HLA-A;TBK1;NUP54
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,0.7308223560843813,1.2354197353200436,0.23636363636363636,1.0,1.0,6/7,24.89%,YWHAB;YWHAZ;YWHAQ;YWHAG;AKT3;YWHAE
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,0.718683292023877,1.2350094517462225,0.21428571428571427,1.0,1.0,4/11,18.99%,YES1;PIK3CA;GRB2;CRK
prerank,KEGG_2021_Human__Alzheimer disease,0.4930484034874308,1.2349416507791893,0.11764705882352941,1.0,1.0,24/82,17.03%,PSMD14;ITPR3;GRM5;ATP2A2;MAPK10;TUBB4B;BACE2;KRAS;PLCB1;PIK3CA;AMBRA1;CAPN2;SEM1;IDE;RTN4;CACNA1C;ITPR2;PPP3CA;PPP3CB;ADAM10;ATG2B;CALM1;TUBA1B;PSEN1
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,0.7261339566624929,1.23402007860019,0.18,1.0,1.0,5/8,22.97%,YES1;PPP2CB;PPP2R5E;AKT3;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.7001225622272785,-1.233797951793856,0.20833333333333334,0.6791572862478348,1.0,2/10,11.61%,PLCG2;VIM
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.7056616110781738,-1.2335607961537691,0.17777777777777778,0.6790135751538284,1.0,4/8,17.69%,RFC3;UBC;NPLOC4;RFC1
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.7177507993871411,1.2331173626402219,0.19607843137254902,1.0,1.0,5/11,14.48%,ITPR3;ATP2A2;MICU3;CACNA1C;SLC8A1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.7474439454812389,-1.2327659058491447,0.18,0.6807015460709321,1.0,2/10,7.28%,TPM1;DSP
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.731237033922836,-1.2326791372548764,0.2037037037037037,0.6800318578533103,1.0,3/10,14.08%,PRKN;B2M;IREB2
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,0.8182130280204479,1.2326040220800678,0.1702127659574468,1.0,1.0,1/6,2.23%,UGP2
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.7664048175549073,1.2322821024035768,0.2037037037037037,1.0,1.0,4/7,17.18%,FGF12;PIK3CA;CACNA1C;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.8142951344523288,-1.2322750764323809,0.12244897959183673,0.6806540680896508,1.0,1/5,3.88%,MAP2
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,-0.6141269615615973,-1.2314174915985827,0.21818181818181817,0.6823719762053146,1.0,3/22,1.51%,PSMA1;ABCA5;PSMB9
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.6425041106097162,-1.2310392882449004,0.23076923076923078,0.6827476199945595,1.0,4/20,8.92%,PPARG;SMAD3;FOS;JUN
prerank,Reactome_2022__ROBO Receptors Bind AKAP5 R-HSA-9010642,0.7817774694148004,1.2309749992090397,0.2037037037037037,1.0,1.0,3/5,18.67%,ROBO2;PPP3CB;PRKCA
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.6334440383660658,-1.2307687665125928,0.23076923076923078,0.6827023402922358,1.0,3/35,2.79%,EPSTI1;PPARG;CXCL12
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.631458559568093,1.2303572681034374,0.14893617021276595,1.0,1.0,4/19,5.21%,PDK4;CRY1;HECTD4;BACE2
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.6727360962628095,-1.2300507966654854,0.19230769230769232,0.6842969228359812,1.0,1/16,1.01%,PPARG
prerank,CellMarker_Augmented_2021__Stem cell:Salivary Gland,-0.5645825196247292,-1.2286552865785112,0.24561403508771928,0.6881092724331168,1.0,11/54,9.46%,PARP14;DDX60;SAMD9L;MAP3K2;SP100;ZC3HAV1;B2M;NFKB1;ERO1A;S100A6;PMAIP1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.8276479472188929,1.2278128367904753,0.18,1.0,1.0,1/5,2.15%,UBQLN1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.682925327203853,-1.227566763582503,0.3191489361702128,0.6911006889644603,1.0,5/20,6.56%,SLC6A6;SLCO1A2;SLC5A6;SLC38A3;SLCO2B1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.7785165116568419,1.22728303768063,0.18518518518518517,1.0,1.0,1/5,5.05%,PEX14
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.7369580882994037,-1.227248816649465,0.28846153846153844,0.69108331292037,1.0,3/9,10.20%,MAP3K2;LCP2;BST2
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.8106261695352597,-1.2268577563429222,0.3,0.6916857584995493,1.0,1/5,2.12%,STAT1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.7396380123937718,1.2263786834127934,0.1836734693877551,1.0,1.0,6/11,17.74%,FGF12;NKAIN2;ATP2B4;ATP1A1;WNK1;ANK3
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8173760684206979,-1.2263532419640866,0.25,0.692552012578912,1.0,3/5,13.84%,B2M;UBC;PGK1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.758760025980099,-1.2262507678205687,0.2558139534883721,0.691329283926599,1.0,5/7,21.12%,RFC3;UBC;RFC1;POLK;CUL4A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.758760025980099,-1.2262507678205687,0.2558139534883721,0.691329283926599,1.0,5/7,21.12%,RFC3;UBC;RFC1;POLK;CUL4A
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.4895364442099799,-1.2261631932165777,0.1044776119402985,0.6906824106184165,1.0,15/152,8.15%,CD74;HES1;ZIC1;PPARG;RREB1;MAP3K2;STAT1;IRF1;SP100;SMARCA1;MAP3K5;SMAD3;FOXK1;NFKB1;FOS
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7841421786012615,-1.2261502351861988,0.20930232558139536,0.6898611281816533,1.0,2/5,8.23%,RPL7A;ZNHIT6
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,0.6909745583090824,1.2260516553421255,0.17307692307692307,1.0,1.0,5/14,17.42%,HSPH1;HSP90AA1;HSPA8;CREBBP;EP300
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,-0.7791883426567461,-1.2258275308524285,0.26,0.689883085193158,1.0,3/8,11.71%,NFKBIA;NFKB1;UBC
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,0.7123076890979816,1.2254017239215949,0.2807017543859649,1.0,1.0,4/9,23.64%,NCOA2;NCOA1;MAOA;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.6308595857007928,1.2247950434573298,0.11538461538461539,1.0,1.0,6/20,22.10%,CCDC88A;CNOT2;RALB;G3BP1;FSCN1;RAB3GAP2
prerank,CellMarker_Augmented_2021__Effector Regulatory T (Treg) cell:Peripheral Blood,-0.7397773642908732,-1.2247063669645928,0.25,0.6928645009673836,1.0,2/8,10.46%,LCP2;ARHGAP15
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.759340795457532,-1.2245022227124926,0.25,0.6926071873424708,1.0,1/6,1.30%,IFIH1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.794735647142963,1.2244517479629704,0.1568627450980392,1.0,1.0,2/6,7.89%,PNP;ACAT1
prerank,CellMarker_Augmented_2021__Erythroblast:Blood,0.6138457137455235,1.2244316796138341,0.22916666666666666,1.0,1.0,10/23,19.92%,PSMD14;NAA50;LARP4;XPO1;HSPD1;G3BP1;HSPA9;WDR43;NUDCD1;CANX
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Subcutaneous Adipose Tissue,0.6138457137455235,1.2244316796138341,0.22916666666666666,1.0,1.0,10/23,19.92%,PSMD14;NAA50;LARP4;XPO1;HSPD1;G3BP1;HSPA9;WDR43;NUDCD1;CANX
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Peripheral Blood,0.6138457137455235,1.2244316796138341,0.22916666666666666,1.0,1.0,10/23,19.92%,PSMD14;NAA50;LARP4;XPO1;HSPD1;G3BP1;HSPA9;WDR43;NUDCD1;CANX
prerank,CellMarker_Augmented_2021__Mast Cell progenitor:Bone Marrow,0.6138457137455235,1.2244316796138341,0.22916666666666666,1.0,1.0,10/23,19.92%,PSMD14;NAA50;LARP4;XPO1;HSPD1;G3BP1;HSPA9;WDR43;NUDCD1;CANX
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,0.4996108794665212,1.2239060314400076,0.12195121951219512,1.0,1.0,16/53,18.57%,FUT8;COG6;MCFD2;MAN1A2;MGAT5;BET1;ANKRD28;TFG;CD59;ANK2;CAPZB;COG5;ARF4;ANK3;PPP6R3;PPP6C
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Blood,-0.752351652487152,-1.2238926845829707,0.2692307692307692,0.6928441096034145,1.0,3/8,17.26%,LCP2;ARHGAP15;GIMAP8
prerank,CellMarker_Augmented_2021__Naive Regulatory T (Treg) cell:Peripheral Blood,-0.752351652487152,-1.2238926845829707,0.2692307692307692,0.6928441096034145,1.0,3/8,17.26%,LCP2;ARHGAP15;GIMAP8
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.5702136359330731,-1.2230653142186318,0.21666666666666667,0.6946593209620501,1.0,10/54,8.31%,CD74;CX3CL1;APOL3;PLK2;SHISA5;PRKN;TNFSF10;ZDHHC17;TRIM25;TFRC
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.7782928386959485,-1.2226082228499575,0.3137254901960784,0.6953234220353575,1.0,1/5,3.37%,RNF213
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Corneal Epithelium,-0.7163570800357741,-1.2223736001098013,0.2608695652173913,0.6950771346460836,1.0,1/11,1.54%,SOD2
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,0.6054049964952114,1.222176076265668,0.23255813953488372,1.0,1.0,8/20,22.97%,YES1;PIK3CA;PPP2CB;GRB2;CDC42;PPP2R5E;AKT3;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7080284987104846,-1.2221457178051742,0.3103448275862069,0.6949682172652789,1.0,1/10,0.21%,RSAD2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Undefined,-0.6587454661314145,-1.221979803768206,0.2,0.6945615111776036,1.0,3/33,2.52%,CX3CL1;ABCA5;IFI27
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.7241434319879491,-1.2218774469108828,0.13953488372093023,0.6939449234736133,1.0,6/10,22.60%,PABPC1;PARN;DHX36;FUS;LARP1;TENT2
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.799549378231132,1.2216152908866726,0.25,1.0,1.0,1/5,4.33%,TUBB4B
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.799549378231132,1.2216152908866726,0.25,1.0,1.0,1/5,4.33%,TUBB4B
prerank,KEGG_2021_Human__TNF signaling pathway,-0.585378330443886,-1.2215861760565119,0.19642857142857142,0.6939616566657717,1.0,8/44,8.92%,VCAM1;CX3CL1;IRF1;MAP3K5;NFKBIA;NFKB1;FOS;JUN
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.6163162171819357,-1.2214550252866128,0.2222222222222222,0.6936195061081468,1.0,4/41,5.26%,CD74;CD99L2;FN1;GRB14
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.7180783814104271,-1.2211498552123672,0.24489795918367346,0.6936613090511499,1.0,1/10,1.57%,RIMS1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.6374340276526531,-1.220716739026486,0.20408163265306123,0.6942831854433439,1.0,1/12,0.69%,ZIC1
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,0.5758241206185941,1.219774633073522,0.2857142857142857,1.0,1.0,7/27,12.11%,IL1R1;ITPR3;MAPK10;PLCB1;PIK3CA;PPP1CB;ITPR2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.6966161224027898,1.2195141891419237,0.19607843137254902,1.0,1.0,5/10,23.67%,PARVA;CDC42;CYFIP1;RAC1;GSN
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.6602893289669215,1.219199502112501,0.24444444444444444,1.0,1.0,2/17,3.03%,YWHAB;HSP90B1
prerank,Reactome_2022__N-Glycan Antennae Elongation R-HSA-975577,0.8391929454042065,1.2190716726112731,0.15217391304347827,1.0,1.0,1/6,4.99%,MGAT5
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.6778912557677736,-1.2187392584292824,0.19148936170212766,0.6995270515151246,1.0,1/11,0.56%,CYLD
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.5644597030007258,-1.2181379370241765,0.14285714285714285,0.7006083437619726,1.0,7/56,9.46%,MX1;IFI27;IRF1;SCN2A;NFKBIA;BCL2L14;PMAIP1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.7316579584472173,1.2178404565302028,0.23404255319148937,1.0,1.0,1/7,0.24%,HSD17B4
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.5849229592635854,-1.217834013284606,0.14754098360655737,0.7007276643888404,1.0,5/46,6.00%,HES1;CXCL12;DOK5;SLC38A3;SPC25
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.604959635957047,-1.2176564356287103,0.1724137931034483,0.700343014408812,1.0,8/46,7.65%,SLC22A5;SLC6A6;SLC16A2;SLCO1A2;SLC5A6;SLC38A3;SLCO2B1;SLC2A3
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Pancreas,0.8204469619382067,1.2175528281741899,0.16363636363636364,1.0,1.0,2/5,12.56%,CDH2;CHN1
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.6561933539136837,1.21718953377878,0.2765957446808511,1.0,1.0,2/17,1.25%,PDIA3;CALR
prerank,Reactome_2022__Immune System R-HSA-168256,-0.43097769297213034,-1.217114854767842,0.05952380952380952,0.7017016672966798,1.0,60/508,9.19%,VCAM1;CD74;RSAD2;MX1;CYLD;KLHL20;PSMA1;GBP1;IFIH1;XAF1;PSMB9;ISG15;HGSNAT;STAT1;IRF2;PLCG2;FN1;IFI27;ITGB5;HLA-F;HLA-B;IRF1;HLA-C;UFL1;RNF213;VAV3;HEBP2;ATP6V1E1;IL32;SP100;RNF19A;ARIH2;PRKN;HERC6;LGALS3;EIF2AK2;NLRC5;UBR2;IGF2R;OAS3;GBP4;MEF2A;TMEM30A;SMAD3;SAMHD1;LCP2;NFKBIA;B2M;SLC2A3;NFKB1;LRRFIP1;TRIM25;FOS;CDA;TANK;CD47;ERAP1;JUN;STAT5B;HLA-E
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.7943338280272306,-1.2169990013244063,0.3191489361702128,0.7011819607035614,1.0,3/5,18.25%,DSP;VIM;KLHL24
prerank,CellMarker_Augmented_2021__Epidermal Transit Amplifying cell:Foreskin,0.620744371313044,1.2169200965468063,0.14814814814814814,1.0,1.0,3/19,2.84%,PSMD14;NDUFAF2;RALA
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.558322896201025,1.216622074176586,0.2765957446808511,1.0,1.0,10/25,17.18%,ITPR3;STIM1;ATP2A2;CELF2;ITPR2;SLC8A1;ANK2;CALM1;ATP2B4;ATP1A1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.6300188414665009,-1.2165362001163078,0.21568627450980393,0.7018875960247306,1.0,1/21,0.56%,CYLD
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.7032163358597171,1.216177376979889,0.25,1.0,1.0,6/10,19.73%,ABL2;ABL1;NRP1;CDC42;ESAM;FES
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.6376994564069098,-1.2158656187120966,0.24074074074074073,0.7016769370242325,1.0,4/15,11.71%,HMGN1;RFC3;POLR2A;UBC
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,-0.6376994564069098,-1.2158656187120966,0.24074074074074073,0.7016769370242325,1.0,4/15,11.71%,HMGN1;RFC3;POLR2A;UBC
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.6376994564069098,-1.2158656187120966,0.24074074074074073,0.7016769370242325,1.0,4/15,11.71%,HMGN1;RFC3;POLR2A;UBC
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.7419861900568627,1.2153310874701875,0.2608695652173913,1.0,1.0,2/7,21.57%,DICER1;AGO2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.6730600778823648,-1.215094004935431,0.28,0.7030608726595909,1.0,1/17,0.56%,CYLD
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.81892781942834,-1.2149703501729967,0.3181818181818182,0.7025797579377956,1.0,1/5,9.85%,POLR2A
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.7869183724259419,1.2149198253075493,0.2708333333333333,1.0,1.0,3/5,10.31%,TET2;UPP1;DPYSL2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.8104505328319466,1.2146554861235428,0.23076923076923078,1.0,1.0,2/5,13.86%,ANXA2;EPHA4
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,-0.5002220473729277,-1.2144242539972243,0.15517241379310345,0.703849958463944,1.0,13/84,9.03%,CYLD;PSMA1;IFIH1;PSMB9;TNIP1;PRKN;SMAD3;NFKBIA;FOXK1;TRIM25;ATXN7;TANK;BABAM2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.6438110012570459,-1.214333758931896,0.2830188679245283,0.7033083505919593,1.0,3/18,8.55%,ULK4;EIF2AK2;TAOK3
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",0.6126737077698571,1.2142710614312198,0.20930232558139536,1.0,1.0,2/13,6.24%,NDUFAF2;CCNI
prerank,CellMarker_Augmented_2021__T cell:Undefined,0.678183148255445,1.2142134039071462,0.3269230769230769,1.0,1.0,5/11,17.34%,IL6R;NCAM1;ENTPD1;NRP1;CD81
prerank,CellMarker_Augmented_2021__M2 macrophage:Brain,-0.758473225644936,-1.2141024870379151,0.32,0.7014492579574514,1.0,2/5,17.26%,LCP2;GIMAP8
prerank,CellMarker_Augmented_2021__Kupffer cell:Fetal Liver,-0.758473225644936,-1.2141024870379151,0.32,0.7014492579574514,1.0,2/5,17.26%,LCP2;GIMAP8
prerank,CellMarker_Augmented_2021__M2 macrophage:Serum,-0.758473225644936,-1.2141024870379151,0.32,0.7014492579574514,1.0,2/5,17.26%,LCP2;GIMAP8
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.7785547447799406,1.2139162019491512,0.2222222222222222,1.0,1.0,2/5,17.32%,PXK;WNK1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7599459406372433,-1.2132935268220337,0.24074074074074073,0.7030395347112985,1.0,1/6,0.24%,HES1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.5955960483991752,1.2132158871972705,0.19230769230769232,1.0,1.0,4/19,11.77%,PSMD14;UIMC1;ERCC6;HERC2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5748894812456996,-1.2130551943365424,0.25,0.7030692716690506,1.0,8/44,8.74%,CX3CL1;PSMA1;GBP1;PSMB9;NFKBIA;NFKB1;TANK;CD47
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8186148325543612,1.2123294145025805,0.18518518518518517,1.0,1.0,2/5,6.51%,CALR;CTBP2
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.8176010620152885,-1.212210833110461,0.225,0.704091725944934,1.0,1/5,9.85%,POLR2A
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,-0.8176010620152885,-1.212210833110461,0.225,0.704091725944934,1.0,1/5,9.85%,POLR2A
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.7585468851301829,-1.2121792769304947,0.2962962962962963,0.7033625020796749,1.0,1/5,4.59%,RFC3
prerank,Reactome_2022__CD28 Dependent Vav1 Pathway R-HSA-389359,0.7352051856656867,1.2120759493645286,0.1702127659574468,1.0,1.0,2/6,15.91%,GRB2;CDC42
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.7048767529148857,1.2112872387661768,0.22916666666666666,1.0,1.0,2/6,8.07%,YWHAB;URI1
prerank,CellMarker_Augmented_2021__Monocyte:Fetal Kidney,-0.46588782983626953,-1.2108970660385125,0.1,0.7068270608433086,1.0,31/219,10.89%,CD74;BTG2;SAT1;LRPAP1;SOD2;DDX60L;DENND3;HLA-B;HLA-C;HEBP2;TNIP1;SNX2;LGALS3;IGF2R;ESYT2;SAMHD1;NFKBIA;WARS1;GPCPD1;SLC2A3;LRRFIP1;TRIM25;CDA;TANK;S100A6;HLA-E;CST3;LBR;ACTN1;WSB1;IFNGR2
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,0.7793509518236345,1.2108353494404716,0.22916666666666666,1.0,1.0,1/6,11.93%,PPP2CB
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.5924805257123762,1.2107647738153815,0.22,1.0,1.0,6/26,15.30%,BAG3;HSPH1;NUP58;RANBP2;HSPA8;HSPA9
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,0.683218932660999,1.2107439688870612,0.1794871794871795,1.0,1.0,2/10,4.81%,IL6R;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7723813083244577,1.2105432139901657,0.21739130434782608,1.0,1.0,2/5,17.34%,SLC39A10;CD81
prerank,Reactome_2022__NOTCH4 Activation And Transmission Of Signal To Nucleus R-HSA-9013700,0.7887269412613374,1.209977693626343,0.275,1.0,1.0,3/5,17.03%,YWHAZ;ADAM10;PSEN1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.6634290790658922,-1.2099368272367286,0.27906976744186046,0.7088557977594552,1.0,4/24,8.37%,PPARG;TNFSF10;SMAD3;ACER2
prerank,CellMarker_Augmented_2021__Effector CD4+ Memory T (Tem) cell:Blood,-0.8335076596782957,-1.2093999243327982,0.22916666666666666,0.7095855646362348,1.0,2/5,10.46%,LCP2;ARHGAP15
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.6249566223697032,1.2093430682273292,0.2,1.0,1.0,6/17,17.42%,TAF1;ZBTB1;YY1;INO80;CREBBP;EP300
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.6409716705395052,1.2090063057185307,0.18,1.0,1.0,2/16,0.72%,PDK4;PSMD14
prerank,CellMarker_Augmented_2021__Megakaryocyte:Undefined,-0.7936662565437662,-1.20873530536254,0.34782608695652173,0.7106368083930762,1.0,1/5,12.70%,ITGAV
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,-0.7016479083861495,-1.208311178974506,0.22,0.7110160837703532,1.0,3/7,17.74%,RFC3;UBC;POLK
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Fetal Pancreas,0.7543455277057702,1.20829859591571,0.24074074074074073,1.0,1.0,3/5,12.56%,SNAP25;TRIM9;CHN1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.7513725795050004,-1.2079558261252101,0.24444444444444444,0.7115855442314524,1.0,1/11,2.36%,TPM1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.6715261771827821,-1.2074147210071586,0.37209302325581395,0.7125473001875555,1.0,2/11,14.37%,SAMHD1;PRIMPOL
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.7588336772715998,1.2072395415624377,0.22448979591836735,1.0,1.0,3/6,18.67%,YES1;GRB2;PRKCA
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,0.5941679329618312,1.2066377124936802,0.16326530612244897,1.0,1.0,5/19,14.87%,AVEN;YWHAB;YWHAZ;YWHAQ;BCL2L1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.7327966799645518,-1.2064717548073631,0.28888888888888886,0.7145790838881139,1.0,2/6,19.81%,IGF2R;CFL1
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Embryonic Prefrontal Cortex,0.5615394848516589,1.205568505619947,0.20408163265306123,1.0,1.0,6/30,12.06%,NOVA1;CADM2;DUSP6;ALCAM;RTN1;CNTN1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.7081200312443499,1.2055544968895449,0.32,1.0,1.0,7/9,26.72%,ZMYND11;RNF168;WDR43;CDK12;CDC73;TCERG1;BRD4
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.7194224093253467,-1.2051827438924956,0.29411764705882354,0.7175581693536239,1.0,3/8,20.85%,PABPC1;FUS;LARP1
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.733955598377208,-1.204558210666905,0.2549019607843137,0.7185215476482201,1.0,2/6,11.71%,HGSNAT;UBC
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Brain,-0.544985060697402,-1.2044618290967226,0.25396825396825395,0.7179986144320261,1.0,6/38,9.27%,CLEC1A;TIE1;MMRN2;SLCO2B1;LCP2;SCARF1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.568764415768738,-1.2042637308136621,0.2857142857142857,0.7177970813157151,1.0,3/36,1.51%,PPARG;PSMA1;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.5253700741654198,-1.2037162711932499,0.24528301886792453,0.7187923820889298,1.0,1/65,0.13%,CD74
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.7196252966057342,-1.2033124434366171,0.23076923076923078,0.7191228189824456,1.0,3/7,13.89%,MAP3K5;TAOK3;MAP3K4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.8230121424503463,1.203181153461334,0.18604651162790697,1.0,1.0,2/6,10.94%,ZBTB1;ZMIZ1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.5245797171209925,1.2024389249608913,0.1951219512195122,1.0,1.0,18/53,21.35%,DUSP6;BTRC;CTDSP2;PPM1F;CDC14B;PPP4R2;PPP1CB;PPP2CB;PPP3CA;PTPN21;PPP3CB;PLPPR4;PTEN;PPP6C;MTMR3;PTPN1;PPP4R1;PPP2R5E
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.7379264629085843,-1.201880068873738,0.3125,0.7225369765970309,1.0,2/7,4.01%,SOD2;PRKN
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.5834708249788154,1.2017881816985658,0.22033898305084745,1.0,1.0,7/27,9.16%,ABL2;ERBB4;INPP5F;PRAG1;NRG2;DIAPH1;ABL1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.5235824508407354,-1.2017022619833437,0.23529411764705882,0.7221186705121614,1.0,17/70,14.13%,CD74;IFIH1;ISG15;PLCG2;IRF1;EIF2AK2;SERPINE1;NFKB1;LRRFIP1;HLA-E;AFAP1L2;RAB1A;SULF2;RORA;HLA-A;TBK1;IL18R1
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,0.5798724190765578,1.2015707407275484,0.2727272727272727,1.0,1.0,11/29,18.67%,ITPR3;STIM1;ATP2A2;FGF12;CACNA1C;FGF14;ITPR2;SLC8A1;CALM1;ATP2B4;PRKCA
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.7828396728195354,-1.201472335616686,0.18,0.7220314676494138,1.0,1/5,4.38%,LGALS3
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.5164789577831101,1.2013507798844407,0.14634146341463414,1.0,1.0,11/61,8.84%,PDIA3;CALR;UBQLN1;HSP90B1;HSPH1;MAPK10;MAN1A2;STT3B;HSP90AA1;DNAJC5;CAPN2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Blood,0.7262528113779452,1.201331453757061,0.21568627450980393,1.0,1.0,1/5,2.55%,CDH2
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,-0.5723625820404916,-1.2010045305458499,0.18,0.7225804356772039,1.0,4/27,4.41%,CX3CL1;CXCL12;IL32;TNFSF10
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.7700067635740433,-1.2009847663534625,0.3076923076923077,0.7218106070302682,1.0,2/5,8.71%,TNIP1;TANK
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.6220880634571277,-1.2008758252693739,0.2777777777777778,0.7214185501276735,1.0,6/16,17.74%,HMGN1;RFC3;POLR2A;UBC;RFC1;POLK
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7489245502577125,1.2008230449772213,0.22916666666666666,1.0,1.0,4/6,21.25%,CACNA1C;SLC8A1;ATP1A1;RYR2
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.6956949568660481,1.2000593768579984,0.25,1.0,1.0,2/9,4.01%,ERBB4;NRG2
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Heart,0.6019674072381771,1.1994828599774927,0.29545454545454547,1.0,1.0,6/25,15.43%,GOLM1;SEMA3F;GULP1;PTPN21;ADGRL2;RAI14
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.7754734162292172,1.1992108387815468,0.19230769230769232,1.0,1.0,2/6,8.10%,SMAD6;ROBO2
prerank,KEGG_2021_Human__Platelet activation,0.5242319123487638,1.1990655782881465,0.22727272727272727,1.0,1.0,10/46,12.11%,ITPR3;STIM1;PRKG1;ACTG1;ITGA2;PLCB1;PIK3CA;ACTB;PPP1CB;ITPR2
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,-0.5135158285538275,-1.1989708813203293,0.23728813559322035,0.7263676384983,1.0,26/101,13.49%,PARP14;IFIH1;ISG15;RPS12;STAT1;HLA-F;HLA-B;HLA-C;PATJ;RPS8;RPS6;GEMIN5;B2M;TRIM25;HLA-E;RPS28;RPS19;PARP9;RPS7;RPS14;RPS15;GPC3;UBC;SRPK1;HLA-A;TBK1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.5383276949911991,-1.1989374678466413,0.2,0.7256430146142892,1.0,8/51,10.92%,RHOBTB1;TPM1;CARMIL1;CASS4;PPP1R9A;ARHGAP17;ACTN1;CD2AP
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,0.6494975693066749,1.1987395999797803,0.3125,1.0,1.0,2/11,3.16%,YWHAB;SLC38A9
prerank,KEGG_2021_Human__Breast cancer,-0.5865066270806341,-1.1987340974135827,0.3076923076923077,0.7254118656553723,1.0,1/46,0.24%,HES1
prerank,CellMarker_Augmented_2021__FGFR1LowNME5- Epithelial cell:Esophagus,-0.7204513919843406,-1.1982794273309327,0.28,0.7258479534708915,1.0,3/8,16.97%,SLC2A3;PHTF2;PWWP2A
prerank,CellMarker_Augmented_2021__Ureteric Bud cell:Fetal Kidney,0.6833211033669855,1.1981063135496945,0.2564102564102564,1.0,1.0,4/13,17.37%,TEAD4;GULP1;RAI14;ROR1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.6759449744672352,-1.1978747926412756,0.2631578947368421,0.7260844311673917,1.0,3/14,4.01%,SOD2;SNX6;PRKN
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7147490676547876,-1.1976760082879552,0.3125,0.726051959727464,1.0,1/7,2.36%,TPM1
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.6707793860472603,1.1974164728247207,0.23529411764705882,1.0,1.0,5/13,7.54%,ERBB4;NRG2;PIK3CA;PIGU;HSP90AA1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7919042763758116,-1.1973511483309685,0.3125,0.7262526977933061,1.0,4/7,11.58%,RPS28;RPS19;RPS14;RPS15
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.852018010139237,-1.1972682365023557,0.2711864406779661,0.7256961491414713,1.0,1/5,4.28%,SPG7
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Undefined,0.7225517659229925,1.196960706843081,0.26,1.0,1.0,3/6,7.52%,IL1R1;ITGA2;ENTPD1
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,-0.7350139394319399,-1.1969435333560188,0.2777777777777778,0.7260945514287669,1.0,5/13,9.19%,PLCG2;VAV3;LCP2;B2M;HLA-E
prerank,KEGG_2021_Human__PPAR signaling pathway,-0.6743002550651649,-1.1967967489393712,0.21428571428571427,0.7257717860904834,1.0,2/15,4.94%,PPARG;ACSL4
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.7274592366665709,1.1967125233858864,0.3018867924528302,1.0,1.0,1/7,2.79%,PRKD1
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,0.5453099601376121,1.196475582029974,0.17777777777777778,1.0,1.0,1/23,0.32%,ANO5
prerank,KEGG_2021_Human__Hepatitis B,0.5261180631290238,1.196418014269196,0.175,1.0,1.0,9/54,8.63%,CREB5;HSPG2;YWHAB;IFNAR1;MAPK10;KRAS;PIK3CA;TAB2;YWHAZ
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.6738693332077241,1.196380824851219,0.19607843137254902,1.0,1.0,7/13,25.63%,ABL1;PPM1F;NRP1;RAC1;ROCK1;TEK;MAP4K4
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.660659974671639,1.1960972287657314,0.24528301886792453,1.0,1.0,1/10,2.02%,SLC26A3
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6361699803861075,1.1959898995194327,0.25925925925925924,1.0,1.0,5/10,20.82%,TAF1;NCOA3;NRP1;EDN1;ADAM17
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.5933246838435922,1.19570509746377,0.2558139534883721,1.0,1.0,9/29,20.82%,ERBB4;NRG2;PIK3CA;HSP90AA1;GAREM1;RPS6KA5;GRB2;PRKCA;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.7804318097745657,-1.1956846772654122,0.25925925925925924,0.728397177078651,1.0,1/6,10.07%,PARP9
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.6796862282273934,-1.1954160987967521,0.2222222222222222,0.7282695850894008,1.0,1/8,1.30%,IFIH1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.7543826616535569,1.1949768253643935,0.2909090909090909,1.0,1.0,2/8,4.57%,DTWD1;TRMT9B
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.6277543445212104,-1.1948722907571994,0.21428571428571427,0.7289064189209514,1.0,6/19,15.56%,NFKBIA;NFKB1;LRRFIP1;UBC;TBK1;DHX36
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.7305464501258911,1.194861424447174,0.21568627450980393,1.0,1.0,4/7,23.45%,HECTD4;CHST15;HK1;GALK2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.7536352872614444,1.1948344151879258,0.32786885245901637,1.0,1.0,1/5,7.57%,SMAD6
prerank,CellMarker_Augmented_2021__Inflammatory cell:Muscle,-0.5764817017634944,-1.1948021148095633,0.21052631578947367,0.7258378995999333,1.0,6/35,9.27%,CLEC1A;APOL3;TIE1;GBP4;LCP2;SCARF1
prerank,CellMarker_Augmented_2021__Immature Endothelial cell:Subcutaneous Adipose Tissue,-0.5764817017634944,-1.1948021148095633,0.21052631578947367,0.7258378995999333,1.0,6/35,9.27%,CLEC1A;APOL3;TIE1;GBP4;LCP2;SCARF1
prerank,CellMarker_Augmented_2021__Endothelial cell:Lymph Node,-0.5764817017634944,-1.1948021148095633,0.21052631578947367,0.7258378995999333,1.0,6/35,9.27%,CLEC1A;APOL3;TIE1;GBP4;LCP2;SCARF1
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Subcutaneous Adipose Tissue,-0.5764817017634944,-1.1948021148095633,0.21052631578947367,0.7258378995999333,1.0,6/35,9.27%,CLEC1A;APOL3;TIE1;GBP4;LCP2;SCARF1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.6948669814687028,-1.1942176626754233,0.26785714285714285,0.7267732236281039,1.0,2/11,5.60%,TNFSF10;SERPINE1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.6375083598410135,1.19391523952433,0.2807017543859649,1.0,1.0,2/13,2.55%,HDAC9;CDH2
prerank,Reactome_2022__TRAF3-dependent IRF Activation Pathway R-HSA-918233,-0.6992868321492752,-1.193724166206614,0.2553191489361702,0.7272004519422716,1.0,3/7,13.49%,IFIH1;TRIM25;TBK1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5991863760305738,1.1936396124991133,0.27906976744186046,1.0,1.0,7/15,27.22%,OTUD7B;ROCK2;PICALM;NEDD4L;MFHAS1;CTNNA1;LATS2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.7701870468101568,-1.1936001908817102,0.19148936170212766,0.7267077562414138,1.0,2/9,2.12%,CX3CL1;STAT1
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.7981855037041051,1.1929721288097925,0.2857142857142857,1.0,1.0,1/5,2.55%,CDH2
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,0.754545842513942,1.192857046901313,0.2413793103448276,1.0,1.0,2/6,4.01%,ERBB4;NRG2
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.7867601573738248,-1.1928033761990076,0.21739130434782608,0.7285224851317029,1.0,3/5,17.74%,RFC3;UBC;POLK
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.6726903110576729,-1.19261678475883,0.2708333333333333,0.7284993315243836,1.0,3/14,7.60%,PIGC;PLA1A;GPCPD1
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.642033741978228,1.1926136489292296,0.22,1.0,1.0,6/13,22.97%,YWHAB;PPP1CB;PPP2CB;CALM1;PPP2R5E;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.7117149606103915,1.1922461573681595,0.28,1.0,1.0,7/10,25.63%,ABL1;PPM1F;NRP1;RAC1;ROCK1;TEK;MAP4K4
prerank,CellMarker_Augmented_2021__Stem cell:Submandibular Gland,0.499166634069222,1.192147481613926,0.19047619047619047,1.0,1.0,7/46,12.99%,PDK4;SLCO2A1;TM4SF18;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.6487180571422805,-1.1919273918566484,0.25925925925925924,0.7294379143907735,1.0,4/22,3.88%,ZIC1;PARP12;ISG15;MAP2
prerank,CellMarker_Augmented_2021__Endothelial cell:Plasma,-0.7170918545139991,-1.1917158589833219,0.34782608695652173,0.72925368974936,1.0,3/8,18.70%,LCP2;GIMAP8;CARD8
prerank,Reactome_2022__SHC1 Events In ERBB4 Signaling R-HSA-1250347,0.7630081751081914,1.1915280746048593,0.2807017543859649,1.0,1.0,2/5,4.01%,ERBB4;NRG2
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.5915981154584102,-1.1914245327108794,0.2786885245901639,0.7293897230593485,1.0,4/26,2.12%,PSMA1;PSMB9;TMSB4X;STAT1
prerank,CellMarker_Augmented_2021__Stem cell:Lacrimal Gland,-0.5789714503620629,-1.1913353683160377,0.18518518518518517,0.727518992110631,1.0,4/35,7.28%,PPARG;ITGB5;CCDC68;DSP
prerank,CellMarker_Augmented_2021__Stem cell:Limbal Epithelium,-0.5789714503620629,-1.1913353683160377,0.18518518518518517,0.727518992110631,1.0,4/35,7.28%,PPARG;ITGB5;CCDC68;DSP
prerank,CellMarker_Augmented_2021__Corneal Epithelial Progenitor cell:Embryonic Stem Cell,-0.5789714503620629,-1.1913353683160377,0.18518518518518517,0.727518992110631,1.0,4/35,7.28%,PPARG;ITGB5;CCDC68;DSP
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,0.5942323229641707,1.19130561371932,0.16071428571428573,1.0,1.0,2/20,1.38%,CREB5;ITPR3
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.7365447779393148,1.191089802152706,0.2553191489361702,1.0,1.0,6/10,21.33%,NAV3;CLASP1;RAC1;FES;CDK5RAP2;CLIP1
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,-0.6170914073959307,-1.1910545623482902,0.25,0.7275767380222045,1.0,5/15,12.56%,ISG15;RFC3;TRIM25;UBC;NPLOC4
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.7116990912950018,-1.1908518381294384,0.2765957446808511,0.7273957985681851,1.0,3/7,9.75%,LGALS3;CD47;RPS19
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6752760565375285,1.1907530979411516,0.21739130434782608,1.0,1.0,4/9,23.11%,PITPNC1;SCP2;PITPNB;PRELID2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.48429492622255604,-1.190066937955449,0.22807017543859648,0.7289400510252366,1.0,12/88,9.03%,CYLD;PSMA1;IFIH1;PSMB9;TNIP1;PRKN;SMAD3;NFKBIA;FOXK1;ATXN7;SENP7;BABAM2
prerank,KEGG_2021_Human__N-Glycan biosynthesis,0.6687193785928225,1.1899732224608992,0.22,1.0,1.0,4/12,7.28%,FUT8;MAN1A2;MGAT5;STT3B
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.5767771519668797,1.1895438919379167,0.30612244897959184,1.0,1.0,6/20,17.42%,TAF1;ZBTB1;YY1;INO80;CREBBP;EP300
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,0.4660040565212029,1.1892377522725377,0.14285714285714285,1.0,1.0,28/89,21.35%,YWHAB;ACTG1;KDM4C;AHCTF1;MRTFA;RANBP2;DIAPH1;YWHAZ;ABL1;XPO1;PPP1CB;NCOA2;YWHAQ;CLASP1;PPP2CB;DIAPH2;GRB2;CDC42;CALM1;CYFIP1;WASF2;PRKCA;ROCK1;YWHAG;LIMK2;TAOK1;CLIP1;PPP2R5E
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.7235967012503327,1.1891554731053795,0.17647058823529413,1.0,1.0,6/6,27.76%,ABL1;NRP1;CDC42;FES;TEK;BCAS3
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.5087044773750642,1.1891100968000063,0.23684210526315788,1.0,1.0,19/60,21.35%,DUSP6;BTRC;CTDSP2;PPM1F;CDC14B;PPP4R2;PPP1CB;PPP2CB;PPP3CA;PTPN21;PPP3CB;PPP2R2B;PTEN;PPP6C;MTMR3;RPAP2;PTPN1;PPP4R1;PPP2R5E
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.7467421508439246,1.1890634258166364,0.22448979591836735,1.0,1.0,6/9,23.61%,FGF12;CACNA1C;ANK2;ATP1A1;RYR2;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.6793996048632919,-1.1888622006640734,0.3137254901960784,0.7312176511256332,1.0,2/14,3.61%,PPARG;SP100
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.6990101405347494,1.1887502177598241,0.2909090909090909,1.0,1.0,1/7,1.99%,TRAM2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.7534886299772213,-1.1887379298304754,0.2727272727272727,0.7298766985395092,1.0,1/5,0.40%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.7534886299772213,-1.1887379298304754,0.2727272727272727,0.7298766985395092,1.0,1/5,0.40%,PARP14
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.6666842804369407,1.1885347692266344,0.24,1.0,1.0,5/14,7.54%,ERBB4;NRG2;PIK3CA;PIGU;HSP90AA1
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,0.5003547713244457,1.1880900319045078,0.17777777777777778,1.0,1.0,7/34,12.11%,ITPR3;SNAP25;PLCB1;CACNA1C;GNB4;PPP2CB;ITPR2
prerank,CellMarker_Augmented_2021__Lymphoid cell:Peripheral Blood,0.6367569690905801,1.1879314923324484,0.27906976744186046,1.0,1.0,3/11,10.68%,NCAM1;ELMO1;CELF2
prerank,Reactome_2022__Small Interfering RNA (siRNA) Biogenesis R-HSA-426486,0.756084132254367,1.1869265592886094,0.28846153846153844,1.0,1.0,2/5,21.57%,DICER1;AGO2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.7118850746864983,1.186387963109705,0.27450980392156865,1.0,1.0,2/7,15.83%,DIAPH1;ANK2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.42614967021278566,1.1860086714811875,0.12195121951219512,1.0,1.0,34/142,19.12%,PDK4;ERBB4;COL4A2;PRKD1;ACTG1;YES1;ANGPT2;PLCB1;PIK3CA;HSP90AA1;ELMO1;ACTB;IDE;GRB10;SETX;FRS2;CHN1;AP2B1;EPHA4;NRP1;GRB2;CDC42;APPL1;PSEN1;ROR1;CYFIP1;TIAM1;RAC1;WASF2;FOXC1;ROCK1;PXN;CRK;RYK
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.5768642812743162,-1.1858626314836616,0.25925925925925924,0.7376701339096303,1.0,6/29,9.99%,BTG2;CNOT8;EIF2AK2;NFKB1;CST3;CAPRIN1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.6958452295388966,1.1856411052126297,0.2909090909090909,1.0,1.0,7/11,22.90%,GRM5;SOBP;CHD7;SHROOM4;CYFIP1;NIPBL;NF1
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,-0.4584797920997098,-1.1855797836210595,0.1518987341772152,0.737569564103263,1.0,34/211,9.19%,VCAM1;RSAD2;MX1;PSMA1;GBP1;XAF1;PSMB9;ISG15;STAT1;IRF2;FN1;IFI27;HLA-F;HLA-B;IRF1;HLA-C;IL32;SP100;EIF2AK2;NLRC5;OAS3;GBP4;MEF2A;SMAD3;SAMHD1;NFKBIA;B2M;NFKB1;TRIM25;FOS;TANK;JUN;STAT5B;HLA-E
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,0.6656016852003561,1.1854169542784083,0.3333333333333333,1.0,1.0,4/12,17.29%,CDH2;CADM2;CDH12;NECTIN3
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5791366108246967,-1.1849673029588284,0.26785714285714285,0.7384837399446988,1.0,3/38,0.93%,TBX3;TLL1;KIAA1217
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.5563497820146925,-1.1843599016222524,0.2698412698412698,0.7394071689358898,1.0,3/42,4.06%,TBX3;FN1;SMARCA1
prerank,CellMarker_Augmented_2021__1-Cell Stage Cell (Blastomere):Embryo,-0.716171600547713,-1.1843347326689093,0.23076923076923078,0.7386863976638975,1.0,1/6,5.47%,BLCAP
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,-0.7554882612287889,-1.184063247656962,0.2765957446808511,0.7388098644814826,1.0,4/6,21.12%,RFC3;UBC;POLK;CUL4A
prerank,CellMarker_Augmented_2021__Gonadal Endothelial cell:Fetal Gonad,0.41822164692078667,1.1837733701852622,0.07407407407407407,1.0,1.0,31/227,11.58%,CREB5;PDK4;PNP;CRIP2;RARB;CLIC1;RALA;ZEB1;DUSP6;PLEKHA1;CCDC85B;SKAP2;NAV3;CTDSP2;HSPB1;DOCK4;ENTPD1;CYYR1;TPST2;ELF1;CHST15;PPM1F;ITGA5;ACTB;GRB10;HDAC7;ANXA2;ID3;SMAD1;RALB;MPDZ
prerank,KEGG_2021_Human__Olfactory transduction,0.7457698392841322,1.183735711113252,0.2631578947368421,1.0,1.0,3/8,16.49%,PRKG1;SLC8A1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.8083992587924345,-1.183698441331319,0.32608695652173914,0.7390677390886554,1.0,1/5,2.23%,PLCG2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.6114879147193334,-1.183664807492024,0.22641509433962265,0.7383384910653554,1.0,3/19,10.23%,SLC5A6;CPM;BTD
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.7845915081876498,1.1833250091877279,0.2978723404255319,1.0,1.0,1/5,0.53%,PNP
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.6592385719781501,-1.1832006584062826,0.27586206896551724,0.7388538863709219,1.0,2/16,5.05%,NR3C2;EIF2AK2
prerank,KEGG_2021_Human__Hedgehog signaling pathway,0.6327737831344958,1.182544570551271,0.32432432432432434,1.0,1.0,6/17,24.99%,BTRC;CSNK1G3;SPOPL;SMURF2;BOC;SMURF1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.7095104938227537,-1.182022549376761,0.2830188679245283,0.7413481585530812,1.0,3/10,2.36%,PPARG;SOD2;TPM1
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,0.5454762520756791,1.1819311473353524,0.2962962962962963,1.0,1.0,5/30,12.93%,HSD17B4;INSIG1;NFYC;NCOA2;STARD4
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.7059363886500671,1.1818103805763829,0.2459016393442623,1.0,1.0,2/6,21.57%,DICER1;AGO2
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,-0.7236794445272197,-1.181475846127763,0.23076923076923078,0.7421943803022178,1.0,3/8,13.23%,STAT1;STAT5B;JAK2
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.8103624632363406,1.1811083464764955,0.24528301886792453,1.0,1.0,2/5,9.16%,NRCAM;ABL1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.7301922575044014,1.1810087379165912,0.2962962962962963,1.0,1.0,1/5,2.05%,STIM1
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,0.6207540790712787,1.1809005173063094,0.18181818181818182,1.0,1.0,2/11,6.24%,NDUFAF2;CCNI
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.7150127573538906,-1.1806601623418933,0.3111111111111111,0.7436191897055601,1.0,1/7,0.40%,PARP14
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.5760492324813724,1.1804755017299706,0.2653061224489796,1.0,1.0,4/25,9.22%,TRIM5;WDPCP;HSP90AA1;PPM1F
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.7163071840510664,1.1802022203482514,0.27450980392156865,1.0,1.0,5/8,23.67%,PARVA;CDC42;CYFIP1;RAC1;GSN
prerank,Reactome_2022__TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,-0.7301855819534674,-1.1801869931507862,0.2608695652173913,0.7441377542407436,1.0,3/6,13.49%,TANK;UBC;TBK1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.7695770757177405,-1.1794141982705246,0.23404255319148937,0.7447487289842274,1.0,2/6,14.02%,ACSL4;ELOVL5
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.7695770757177405,-1.1794141982705246,0.23404255319148937,0.7447487289842274,1.0,2/6,14.02%,ACSL4;ELOVL5
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.8037145963936014,-1.1793807206755684,0.32,0.7441196702721729,1.0,1/5,0.27%,TBX3
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6316640855618529,1.1793023397941693,0.25,1.0,1.0,1/10,1.70%,SOX5
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5694970986417933,-1.1792706621041673,0.25862068965517243,0.743680702064763,1.0,8/27,17.74%,HMGN1;RFC3;POLR2A;UBC;RNF111;XPC;RFC1;POLK
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.7852454356218954,1.1789863989878466,0.28888888888888886,1.0,1.0,4/5,20.82%,ADAM10;PSEN1;DYRK1A;ADAM17
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.6830351516402267,1.178756872938799,0.25925925925925924,1.0,1.0,3/6,16.49%,HSP90AA1;GCH1;CALM1
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.5824677437213542,1.1785407799839829,0.1875,1.0,1.0,7/16,24.41%,YAF2;CBFB;PHC2;ARID1A;EP300;PHC3;PBRM1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.6507743786506849,1.1783829169828464,0.3269230769230769,1.0,1.0,3/13,11.26%,AEBP2;DNMT3A;PPHLN1
prerank,CellMarker_Augmented_2021__Suppressor T cell:Peripheral Blood,-0.7605593639919774,-1.1781021994544503,0.28,0.74547534107837,1.0,2/5,17.26%,LCP2;GIMAP8
prerank,CellMarker_Augmented_2021__T cell:Ascites,-0.7605593639919774,-1.1781021994544503,0.28,0.74547534107837,1.0,2/5,17.26%,LCP2;GIMAP8
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,0.6434312131307789,1.1780028476163662,0.24444444444444444,1.0,1.0,4/14,10.41%,BTRC;YWHAZ;TLE4;XPO1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.6258451288098905,1.1779485092287183,0.24444444444444444,1.0,1.0,7/17,21.46%,PIK3CA;CDC42;CAPZB;CYFIP1;RAC1;WASF2;FSCN1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.6272063600296494,-1.1776793868084927,0.22413793103448276,0.7459879874872114,1.0,2/27,2.66%,PLK2;CDK14
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5728484605700612,-1.1776300327077147,0.21818181818181817,0.745250444210457,1.0,1/25,0.56%,CYLD
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,0.6131436658913618,1.17743967871568,0.2926829268292683,1.0,1.0,5/17,15.56%,ABL2;PIK3CA;GRB10;FOXO3;GRB2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.5356507522367933,-1.1773524685049204,0.2,0.7455634739606037,1.0,8/42,9.61%,BTG2;TPM1;CARMIL1;MAP2;GPM6A;PPP1R9A;FRYL;LIMA1
prerank,Reactome_2022__Pexophagy R-HSA-9664873,-0.7353634322932461,-1.1770810498179398,0.33962264150943394,0.7453905071641541,1.0,5/6,26.51%,UBC;ATM;EPAS1;SQSTM1;RPS27A
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6392435752575695,1.1766295986483124,0.2682926829268293,1.0,1.0,3/9,11.93%,DUSP6;PPM1F;PPP2CB
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.6275639968378073,1.1764538945937157,0.18181818181818182,1.0,1.0,1/12,0.24%,HSD17B4
prerank,CellMarker_Augmented_2021__Bipolar cell:Eye,0.5345278922446399,1.17618564818401,0.2222222222222222,1.0,1.0,11/45,12.56%,CDH2;ANKH;SNAP25;ZEB1;PITPNM2;CCDC88A;NAV3;DGKI;DPYSL2;NEGR1;CHN1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.6769642924577822,-1.1760062387953036,0.37037037037037035,0.7475868311541862,1.0,6/15,20.56%,RAB1A;PPP1R16B;RAPGEF2;AFDN;TJP1;MSN
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.6315339194997859,1.1759663141630319,0.21428571428571427,1.0,1.0,5/19,13.44%,PSMD14;YY1;MORF4L1;SEM1;INO80
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6072223429915937,1.175610931166571,0.25,1.0,1.0,5/20,17.29%,CDH2;CADM2;ACTB;CDH12;NECTIN3
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.7436258880647264,1.1755206750775953,0.21818181818181817,1.0,1.0,4/6,23.67%,PIK3CA;SLC8A1;ATP1A1;GSN
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.7436258880647264,1.1755206750775953,0.21818181818181817,1.0,1.0,4/6,23.67%,PIK3CA;SLC8A1;ATP1A1;GSN
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Liver,0.6301813753896536,1.175322331562036,0.2413793103448276,1.0,1.0,7/14,19.26%,ZBTB1;ITGA1;ALCAM;USP46;ID3;ROR1;AKAP12
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5836595694252777,1.175148603480191,0.21212121212121213,1.0,1.0,11/26,18.27%,CALR;STIM1;VAPB;ATP2A2;NPTN;SLC8A1;SLC24A2;ANK2;ATP2B4;ATP1A1;EDN1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.7567741303631668,1.1749258808525957,0.19607843137254902,1.0,1.0,1/5,1.04%,TEAD4
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.764994975863683,1.1747552635108363,0.2222222222222222,1.0,1.0,1/5,1.86%,RARB
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.6247953092213666,1.1746348036558807,0.2826086956521739,1.0,1.0,3/17,7.30%,PI4KA;PIK3CA;TTC7A
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.7636868680276732,1.1744643419378527,0.2807017543859649,1.0,1.0,4/5,16.49%,HSP90AA1;GCH1;MTHFD1L;CALM1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.6990235799418149,-1.1742790067037625,0.2916666666666667,0.7518256336618743,1.0,2/11,6.99%,NR4A1;LCP2
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.7679618065722837,1.1741780360720135,0.2830188679245283,1.0,1.0,4/6,21.54%,PHACTR4;SKI;MTHFD1L;DEAF1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.7679618065722837,1.1741780360720135,0.2830188679245283,1.0,1.0,4/6,21.54%,PHACTR4;SKI;MTHFD1L;DEAF1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.7679618065722837,1.1741780360720135,0.2830188679245283,1.0,1.0,4/6,21.54%,PHACTR4;SKI;MTHFD1L;DEAF1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.735065169129504,1.17396473844409,0.3148148148148148,1.0,1.0,2/6,11.29%,FUT8;ST8SIA4
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.7641369720974157,-1.173778041759909,0.2982456140350877,0.7524491177032688,1.0,1/7,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.7008680306998675,-1.1736524388012781,0.3559322033898305,0.7520608455239024,1.0,2/10,4.91%,BTG2;PABPC1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.5577553522473438,-1.1734516915988817,0.23333333333333334,0.751892825715184,1.0,3/46,4.97%,CX3CL1;CXCL12;MMRN2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.686590906645413,1.1733182351154858,0.2826086956521739,1.0,1.0,4/13,20.11%,BMP6;PPM1F;WNK1;RGCC
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.6907058671126722,1.1730773291642895,0.21951219512195122,1.0,1.0,4/9,23.56%,PTBP3;SFSWAP;SRSF7;PTBP2
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.6697982988263949,-1.1728866130106348,0.32558139534883723,0.7519191352604776,1.0,2/8,11.71%,ANAPC16;UBC
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.6697982988263949,-1.1728866130106348,0.32558139534883723,0.7519191352604776,1.0,2/8,11.71%,ANAPC16;UBC
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.7054430640479044,1.1726095535838263,0.26666666666666666,1.0,1.0,3/6,22.26%,FRS2;GRB2;SORT1
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.65408917984558,1.172448161880081,0.24074074074074073,1.0,1.0,3/13,17.42%,IL6R;CBFB;EP300
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.7204226559898232,1.1724206566982733,0.3111111111111111,1.0,1.0,2/6,13.33%,TPST2;PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7204226559898232,1.1724206566982733,0.3111111111111111,1.0,1.0,2/6,13.33%,TPST2;PAPSS2
prerank,Reactome_2022__Interleukin-35 Signaling R-HSA-8984722,-0.7284044411968521,-1.1723637481397646,0.30434782608695654,0.7511890418285928,1.0,2/6,13.23%,STAT1;JAK2
prerank,Reactome_2022__Interleukin-27 Signaling R-HSA-9020956,-0.7284044411968521,-1.1723637481397646,0.30434782608695654,0.7511890418285928,1.0,2/6,13.23%,STAT1;JAK2
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.7284044411968521,-1.1723637481397646,0.30434782608695654,0.7511890418285928,1.0,2/6,13.23%,STAT1;JAK2
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,0.5120451532110499,1.1722669706789801,0.1956521739130435,1.0,1.0,6/27,12.11%,ITPR3;SNAP25;PLCB1;CACNA1C;GNB4;ITPR2
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,0.7579649083671571,1.1722426924196185,0.36065573770491804,1.0,1.0,3/6,15.56%,RALA;RALB;GRB2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.6874799571548507,-1.171971688691353,0.2619047619047619,0.7515571755872829,1.0,1/8,2.23%,PLCG2
prerank,Reactome_2022__Integration Of Provirus R-HSA-162592,0.8082798132635913,1.1715593932698636,0.35294117647058826,1.0,1.0,3/5,14.69%,SGIP1;PSIP1;KPNA1
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,0.8082798132635913,1.1715593932698636,0.35294117647058826,1.0,1.0,3/5,14.69%,SGIP1;PSIP1;KPNA1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6876232493690728,1.1715558157513453,0.30434782608695654,1.0,1.0,2/10,7.68%,PRKD1;AMBRA1
prerank,KEGG_2021_Human__Circadian rhythm,0.6555609365026903,1.171284963918456,0.25925925925925924,1.0,1.0,2/14,5.52%,CRY1;BTRC
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.6544988075271013,1.1711977579817678,0.32075471698113206,1.0,1.0,3/13,7.46%,NUP58;PIAS1;RANBP2
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Stem Cell,-0.6816662909041957,-1.1707934481191569,0.32,0.7516433349541836,1.0,3/11,17.26%,LCP2;SCARF1;GIMAP8
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Umbilical Cord Blood,-0.6816662909041957,-1.1707934481191569,0.32,0.7516433349541836,1.0,3/11,17.26%,LCP2;SCARF1;GIMAP8
prerank,CellMarker_Augmented_2021__Platelet:Bone Marrow,-0.6816662909041957,-1.1707934481191569,0.32,0.7516433349541836,1.0,3/11,17.26%,LCP2;SCARF1;GIMAP8
prerank,CellMarker_Augmented_2021__Endothelial cell:Eye,-0.6816662909041957,-1.1707934481191569,0.32,0.7516433349541836,1.0,3/11,17.26%,LCP2;SCARF1;GIMAP8
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.584554227808578,1.1707645727726077,0.29545454545454547,1.0,1.0,6/19,18.59%,ACTG1;ABL1;GRB2;CDC42;CYFIP1;WASF2
prerank,KEGG_2021_Human__Salmonella infection,0.432816887616377,1.1701239556344918,0.13513513513513514,1.0,1.0,18/89,17.77%,KPNA3;RALA;HSP90B1;ACTG1;MAPK10;TUBB4B;PIK3CA;HSP90AA1;TAB2;ELMO1;ACTB;ANXA2;RAB7A;KPNA1;CDC42;TUBA1B;CYFIP1;RAC1
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.6445138610118022,-1.1699681810788192,0.2982456140350877,0.7533102652998346,1.0,2/16,7.68%,CYLD;NFKB1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.7093724011562597,1.1697050481135653,0.22916666666666666,1.0,1.0,1/7,0.08%,PDK4
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.7248767362922814,-1.1695983417032674,0.3023255813953488,0.7529545566246503,1.0,3/8,14.02%,ACSL4;CBR4;ELOVL5
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.7248767362922814,-1.1695983417032674,0.3023255813953488,0.7529545566246503,1.0,3/8,14.02%,ACSL4;CBR4;ELOVL5
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.5135633645884596,1.1695586867051093,0.20454545454545456,1.0,1.0,9/42,13.44%,PSMD14;UIMC1;TENT4A;YY1;MORF4L1;SEM1;SETX;HERC2;INO80
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.7058972262343278,1.1694141308536994,0.2553191489361702,1.0,1.0,7/9,27.12%,TRIOBP;CAPZB;ADD3;GSN;ADD1;CAPZA1;SVIL
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.7058972262343278,1.1694141308536994,0.2553191489361702,1.0,1.0,7/9,27.12%,TRIOBP;CAPZB;ADD3;GSN;ADD1;CAPZA1;SVIL
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.7434684961609617,1.1689253346684914,0.36363636363636365,1.0,1.0,4/5,23.77%,ANKH;LRRC8B;ADD3;ADD1
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,0.7562702783885686,1.1688619911084428,0.25925925925925924,1.0,1.0,3/6,8.02%,ERBB4;NRG2;DIAPH1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6811066170454041,1.1688201766593462,0.33962264150943394,1.0,1.0,4/13,18.33%,HSP90B1;ITGA1;CALM1;PPP6R3
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.7153390002899793,1.1687151686600885,0.21428571428571427,1.0,1.0,3/7,14.08%,MORC3;TAF3;PINK1
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.5655012326415995,-1.168455286200546,0.2830188679245283,0.755468765900725,1.0,3/23,2.12%,PSMA1;PSMB9;STAT1
prerank,Reactome_2022__TRP Channels R-HSA-3295583,-0.7434740094999045,-1.1684425669655192,0.3793103448275862,0.7547275249424604,1.0,3/5,14.45%,TRPM6;TRPM3;TRPC4AP
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.6531938285159928,-1.168189821278691,0.2553191489361702,0.7545487413760251,1.0,3/18,5.58%,NR4A1;STAT1;PLXND1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.6662338472555301,1.1681748461770025,0.32,1.0,1.0,6/12,21.33%,NAV3;CLASP1;RAC1;FES;CDK5RAP2;CLIP1
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,-0.6130350005311141,-1.1678613041321184,0.26,0.7547582398758589,1.0,1/18,0.19%,EPSTI1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.7101407662262658,1.16774351705106,0.3333333333333333,1.0,1.0,1/7,4.75%,KDM4C
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.7901920472424504,-1.1677192097490783,0.23255813953488372,0.7543968134377885,1.0,3/7,15.43%,SERPINE1;ACER2;PDE3B
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.7670638988182442,1.1677025702394164,0.3404255319148936,1.0,1.0,1/5,1.70%,SOX5
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,0.5699079360358743,1.167612441724469,0.2857142857142857,1.0,1.0,6/31,10.17%,HDAC9;ACTG1;PLCB1;PIK3CA;ACTB;HDAC7
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.5996765724447101,1.167174778873982,0.3469387755102041,1.0,1.0,3/15,8.61%,UIMC1;WRNIP1;ERCC6
prerank,CellMarker_Augmented_2021__Endothelial cell:Liver,-0.557728511868894,-1.1660270623997453,0.2857142857142857,0.7585199748463545,1.0,12/40,16.10%,HES1;ARGLU1;GBP4;TFRC;BTNL9;BST2;EFNB2;DUSP5;PPWD1;MFN1;RIN2;ATP10D
prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.5097615925951805,1.1658260935268792,0.2127659574468085,1.0,1.0,16/49,22.79%,ITPR3;ACTG1;KRAS;PLCB1;ACTB;PPP1CB;CACNA1C;ITPR2;PPP3CA;PPP3CB;CALM1;PRKCA;ROCK1;RYR2;CAMK1D;ROCK2
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.731853587388215,1.1657185959987695,0.36363636363636365,1.0,1.0,4/7,14.48%,ATP2A2;MICU3;CACNA1C;SLC8A1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.8400011096938261,-1.1655940316939506,0.22727272727272727,0.7592509820953124,1.0,1/5,0.93%,KIAA1217
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,0.5921567414816025,1.165434770627807,0.2553191489361702,1.0,1.0,4/21,7.86%,ERBB4;GRIA2;PRKX;LRRC7
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.6747487047889373,-1.1654293214136549,0.35,0.758939640795991,1.0,1/7,1.65%,RREB1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.5901111515032107,1.1650631972478682,0.24444444444444444,1.0,1.0,4/17,7.28%,FUT8;MCFD2;MGAT5;STT3B
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,0.7815235378118559,1.164954567427035,0.3269230769230769,1.0,1.0,2/5,11.53%,KDM4C;NCOA2
prerank,CellMarker_Augmented_2021__Flk1+ Mesodermal cell:Pluripotent Stem Cell,-0.55052610550432,-1.1649478670744668,0.2857142857142857,0.7596150874012741,1.0,3/36,7.28%,KIAA1217;PPP1R9A;DSP
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.5143840668755463,1.1647135489591884,0.20930232558139536,1.0,1.0,4/37,5.63%,TRIM5;MTDH;PRKD1;FBXO7
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.7366600660555837,-1.1645996772142366,0.3409090909090909,0.7599678930603081,1.0,3/6,20.00%,PMAIP1;ATM;DDX5
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,0.6988133873747255,1.1645123583098993,0.2962962962962963,1.0,1.0,3/8,19.36%,AEBP2;DNMT3A;JARID2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.7662747343746779,-1.164084692746381,0.37777777777777777,0.7607050379775665,1.0,1/5,3.93%,SNX6
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7567261830769375,-1.1639484452412439,0.3508771929824561,0.7602225131069504,1.0,1/5,4.86%,TIE1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7103902528721322,-1.1637035828693567,0.3,0.7602640315600856,1.0,2/5,11.69%,RNF213;GPC3
prerank,Reactome_2022__Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,0.7669547437682886,1.1634754726877745,0.3090909090909091,1.0,1.0,4/5,18.91%,YWHAB;YWHAZ;YWHAQ;YWHAG
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6632389098445273,-1.1628499689496203,0.26785714285714285,0.762086213358794,1.0,1/11,1.57%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.6053881136293439,-1.1627286492987177,0.32,0.7616357137348657,1.0,10/32,18.91%,PPARG;PLCG2;PLK2;RPS19;RORA;PRKAR1A;RAMP3;OTULIN;MAPK14;PTPN2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6288635795301175,-1.1627193956384478,0.2857142857142857,0.7608456351936469,1.0,6/16,11.58%,RPS6;RPL38;RPS28;RPS19;RPS7;RPS15
prerank,KEGG_2021_Human__Antigen processing and presentation,-0.6086913727850867,-1.1625430246154,0.22916666666666666,0.7604717649740523,1.0,5/19,4.49%,CD74;HLA-F;HLA-B;HLA-C;TAP1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.674654159424839,1.1624761548229356,0.2708333333333333,1.0,1.0,5/9,15.19%,AHCTF1;RTN4;PLEKHA7;ADAM10;ANO6
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.4750116051054551,-1.1624520396546698,0.21428571428571427,0.7599075264940659,1.0,11/88,9.03%,CYLD;PSMA1;IFIH1;PSMB9;TNIP1;PRKN;SMAD3;NFKBIA;FOXK1;ATXN7;BABAM2
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.7661911727598982,1.1622670903905907,0.27586206896551724,1.0,1.0,3/6,11.34%,PKM;ITGA5;SMAD1
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.6502316933611425,1.162257680417837,0.2777777777777778,1.0,1.0,5/13,14.69%,NUP58;SGIP1;RANBP2;PSIP1;KPNA1
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.6502316933611425,1.162257680417837,0.2777777777777778,1.0,1.0,5/13,14.69%,NUP58;SGIP1;RANBP2;PSIP1;KPNA1
prerank,Reactome_2022__Signaling By Leptin R-HSA-2586552,-0.7540750297657577,-1.1622242146935227,0.35,0.7600021532527268,1.0,2/5,13.23%,STAT5B;JAK2
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.5782515978233906,-1.1621225556693167,0.22950819672131148,0.7594183715356139,1.0,5/38,4.06%,ZIC1;EML1;CXCL12;LAMA4;SMARCA1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.5180347071573023,1.162070599476604,0.24489795918367346,1.0,1.0,8/29,17.42%,TAF1;ZBTB1;YY1;UBE2B;ERCC6;INO80;CREBBP;EP300
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.661525598393149,1.1619573291781453,0.2926829268292683,1.0,1.0,3/9,16.44%,GRIA2;LRRC7;NLGN1
prerank,KEGG_2021_Human__ErbB signaling pathway,0.5308662377434566,1.1618860079201496,0.26666666666666666,1.0,1.0,7/40,9.16%,ABL2;ERBB4;MAPK10;NRG2;KRAS;PIK3CA;ABL1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.4909830380959256,-1.1613976221554632,0.2033898305084746,0.7607942309111324,1.0,11/112,10.33%,CD74;RIMS1;PLCG2;FN1;PRKN;SMAD3;WARS1;RPL23;TFRC;RPS7;AHI1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex3:Brain,0.5142310969793871,1.1613176471548987,0.25,1.0,1.0,11/36,13.39%,ZNF385D;NOVA1;CADM2;GRIA2;FGF12;NCAM1;NRXN1;ADGRB3;RBFOX1;NEGR1;PPP2R2B
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.7594155113019376,1.1609924998922079,0.2653061224489796,1.0,1.0,1/6,0.66%,ARHGEF4
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.7784834179024145,-1.1608396856287237,0.28205128205128205,0.7615115893304006,1.0,1/6,9.85%,POLR2A
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.7826241618548704,-1.1607897121416093,0.36538461538461536,0.7609069280734876,1.0,1/6,1.51%,PSMB9
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.60080701456355,1.1607287482017847,0.28888888888888886,1.0,1.0,5/19,14.08%,EIF4G3;PIK3CA;TAB2;LRRK2;PINK1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.7460264294147193,1.1604498108809973,0.32653061224489793,1.0,1.0,1/5,12.93%,STARD4
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,-0.6433530627260814,-1.1604369811599062,0.18867924528301888,0.7611794488378016,1.0,2/15,7.68%,ANAPC16;NFKB1
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.7099961737101523,-1.1603981116050253,0.3333333333333333,0.7605025734649968,1.0,2/7,8.71%,TNFSF10;TANK
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.6134956760614836,-1.1603130429175377,0.3541666666666667,0.75995346955427,1.0,6/16,15.46%,NLRC5;NFKBIA;NFKB1;TANK;UBC;N4BP1
prerank,Reactome_2022__ALK Mutants Bind TKIs R-HSA-9700645,-0.6936279160152719,-1.1601699091756104,0.36,0.7595422649586712,1.0,1/9,2.39%,FN1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5905712218005914,-1.159940847173339,0.2545454545454545,0.7592159847258491,1.0,8/15,17.74%,ISG15;RFC3;TRIM25;UBC;NPLOC4;PRIMPOL;RFC1;POLK
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.5560358209643507,-1.159694907410604,0.2777777777777778,0.7589848675436457,1.0,9/44,8.92%,CYLD;PPARG;STAT1;PLCG2;LCP2;NFKBIA;NFKB1;FOS;JUN
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5203927772869883,1.159453262758258,0.2631578947368421,1.0,1.0,12/37,16.15%,GRIA2;TTLL7;SNAP25;MAPK10;NOVA2;NRXN1;ADGRB3;RBFOX1;DST;CNTN1;ANK2;PLPPR4
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5561618559531304,1.1593786826728587,0.2978723404255319,1.0,1.0,5/21,12.08%,ABL2;DEPP1;HSPB1;ABL1;LRRK2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Lung,0.6699053729582611,1.1590915467151701,0.30357142857142855,1.0,1.0,1/7,6.43%,ALCAM
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.698548829008888,1.158881932301817,0.2857142857142857,1.0,1.0,2/8,2.50%,ANO5;CLIC1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.5815657475931381,1.158592583267266,0.28,1.0,1.0,4/21,9.03%,COL4A2;HSPG2;SEMA3F;PARVA
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6618569075749331,-1.1584484003532471,0.28,0.761743509053341,1.0,1/12,1.57%,RIMS1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.5597165903175505,-1.1578672300861916,0.28125,0.7625790392288938,1.0,8/30,13.47%,SOD2;RNF213;SAMHD1;B2M;APPL2;CBR4;CLYBL;SPAST
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.5510604833879499,-1.157836185405781,0.3137254901960784,0.761884635891802,1.0,6/49,8.92%,VCAM1;MAP3K5;MEF2A;NFKB1;FOS;JUN
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.6808890206640722,1.1576843614300343,0.3389830508474576,1.0,1.0,2/6,10.86%,CRY1;PPP1CB
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.6371656933936556,-1.1575299858360446,0.3023255813953488,0.7619340702259384,1.0,5/11,13.23%,STAT1;CDC37;PARP9;IFNGR2;JAK2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.6570219200411828,1.157455434511931,0.2978723404255319,1.0,1.0,6/8,31.77%,OTUD7B;MFHAS1;CTNNA1;LATS2;UFM1;LATS1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.6500205640382765,-1.1570654982772342,0.37037037037037035,0.7624430278392662,1.0,2/10,9.80%,SHLD1;CYREN
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.5553359209303176,1.1569167862883099,0.2857142857142857,1.0,1.0,8/32,17.42%,BAG3;HSPH1;NUP58;RANBP2;HSP90AA1;HSPA8;CREBBP;EP300
prerank,KEGG_2021_Human__Sphingolipid metabolism,0.618140794027717,1.1568451603439478,0.3137254901960784,1.0,1.0,2/12,4.78%,KDSR;UGCG
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.7878394768967671,-1.1567184132571422,0.36363636363636365,0.762408310566592,1.0,2/5,15.62%,SPG7;IMMP2L
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.4731372358059638,1.1566338599621009,0.22727272727272727,1.0,1.0,8/62,8.66%,HDAC9;NOVA1;CALR;MCC;SMAD6;NOVA2;CHSY1;KLF7
prerank,Reactome_2022__TNF Signaling R-HSA-75893,-0.6021052584231427,-1.1566204603255799,0.35294117647058826,0.762060920835838,1.0,4/20,11.71%,CYLD;TANK;SPPL2A;UBC
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.5508124554521567,1.1565080137831352,0.3488372093023256,1.0,1.0,8/23,18.57%,VAPB;MCFD2;BET1;ANKRD28;TFG;CD59;PPP6R3;PPP6C
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.627800951950585,-1.1564756225167825,0.37254901960784315,0.7617038222810754,1.0,2/11,8.31%,SHLD1;TFRC
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.7176236951786706,1.1564485216558493,0.27906976744186046,1.0,1.0,4/7,19.71%,PEX14;DNAJC15;HSPD1;SEC63
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.6036124836744884,-1.1561059886786806,0.3333333333333333,0.7620132798603302,1.0,4/21,12.54%,LRPAP1;SERPINE1;B2M;CLU
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,0.5399496998652089,1.1560635430088095,0.23529411764705882,1.0,1.0,9/36,17.42%,BAG3;HSPH1;NUP58;RANBP2;HSP90AA1;HSPA8;HSPA9;CREBBP;EP300
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.49207471925355106,1.1557065033774625,0.22727272727272727,1.0,1.0,3/55,3.16%,PDK4;PRKD1;SLC38A9
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.6797719258460542,1.1555962429983289,0.3050847457627119,1.0,1.0,7/10,23.64%,HSP90AA1;ANKRD28;SHQ1;POT1;PPP6R3;PPP6C;HSP90AB1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.6797719258460542,1.1555962429983289,0.3050847457627119,1.0,1.0,7/10,23.64%,HSP90AA1;ANKRD28;SHQ1;POT1;PPP6R3;PPP6C;HSP90AB1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.6797719258460542,1.1555962429983289,0.3050847457627119,1.0,1.0,7/10,23.64%,HSP90AA1;ANKRD28;SHQ1;POT1;PPP6R3;PPP6C;HSP90AB1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.7310411404015892,1.1555750836669607,0.3333333333333333,1.0,1.0,1/6,19.73%,FES
prerank,CellMarker_Augmented_2021__Epithelial cell:Mammary Epithelium,-0.725006934348154,-1.1553211735487419,0.3584905660377358,0.7633094530832313,1.0,1/5,7.28%,DSP
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.7411262352660095,-1.1550699442034424,0.3409090909090909,0.7630663833195875,1.0,1/5,3.37%,RNF213
prerank,Reactome_2022__MAPK1 (ERK2) Activation R-HSA-112411,0.7361871615906788,1.154945012245035,0.24,1.0,1.0,1/6,3.13%,IL6R
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.7117012203847418,-1.1548541544223703,0.3469387755102041,0.7627408285919887,1.0,3/6,23.80%,KANSL1;MSL2;KMT2A
prerank,KEGG_2021_Human__Hippo signaling pathway,0.4750257520284504,1.1548373172795998,0.2608695652173913,1.0,1.0,13/56,14.66%,TEAD4;BMP6;YWHAB;ACTG1;BTRC;YWHAZ;ACTB;PPP1CB;SMAD1;YWHAQ;PPP2CB;PPP2R2B;PARD3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6821386776092934,-1.154509263981351,0.26,0.7629650956606304,1.0,3/13,2.36%,PPARG;SOD2;TPM1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.5847607043630386,1.1543411717022896,0.25,1.0,1.0,1/12,5.31%,PCM1
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.6948722206493351,1.1543121857537098,0.32,1.0,1.0,3/7,27.84%,ACTB;NEDD4L;CTTNBP2NL
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6549825865085561,-1.1542226985926132,0.32653061224489793,0.7631785589903751,1.0,4/11,6.56%,SAT1;IFI27;TNFSF10;SLCO2B1
prerank,CellMarker_Augmented_2021__Stromal cell:Amniotic Membrane,0.49031452480620424,1.154141747236571,0.23809523809523808,1.0,1.0,9/42,11.18%,JAZF1;ZEB1;SLFN12;ZEB2;ITGA5;S1PR1;ARHGAP31;CELF2;GNB4
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5375683685883188,1.1538181891568835,0.3333333333333333,1.0,1.0,7/35,11.34%,STIM1;MTDH;PRKD1;PKM;HSPB1;ITGA5;SMAD1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7804796706629221,1.1536225716521753,0.3404255319148936,1.0,1.0,3/5,16.10%,SEMA3F;NRP1;UNC5C
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex6:Brain,0.6601309666046733,1.1535200454696395,0.3508771929824561,1.0,1.0,3/10,2.34%,ZNF385D;RBM20;MCC
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.6338630640302466,1.153341649708788,0.3148148148148148,1.0,1.0,4/15,7.54%,ERBB4;NRG2;PIK3CA;HSP90AA1
prerank,CellMarker_Augmented_2021__Goblet cell:Small Intestine,0.7622808073448454,1.1531507660606646,0.22448979591836735,1.0,1.0,4/5,23.67%,MT1M;FAM193B;MSANTD2;GSN
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.6527571029490687,-1.1530234838061724,0.22916666666666666,0.7658630184578201,1.0,4/11,12.86%,PDXDC1;CPQ;ERAP1;ENPP2
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.6744873752145372,1.1529862610491375,0.3584905660377358,1.0,1.0,4/9,23.64%,HSP90AA1;NRP1;FES;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.6446138567496296,1.152070978400272,0.26229508196721313,1.0,1.0,6/14,16.68%,PRAG1;CBFA2T2;RTN4;EPHA4;NLGN1;PTEN
prerank,Reactome_2022__Reduction Of Cytosolic Ca++ Levels R-HSA-418359,0.7529195153714385,1.151703547655782,0.3508771929824561,1.0,1.0,4/5,16.57%,ATP2A2;SLC8A1;CALM1;ATP2B4
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,-0.6829200091057922,-1.1516034409407585,0.39344262295081966,0.7689862733319012,1.0,4/8,13.09%,RFC3;TOPBP1;MSH2;ATM
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.7611971176406807,1.1515746042376107,0.2708333333333333,1.0,1.0,3/5,22.55%,CDH2;ANXA1;CDK6
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.6697891780553036,-1.151358703551814,0.32,0.7688215188270223,1.0,3/16,11.08%,PPARG;ACSL4;CBR4
prerank,KEGG_2021_Human__Huntington disease,0.47676040412175663,1.1511500327049964,0.3023255813953488,1.0,1.0,10/60,9.59%,CREB5;PSMD14;GRM5;GRIA2;MAPK10;TUBB4B;PLCB1;AMBRA1;REST;SEM1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.6864388202547254,-1.1511247800203295,0.3333333333333333,0.7689045239358585,1.0,1/13,1.01%,PPARG
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.7319501527331781,1.1510107919317303,0.3018867924528302,1.0,1.0,2/5,13.97%,CDH2;PLEKHA7
prerank,CellMarker_Augmented_2021__Myofibroblast:Lung,-0.6289720964604577,-1.1507206419909446,0.2830188679245283,0.7695641157635048,1.0,4/17,4.04%,TPM1;FN1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.7927797134888493,-1.1505212645487461,0.375,0.7693684109153495,1.0,2/5,11.29%,PRKN;MTMR2
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryo,-0.5533411049216728,-1.1500091232056127,0.30357142857142855,0.7700262160990732,1.0,4/27,9.27%,CLEC1A;TIE1;LCP2;SCARF1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.5542946161267344,-1.1495657311884737,0.32653061224489793,0.7705389490046132,1.0,6/29,13.09%,ISG15;LGALS3;WARS1;TFRC;CLU;ATM
prerank,KEGG_2021_Human__Human papillomavirus infection,-0.4870513496116299,-1.1494713684023,0.20967741935483872,0.7699838274489158,1.0,14/112,5.05%,HES1;MX1;ISG15;STAT1;FN1;ITGB5;HLA-F;HLA-B;IRF1;HLA-C;ATP6V1E1;LAMA4;PATJ;EIF2AK2
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7026640769513368,1.1494170970267428,0.3170731707317073,1.0,1.0,2/6,13.31%,PPP3CA;PPP3CB
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7026640769513368,1.1494170970267428,0.3170731707317073,1.0,1.0,2/6,13.31%,PPP3CA;PPP3CB
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,-0.7146892350915579,-1.1487135769774672,0.42857142857142855,0.7716740664488354,1.0,3/6,26.51%,UBC;FANCL;RPS27A
prerank,CellMarker_Augmented_2021__SLC16A7+ cell:Lung,-0.4478220518262424,-1.1485798066758115,0.18461538461538463,0.77135438247916,1.0,21/238,8.66%,IFI44L;RSAD2;SLC22A5;ABCA5;XAF1;CENATAC;ITIH5;NEK3;SPG7;CPM;ARGLU1;GBP4;ZKSCAN1;PAXBP1;SLC2A3;TMEM168;ZNF33B;SENP7;FNBP1;LARS1;CCDC88C
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.7092331558006313,1.148453912901908,0.3442622950819672,1.0,1.0,2/7,11.85%,RANBP9;CLASP1
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.7710420903238068,1.1482859109732753,0.3333333333333333,1.0,1.0,1/5,1.73%,HSPG2
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,0.7710420903238068,1.1482859109732753,0.3333333333333333,1.0,1.0,1/5,1.73%,HSPG2
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.5738064631958539,1.1482774792563097,0.2857142857142857,1.0,1.0,8/19,26.06%,PLCB1;PPM1F;INO80;ADAM10;CDC42;ADAM17;AKAP6;RFTN1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.6488686833160647,-1.1481094319877017,0.32727272727272727,0.7718944282613973,1.0,3/11,15.51%,UBR2;ATM;SPAAR
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.4943163021313032,-1.1480791838040445,0.21311475409836064,0.7712175630340341,1.0,9/63,12.24%,CYLD;TMSB4X;STAT1;TNIP1;UBR2;DGKG;TANK;CD2AP;RORA
prerank,KEGG_2021_Human__RNA degradation,-0.6035829610000311,-1.1479857491059708,0.3076923076923077,0.7705930794842869,1.0,3/22,4.91%,BTG2;CNOT8;PABPC1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.7472842175968981,1.1475827581154407,0.2641509433962264,1.0,1.0,2/7,14.21%,PEX14;MFF
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,0.5115715251096634,1.1475691028223982,0.13513513513513514,1.0,1.0,18/52,19.95%,YWHAB;RALA;DUSP6;PIK3CA;PIGU;REST;DOCK3;FRS2;ID3;RALB;PPP2CB;AP2B1;RPS6KA5;GRB2;EP300;TIAM1;CRK;ID1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.7468609132720019,1.1474589812561546,0.3333333333333333,1.0,1.0,3/5,16.44%,NRXN1;IL1RAPL1;NLGN1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.4895682930679822,-1.1474172171307442,0.21875,0.7712852234099598,1.0,34/125,14.63%,RPS12;FN1;DENND3;RPL31;SHISA5;TNIP1;PRKN;SPG7;RPS18;RPL34;RPS8;RPL15;RPS6;RPL7A;RPL38;WARS1;RPL23;RPL30;PRSS23;ERO1A;RPS28;RPS19;CST3;RPS7;RPS14;RPS15;GPC3;UBE2D2;RPL28;RPL10;RPL9;EEF1A1;RPL24;RPL37
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.7266531845165716,-1.1470078741415985,0.3404255319148936,0.7715074061053394,1.0,3/9,12.70%,LRPAP1;MTMR2;ITGAV
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,-0.4816218973276075,-1.1466955941409676,0.2222222222222222,0.7717087948447561,1.0,22/92,11.98%,PSMA1;PSMB9;RPS12;CXCL12;RPL31;RPL34;PABPC1;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;RPS7;RPS14;RPS15;UBC;UPF3A;RPL28
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.5357019515696773,-1.146225209128655,0.27692307692307694,0.7722961103678163,1.0,4/42,4.01%,CYLD;PSMA1;PSMB9;PRKN
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.7351204739390509,-1.1461141758958315,0.37735849056603776,0.7718463093718144,1.0,1/6,4.59%,RFC3
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.7632052071466393,1.14577692014512,0.2857142857142857,1.0,1.0,1/5,8.34%,MORF4L1
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5334751291297597,-1.1454973546188227,0.32,0.772929498721591,1.0,3/52,2.23%,CD74;CX3CL1;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.7341231284716698,-1.1454320443704094,0.3181818181818182,0.7724292791070999,1.0,2/6,4.01%,ATP9A;PRKN
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.45195236424815594,1.1453793273480661,0.24324324324324326,1.0,1.0,6/71,7.01%,CREB5;IL1R1;CALR;MAPK10;KRAS;PIK3CA
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.7383723144467826,1.14498906744377,0.3275862068965517,1.0,1.0,2/5,10.49%,AHCTF1;RTN4
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.7230903352870872,-1.1445073280415337,0.3125,0.7741477131079,1.0,2/6,14.42%,KIDINS220;RAPGEF2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.6408066341709069,-1.1442470827776543,0.2916666666666667,0.774213793894785,1.0,3/8,9.61%,TPM1;CARMIL1;LIMA1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.7024590023270982,-1.1440508445965907,0.34782608695652173,0.7731541866932735,1.0,2/7,8.39%,UBR2;LARS1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.7024590023270982,-1.1440508445965907,0.34782608695652173,0.7731541866932735,1.0,2/7,8.39%,UBR2;LARS1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.7043427938304812,-1.1439065244595152,0.3958333333333333,0.772716724440395,1.0,1/5,15.43%,PDE3B
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.7350100960851583,1.143842129943544,0.32653061224489793,1.0,1.0,5/7,18.83%,CNOT2;REST;NCOA3;ZNF706;WDR43
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5060805658123554,1.1431434333640402,0.25,1.0,1.0,17/39,16.15%,NOVA1;ERBB4;GRIA2;SNAP25;MAPK10;FGF12;NRXN1;PXK;RNF180;FGF14;CNTN1;ADGRL2;GAREM1;ANK2;THSD7A;UNC5C;PLPPR4
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.6062506277096418,-1.142374677208272,0.35294117647058826,0.776340988397519,1.0,4/24,3.72%,GBP1;RREB1;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6648777062226667,-1.1423635001142967,0.37254901960784315,0.7756093229656565,1.0,2/11,13.09%,SP100;ATM
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.669846606458665,-1.1423214643141182,0.2857142857142857,0.7749394331784242,1.0,1/8,3.93%,SNX6
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.7511507472306092,1.1420841145486238,0.3090909090909091,1.0,1.0,3/5,21.25%,STIM1;CALM1;RYR2
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,0.529420811808031,1.1415727077459066,0.2653061224489796,1.0,1.0,8/31,12.11%,ITPR3;GRM5;GRIA2;MAPK10;PLCB1;CACNA1C;GNB4;ITPR2
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.6464646231901552,1.1413427717900126,0.2962962962962963,1.0,1.0,6/10,26.40%,ROBO2;NRXN1;IL1RAPL1;NLGN1;SETD5;MEF2C
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.47575096419180124,1.1411044705268225,0.2222222222222222,1.0,1.0,17/65,18.22%,CALR;BAG3;TAF1;MORC3;UBE2B;HSP90AA1;PARVA;RTN4;NLK;HSPD1;EPHA4;ATF7IP;PINK1;ANK2;PTEN;EP300;ZNF207
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.61484148344837,-1.140932987782676,0.29310344827586204,0.7782595084354546,1.0,2/16,4.97%,PPARG;MMRN2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.7176480017626707,1.1407806185914626,0.32608695652173914,1.0,1.0,2/6,14.08%,ABL1;PINK1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7785434110908266,-1.1407443732007456,0.34615384615384615,0.7779697482923317,1.0,6/7,13.44%,HLA-F;TAP1;B2M;ERAP1;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.6070719518581905,-1.1407330756557252,0.26229508196721313,0.7772393515817131,1.0,2/17,4.01%,PSTPIP2;PRKN
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.6591498695737327,1.140619341685782,0.3392857142857143,1.0,1.0,1/9,1.70%,SOX5
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.6979288737077692,-1.1401431519518392,0.30357142857142855,0.7780230314638792,1.0,3/6,13.44%,GBP4;HLA-E;HLA-A
prerank,Reactome_2022__SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,0.7523277467411547,1.139904942444498,0.35185185185185186,1.0,1.0,6/6,24.89%,YWHAB;YWHAZ;YWHAQ;YWHAG;AKT3;YWHAE
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5550535381928643,-1.139728149205172,0.2711864406779661,0.7783348167100177,1.0,3/27,4.54%,CX3CL1;GBP1;NUB1
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.5057119864102149,-1.1395816641404848,0.31746031746031744,0.7780761069037637,1.0,15/59,9.19%,HES1;ISG15;STAT1;PLCG2;HLA-F;HLA-B;HLA-C;TAP1;EIF2AK2;OAS3;NFKBIA;B2M;NFKB1;JUN;HLA-E
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.6294057650396433,1.1394700930858415,0.2037037037037037,1.0,1.0,5/12,16.31%,HOMER1;LRRK2;EPHA4;IL1RAPL1;TANC2
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.5945723632708917,-1.139188532641008,0.29411764705882354,0.7783572684310495,1.0,6/26,14.53%,PARP14;SLC5A6;SLC2A3;PARP9;ENPP2;PDXK
prerank,Reactome_2022__MAPK3 (ERK1) Activation R-HSA-110056,0.7360205662027431,1.1387641679521205,0.2830188679245283,1.0,1.0,1/6,3.13%,IL6R
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.6998861641071586,1.1385821581260542,0.3333333333333333,1.0,1.0,5/10,17.32%,FGF12;HOMER1;DPP10;ATP2B4;WNK1
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.6721883460985528,-1.1383117281502528,0.3389830508474576,0.7800149257658325,1.0,4/10,8.42%,TLL1;LAMA4;COL8A1;COL18A1
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,-0.684260397848579,-1.1381968109445606,0.3333333333333333,0.7796157732237425,1.0,1/10,2.82%,OPTN
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6012748814984947,1.1381115748356476,0.29545454545454547,1.0,1.0,1/17,0.27%,HDAC9
prerank,CellMarker_Augmented_2021__Neuron:Spinal Cord,0.4542147494343465,1.1381030862246249,0.2894736842105263,1.0,1.0,13/51,16.44%,ATRNL1;CADM2;GRIA2;TTLL7;SNAP25;MAPK10;NRCAM;MPDZ;CNTN1;ADGRL2;ANK2;PLPPR4;NLGN1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.662583624411846,1.1376378292935478,0.40425531914893614,1.0,1.0,3/9,20.98%,MAP4;CLASP1;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.7257477485765114,1.1373815578325372,0.34146341463414637,1.0,1.0,2/7,20.03%,DIP2A;TAOK1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.677186228611622,-1.1370268055453512,0.375,0.7821055623582991,1.0,2/7,17.77%,MSH2;RAD21
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.7940901628106987,-1.136993287851788,0.28888888888888886,0.7814365188836438,1.0,2/5,4.01%,HEBP2;PRKN
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.6573844202929793,-1.136335860602134,0.2549019607843137,0.7825480131179187,1.0,3/15,4.38%,PPARG;TDRD7;LGALS3
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.5837830165290956,1.1362855984242464,0.28205128205128205,1.0,1.0,5/26,9.22%,ERBB4;GRIA2;PRKX;LRRC7;PPM1F
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,-0.6075492219327767,-1.1360402764215571,0.3076923076923077,0.7824657227232945,1.0,2/24,2.79%,CX3CL1;CXCL12
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.5666876013069125,1.1359081323766613,0.35135135135135137,1.0,1.0,8/28,19.36%,AEBP2;TET2;ERCC6;DNMT3A;BAZ1B;BAZ2A;EP300;JARID2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.7040649507830443,1.1357065792159957,0.3829787234042553,1.0,1.0,4/8,23.56%,PTBP3;SHQ1;NCOR2;PTBP2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.6124149543972667,1.134626268969776,0.32608695652173914,1.0,1.0,6/15,21.46%,PIK3CA;CDC42;CYFIP1;RAC1;WASF2;FSCN1
prerank,CellMarker_Augmented_2021__Glial cell:Brain,0.5527586462648243,1.1346166388826002,0.2916666666666667,1.0,1.0,3/16,3.43%,GRM5;CADM2;GRIA2
prerank,CellMarker_Augmented_2021__Glial cell:Sympathetic Ganglion,0.5527586462648243,1.1346166388826002,0.2916666666666667,1.0,1.0,3/16,3.43%,GRM5;CADM2;GRIA2
prerank,CellMarker_Augmented_2021__Astrocyte:Spinal Cord,0.5527586462648243,1.1346166388826002,0.2916666666666667,1.0,1.0,3/16,3.43%,GRM5;CADM2;GRIA2
prerank,CellMarker_Augmented_2021__Schwann cell:Intervertebral Disc,0.5527586462648243,1.1346166388826002,0.2916666666666667,1.0,1.0,3/16,3.43%,GRM5;CADM2;GRIA2
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Undefined,-0.7154495779724059,-1.1343363141444731,0.3333333333333333,0.7860840008052369,1.0,1/8,11.69%,GPC3
prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.49834978483526576,1.1341956844090284,0.2631578947368421,1.0,1.0,11/45,12.11%,PSMD14;ITPR3;GRIA2;ATP2A2;MAPK10;PLCB1;PIK3CA;AMBRA1;SEM1;FGF14;ITPR2
prerank,KEGG_2021_Human__Fatty acid biosynthesis,-0.7319140988926507,-1.134140005998637,0.425531914893617,0.7858200535150806,1.0,2/6,11.08%,ACSL4;CBR4
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.6450668975175871,1.1340217598729294,0.36507936507936506,1.0,1.0,3/9,18.22%,RANBP9;CLASP1;ZNF207
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.7854316558124614,-1.133938108448979,0.37209302325581395,0.7856754339738611,1.0,1/5,2.42%,CNOT8
prerank,Reactome_2022__Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,-0.7636256353376488,-1.1337471057480983,0.4166666666666667,0.7854222817006011,1.0,2/5,13.49%,UBC;TBK1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.542793530153916,1.1332576838672201,0.21428571428571427,1.0,1.0,4/24,7.84%,RBM20;PRKG1;ATP2A2;CKMT2
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,0.6353329541262979,1.1331601662456068,0.2653061224489796,1.0,1.0,5/15,15.56%,PIK3CA;PIGU;GRB10;FRS2;GRB2
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.4687655613157739,-1.132881707899053,0.2631578947368421,0.7870670453788259,1.0,9/101,12.40%,CD74;SNX6;SEPTIN11;DMD;AHI1;RAB1A;COPA;USO1;STX17
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,0.6048867376453568,1.132478241304824,0.28888888888888886,1.0,1.0,2/16,7.01%,PRKG1;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.6895881790503491,1.1322930745453672,0.32653061224489793,1.0,1.0,3/8,17.80%,BMP6;RBPMS;ACVR2A
prerank,KEGG_2021_Human__Proteasome,-0.649049046566,-1.132236235447214,0.2765957446808511,0.7878891900681427,1.0,3/13,1.94%,PSMA1;PSMB9;POMP
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.7620459640403973,1.1320970518414748,0.34615384615384615,1.0,1.0,1/5,1.25%,CALR
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7546651676668316,1.131064435468167,0.3389830508474576,1.0,1.0,2/5,8.87%,HDAC9;REST
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,-0.6886736557203122,-1.130943093317391,0.3125,0.7908599822695485,1.0,5/15,8.92%,PLCG2;VAV3;LCP2;FOS;JUN
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6526359433181111,1.1309420406893627,0.4,1.0,1.0,1/7,4.44%,INVS
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.6301391652142648,-1.1307516048011315,0.32727272727272727,0.7904451590289873,1.0,4/17,10.07%,ZIC1;SMAD3;TFRC;PARP9
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.7357677745974964,-1.130586907902664,0.34,0.7901394215165352,1.0,1/5,0.24%,HES1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.6991239963854541,-1.1302872880042985,0.3076923076923077,0.7902768481219825,1.0,3/10,13.89%,MAP3K5;TAOK3;MAP3K4
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.6744287437279525,1.1302196187834066,0.3389830508474576,1.0,1.0,3/8,24.99%,PIGU;ANK2;SMURF1
prerank,CellMarker_Augmented_2021__T Helper cell:Undefined,0.720556821344307,1.1290437974447083,0.3148148148148148,1.0,1.0,2/5,7.52%,IL6R;ENTPD1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5840474873667122,1.1290380622480707,0.2857142857142857,1.0,1.0,6/18,17.32%,SLC12A6;SLC26A3;SLC8A1;ANO6;SLC24A2;WNK1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.5153989854640635,-1.1287794731995218,0.2857142857142857,0.793420658162687,1.0,5/65,3.72%,CEMIP;SOD2;CXCL12;CARMIL1;CASS4
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.5775741481472428,-1.1286479102305917,0.3103448275862069,0.7930246048353209,1.0,3/33,2.39%,TBX3;TPM1;FN1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.6302127138098497,-1.1284785098729158,0.3673469387755102,0.7928548664622395,1.0,1/13,1.57%,RIMS1
prerank,Reactome_2022__Circadian Clock R-HSA-400253,0.5125543901303202,1.1283517463026074,0.2962962962962963,1.0,1.0,6/35,12.67%,HSD17B4;CRY1;BTRC;PPP1CB;NCOA2;CRTC3
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,-0.5523979534636763,-1.1282583450020487,0.28846153846153844,0.7927050473049801,1.0,4/25,7.04%,PSMA1;PSMB9;RFC3;ANAPC16
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,0.5706690359315044,1.1280277886006385,0.2857142857142857,1.0,1.0,4/15,15.91%,RALA;ANXA2;HSPA9;CDC42
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5803468852847664,-1.127311334583165,0.32075471698113206,0.7943467437502213,1.0,2/19,6.77%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.6462009759154469,-1.127130911879822,0.36,0.793980654237013,1.0,4/12,18.65%,TFRC;ATP7B;IREB2;FTH1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.7213869883924051,-1.127106333608836,0.36363636363636365,0.7932635601705392,1.0,1/5,1.75%,PIGC
prerank,KEGG_2021_Human__Mineral absorption,0.5977021380451942,1.1269392274993162,0.3181818181818182,1.0,1.0,7/18,17.18%,SLC26A3;MT2A;MT1M;MT1E;SLC8A1;ATP2B4;ATP1A1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.5116805003382322,-1.126922647068315,0.24561403508771928,0.7929772795360036,1.0,7/71,10.46%,CX3CL1;VAV3;PLXND1;RGS6;LARS1;NET1;ARHGAP15
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.5832212014973179,-1.1267354379403027,0.3877551020408163,0.7927402977767707,1.0,5/21,14.32%,STAT1;SERPINE1;SMAD3;UBC;RNF111
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.527228718525834,-1.1266256445932668,0.2916666666666667,0.7923186745288683,1.0,6/28,12.54%,LGALS3;TMEM30A;WARS1;TFRC;GPC3;CLU
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.7048962683067662,-1.1264458545992722,0.3333333333333333,0.79212169699446,1.0,1/7,6.03%,AGPAT3
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.6874860699159688,1.126013038381266,0.3829787234042553,1.0,1.0,2/6,11.13%,STIM1;CACNA1C
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.7063893908719525,1.1257671121973645,0.2807017543859649,1.0,1.0,2/5,21.57%,DICER1;AGO2
prerank,KEGG_2021_Human__Wnt signaling pathway,0.4825636982685845,1.1246138995963868,0.3,1.0,1.0,17/53,20.16%,MAPK10;INVS;BTRC;CTBP2;PLCB1;TLE4;NLK;PPP3CA;PPP3CB;PSEN1;ROR1;CREBBP;EP300;RAC1;PRKCA;RYK;CTNND2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.7172525814994022,1.124596228421868,0.3333333333333333,1.0,1.0,3/6,23.61%,SLC8A1;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.7172525814994022,1.124596228421868,0.3333333333333333,1.0,1.0,3/6,23.61%,SLC8A1;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.7172525814994022,1.124596228421868,0.3333333333333333,1.0,1.0,3/6,23.61%,SLC8A1;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.526332170814933,1.1242274865421895,0.2857142857142857,1.0,1.0,8/22,18.46%,ITPR3;MT2A;HOMER1;PPP2CB;PPP3CA;CALM1;PAM;ANXA11
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.7437074413295403,-1.1237379626484147,0.4230769230769231,0.7991105342517685,1.0,1/6,5.60%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6909995122805088,1.123386571896565,0.3617021276595745,1.0,1.0,2/7,7.68%,PRKD1;AMBRA1
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,0.6051900016197715,1.1232108893925805,0.23684210526315788,1.0,1.0,5/11,18.67%,PPP2CB;PPP3CA;PPP3CB;CALM1;PRKCA
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.7142769443916921,1.122977475920495,0.38095238095238093,1.0,1.0,5/7,22.79%,ACTG1;CDC42;RAC1;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.5252990747846672,-1.122546210021363,0.2786885245901639,0.8015205608119629,1.0,5/50,4.01%,CYLD;PSMA1;PSMB9;RNF213;PRKN
prerank,Reactome_2022__Repression Of WNT Target Genes R-HSA-4641265,0.7399072530337714,1.122425165185338,0.4,1.0,1.0,2/6,8.98%,CTBP2;TLE4
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.7183460697494527,1.1223864555007586,0.36363636363636365,1.0,1.0,4/7,25.07%,ST8SIA4;SPTLC1;SAMD8;ST6GALNAC3
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.5727060567419407,-1.1223005094875393,0.36538461538461536,0.8006550059374234,1.0,4/19,11.71%,TNFSF10;CDC37;TANK;UBC
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.5727060567419407,-1.1223005094875393,0.36538461538461536,0.8006550059374234,1.0,4/19,11.71%,TNFSF10;CDC37;TANK;UBC
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5590415601995476,1.1222596532069213,0.28,1.0,1.0,3/26,6.14%,HDAC9;INSIG1;PKM
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,-0.5852315816728119,-1.1222414563729586,0.34615384615384615,0.8001992383250235,1.0,4/15,11.71%,IFIH1;TNIP1;TRIM25;UBC
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.5985521508493173,-1.1221738033785598,0.38,0.7995894933517432,1.0,3/18,7.28%,TPM1;SMAD3;DSP
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5171704791681491,1.122070040252636,0.358974358974359,1.0,1.0,4/24,10.17%,HDAC9;PRKD1;HSPB1;HDAC7
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.5689975168725379,-1.1218509173951952,0.3114754098360656,0.7996480042658594,1.0,3/23,4.01%,SOD2;CXCL12;PRKN
prerank,CellMarker_Augmented_2021__Pericyte:Skeletal Muscle,0.4673161330328782,1.1218418924009874,0.35,1.0,1.0,13/58,12.99%,MMRN1;ZEB1;NCAM1;SGIP1;CYYR1;ZEB2;ELMO1;S1PR1;CELF2;CACNA1C;ADGRL4;SHROOM4;CALCRL
prerank,Reactome_2022__Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,0.7080845464262793,1.1214450689228057,0.375,1.0,1.0,6/7,22.82%,YWHAB;YWHAZ;YWHAQ;FOXO3;YWHAG;AKT3
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,-0.45421225064380866,-1.1213574286891772,0.26153846153846155,0.8002569740607987,1.0,30/137,13.49%,PARP14;IFIH1;ISG15;RPS12;STAT1;PLCG2;HLA-F;HLA-B;HLA-C;PATJ;RPS8;RPS6;GEMIN5;B2M;TRIM25;HLA-E;RPS28;RCOR1;RPS19;PARP9;RPS7;RPS14;IFNGR2;RPS15;GPC3;UBC;SRPK1;JAK2;HLA-A;TBK1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.6669094057662415,1.1212040571176054,0.40384615384615385,1.0,1.0,4/7,28.23%,ETFA;NDUFS4;MTFR1;UQCRC2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.7003988426703521,1.1211746214434946,0.34,1.0,1.0,3/7,17.18%,URI1;UBE3A;ATP1A1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.6161216841053128,-1.121049936684455,0.35294117647058826,0.8002664968675897,1.0,3/11,10.07%,SHLD1;CYREN;PARP9
prerank,Reactome_2022__Downregulation Of ERBB4 Signaling R-HSA-1253288,0.6866075379378552,1.1206455060933493,0.375,1.0,1.0,1/7,1.57%,ERBB4
prerank,CellMarker_Augmented_2021__Migration Phase Fetal Germ cell:Fetal Gonad,-0.5564263303880966,-1.1204885452924782,0.3333333333333333,0.8009026635432978,1.0,6/26,10.65%,SAT1;TMSB4X;LAMA4;ZC3HAV1;CEBPZ;RPS14
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.6808420201251715,1.1202209592908983,0.36666666666666664,1.0,1.0,2/7,10.86%,CRY1;PPP1CB
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Lung,-0.6743663478166277,-1.1201677372644396,0.40350877192982454,0.8008634026969005,1.0,1/10,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.7307850471088374,1.1200246416106459,0.3333333333333333,1.0,1.0,4/5,26.72%,CDK12;CDC73;TCERG1;BRD4
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,0.5893649509394041,1.1196643117623473,0.33962264150943394,1.0,1.0,2/17,4.09%,COG6;MAN1A2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.6035663523293002,1.1193019906473436,0.30612244897959184,1.0,1.0,4/16,15.91%,PEX14;TRAK1;TRAK2;CDC42
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.589252708373365,-1.1192072169347052,0.26785714285714285,0.8028257708491386,1.0,9/28,13.23%,STAT1;NFKBIA;MAML3;NFKB1;FOS;JUN;STAT5B;IFNGR2;JAK2
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.6187590947410115,-1.118815544955459,0.2830188679245283,0.8030924242388264,1.0,3/12,8.98%,STAT1;LRRFIP1;STAT5B
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.6846759157819262,-1.1187801629969003,0.4,0.8024173037750063,1.0,1/11,2.82%,OPTN
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.737936557490374,1.1185936426640093,0.4339622641509434,1.0,1.0,2/5,14.26%,SEMA3F;NRP1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7539329809558895,1.118229202774358,0.39622641509433965,1.0,1.0,2/5,10.15%,ITGA5;GRB10
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,0.669581334935792,1.1182099146357722,0.375,1.0,1.0,3/6,19.73%,DPYSL2;NRP1;FES
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5682236992311829,-1.1182053284011118,0.37037037037037035,0.8033939337993292,1.0,1/28,0.53%,CEMIP
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.5852437036797673,-1.1178595912990659,0.3191489361702128,0.8036209610137285,1.0,5/15,14.26%,STAT1;TNIP1;TANK;RORA;RIOK3
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.5492835470769282,1.1177625175149568,0.32608695652173914,1.0,1.0,7/29,17.77%,ABL2;BCR;PRAG1;ABL1;NRP1;HEG1;RAC1
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,0.5938651370054533,1.117723084513496,0.3333333333333333,1.0,1.0,4/15,15.91%,YES1;PIK3CA;GRB2;CDC42
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6664091510188819,1.117642361707651,0.3559322033898305,1.0,1.0,1/6,2.15%,UBQLN1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.7456512654283453,-1.1172003497505032,0.3541666666666667,0.8043647729018011,1.0,1/5,4.01%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.738216556192577,-1.1168770839324282,0.375,0.8044277978751565,1.0,1/5,4.97%,MMRN2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.6856300422560461,1.116863344497943,0.3333333333333333,1.0,1.0,2/7,15.91%,BAG3;CDC42
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.674427983967153,-1.1168589578934496,0.2619047619047619,0.8037067784114608,1.0,2/6,10.07%,STAT1;PARP9
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,0.5214966337617641,1.1164510953060045,0.2857142857142857,1.0,1.0,11/40,18.78%,ITPR3;PRKG1;PLCB1;PPP1CB;CACNA1C;ITPR2;CALCRL;CALM1;EDN1;PRKCA;ROCK1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.589930140052409,1.1156308207782535,0.2978723404255319,1.0,1.0,9/16,11.61%,GRM5;CADM2;GRIA2;SNAP25;NRXN1;YWHAZ;ADGRB3;RTN4;RBFOX1
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,0.5264666400380615,1.1153158310001747,0.2553191489361702,1.0,1.0,8/26,20.96%,ERBB4;NRG2;ELMO1;KHDRBS3;LRRK2;KHDRBS1;CRK;PTPN1
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,0.6617865783009672,1.1151332670166152,0.34375,1.0,1.0,2/8,18.67%,GRB2;PRKCA
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,-0.6787958391476113,-1.1151282484765048,0.3888888888888889,0.8080874336326783,1.0,3/13,6.99%,PLCG2;VAV3;LCP2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.6236383124162448,1.1149537339478435,0.39215686274509803,1.0,1.0,1/10,2.44%,NDUFAF2
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Embryo,0.5277943559178808,1.114864173535346,0.27906976744186046,1.0,1.0,6/25,5.50%,SMAD9;COL4A2;BMP6;CDH2;SLCO2A1;P4HA1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.7705030888616128,1.11442256374867,0.4230769230769231,1.0,1.0,1/5,2.55%,CDH2
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.6374378523866195,-1.1142102024653837,0.3673469387755102,0.8099216873416473,1.0,11/15,24.09%,RPS28;RPS19;RPS14;RPS15;RPL10;RPL24;RPL11;DHX29;RPS27;RPL3;NPM1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6585865032415494,1.1141839247570295,0.32653061224489793,1.0,1.0,2/8,15.48%,WAPL;YLPM1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.6899600656399979,-1.1141621696676614,0.38,0.8093310403356305,1.0,1/6,5.44%,YTHDC1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.554264576022647,1.1140653583212705,0.32075471698113206,1.0,1.0,6/14,15.35%,GRIA2;ST18;DLGAP2;NRXN1;RPS6KA5;SLC24A2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.68643726038049,-1.1127708308270101,0.4230769230769231,0.8121227155561832,1.0,2/6,14.10%,STK39;HECW2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7304103431724318,1.1127201510154456,0.4528301886792453,1.0,1.0,3/5,18.75%,PIK3CA;NRP1;FOXC1
prerank,KEGG_2021_Human__Autophagy,0.4672960556924026,1.1126519220946531,0.2926829268292683,1.0,1.0,14/52,19.68%,RRAS2;ATG4C;MAPK10;KRAS;PIK3CA;AMBRA1;PPP2CB;RAB7A;VMP1;BCL2L1;ATG2B;PTEN;UVRAG;MTMR3
prerank,Reactome_2022__Influenza Infection R-HSA-168255,-0.47350225500318727,-1.112003219387865,0.25862068965517243,0.8132439563660978,1.0,23/75,14.63%,ISG15;RPS12;RPL31;RPL34;EIF2AK2;RPS8;RPL15;RPS6;RPL7A;RPL38;RPL23;RPL30;RPS28;RPS19;POLR2A;RPS7;RPS14;RPS15;RPL28;CLTA;RPL9;NUP54;RPL37
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,-0.6693850475973793,-1.111892806124406,0.3333333333333333,0.812937080263964,1.0,1/5,4.59%,RFC3
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.6982506409996317,-1.1115718852925718,0.4888888888888889,0.8130391916710236,1.0,1/8,2.79%,CXCL12
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreas,0.5026085337042292,1.1108671564695047,0.27450980392156865,1.0,1.0,8/42,9.91%,MTDH;ZNF800;SLC25A46;STT3B;URI1;CBFB;APPBP2;ZMYND11
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.45541554499911785,1.110528267041382,0.25806451612903225,1.0,1.0,10/72,8.15%,TRIM5;PDIA3;CALR;ITPR3;MAPK10;KRAS;BTRC;AP1S2;PIK3CA;TAB2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.7182100237663618,1.1099982127301202,0.38333333333333336,1.0,1.0,2/6,13.07%,ANKRD11;SKI
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.69787448817038,1.109740792109759,0.3448275862068966,1.0,1.0,2/5,25.76%,DIP2A;SETD5
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.614695201184714,-1.1092424441355662,0.38,0.8183813143678652,1.0,2/11,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.614695201184714,-1.1092424441355662,0.38,0.8183813143678652,1.0,2/11,1.51%,PSMA1;PSMB9
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.5158745676989739,1.1088171654530141,0.275,1.0,1.0,6/34,15.43%,TEAD4;COL4A2;PARVA;MPDZ;PTPN21;RAI14
prerank,CellMarker_Augmented_2021__Interneuron:Embryonic Prefrontal Cortex,0.663911844599888,1.1088026341489445,0.36363636363636365,1.0,1.0,2/7,11.82%,ERBB4;NRXN3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In2:Brain,0.4904544280244514,1.1086901328306336,0.36,1.0,1.0,14/36,15.88%,ATRNL1;TTLL7;FGF12;LRRTM4;NAV3;PEX5L;HOMER1;FRMD5;USP46;RBFOX1;SLC24A2;UBE3A;ANK2;IL1RAPL1
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone Marrow,-0.5343216123607099,-1.1085601037780712,0.3333333333333333,0.8195200151135769,1.0,1/44,0.32%,CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.5246793537313776,1.1082054183185803,0.30434782608695654,1.0,1.0,4/29,7.41%,STIM1;MTDH;PRKD1;HSPB1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.46856367326479925,-1.10810342696599,0.2833333333333333,0.8199184952429959,1.0,19/68,20.08%,BTG2;SP100;RFC3;SAMHD1;TOPBP1;MSH2;UBC;SMARCAD1;PWWP3A;ATM;PDS5B;PRIMPOL;XPC;RFC1;POLK;RAD21;ORC2;PSME4;FANCL
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.4772591464004673,-1.1079353673138963,0.3,0.8196260732053373,1.0,10/106,6.80%,HES1;TBX3;ZIC1;FN1;PRKN;SPG7;GPM6A;PLXND1;RAPGEF5;SCN2A
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.6861938068364781,-1.1077078901723039,0.391304347826087,0.8195136569643298,1.0,2/6,12.54%,CXCL12;CLU
prerank,KEGG_2021_Human__Pyrimidine metabolism,0.6636585162826145,1.1076863422815364,0.3488372093023256,1.0,1.0,3/10,7.52%,PNP;UPP1;ENTPD1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.6252591609519957,1.1072482511050372,0.32558139534883723,1.0,1.0,5/11,8.39%,ATRNL1;GRIA2;SNAP25;NOVA2;NRXN1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.65838948646278,1.1072393693283784,0.3125,1.0,1.0,5/6,31.77%,DUSP6;PTEN;LATS2;WWC3;LATS1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.6767843648969368,-1.1068058085979617,0.43137254901960786,0.8202228443695598,1.0,2/9,6.77%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.6767843648969368,-1.1068058085979617,0.43137254901960786,0.8202228443695598,1.0,2/9,6.77%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.44290605096198105,1.1063861235127097,0.3,1.0,1.0,11/65,18.78%,PACS2;MAP7;TTC7A;LRRC7;NRXN1;DPP10;ANK2;NLGN1;CD81;ANK3;ROCK1
prerank,KEGG_2021_Human__Renal cell carcinoma,0.49735921276543904,1.1062491244853094,0.27906976744186046,1.0,1.0,12/33,26.16%,KRAS;PIK3CA;GRB2;CDC42;CREBBP;EP300;RAC1;CRK;AKT3;ETS1;SOS2;ARNT
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.5572796411710496,1.1058191413072551,0.32075471698113206,1.0,1.0,5/20,17.64%,INSIG1;NFYC;NCOA2;CREBBP;NCOA1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6418322165198777,1.105819041830554,0.42857142857142855,1.0,1.0,2/8,13.86%,ABL1;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.7299262604178836,-1.105522727778895,0.4222222222222222,0.8227005865608502,1.0,1/5,3.24%,UFL1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.551882328381532,1.1054738341337202,0.3333333333333333,1.0,1.0,7/16,15.41%,UBQLN1;ATP2A2;PACS2;AMBRA1;RAB7A;VMP1;ATG2B
prerank,CellMarker_Augmented_2021__Neural Stem cell:Undefined,-0.6100951353155553,-1.1050314425079326,0.40816326530612246,0.8231221882142196,1.0,1/15,0.69%,ZIC1
prerank,CellMarker_Augmented_2021__Leydig Precursor cell:Fetal Gonad,-0.5097599306384903,-1.1048864037749766,0.2807017543859649,0.8228566449598649,1.0,23/75,14.58%,RPS12;TMSB4X;TPM1;CXCL12;RPL31;RPS18;RPL34;RPL15;RPS6;SCN2A;RPL23;EBF1;RPS19;RPS7;NID1;VIM;ADAMTS1;GPC3;RPL10;LAMA2;RPL9;EEF1A1;RPL24
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.712329981364647,1.1047226678831639,0.3620689655172414,1.0,1.0,1/5,20.21%,NCOR2
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.5981626595238196,1.1046546686871521,0.3584905660377358,1.0,1.0,4/12,20.21%,KDM4C;NCOA2;EP300;NCOR2
prerank,Reactome_2022__Mitophagy R-HSA-5205647,-0.6626093433251186,-1.1044880165923996,0.41509433962264153,0.8225334894886147,1.0,4/9,15.59%,PRKN;UBC;MFN1;ATG12
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.6626093433251186,-1.1044880165923996,0.41509433962264153,0.8225334894886147,1.0,4/9,15.59%,PRKN;UBC;MFN1;ATG12
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.6278948114935412,1.1042735039035767,0.3673469387755102,1.0,1.0,1/8,2.12%,YWHAB
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,-0.6520094504389458,-1.1042257378533498,0.28888888888888886,0.821518281743168,1.0,1/12,2.39%,FN1
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,-0.6520094504389458,-1.1042257378533498,0.28888888888888886,0.821518281743168,1.0,1/12,2.39%,FN1
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,0.6236932349481459,1.1037771848396252,0.3181818181818182,1.0,1.0,4/12,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,0.5630385812453474,1.103734631576898,0.3829787234042553,1.0,1.0,3/16,12.11%,ITPR3;GNB4;ITPR2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.7377981193309181,1.1036415866797695,0.3508771929824561,1.0,1.0,3/5,24.89%,NEDD4L;AKAP6;YWHAE
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,0.72906130366127,1.1036045999000366,0.42,1.0,1.0,3/5,25.82%,FRS2;GRB2;FGFR1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.7184707986536161,-1.1035212245384909,0.43478260869565216,0.822678051656188,1.0,1/7,5.05%,EIF2AK2
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Undefined,-0.5281139632236258,-1.1031397355009531,0.39344262295081966,0.8229286668404175,1.0,2/45,2.79%,VCAM1;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.5609905268513802,1.1031329837773682,0.4117647058823529,1.0,1.0,3/18,10.60%,RBM20;HNRNPLL;SETX
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6554283651560978,1.1031196093264415,0.35555555555555557,1.0,1.0,1/9,1.70%,SOX5
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,-0.5269393465064389,-1.1028942371847674,0.3220338983050847,0.82294526516844,1.0,3/43,1.51%,SLC22A5;PSMA1;PSMB9
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.5213806998916938,1.1028846468659175,0.375,1.0,1.0,10/36,17.42%,HDAC9;NAA50;UBE2B;MORF4L1;RPS6KA5;BAZ1B;BAZ2A;USP22;CREBBP;EP300
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6527552778633651,-1.1028168739563464,0.3617021276595745,0.8223644628161282,1.0,7/12,18.91%,UFL1;RPS19;RPS14;JAK2;ACIN1;CDIN1;PTPN2
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.655095154913634,-1.1025025868916922,0.43137254901960786,0.8223722184498401,1.0,4/13,20.56%,COL18A1;PPP1R16B;RAPGEF2;MSN
prerank,CellMarker_Augmented_2021__Retinoid Acid Signaling-Responsive Fetal Germ cell:Fetal Gonad,-0.5195085253154361,-1.102363218433455,0.3728813559322034,0.8220631834123414,1.0,6/44,10.62%,CD74;CALCOCO2;B2M;DDX24;CST3;LBR
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Visceral Adipose Tissue,-0.5447584597439089,-1.1018946919714996,0.3392857142857143,0.8218745973638888,1.0,2/36,2.97%,CX3CL1;DOK5
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Visceral Adipose Tissue,-0.5447584597439089,-1.1018946919714996,0.3392857142857143,0.8218745973638888,1.0,2/36,2.97%,CX3CL1;DOK5
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.44469500202845846,-1.1018696182746577,0.2711864406779661,0.8211951872193284,1.0,25/147,14.42%,NR4A1;BTG2;LRPAP1;SOD2;IRF1;SP100;PRKN;EIF2AK2;PLXND1;UBR2;SMAD3;WARS1;COL18A1;CDA;BST2;ACTN1;APPL2;GNG4;ADAMTS1;CLU;SMARCA2;JAK2;PDS5B;BRD7;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7403571323678457,1.101739475695566,0.45161290322580644,1.0,1.0,2/5,22.79%,ROCK1;ROCK2
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Liver,-0.46880209108086474,-1.1015672000052363,0.26229508196721313,0.8213524976360143,1.0,10/60,8.87%,SAMD9L;IFIH1;DDX60L;SP100;ZC3HAV1;CD109;NFKB1;TFRC;TANK;ERAP1
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.5659988500848233,-1.1014935296768915,0.3333333333333333,0.8207953610397768,1.0,1/21,0.40%,PARP14
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.4827815761538862,-1.101474701704455,0.26153846153846155,0.8201187670350156,1.0,2/82,1.57%,CD74;RIMS1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.6173257289848219,-1.101052393676714,0.4,0.8205451078227486,1.0,3/13,6.77%,BTG2;PLK2;SMAD3
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.555934192969617,1.100989901319204,0.3448275862068966,1.0,1.0,4/17,8.92%,PNP;SLC25A37;FBXO7;ELF1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.7262114427894129,-1.1003134448349483,0.34,0.8217939073545781,1.0,2/5,14.42%,KIDINS220;RAPGEF2
prerank,CellMarker_Augmented_2021__Endothelial cell:Lung,-0.7016320904807332,-1.100111269857808,0.41304347826086957,0.8216265202387738,1.0,2/6,23.59%,CD34;FLT1
prerank,Reactome_2022__RHO GTPases Activate IQGAPs R-HSA-5626467,0.6854721581028526,1.0999609910763632,0.4,1.0,1.0,4/7,25.60%,CDC42;CALM1;CLIP1;CTNNA1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.6671327662337009,-1.099940258509271,0.38461538461538464,0.8212747725037385,1.0,2/10,6.77%,ZIC1;SMAD3
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.6804115533535953,-1.09975163526775,0.38636363636363635,0.821034354938477,1.0,1/5,22.07%,LPGAT1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.6404583239200295,1.0988997941668552,0.45614035087719296,1.0,1.0,2/8,10.60%,ABL2;SETX
prerank,Reactome_2022__DNA Replication R-HSA-69306,-0.5232159439573958,-1.098844409064444,0.36538461538461536,0.8227206191316098,1.0,4/29,7.04%,PSMA1;PSMB9;RFC3;ANAPC16
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.7076694629452465,-1.0987732617059258,0.4230769230769231,0.8221478389348827,1.0,2/6,6.43%,ACSL4;MYRIP
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.551454191256723,-1.0987664051746435,0.36363636363636365,0.8214380865352366,1.0,3/29,4.38%,PLCG2;PLK2;LGALS3
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.5744374574144633,1.0986205312806554,0.4,1.0,1.0,4/15,20.80%,WRNIP1;KPNA1;YLPM1;PARG
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,0.6171097690517334,1.0981483497155646,0.28888888888888886,1.0,1.0,4/13,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,0.6171097690517334,1.0981483497155646,0.28888888888888886,1.0,1.0,4/13,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.6171097690517334,1.0981483497155646,0.28888888888888886,1.0,1.0,4/13,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.6607069703808988,-1.0981237053255284,0.42857142857142855,0.8224668431360963,1.0,2/7,14.10%,STK39;HECW2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.5586389291469284,1.0980723293447359,0.358974358974359,1.0,1.0,8/24,17.69%,DEPP1;SNAP25;MAPK10;PGR;FGF14;PDZRN3;PLPPR4;KCNT2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.6614004060669659,1.0980099884094563,0.36538461538461536,1.0,1.0,3/8,13.92%,HSPG2;GCNT2;EXT1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6820396919265219,-1.0978402345790432,0.3888888888888889,0.8223641870603978,1.0,2/8,18.49%,TOPBP1;ORC2
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,0.6703466213473426,1.0978221804845365,0.39285714285714285,1.0,1.0,3/5,16.49%,HSP90AA1;GCH1;CALM1
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.6687879158865758,1.0977557604516648,0.39215686274509803,1.0,1.0,4/8,14.98%,HSPG2;GLCE;EXT1;HS6ST3
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.6687879158865758,1.0977557604516648,0.39215686274509803,1.0,1.0,4/8,14.98%,HSPG2;GLCE;EXT1;HS6ST3
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.6682874022751851,1.0975681874130487,0.3283582089552239,1.0,1.0,5/7,30.60%,DLGAP2;DLGAP4;ROCK2;NOS3;DLGAP1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.6481523865770742,1.0973442592962153,0.391304347826087,1.0,1.0,3/11,17.42%,NAA50;CREBBP;EP300
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.6627337975442523,-1.0972669715582708,0.3076923076923077,0.8232618209338292,1.0,3/10,15.30%,STAT1;STAT5B;RAMP3
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.5977700504259835,-1.0966700008645665,0.37254901960784315,0.8238736707392059,1.0,1/8,3.24%,UFL1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.6861905788568785,-1.096584374182604,0.4528301886792453,0.8233120884002312,1.0,1/6,3.51%,ATP6V1E1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5294078915080263,-1.0961380237678544,0.34375,0.823794691494979,1.0,7/33,12.62%,STAT1;FN1;CXCL12;LAMA4;HMCN1;NID1;LAMA2
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.5916652725567711,1.095592522658382,0.34,1.0,1.0,3/17,12.70%,INPP5F;SGIP1;AP2B1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.7002512057295512,-1.0955042002051971,0.3888888888888889,0.8247427057487409,1.0,2/7,10.92%,MAPKAP1;CD2AP
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,0.5598524549163596,1.0954988362430584,0.32075471698113206,1.0,1.0,3/14,7.54%,ERBB4;NRG2;HSP90AA1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.5382316292265532,-1.0954712726628641,0.3333333333333333,0.8240813709875033,1.0,3/21,7.04%,PSMA1;PSMB9;ANAPC16
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.7143221101507651,1.0953631091640024,0.4,1.0,1.0,2/5,19.47%,MAP4;LIMK2
prerank,KEGG_2021_Human__Viral carcinogenesis,0.45521090193346136,1.0952244449664084,0.2978723404255319,1.0,1.0,10/64,11.66%,CREB5;HDAC9;YWHAB;KRAS;PKM;PIK3CA;YWHAZ;HDAC7;RASA2;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.5440590534354606,-1.0948740898151272,0.3023255813953488,0.825118706418399,1.0,6/36,9.46%,PPARG;TNFSF10;MAP3K5;SMAD3;ACER2;PMAIP1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.6800715800503643,1.0947313189790435,0.4166666666666667,1.0,1.0,2/6,6.85%,IGFBP3;PLCB1
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,0.5163245394409391,1.094132649105326,0.2777777777777778,1.0,1.0,6/35,8.13%,INPP5F;PLEKHA1;PI4KA;SBF2;PIK3CA;TNFAIP8
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,0.48810947938914834,1.093909128774785,0.2857142857142857,1.0,1.0,16/44,21.38%,YWHAB;RALA;DUSP6;PIK3CA;REST;FRS2;ID3;RALB;PPP2CB;AP2B1;RPS6KA5;GRB2;EP300;CRK;ID1;TCF12
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.6319111387924045,1.0938117124689526,0.2857142857142857,1.0,1.0,5/9,22.79%,CBFB;NCOA3;FOXC1;ROCK1;ROCK2
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.4367397877884978,1.0925673269971115,0.2682926829268293,1.0,1.0,19/105,12.22%,CREB5;ERBB4;COL4A2;YWHAB;HSP90B1;IL6R;IFNAR1;ANGPT2;ITGA2;ITGA1;KRAS;PIK3CA;HSP90AA1;YWHAZ;ITGA5;GNB4;YWHAQ;PPP2CB;FOXO3
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5728891991931873,-1.092345835210181,0.37735849056603776,0.8309868418647334,1.0,1/16,0.48%,NR4A1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.5204606701185495,1.0921569172272605,0.30434782608695654,1.0,1.0,9/28,21.73%,AEBP2;ERCC6;ACTB;DNMT3A;PPHLN1;BAZ1B;EP300;JARID2;HDAC4
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.6669516485111592,1.0917503673797073,0.4222222222222222,1.0,1.0,1/5,6.11%,CHD7
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.6178248582724926,1.0917458034874727,0.4,1.0,1.0,3/11,10.41%,NUP58;RANBP2;XPO1
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.7149375194781269,1.0916393556579174,0.29545454545454547,1.0,1.0,3/7,16.49%,GRIA2;LRRC7;CALM1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5721456832384281,-1.091637938222486,0.3333333333333333,0.8321437434180085,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.560695470531581,-1.091308163993081,0.34545454545454546,0.8322609621765795,1.0,2/25,1.65%,NR4A1;RREB1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.6805462347780464,-1.0908931272198479,0.44642857142857145,0.8326326035890151,1.0,4/8,13.68%,SCN3A;SCN2A;DMD;GNA14
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,-0.5789883588555373,-1.0908555593146412,0.3148148148148148,0.8319950527286251,1.0,4/20,11.71%,STAT1;PLXND1;MAML3;UBC
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Small Intestine,-0.7122654784559335,-1.0908410432104516,0.42592592592592593,0.8312950853230594,1.0,1/8,0.37%,MX1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.4655734332143385,1.0908267918678687,0.2916666666666667,1.0,1.0,6/48,7.46%,BTBD10;GRM5;CCDC88A;NUP58;HSPB1;RANBP2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.6662675150603407,-1.0897746986119594,0.37254901960784315,0.8333626520672028,1.0,2/8,14.02%,ACSL4;ELOVL5
prerank,Reactome_2022__Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,0.709571387794895,1.0895990814102003,0.3404255319148936,1.0,1.0,2/7,15.56%,PIK3CA;GRB2
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.6409496996389463,1.0895076910412202,0.36538461538461536,1.0,1.0,2/8,20.53%,PCM1;CEP290
prerank,CellMarker_Augmented_2021__Proerythroblast:Germ,-0.7200648968823022,-1.0894455615443104,0.4222222222222222,0.8334873381125828,1.0,3/7,12.72%,TFRC;SCARF1;SRGN
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.5791263376986491,1.0891471586251689,0.4230769230769231,1.0,1.0,6/13,22.66%,PBX3;CACNA1C;SKI;FOXC1;CEP290;NIPBL
prerank,CellMarker_Augmented_2021__Cortical Thymus Epithelial cell:Thymus,0.5833952293268585,1.0889419196205703,0.42105263157894735,1.0,1.0,4/13,8.92%,AFTPH;PTBP3;TES;ELF1
prerank,CellMarker_Augmented_2021__Medullary Thymus Epithelial cell:Thymus,0.5833952293268585,1.0889419196205703,0.42105263157894735,1.0,1.0,4/13,8.92%,AFTPH;PTBP3;TES;ELF1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.49789392576901254,1.0888698979355447,0.3333333333333333,1.0,1.0,8/26,21.81%,GRM5;ACTG1;ACTB;VMP1;CDC42;PSEN1;CTNND2;OPHN1
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,-0.5282650491038545,-1.0887713772024223,0.36538461538461536,0.8343723244237512,1.0,3/42,5.79%,CX3CL1;CXCL12;RGS6
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.6437170582837167,-1.0885600687850912,0.42857142857142855,0.8341612044942527,1.0,1/10,2.07%,TMSB4X
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,-0.4142002942375737,-1.0878713005643763,0.3230769230769231,0.8352699841435204,1.0,38/187,14.93%,PSMA1;PSMB9;RPS12;CNOT8;RPL31;MTERF4;RPL34;PABPC1;RPS8;RPL15;RPS6;GEMIN5;RPL7A;RPL38;RPL23;RPL30;USP39;RPS28;RPS19;POLR2A;RPS7;SPPL2A;RPS14;RPP38;RPS15;UBC;UPF3A;RPL28;SRSF5;RNPC3;ENPP2;RPL9;SRRM1;NUP54;RIOK3;PPWD1;RPL37;PARN
prerank,CellMarker_Augmented_2021__Astroglial Progenitor cell:Embryo,-0.5173389106709688,-1.0878484391193046,0.2692307692307692,0.8345618009825927,1.0,6/30,9.19%,APOL3;HLA-B;HLA-C;TRANK1;B2M;HLA-E
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.6787739333257621,-1.0871303330389133,0.34,0.835758497567051,1.0,1/8,6.03%,AGPAT3
prerank,CellMarker_Augmented_2021__Cartilage Progenitor cell:Cartilage,0.4670874365947007,1.0871302537990597,0.30434782608695654,1.0,1.0,10/39,22.47%,COL4A2;CDH2;MPDZ;PTPN21;ADGRL2;RAI14;AKAP12;MAGI1;FBXL7;TEAD1
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.6001725063215897,-1.087128661215018,0.42857142857142855,0.8350240876394877,1.0,3/13,11.71%,HMGN1;POLR2A;UBC
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.6984190318666683,1.0864240012574813,0.4489795918367347,1.0,1.0,3/6,16.44%,LRRC7;NRXN1;NLGN1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Brain,-0.529145256126307,-1.0861362984135325,0.32727272727272727,0.8366415647000988,1.0,7/42,9.27%,CLEC1A;TIE1;MMRN2;PLXND1;SLCO2B1;LMO2;SCARF1
prerank,KEGG_2021_Human__Necroptosis,-0.5429029327325948,-1.086092639916126,0.3404255319148936,0.8360336436745182,1.0,6/38,10.89%,CYLD;STAT1;TNFSF10;EIF2AK2;STAT5B;IFNGR2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.6430245485403087,-1.0858703488251042,0.3409090909090909,0.8359302469471003,1.0,2/10,2.23%,VCAM1;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.48939993120678094,-1.0858375195350876,0.3114754098360656,0.8352162239131884,1.0,5/52,6.77%,CEMIP;ZIC1;ARIH2;TMEM30A;SMAD3
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.6288604337570494,1.0856945744499502,0.4107142857142857,1.0,1.0,2/9,12.14%,STX8;RAB7A
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.6322855759962347,-1.0854765263689783,0.40816326530612246,0.8354368089645732,1.0,3/10,8.74%,PLCG2;HLA-B;CD47
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.6614605462679013,1.0854530977854417,0.41509433962264153,1.0,1.0,2/8,14.40%,BAG3;XPO4
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.719058734495811,-1.0854096386086698,0.4375,0.8349307009827395,1.0,4/7,6.56%,SLC16A2;SLCO1A2;SLC5A6;SLCO2B1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.7096628524534919,1.085328089572617,0.4489795918367347,1.0,1.0,2/5,17.18%,URI1;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.5623531678340067,-1.085303394813619,0.32,0.83451506629965,1.0,2/24,3.53%,GBP1;TNIP1
prerank,Reactome_2022__Insulin Processing R-HSA-264876,-0.5789920207025192,-1.0849970358912697,0.3829787234042553,0.8347535879519764,1.0,5/12,25.26%,MYRIP;ERO1A;SLC30A7;EXOC1;EXOC6
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6668204168139715,-1.0849109034295645,0.39215686274509803,0.834168909617021,1.0,3/9,10.20%,KLHL20;EIF2AK2;BST2
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,0.693302706452545,1.0846210247245187,0.4528301886792453,1.0,1.0,1/7,0.24%,HSD17B4
prerank,CellMarker_Augmented_2021__Lymphoid cell:Blood,0.46973882916754583,1.0842458207773236,0.3409090909090909,1.0,1.0,5/31,10.68%,BACH2;NCAM1;ZEB2;ELMO1;CELF2
prerank,CellMarker_Augmented_2021__Gonadal Mitotic Phase Fetal Germ cell:Fetal Gonad,0.4579370290751234,1.083929429439831,0.3684210526315789,1.0,1.0,6/49,2.71%,PNP;CALR;COL4A2;TRAM2;FLVCR2;SLC25A16
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.5346210907052871,-1.0832636594028415,0.375,0.8376509091667863,1.0,8/36,10.89%,PLCG2;HLA-B;HLA-C;VAV3;TNFSF10;LCP2;HLA-E;IFNGR2
prerank,KEGG_2021_Human__Longevity regulating pathway,0.4956856931159796,1.082989968947671,0.35555555555555557,1.0,1.0,3/35,7.01%,CREB5;KRAS;PIK3CA
prerank,CellMarker_Augmented_2021__Colony-forming cell:Prostate,0.43810073775801617,1.0825271000890138,0.34,1.0,1.0,12/59,19.12%,YES1;ITGA2;OSBPL10;BACE2;PLEKHA1;CAPN2;PARVA;LPP;NECTIN3;PAM;PHLDB2;RYK
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.7002806165467746,-1.0821884337299568,0.5087719298245614,0.8399483863618067,1.0,2/5,15.64%,ATM;TNKS2
prerank,Reactome_2022__Biotin Transport And Metabolism R-HSA-196780,-0.7349434383731542,-1.081890680287757,0.4583333333333333,0.839976194325265,1.0,1/5,4.17%,SLC5A6
prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.49914055392307033,1.0817494212475263,0.3191489361702128,1.0,1.0,5/28,7.01%,INPP5A;INPP5F;PI4KA;PLCB1;PIK3CA
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.6268727546380306,1.081646783654904,0.40625,1.0,1.0,2/9,7.54%,BAG3;HSP90AA1
prerank,CellMarker_Augmented_2021__Epithelial cell:Embryoid Body,-0.5161926116989084,-1.081548922235751,0.3333333333333333,0.8401554617960568,1.0,3/44,1.59%,KIAA1217;EML1;SLC16A2
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4984864976462701,-1.0815458635543556,0.36666666666666664,0.8394261601799144,1.0,4/38,5.58%,CX3CL1;GPM6A;NTNG1;PLXND1
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.593119233144839,-1.0815340714187451,0.46296296296296297,0.8387515042098184,1.0,5/13,17.21%,RNF213;B2M;UBC;PGK1;KPNB1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.7247251828864709,1.0813880821280881,0.44642857142857145,1.0,1.0,3/5,12.27%,MT2A;MT1M;MT1E
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.7179355063905122,-1.081376222232549,0.4782608695652174,0.8385580265342397,1.0,3/6,19.02%,MTERF4;ZC3H13;WTAP
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.5643316237151321,1.0813384865939086,0.3392857142857143,1.0,1.0,4/14,16.68%,PRAG1;CBFA2T2;EPHA4;PTEN
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.6360764965123687,-1.0813194134562172,0.37037037037037035,0.837982985393403,1.0,5/13,17.88%,ATXN7;COL18A1;EYS;ZIC2;OPA1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.64658651729756,-1.0812563639611057,0.43636363636363634,0.8373645707462792,1.0,2/7,8.55%,EIF2AK2;TAOK3
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.5940454391602032,1.0811700133791438,0.42105263157894735,1.0,1.0,4/11,16.97%,CALR;XPO1;XPO4;XPO7
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6657957547089166,1.081025851244356,0.38461538461538464,1.0,1.0,2/8,8.87%,MBNL1;REST
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.5936469735783165,-1.0809395167663023,0.42592592592592593,0.8374653717337222,1.0,3/17,5.50%,DENND3;PRKN;NGLY1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.40753218747909176,1.0808579720617297,0.21212121212121213,1.0,1.0,42/152,22.82%,PDK4;PRKG1;PRKD1;TAF1;BCR;PRAG1;MORC3;MAPK10;IGFBP3;PI4KA;STK38L;PIK3CA;PXK;YWHAZ;ABL1;DGKI;NLK;LRRK2;PPP3CB;FNIP2;PINK1;ADAM10;RPS6KA5;STK24;NEK7;OXSR1;WNK1;ACVR2A;PRKCA;ROCK1;RYK;LIMK2;TOP1;TAOK1;DYRK1A;CDK12;PPP4R1;EIF2AK3;HK1;CDK6;ROCK2;AKT3
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.6645284786039809,1.0807358009620402,0.41818181818181815,1.0,1.0,3/6,16.49%,UGP2;GBE1;CALM1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.6436313371388835,-1.080719310909893,0.3695652173913043,0.8371939478605526,1.0,2/7,14.02%,CBR4;ELOVL5
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Placenta,-0.5324272708026382,-1.080619458808822,0.3333333333333333,0.836772530319461,1.0,12/23,23.40%,ITIH5;CXCL12;LAMA2;PPP1R12B;LRRC32;RAMP3;CD34;ACVRL1;CLEC14A;TNS1;JAM2;FGD5
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,0.6268458329416567,1.0799072136276584,0.36363636363636365,1.0,1.0,4/11,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,CellMarker_Augmented_2021__Blast cell:Bone Marrow,-0.5335457268711982,-1.079906980024457,0.37037037037037035,0.8378021042413872,1.0,4/38,5.21%,CLEC1A;APOL3;TIE1;CPQ
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.6043503076898844,-1.078942093983763,0.37735849056603776,0.8399608436708237,1.0,4/14,5.23%,PIGC;CD109;CPM;LY6E
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.6810152133160403,1.0785546077913826,0.43478260869565216,1.0,1.0,3/10,9.93%,ACTG1;PRKX;ACTB
prerank,CellMarker_Augmented_2021__Endothelial cell:Heart,0.4583364489568149,1.0783755883003585,0.34146341463414637,1.0,1.0,2/44,1.22%,PDK4;MMRN1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.6311066643591898,-1.078087688294317,0.41509433962264153,0.8414626060426101,1.0,2/7,13.09%,NLRC5;ATM
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.4593135258382336,-1.0779636963476802,0.28,0.8410389675315981,1.0,7/86,8.66%,CD74;FN1;PRKN;WARS1;TFRC;LIMCH1;CCDC88C
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.683884749305484,1.0779500399543862,0.375,1.0,1.0,5/8,25.76%,TET2;WDR82;SETD3;KMT5B;SETD5
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.606945601495194,-1.0777640191304316,0.40816326530612246,0.8407923107209461,1.0,4/9,12.54%,PRKN;TNFSF10;PMAIP1;CLU
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Abdominal Adipose Tissue,0.6904464059940201,1.0764158824123182,0.38461538461538464,1.0,1.0,1/6,1.78%,NREP
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Abdominal Adipose Tissue,0.6904464059940201,1.0764158824123182,0.38461538461538464,1.0,1.0,1/6,1.78%,NREP
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.600323024778046,-1.0763826514342585,0.35294117647058826,0.8438303891357039,1.0,3/13,8.98%,STAT1;LRRFIP1;STAT5B
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.517968005072853,1.0762236602616007,0.37037037037037035,1.0,1.0,4/25,7.46%,HDAC9;NUP58;PIAS1;RANBP2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.6325958513578936,1.076171773515824,0.34545454545454546,1.0,1.0,2/7,18.75%,PBX3;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.6834394470182862,1.0760042428156664,0.43859649122807015,1.0,1.0,4/6,22.90%,MORC3;SKI;CDC73;NF1
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,0.561825047570165,1.074898335499167,0.30952380952380953,1.0,1.0,3/16,11.93%,YWHAB;DUSP6;PPP2CB
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.6955078164204359,1.0745905998192595,0.40384615384615385,1.0,1.0,1/6,5.66%,SYNE2
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.7056579506389886,1.0744645699536088,0.41818181818181815,1.0,1.0,3/6,22.50%,RTN4;ATL2;RTN3
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.7161787383630059,-1.0744155273920533,0.43636363636363634,0.8484380221575257,1.0,2/8,3.43%,PLCG2;VAV3
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.5541921672806936,-1.0743924294440392,0.4074074074074074,0.8477901076055389,1.0,2/16,6.72%,ATP9A;TMEM30A
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.6925162161448613,-1.0740983798794197,0.42857142857142855,0.8476878180860141,1.0,3/5,14.71%,SULF2;CHST12;CSGALNACT1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6785978009122983,-1.0739337981052037,0.425531914893617,0.8474891786065496,1.0,1/5,1.54%,SOD2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.7073068603488816,1.073802570635889,0.45098039215686275,1.0,1.0,3/5,22.90%,SEMA3F;NRP1;NF1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.5730339602483603,-1.0731668478170857,0.4074074074074074,0.8485709331963157,1.0,4/19,12.72%,SPG7;CPM;VSIR;SRGN
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.594986075312519,1.0730706846564786,0.38636363636363635,1.0,1.0,3/11,8.87%,ZEB1;NRCAM;REST
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6209256472725465,1.072810158864954,0.39215686274509803,1.0,1.0,4/8,31.47%,DICER1;AGO2;TUT7;TUT4
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,0.6566929205710084,1.0728022505030268,0.4423076923076923,1.0,1.0,2/7,11.16%,MAT2A;DNMT3A
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.6579019216363342,1.0727800962671126,0.3508771929824561,1.0,1.0,4/7,26.40%,ITGA1;CALM1;HSP90AB1;MEF2C
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,0.6389902811366102,1.0725924331097811,0.3695652173913043,1.0,1.0,4/10,15.56%,PIK3CA;PIGU;FRS2;GRB2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.6606724718371219,-1.072555989640128,0.41304347826086957,0.849493160041285,1.0,3/5,28.58%,DHX36;RPTOR;MTOR
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,0.6069103658830616,1.0723580629151805,0.4375,1.0,1.0,3/10,12.11%,ITPR3;DGKI;ITPR2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.5381293526805628,-1.0721207295745843,0.42592592592592593,0.8500724642523164,1.0,3/24,5.60%,LGALS3;TNFSF10;SERPINE1
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.5231126411627347,-1.0720983605816246,0.36363636363636365,0.8486942009136234,1.0,2/20,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,-0.5231126411627347,-1.0720983605816246,0.36363636363636365,0.8486942009136234,1.0,2/20,1.51%,PSMA1;PSMB9
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.6253052349744853,1.0714983767534279,0.39344262295081966,1.0,1.0,1/8,1.41%,BCL6
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.6389868748740823,1.0714159865170694,0.37735849056603776,1.0,1.0,1/8,3.72%,MT2A
prerank,CellMarker_Augmented_2021__Multilymphoid Progenitor cell:Umbilical Cord Blood,-0.42625480445334146,-1.071366944167824,0.3287671232876712,0.8497441361769337,1.0,4/156,2.95%,IFI44L;HES1;ATP9A;HLA-B
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,0.6097424253325274,1.0713259253679484,0.3673469387755102,1.0,1.0,2/12,8.55%,TAF1;TAF3
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.5991751629669554,1.071130460118962,0.37037037037037035,1.0,1.0,6/16,17.64%,NCOA2;CRTC3;SSBP1;CALM1;CREBBP;NCOA1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.45470043772231855,1.0710279567462746,0.30303030303030304,1.0,1.0,9/34,18.46%,ITPR3;STIM1;CPNE8;HOMER1;CLIC4;PPP3CA;NLGN1;CALM1;ANXA11
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.5349443291226871,-1.0709018018734409,0.38461538461538464,0.8501555240239625,1.0,7/25,10.73%,CYLD;TMSB4X;IRF1;UFL1;SAMHD1;ERAP1;APPL2
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.4560986336218146,1.0706832306818332,0.35714285714285715,1.0,1.0,10/52,18.78%,PACS2;CCDC88A;MAP7;TTC7A;DPP10;ANK2;NECTIN3;CD81;ANK3;ROCK1
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,0.5044377869758823,1.0704892498048433,0.375,1.0,1.0,2/30,6.37%,GFOD1;CPNE8
prerank,Reactome_2022__Signal Attenuation R-HSA-74749,0.7328807336589311,1.070361723490996,0.4642857142857143,1.0,1.0,2/5,15.56%,GRB10;GRB2
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,-0.4301692407769217,-1.0703414069558477,0.37142857142857144,0.8508102427251819,1.0,12/157,4.75%,SLC22A5;SLC6A6;PSMA1;ABCA5;PSMB9;SLC16A2;ATP9A;ATP6V1E1;SLCO1A2;SLC5A6;SPG7;SLC38A3
prerank,CellMarker_Augmented_2021__Cardiovascular Progenitor cell:Heart,0.49719621569074113,1.0702194309941522,0.35714285714285715,1.0,1.0,3/30,5.23%,COL4A2;PRKG1;SLCO2A1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.6386697261336078,1.0700681604243807,0.4583333333333333,1.0,1.0,3/8,9.93%,ACTG1;HSPB1;ACTB
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6933505827019012,-1.069617296368124,0.55,0.8519166635149503,1.0,1/6,1.57%,RIMS1
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,0.6173601851641082,1.0695242526346387,0.4117647058823529,1.0,1.0,3/10,7.28%,FUT8;MAN1A2;STT3B
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,0.46764211539143324,1.0694016911176742,0.3488372093023256,1.0,1.0,7/41,11.00%,TAF1;NUP58;SGIP1;RANBP2;TAF3;XPO1;PSIP1
prerank,CellMarker_Augmented_2021__Stem cell:Endometrium,0.7013109962213396,1.0692982374924338,0.47619047619047616,1.0,1.0,1/5,6.43%,ALCAM
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.7333901740630973,1.0690163950203655,0.45454545454545453,1.0,1.0,3/5,21.73%,PIAS1;ZMIZ1;HDAC4
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.6841422755011989,-1.0689968242262902,0.44680851063829785,0.8527079869327637,1.0,2/10,11.87%,PLCG2;HOMER2
prerank,CellMarker_Augmented_2021__Decidual cell:Placenta,-0.5519571637731846,-1.0689606601734263,0.3793103448275862,0.8520288190248115,1.0,3/24,5.60%,PLK2;FN1;SERPINE1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.6141689538105122,1.0688800387828783,0.3673469387755102,1.0,1.0,2/13,1.51%,HDAC9;INSIG1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.6141689538105122,1.0688800387828783,0.3673469387755102,1.0,1.0,2/13,1.51%,HDAC9;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.5584825617692373,1.0685684487553617,0.43902439024390244,1.0,1.0,4/13,10.89%,GRIK2;INPP5F;HOMER1;ANXA2
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Intestine,-0.5192181202786627,-1.0684275670018457,0.43859649122807015,0.8525841898411756,1.0,3/33,5.60%,PLK2;FN1;SERPINE1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.6630596547600403,1.068071963484924,0.4727272727272727,1.0,1.0,1/8,2.90%,BAG3
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.6019106917780807,-1.06799470064966,0.375,0.8529216587798919,1.0,1/12,0.90%,PSTPIP2
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.6039028701432563,1.0674771921251491,0.375,1.0,1.0,1/10,2.12%,YWHAB
prerank,CellMarker_Augmented_2021__Osteogenic Precursor-Like cell:Dermis,0.4392573805564235,1.067467764948908,0.3409090909090909,1.0,1.0,8/48,5.55%,NOVA1;SRGAP1;ERBB4;PRKD1;TTLL7;MAPK10;FGF12;GULP1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.5437280489779942,-1.0673414217777675,0.425531914893617,0.8537528127696522,1.0,4/25,5.60%,PPARG;CD109;CTNNA2;SERPINE1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.6548604392086863,-1.0671382417871054,0.38636363636363635,0.8535255758950685,1.0,2/9,14.71%,SLC2A3;CSGALNACT1
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,0.42877874839932084,1.0667399319273363,0.24444444444444444,1.0,1.0,20/80,20.21%,AEBP2;KDM4C;BRWD1;UTY;MORF4L1;REST;DNMT3A;NCOA2;KDM5A;ATF7IP;ARID1A;ZZZ3;PHF21A;USP22;CREBBP;EP300;NCOA1;SETD7;SETD3;NCOR2
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.637539138338613,1.0666902703542935,0.45,1.0,1.0,3/9,18.67%,GRIA2;AP2B1;PRKCA
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.6372437777660204,-1.0666833053979132,0.423728813559322,0.8538354265163168,1.0,6/8,33.25%,UNC13B;RACK1;ZBTB20;GAS6;PCK1;IGF1R
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.713380303277376,-1.0665088525242068,0.44680851063829785,0.8536258016166253,1.0,1/5,2.36%,TPM1
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,0.5357872646520427,1.0656308730483528,0.4,1.0,1.0,7/24,17.64%,NCOA2;CRTC3;HSPA9;SSBP1;CALM1;CREBBP;NCOA1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.5783791413354009,-1.0655822132857,0.36363636363636365,0.8551103482311155,1.0,1/14,1.20%,RHOBTB1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.6568577088459062,-1.0650911535834964,0.49019607843137253,0.8557030260597929,1.0,1/7,1.01%,PPARG
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.6325089005478107,1.064378336266461,0.40425531914893614,1.0,1.0,2/8,5.58%,NUP58;AHCTF1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.6211229076088635,-1.0643410950622803,0.4222222222222222,0.8570452902054603,1.0,2/15,3.53%,GBP1;TNIP1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Blood,-0.468173958729069,-1.0638369863131742,0.3333333333333333,0.857575004928759,1.0,2/91,1.65%,IFI44L;RREB1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.6085719224218962,-1.063653590573448,0.42,0.8572253137052457,1.0,3/9,15.19%,CXCL12;STK39;RHOA
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,0.441088467363689,1.0634848966818067,0.3181818181818182,1.0,1.0,12/60,13.12%,ERBB4;GRIA2;SNAP25;PLCB1;PRKX;DNAJC5;LRRC7;PPM1F;GNB4;NPTN;AP2B1;HSPA8
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.5513058254183798,1.063459750023714,0.40350877192982454,1.0,1.0,6/14,27.09%,NFYC;NCOA2;CREBBP;NCOA1;ACACA;FDFT1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.46318564541080054,-1.0634103026843162,0.36923076923076925,0.8570483228211991,1.0,17/87,11.71%,TLL1;RHOBTB1;TPM1;CARMIL1;PRKN;COL8A1;PPP1R9A;DSP;B2M;COL18A1;CCDC88C;ARHGAP17;CST3;ACTN1;CD2AP;VIM;UBC
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.6496456684983315,1.0632833045321515,0.36363636363636365,1.0,1.0,4/10,23.88%,ANO6;ANK2;WNK1;AKAP6
prerank,CellMarker_Augmented_2021__T Helper cell:Lung,0.6447870901994185,1.0630670418645882,0.5084745762711864,1.0,1.0,1/7,8.02%,DIAPH1
prerank,CellMarker_Augmented_2021__Platelet:Liver,0.6447870901994185,1.0630670418645882,0.5084745762711864,1.0,1.0,1/7,8.02%,DIAPH1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.687416866187816,-1.0627915119115545,0.5111111111111111,0.8577744676859406,1.0,6/6,31.39%,BCOR;KMT2A;KDM1A;AUTS2;CTNNB1;MACROH2A1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.45726934106506245,-1.0625576591488253,0.36666666666666664,0.857794912449561,1.0,5/71,4.06%,TBX3;ZIC1;EML1;PRKN;SMARCA1
prerank,CellMarker_Augmented_2021__B cell:Undefined,0.6267360053588645,1.0625547966141922,0.4,1.0,1.0,3/13,7.52%,IL6R;BCR;ENTPD1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.5419096284393963,1.062454995511542,0.3793103448275862,1.0,1.0,8/19,17.66%,CDH2;ROBO2;TIAM2;RTN4;CHN1;EPHA4;PTEN;TIAM1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.4750496750708428,-1.0623502098151545,0.38461538461538464,0.8575148803275139,1.0,3/44,2.36%,KLHL20;RHOBTB1;TPM1
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,0.61796228204163,1.0620851389980697,0.4583333333333333,1.0,1.0,2/9,8.55%,TAF1;TAF3
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.6195337184550874,1.0618995396376758,0.4444444444444444,1.0,1.0,5/9,33.04%,LRRK2;WNK1;BCAS3;ARFGEF1;CPEB2
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,0.5992568075921842,1.0617443044665331,0.5,1.0,1.0,2/11,7.54%,HSPH1;HSP90AA1
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Peripheral Blood,0.6297562009558647,1.061358007465601,0.43859649122807015,1.0,1.0,4/9,9.83%,ITGA1;NCAM1;ENTPD1;ITGA5
prerank,Reactome_2022__Uptake And Function Of Diphtheria Toxin R-HSA-5336415,0.7262857789733834,1.0611463966293977,0.45901639344262296,1.0,1.0,2/5,23.64%,HSP90AA1;HSP90AB1
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6227563768556093,1.0610984298861268,0.46808510638297873,1.0,1.0,1/7,12.93%,STARD4
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.49270452568899786,1.060920805818542,0.3695652173913043,1.0,1.0,4/28,8.55%,CALR;MORC3;PPP1R10;TAF3
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.5448142904338658,1.060498312468985,0.44642857142857145,1.0,1.0,2/17,9.08%,CCDC88A;WAPL
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.6990851302802006,-1.059546862675613,0.5370370370370371,0.8636765675764994,1.0,3/5,20.48%,VIM;NOD1;NLRP1
prerank,Reactome_2022__Erythropoietin Activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276,0.7012511423212715,1.0591402194802073,0.46808510638297873,1.0,1.0,2/6,7.44%,PIK3CA;PIGU
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.43455310474438735,-1.0590284483914547,0.31746031746031744,0.8641290867698789,1.0,26/146,14.00%,CYLD;GBP1;TMSB4X;PLCG2;ULK4;OPTN;UFL1;VAV3;RFC3;RASGRF2;ARAP2;NFKBIA;TAOK3;TOPBP1;ARHGAP17;NET1;ARHGAP15;MAPKAP1;ARHGEF11;MCF2L;ITGAV;GNA12;ATM;PPP1R16B;BRD7;PRKAR1A
prerank,CellMarker_Augmented_2021__Enterocyte Progenitor cell:Small Intestine,0.6040927495009524,1.058967817313469,0.4090909090909091,1.0,1.0,3/13,5.05%,PNP;KIF26B;PEX14
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.6761638799999475,1.0588680342889334,0.4423076923076923,1.0,1.0,1/5,1.51%,INSIG1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.6761638799999475,1.0588680342889334,0.4423076923076923,1.0,1.0,1/5,1.51%,INSIG1
prerank,CellMarker_Augmented_2021__Epithelial cell:Thymus,-0.5819651151817657,-1.058219237868582,0.39622641509433965,0.8653343575653301,1.0,2/18,7.28%,KIAA1217;DSP
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.5857499057224422,1.0580820298103566,0.4375,1.0,1.0,1/9,1.97%,INPP5F
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.5829879653608596,1.0578760183683789,0.37037037037037035,1.0,1.0,3/12,10.41%,NUP58;RANBP2;XPO1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.4325783257415017,1.0576530291112825,0.3333333333333333,1.0,1.0,11/52,16.20%,SMAD9;SOX5;SMAD6;ZMIZ1;NLK;SMAD1;SMAD5;GCNT2;SKI;PARD3;APPL1
prerank,Reactome_2022__Miro GTPase Cycle R-HSA-9715370,0.6935405805832251,1.0574978755709987,0.4339622641509434,1.0,1.0,2/5,7.78%,TRAK1;TRAK2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.5209583637181615,1.0574367473263842,0.40476190476190477,1.0,1.0,3/23,1.14%,BTBD10;INPP5A;RRAS2
prerank,KEGG_2021_Human__Mismatch repair,-0.6808592102271475,-1.0570857110269336,0.46,0.8673418291470504,1.0,3/5,17.69%,RFC3;MSH2;RFC1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7423545841985255,1.0570446673345,0.5,1.0,1.0,2/5,13.94%,PPHLN1;ATF7IP
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7423545841985255,1.0570446673345,0.5,1.0,1.0,2/5,13.94%,PPHLN1;ATF7IP
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,0.5851133411807805,1.0567921180063284,0.4,1.0,1.0,1/9,1.94%,PRPF8
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.5965482794239338,-1.056785840726371,0.40425531914893614,0.8665807583980872,1.0,4/10,19.87%,AGPAT3;DGKG;DGKE;LCLAT1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.5965482794239338,-1.056785840726371,0.40425531914893614,0.8665807583980872,1.0,4/10,19.87%,AGPAT3;DGKG;DGKE;LCLAT1
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.5613499744245831,1.0566007005746776,0.40350877192982454,1.0,1.0,3/13,10.41%,NUP58;RANBP2;XPO1
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,0.6021231799063264,1.0565977266208766,0.4888888888888889,1.0,1.0,3/10,14.26%,NCAM1;ITGA5;NRP1
prerank,KEGG_2021_Human__Oxidative phosphorylation,-0.5956015447701015,-1.0565834659567315,0.4230769230769231,0.8664571953525738,1.0,3/14,14.90%,ATP6V1E1;PPA2;COX6C
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.6649755142024648,1.0561039186007442,0.43478260869565216,1.0,1.0,3/6,23.67%,ANO6;RGCC;GSN
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.6102610637604741,-1.0558592493470815,0.38461538461538464,0.8673400227618028,1.0,2/8,12.01%,STAT1;SULF2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.5721034071161102,-1.05558647482641,0.44680851063829785,0.8674886714581854,1.0,5/16,22.52%,FOXK1;FOXO1;UNC13B;RACK1;ZBTB20
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.5821569775313408,1.0551980440295334,0.4230769230769231,1.0,1.0,4/8,26.77%,ANXA2;MTMR3;RAB5A;PIKFYVE
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.6481423389840072,-1.0547297232723742,0.41818181818181815,0.868913999299039,1.0,3/5,22.23%,PMAIP1;RIOK3;SLC3A2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.7147420989985781,-1.0544134964946021,0.4782608695652174,0.8690185674568817,1.0,4/5,13.44%,TAP1;B2M;ERAP1;HLA-A
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.478359051622807,1.0542671680168103,0.36,1.0,1.0,8/25,18.49%,KPNA3;PPP1R10;RANBP2;KPNA1;CBLB;APPL1;KPNA5;IPO8
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.5171233002349601,1.0540914603050824,0.44,1.0,1.0,4/22,13.20%,UBQLN1;HSP90B1;STT3B;UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6285212146916527,1.0540174621072433,0.42,1.0,1.0,5/8,23.88%,VMP1;ANK2;CALM1;RYR2;AKAP6
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.6471673230661411,-1.0539731879634717,0.4222222222222222,0.8693949218112446,1.0,3/6,25.29%,SENP6;ATG10;ATG7
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,-0.6917194266650155,-1.0538238550362231,0.425531914893617,0.8690064002478949,1.0,2/6,16.20%,CLTA;TJP1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6655395834604316,1.0538194646534278,0.5098039215686274,1.0,1.0,2/5,14.34%,UGP2;GBE1
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,0.6038178231910744,1.0536822562389236,0.4482758620689655,1.0,1.0,3/10,7.54%,ERBB4;NRG2;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6404766073027973,1.053631282063689,0.5192307692307693,1.0,1.0,3/8,17.56%,PKM;CPEB3;CPEB4
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,0.4779833774281149,1.0530537265042772,0.40476190476190477,1.0,1.0,6/37,10.41%,TAF1;NUP58;SGIP1;RANBP2;TAF3;XPO1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5336120289690339,-1.0527190780563194,0.4,0.8709857455023946,1.0,2/17,10.07%,SHLD1;PARP9
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,-0.6068136622093385,-1.0527101371958187,0.3508771929824561,0.8702913555584503,1.0,4/13,8.42%,TLL1;LAMA4;COL8A1;COL18A1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.6121852837965277,1.0526795817870311,0.5094339622641509,1.0,1.0,2/9,9.22%,BMP6;PPM1F
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.647978210436484,1.052489630105435,0.49019607843137253,1.0,1.0,5/7,26.80%,AGTPBP1;SKI;NIPBL;NF1;STAT3
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.6203704850856272,1.0523601513906862,0.40816326530612246,1.0,1.0,2/8,11.71%,SMAD1;SMAD5
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4356153122162123,1.0523527563458996,0.32,1.0,1.0,13/54,16.20%,SMAD9;BMP6;SMAD6;HIVEP1;ZMIZ1;NLK;SMAD1;SMAD5;GCNT2;SKI;PARD3;SMURF2;APPL1
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,0.5027718822402922,1.052306478034662,0.3333333333333333,1.0,1.0,7/28,18.67%,MCPH1;NUP58;RANBP2;PPP2CB;LEMD3;NEK7;PRKCA
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Skin,0.5863947432279053,1.0521309932925373,0.4528301886792453,1.0,1.0,3/15,8.39%,ERBB4;MAPK10;NRXN1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In1:Brain,0.5838040284607856,1.0519720916860802,0.44,1.0,1.0,6/14,11.61%,GRIA2;NCAM1;NRXN1;CNTNAP2;ADGRB3;RBFOX1
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.41248386244585566,1.0518808583274988,0.3684210526315789,1.0,1.0,20/83,15.41%,PSMD14;ITPR3;ERBB4;UBQLN1;VAPB;ACTG1;GRIA2;NRG2;TUBB4B;NUP58;RANBP2;AMBRA1;SEM1;ACTB;SETX;PPP3CA;PPP3CB;PINK1;BCL2L1;ATG2B
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.5156463543581524,-1.0515592975119117,0.37037037037037035,0.8723002534459969,1.0,2/31,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6573097545337804,1.051515803206946,0.4745762711864407,1.0,1.0,2/6,16.49%,PARD3;CALM1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6746037463492482,1.0514973137327808,0.4318181818181818,1.0,1.0,2/6,26.51%,APPL1;C2CD5
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.5253829312784624,-1.0511645079906906,0.4117647058823529,0.8724607557083568,1.0,3/18,7.04%,PSMA1;PSMB9;ANAPC16
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.4332262410877958,-1.0510610838444057,0.39655172413793105,0.8720290246795251,1.0,18/136,13.09%,CD74;RIMS1;PLCG2;FN1;PRKN;EIF2AK2;SMAD3;TAF1D;WARS1;RPL23;TFRC;POLR2A;RPS7;VIM;UPF3A;VSIR;CLU;ATM
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.6389323302116423,-1.0509510906794335,0.4791666666666667,0.8716064546335333,1.0,1/5,7.92%,CEP57
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.6277505761028269,-1.0508914506119058,0.48,0.8710579385574542,1.0,2/14,13.09%,SP100;ATM
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.47419171095941165,-1.0508187100739446,0.36666666666666664,0.8705356321404882,1.0,7/49,12.72%,LAP3;SPG7;CPM;CPQ;ERAP1;SPPL2A;SRGN
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6215093291335558,1.0507998343783116,0.5833333333333334,1.0,1.0,4/8,16.68%,BTRC;CDC14B;PINK1;PTEN
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5665088311301418,1.0505510203723403,0.36585365853658536,1.0,1.0,6/18,21.57%,PLCB1;NLK;PPP3CA;PPP3CB;CALM1;AGO2
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.6757744051499853,1.0499677092235289,0.4166666666666667,1.0,1.0,2/5,25.07%,ST8SIA4;ST6GALNAC3
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.5220474870137548,-1.0496616470713922,0.35294117647058826,0.8725259962276922,1.0,1/36,0.21%,RSAD2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.6657056777274483,1.0494884845050365,0.5333333333333333,1.0,1.0,2/6,26.06%,ANXA2;RFTN1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.6475128567281472,1.048784145853454,0.509090909090909,1.0,1.0,1/8,5.31%,PCM1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Undefined,0.607083088111688,1.0487665320485062,0.3958333333333333,1.0,1.0,2/7,6.75%,ITGA2;NCAM1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.5032174211497751,1.048661486734416,0.46153846153846156,1.0,1.0,16/33,28.45%,ACTG1;ABL1;PPM1F;CLASP1;NRP1;PTEN;RAC1;PHLDB2;ROCK1;ROCK2;TEK;MAP4K4;EFNA5;BCAS3;PTK2;CORO1C
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.5995442128277498,-1.0483541307415147,0.4444444444444444,0.8747573294725413,1.0,6/14,13.04%,GMPS;ADSS2;SAMHD1;CDA;CMPK1;ENTPD4
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.580518845977796,1.0483041049187605,0.47058823529411764,1.0,1.0,1/11,3.27%,BCR
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.6490741815139277,-1.0482409719237011,0.4339622641509434,0.8744688956719923,1.0,1/5,5.39%,CTNNA2
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Colon,0.47165154015949073,1.0480317041269898,0.4166666666666667,1.0,1.0,14/47,16.44%,ATRNL1;NOVA1;MAPK10;NTM;NOVA2;ADGRB3;MPDZ;CNTN1;CHN1;ADGRL2;PDZRN3;ANK2;PLPPR4;NLGN1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestine,0.47165154015949073,1.0480317041269898,0.4166666666666667,1.0,1.0,14/47,16.44%,ATRNL1;NOVA1;MAPK10;NTM;NOVA2;ADGRB3;MPDZ;CNTN1;CHN1;ADGRL2;PDZRN3;ANK2;PLPPR4;NLGN1
prerank,CellMarker_Augmented_2021__Esophageal Mucosal cell:Esophagus,0.47165154015949073,1.0480317041269898,0.4166666666666667,1.0,1.0,14/47,16.44%,ATRNL1;NOVA1;MAPK10;NTM;NOVA2;ADGRB3;MPDZ;CNTN1;CHN1;ADGRL2;PDZRN3;ANK2;PLPPR4;NLGN1
prerank,CellMarker_Augmented_2021__Small Intestinal Stem cell:Small Intestinal Crypt,0.47165154015949073,1.0480317041269898,0.4166666666666667,1.0,1.0,14/47,16.44%,ATRNL1;NOVA1;MAPK10;NTM;NOVA2;ADGRB3;MPDZ;CNTN1;CHN1;ADGRL2;PDZRN3;ANK2;PLPPR4;NLGN1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Esophagus,0.47165154015949073,1.0480317041269898,0.4166666666666667,1.0,1.0,14/47,16.44%,ATRNL1;NOVA1;MAPK10;NTM;NOVA2;ADGRB3;MPDZ;CNTN1;CHN1;ADGRL2;PDZRN3;ANK2;PLPPR4;NLGN1
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.5367666702280938,-1.0478409147469177,0.42857142857142855,0.8740362673105919,1.0,2/23,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.5367666702280938,-1.0478409147469177,0.42857142857142855,0.8740362673105919,1.0,2/23,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Esophagus,0.573666193758416,1.0471407872122205,0.3958333333333333,1.0,1.0,2/12,1.17%,HDAC9;MCPH1
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.5958812973412546,-1.0464821585654247,0.37735849056603776,0.8764773154857145,1.0,1/10,6.83%,TAF1D
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6720389493363063,1.0464368729214477,0.45614035087719296,1.0,1.0,3/6,23.64%,ITGA1;CALM1;HSP90AB1
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.521663143217031,1.046066901499612,0.3541666666666667,1.0,1.0,8/17,28.82%,CCDC88A;DST;LEMD3;ROCK1;PICALM;TMOD3;KTN1;PKP4
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,0.6863549328970275,1.045659983862193,0.45098039215686275,1.0,1.0,2/6,3.16%,YWHAB;SLC38A9
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.5168108485330867,-1.0450485695674234,0.46153846153846156,0.8759037611533587,1.0,3/19,7.04%,PSMA1;PSMB9;ANAPC16
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.5168108485330867,-1.0450485695674234,0.46153846153846156,0.8759037611533587,1.0,3/19,7.04%,PSMA1;PSMB9;ANAPC16
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.5168108485330867,-1.0450485695674234,0.46153846153846156,0.8759037611533587,1.0,3/19,7.04%,PSMA1;PSMB9;ANAPC16
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.5168108485330867,-1.0450485695674234,0.46153846153846156,0.8759037611533587,1.0,3/19,7.04%,PSMA1;PSMB9;ANAPC16
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.5168108485330867,-1.0450485695674234,0.46153846153846156,0.8759037611533587,1.0,3/19,7.04%,PSMA1;PSMB9;ANAPC16
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.5168108485330867,-1.0450485695674234,0.46153846153846156,0.8759037611533587,1.0,3/19,7.04%,PSMA1;PSMB9;ANAPC16
prerank,Reactome_2022__Innate Immune System R-HSA-168249,-0.391646025442158,-1.0447655002131597,0.37333333333333335,0.8760340714226372,1.0,32/267,10.20%,CYLD;PSMA1;IFIH1;PSMB9;ISG15;HGSNAT;PLCG2;HLA-B;HLA-C;VAV3;HEBP2;ATP6V1E1;LGALS3;NLRC5;IGF2R;MEF2A;TMEM30A;LCP2;NFKBIA;B2M;SLC2A3;NFKB1;LRRFIP1;TRIM25;FOS;CDA;TANK;CD47;JUN;HLA-E;CST3;BST2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.45821443400632095,-1.04458252065134,0.38181818181818183,0.8756971402263133,1.0,4/68,10.09%,CX3CL1;RGS6;LARS1;NET1
prerank,Reactome_2022__Glycogen Synthesis R-HSA-3322077,0.6551631368990611,1.0444468179854436,0.46296296296296297,1.0,1.0,2/5,14.34%,UGP2;GBE1
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.5401369563370173,-1.0444260895028517,0.4426229508196721,0.8753607564405438,1.0,7/30,10.12%,PLCG2;VAV3;NFKBIA;NFKB1;FOS;JUN;INPP5D
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,-0.5873863075572675,-1.0442105745122376,0.4782608695652174,0.875224749338385,1.0,1/12,2.12%,STAT1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6498983344847371,1.0438923998662228,0.5,1.0,1.0,1/5,2.47%,BACH2
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,0.497010409471198,1.0434625767190817,0.44,1.0,1.0,5/24,15.56%,PIK3CA;PIGU;FRS2;PPP2CB;GRB2
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.6419984690549243,-1.0434610942691245,0.42,0.8755352910662422,1.0,3/7,11.61%,TPM1;DMD;VIM
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.6419984690549243,-1.0434610942691245,0.42,0.8755352910662422,1.0,3/7,11.61%,TPM1;DMD;VIM
prerank,CellMarker_Augmented_2021__Mesothelial cell:Undefined,-0.6783362616215622,-1.0433579562020168,0.5106382978723404,0.8751170673397476,1.0,3/6,23.37%,FLNB;PLEC;LSR
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,-0.4867969204709283,-1.0431062692794897,0.45454545454545453,0.8750480921845049,1.0,12/60,12.19%,CYLD;VAV3;TNFSF10;RASGRF2;ARHGEF37;NFKBIA;NFKB1;TANK;SPPL2A;ARHGEF11;UBC;MCF2L
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.4675033648939213,1.0428129756760218,0.3333333333333333,1.0,1.0,8/42,12.11%,INPP5A;ITPR3;INPP5F;PI4KA;PLCB1;PIK3CA;DGKI;ITPR2
prerank,Reactome_2022__tRNA Processing R-HSA-72306,0.5709154824713237,1.042475091269167,0.42857142857142855,1.0,1.0,3/18,7.46%,TRMT9B;NUP58;RANBP2
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.5138030132837182,-1.0417736574707768,0.46153846153846156,0.8778070120161463,1.0,7/35,15.75%,PLK2;CENATAC;PRKN;GPC3;EEF1A1;HECW2;FOXO1
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,-0.5480411946556332,-1.0414258489221881,0.37037037037037035,0.8779679812847407,1.0,5/24,8.92%,PLCG2;ATP6V1E1;NFKBIA;NFKB1;JUN
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Venous Blood,0.5875011350908955,1.0400046461659138,0.4339622641509434,1.0,1.0,1/7,3.27%,BCR
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.6844593262909164,1.039910902322368,0.4915254237288136,1.0,1.0,3/5,21.65%,DICER1;PARD3;EIF2AK3
prerank,Reactome_2022__G1/S Transition R-HSA-69206,-0.5142152272834495,-1.0397874981938042,0.36666666666666664,0.8806455778970501,1.0,2/28,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.4710750249990959,1.0396400356139757,0.3888888888888889,1.0,1.0,10/30,17.03%,STIM1;ATP2A2;CACNA1C;CALCRL;SLC8A1;ANO6;SLC24A2;ANK2;ATP2B4;PSEN1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.5501493223073176,1.039434437927421,0.4782608695652174,1.0,1.0,2/15,14.95%,YTHDF2;G3BP1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In6:Brain,0.46543602838675163,1.0388367354601828,0.3617021276595745,1.0,1.0,2/31,3.85%,PDK4;PACS2
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.5736759495675706,-1.0388340152193098,0.43103448275862066,0.882177242891306,1.0,4/14,14.32%,SERPINE1;SMAD3;UBC;RNF111
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.5973305135520748,-1.0387145684653207,0.4909090909090909,0.8817970185573039,1.0,5/11,17.74%,RFC3;TOPBP1;UBC;ATM;POLK
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5912549449882927,1.0385561068447735,0.39215686274509803,1.0,1.0,3/14,4.94%,ERBB4;PHACTR4;SEMA3F
prerank,CellMarker_Augmented_2021__Beta cell:Pancreatic Islet,0.4924108680014277,1.0385085227743707,0.3541666666666667,1.0,1.0,6/18,12.40%,ALCAM;RNF130;CYYR1;ROBO2;ELMO1;HSPD1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.5780881835779254,1.0382474109244302,0.4418604651162791,1.0,1.0,1/9,5.92%,OTUD7B
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6582592413039594,1.0376988971333991,0.515625,1.0,1.0,1/7,7.57%,SMAD6
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.5431638953965313,1.0376691530746736,0.43137254901960786,1.0,1.0,4/15,17.42%,NUP58;RANBP2;PINK1;EP300
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Umbilical Cord Blood,0.602735758149331,1.037532902188481,0.35135135135135137,1.0,1.0,8/14,28.87%,ITGA2;SLCO2A1;ATP8B1;LPP;PLSCR4;MECOM;VWA2;CMAHP
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.4906004695355657,1.0374712399098416,0.4117647058823529,1.0,1.0,2/27,5.31%,BMP6;PCM1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6531374400350909,1.03740678945641,0.4745762711864407,1.0,1.0,4/6,23.29%,RANBP9;ROCK1;ROCK2;PICALM
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.4514804751708219,-1.037067225113746,0.3559322033898305,0.8852992474200055,1.0,5/69,4.01%,KLHL20;PSMA1;PSMB9;IFI27;PRKN
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.4929223408236043,1.0368582991053725,0.37037037037037035,1.0,1.0,7/28,15.22%,PKM;YTHDF2;LARP4;SAMD4A;CPEB3;EIF3E;KHDRBS1
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,-0.3708950458669364,-1.0367139540483452,0.3116883116883117,0.8853049949977517,1.0,70/482,12.56%,DPH6;CYLD;PPARG;KLHL20;PSMA1;IFIH1;PSMB9;PIGC;RPS12;FN1;HLA-B;RPL31;SHISA5;TNIP1;SP100;PRKN;NUB1;CD109;RPL34;NR3C2;PABPC1;CPM;RPS8;LY6E;RPL15;ALG11;NGLY1;RPS6;RGS6;RPL7A;RPL38;MYRIP;SMAD3;NFKBIA;WARS1;FOXK1;RPL23;B2M;TRIM25;ATXN7;RPL30;LARS1;GOSR1;TANK;PRSS23;BABAM2;ERO1A;CAMKMT;CBX5;RPS28;RPS19;CST3;RPS7;RPS14;WSB1;RECK;RAB1A;COPA;STAM2;GNG4;RPS15;ADAMTS1;GPC3;UBC;UBE2D2;RPL28;USO1;RORA;STX17;NPLOC4
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreatic Islet,-0.6118460171550079,-1.0366080554149257,0.45614035087719296,0.8848407137584415,1.0,3/11,7.01%,SOD2;IL32;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.5889244469967735,-1.0364171836376397,0.42857142857142855,0.8846161190449666,1.0,5/13,13.44%,HLA-F;HLA-B;B2M;HLA-E;HLA-A
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.5617106222167894,1.0360762456125063,0.4166666666666667,1.0,1.0,6/16,17.42%,ERCC6;ACTB;ZMIZ1;ARID1A;BAZ1B;EP300
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.6481650067109797,1.036020938465716,0.5,1.0,1.0,1/8,7.54%,HSP90AA1
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.5543901635623257,-1.035922676143165,0.4230769230769231,0.8852233897179473,1.0,2/15,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.4018762561488768,-1.0358559421349691,0.39655172413793105,0.8847520647560133,1.0,15/168,9.99%,HES1;TBX3;BTG2;PPARG;CNOT8;IRF1;SNX6;EIF2AK2;FOXK1;SCML1;BHLHE40;JUN;CBX5;RCOR1;CAPRIN1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.5216483613165556,-1.0357547590035237,0.43137254901960786,0.8842732755944109,1.0,2/24,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5457373480283068,1.0356174415807835,0.4444444444444444,1.0,1.0,5/15,20.37%,INPP5F;PLPPR4;PTEN;MTMR3;MTMR10
prerank,CellMarker_Augmented_2021__Lymphoid Stem cell:Peripheral Blood,-0.6381039698914268,-1.0355698630478387,0.4888888888888889,0.8839923638427046,1.0,1/6,1.09%,PSMA1
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,-0.5191684219312249,-1.0353061671431285,0.45614035087719296,0.884023743871541,1.0,2/21,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.6689755736496236,1.0352530244522247,0.45098039215686275,1.0,1.0,1/6,3.72%,MT2A
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4860744926816155,1.0352506614148689,0.37777777777777777,1.0,1.0,7/26,16.68%,MED4;CBFB;CCNC;MED15;ATF7IP;MED27;PTEN
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,0.6638988459288169,1.0352468026100574,0.42857142857142855,1.0,1.0,5/6,31.69%,TUBB4B;TUBA1B;TBCA;TUBB6;TUBB
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,-0.49292380869869545,-1.0351704779998043,0.4423076923076923,0.883645082880752,1.0,3/26,7.04%,PSMA1;PSMB9;ANAPC16
prerank,CellMarker_Augmented_2021__Hepatic Progenitor-Like cell:Pluripotent Stem Cell,0.578932291594832,1.0350049712863947,0.48936170212765956,1.0,1.0,2/12,7.97%,DUSP6;CYYR1
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.6175856401387622,1.0350035558156456,0.44,1.0,1.0,4/9,17.82%,NRXN1;IL1RAPL1;NLGN1;SPEN
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,0.4735083075820653,1.0346361751230735,0.4375,1.0,1.0,5/27,15.56%,PIK3CA;PIGU;FRS2;PPP2CB;GRB2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.6119008090493198,1.0346107403300733,0.423728813559322,1.0,1.0,4/10,22.97%,PLEKHA1;PHLPP1;PTEN;PPP2R5C
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.5276297183181899,-1.0345250954267802,0.46,0.8844960169286707,1.0,2/26,2.55%,TPM1;ITGB5
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5315475760776325,-1.0343428765580696,0.3888888888888889,0.8842321976333829,1.0,8/16,17.74%,ISG15;RFC3;TRIM25;MSH2;UBC;PRIMPOL;RFC1;POLK
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.6142948665335531,-1.034084078332563,0.4423076923076923,0.8841487635079576,1.0,4/12,17.88%,ATXN7;COL18A1;ZIC2;OPA1
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.6554760138058702,-1.0337162976284757,0.47368421052631576,0.8829526190956911,1.0,3/6,13.09%,RFC3;TOPBP1;ATM
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.6554760138058702,-1.0337162976284757,0.47368421052631576,0.8829526190956911,1.0,3/6,13.09%,RFC3;TOPBP1;ATM
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.6554760138058702,-1.0337162976284757,0.47368421052631576,0.8829526190956911,1.0,3/6,13.09%,RFC3;TOPBP1;ATM
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.5601393694136797,-1.0335006067162904,0.4117647058823529,0.8827807713238675,1.0,2/20,2.26%,PLCG2;PLK2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.5736006489693175,-1.0332567522372218,0.42857142857142855,0.8826336396829995,1.0,5/13,20.00%,PMAIP1;FHIT;MSH2;ZNF385B;DDX5
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.4845496866634201,-1.0331887458319118,0.45901639344262296,0.8820552554980511,1.0,7/44,10.12%,PSMA1;PSMB9;PLCG2;LCP2;NFKB1;BTNL9;INPP5D
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.4560251223183752,1.0330579422589568,0.325,1.0,1.0,10/45,12.83%,GRM5;CADM2;GRIA2;MAPK10;NRXN1;ZEB2;ADGRB3;RBFOX1;NRXN3;BAALC
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6408283300361035,1.033015334541593,0.48214285714285715,1.0,1.0,2/6,9.93%,ACTG1;ACTB
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.5960933880620901,-1.0329019862780668,0.39215686274509803,0.8820553587969809,1.0,1/9,6.83%,TAF1D
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.5885431451974402,-1.0328477851985056,0.5185185185185185,0.8815189911768545,1.0,4/14,6.56%,SLC16A2;SLCO1A2;SLC5A6;SLCO2B1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.47407173819105236,-1.0327732653434465,0.49056603773584906,0.8809347414574256,1.0,8/38,15.19%,STAT1;ITGB5;SERPINE1;SMAD3;UBC;ITGAV;RNF111;RHOA
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.59215816359331,1.0325075225116462,0.42105263157894735,1.0,1.0,8/14,23.29%,SLC2A13;RTN1;RTN4;EPHA4;ROCK1;RTN3;ROCK2;PICALM
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.5235210450897699,-1.0323856750126792,0.4262295081967213,0.881025001312014,1.0,4/30,4.04%,PPARG;FN1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.666629965830414,-1.0323775242200952,0.4666666666666667,0.880344756996526,1.0,3/8,4.17%,SLC6A6;SLC16A2;SLC5A6
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5015958185453997,1.0323660206632355,0.375,1.0,1.0,10/32,20.48%,PRKD1;TAF1;NLK;LRRK2;GALNT2;OXSR1;WNK1;PRKCA;ROCK1;DYRK1A
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.5852679427123177,1.0322058836061985,0.45652173913043476,1.0,1.0,3/10,9.96%,BCR;UGCG;CLIC4
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,0.4720938925366786,1.032012439724777,0.4444444444444444,1.0,1.0,15/43,17.74%,ITGA2;ITGA1;ALCAM;NCAM1;NRCAM;ITGA5;DPYSL2;RANBP9;CNTN1;AP2B1;HSPA8;NRP1;RPS6KA5;ANK2;ANK3
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.6784141109287004,1.0298499965515904,0.47368421052631576,1.0,1.0,3/6,17.80%,SKI;LEMD3;ACVR2A
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5904491641902406,-1.0298213759385448,0.4807692307692308,0.885734481756806,1.0,2/12,8.39%,VAV3;LARS1
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,-0.6470035729488051,-1.0297552466484072,0.47058823529411764,0.8852863859577919,1.0,3/6,11.61%,TPM1;DMD;VIM
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4693576752415805,1.029416915123743,0.4418604651162791,1.0,1.0,3/38,2.84%,ABL2;INPP5F;RALA
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.5506285567720769,-1.0292051145573846,0.42857142857142855,0.8858664120219886,1.0,1/20,0.90%,PSTPIP2
prerank,CellMarker_Augmented_2021__Eosinophil:Sputum,-0.5295412584003533,-1.0290983864227752,0.4423076923076923,0.885491670045923,1.0,2/18,7.28%,ITGB5;DSP
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.6386184215291937,-1.0288452973511644,0.4423076923076923,0.8853759867780998,1.0,3/8,17.08%,ISG15;UBC;CHFR
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5808580449301978,1.0287834953336066,0.41509433962264153,1.0,1.0,3/11,11.66%,YWHAB;YWHAZ;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5808580449301978,1.0287834953336066,0.41509433962264153,1.0,1.0,3/11,11.66%,YWHAB;YWHAZ;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.5435063723490154,-1.0282828802255135,0.40384615384615385,0.8860352811602238,1.0,2/20,3.45%,RREB1;CARMIL1
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,0.5752737678999934,1.028138479553568,0.4230769230769231,1.0,1.0,6/11,24.89%,YWHAB;YWHAZ;YWHAQ;YWHAG;AKT3;YWHAE
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.5562765115311682,-1.0276103378290218,0.46808510638297873,0.8868386988844967,1.0,1/15,0.56%,CYLD
prerank,Reactome_2022__APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,0.6611912951356729,1.027578065159638,0.5517241379310345,1.0,1.0,3/6,22.97%,PPP2CB;PPP2R5E;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.6778630080713453,1.0275441367912324,0.49230769230769234,1.0,1.0,1/5,6.14%,PKM
prerank,Reactome_2022__Kinesins R-HSA-983189,0.6130235402509655,1.0272249076884468,0.4,1.0,1.0,1/7,4.12%,KIF26B
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.5657971036142677,-1.0271516858130831,0.42857142857142855,0.8873427043805578,1.0,5/20,11.63%,TPM1;CXCL12;LAMA4;NID1;ADAMTS1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.4617167846810976,1.0271208806695726,0.34782608695652173,1.0,1.0,13/38,22.23%,ZBTB1;KDM4C;ERCC6;ACTB;KDM5A;INO80;ARID1A;BAZ1B;BAZ2A;JARID2;TOP1;HDAC4;BPTF
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.43358337467172053,-1.0270129782757584,0.3157894736842105,0.8869280154358679,1.0,1/69,0.13%,CD74
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.6661922350201708,1.026896664668751,0.5581395348837209,1.0,1.0,2/5,26.06%,ANXA2;RFTN1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.4470614098871369,1.0268934253727968,0.42857142857142855,1.0,1.0,8/32,17.24%,RALA;MICALL2;PARVA;S1PR1;NRP1;GRB2;THSD7A;ANXA1
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,0.5192927903320611,1.0264999743521288,0.38461538461538464,1.0,1.0,4/22,11.93%,NUP58;PKM;RANBP2;PPP2CB
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,-0.4938218078605759,-1.0263094098836103,0.42592592592592593,0.88789779740003,1.0,3/24,7.04%,PSMA1;PSMB9;ANAPC16
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.44983856571782416,1.0262153377674714,0.46153846153846156,1.0,1.0,9/42,16.15%,IL1R1;COL4A2;NTM;MPDZ;PTPN21;ADGRL2;PDZRN3;ANK2;PLPPR4
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,0.359216441234721,1.0258605606346578,0.4166666666666667,1.0,1.0,41/174,18.99%,ITPR3;ERBB4;COL4A2;YWHAB;RALA;NRG2;YES1;DUSP6;ITGA2;PIK3CA;HSPB1;PIGU;HSP90AA1;DIAPH1;TAB2;REST;PGR;ELMO1;DOCK3;GRB10;FRS2;ID3;RANBP9;RALB;PPP2CB;ITPR2;AP2B1;NRP1;ADAM10;RPS6KA5;GRB2;CDC42;CALM1;PSEN1;EP300;CYFIP1;TIAM1;WASF2;PRKCA;ROCK1;CRK
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6450944439670019,-1.0257152176314699,0.5217391304347826,0.8885444928372933,1.0,2/7,10.73%,IRF1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.5970724177447222,1.0255331009337891,0.45714285714285713,1.0,1.0,1/9,0.53%,PNP
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.5960153135620878,1.0253570531066603,0.5,1.0,1.0,7/13,28.45%,ROBO2;PTEN;PHLDB2;ROCK1;ROCK2;BCAS3;CORO1C
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.5304774919325305,1.025134001776501,0.45454545454545453,1.0,1.0,3/15,12.43%,NUP58;RANBP2;PHC2
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Fetal Kidney,-0.3465300360012541,-1.0247873774516847,0.4,0.8900577250709475,1.0,216/1465,15.46%,VCAM1;CD74;PARP14;SLFN12L;NR4A1;DDX60;CYLD;SAMD9L;BTG2;SLC6A6;FAM118A;KLHL20;LRPAP1;PSMA1;GBP1;IFIH1;ABCA5;XAF1;PSMB9;ISG15;APOL3;RPS12;POMP;MAP3K2;IRF2;PLCG2;KLF3;HMGN1;HLA-F;ITIH5;OPTN;HLA-B;IRF1;GMPS;HLA-C;UFL1;SPAG1;LYPLA1;RPL31;SHISA5;RNF213;ATP6V1E1;TNIP1;IL32;SP100;ZRANB2;RNF19A;PDXDC1;GABARAPL1;ARIH2;SPG7;ZC3HAV1;TNFSF10;TAP1;RPS18;NUB1;MTERF4;RPL34;TIE1;PABPC1;EIF2AK2;ARAP2;RPS8;LY6E;TRANK1;RPL15;CDC37;YTHDC1;NGLY1;CALCOCO2;RPS6;RPL7A;ARGLU1;SLFN5;RPL38;GBP4;PPP1R9A;TMEM30A;CDC14A;SMAD3;TAF1D;ZKSCAN1;ADSS2;PAXBP1;NFKBIA;ANAPC16;MYCBP2;FAM177A1;RPL23;GPCPD1;B2M;SLC2A3;NFKB1;STK39;LRRFIP1;EWSR1;CEP57;TCF25;SENP7;FOS;RPL30;FNBP1;CEBPZ;LARS1;COL18A1;TAOK3;TOPBP1;BHLHE40;CCDC88C;GOSR1;TANK;CD47;ERAP1;JUN;FRYL;STAT5B;VPS36;S100A6;DDX24;CAMKMT;HLA-E;PMAIP1;RPS28;SCLT1;MYL12A;SLC25A26;RPS19;POLR2A;CMPK1;PTMA;ITM2A;INPP5D;RPS7;BST2;AHI1;ARHGAP15;GLCCI1;SPPL2A;MAPKAP1;LBR;RPS14;WSB1;CD2AP;RAB1A;FHIT;MSH2;MTMR2;NDFIP1;CCDC91;RPS15;VIM;RSRP1;UBC;UBE2D2;DUSP5;UPF3A;RPL28;RPL10;USO1;RORA;STX17;SRPK1;SUCLG2;SMARCA2;SP110;SRGN;SRSF5;SMARCAD1;ZMAT3;KANSL1;ATM;RPL9;MLLT6;ZC3H7A;ANKRD44;SERBP1;HLA-A;TBK1;SYPL1;PRKRIP1;NMT2;SRRM1;PPP1R16B;ARL4A;PGK1;PDS5B;FBXO33;BRD7;PRKAR1A;ELOVL5;IREB2;IL18R1;NUP54;RIOK3;TRPC4AP;PPWD1;PDXK;RPL24;RPL37;LUC7L;CHST12;KLF12;STOM;PPA2;COX6C;FBXO9;FLNB;ACYP2;RHOA;ATF7IP2;SEC23A;EYS;XPC;CFDP1;PDE3B;N4BP1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6261867537603191,1.0244016467788142,0.5111111111111111,1.0,1.0,5/7,36.71%,IHO1;ZNF207;SMC6;SMC5;PUM2
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,-0.608128996562154,-1.0240531562210409,0.46808510638297873,0.891006728476622,1.0,4/7,24.83%,TSC22D1;HIF3A;EPAS1;PBX1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.49407211223518255,-1.0240045925362051,0.34,0.8904384101101492,1.0,1/28,1.01%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.6749346759696618,1.0237670575247706,0.5,1.0,1.0,2/5,20.11%,ANO6;RGCC
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5354914000474511,1.02335637679679,0.45454545454545453,1.0,1.0,4/20,17.24%,RALA;CLASP1;IL1RAPL1;ANXA1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.48578080970079907,1.0232337547899322,0.4489795918367347,1.0,1.0,6/18,16.15%,GRIA2;SNAP25;NTM;ADGRB3;ANK2;PLPPR4
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,-0.4184054968874838,-1.0228531757219652,0.3787878787878788,0.8926037673571123,1.0,15/138,8.98%,VCAM1;PSMA1;PSMB9;STAT1;FN1;IL32;NLRC5;MEF2A;SMAD3;NFKBIA;NFKB1;FOS;TANK;JUN;STAT5B
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.594403832751369,1.0222819841032071,0.425531914893617,1.0,1.0,8/11,22.90%,PRKX;ROBO2;FOXC1;ZBTB16;CEP290;C1GALT1;NIPBL;NF1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.570619508609975,-1.0221145150091464,0.45454545454545453,0.8936206307842431,1.0,1/11,4.75%,SLC38A3
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.4603513367330599,1.0215872325685114,0.4523809523809524,1.0,1.0,3/49,2.79%,TRIM5;MTDH;PRKD1
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,-0.5273673748780664,-1.0215356458557603,0.4339622641509434,0.8942838401897762,1.0,2/18,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5848554139356056,1.0215124595951337,0.4782608695652174,1.0,1.0,4/10,15.64%,PSMD14;EPHA4;PINK1;UBE3A
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.6379942085898918,1.0212113907426323,0.5,1.0,1.0,2/7,17.34%,HSP90AA1;CD81
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.6617690522389715,-1.0210673367610095,0.5,0.8945382554055865,1.0,2/5,26.27%,KPNB1;SREBF2
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,-0.47315708362721637,-1.0202055165372095,0.4074074074074074,0.8958707993358832,1.0,6/39,11.71%,OMD;HGSNAT;ALG11;ADAMTS1;GPC3;UBC
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.4587854717965953,-1.0201661208900494,0.4,0.8952853836130834,1.0,8/72,6.56%,VCAM1;LRATD1;CXCL12;OPTN;SMARCA1;GPM6A;TRANK1;SLCO2B1
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.6204427876929152,-1.0186892502194413,0.47619047619047616,0.8974329892118053,1.0,2/8,11.77%,UBC;UBE2D2
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.6204427876929152,-1.0186892502194413,0.47619047619047616,0.8974329892118053,1.0,2/8,11.77%,UBC;UBE2D2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.5500228589971089,1.018125203102529,0.5106382978723404,1.0,1.0,2/10,15.48%,PPP1R10;YLPM1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.6176396531777048,-1.0181243931726007,0.4222222222222222,0.8981140420167705,1.0,6/16,19.76%,SERPINE1;NFKB1;VIM;RHOA;MAPK14;ZFP36
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.5506277577625502,-1.0179803774637877,0.45,0.8977196966794224,1.0,3/14,8.42%,TLL1;COL8A1;COL18A1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4616398126081768,1.0179018140514469,0.3902439024390244,1.0,1.0,13/35,18.99%,PRKD1;PIK3CA;HSPB1;HSP90AA1;ELMO1;NRP1;CDC42;CYFIP1;RAC1;WASF2;ROCK1;PXN;CRK
prerank,PanglaoDB_Augmented_2021__Interneurons,0.4150700597464479,1.017845777677483,0.3695652173913043,1.0,1.0,14/62,13.49%,SRGAP1;GRM5;CADM2;GRIA2;SNAP25;FGF12;NRXN1;SLC16A1;TRIM9;ELMO1;ADGRB3;RBFOX1;CHN1;ADGRL2
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,-0.5372857029635878,-1.0176549346443968,0.45098039215686275,0.8978507891590711,1.0,2/18,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.60572925207937,-1.0168797241483318,0.4807692307692308,0.8989987353312867,1.0,2/6,13.71%,MTMR2;PPP1R16B
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.623307730801776,1.016640778627204,0.45,1.0,1.0,2/8,7.68%,PRKD1;AMBRA1
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.5134705680820191,-1.0166395867958977,0.4339622641509434,0.8991206953072814,1.0,3/22,7.04%,PSMA1;PSMB9;ANAPC16
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.5883903075775039,1.0163119673657137,0.5581395348837209,1.0,1.0,6/12,28.76%,YTHDF2;DIS3L2;SND1;XRN2;MTREX;HSPA1A
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.5154036002817837,-1.0159100418496732,0.4583333333333333,0.9002420833110343,1.0,3/20,7.04%,PSMA1;PSMB9;ANAPC16
prerank,Reactome_2022__TCR Signaling R-HSA-202403,-0.5123603307836899,-1.015899519384269,0.4915254237288136,0.8995701604594258,1.0,9/37,11.77%,PSMA1;PSMB9;PLCG2;LCP2;NFKBIA;NFKB1;INPP5D;UBC;UBE2D2
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.7044108994498597,1.0156921117012236,0.5490196078431373,1.0,1.0,3/6,16.49%,LRRC7;PPM1F;CALM1
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,0.4919463745882259,1.0156460753396028,0.4716981132075472,1.0,1.0,6/19,20.08%,DIAPH1;RAB7A;DIAPH2;CAPZB;AKAP12;ADD3
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.48731286111325406,-1.0154685764784386,0.5,0.8997389239270059,1.0,8/48,10.12%,PSMA1;PSMB9;PLCG2;VAV3;LCP2;NFKB1;BTNL9;INPP5D
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.5040973565674247,-1.0153030866902506,0.48148148148148145,0.8993612849767495,1.0,5/26,11.71%,ISG15;PRKN;NGLY1;PMAIP1;UBC
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.6700981209979704,1.0150982075465902,0.4897959183673469,1.0,1.0,1/5,4.78%,UGCG
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.5543600109758828,-1.0147677246997837,0.4339622641509434,0.8997988552032217,1.0,1/23,0.48%,NR4A1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5737837050574285,-1.0145149369701294,0.40816326530612246,0.8996825478348219,1.0,2/11,3.61%,IFI27;SP100
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.4605735861662196,-1.014012195050593,0.4166666666666667,0.9002613398293208,1.0,6/41,9.99%,CX3CL1;CARMIL1;PLXND1;KIDINS220;SCARF1;CAPRIN1
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,-0.6299341146177921,-1.0135370412585312,0.5217391304347826,0.9008392413745974,1.0,2/7,13.09%,PMAIP1;ATM
prerank,CellMarker_Augmented_2021__Endometrial Progenitor cell:Endometrium,-0.5121595383680891,-1.0132685300601008,0.4807692307692308,0.9007933646564071,1.0,1/11,2.20%,MLLT1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.5179223067629128,-1.013262214452314,0.46153846153846156,0.9001093896997662,1.0,7/22,17.24%,CLIC5;PPP1R9A;APCDD1;MCF2L;PDE9A;NEBL;ZNF423
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Liver,-0.4726473259229765,-1.013210070689844,0.45614035087719296,0.8995209355437633,1.0,6/52,6.56%,CLEC1A;ITIH5;CXCL12;TIE1;MMRN2;SLCO2B1
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.6648468889904758,1.0130290023293067,0.5283018867924528,1.0,1.0,4/7,32.35%,ERCC6;MTA3;RBBP4;H3-3B
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.5545266072447091,1.0129539669588608,0.5192307692307693,1.0,1.0,1/17,1.25%,CALR
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6307224956956639,-1.0128835853391926,0.48936170212765956,0.8996492392706671,1.0,1/6,1.57%,RIMS1
prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.3798924932267149,1.012754471809304,0.40625,1.0,1.0,25/108,17.03%,PSMD14;ITPR3;GRM5;VAPB;GRIA2;ATP2A2;MAPK10;TUBB4B;KRAS;PLCB1;AMBRA1;CAPN2;SEM1;CACNA1C;LRRK2;ITPR2;PPP3CA;UBE2J1;PPP3CB;PINK1;BCL2L1;ATG2B;CALM1;TUBA1B;PSEN1
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant R-HSA-2660826,0.6974810752216191,1.0126152611361263,0.5471698113207547,1.0,1.0,2/5,20.82%,ADAM10;ADAM17
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.5247068301482573,1.0123694412962043,0.4583333333333333,1.0,1.0,3/17,6.75%,ERBB4;GRM5;NCAM1
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.42283087269338837,-1.0122892073350278,0.46551724137931033,0.9003275823617372,1.0,10/105,5.87%,KLHL20;PSMA1;PSMB9;UFL1;RNF213;RNF19A;ARIH2;PRKN;HERC6;UBR2
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.4439714166362162,-1.0121095557389759,0.4918032786885246,0.8999916567243577,1.0,6/88,4.06%,KIAA1217;TPM1;ITGB5;OPTN;CLIC5;SMARCA1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.6183202887129684,-1.0120935064428465,0.40384615384615385,0.8993501541764883,1.0,1/11,2.07%,TMSB4X
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.6140875928953232,1.0120591049410945,0.425531914893617,1.0,1.0,5/10,17.77%,ELMO1;HACE1;CYFIP1;TIAM1;RAC1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.4787581498873168,-1.0116484660508078,0.4838709677419355,0.8998781628675074,1.0,10/42,17.64%,TMSB4X;FN1;CD109;SERPINE1;ACTN1;CLU;SRGN;PDGFB;FAM3C;STXBP1
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,0.3957189980370392,1.0115663100941148,0.4411764705882353,1.0,1.0,23/87,17.42%,PSMD14;ITPR3;PRKG1;BTRC;CTBP2;PLCB1;YWHAZ;TLE4;SEM1;NCOA3;XPO1;GNB4;NLK;PPP2CB;ITPR2;PPP3CA;AP2B1;PPP3CB;ZRANB1;SMURF2;CALM1;CREBBP;EP300
prerank,KEGG_2021_Human__Insulin signaling pathway,0.47355940634741595,1.0114666457336212,0.5,1.0,1.0,12/47,22.82%,INPP5A;MAPK10;KRAS;PIK3CA;PPP1CB;GRB2;CBLB;CALM1;CRK;PTPN1;HK1;AKT3
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.49730129203698514,-1.011004777850168,0.43478260869565216,0.9008128625289858,1.0,5/25,11.71%,SNX6;CD109;SMAD3;SNX25;UBC
prerank,CellMarker_Augmented_2021__Muscle Satellite cell:Muscle,0.5373416973421234,1.010531830831469,0.4772727272727273,1.0,1.0,8/18,26.22%,NCAM1;CAPN2;RBFOX1;BOC;ADGRG1;GSN;NAV1;VWA2
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6822604288686334,1.010507596093152,0.5813953488372093,1.0,1.0,2/5,21.65%,PLCB1;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.547332238589843,1.0103417840754534,0.5,1.0,1.0,4/15,16.52%,PKM;ITGA5;SMAD1;KLF2
prerank,CellMarker_Augmented_2021__Epithelial cell:Endometrium,0.6150064771605679,1.0102300382399156,0.48,1.0,1.0,3/6,30.33%,MLKL;FES;RAB27A
prerank,CellMarker_Augmented_2021__4-Cell Stage Cell (Blastomere):Embryo,-0.5358874094236382,-1.010215101871283,0.5510204081632653,0.9019262369509253,1.0,3/12,9.54%,GIT2;GEMIN5;ARHGAP17
prerank,KEGG_2021_Human__Complement and coagulation cascades,-0.5898076547208607,-1.0102137318907256,0.47058823529411764,0.9012539178855317,1.0,2/10,12.54%,SERPINE1;CLU
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.4976712161424682,1.0102110113455103,0.43137254901960786,1.0,1.0,7/19,15.41%,UBQLN1;ATP2A2;PACS2;AMBRA1;RAB7A;VMP1;ATG2B
prerank,KEGG_2021_Human__Rap1 signaling pathway,0.415082330742476,1.0101480245720451,0.4473684210526316,1.0,1.0,19/76,20.61%,PRKD1;RALA;ACTG1;ANGPT2;KRAS;PLCB1;PIK3CA;DOCK4;ACTB;RALB;PARD3;CDC42;CALM1;TIAM1;RAC1;PRKCA;CRK;ID1;MAGI1
prerank,Reactome_2022__Platelet Adhesion To Exposed Collagen R-HSA-75892,0.6876148332942315,1.0100490301118863,0.5,1.0,1.0,2/6,5.26%,ITGA2;ITGA1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6437373684899033,1.0099300002231226,0.5,1.0,1.0,5/8,25.18%,ANKH;S1PR1;ROCK1;ROCK2;NOS3
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.49072962132795955,-1.0098922233387337,0.3333333333333333,0.9013566626753267,1.0,3/28,5.05%,BTG2;CNOT8;EIF2AK2
prerank,KEGG_2021_Human__Systemic lupus erythematosus,-0.6221084547364126,-1.0096597234928395,0.5102040816326531,0.9013108111660608,1.0,1/7,10.70%,ACTN1
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.6091752035042092,-1.0094209644225054,0.5,0.9011479293191773,1.0,2/9,7.22%,SMAD3;MAML3
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5609373630601107,-1.009219182807027,0.4716981132075472,0.900938490770419,1.0,5/10,12.70%,FN1;ITGB5;COL8A1;DUSP5;ITGAV
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.5477134083687412,-1.0089207568043417,0.46,0.8996816604069101,1.0,2/16,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.5477134083687412,-1.0089207568043417,0.46,0.8996816604069101,1.0,2/16,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.5477134083687412,-1.0089207568043417,0.46,0.8996816604069101,1.0,2/16,1.51%,PSMA1;PSMB9
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5192030294982424,1.008493823849763,0.4,1.0,1.0,6/15,26.93%,ATN1;PDZRN3;ANK2;CTNND2;FGFR1;GALNT18
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.5875746097327248,-1.0081223727115158,0.4883720930232558,0.9007727413414384,1.0,3/8,19.23%,PRKN;CLU;PSMC6
prerank,Reactome_2022__S Phase R-HSA-69242,-0.46044083670836505,-1.008007260137596,0.44,0.9003856429784336,1.0,4/42,7.04%,PSMA1;PSMB9;RFC3;ANAPC16
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.5731389762570198,1.0079635670870581,0.42857142857142855,1.0,1.0,2/11,7.01%,SLC38A9;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4993588223978117,1.0077707519165207,0.5192307692307693,1.0,1.0,8/22,23.64%,BMP6;ZEB2;RBPMS;CREBBP;EP300;ACVR2A;ADAM17;HSP90AB1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5073705299862715,1.0076236408810817,0.45652173913043476,1.0,1.0,10/29,22.79%,PRKD1;TAF1;NLK;LRRK2;OXSR1;WNK1;PRKCA;ROCK1;DYRK1A;ROCK2
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6417546421332763,1.007526026848501,0.52,1.0,1.0,4/6,20.16%,CDC42;DIP2A;PTEN;CTNND2
prerank,Reactome_2022__CHL1 Interactions R-HSA-447041,0.641198280260594,1.0073851321997112,0.6078431372549019,1.0,1.0,4/7,14.26%,ITGA2;ITGA1;HSPA8;NRP1
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.6113507414824408,-1.0073824025020455,0.4489795918367347,0.9012571104871354,1.0,6/9,31.29%,ELOVL5;MFSD2A;LPGAT1;ZBTB20;MTOR;SORBS1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.4443770227475944,-1.007176313755122,0.41935483870967744,0.9010564577627214,1.0,6/46,11.55%,KLHL20;SNX6;SNX2;GOSR1;ANKFY1;CCDC91
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.5003010193560484,-1.0068398112992638,0.509090909090909,0.9011429904022635,1.0,2/27,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.4650536144438643,1.0067987242082932,0.425531914893617,1.0,1.0,9/23,20.08%,VAPB;CPNE8;DIAPH1;RAB7A;LEMD3;DIAPH2;CAPZB;AKAP12;ADD3
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,-0.6511335401461302,-1.0065037033999555,0.48936170212765956,0.9004718005516776,1.0,1/5,12.75%,CLTA
prerank,Reactome_2022__Gap Junction Degradation R-HSA-190873,-0.6511335401461302,-1.0065037033999555,0.48936170212765956,0.9004718005516776,1.0,1/5,12.75%,CLTA
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.5572475214929196,-1.0064033775749814,0.42,0.9000247925069902,1.0,2/16,1.51%,PSMA1;PSMB9
prerank,KEGG_2021_Human__Ras signaling pathway,0.41842644526841244,1.0063870653853006,0.45714285714285713,1.0,1.0,18/76,18.67%,ABL2;RRAS2;RALA;MAPK10;ANGPT2;KRAS;PIK3CA;ABL1;GNB4;RASA2;RALB;BCL2L1;GRB2;CDC42;CALM1;TIAM1;RAC1;PRKCA
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.5671256751575764,1.0059880246900694,0.5084745762711864,1.0,1.0,6/11,28.69%,ROCK1;ROCK2;TEK;CYRIB;BCAS3;ARFGEF1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.5935599404566685,1.0059109513242324,0.5660377358490566,1.0,1.0,3/7,26.08%,ZMIZ1;ARID1A;KDM3A
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6588461226996348,1.0058170640502198,0.5686274509803921,1.0,1.0,4/6,31.29%,ANK2;ANK3;AKAP6;KCNMB4
prerank,KEGG_2021_Human__Cholesterol metabolism,-0.6286503695397239,-1.0057308326949104,0.4444444444444444,0.9009235124119684,1.0,1/10,1.06%,LRPAP1
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.49345910351111344,-1.0053857574160652,0.4230769230769231,0.9010870631187181,1.0,6/36,8.07%,MX1;ISG15;STAT1;EIF2AK2;OAS3;TRIM25
prerank,KEGG_2021_Human__DNA replication,-0.6550144046826261,-1.0048891487756941,0.54,0.9016131401917209,1.0,1/5,4.59%,RFC3
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.46292496715302506,1.0048550959559122,0.425531914893617,1.0,1.0,7/25,16.68%,MED4;CBFB;SETX;CCNC;MED15;MED27;PTEN
prerank,CellMarker_Augmented_2021__Endothelial cell:Intervertebral Disc,-0.4807217438740971,-1.0046301718538246,0.5166666666666667,0.9013594373878495,1.0,5/41,9.27%,CLEC1A;ITIH5;TIE1;SLCO2B1;SCARF1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.6506717419143586,1.0046275668934117,0.5116279069767442,1.0,1.0,3/5,13.52%,AGTPBP1;NRXN1;GCH1
prerank,Reactome_2022__Glycolysis R-HSA-70171,0.5319862915586064,1.0044121448449306,0.4807692307692308,1.0,1.0,4/18,11.93%,NUP58;PKM;RANBP2;PPP2CB
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.6396579770982008,1.0043934771103398,0.5178571428571429,1.0,1.0,2/5,21.65%,WDR43;EIF2AK3
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.4383941406013985,1.004082987913656,0.4,1.0,1.0,4/35,3.53%,PDIA3;UBQLN1;HSP90B1;ATP2A2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5632235243180254,-1.0036243604105055,0.4583333333333333,0.9030251502203154,1.0,3/16,4.04%,FN1;CXCL12;LAMA4
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Kidney,0.47659154757781835,1.0035810949059196,0.4090909090909091,1.0,1.0,8/33,13.39%,NCAM1;NRXN1;ELMO1;RTN1;CELF2;DNMT3A;DPP10;PPP2R2B
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,0.5025530508340114,1.0035643481476788,0.4444444444444444,1.0,1.0,7/19,22.79%,ACTG1;YES1;CDC42;TIAM1;ROCK1;LIMK2;ROCK2
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,-0.5289217921963251,-1.0032127629033079,0.4716981132075472,0.9032713449522702,1.0,1/25,0.29%,SLC22A5
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5717187637521138,1.0030666413037852,0.42857142857142855,1.0,1.0,5/10,25.92%,GULP1;ELMO1;CDC42;GSN;MYH9
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.5849726173157891,-1.0029095434264397,0.5,0.9019100186988632,1.0,2/11,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,-0.5849726173157891,-1.0029095434264397,0.5,0.9019100186988632,1.0,2/11,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.5849726173157891,-1.0029095434264397,0.5,0.9019100186988632,1.0,2/11,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,0.5279083897056078,1.002550110167913,0.4339622641509434,1.0,1.0,5/18,17.42%,RARB;YY1;NCOA3;CREBBP;EP300
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.5007484935619341,-1.002290202371829,0.4807692307692308,0.9027168139125651,1.0,9/26,9.19%,PSMA1;PSMB9;ITGB5;HLA-F;HLA-B;HLA-C;TAP1;B2M;HLA-E
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,-0.44276721213075676,-1.0022240498656574,0.44776119402985076,0.9022180977731592,1.0,17/73,13.49%,STAT1;PLCG2;HLA-F;HLA-B;HLA-C;GABARAPL1;EIF2AK2;NFKBIA;NFKB1;FOS;JUN;HLA-E;GNG4;UBC;JAK2;HLA-A;TBK1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.4366214192708732,-1.002039653184097,0.5254237288135594,0.9019807930313725,1.0,9/72,10.73%,LRPAP1;RREB1;SHLD1;EIF2AK2;SERPINE1;SMAD3;TFRC;RPS19;APPL2
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6568350837722516,1.0018861794593572,0.509090909090909,1.0,1.0,3/6,22.10%,ANXA2;RALB;RAB3GAP2
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.4024145682363917,-1.0017194176106439,0.4838709677419355,0.9020043140007277,1.0,13/128,4.22%,KLHL20;PSMA1;PSMB9;ITGB5;HLA-F;HLA-B;HLA-C;UFL1;RNF213;RNF19A;ARIH2;PRKN;HERC6
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.4675647421067151,-1.001287018664257,0.41304347826086957,0.9022421455291408,1.0,4/33,9.72%,PPARG;FAM120B;NFKB1;EBF1
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,0.4403338533310241,1.0011546422038575,0.48717948717948717,1.0,1.0,11/39,18.67%,ITPR3;GRM5;PLCB1;PIK3CA;DGKI;GNB4;ITPR2;GRB2;ANXA1;EDN1;PRKCA
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,0.4477981338520837,1.0006259240857864,0.5,1.0,1.0,15/37,23.98%,ACTG1;AHCTF1;MRTFA;RANBP2;DIAPH1;XPO1;CLASP1;PPP2CB;DIAPH2;CDC42;TAOK1;CLIP1;PPP2R5E;PPP2R5C;FMNL2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.5001091732328835,-1.000355995411326,0.46153846153846156,0.9035429019801601,1.0,9/27,9.19%,PSMA1;PSMB9;ITGB5;HLA-F;HLA-B;HLA-C;TAP1;B2M;HLA-E
prerank,CellMarker_Augmented_2021__Pericyte:Subcutaneous Adipose Tissue,-0.4942101969902073,-1.0001852776936029,0.4915254237288136,0.9031753728761471,1.0,5/49,4.97%,CLEC1A;ITIH5;LAMA4;TIE1;MMRN2
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,-0.6356470425846543,-1.0001064903306347,0.5098039215686274,0.9028465816081411,1.0,3/5,20.98%,NFKB1;SUGT1;TXNIP
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,0.5012956806888735,0.9998353433776259,0.4339622641509434,1.0,1.0,5/16,18.67%,NUP58;RANBP2;LEMD3;NEK7;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.6555735684109636,0.9997090545401027,0.52,1.0,1.0,1/5,13.52%,GCH1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.6555735684109636,0.9997090545401027,0.52,1.0,1.0,1/5,13.52%,GCH1
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Embryonic Prefrontal Cortex,0.486261373235379,0.9995240292858492,0.4883720930232558,1.0,1.0,9/28,10.07%,CREB5;CLIC1;SNAP25;TUBB4B;NTM;HSPB1;NRXN1;ZEB2;RTN1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.6488794944711717,-0.9994745208204173,0.4583333333333333,0.9036402452029971,1.0,4/5,9.75%,OPTN;SERPINE1;RPL30;RPS19
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.4668643550421928,0.9994695722086648,0.39215686274509803,1.0,1.0,2/19,7.70%,NOVA1;NOVA2
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5318635043046323,0.9992747811079519,0.5,1.0,1.0,3/15,10.36%,ARHGEF4;CCDC88A;S1PR1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.5664839758928241,0.9991693204461989,0.45161290322580644,1.0,1.0,6/11,28.69%,ROCK1;ROCK2;GSN;CYRIB;BCAS3;ARFGEF1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.575509157332253,0.9987917907183403,0.5178571428571429,1.0,1.0,5/10,30.70%,LRRK2;ANK2;RYR2;UBAC2;HSPA5
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.6565715735727093,-0.9987371431399802,0.5614035087719298,0.9046081437482898,1.0,3/5,13.09%,RFC3;TOPBP1;ATM
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,-0.5527929084949816,-0.9985183460859868,0.38461538461538464,0.9044466845511226,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.5479433651877269,-0.9983331136713055,0.47058823529411764,0.9043463884476994,1.0,1/9,3.88%,MAP2
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.5869731715298981,0.9981914602179474,0.46153846153846156,1.0,1.0,2/11,7.46%,NUP58;RANBP2
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.5869731715298981,0.9981914602179474,0.46153846153846156,1.0,1.0,2/11,7.46%,NUP58;RANBP2
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Membrane,-0.4890429160810107,-0.99776791967667,0.4909090909090909,0.9051518038830605,1.0,4/46,5.60%,GBP1;LGALS3;CD109;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5998672840391244,0.9976636850585533,0.5961538461538461,1.0,1.0,1/6,8.61%,ERCC6
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.5614329772775022,0.9975680338472033,0.4339622641509434,1.0,1.0,5/10,17.56%,SLC38A9;CAPN2;CPEB3;KLF2;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.6024952192309599,-0.997553046981833,0.48936170212765956,0.9049598842211173,1.0,1/8,2.07%,TMSB4X
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.5791653311556759,0.997436839536391,0.4716981132075472,1.0,1.0,5/9,33.57%,CCDC186;LIMK2;KIF5B;RAB27A;SPG11
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.5279060828773464,-0.9973764852789867,0.5178571428571429,0.904639074433586,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Oral Keratinocyte Stem cell:Oral Mucosa,-0.5000990649569752,-0.9973229822098388,0.39622641509433965,0.9040302104028274,1.0,7/27,15.09%,KIAA1217;DSP;TFRC;LIMA1;NET1;FZD6;FLNB
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6369020141649557,0.9972581845474314,0.5714285714285714,1.0,1.0,2/6,14.34%,UGP2;GBE1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.5624371413842073,0.9972147147355739,0.5111111111111111,1.0,1.0,3/11,14.08%,PIK3CA;LRRK2;PINK1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5724377884293363,-0.9968010223153744,0.46,0.9045223992855249,1.0,4/12,21.99%,FHIT;N4BP1;RPL11;USP14
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.5170364880754991,-0.9967380402952449,0.5535714285714286,0.9039903380000054,1.0,1/22,0.24%,HES1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.6339771577837915,-0.9966964758708328,0.5172413793103449,0.9034060302778553,1.0,1/5,7.73%,STK39
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.5392959776744712,-0.9965742653948038,0.44,0.903057269212421,1.0,2/21,2.26%,PLCG2;PLK2
prerank,KEGG_2021_Human__Melanoma,0.4926296139202232,0.9957945771015664,0.5,1.0,1.0,6/22,25.82%,KRAS;PIK3CA;PTEN;CDK6;AKT3;FGFR1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.6070142164312053,-0.9956573460493053,0.5714285714285714,0.9044867682745309,1.0,2/8,10.07%,IFIH1;PARP9
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.5148071314919482,-0.9955690249001303,0.48,0.9040016573963896,1.0,1/14,1.01%,PPARG
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Peripheral Blood,0.5747949917052535,0.995489464803951,0.4716981132075472,1.0,1.0,1/12,1.06%,TSHZ2
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.41655926212826844,-0.9953189102765219,0.42857142857142855,0.9038798402112013,1.0,7/56,7.84%,PPARG;MLLT1;KLF3;CDK14;LMO2;NFKB1;EWSR1
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,0.4703565007914334,0.9952490430733681,0.44,1.0,1.0,5/25,9.43%,ERBB4;NRG2;PIK3CA;TAB2;PGR
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,0.4989058835887396,0.9950964316705485,0.5,1.0,1.0,2/15,2.05%,ITPR3;STIM1
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.5198183362381663,-0.994667793570065,0.4603174603174603,0.9046337907104242,1.0,8/34,14.45%,SLC6A6;SCN3A;SCN2A;TRPM6;NNT;TRPM3;ITGAV;TRPC4AP
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.6025361713148941,0.9946407608930528,0.5348837209302325,1.0,1.0,3/9,9.96%,BCR;UGCG;CLIC4
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.663133837582618,0.994618843951981,0.54,1.0,1.0,2/5,16.28%,EIF5;EIF4A2
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.6171102931537178,-0.9944393135368604,0.62,0.9044966026126156,1.0,1/8,3.51%,ATP6V1E1
prerank,Reactome_2022__Transport Of Organic Anions R-HSA-879518,-0.67424984001588,-0.9943634094759282,0.5833333333333334,0.903356702519019,1.0,3/6,6.56%,SLC16A2;SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.67424984001588,-0.9943634094759282,0.5833333333333334,0.903356702519019,1.0,3/6,6.56%,SLC16A2;SLCO1A2;SLCO2B1
prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.4009112542170993,0.9943007538668851,0.42857142857142855,1.0,1.0,9/84,7.01%,CREB5;PDIA3;IL1R1;CALR;ITPR3;IL6R;KRAS;PLCB1;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4642128821696423,0.9942533697718605,0.5128205128205128,1.0,1.0,9/31,18.59%,RALA;CCDC88A;PIK3CA;NRP1;CDC42;NLGN1;CYFIP1;RAC1;WASF2
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.5176948640631178,-0.9941812553492625,0.3958333333333333,0.9030702328586921,1.0,1/14,0.27%,TBX3
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.5555019147115727,-0.9940395785713765,0.38,0.9027841832418554,1.0,2/15,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.44089561716610687,0.9936953899124983,0.4,1.0,1.0,13/42,18.99%,ITPR3;ACTG1;YES1;PIK3CA;HSP90AA1;ABL1;ELMO1;ITPR2;GRB2;CDC42;CYFIP1;WASF2;CRK
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.6132708511054239,-0.9934188268357317,0.46,0.9036408323121495,1.0,3/9,8.42%,TLL1;COL8A1;COL18A1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6013851568090361,-0.9934126900785952,0.5094339622641509,0.9029868185045343,1.0,3/9,9.96%,MEF2A;POLR2A;PTMA
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.42984446610377036,0.9933540259453085,0.5,1.0,1.0,15/49,29.93%,PACS2;MAP7;TTC7A;DPP10;ANK2;CD81;ANK3;ROCK1;ROCK2;SMURF1;C2CD5;DPP6;TTC7B;TSPAN14;PACS1
prerank,KEGG_2021_Human__Melanogenesis,0.47236066077156924,0.9932561411616782,0.4375,1.0,1.0,7/29,18.67%,KRAS;PLCB1;CALM1;CREBBP;EP300;EDN1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.5056808203511439,-0.9930281687989996,0.46551724137931033,0.9032042258208108,1.0,6/18,12.54%,SERPINE1;B2M;APPL2;ANKFY1;GPC3;CLU
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,0.5460168358996182,0.992163612632606,0.5161290322580645,1.0,1.0,3/13,18.67%,PRKX;CALM1;PRKCA
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.39602505710011343,0.9920386527542632,0.5,1.0,1.0,20/71,23.48%,PRKD1;TAF1;MORC3;CSNK1G3;STK38L;PRKX;NLK;LRRK2;PINK1;RPS6KA5;WNK1;PRKCA;ROCK1;TOP1;DYRK1A;EIF2AK3;CAMK1D;ROCK2;AKT3;MAST2
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7001285284189378,0.9919936712050702,0.6428571428571429,1.0,1.0,3/5,21.57%,PLCB1;SMURF2;AGO2
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,-0.5433796611843915,-0.9919101401545312,0.5098039215686274,0.9049960038377012,1.0,2/18,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Epiblast cell:Embryo,-0.5500869126390007,-0.991823172572075,0.5370370370370371,0.9045297593125141,1.0,2/16,2.79%,SAT1;CXCL12
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.5508785821930597,0.9916061121051133,0.5,1.0,1.0,3/13,10.41%,NUP58;RANBP2;XPO1
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,-0.5542098094489826,-0.9912953440027833,0.49056603773584906,0.9049327535740387,1.0,2/15,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6645242600734906,0.9912711384092859,0.6037735849056604,1.0,1.0,3/5,25.82%,ADAM17;AKT3;FGFR1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.5241925508750918,0.9906419405627971,0.5217391304347826,1.0,1.0,3/19,7.78%,CCDC186;TRAK1;TRAK2
prerank,CellMarker_Augmented_2021__Endothelial cell:Peripheral Blood,-0.6591928993955516,-0.9903981999175778,0.5,0.9061806382417574,1.0,1/5,18.03%,CD34
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.45149514544195024,0.990093384608539,0.48,1.0,1.0,6/35,12.27%,BCL6;MT2A;CCDC85B;MT1M;RTN4;MT1E
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.5900752517564775,-0.9899082458452866,0.5238095238095238,0.9066566083368436,1.0,6/13,20.72%,SUN1;ATXN7;RPS19;NUP54;NUP98;SUN2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.43089391750928513,-0.9898696154212728,0.45614035087719296,0.9060933869355992,1.0,9/62,12.01%,CX3CL1;LRPAP1;MMRN2;GRB14;CD47;APCDD1;MTMR2;GPC3;SULF2
prerank,KEGG_2021_Human__Vitamin digestion and absorption,-0.6311257083362375,-0.9891617488737339,0.46296296296296297,0.9071137290846419,1.0,2/6,10.23%,SLC5A6;BTD
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.4756192652655525,-0.989102065352406,0.4642857142857143,0.9066032168614512,1.0,2/38,3.72%,CX3CL1;CASS4
prerank,KEGG_2021_Human__Lysosome,-0.5086247923866165,-0.9890787804504095,0.41818181818181815,0.9059816228488697,1.0,8/24,22.58%,HGSNAT;IGF2R;CLTA;ENTPD4;ARSG;AP4S1;LAPTM4A;AP1G1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.4535856364852253,-0.9890545223735914,0.5185185185185185,0.9054130782086879,1.0,1/44,1.04%,KLHL20
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.5481263754369298,0.9889970106000394,0.5652173913043478,1.0,1.0,4/12,20.37%,INPP5F;PTEN;MTMR3;MTMR10
prerank,CellMarker_Augmented_2021__Immature neuron:Undefined,0.5385821987609744,0.9889697408391698,0.4,1.0,1.0,3/10,9.06%,GRIA2;SNAP25;FRMD5
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.5907396645388624,0.988660070517026,0.5576923076923077,1.0,1.0,2/10,7.46%,NUP58;RANBP2
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.5907396645388624,0.988660070517026,0.5576923076923077,1.0,1.0,2/10,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.5907396645388624,0.988660070517026,0.5576923076923077,1.0,1.0,2/10,7.46%,NUP58;RANBP2
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.5907396645388624,0.988660070517026,0.5576923076923077,1.0,1.0,2/10,7.46%,NUP58;RANBP2
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.5907396645388624,0.988660070517026,0.5576923076923077,1.0,1.0,2/10,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.5907396645388624,0.988660070517026,0.5576923076923077,1.0,1.0,2/10,7.46%,NUP58;RANBP2
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.5292239886479988,0.9886092163724305,0.48936170212765956,1.0,1.0,6/13,21.78%,CNTN1;ADAM10;MIB1;PSEN1;ADAM17;ITCH
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.4958837186911572,-0.988549163410716,0.4528301886792453,0.9056642098467106,1.0,5/25,14.32%,STAT1;SERPINE1;SMAD3;UBC;RNF111
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,0.6204761779759022,0.9884465846004171,0.5813953488372093,1.0,1.0,2/7,15.46%,MCFD2;CD59
prerank,Reactome_2022__Abacavir ADME R-HSA-2161522,-0.6357310870148564,-0.9884280018167056,0.5952380952380952,0.9053645132574626,1.0,3/5,33.07%,ABCB1;ABCG2;PCK1
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Umbilical Cord Blood,0.4824669011784877,0.9884209463757836,0.5365853658536586,1.0,1.0,6/21,17.24%,CALR;FNDC3B;UBE2J1;VMP1;APPL1;ANXA1
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,-0.4776074037469032,-0.987810805947808,0.43636363636363634,0.9060092816857013,1.0,4/35,5.05%,MX1;ISG15;STAT1;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.46692753817166016,0.9877242481537915,0.46,1.0,1.0,2/18,7.70%,NOVA1;NOVA2
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.5207283606332757,0.9873253382846435,0.5636363636363636,1.0,1.0,3/16,10.65%,UIMC1;ERCC6;FAM168A
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.5586508942731038,0.9868659352648429,0.52,1.0,1.0,2/12,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.47829462064488326,0.9868550881307264,0.43478260869565216,1.0,1.0,7/20,18.57%,MCFD2;BET1;ANKRD28;TFG;CD59;PPP6R3;PPP6C
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.47829462064488326,0.9868550881307264,0.43478260869565216,1.0,1.0,7/20,18.57%,MCFD2;BET1;ANKRD28;TFG;CD59;PPP6R3;PPP6C
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.47829462064488326,0.9868550881307264,0.43478260869565216,1.0,1.0,7/20,18.57%,MCFD2;BET1;ANKRD28;TFG;CD59;PPP6R3;PPP6C
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.5460394259413511,0.9868423525511197,0.49056603773584906,1.0,1.0,5/11,22.90%,PLEKHA1;PIK3CA;PTEN;EDN1;NF1
prerank,Reactome_2022__Prolonged ERK Activation Events R-HSA-169893,0.5793175530876954,0.9865854432568593,0.627906976744186,1.0,1.0,2/9,10.81%,YWHAB;FRS2
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.5632023458368353,-0.9865814490923771,0.46808510638297873,0.9082278374697949,1.0,4/16,13.23%,STAT1;STAT5B;INPP5D;JAK2
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.5793904612924013,-0.9865561880827485,0.4883720930232558,0.9076226116812993,1.0,2/12,5.60%,RREB1;SERPINE1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.616039588900945,-0.9864888677888656,0.5454545454545454,0.9071666048904713,1.0,3/7,17.24%,CXCL12;GPC3;ZNF423
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.499608590887319,-0.9859309227434888,0.4838709677419355,0.9078304432233227,1.0,3/36,4.38%,CEMIP;PRKN;LGALS3
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.4595640711812907,-0.9859247217589082,0.5081967213114754,0.9071823764564537,1.0,2/34,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.6285252295284787,0.9856792936968654,0.49019607843137253,1.0,1.0,1/5,3.03%,HSP90B1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.5555258686542481,0.9856669773759714,0.574468085106383,1.0,1.0,3/16,19.39%,MICALL2;RAB7A;DENND1A
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.6564216260952314,0.9856196619404346,0.5833333333333334,1.0,1.0,2/5,16.68%,SETX;PTEN
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.3813658744693838,-0.9855829591194076,0.4691358024691358,0.9073049627407824,1.0,29/187,14.24%,CD74;CD99L2;TMSB4X;IRF2;PLCG2;FN1;IRF1;VAV3;CARMIL1;CD109;GRB14;SERPINE1;LCP2;DGKG;CD47;ITGA10;CBX5;RCOR1;INPP5D;ACTN1;GNG4;CLU;ITGAV;SRGN;GNA12;JAK2;GNA14;PRKAR1A;PDE9A
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.511438334695355,0.9854907039646891,0.4807692307692308,1.0,1.0,2/15,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.597012425643711,-0.9853832691995029,0.56,0.9070649781837614,1.0,1/8,3.93%,SNX6
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.5888566784706524,0.9853699420584999,0.5737704918032787,1.0,1.0,1/7,5.44%,RAB11FIP2
prerank,Reactome_2022__ARMS-mediated Activation R-HSA-170984,0.625852235903684,0.9851853764941351,0.52,1.0,1.0,1/5,2.12%,YWHAB
prerank,CellMarker_Augmented_2021__CD4+ Cytotoxic T cell:Liver,0.50227897845005,0.9850689905614859,0.4375,1.0,1.0,7/24,21.70%,SYNE2;PLEKHA1;ZEB2;SH3BP5;PXN;DSTN;ADGRG1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.5873973276990986,-0.985035039952221,0.5434782608695652,0.9071653010043831,1.0,3/8,15.51%,LARS1;ATM;SPAAR
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.4757087620894449,-0.984941590390211,0.5517241379310345,0.9067263635394311,1.0,2/28,1.89%,CX3CL1;APOL3
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.5563072219507219,-0.9847528666761011,0.5102040816326531,0.9065168325344332,1.0,2/14,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.5264519676501758,-0.9846170255234797,0.43636363636363634,0.9061453631380568,1.0,3/15,6.67%,MAP2;CTNNA2;MEF2A
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.5281418940372485,0.984526492991383,0.48214285714285715,1.0,1.0,6/12,14.21%,RALA;LRRK2;DDHD1;PINK1;MARCHF5;MFF
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6531235722888277,0.9845148881081893,0.56,1.0,1.0,4/5,28.50%,SKI;SORT1;MEF2C;AKAP13
prerank,Reactome_2022__Regulation Of PTEN mRNA Translation R-HSA-8943723,0.5637887543741689,0.9844031573851176,0.5283018867924528,1.0,1.0,2/9,21.57%,PTEN;AGO2
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,-0.5480279725421725,-0.9843774300696048,0.5102040816326531,0.9059586582650566,1.0,5/19,11.63%,TLL1;LAMA4;COL18A1;NID1;ADAMTS1
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.5900782870421224,0.9843099033722577,0.5208333333333334,1.0,1.0,3/8,16.92%,ABL1;EIF4A2;POT1
prerank,Reactome_2022__Signal Transduction R-HSA-162582,0.3085739142085249,0.984249977357824,0.46153846153846156,1.0,1.0,98/689,12.22%,PDK4;HDAC9;GFOD1;SMAD9;ARHGEF4;PSMD14;ABL2;RRAS2;SRGAP1;ITPR3;ERBB4;COL4A2;GRM5;RARB;YWHAB;PRKG1;VAPB;ATN1;RALA;ACTG1;IL6R;SLC38A9;FAM13B;ATP2A2;PRAG1;NRG2;YES1;KDM4C;DUSP6;ITGA2;CCDC88A;BTRC;AHCTF1;TPM4;OTUD7B;TRAK1;MRTFA;CPNE8;CTBP2;NCAM1;PLCB1;PIK3CA;YY1;PRKX;HSPB1;PIGU;RANBP2;DOCK4;HSP90AA1;SMAD6;TRAK2;LRRC7;DIAPH1;TAB2;CBFB;YWHAZ;REST;TLE4;TIAM2;ABL1;PGR;SEM1;ELMO1;DOCK3;ITGA5;GRB10;HDAC7;DGKI;NCOA3;S1PR1;ARHGAP31;XPO1;RTN4;KHDRBS3;FRS2;ARHGAP23;PPP1CB;ID3;GNB4;RANBP9;SPOPL;NLK;SMAD1;RASA2;RALB;NCOA2;YWHAQ;SMAD5;DST;CCNC;CLASP1;PPP2CB;CNTN1;LRRK2;ITPR2;RAB7A;PPP3CA;FOXO3
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,-0.4813490700596632,-0.9842434323478562,0.44642857142857145,0.9056175786730604,1.0,2/27,0.85%,CEMIP;OMD
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.6234244773048494,0.9839694807189755,0.6304347826086957,1.0,1.0,2/7,4.78%,ATP2A2;UGCG
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.4964108059610257,-0.9837714992911583,0.5192307692307693,0.9060422890054619,1.0,4/27,8.92%,LRPAP1;SP100;NFKBIA;JUN
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.4760275276912032,-0.9837469301521781,0.4318181818181818,0.9054295632467121,1.0,3/34,5.05%,BTG2;CNOT8;EIF2AK2
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.538099245395059,-0.9832840473948111,0.5471698113207547,0.9057141855731493,1.0,2/15,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.6434932042093634,-0.9831230342389166,0.5365853658536586,0.9054550290114098,1.0,2/6,17.32%,MVB12B;CDH13
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.4984478162575602,-0.9831010225078798,0.5384615384615384,0.9048220253727891,1.0,4/23,7.04%,PSMA1;PSMB9;CDC14A;ANAPC16
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.5705599619607864,0.9830014582736154,0.5192307692307693,1.0,1.0,3/9,23.61%,FGF12;ATP2B4;NEDD4L
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.4461555052826575,0.9829516824030312,0.5087719298245614,1.0,1.0,10/44,17.42%,BAG3;HSPH1;NUP58;RANBP2;HSP90AA1;ABL1;HSPA8;PINK1;CREBBP;EP300
prerank,KEGG_2021_Human__Glycerolipid metabolism,-0.5330157704735526,-0.982520985567327,0.5102040816326531,0.9055977397187086,1.0,5/11,19.87%,AGPAT3;DGKG;MGLL;DGKE;LCLAT1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.5869189622025722,0.98239318705378,0.5357142857142857,1.0,1.0,4/7,28.47%,YTHDF2;KHDRBS1;YTHDF3;HABP4
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,0.44600430004104297,0.9822475709135464,0.5,1.0,1.0,14/47,18.99%,ITPR3;PIK3CA;HSPB1;HSP90AA1;ELMO1;ITPR2;NRP1;CDC42;CALM1;CYFIP1;WASF2;PRKCA;ROCK1;CRK
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.47258223107204395,-0.9821425624435454,0.5081967213114754,0.9057495405124636,1.0,1/30,0.32%,CX3CL1
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,-0.5285427537070585,-0.9820488997593144,0.5098039215686274,0.9053373388957637,1.0,2/16,4.91%,CNOT8;PABPC1
prerank,CellMarker_Augmented_2021__Endothelial cell:Muscle,0.6237690418760101,0.9819835691106675,0.5737704918032787,1.0,1.0,1/5,6.75%,NCAM1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.6028732540458557,0.9819590033349728,0.4883720930232558,1.0,1.0,1/7,1.51%,INSIG1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.6014066455621614,-0.9818860761959017,0.5,0.9050501086856979,1.0,2/7,8.87%,CPQ;ERAP1
prerank,CellMarker_Augmented_2021__Purkinje cell:Brain,0.4114691425354218,0.981876320690593,0.4222222222222222,1.0,1.0,9/44,13.07%,ATN1;ATP2A2;PACS2;ABL1;MAP4;FAM168A;ARHGAP23;HERC2;SKI
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.47347539685393275,-0.9817534678034562,0.47368421052631576,0.9046463046500173,1.0,8/34,14.24%,ATP9A;PATJ;RAPGEF5;MYRIP;PPP1R9A;PIK3C2B;MCF2L;PDE9A
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.41586226774014556,0.9815961851600746,0.3829787234042553,1.0,1.0,24/52,26.40%,BCL6;CDH2;PDZD8;LARP4;ADGRB3;CLASP1;LRRK2;CHN1;EPHA4;MARCHF5;ZRANB1;CAPZB;TANC2;PHLDB2;PHIP;RC3H1;NF1;NEDD4L;FMNL2;CYRIB;ETS1;MARK2;EFNA5;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.6116619054025634,0.9815901419328114,0.5681818181818182,1.0,1.0,2/6,22.92%,SFSWAP;SRSF7
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6116619054025634,0.9815901419328114,0.5681818181818182,1.0,1.0,2/6,22.92%,SFSWAP;SRSF7
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.6236049802299758,-0.9806601872913357,0.5121951219512195,0.9065445437109745,1.0,2/10,4.83%,PPARG;NR3C2
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,-0.5186602754832813,-0.9805762833262557,0.5098039215686274,0.9060891435011137,1.0,2/25,4.94%,SLC22A5;ACSL4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6002944723227918,-0.9803252870432035,0.5660377358490566,0.9060502547803584,1.0,1/7,1.12%,GBP1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4771212644148083,0.9801689879275435,0.475,1.0,1.0,4/30,12.96%,PRPF8;HNRNPR;YTHDF2;DIS3L2
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,0.4177871681625701,0.9799012715560607,0.5111111111111111,1.0,1.0,16/63,17.64%,ERBB4;PIK3CA;YY1;HSP90AA1;CBFB;PGR;NCOA3;XPO1;GNB4;NCOA2;FOXO3;SMC1A;CALM1;CREBBP;EP300;NCOA1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.6449248052086556,0.979695559147636,0.5769230769230769,1.0,1.0,2/5,23.61%,WNK1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5506589586390409,0.9796331929262484,0.5,1.0,1.0,3/13,11.66%,YWHAB;YWHAZ;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.5729320079820666,-0.9796268677858958,0.5576923076923077,0.906711325550711,1.0,2/11,8.98%,STAT1;STAT5B
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.487239017684133,-0.9796217394366438,0.46551724137931033,0.9054461383698935,1.0,8/45,8.92%,PSMA1;PSMB9;PLCG2;VAV3;LCP2;NFKB1;FOS;JUN
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.487239017684133,-0.9796217394366438,0.46551724137931033,0.9054461383698935,1.0,8/45,8.92%,PSMA1;PSMB9;PLCG2;VAV3;LCP2;NFKB1;FOS;JUN
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.5194652017808773,-0.9795725495560308,0.48333333333333334,0.9049203804971191,1.0,2/21,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6588043665212919,0.9795675264363386,0.6,1.0,1.0,2/5,7.78%,TRAK1;TRAK2
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.45768922432228065,-0.979430797075978,0.4426229508196721,0.9047225178870586,1.0,7/45,12.72%,TMSB4X;FN1;CD109;SERPINE1;ACTN1;CLU;SRGN
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5794473685174956,0.9792178755950085,0.49019607843137253,1.0,1.0,3/9,20.96%,ABL1;NRP1;PTPN1
prerank,Reactome_2022__cGMP Effects R-HSA-418457,0.6417010221793741,0.9790746032321654,0.6111111111111112,1.0,1.0,1/6,2.18%,PRKG1
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.6417010221793741,0.9790746032321654,0.6111111111111112,1.0,1.0,1/6,2.18%,PRKG1
prerank,Reactome_2022__Josephin Domain DUBs R-HSA-5689877,-0.6402524213884405,-0.9787742379328151,0.58,0.9055783390844706,1.0,2/7,11.71%,PRKN;UBC
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.48327772114328094,-0.9785428258550027,0.4807692307692308,0.9054891865475037,1.0,4/25,7.09%,PSMA1;PSMB9;EIF2AK2;LMO2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5765311643035238,0.9784610743073419,0.5217391304347826,1.0,1.0,2/8,8.90%,GRM5;HOMER1
prerank,KEGG_2021_Human__Basal cell carcinoma,-0.5273803093461055,-0.9783423114464186,0.4909090909090909,0.905305850616368,1.0,6/13,23.11%,FZD6;POLK;APC;TCF7L1;GLI3;GADD45B
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.5118133351450445,-0.9781873164357703,0.5111111111111111,0.9049705353767905,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,-0.5559437859454597,-0.9779885327919208,0.5416666666666666,0.9040262344595713,1.0,2/15,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.5559437859454597,-0.9779885327919208,0.5416666666666666,0.9040262344595713,1.0,2/15,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5911385257294569,0.9774035543120468,0.5510204081632653,1.0,1.0,1/6,20.03%,TAOK1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6963590069779146,0.9767161067342224,0.6440677966101694,1.0,1.0,2/6,13.94%,PPHLN1;ATF7IP
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4671395592336323,0.9763358534268772,0.5,1.0,1.0,5/25,16.57%,PRKD1;HSP90AA1;FNIP2;PINK1;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.4847805427718563,-0.9761036988115381,0.5686274509803921,0.9075844834082765,1.0,8/24,16.31%,TPM1;CXCL12;CD47;ITGAV;ATM;JAK2;AFDN;PDGFB
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,-0.4696403578470966,-0.9755096895389452,0.4576271186440678,0.9082171954815171,1.0,7/43,12.72%,TMSB4X;FN1;CD109;SERPINE1;ACTN1;CLU;SRGN
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5352445718930565,-0.9751540988239777,0.46938775510204084,0.9082927743155985,1.0,2/12,4.01%,ARIH2;PRKN
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.5936770692233357,0.9741056826905893,0.5227272727272727,1.0,1.0,3/9,9.96%,BCR;UGCG;CLIC4
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,-0.6521773494239842,-0.9734627314199591,0.5434782608695652,0.9115950680887669,1.0,1/8,4.75%,SLC38A3
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.5166386309968933,-0.973427178223379,0.5,0.9110549953232601,1.0,4/19,12.70%,ITGB5;SMAD3;UBC;ITGAV
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.45758442941415534,-0.9733738241869662,0.52,0.9105084729262855,1.0,5/40,8.95%,BTG2;MAP2;GPM6A;PPP1R9A;FRYL
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.5017726919440689,0.9733102896828447,0.55,1.0,1.0,10/18,31.47%,YTHDF2;CPEB3;DIS3L2;ROCK1;RC3H1;ROCK2;TUT7;YTHDF3;GIGYF2;TUT4
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,0.5766669145632914,0.9731429470520675,0.5384615384615384,1.0,1.0,1/6,6.67%,CTDSP2
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.550518201398259,0.9730977814874759,0.5416666666666666,1.0,1.0,4/13,8.39%,GRIA2;SNAP25;ALCAM;NRXN1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Anterior Cruciate Ligament,-0.502580924017356,-0.9729213355481974,0.43636363636363634,0.9106974885194796,1.0,4/24,9.11%,FN1;COL8A1;SERPINE1;S100A6
prerank,KEGG_2021_Human__Pathways in cancer,-0.39256917804078156,-0.9728712135433965,0.5538461538461539,0.910252764120495,1.0,25/164,13.23%,HES1;PPARG;STAT1;PLCG2;FN1;CXCL12;LAMA4;CTNNA2;SMAD3;NFKBIA;NFKB1;LPAR6;FOS;JUN;STAT5B;PMAIP1;IFNGR2;ARHGEF11;MSH2;GNG4;LAMA2;ITGAV;FZD6;GNA12;JAK2
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.543074853449089,-0.972498580116086,0.5102040816326531,0.9103985327648535,1.0,2/16,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.43012172197277215,0.9724010672713282,0.5238095238095238,1.0,1.0,6/39,7.01%,INPP5F;PITPNM2;PLEKHA1;PI4KA;PLCB1;PIK3CA
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5928797922013436,-0.9723019289769975,0.5102040816326531,0.910141541830066,1.0,2/7,13.55%,CDA;PRKRIP1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5073524248603897,-0.9721143730827815,0.4727272727272727,0.9099136446391923,1.0,1/16,2.28%,SHLD1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.39390757504885665,0.9721100641027006,0.4864864864864865,1.0,1.0,3/45,2.79%,TRIM5;MTDH;PRKD1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.43415229958091484,-0.9721040806515522,0.5689655172413793,0.909312788243748,1.0,6/58,8.95%,BTG2;MAP2;GPM6A;PPP1R9A;TAOK3;FRYL
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.6600613115569101,0.9717394781439466,0.5869565217391305,1.0,1.0,2/5,23.61%,LRRK2;NEDD4L
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.48239655706127255,0.9716793409787363,0.5,1.0,1.0,7/27,16.15%,BAG3;GRIA2;NTM;RBFOX1;PDZRN3;ANK2;PLPPR4
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.49409502736764577,-0.9715273395407628,0.5370370370370371,0.9097959565688499,1.0,2/22,0.85%,CEMIP;OMD
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.6244000380049565,0.971118271847047,0.5370370370370371,1.0,1.0,4/6,26.40%,ADGRB3;SKI;SORT1;MEF2C
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,-0.49124750617942037,-0.9711071174264067,0.48936170212765956,0.909970208685444,1.0,6/18,25.26%,MYRIP;ERO1A;SLC30A7;EXOC1;SPCS3;EXOC6
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.5915748903097441,0.9710738645180111,0.5384615384615384,1.0,1.0,2/8,16.52%,SMAD6;KLF2
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.5156430432126174,-0.9707578136856408,0.5490196078431373,0.9100367666184618,1.0,5/23,10.09%,TPM1;MAP3K5;FOS;JUN;NET1
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,0.3596044458012261,0.9707354976845306,0.6,1.0,1.0,19/102,12.22%,PSMD14;ERBB4;YWHAB;IL6R;NRG2;DUSP6;NCAM1;PIK3CA;HSPB1;LRRC7;SEM1;NCOA3;XPO1;FRS2;PPP1CB;RANBP9;RASA2;PPP2CB;FOXO3
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.4465315253295539,0.9705650318105781,0.5,1.0,1.0,14/47,23.29%,ABL2;STK38L;HSP90AA1;URI1;ABL1;HSPA8;CHPT1;PINK1;ROCK1;PTPN1;ITCH;OPHN1;ROCK2;PICALM
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.45914276156891426,0.9704672069015989,0.5,1.0,1.0,6/25,15.64%,CRY1;UBQLN1;PIAS1;LRRK2;PINK1;UBE3A
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Peripheral Blood,0.569900456181716,0.9704371335676318,0.5535714285714286,1.0,1.0,2/10,7.52%,CLDND1;ENTPD1
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,0.4240655080022102,0.9703749557555258,0.5476190476190477,1.0,1.0,18/49,21.35%,TUBB4B;PCM1;AHCTF1;RANBP2;HSP90AA1;WAPL;XPO1;CLASP1;PPP2CB;SMC1A;NEK7;PRKCA;YWHAG;TAOK1;CEP290;CDK5RAP2;CLIP1;PPP2R5E
prerank,CellMarker_Augmented_2021__Bile Duct cell:Liver,0.5488812095907556,0.9703260732096286,0.5087719298245614,1.0,1.0,2/10,4.94%,ITGA2;SEMA3F
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.5360188951066309,0.9695553815138859,0.48148148148148145,1.0,1.0,3/11,15.83%,STIM1;HOMER1;ANK2
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.5481226649815043,0.9692217578414055,0.5102040816326531,1.0,1.0,3/10,15.56%,FRS2;PPP2CB;GRB2
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.5481226649815043,0.9692217578414055,0.5102040816326531,1.0,1.0,3/10,15.56%,FRS2;PPP2CB;GRB2
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.5481226649815043,0.9692217578414055,0.5102040816326531,1.0,1.0,3/10,15.56%,FRS2;PPP2CB;GRB2
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,0.5105306194524163,0.9690456958221836,0.49019607843137253,1.0,1.0,4/15,13.33%,UGP2;TPST2;MAT2A;PAPSS2
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.5209217966610211,0.9686238883350401,0.5121951219512195,1.0,1.0,2/14,17.42%,CBFB;EP300
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.5855018744731186,-0.9685800665535138,0.5192307692307693,0.9138613857634929,1.0,2/11,7.73%,SCN2A;STK39
prerank,CellMarker_Augmented_2021__Endothelial cell:Skin,-0.45318660829677365,-0.9680633559488795,0.5166666666666667,0.9142541936115105,1.0,5/40,9.27%,CLEC1A;TIE1;MMRN2;SLCO2B1;SCARF1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.616193547937413,-0.968019550648879,0.5178571428571429,0.913731457265968,1.0,1/8,4.28%,SPG7
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5247046658021504,0.9678416537621357,0.5178571428571429,1.0,1.0,2/11,7.78%,TRAK1;TRAK2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.566021724682101,-0.967565929217946,0.52,0.9140523741680963,1.0,2/12,4.01%,GBP1;PRKN
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Retina,0.5345575993173102,0.9675525422551595,0.5365853658536586,1.0,1.0,3/10,22.47%,FRMD5;FSCN1;TEAD1
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,-0.3890437681046097,-0.9675287053643047,0.49230769230769234,0.9135090904174076,1.0,14/99,11.71%,BTG2;PLK2;CNOT8;NDRG1;RFC3;BCL2L14;FOS;TOPBP1;JUN;PMAIP1;POLR2A;MAPKAP1;MSH2;UBC
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.5126320701064873,-0.9669317172730276,0.4583333333333333,0.9142077910482337,1.0,2/19,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,0.5021850984962674,0.9665774907536598,0.43478260869565216,1.0,1.0,8/24,20.66%,UGP2;TPST2;MAT2A;NCOA2;PAPSS2;NCOA1;MGST2;MAOA
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.6135464862698914,0.9663563611940384,0.5957446808510638,1.0,1.0,4/5,37.42%,IL1RAPL1;PPFIA1;PTPRD;PPFIA2
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,-0.5589453197676338,-0.9662259500532908,0.5333333333333333,0.9150552199570623,1.0,2/9,6.69%,AGPAT3;GPD2
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.548617754743234,0.9661541598139436,0.5714285714285714,1.0,1.0,3/10,18.19%,HSPG2;NRP1;UVRAG
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.5136157933598535,-0.965774827742494,0.48717948717948717,0.9153387081884623,1.0,1/10,7.04%,ANAPC16
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.5460795173769083,-0.9656884850253002,0.5306122448979592,0.9148885822624858,1.0,4/14,8.87%,CPM;CPQ;DMD;ERAP1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.585885033996086,0.9650700011414811,0.509090909090909,1.0,1.0,5/7,25.18%,KLF2;EDN1;ROCK1;ROCK2;NOS3
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.6553185107451392,-0.9650155794712444,0.5918367346938775,0.915783572003373,1.0,4/5,30.62%,ARHGAP17;ALS2;AUTS2;PIK3CB
prerank,CellMarker_Augmented_2021__Trophoblast cell:Placenta,0.43256827128208786,0.9648977043364708,0.4883720930232558,1.0,1.0,8/31,17.24%,COL4A2;HSPG2;ARHGAP23;ANXA2;EXT1;RAI14;CD59;ANXA1
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.5085287011295541,-0.9648541685957256,0.48148148148148145,0.9148419511772284,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.5085287011295541,-0.9648541685957256,0.48148148148148145,0.9148419511772284,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.5027538513146917,-0.9646189476558531,0.4716981132075472,0.9147057684966149,1.0,3/19,4.91%,PSMA1;PSMB9;PABPC1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.4142276232081678,-0.9640853953873484,0.5833333333333334,0.9150734504869296,1.0,9/69,8.31%,CX3CL1;PPARG;PLCG2;EIF2AK2;SMAD3;NFKBIA;NFKB1;TRIM25;TFRC
prerank,KEGG_2021_Human__Drug metabolism,-0.5563983296049847,-0.9639963963993985,0.5416666666666666,0.9146749982382345,1.0,3/9,9.93%,GMPS;CDA;CMPK1
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.4229215790786427,0.963897431076568,0.5476190476190477,1.0,1.0,8/57,11.45%,RRAS2;GRM5;RALA;KRAS;PLCB1;PIK3CA;DGKI;RALB
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",0.331193953930059,0.9637390044410831,0.5172413793103449,1.0,1.0,39/257,12.14%,GFOD1;ARHGEF4;ABL2;RRAS2;SRGAP1;YWHAB;VAPB;ACTG1;FAM13B;PRAG1;KDM4C;CCDC88A;AHCTF1;TPM4;TRAK1;MRTFA;CPNE8;PIK3CA;RANBP2;DOCK4;HSP90AA1;TRAK2;DIAPH1;YWHAZ;TIAM2;ABL1;DOCK3;NCOA3;ARHGAP31;XPO1;FRS2;ARHGAP23;PPP1CB;NCOA2;YWHAQ;DST;CLASP1;PPP2CB;RAB7A
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.31227763245410217,0.9636923984109793,0.6521739130434783,1.0,1.0,77/490,12.46%,CREB5;HDAC9;SMAD9;IRF2BP2;CRY1;TEAD4;TSHZ2;CALR;BCL6;ZBTB10;ERBB4;SOX5;FOXN2;UIMC1;MTDH;BACH2;AEBP2;ZBTB1;ZEB1;ZNF160;MED4;BICRAL;YAF2;KDM4C;PEX14;BRWD1;BTRC;PIAS1;GPBP1L1;PBX3;CNOT2;TRAK1;ST18;TRPS1;CCDC85B;CHD7;ZNF608;CTBP2;PLCB1;YY1;CBFA2T2;SMAD6;NFYC;URI1;SLTM;ZNF708;CBFB;ERCC6;KLF7;REST;ELF1;ZEB2;ABL1;PPM1F;PGR;ZNF704;ZMYND11;EPC2;TOX2;HIVEP1;ATP8B1;ZNF644;ZMIZ1;PSIP1;ID3;TFCP2;NLK;SMAD1;NCOA2;YWHAQ;ZNF706;SMAD5;CCNC;FOXO3;HSPD1;PHC2;KDM5A
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.5905141582338845,0.9635017935646123,0.6382978723404256,1.0,1.0,5/7,31.77%,INO80;SMC1A;ZNF207;TOP2B;LATS1
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Peripheral Blood,-0.44604533183799827,-0.9634594898444955,0.5396825396825397,0.9151767940803207,1.0,5/43,9.27%,CLEC1A;TIE1;MMRN2;SLCO2B1;SCARF1
prerank,CellMarker_Augmented_2021__Mitotic Arrest Phase Fetal Germ cell:Fetal Gonad,-0.3704166102688449,-0.9634156726047705,0.5616438356164384,0.9146372335767651,1.0,25/280,8.71%,HES1;TBX3;CYLD;ABCA5;ATP9A;ISG15;STAT1;PLK2;FN1;GMPS;NDRG1;VAV3;MAP2;SMARCA1;NR3C2;NGLY1;DENND2C;PPP1R9A;NFKBIA;MYCBP2;NFKB1;ZNF518A;LIMCH1;CCDC88C;TANK
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.5456152065919799,0.9631653481098745,0.5714285714285714,1.0,1.0,1/14,0.24%,HSD17B4
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Amniotic Membrane,0.4315422332423167,0.9631253080253884,0.5348837209302325,1.0,1.0,8/30,16.65%,COL4A2;IGFBP3;ALCAM;PARVA;ADGRL4;NRP1;CD59;HEG1
prerank,CellMarker_Augmented_2021__Dental Pulp cell:Dental Pulp,0.4315422332423167,0.9631253080253884,0.5348837209302325,1.0,1.0,8/30,16.65%,COL4A2;IGFBP3;ALCAM;PARVA;ADGRL4;NRP1;CD59;HEG1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.604510838573979,0.962969836963122,0.5818181818181818,1.0,1.0,2/6,10.49%,AHCTF1;RTN4
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.6515879281118705,0.9629344394254206,0.5909090909090909,1.0,1.0,4/6,29.69%,SKI;MEF2C;SVIL;MYL6
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.5736166720258904,-0.9628925407178532,0.5660377358490566,0.9150534697772367,1.0,2/8,12.93%,UBC;FZD6
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.5737461575435147,-0.962861478614615,0.5357142857142857,0.9144864596257629,1.0,2/8,20.56%,MTMR2;MSN
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.36116282271857403,0.9628265418693815,0.5135135135135135,1.0,1.0,22/118,18.75%,CALR;FOXN2;GRM5;YAF2;CCDC88A;GPBP1L1;CHD7;NFYC;ZNF708;REST;ABL1;NLK;NCOA2;FOXO3;TRIM22;RPS6KA5;BAZ2A;CREBBP;EP300;CYFIP1;ZNF280D;FOXC1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5629336989512262,0.9627486813253152,0.5833333333333334,1.0,1.0,6/10,21.25%,ATP2A2;CACNA1C;SLC8A1;ANK2;CALM1;RYR2
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,-0.5215114656457509,-0.9625198146416312,0.5769230769230769,0.9145277962619968,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Tooth,-0.5391186619944943,-0.9625055406183696,0.5636363636363636,0.9139266290824907,1.0,6/15,17.26%,GBP4;LCP2;ITM2A;ARHGAP15;PPP1R16B;GIMAP8
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.5832603445393234,-0.9623696203956508,0.5116279069767442,0.9136508188530621,1.0,3/8,18.03%,SERPINE1;PDGFB;CD34
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.42783972026015327,-0.9622896414488188,0.5076923076923077,0.9131286324254299,1.0,5/78,4.01%,CYLD;PSMA1;PSMB9;CDK14;PRKN
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Deciduous Tooth,-0.45565844602890077,-0.9622483813396542,0.5396825396825397,0.9125860273573618,1.0,5/46,6.99%,CLEC1A;ITIH5;TIE1;MMRN2;LCP2
prerank,CellMarker_Augmented_2021__Fibroblast:Undefined,0.5734499308953896,0.9622066136115073,0.5777777777777777,1.0,1.0,1/8,1.09%,IL1R1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.6329431982557685,-0.9618067070489498,0.5740740740740741,0.9129312668809064,1.0,1/9,5.60%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.5481563063644386,-0.9617842412301432,0.5227272727272727,0.912340291976015,1.0,2/11,3.88%,ATP9A;MAP2
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5517686014767414,0.9617663299290949,0.5102040816326531,1.0,1.0,4/12,17.80%,BMP6;SMAD6;RBPMS;ACVR2A
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.5288891948144777,-0.9616631750143794,0.4909090909090909,0.9120102676406062,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,-0.6281142539526849,-0.9616175692623986,0.5217391304347826,0.9114909931878716,1.0,2/5,12.70%,ITGB5;ITGAV
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,0.3256514431989629,0.9614605166885483,0.5757575757575758,1.0,1.0,33/226,16.49%,CALR;COL4A2;YWHAB;UBQLN1;RALA;COG6;HSP90B1;MCFD2;HSPH1;MAN1A2;KIF26B;AP1S2;SBF2;SGIP1;HSP90AA1;RALGAPB;YWHAZ;YWHAQ;RAB7A;BET1;DENND5B;AP2B1;GALNT2;HSPA8;TPD52L1;ANKRD28;TFG;CD59;GRB2;ANK2;CAPZB;COG5;CALM1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.4718299320732979,-0.9613970693091499,0.5636363636363636,0.9113375319087295,1.0,2/24,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Corneal Epithelium,0.5023246640381307,0.9608763286701231,0.54,1.0,1.0,3/14,21.43%,SEMA3F;ADGRL2;BOC
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Corneal Epithelium,0.5023246640381307,0.9608763286701231,0.54,1.0,1.0,3/14,21.43%,SEMA3F;ADGRL2;BOC
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Liver,0.5023246640381307,0.9608763286701231,0.54,1.0,1.0,3/14,21.43%,SEMA3F;ADGRL2;BOC
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Laryngeal Squamous Epithelium,0.5023246640381307,0.9608763286701231,0.54,1.0,1.0,3/14,21.43%,SEMA3F;ADGRL2;BOC
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.44379066375505466,0.9607878853842895,0.46511627906976744,1.0,1.0,4/31,4.78%,VAPB;PRKD1;KDSR;UGCG
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.6365625129725387,-0.9606887188539137,0.574468085106383,0.9122718219596747,1.0,1/5,2.79%,CXCL12
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,-0.592364797051103,-0.9605587202718248,0.5686274509803921,0.911879642345639,1.0,1/6,3.21%,CHKA
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,0.36772039671994955,0.9603234569729137,0.5294117647058824,1.0,1.0,15/79,11.93%,PSMD14;ERBB4;YWHAB;IL6R;NRG2;DUSP6;NCAM1;PIK3CA;LRRC7;SEM1;FRS2;PPP1CB;RANBP9;RASA2;PPP2CB
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.5115282863544053,0.9603203242031315,0.5294117647058824,1.0,1.0,2/14,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.43771051628165547,-0.9598590289896825,0.5,0.912791265317439,1.0,8/39,13.84%,PSMA1;PSMB9;NDRG1;SCN2A;PMAIP1;UBC;RORA;PGK1
prerank,KEGG_2021_Human__Peroxisome,0.4957765912624511,0.959834652555994,0.4594594594594595,1.0,1.0,4/15,11.55%,HSD17B4;PEX14;PEX5L;ACOX1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.4275897227937205,-0.9597534827565467,0.578125,0.9123782604491653,1.0,5/72,7.28%,HES1;ZIC1;SMARCA1;SMAD3;DSP
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.5834532039389746,-0.9596141775950425,0.5319148936170213,0.9120357915432618,1.0,1/16,2.42%,CNOT8
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.5664972190400419,0.9595394763393539,0.5769230769230769,1.0,1.0,2/11,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.6512379077633592,0.9590327602370791,0.5454545454545454,1.0,1.0,1/5,6.85%,PLCB1
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,0.462662027422572,0.9588214493235454,0.44680851063829785,1.0,1.0,6/24,21.57%,NUP58;RANBP2;HSP90AA1;DICER1;IPO8;AGO2
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.5479106243753782,0.9587925069731741,0.5,1.0,1.0,3/11,15.62%,NUP58;RANBP2;NEK7
prerank,CellMarker_Augmented_2021__Lymphoid-primed Multipotent Progenitor cell:Umbilical Cord Blood,-0.5316335392176694,-0.9587657614821989,0.5094339622641509,0.9132111581306461,1.0,7/18,18.03%,RNF213;CD47;EBF1;DENND11;ANKRD44;FGD6;CD34
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,-0.646487715649998,-0.9584280393582575,0.625,0.9133996550588572,1.0,1/5,13.84%,PGK1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.5382464802128377,-0.9583784138180811,0.5283018867924528,0.9128826161967669,1.0,4/16,11.71%,MAP3K5;NFKB1;CCDC88C;UBC
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.5439523146492725,-0.9580719081854849,0.52,0.9127989299105512,1.0,4/12,17.21%,RNF213;UBC;PGK1;KPNB1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4012914580510678,0.9578181008784271,0.4230769230769231,1.0,1.0,10/45,16.20%,SMAD9;SMAD6;ZMIZ1;NLK;SMAD1;SMAD5;GCNT2;SKI;PARD3;APPL1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.30655256318684726,0.9574268313177546,0.7307692307692307,1.0,1.0,75/514,12.67%,CREB5;HDAC9;SMAD9;IRF2BP2;JAZF1;CRY1;TEAD4;TSHZ2;MCPH1;CALR;BCL6;ZBTB10;SOX5;RARB;BMP6;MTDH;BACH2;AEBP2;ATN1;PRKD1;TAF1;ZBTB1;ZEB1;ZNF160;GABPB1;MED4;KDM4C;BRWD1;PIAS1;PBX3;OTUD7B;CNOT2;TRAK1;ST18;TRPS1;MRTFA;ZNF608;TET2;CTBP2;YY1;SMAD6;NFYC;URI1;SLTM;TAF3;CBFB;KLF7;REST;ELF1;ZEB2;ABL1;PGR;ZNF704;EPC2;TOX2;HIVEP1;NCOA3;SETX;CPEB3;ZNF644;ZMIZ1;PSIP1;ID3;TFCP2;DNMT3A;SMAD1;NCOA2;SMAD5;CCNC;MED15;PPP3CA;FOXO3;HSPD1;SS18;CRTC3
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.5728507915409661,-0.9571332956444616,0.49019607843137253,0.9141658387048421,1.0,1/8,1.57%,RIMS1
prerank,Reactome_2022__Regulation Of BACH1 Activity R-HSA-9708530,-0.6083904271566086,-0.9568638036625603,0.5576923076923077,0.9141232067506398,1.0,4/6,27.65%,UBC;MAFK;RPS27A;CUL1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5593404080347462,0.9566526866232359,0.6097560975609756,1.0,1.0,1/9,5.44%,RAB11FIP2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5582740288156726,0.9563172615149403,0.5918367346938775,1.0,1.0,5/9,17.18%,FGF12;CACNA1C;SLC8A1;ANK2;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.5493779808767991,-0.956147306387258,0.4807692307692308,0.9150138085999887,1.0,2/9,11.29%,PLK2;MTMR2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.32051427543041977,0.9561461988243881,0.7037037037037037,1.0,1.0,28/279,9.43%,TRIM5;AFF3;RBM20;NOVA1;CALR;BCL6;FOXN2;BMP6;TAF1;ACTG1;PTBP3;YAF2;KRAS;MBNL1;GPBP1L1;CHD7;YY1;UTY;YTHDF2;NOVA2;NFYC;ZNF708;HNRNPLL;LARP4;REST;ABL1;PPM1F;PGR
prerank,CellMarker_Augmented_2021__Granulosa cell:Fetal Gonad,-0.43816116846806835,-0.9559594144885493,0.5263157894736842,0.9147827587855739,1.0,11/43,13.84%,RPL31;RPL34;NFKBIA;NFKB1;TFRC;RPS28;PTMA;RPS14;GPC3;SRGN;PGK1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.418174888967267,-0.9558552639610375,0.5172413793103449,0.9143572946718728,1.0,12/90,13.60%,MX1;RIMS1;SUN1;IGF2R;FNBP1;TFRC;STAM2;UBC;USO1;CLTA;SPAST;DNM3
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4676959368661664,-0.9557377168403427,0.4909090909090909,0.9140714039663184,1.0,4/42,6.72%,GBP1;ISG15;OPTN;TMEM30A
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.5010547277294498,-0.9556726163851156,0.48214285714285715,0.9135844913374228,1.0,4/23,7.68%,PSMA1;PSMB9;NFKBIA;NFKB1
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,-0.5568074067996677,-0.9554021692923247,0.52,0.9134869022588724,1.0,2/11,4.91%,CNOT8;PABPC1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.6116729925652303,0.9553405741588104,0.6666666666666666,1.0,1.0,1/6,13.73%,MTHFD1L
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.5015101692653157,-0.9551354868427286,0.5102040816326531,0.9133963808944984,1.0,3/35,4.04%,ZIC1;CXCL12;LAMA4
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.4492919710235181,-0.9550115759550727,0.46551724137931033,0.9130772568247889,1.0,12/51,13.60%,PLCG2;NLRC5;MEF2A;NFKBIA;NFKB1;FOS;TANK;JUN;UBC;UBE2D2;TBK1;DNM3
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.6167043719883156,0.9549074263716746,0.6470588235294118,1.0,1.0,4/6,22.90%,DICER1;SKI;PARD3;NF1
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreas,-0.6229093196154702,-0.9545852541964771,0.5,0.9134719810146714,1.0,1/5,4.06%,SMARCA1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5507410813122101,0.9545103473092327,0.5370370370370371,1.0,1.0,4/8,32.64%,S1PR1;TEK;RBPJ;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.564161901240027,0.9544063201908192,0.574468085106383,1.0,1.0,3/7,31.98%,NRP1;DSCAM;GOLGA4
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.520981555898095,-0.9540718984116912,0.5555555555555556,0.9140322935029729,1.0,6/18,19.18%,SLC5A6;SLC2A3;BTD;PDXK;PCCA;CD320
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.587336163484837,-0.9539888556436318,0.5111111111111111,0.9135473772235289,1.0,4/8,17.88%,PRKN;TFRC;CLU;OPA1
prerank,Reactome_2022__Regulation Of IFNG Signaling R-HSA-877312,-0.5477730708512312,-0.9539340944372363,0.5238095238095238,0.913070026849522,1.0,3/10,13.23%,STAT1;IFNGR2;JAK2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.5378492516293969,0.9535324083497856,0.5238095238095238,1.0,1.0,3/14,9.08%,YAF2;PPP1R10;WAPL
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.485300108490411,-0.9533922340457898,0.4909090909090909,0.9135189544751586,1.0,3/29,6.00%,EML1;PLK2;SPC25
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.5690031729150999,0.9531333830416602,0.5192307692307693,1.0,1.0,1/9,0.96%,CRY1
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,0.5398896800472235,0.9529878682265407,0.5576923076923077,1.0,1.0,3/11,12.38%,STX8;STX2;BET1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5212173992136956,0.9528401268357813,0.5686274509803921,1.0,1.0,4/12,11.53%,CALR;KDM4C;CBFB;NCOA2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.5937509112627042,-0.9527782503503974,0.5849056603773585,0.9141674670987324,1.0,1/6,2.07%,TMSB4X
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.6153213074924061,0.9526366987415308,0.6274509803921569,1.0,1.0,1/6,6.11%,CHD7
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.4996179934269724,0.9525054373601711,0.48,1.0,1.0,2/15,7.46%,NUP58;RANBP2
prerank,Reactome_2022__Disease R-HSA-1643685,-0.3467706400352193,-0.9523775280055766,0.6296296296296297,0.9144218967508809,1.0,67/514,11.71%,SLC22A5;PARP14;NR4A1;OMD;PSMA1;IFIH1;PSMB9;ISG15;HGSNAT;RPS12;STAT1;PLCG2;PLK2;FN1;HLA-F;HLA-B;HLA-C;RPL31;RNF213;VAV3;ZC3HAV1;PATJ;RFC3;RPL34;EIF2AK2;RPS8;RPL15;CDC37;ALG11;RPS6;GEMIN5;RPL7A;RPL38;SMAD3;NFKBIA;ANAPC16;MAML3;RPL23;B2M;NFKB1;LRRFIP1;TRIM25;RPL30;TOPBP1;TANK;JUN;STAT5B;VPS36;HLA-E;MVB12B;RPS28;RCOR1;RPS19;POLR2A;PARP9;RPS7;MAPKAP1;RPS14;IFNGR2;MSH2;NRG3;STAM2;GNG4;RPS15;ADAMTS1;GPC3;UBC
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.5900098721493692,0.9520389201934327,0.6041666666666666,1.0,1.0,3/6,33.31%,DST;KIF5B;DYNC1H1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.49054772517184864,-0.9517972236368462,0.5357142857142857,0.9153860455999459,1.0,6/27,9.11%,MAP2;CTNNA2;NTNG1;ZDHHC17;MEF2A;S100A6
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.4729472340409958,-0.9513375672133828,0.5192307692307693,0.9157908768146272,1.0,9/34,17.80%,TMEM117;MAP3K5;SCN2A;ERO1A;PMAIP1;FHIT;ATM;DNAJC10;ZNF385B
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Foreskin,0.371743376341658,0.9512134988137222,0.5581395348837209,1.0,1.0,9/71,14.50%,AFTPH;PTBP3;GPBP1L1;STT3B;MON2;SPOPL;TMEM87B;VMP1;ADAM10
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.49207556015095244,-0.950856733382898,0.5625,0.9161607419098599,1.0,1/19,1.57%,RIMS1
prerank,CellMarker_Augmented_2021__Neural cell:Embryoid Body,0.5002987748134288,0.9508250357429097,0.5961538461538461,1.0,1.0,5/14,20.16%,MAPK10;NRXN1;ANK2;NLGN1;CTNND2
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,-0.4741438065752302,-0.9507685662545022,0.5161290322580645,0.9156907597847072,1.0,7/36,8.92%,CYLD;STAT1;PLCG2;IRF1;NFKBIA;NFKB1;JUN
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Jejunum,-0.5837535369860968,-0.9507434446406301,0.5909090909090909,0.9145122094017197,1.0,2/10,9.11%,LGALS3;S100A6
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Breast,-0.5837535369860968,-0.9507434446406301,0.5909090909090909,0.9145122094017197,1.0,2/10,9.11%,LGALS3;S100A6
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.45418815429826354,0.9506306272365211,0.5636363636363636,1.0,1.0,8/24,24.01%,UIMC1;PPP1R10;ERCC6;POT1;RNF168;RGCC;OTUD4;USP9X
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.6106973299799299,0.950574177806604,0.6491228070175439,1.0,1.0,3/7,22.97%,PPP2CB;PPP2R5E;PPP2R5C
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.6106973299799299,0.950574177806604,0.6491228070175439,1.0,1.0,3/7,22.97%,PPP2CB;PPP2R5E;PPP2R5C
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.5139726273134415,-0.9505319905451346,0.45098039215686275,0.9143120528134937,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Lung,-0.4515301206385338,-0.9503762769077788,0.5333333333333333,0.9139817951296749,1.0,5/50,8.84%,KIAA1217;PLK2;ITGB5;SERPINE1;PRSS23
prerank,PanglaoDB_Augmented_2021__Platelets,-0.44073808635929107,-0.9500575066424113,0.5471698113207547,0.9140085394599478,1.0,13/35,19.04%,CAVIN2;CD109;SERPINE1;LCP2;SLC2A3;ERO1A;HLA-E;SRGN;HLA-A;LRRC32;GIMAP8;MAPK14;WIPF1
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,0.4467714121085242,0.9499497393170848,0.5384615384615384,1.0,1.0,13/43,18.99%,ITPR3;PIK3CA;HSPB1;HSP90AA1;ELMO1;ITPR2;CDC42;CALM1;CYFIP1;WASF2;PRKCA;ROCK1;CRK
prerank,CellMarker_Augmented_2021__Clara cell:Undefined,0.39231990165378494,0.9495090201556143,0.575,1.0,1.0,12/60,19.02%,PRPF8;MGAT5;PI4KA;DOCK4;RALGAPB;TRIM9;FAM168A;ZMIZ1;ATG2B;WNK1;SPEN;SRRM2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.45997847338287623,-0.9490213182133713,0.5370370370370371,0.9154605372986988,1.0,2/26,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.558172705815384,0.9489074670107195,0.5918367346938775,1.0,1.0,5/11,28.07%,TLE4;CREBBP;EP300;CDC73;TCF7L2
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.5624006299186233,0.9484616800179212,0.6222222222222222,1.0,1.0,5/9,24.65%,DICER1;DIS3L2;SND1;AGO2;TUT7
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5691260739068574,0.9484236071203535,0.5178571428571429,1.0,1.0,5/9,23.29%,SLC2A13;RANBP9;EPHA4;ROCK2;PICALM
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.48028310261283536,-0.9482688082597197,0.5535714285714286,0.916335383222292,1.0,3/18,9.46%,TNFSF10;MAP3K5;PMAIP1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.5981783724701621,0.9479899240122344,0.6346153846153846,1.0,1.0,2/6,23.61%,WNK1;NEDD4L
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.5725559143866685,-0.947698993353374,0.5833333333333334,0.9168874310578191,1.0,8/11,28.37%,RPL7A;RPL10;RPL24;RPL11;RPL3;NPM1;RPL23A;RPL5
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.5584826533263063,-0.9474145399757123,0.5686274509803921,0.9171241650488632,1.0,2/8,14.10%,STK39;HECW2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5597234227415986,0.9469099707237866,0.576271186440678,1.0,1.0,5/8,23.64%,ZEB2;CREBBP;EP300;ADAM17;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5597234227415986,0.9469099707237866,0.576271186440678,1.0,1.0,5/8,23.64%,ZEB2;CREBBP;EP300;ADAM17;HSP90AB1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.5385330710308456,-0.946887919811058,0.5121951219512195,0.9177432927202337,1.0,7/23,19.31%,ATP9A;MAP2;MAPKAP1;HOMER2;STOM;STXBP1;KLHL5
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.5002199448282054,-0.9468681964963163,0.54,0.9171800853334487,1.0,2/25,6.77%,PPARG;SMAD3
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Eye,0.46166297259514927,0.9468580168751883,0.5348837209302325,1.0,1.0,5/21,15.88%,GRM5;GRIA2;FRMD5;CNTN1;IL1RAPL1
prerank,CellMarker_Augmented_2021__Epithelial cell:Amniotic Membrane,-0.6078255956899417,-0.9466923385989277,0.574468085106383,0.9168223773133102,1.0,2/7,7.28%,PATJ;DSP
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.5379506318306071,0.9466810526623699,0.5909090909090909,1.0,1.0,4/9,17.03%,CNTN1;ADAM10;MIB1;PSEN1
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,0.622740626561572,0.9462351607398105,0.6326530612244898,1.0,1.0,1/5,6.61%,PI4KA
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,0.40507560790886993,0.9456746963807193,0.5652173913043478,1.0,1.0,13/43,18.57%,COG6;MCFD2;BET1;ANKRD28;TFG;CD59;ANK2;CAPZB;COG5;ARF4;ANK3;PPP6R3;PPP6C
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.48477275072849,0.9456532617597473,0.5957446808510638,1.0,1.0,4/18,12.43%,NUP58;PIAS1;RANBP2;PHC2
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Brain,0.4360122599982141,0.9456274443475806,0.5,1.0,1.0,7/31,16.15%,COL4A2;PRKG1;NTM;BAALC;PDZRN3;ANK2;PLPPR4
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.4671648122416145,0.9453789019913373,0.4666666666666667,1.0,1.0,3/20,10.89%,CALR;ACTB;ANXA2
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.4933137573047455,-0.9451200267094161,0.5892857142857143,0.9196298381834767,1.0,2/18,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,0.5903304739220747,0.945037991458837,0.6551724137931034,1.0,1.0,3/8,22.97%,PPP2CB;PPP2R5E;PPP2R5C
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.47169621396925365,-0.9448648029326542,0.6037735849056604,0.9196117741624635,1.0,3/21,7.04%,PSMA1;PSMB9;ANAPC16
prerank,CellMarker_Augmented_2021__Platelet:Blood,-0.5210155090858123,-0.9444678102301501,0.54,0.9199002472118262,1.0,6/15,18.14%,CD109;CD47;ITGAV;LRRC32;PDGFB;BSG
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,0.4398517325830985,0.9442387395930448,0.5365853658536586,1.0,1.0,9/30,18.99%,ACTG1;YES1;ABL1;ELMO1;GRB2;CDC42;CYFIP1;WASF2;CRK
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,-0.4888966684409813,-0.9442150362547057,0.5714285714285714,0.9198207657913604,1.0,2/22,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Interstitial cell:Bladder,0.43184055196455984,0.9440267502043375,0.5853658536585366,1.0,1.0,12/37,19.26%,COL4A2;CDH2;PRKD1;KHDRBS3;MPDZ;CHN1;ADGRL2;ANK2;NLGN1;NECTIN3;KCNT2;AKAP12
prerank,CellMarker_Augmented_2021__Mesothelial cell:Lung,0.43184055196455984,0.9440267502043375,0.5853658536585366,1.0,1.0,12/37,19.26%,COL4A2;CDH2;PRKD1;KHDRBS3;MPDZ;CHN1;ADGRL2;ANK2;NLGN1;NECTIN3;KCNT2;AKAP12
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Germ,0.43184055196455984,0.9440267502043375,0.5853658536585366,1.0,1.0,12/37,19.26%,COL4A2;CDH2;PRKD1;KHDRBS3;MPDZ;CHN1;ADGRL2;ANK2;NLGN1;NECTIN3;KCNT2;AKAP12
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.4247078753409021,-0.9438304222476541,0.5573770491803278,0.9200270892445386,1.0,9/55,12.72%,RIMS1;TMSB4X;FN1;CD109;SERPINE1;ARHGAP17;ACTN1;CLU;SRGN
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5709658171636836,0.943772802100271,0.559322033898305,1.0,1.0,5/9,30.78%,YTHDF2;ROCK1;ROCK2;YTHDF3;GIGYF2
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.4462092342688482,0.9434866087901356,0.56,1.0,1.0,10/34,23.32%,CALR;PRKD1;ABL1;NRP1;RAC1;EDN1;PRKCA;ROCK2;NF1;TEK
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.44351400969649,0.9431258260572992,0.5882352941176471,1.0,1.0,6/33,12.54%,BTRC;HSP90AA1;LARP4;SAMD4A;CPEB3;EIF3E
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",-0.6025986139367916,-0.9427161642567025,0.5918367346938775,0.9217286684944461,1.0,2/6,19.60%,ADSS2;RIMKLB
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6062292137507795,-0.9426833545538565,0.575,0.9211929790995549,1.0,2/5,9.46%,TNFSF10;PMAIP1
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.5829548967482399,-0.9424158462646705,0.5490196078431373,0.9210789082272324,1.0,3/8,13.68%,RGS6;GNG4;GNA14
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5580394005026366,0.9423898051330736,0.5,1.0,1.0,5/9,36.60%,KLF2;HSPA5;ATF6;RBPJ;ATF3
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,0.36916440548799473,0.9422356812796199,0.5789473684210527,1.0,1.0,12/81,13.47%,ARHGEF4;ABL2;SRGAP1;FAM13B;PIK3CA;DOCK4;TIAM2;DOCK3;ARHGAP31;ARHGAP23;RAB7A;LEMD3
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.47303763343413957,0.9420731987412545,0.5319148936170213,1.0,1.0,7/21,25.82%,LRRK2;TPD52L1;EDN1;CDK12;PTPN1;NF1;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.5025316007101839,0.9420644980645314,0.5961538461538461,1.0,1.0,4/12,18.19%,KATNBL1;ANXA2;ANXA1;UVRAG
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.4009463997063106,0.9420032150101219,0.4782608695652174,1.0,1.0,19/48,25.18%,MAPK10;KRAS;PLCB1;PIK3CA;S1PR1;PPP2CB;PPP2R2B;NSMAF;PTEN;SPTLC1;RAC1;PRKCA;ROCK1;PPP2R5E;ROCK2;AKT3;PPP2R5C;GNAQ;NOS3
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.6323787170019899,0.9418770115064627,0.6382978723404256,1.0,1.0,3/5,20.56%,SERINC1;SPTLC1;MGST2
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.5970724840074635,0.9417268390979525,0.5849056603773585,1.0,1.0,1/6,3.03%,HSP90B1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.48064624834270714,-0.9414367376048872,0.4897959183673469,0.9222879408656036,1.0,7/24,20.29%,TNFSF10;MAP3K5;PMAIP1;DELE1;CARD8;MAP2K5;NOD1
prerank,Reactome_2022__Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,0.5894245639355754,0.9413876885526898,0.574468085106383,1.0,1.0,1/6,4.01%,NRG2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5758113888579146,-0.9413394925169236,0.5102040816326531,0.9219631205389339,1.0,3/9,21.67%,POLR2A;ZFP36;IFITM3
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,0.3237229025084899,0.9412829850089826,0.6896551724137931,1.0,1.0,37/252,12.14%,GFOD1;ARHGEF4;ABL2;RRAS2;SRGAP1;YWHAB;VAPB;ACTG1;FAM13B;PRAG1;KDM4C;CCDC88A;AHCTF1;TPM4;MRTFA;CPNE8;PIK3CA;RANBP2;DOCK4;HSP90AA1;DIAPH1;YWHAZ;TIAM2;ABL1;DOCK3;NCOA3;ARHGAP31;XPO1;FRS2;ARHGAP23;PPP1CB;NCOA2;YWHAQ;DST;CLASP1;PPP2CB;RAB7A
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,-0.45207391181623313,-0.9411349561089651,0.5510204081632653,0.9217132588138904,1.0,3/29,10.62%,PPARG;SLC2A3;LBR
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5261918085010187,-0.9403550850843234,0.5471698113207547,0.9226824957840458,1.0,3/11,11.71%,CDC14A;ANAPC16;UBC
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.48016784968375203,0.9401136503103968,0.49122807017543857,1.0,1.0,7/20,14.93%,SMAD9;SMAD6;SMAD1;SMAD5;SKI;LEMD3;SMURF2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3212105022744658,0.940018109834905,0.6470588235294118,1.0,1.0,27/199,9.14%,HDAC9;IRF2BP2;JAZF1;CRY1;MCPH1;CALR;BCL6;RARB;BMP6;MTDH;ATN1;BAG3;TAF1;ZBTB1;ZEB1;OTUD7B;CNOT2;TRPS1;ZNF608;CTBP2;YY1;URI1;TAF3;CBFB;KLF7;REST;ZEB2
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Corpus,-0.5039414386245015,-0.9396719136132007,0.6153846153846154,0.9234948252281674,1.0,1/21,0.93%,KIAA1217
prerank,CellMarker_Augmented_2021__Ectoderm cell:Germ,0.4575570016761517,0.9396272463008465,0.5925925925925926,1.0,1.0,6/24,22.07%,NCAM1;RTN1;CELF2;CREBBP;HDAC4;INPP4A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovial Fluid,0.44911242127468926,0.9395833799600625,0.5918367346938775,1.0,1.0,8/28,17.24%,IL1R1;IGFBP3;ARHGAP31;ADGRL4;MT1E;CD59;HEG1;ANXA1
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone,0.44911242127468926,0.9395833799600625,0.5918367346938775,1.0,1.0,8/28,17.24%,IL1R1;IGFBP3;ARHGAP31;ADGRL4;MT1E;CD59;HEG1;ANXA1
prerank,CellMarker_Augmented_2021__Amniotic Fluid Stem cell:Amniotic Fluid,0.44911242127468926,0.9395833799600625,0.5918367346938775,1.0,1.0,8/28,17.24%,IL1R1;IGFBP3;ARHGAP31;ADGRL4;MT1E;CD59;HEG1;ANXA1
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.5823952552146765,0.9395379184101138,0.5714285714285714,1.0,1.0,4/7,22.79%,CBFB;KLF7;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.6398441543934029,0.9394917258674269,0.6326530612244898,1.0,1.0,2/5,20.48%,ABL1;DYRK1A
prerank,Reactome_2022__p75NTR Recruits Signaling Complexes R-HSA-209543,-0.629939509110274,-0.9394756836162325,0.5833333333333334,0.9233188300573061,1.0,3/6,26.51%,UBC;SQSTM1;RPS27A
prerank,Reactome_2022__Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,-0.6067810642990714,-0.9394473490171552,0.5238095238095238,0.922744370917314,1.0,1/7,2.12%,STAT1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.391879770772697,0.9393426888833757,0.5,1.0,1.0,20/70,23.48%,PRKD1;TAF1;MORC3;CSNK1G3;STK38L;PRKX;LRRK2;GALNT2;PINK1;RPS6KA5;WNK1;PRKCA;ROCK1;TOP1;DYRK1A;EIF2AK3;CAMK1D;ROCK2;AKT3;MAST2
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.48793397801925487,-0.9388508114129156,0.509090909090909,0.9220708810921501,1.0,3/29,2.23%,PSMA1;PSMB9;PLCG2
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.48793397801925487,-0.9388508114129156,0.509090909090909,0.9220708810921501,1.0,3/29,2.23%,PSMA1;PSMB9;PLCG2
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.48793397801925487,-0.9388508114129156,0.509090909090909,0.9220708810921501,1.0,3/29,2.23%,PSMA1;PSMB9;PLCG2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Corneal Endothelium,0.40183028088193923,0.9385814868599123,0.47368421052631576,1.0,1.0,12/40,17.24%,COL4A2;TRAM2;TPM4;CAPN2;ITGA5;CLIC4;ANXA2;FNDC3B;NRP1;ANO6;HEG1;ANXA1
prerank,CellMarker_Augmented_2021__Mast cell:Kidney,-0.49237714650207665,-0.9385777697092649,0.543859649122807,0.922017716013252,1.0,6/22,15.33%,ACSL4;CPM;NFKBIA;CST3;CLU;TSC22D1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.41518424728408576,0.9384119874416577,0.5227272727272727,1.0,1.0,10/44,15.91%,PRKD1;FAM174B;YWHAZ;HACE1;ATP8B1;CLASP1;LRRK2;BET1;VMP1;CDC42
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5383987860481096,-0.9383983409954627,0.5714285714285714,0.9217827657145189,1.0,3/12,15.19%,VAV3;LARS1;RHOA
prerank,Reactome_2022__CaM Pathway R-HSA-111997,0.5469651865950931,0.9383745888027927,0.576271186440678,1.0,1.0,3/11,18.67%,PRKX;CALM1;PRKCA
prerank,CellMarker_Augmented_2021__Type I pneumocyte:Undefined,-0.5132335516768117,-0.9382735090068396,0.6,0.9214808142277927,1.0,2/20,7.28%,KIAA1217;DSP
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.6393361935981772,0.9379583430989392,0.6976744186046512,1.0,1.0,1/5,18.11%,AGPS
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colon,0.5991088282421334,0.9379047261472583,0.5740740740740741,1.0,1.0,1/5,6.43%,ALCAM
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.5216694077322752,0.9373796984372094,0.5625,1.0,1.0,5/13,28.07%,TLE4;CREBBP;EP300;CDC73;TCF7L2
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5610734404012145,0.9372307197992475,0.5510204081632653,1.0,1.0,2/6,24.25%,CPT1A;ACACA
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,0.4713019152501796,0.9371306441565518,0.45098039215686275,1.0,1.0,8/21,20.98%,TUBB4B;PCM1;HSP90AA1;CLASP1;PRKCA;YWHAG;CEP290;CDK5RAP2
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,0.4713019152501796,0.9371306441565518,0.45098039215686275,1.0,1.0,8/21,20.98%,TUBB4B;PCM1;HSP90AA1;CLASP1;PRKCA;YWHAG;CEP290;CDK5RAP2
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,0.4564573750203105,0.9369705795386036,0.5294117647058824,1.0,1.0,6/22,20.82%,PIK3CA;PIGU;ADAM10;GRB2;CDC42;ADAM17
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.4559312488936118,-0.9365873104584925,0.6078431372549019,0.924428176806011,1.0,5/38,3.24%,CX3CL1;CYLD;TMSB4X;IRF1;UFL1
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,0.5215654799099338,0.9364093247777814,0.5686274509803921,1.0,1.0,4/13,9.43%,ERBB4;NRG2;TAB2;PGR
prerank,Reactome_2022__Gastrulation R-HSA-9758941,-0.6459552336846524,-0.9360241342690208,0.5531914893617021,0.9250122087258279,1.0,1/5,6.77%,SMAD3
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.5219236779546672,-0.9359596960558305,0.5476190476190477,0.9244870505363009,1.0,4/20,9.46%,DENND3;PRKN;NGLY1;PMAIP1
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,-0.4772973447647289,-0.9358674991696532,0.5263157894736842,0.9240431397091416,1.0,6/24,11.77%,PSMA1;PSMB9;NFKBIA;NFKB1;UBC;UBE2D2
prerank,Reactome_2022__Neddylation R-HSA-8951664,-0.41698611499135346,-0.934787254269552,0.5625,0.9254447683697965,1.0,4/60,4.54%,KLHL20;PSMA1;PSMB9;NUB1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.5559657761692586,0.9347386950000354,0.5862068965517241,1.0,1.0,8/11,41.81%,CCM2;RASA1;ADM;TGFBR3;RASIP1;ENG;SPRED1;SOX18
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.47473200415454425,-0.9346928199672324,0.5,0.9249739936337361,1.0,4/25,7.09%,PSMA1;PSMB9;EIF2AK2;LMO2
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,0.47198045682468937,0.9344995021864791,0.4772727272727273,1.0,1.0,6/25,16.49%,PIK3CA;HSP90AA1;XPO1;GNB4;FOXO3;CALM1
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreas,-0.4672776725400539,-0.9342008039642375,0.5714285714285714,0.9255088604495715,1.0,4/30,16.20%,MAP2;LIMCH1;SHROOM2;TJP1
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,-0.4666853758055415,-0.9341002505226901,0.5576923076923077,0.9250721374843606,1.0,6/30,3.19%,PSMA1;PSMB9;ITGB5;HLA-F;HLA-B;HLA-C
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.39114935233517517,-0.9340803856303007,0.5964912280701754,0.9244954641294717,1.0,10/104,12.40%,CD74;SNX6;CDC37;RANBP17;VPS36;APPL2;RAB1A;COPA;USO1;STX17
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.558920800196247,0.9340666812820747,0.5483870967741935,1.0,1.0,1/7,15.22%,KHDRBS1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.5366651941087199,0.9338605722948521,0.5510204081632653,1.0,1.0,2/8,10.49%,CCDC88A;RTN4
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.4090840977471774,0.9329871968218955,0.5094339622641509,1.0,1.0,9/40,11.45%,RRAS2;PRKD1;RALA;BCR;CCDC88A;KRAS;TIAM2;ARHGAP31;RALB
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6033045614084156,0.9328639009161604,0.6792452830188679,1.0,1.0,3/5,23.85%,SLC8A1;RYR2;SPIDR
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.5729995542206741,-0.9327499394368378,0.6428571428571429,0.92661443334563,1.0,2/10,12.86%,AGPAT3;ENPP2
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.573981779588972,-0.932435947204944,0.6,0.9265788067078404,1.0,3/8,18.01%,CAMKMT;GSPT1;PRMT2
prerank,KEGG_2021_Human__Amoebiasis,0.41862144098264875,0.9322839320266496,0.46511627906976744,1.0,1.0,5/31,7.41%,IL1R1;COL4A2;PLCB1;PIK3CA;HSPB1
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.5085536960468319,-0.9321049999253573,0.5471698113207547,0.9267903260233977,1.0,2/16,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5562224671956422,0.9320819527216043,0.5818181818181818,1.0,1.0,5/7,23.29%,RTN1;RTN4;ROCK1;RTN3;PICALM
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.4539274084586283,0.9320769851313415,0.54,1.0,1.0,7/28,14.93%,SMAD9;SMAD6;SMAD1;SMAD5;SKI;LEMD3;SMURF2
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4820051493948932,0.9318806639435695,0.5625,1.0,1.0,4/14,17.29%,CDH2;ROBO2;NPTN;NECTIN3
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.5877353466637474,0.9318432746076728,0.6326530612244898,1.0,1.0,5/6,34.34%,MEF2C;SVIL;MYL6;BMPR2;PGM5
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.5629036656893016,-0.9318169529816038,0.5227272727272727,0.9267412832622368,1.0,3/10,4.99%,FN1;ITGB5;COL8A1
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,0.5475370113979664,0.931708838766867,0.6181818181818182,1.0,1.0,4/10,15.56%,PIK3CA;PIGU;HSP90AA1;GRB2
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.6487783815141926,-0.9316456148167083,0.6363636363636364,0.9264121776265037,1.0,3/5,13.09%,RFC3;TOPBP1;ATM
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.48286693890999377,-0.9315054223584164,0.5423728813559322,0.9260968303751053,1.0,2/25,2.07%,PPARG;TMSB4X
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.47217778336921223,0.9312929365273048,0.5135135135135135,1.0,1.0,3/30,4.83%,IL1R1;ITPR3;ITGA2
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.509039019684429,0.9312535800332968,0.5510204081632653,1.0,1.0,1/10,1.04%,TEAD4
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,-0.44607562010965895,-0.9311885938438876,0.5909090909090909,0.9261682318372622,1.0,2/27,1.51%,PSMA1;PSMB9
prerank,KEGG_2021_Human__Vibrio cholerae infection,-0.5039195894277412,-0.9308622089024929,0.5660377358490566,0.9262927942117841,1.0,3/17,9.08%,PLCG2;ATP6V1E1;ERO1A
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,-0.4012169080071753,-0.930660125939716,0.4909090909090909,0.9260845759895212,1.0,4/93,1.51%,NR4A1;PPARG;PSMA1;PSMB9
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.5727739927401586,-0.9304784844714208,0.5121951219512195,0.9258566834465289,1.0,1/6,4.83%,NR3C2
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.4845282887526094,0.9302705286610028,0.6071428571428571,1.0,1.0,5/17,22.66%,WDPCP;PLCB1;CLASP1;PHLDB2;NIPBL
prerank,CellMarker_Augmented_2021__Fibroblast:Peripheral Blood,-0.5059482950553388,-0.9301803783286997,0.5714285714285714,0.9258549740659858,1.0,3/16,4.04%,FN1;CXCL12;LAMA4
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Adipose Tissue,-0.45635439696031443,-0.9301762808320602,0.6071428571428571,0.9252623546465967,1.0,5/53,4.97%,CLEC1A;ITIH5;LAMA4;TIE1;MMRN2
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,-0.4241887804377905,-0.9297593871452592,0.5178571428571429,0.9255861551832237,1.0,3/52,1.51%,PPARG;PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.44429020320111484,-0.9293028264952322,0.574468085106383,0.925776919505713,1.0,2/42,1.20%,CYLD;RHOBTB1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.4347904988758535,-0.9290645154813317,0.6,0.9255830947758656,1.0,2/47,3.72%,CX3CL1;CASS4
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.4937882840651933,-0.9290040167149575,0.5192307692307693,0.925078271341884,1.0,2/20,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.5112143193476374,-0.9288652130059623,0.4864864864864865,0.9247594045775436,1.0,1/14,2.52%,IFI27
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.5042780068862173,-0.928687508878173,0.6470588235294118,0.924507086778147,1.0,2/22,1.51%,PSMA1;PSMB9
prerank,KEGG_2021_Human__Toxoplasmosis,-0.4816886992167218,-0.9284806143001086,0.5714285714285714,0.924268313165489,1.0,7/31,13.23%,STAT1;LAMA4;NFKBIA;NFKB1;IFNGR2;LAMA2;JAK2
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.5714899265619011,-0.9283050953668172,0.574468085106383,0.9239109523456496,1.0,2/6,17.88%,SPAST;OPA1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.5603857938970743,0.928070851022511,0.6363636363636364,1.0,1.0,5/8,28.31%,DPP10;ANK2;ANK3;KIF5B;DPP6
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.610100141040985,0.9280473864473789,0.6458333333333334,1.0,1.0,2/6,17.32%,GCNT2;WNK1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.5182446407297068,-0.9277221729507237,0.5925925925925926,0.9246762233213816,1.0,2/11,4.01%,SOD2;PRKN
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.31687809736133454,0.9277206116945691,0.7096774193548387,1.0,1.0,47/272,13.12%,HDAC9;IRF2BP2;JAZF1;CRY1;MCPH1;CALR;BCL6;RARB;BMP6;UIMC1;MTDH;ATN1;TAF1;ZBTB1;ZEB1;YAF2;PEX14;BTRC;OTUD7B;CNOT2;TRPS1;CCDC85B;ZNF608;CTBP2;PLCB1;YY1;CBFA2T2;URI1;TAF3;CBFB;KLF7;REST;ZEB2;PPM1F;ZMYND11;HIVEP1;ATP8B1;CPEB3;ID3;DNMT3A;YWHAQ;ZNF706;FOXO3;PHC2;DICER1;SKI;HSPA8
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.554905833633014,-0.9272120493434296,0.559322033898305,0.9251304620243703,1.0,1/11,4.86%,TIE1
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.43717726484786196,-0.9271323749194388,0.5666666666666667,0.9246743482269942,1.0,3/28,7.09%,PSMA1;PSMB9;LMO2
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.5295819676000373,-0.9267835056252633,0.5192307692307693,0.9248974144244231,1.0,2/6,6.56%,SLCO1A2;SLCO2B1
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,-0.3393399953560893,-0.9264755485530378,0.647887323943662,0.9249226723640271,1.0,33/311,10.62%,NR4A1;BTG2;PPARG;PSMA1;ZNF43;PSMB9;STAT1;MLLT1;PLK2;CNOT8;NDRG1;LGALS3;RFC3;NR3C2;SERPINE1;SMAD3;ZKSCAN1;ANAPC16;LMO2;MAML3;BCL2L14;SLC2A3;NFKB1;ZNF33B;FOS;TOPBP1;JUN;CBX5;PMAIP1;POLR2A;ZNF248;MAPKAP1;LBR
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.4875533694383459,-0.9261216267459352,0.5370370370370371,0.9251058140693512,1.0,2/20,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.5839986367085015,0.9260560503135111,0.6346153846153846,1.0,1.0,2/5,34.32%,BIRC2;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.5839986367085015,0.9260560503135111,0.6346153846153846,1.0,1.0,2/5,34.32%,BIRC2;ARHGEF2
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.42141042165388476,-0.9259941399581184,0.6226415094339622,0.9248152761571619,1.0,8/63,6.27%,CX3CL1;ZIC1;DOK5;GRK5;SP100;GIT2;RGS6;ZDHHC17
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,-0.42080815588690945,-0.9257063659385176,0.5882352941176471,0.9247945383034791,1.0,9/42,10.62%,IL32;ARAP2;GIT2;NHS;TFRC;TAOK3;ARHGAP17;ARHGAP15;LBR
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,0.535365610197523,0.9251703045371946,0.6037735849056604,1.0,1.0,1/7,6.67%,CTDSP2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5867431163693992,0.9249934562493511,0.6122448979591837,1.0,1.0,4/6,21.17%,GLCE;EXT1;HS6ST3;NDST1
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.4741184133819788,-0.924971764747257,0.5272727272727272,0.9257917434701146,1.0,3/22,7.62%,NR4A1;TIE1;B2M
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,0.47378235424362336,0.9249656768657348,0.5277777777777778,1.0,1.0,6/16,27.36%,GXYLT1;GALNT2;GALNT10;C1GALT1;GALNT18;EOGT
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.5638148950799011,-0.9246971383686138,0.54,0.9257769704145794,1.0,1/8,1.57%,RIMS1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.6279524557959164,-0.9246084773576767,0.6363636363636364,0.9253227763115696,1.0,1/5,3.29%,LYPLA1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.4697098836717104,0.92440994313321,0.5813953488372093,1.0,1.0,5/20,11.61%,GRM5;GRIA2;SNAP25;NRXN1;RBFOX1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.541808014435353,-0.9240348620298673,0.6041666666666666,0.9259441193652526,1.0,1/23,2.82%,OPTN
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.5254557160304528,-0.9240171680113872,0.6440677966101694,0.925372490881194,1.0,3/13,13.07%,STAT1;STAT5B;FAXDC2
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.47376562535409994,-0.9235562600089919,0.49019607843137253,0.925724612992834,1.0,1/27,1.57%,RIMS1
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,-0.341980715455685,-0.923397158032005,0.6142857142857143,0.9254547889949964,1.0,32/279,10.62%,NR4A1;BTG2;PPARG;PSMA1;ZNF43;PSMB9;STAT1;PLK2;CNOT8;NDRG1;LGALS3;RFC3;NR3C2;SERPINE1;SMAD3;ZKSCAN1;ANAPC16;LMO2;MAML3;BCL2L14;SLC2A3;NFKB1;ZNF33B;FOS;TOPBP1;JUN;CBX5;PMAIP1;POLR2A;ZNF248;MAPKAP1;LBR
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.5509127510269252,0.9227615060938619,0.62,1.0,1.0,3/5,22.82%,MARCHF5;CDK6;AKT3
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.48938333762608244,-0.9227574208402903,0.5471698113207547,0.9262313735539305,1.0,2/21,1.51%,PSMA1;PSMB9
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.4341597293609271,-0.9227133763896094,0.6557377049180327,0.9257067546606469,1.0,4/29,11.21%,SNX6;SNX2;GOSR1;ANKFY1
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,-0.33355005708654345,-0.9225292937671535,0.6410256410256411,0.9254701051923289,1.0,46/369,12.56%,DPH6;CYLD;PPARG;KLHL20;PSMA1;IFIH1;PSMB9;PIGC;FN1;HLA-B;SHISA5;TNIP1;SP100;PRKN;NUB1;CD109;NR3C2;CPM;LY6E;ALG11;NGLY1;SMAD3;NFKBIA;FOXK1;TRIM25;ATXN7;GOSR1;TANK;PRSS23;BABAM2;CAMKMT;CBX5;CST3;WSB1;RECK;RAB1A;COPA;STAM2;ADAMTS1;GPC3;UBC;UBE2D2;USO1;RORA;STX17;NPLOC4
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,-0.47571514877712373,-0.9224814734569536,0.5862068965517241,0.9249531634474282,1.0,2/25,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.4707373886456322,-0.922417492668725,0.6,0.9245020917563028,1.0,3/22,4.94%,PPARG;SLC5A6;ACSL4
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.4321385410617963,-0.9223106995792587,0.6065573770491803,0.9240972131662901,1.0,5/51,7.12%,PPARG;FN1;PRKN;LAMA4;HMCN1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.5920332206143786,-0.9219573005520012,0.6,0.9243246094682375,1.0,1/6,3.21%,CHKA
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4472745660564561,0.9218718426038198,0.5357142857142857,1.0,1.0,5/21,14.08%,YWHAB;MICALL2;YWHAZ;YWHAQ;PINK1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.41530293265934576,-0.9217860314709678,0.5396825396825397,0.924024499137886,1.0,7/59,5.21%,CLEC1A;FN1;ITGB5;CXCL12;LAMA4;MMRN2;CPQ
prerank,KEGG_2021_Human__Synaptic vesicle cycle,-0.4889863726943727,-0.9216513156434929,0.5576923076923077,0.9236727315163371,1.0,6/20,17.64%,RIMS1;ATP6V1E1;CLTA;DNM3;UNC13B;STXBP1
prerank,Reactome_2022__Dissolution Of Fibrin Clot R-HSA-75205,-0.5953657869067631,-0.9213117202558361,0.5686274509803921,0.9238999645057014,1.0,1/5,5.60%,SERPINE1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.45239630088063826,-0.9212871214340015,0.5769230769230769,0.9233798123502822,1.0,4/33,8.61%,PSMA1;PSMB9;RFC3;TOPBP1
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.4581832240870068,-0.9211309546227121,0.6031746031746031,0.9231200140864488,1.0,7/35,13.23%,STAT1;NFKBIA;NFKB1;FOS;JUN;IFNGR2;JAK2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Breast,-0.6238353913531072,-0.9211157922153764,0.6346153846153846,0.9225491070201195,1.0,2/5,24.01%,CD34;KDM1A
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,0.4220267439240131,0.9211137814861866,0.64,1.0,1.0,10/42,18.78%,IL1R1;IL6R;IFNAR1;HSP90AA1;REST;S1PR1;AP2B1;GRB2;PHF21A;ROCK1
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.5452614590460542,-0.9209482534121269,0.5740740740740741,0.9222447730445849,1.0,1/10,1.57%,RIMS1
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,-0.481930879593635,-0.9207965999803072,0.5227272727272727,0.9219278634062147,1.0,5/21,13.65%,RHOBTB1;CDC37;ACTN1;VIM;SRRM1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.5592248944491622,0.9207647415617055,0.5333333333333333,1.0,1.0,1/8,7.01%,PIK3CA
prerank,CellMarker_Augmented_2021__Stem cell:Gastric Gland,-0.4120685175860327,-0.9206895730087803,0.5166666666666667,0.9186920142694858,1.0,6/45,11.74%,KIAA1217;SMARCA1;RAPGEF5;EFNB2;GPC3;TLN2
prerank,CellMarker_Augmented_2021__Ovarian Somatic cell:Ovary,-0.4120685175860327,-0.9206895730087803,0.5166666666666667,0.9186920142694858,1.0,6/45,11.74%,KIAA1217;SMARCA1;RAPGEF5;EFNB2;GPC3;TLN2
prerank,CellMarker_Augmented_2021__Somatic Stem cell:Endometrium,-0.4120685175860327,-0.9206895730087803,0.5166666666666667,0.9186920142694858,1.0,6/45,11.74%,KIAA1217;SMARCA1;RAPGEF5;EFNB2;GPC3;TLN2
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Gland,-0.4120685175860327,-0.9206895730087803,0.5166666666666667,0.9186920142694858,1.0,6/45,11.74%,KIAA1217;SMARCA1;RAPGEF5;EFNB2;GPC3;TLN2
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Gastrointestinal Tract,-0.4120685175860327,-0.9206895730087803,0.5166666666666667,0.9186920142694858,1.0,6/45,11.74%,KIAA1217;SMARCA1;RAPGEF5;EFNB2;GPC3;TLN2
prerank,CellMarker_Augmented_2021__Corneal Limbal Stem cell:Limbal Epithelium,-0.4120685175860327,-0.9206895730087803,0.5166666666666667,0.9186920142694858,1.0,6/45,11.74%,KIAA1217;SMARCA1;RAPGEF5;EFNB2;GPC3;TLN2
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,0.589667809185019,0.9205026257931045,0.6136363636363636,1.0,1.0,2/6,29.16%,HSPA9;IMMT
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.5895635545676154,-0.9203315983495695,0.574468085106383,0.9188432461695772,1.0,2/7,7.46%,TPM1;DMD
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.6040216340601269,-0.9203011150940339,0.64,0.9183237480512988,1.0,3/7,20.58%,ZDHHC17;ZDHHC20;ZDHHC21
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.4455991368194414,-0.9202201499388238,0.5555555555555556,0.917914441205071,1.0,4/39,4.38%,PSMA1;PSMB9;STAT1;LGALS3
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.44272409518673406,-0.9201721938987186,0.5964912280701754,0.9174026177712314,1.0,7/33,12.70%,ISG15;FN1;ITGB5;CD47;ITGA10;ADAMTS1;ITGAV
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.45758481516614147,-0.9201586741444512,0.5573770491803278,0.9168399536084012,1.0,2/30,4.38%,GBP1;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5361396319366614,-0.9193028825557203,0.5416666666666666,0.9179179840921803,1.0,5/12,29.06%,MSH2;ACVRL1;KMT2A;DACH1;XRCC5
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.5113428931212316,-0.9190983858256745,0.58,0.9177027763215415,1.0,2/15,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.6420850019385391,-0.9190414822176735,0.6744186046511628,0.9172309070425412,1.0,2/5,11.55%,ANKFY1;CCDC91
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.5785584248770024,-0.9189552514662493,0.6222222222222222,0.9168366594105222,1.0,1/5,2.92%,CCDC68
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.570548677417335,-0.9183507775036336,0.5625,0.9173346234605143,1.0,1/7,1.12%,GBP1
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.4123388075463497,-0.9182089127037897,0.55,0.9170946733819223,1.0,9/52,8.92%,GBP1;STAT1;GABARAPL1;OAS3;GBP4;NFKBIA;NFKB1;TANK;JUN
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.5574730088551305,-0.9178931977153211,0.7058823529411765,0.91721382778947,1.0,1/7,17.40%,NUP98
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5696976032823032,-0.9177462095760777,0.6041666666666666,0.9163126270699417,1.0,1/11,4.91%,PABPC1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5696976032823032,-0.9177462095760777,0.6041666666666666,0.9163126270699417,1.0,1/11,4.91%,PABPC1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.5075670200644293,-0.9176487048862005,0.6140350877192983,0.9159140314296029,1.0,2/19,4.01%,DENND3;PRKN
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.5735135453188331,-0.9174739764538083,0.6226415094339622,0.915637366407562,1.0,4/10,17.88%,SPG7;PMAIP1;MFN1;OPA1
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,0.4438858112152904,0.9172416019555943,0.5531914893617021,1.0,1.0,5/21,16.87%,TUBB4B;NUP58;AHCTF1;LEMD3;TUBA1B
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.4818429055650145,-0.9171837824541182,0.5769230769230769,0.9155335024751913,1.0,3/29,4.01%,IFI27;ARIH2;PRKN
prerank,KEGG_2021_Human__Proteoglycans in cancer,0.39394461266264275,0.9171753685324325,0.6666666666666666,1.0,1.0,22/78,18.88%,RRAS2;ITPR3;ERBB4;HSPG2;ACTG1;ITGA2;KRAS;PIK3CA;ITGA5;ACTB;FRS2;PPP1CB;ITPR2;GRB2;ANK2;CDC42;TIAM1;ANK3;RAC1;PRKCA;ROCK1;PXN
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.39102036218577485,0.9171108314777421,0.5531914893617021,1.0,1.0,11/53,17.74%,VAPB;COG6;MCFD2;BET1;TFG;CD59;ANK2;CAPZB;COG5;ARF4;ANK3
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.508164808643234,-0.9169213028974794,0.6122448979591837,0.9154553010271418,1.0,3/18,3.72%,RREB1;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.4532678899531452,-0.9168386870372274,0.4642857142857143,0.9149752987227332,1.0,5/31,13.23%,DENND3;ARHGAP17;MAPKAP1;ARHGEF28;JAK2
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.5813527292456733,-0.9165849092461448,0.6041666666666666,0.9149294182580262,1.0,2/7,10.70%,SP100;ACTN1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.5285019004572191,-0.9164352527885411,0.6153846153846154,0.914615995541341,1.0,3/15,7.62%,SNX6;PRKN;B2M
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.5659145875981251,-0.9162334483853593,0.5283018867924528,0.9145767625224569,1.0,3/10,11.00%,TPM1;DMD;ARHGEF11
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.5945579533307506,0.9162232302089484,0.5384615384615384,1.0,1.0,2/5,14.69%,DICER1;KPNA1
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,-0.34641963019090255,-0.9161692978223871,0.7222222222222222,0.9141175868067901,1.0,57/317,14.16%,PARP14;PSMA1;IFIH1;PSMB9;ISG15;RPS12;STAT1;PLCG2;PLK2;HLA-F;HLA-B;HLA-C;RPL31;RNF213;VAV3;PATJ;RPL34;EIF2AK2;RPS8;RPL15;RPS6;GEMIN5;RPL7A;RPL38;RPL23;B2M;NFKB1;TRIM25;RPL30;JUN;VPS36;HLA-E;MVB12B;RPS28;RCOR1;RPS19;POLR2A;PARP9;RPS7;RPS14;IFNGR2;STAM2;GNG4;RPS15;GPC3;UBC;RPL28;SRPK1;CLTA;RPL9;JAK2;HLA-A;TBK1;NMT2;PGK1;PRKAR1A;NUP54
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.492242506638767,-0.9157952439280542,0.5384615384615384,0.9141868239575527,1.0,2/16,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.6355712755618291,0.9157848189851301,0.6181818181818182,1.0,1.0,3/5,25.18%,ROCK1;ROCK2;NOS3
prerank,CellMarker_Augmented_2021__Nucleus Pulposus cell:Intervertebral Disc,-0.45449636680097083,-0.915772041220493,0.5517241379310345,0.9136966807291519,1.0,3/35,4.04%,TBX3;EML1;LAMA4
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.5328706146561298,-0.9155431141026505,0.5869565217391305,0.9136073006378274,1.0,3/8,5.60%,CXCL12;LGALS3;SERPINE1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3565215756742259,0.9150283133893028,0.6486486486486487,1.0,1.0,20/105,18.75%,CALR;FOXN2;YAF2;GPBP1L1;CHD7;NFYC;ZNF708;REST;ABL1;RALY;ZMIZ1;NLK;NCOA2;TRIM22;RPS6KA5;BAZ2A;CREBBP;EP300;ZNF280D;FOXC1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.5911523077942293,-0.9149767883772992,0.6346153846153846,0.9142988049565872,1.0,2/5,13.44%,HLA-E;HLA-A
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,0.5179190420606016,0.9147196137419146,0.6153846153846154,1.0,1.0,2/12,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.4395945909608474,0.914643130735009,0.5111111111111111,1.0,1.0,4/27,12.27%,BMP6;MT2A;MT1M;MT1E
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,-0.4686529357775707,-0.9143720739160189,0.5932203389830508,0.9151226743864602,1.0,4/28,7.22%,PSMA1;PSMB9;SMAD3;MAML3
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,-0.5551167545414961,-0.9141199408250285,0.6346153846153846,0.9150579383192742,1.0,3/8,12.70%,ITGB5;ACTN1;ITGAV
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.49489037846185074,-0.9140029952895867,0.5636363636363636,0.9147081625808038,1.0,2/9,15.75%,SMAD3;FOXO1
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,0.43166887087648476,0.9139171284878963,0.6382978723404256,1.0,1.0,10/24,22.97%,AHCTF1;RANBP2;XPO1;CLASP1;PPP2CB;NEK7;TAOK1;CLIP1;PPP2R5E;PPP2R5C
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,0.5513556401670001,0.9137238505276828,0.6326530612244898,1.0,1.0,6/9,29.69%,YES1;ROCK1;ROCK2;MYH9;MYH10;MYL6
prerank,Reactome_2022__Synthesis Of PIPs At Late Endosome Membrane R-HSA-1660517,-0.598878735332999,-0.913699774115373,0.6326530612244898,0.9147324114392216,1.0,2/6,19.89%,MTMR2;PIK3C3
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.5685418295162823,0.9133896886210402,0.6545454545454545,1.0,1.0,2/5,11.00%,XPO1;PSIP1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.5919204093452921,0.9130302072495301,0.6086956521739131,1.0,1.0,3/5,22.90%,ROBO2;NIPBL;NF1
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.5238788344694485,0.9128723937608847,0.5869565217391305,1.0,1.0,5/9,36.39%,LRRK2;GNPTAB;TMEM165;ARSB;ABCA1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.47763933831203753,-0.9125808468398916,0.575,0.9164209403125553,1.0,4/16,13.49%,NFKBIA;TANK;UBC;TBK1
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,0.4843233435626017,0.9122902245823479,0.5918367346938775,1.0,1.0,6/18,18.14%,CDH2;CADM2;CDH12;PARD3;NECTIN3;PALS1
prerank,Reactome_2022__Constitutive Signaling By EGFRvIII R-HSA-5637810,0.5473871618035544,0.9121324064027906,0.5818181818181818,1.0,1.0,4/10,15.56%,PIK3CA;PIGU;HSP90AA1;GRB2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.415173794225354,-0.9121215426187496,0.6379310344827587,0.9167413441442871,1.0,5/49,4.91%,PSMA1;PSMB9;CNOT8;ZC3HAV1;PABPC1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.46388227152083145,-0.9119890783084252,0.5384615384615384,0.9164166747407322,1.0,2/30,1.01%,NR4A1;PPARG
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.4728055837818076,0.9119334633032502,0.49122807017543857,1.0,1.0,2/12,6.11%,PBX3;CHD7
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.5135670791776348,-0.9117643524406637,0.5675675675675675,0.9163387480786134,1.0,1/11,7.04%,ANAPC16
prerank,Reactome_2022__DCC Mediated Attractive Signaling R-HSA-418885,0.49833737468870054,0.911760277852618,0.6041666666666666,1.0,1.0,6/10,33.20%,CDC42;ABLIM3;PTK2;WASL;DOCK1;FYN
prerank,CellMarker_Augmented_2021__Epithelial cell:Placenta,0.5065631888438724,0.9116469695500959,0.66,1.0,1.0,3/13,18.27%,ITGA2;ANXA2;EDN1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.562769553354868,0.911640397141614,0.6170212765957447,1.0,1.0,2/7,8.18%,SMAD6;CHSY1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.44284248846629104,-0.9115491112869483,0.6666666666666666,0.9162419795334144,1.0,6/50,10.25%,EML1;SLC16A2;TPM1;LAMA4;LIMCH1;DIXDC1
prerank,CellMarker_Augmented_2021__Oogenesis Phase Fetal Germ cell:Fetal Gonad,-0.34962850784998545,-0.9109379974003924,0.6447368421052632,0.9168897584224435,1.0,25/245,10.46%,EPSTI1;TBX3;ATP9A;STAT1;FN1;ULK4;KLHL7;ITGB5;VAV3;HERC6;LGALS3;NR3C2;RASGRF2;ARAP2;ADSS2;NFKBIA;MYCBP2;STK39;ATXN7;CCDC88C;SLC25A26;DENND11;CMPK1;NOSTRIN;ARHGAP15
prerank,Reactome_2022__Regulation Of IFNA/IFNB Signaling R-HSA-912694,-0.5648923044761838,-0.9106004323002828,0.5581395348837209,0.9169062572446226,1.0,1/7,2.12%,STAT1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.34564454839331704,0.9105371470504448,0.627906976744186,1.0,1.0,26/126,16.23%,AGTPBP1;VAPB;PRKD1;GABPB1;PEX14;BRWD1;WDPCP;FAM174B;YTHDF2;DIAPH1;PDZD8;LARP4;HACE1;DPYSL2;ATP8B1;RANBP9;DST;CLASP1;LRRK2;RAB7A;VMP1;PINK1;ZRANB1;CDC42;CAPZB;SSBP1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.47762414512451634,-0.9104300673087661,0.5769230769230769,0.9166832991258808,1.0,1/22,1.01%,PPARG
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,0.595400242656077,0.9104192939596618,0.625,1.0,1.0,3/7,18.67%,PRKX;CALM1;PRKCA
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.62574390738461,0.910404790026573,0.66,1.0,1.0,2/5,11.18%,PLCB1;GNB4
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,0.62574390738461,0.910404790026573,0.66,1.0,1.0,2/5,11.18%,PLCB1;GNB4
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.4757812652070212,-0.9103713736830628,0.5510204081632653,0.9162339192491784,1.0,4/16,9.59%,PPARG;DAB1;COL18A1;TRPM6
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.5216597585099284,-0.9103165214776819,0.5490196078431373,0.9157473313559693,1.0,1/10,1.57%,RIMS1
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,-0.4264343624975936,-0.9102505041245101,0.5573770491803278,0.9152676295123595,1.0,5/31,14.82%,GIT2;FNBP1;TFRC;FMNL3;STOM
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.5709540284088913,0.9095377433418067,0.64,1.0,1.0,1/5,8.47%,TPST2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.4590577014411673,-0.9094848772417885,0.6538461538461539,0.9161461881855503,1.0,6/27,15.75%,PLK2;PRKN;GPC3;VSIR;HECW2;FOXO1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.5029675987516075,-0.9094538869087427,0.603448275862069,0.9156354212417005,1.0,1/14,4.17%,SLC5A6
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,0.4606332476010258,0.9085336081520825,0.5,1.0,1.0,8/22,20.98%,TUBB4B;PCM1;HSP90AA1;CLASP1;PRKCA;YWHAG;CEP290;CDK5RAP2
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,0.4606332476010258,0.9085336081520825,0.5,1.0,1.0,8/22,20.98%,TUBB4B;PCM1;HSP90AA1;CLASP1;PRKCA;YWHAG;CEP290;CDK5RAP2
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.5554414557358172,-0.908487898236685,0.6470588235294118,0.9169709609319934,1.0,4/11,22.55%,MAP2;SSH1;HIP1R;KANK3
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.43336664617057175,-0.908425085880538,0.6296296296296297,0.9165544241580453,1.0,4/23,8.39%,ATP6V1E1;EIF2AK2;MAP3K5;LARS1
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.5493967792825112,0.9083678688162987,0.6379310344827587,1.0,1.0,3/10,18.67%,PRKX;CALM1;PRKCA
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.5860293396354144,0.9079831754969153,0.6274509803921569,1.0,1.0,3/8,22.79%,CBFB;ROCK1;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.4673340571150292,-0.9078790573576652,0.6046511627906976,0.916972327011946,1.0,2/16,8.71%,TNIP1;TANK
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.4109570622941074,0.9070340754539374,0.6,1.0,1.0,7/35,16.68%,PRKD1;HSP90AA1;PPM1F;FNIP2;PINK1;ATP2B4;PTEN
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.5781244533990993,-0.9066508668173521,0.6981132075471698,0.9186116523219958,1.0,1/8,3.51%,ATP6V1E1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.5306956341169876,0.9065203721153297,0.62,1.0,1.0,4/10,17.56%,SLC38A9;CAPN2;CPEB3;CPEB4
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Gonad,-0.3984551616542983,-0.9064542529503391,0.603448275862069,0.9184203267073197,1.0,10/72,11.69%,TMSB4X;PLK2;FN1;KLHL7;LAMA4;GPCPD1;HLA-E;PTMA;ITM2A;GPC3
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.4648606287120999,0.906169484222073,0.5660377358490566,1.0,1.0,7/17,26.77%,RALB;LRRK2;PINK1;MTMR3;RAB3GAP2;RAB5A;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.4427323734435336,0.9061640320119185,0.6551724137931034,1.0,1.0,8/30,20.74%,CCNI;ABL1;ACTB;RALB;SLC8A1;CALM1;UVRAG;CDK12
prerank,Reactome_2022__Disorders Of Developmental Biology R-HSA-9675151,0.5264128863333764,0.9061280596800765,0.6206896551724138,1.0,1.0,3/7,20.21%,CALM1;PRKCA;NCOR2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.37812908959224195,0.905681418268433,0.6136363636363636,1.0,1.0,6/56,8.07%,SMAD9;SOX5;BMP6;PRKD1;HSPB1;URI1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Brown Adipose Tissue,0.38255799312780175,0.9055002794849357,0.6153846153846154,1.0,1.0,12/54,18.54%,ERBB4;PRKG1;CDH2;FGF12;MPDZ;DST;PTPN21;ADGRL2;GAREM1;ANK2;KCNT2;LRP1B
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.48093038153635487,-0.9054533422527511,0.6274509803921569,0.9198877838841895,1.0,2/27,2.23%,RREB1;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.36390677861533705,-0.9052376953303042,0.6833333333333333,0.9196834037435665,1.0,11/141,9.56%,HES1;TBX3;PPARG;IRF1;SNX6;FOXK1;SCML1;BHLHE40;JUN;CBX5;RCOR1
prerank,CellMarker_Augmented_2021__Stem cell:Ovarian Cortex,-0.5766843796949566,-0.9049906002258243,0.6944444444444444,0.919479272695132,1.0,1/6,3.75%,SLCO1A2
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Uterus,-0.5049933261160962,-0.9046612706904458,0.6,0.9195190327157485,1.0,5/19,8.63%,PARP12;TNIP1;LGALS3;NFKBIA;BHLHE40
prerank,KEGG_2021_Human__Apoptosis,0.3893494917668308,0.9040903810307765,0.627906976744186,1.0,1.0,8/42,12.11%,ITPR3;ACTG1;MAPK10;KRAS;PIK3CA;CAPN2;ACTB;ITPR2
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.496674036154107,0.9040281064966671,0.6481481481481481,1.0,1.0,3/15,15.91%,ITGA1;GRB2;CDC42
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5569119686199321,-0.9039772943358416,0.6304347826086957,0.9195609697966511,1.0,2/6,12.24%,SULF2;RORA
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5569119686199321,-0.9039772943358416,0.6304347826086957,0.9195609697966511,1.0,2/6,12.24%,SULF2;RORA
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5031609566020195,0.903955621347335,0.6481481481481481,1.0,1.0,1/12,1.78%,NREP
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.5493860334560351,0.903854907079228,0.6222222222222222,1.0,1.0,3/8,8.87%,PCM1;ROBO2;REST
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.39915444221498164,0.9037158135070495,0.6976744186046512,1.0,1.0,6/33,8.15%,PSMD14;IL1R1;BTRC;ST18;PLCB1;TAB2
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.536261446611631,0.9032885997021125,0.5531914893617021,1.0,1.0,1/10,1.25%,CALR
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5436429531433947,0.902968702751962,0.6222222222222222,1.0,1.0,2/10,5.82%,CCDC88A;CCDC186
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.5678975959798319,0.9028090739602012,0.6666666666666666,1.0,1.0,3/8,4.94%,ERBB4;PHACTR4;SEMA3F
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.557914783590227,0.9027362468152851,0.6122448979591837,1.0,1.0,1/6,4.49%,MED4
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.4079252285394699,0.9025715489170997,0.6046511627906976,1.0,1.0,7/28,13.65%,NUP58;PIAS1;RANBP2;HDAC7;HERC2;PHC2;SMC1A
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,-0.48729331050594465,-0.9024555826824688,0.5370370370370371,0.9219764659970221,1.0,4/20,9.85%,STAT1;LRRFIP1;STAT5B;POLR2A
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,-0.4406269063581807,-0.9022284121819816,0.6071428571428571,0.9219398275445507,1.0,4/25,11.69%,OMD;ALG11;ADAMTS1;GPC3
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5669470177273362,0.9015963517698998,0.723404255319149,1.0,1.0,2/8,10.25%,PDZD8;MICU3
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.4380951243267062,-0.9015962160793731,0.5849056603773585,0.922438865347303,1.0,3/25,10.20%,RHOBTB1;ARHGAP17;BST2
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.606347277458212,0.9014999153116816,0.6470588235294118,1.0,1.0,1/5,2.07%,BMP6
prerank,KEGG_2021_Human__Legionellosis,-0.5218115459730002,-0.9013137355290289,0.603448275862069,0.9224206642679408,1.0,4/12,13.76%,NFKBIA;NFKB1;RAB1A;EEF1A1
prerank,CellMarker_Augmented_2021__Myogenic Endothelial cell:Skeletal Muscle,-0.4149853253659103,-0.9004601345325713,0.5645161290322581,0.9235719810605095,1.0,5/48,6.99%,CLEC1A;ITIH5;TIE1;SLCO2B1;LCP2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.5638454150654251,-0.9002863505033711,0.574468085106383,0.9233417389318808,1.0,2/9,7.46%,TPM1;DMD
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,0.46998752888370565,0.900238223982063,0.5918367346938775,1.0,1.0,5/15,18.43%,UIMC1;ABL1;HERC2;BAZ1B;RNF168
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,0.46998752888370565,0.900238223982063,0.5918367346938775,1.0,1.0,5/15,18.43%,UIMC1;ABL1;HERC2;BAZ1B;RNF168
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.53610282402153,0.900001863813894,0.7021276595744681,1.0,1.0,5/10,20.98%,EDN1;TOM1L2;RGCC;PHIP;CDK5RAP2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.458834925455763,-0.8999835584530942,0.5333333333333333,0.9233354504339077,1.0,6/21,13.09%,UFL1;PRKN;CALCOCO2;VIM;UBC;ATM
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.41089708292871135,0.899669979071705,0.4772727272727273,1.0,1.0,4/22,6.85%,CRY1;YWHAB;KCTD8;PLCB1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.5879154353288202,0.8995126865810585,0.7083333333333334,1.0,1.0,1/5,2.97%,TAF1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.5879154353288202,0.8995126865810585,0.7083333333333334,1.0,1.0,1/5,2.97%,TAF1
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.47372913448297027,-0.8994129250420089,0.5531914893617021,0.9235589182967463,1.0,2/25,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.42593606282921026,0.8986253280478771,0.574468085106383,1.0,1.0,15/36,25.82%,CALR;PRKD1;HSPB1;ABL1;NRP1;RAC1;EDN1;PRKCA;ADAM17;ROCK2;AKT3;TEK;ETS1;NOS3;FGFR1
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.4044586162301798,0.8985102143608679,0.5,1.0,1.0,5/32,17.42%,PRAG1;YTHDF2;ZMIZ1;CREBBP;EP300
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.46795801152211797,-0.8981673612949284,0.5192307692307693,0.925184597009618,1.0,2/21,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.5472443613258762,-0.8981552891487947,0.52,0.9246438408526169,1.0,1/8,1.57%,RIMS1
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.508321973721249,-0.8977401159689004,0.5490196078431373,0.9249156984283687,1.0,3/10,17.45%,STAM2;UBC;SH3GL1
prerank,KEGG_2021_Human__Phagosome,-0.4358795252014857,-0.8972472049903636,0.6481481481481481,0.9251376722577257,1.0,8/41,9.19%,ITGB5;HLA-F;HLA-B;HLA-C;ATP6V1E1;TAP1;TFRC;HLA-E
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.49411872625978026,-0.8966875620141425,0.6119402985074627,0.9255450988243411,1.0,2/18,6.67%,PLCG2;MEF2A
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,-0.44965368964485986,-0.8964456869898998,0.5862068965517241,0.9255622557690898,1.0,7/29,11.77%,PSMA1;PSMB9;NFKBIA;NFKB1;INPP5D;UBC;UBE2D2
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5009007256515411,0.896349304244702,0.5849056603773585,1.0,1.0,4/12,21.81%,CLASP1;PARD3;CDC42;OPHN1
prerank,CellMarker_Augmented_2021__B cell:Kidney,-0.3555641511929969,-0.8963491585910711,0.6,0.9252207649511732,1.0,27/178,13.52%,CD74;PARP14;NR4A1;CDK14;LYPLA1;SP100;SNX2;GPM6A;NR3C2;NGLY1;RAPGEF5;MEF2A;TAF1D;MYCBP2;PKHD1L1;HLA-E;BTNL9;EBF1;INPP5D;IFNGR2;GPC3;USO1;COBLL1;SP110;ANKRD44;DAAM1;SYPL1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.35100580642210444,0.8962885362445892,0.7878787878787878,1.0,1.0,16/93,11.90%,HDAC9;TEAD4;SOX5;RARB;TAF1;ZBTB1;MED4;ELL2;TAF3;CBFB;ERCC6;PGR;HDAC7;SETX;TFCP2;GTF2I
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.5002993982002902,0.8961834874536695,0.5918367346938775,1.0,1.0,1/10,0.48%,GRIK2
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.4380558104638013,-0.8961543929323692,0.5087719298245614,0.9250465320860288,1.0,5/37,9.08%,SOD2;TPM1;FOS;JUN;ERO1A
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.5659142219794491,-0.8952727051564173,0.5333333333333333,0.9260953135167812,1.0,2/6,6.91%,NGLY1;SAMHD1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.45811161907211645,0.8950793166230862,0.717948717948718,1.0,1.0,5/15,11.24%,CRY1;TAF1;IVNS1ABP;ABL1;SPOPL
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.3390481974400794,0.8949723121786631,0.7096774193548387,1.0,1.0,16/91,12.08%,PSMD14;ERBB4;YWHAB;NRG2;DUSP6;KRAS;BTRC;NCAM1;PIK3CA;LRRC7;SETX;FRS2;PPP1CB;RANBP9;RASA2;LRRK2
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,-0.44975398666026983,-0.8949054453935253,0.5714285714285714,0.9261367863712581,1.0,2/32,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,-0.4996361307177384,-0.8944049455246209,0.631578947368421,0.9264496168824548,1.0,2/15,8.98%,STAT1;STAT5B
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.5424022113977834,0.89415540815126,0.6444444444444445,1.0,1.0,5/8,35.91%,MEF2C;SVIL;MYL6;FXR1;BASP1
prerank,CellMarker_Augmented_2021__Basal cell:Lung,-0.5191297497365385,-0.893838273047679,0.5714285714285714,0.9269963279472289,1.0,1/9,4.65%,CD109
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.5417971163098123,0.8937231272765093,0.6785714285714286,1.0,1.0,2/7,22.90%,FOXO3;NF1
prerank,CellMarker_Augmented_2021__Neuron:Embryo,0.5796964256335376,0.8934151479579194,0.660377358490566,1.0,1.0,3/6,11.61%,GRIA2;NRXN1;RBFOX1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.5535550788542756,-0.8933415422815525,0.5714285714285714,0.9267024008774317,1.0,1/5,9.85%,POLR2A
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.5535550788542756,-0.8933415422815525,0.5714285714285714,0.9267024008774317,1.0,1/5,9.85%,POLR2A
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,-0.43167017040140854,-0.8932507546125276,0.5806451612903226,0.9263187900737118,1.0,4/41,10.97%,DENND3;OPTN;DENND2C;RAB1A
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.3035466490483837,0.8932453347385182,0.8,1.0,1.0,41/324,12.19%,PDK4;PSMD14;ABL2;PRKG1;CDH2;GOLM1;PRKD1;TAF1;HSP90B1;BCR;PRAG1;DCAF10;MORC3;MAPK10;YES1;COP1;UGCG;DUSP6;BTRC;FBXO7;IGFBP3;FEM1C;CTDSP2;CSNK1G3;STK38L;STT3B;PIGU;PXK;YWHAZ;ABL1;PPM1F;CDC14B;PGGT1B;PPP4R2;PPP1CB;ST8SIA4;NLK;PPP2CB;LRRK2;PPP3CA;GCNT2
prerank,Reactome_2022__Metabolism R-HSA-1430728,-0.32173744294751017,-0.8931852008693304,0.7763157894736842,0.925861840881676,1.0,75/430,14.90%,SLC22A5;PARP14;CEMIP;OMD;PPARG;PSMA1;PSMB9;RPS12;PLCG2;FAM120B;GMPS;CHKA;LYPLA1;RPL31;SLCO1A2;SLC5A6;TMLHE;PLA1A;SLC38A3;RPL34;ACSL4;RPS8;RPL15;RPS6;RPL7A;AGPAT3;RPL38;ESYT2;SLCO2B1;GPD2;ADSS2;SAMHD1;RPL23;GPCPD1;SLC2A3;RPL30;ACER2;LARS1;CDA;RPS28;RPS19;CMPK1;PARP9;INPP5D;RPS7;PIK3C2B;NNT;NOSTRIN;LBR;RPS14;CBR4;MTMR2;GNG4;RPS15;GPC3;UBC;PHKB;RPL28;HIBCH;RORA;SUCLG2;ENPP2;ENTPD4;RPL9;GNA14;PGK1;PRKAR1A;ELOVL5;NUP54;PDXK;RPL37;CHST12;CSGALNACT1;PPA2;COX6C
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.5640605887105183,0.8930063728543722,0.625,1.0,1.0,1/7,9.93%,ACTB
prerank,KEGG_2021_Human__Acute myeloid leukemia,0.41848834113716515,0.8929345397411453,0.5641025641025641,1.0,1.0,3/25,7.01%,DUSP6;KRAS;PIK3CA
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.4858644350271264,-0.8927707537166697,0.6037735849056604,0.9261860038701897,1.0,5/13,21.12%,RFC3;UBC;RFC1;POLK;CUL4A
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.43106488675722054,0.892677649338543,0.574468085106383,1.0,1.0,5/24,20.11%,BMP6;CLASP1;FRMD4A;EDN1;RGCC
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,0.4327518354177252,0.8922967905914059,0.6363636363636364,1.0,1.0,7/26,17.64%,MORF4L1;NCOA2;ZZZ3;USP22;CREBBP;EP300;NCOA1
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,0.5477427650439819,0.8920299484642179,0.6379310344827587,1.0,1.0,3/7,16.49%,UGP2;GBE1;CALM1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.44012329926907456,-0.8919768269899425,0.62,0.9272038808763311,1.0,4/31,7.28%,KIAA1217;CLIC5;SMARCA1;DSP
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.48484046145678883,0.8919119026547312,0.5686274509803921,1.0,1.0,5/12,24.89%,FGF12;HOMER1;ANK2;NEDD4L;YWHAE
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.49393094350010597,-0.8918534404968662,0.6226415094339622,0.9268699988171322,1.0,1/22,2.26%,PLK2
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Tonsil,-0.4220471386616057,-0.8917585381574368,0.574468085106383,0.9264997052372751,1.0,3/32,7.28%,ITGB5;LGALS3;DSP
prerank,KEGG_2021_Human__GnRH signaling pathway,0.42732129222663906,0.8914543757436846,0.6808510638297872,1.0,1.0,9/33,16.49%,ITPR3;MAPK10;KRAS;PLCB1;CACNA1C;ITPR2;GRB2;CDC42;CALM1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.4772526946677548,-0.8914423469732884,0.5789473684210527,0.9265590581396956,1.0,3/21,8.55%,SNX2;GPM6A;TAOK3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.4245329276740183,0.8914245191953116,0.6122448979591837,1.0,1.0,8/26,25.42%,CALR;XPO1;XPO4;XPO7;WASHC4;SRSF7;SMURF1;SRSF11
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.48005608790087206,0.890318951535895,0.6326530612244898,1.0,1.0,5/11,18.19%,UBQLN1;ATP2A2;VMP1;CALM1;UVRAG
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,-0.39751260458783366,-0.8902528805904508,0.6326530612244898,0.9283218741620316,1.0,6/39,14.82%,TFRC;ARHGEF11;ARHGEF28;MCF2L;DAAM1;STOM
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.42493838846029997,-0.8901954947477457,0.6545454545454545,0.9279146320321658,1.0,4/24,8.39%,ATP6V1E1;EIF2AK2;MAP3K5;LARS1
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.4528916091932218,-0.8901661370394813,0.639344262295082,0.9274221887619192,1.0,4/29,7.68%,PSMA1;PSMB9;NFKBIA;NFKB1
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,0.5448398276066925,0.8901244233250906,0.6326530612244898,1.0,1.0,2/7,16.87%,TUBB4B;TUBA1B
prerank,CellMarker_Augmented_2021__Bone Marrow Stromal cell:Bone Marrow,0.5050699795851633,0.8899524823766153,0.6346153846153846,1.0,1.0,2/11,9.03%,ITGA2;PARVA
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.5055679287526809,0.8897543690482361,0.6,1.0,1.0,2/8,17.24%,REST;ANXA1
prerank,CellMarker_Augmented_2021__Progenitor cell:Skin,0.5919912578130418,0.8897090306520592,0.6041666666666666,1.0,1.0,2/5,34.13%,MAGI1;FNBP1L
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.44084145861333,-0.8894840215530248,0.6071428571428571,0.928123120120751,1.0,5/32,8.92%,PPARG;MAP3K5;NFKB1;FOS;JUN
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.43590130273867284,-0.8894134767772802,0.7021276595744681,0.9277044980970897,1.0,2/27,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.41517628206017737,0.889315394852486,0.5909090909090909,1.0,1.0,9/29,18.99%,ACTG1;HSP90AA1;ABL1;ELMO1;GRB2;CDC42;CYFIP1;WASF2;CRK
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.5641670023184294,-0.889280367600879,0.5897435897435898,0.92732914173264,1.0,1/6,8.29%,TMEM50B
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.4790734832811902,0.8890236647623597,0.5818181818181818,1.0,1.0,3/13,14.69%,NUP58;RANBP2;KPNA1
prerank,KEGG_2021_Human__Parkinson disease,0.3589852008554711,0.8890108252990164,0.7272727272727273,1.0,1.0,12/54,16.87%,PSMD14;ITPR3;MAPK10;TUBB4B;SEM1;LRRK2;ITPR2;UBE2J1;PINK1;BCL2L1;CALM1;TUBA1B
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,0.3768035566898686,0.8888864251781894,0.625,1.0,1.0,18/70,20.98%,TUBB4B;PCM1;HSP90AA1;NCOA2;CLASP1;CRTC3;HSPA9;SSBP1;CALM1;CREBBP;NCOA1;ARF4;CC2D2A;PRKCA;YWHAG;BBS9;CEP290;CDK5RAP2
prerank,Reactome_2022__Post-transcriptional Silencing By Small RNAs R-HSA-426496,0.5494846765885717,0.8888353618208942,0.5833333333333334,1.0,1.0,1/6,21.57%,AGO2
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.4333313183045615,-0.8887115764909345,0.6666666666666666,0.927662520702401,1.0,1/44,0.27%,TBX3
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.5224035717221567,0.8884888310907851,0.6226415094339622,1.0,1.0,1/8,2.02%,SLC26A3
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.4670456844081182,-0.88843938328405,0.5769230769230769,0.9277208993997742,1.0,3/21,7.62%,LRPAP1;MAP2;B2M
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,0.4223052638140994,0.8883018255185517,0.58,1.0,1.0,9/22,22.97%,AHCTF1;RANBP2;XPO1;CLASP1;PPP2CB;TAOK1;CLIP1;PPP2R5E;PPP2R5C
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.3801247370491021,0.8882702304073303,0.6842105263157895,1.0,1.0,8/29,14.08%,PRKD1;PIK3CA;ABL1;STX2;SETX;LRRK2;FOXO3;PINK1
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.5001524113978875,0.8882667139502678,0.5957446808510638,1.0,1.0,3/11,15.56%,FRS2;PPP2CB;GRB2
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.5416650794050097,0.8881714333110682,0.7045454545454546,1.0,1.0,1/7,6.11%,CHD7
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,0.3455076858380798,0.8878884843311241,0.7575757575757576,1.0,1.0,14/76,11.93%,PSMD14;ERBB4;YWHAB;NRG2;DUSP6;NCAM1;PIK3CA;LRRC7;SEM1;FRS2;PPP1CB;RANBP9;RASA2;PPP2CB
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.46728107771738964,-0.8878287505505439,0.5964912280701754,0.9283829774922021,1.0,4/27,6.56%,ABCA5;CHKA;SLCO1A2;SLCO2B1
prerank,CellMarker_Augmented_2021__Luteinizing Granulosa cell:Ovarian Follicle,0.4645249606572008,0.8878018708358811,0.5555555555555556,1.0,1.0,3/13,11.61%,ERBB4;NRXN1;RBFOX1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5518371484598186,0.88761229242701,0.625,1.0,1.0,2/5,9.19%,CHSY1;CHST15
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.5518371484598186,0.88761229242701,0.625,1.0,1.0,2/5,9.19%,CHSY1;CHST15
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.5518371484598186,0.88761229242701,0.625,1.0,1.0,2/5,9.19%,CHSY1;CHST15
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.41724782115074754,-0.8872027041194053,0.6181818181818182,0.9290625539548886,1.0,2/31,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.4845240713593457,-0.8871177170788987,0.6346153846153846,0.9286631398953825,1.0,2/17,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.5439126355966604,-0.8866180439828949,0.6739130434782609,0.9279906703808611,1.0,1/7,4.28%,SPG7
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,-0.5439126355966604,-0.8866180439828949,0.6739130434782609,0.9279906703808611,1.0,1/7,4.28%,SPG7
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.5439126355966604,-0.8866180439828949,0.6739130434782609,0.9279906703808611,1.0,1/7,4.28%,SPG7
prerank,CellMarker_Augmented_2021__Mitotic Fetal Germ cell:Fetal Gonad,-0.3574787733074407,-0.8865471293666957,0.7205882352941176,0.9275259908341534,1.0,40/173,15.09%,SLC6A6;SAT1;TMSB4X;TPM1;HMGN1;RPL31;SHISA5;GABARAPL1;ZC3HAV1;RPS18;RPL34;ACSL4;LY6E;TRANK1;RPL15;BLCAP;NTNG1;RPS6;RPL7A;RPL38;DSP;DMD;RPL23;CD47;HLA-E;PMAIP1;RPS7;RPS14;ACTN1;VIM;RPL28;SUCLG2;RPL9;EEF1A1;GCNT1;RPL24;RPL37;CHM;STOM;FLNB
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.48177533339868805,-0.8865449093871043,0.6428571428571429,0.9269829073411254,1.0,2/13,8.07%,PRKN;TRIM25
prerank,CellMarker_Augmented_2021__Stem cell:Molar,0.4825070530565684,0.8861784851715575,0.6808510638297872,1.0,1.0,2/17,1.73%,COL4A2;HSPG2
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.44953027501887033,0.886167764721616,0.6428571428571429,1.0,1.0,7/23,13.07%,BMP6;PRKD1;IL6R;SMAD6;REST;HDAC7;SKI
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.3697385439020345,0.8856297112253213,0.6530612244897959,1.0,1.0,7/51,13.86%,GRM5;IL6R;CCDC88A;HSP90AA1;TAB2;RALB;EPHA4
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,0.3785160372384323,0.8855850766751645,0.5806451612903226,1.0,1.0,14/48,17.24%,ITPR3;STIM1;ATP2A2;FGF12;ITGA1;TPM4;ANXA2;CACNA1C;FGF14;ITPR2;SLC8A1;CALM1;ATP2B4;ANXA1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.47067618909276304,0.8855831576530134,0.5862068965517241,1.0,1.0,4/16,27.01%,INO80;ARID1A;BPTF;NAP1L4
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5086267947016393,0.8854936892630939,0.6037735849056604,1.0,1.0,1/10,1.78%,NREP
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.5412648734415613,-0.8853265306683197,0.6521739130434783,0.9284920607724297,1.0,1/10,2.58%,HMGN1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.4983288642352115,0.8851794537537956,0.625,1.0,1.0,5/12,14.87%,SLC25A16;FBXO7;HSP90AA1;MFF;BCL2L1
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,-0.6229389896730575,-0.8846443750524551,0.717391304347826,0.9292229536425715,1.0,1/6,4.75%,SLC38A3
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3461566889083155,0.8845893935188368,0.6428571428571429,1.0,1.0,6/71,9.69%,NOVA1;PRPF8;U2SURP;HNRNPR;NOVA2;RALY
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.3798780879173215,-0.88391371765009,0.6714285714285714,0.9301469867548973,1.0,21/91,19.20%,TMSB4X;PLCG2;FN1;VAV3;CD109;SERPINE1;LCP2;DGKG;ACTN1;GNG4;CLU;SRGN;GNA12;GNA14;RHOA;PDGFB;FAM3C;MAPK14;MGLL;DGKE;SYTL4
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.40902240351442065,0.8837966973151833,0.6808510638297872,1.0,1.0,7/23,21.86%,RALA;PPP1R10;PINK1;APPL1;IPO8;RYR2;HK1
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.5800622074074835,0.883639507665339,0.6862745098039216,1.0,1.0,1/5,5.84%,PPIG
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.5800622074074835,0.883639507665339,0.6862745098039216,1.0,1.0,1/5,5.84%,PPIG
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.5965746985845579,-0.8836009679045939,0.6216216216216216,0.9301671298721877,1.0,1/5,3.45%,CARMIL1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.4590206278405754,0.8834543298951502,0.6808510638297872,1.0,1.0,4/24,7.62%,ZNF160;TET2;PRKX;YTHDF2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.5881875112223753,-0.8832537943971014,0.625,0.9302417484639494,1.0,2/7,14.42%,SRGAP2C;RAPGEF2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.40949637844582576,0.883235923493563,0.5813953488372093,1.0,1.0,13/35,18.99%,ACTG1;YES1;PIK3CA;HSP90AA1;ABL1;ELMO1;ACTB;GRB2;CDC42;CYFIP1;RAC1;WASF2;CRK
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.40949637844582576,0.883235923493563,0.5813953488372093,1.0,1.0,13/35,18.99%,ACTG1;YES1;PIK3CA;HSP90AA1;ABL1;ELMO1;ACTB;GRB2;CDC42;CYFIP1;RAC1;WASF2;CRK
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.40949637844582576,0.883235923493563,0.5813953488372093,1.0,1.0,13/35,18.99%,ACTG1;YES1;PIK3CA;HSP90AA1;ABL1;ELMO1;ACTB;GRB2;CDC42;CYFIP1;RAC1;WASF2;CRK
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,0.41260235494246444,0.8831985348083754,0.5490196078431373,1.0,1.0,8/28,11.13%,CDH2;ACTG1;ATP2A2;ITGA2;ITGA1;ITGA5;ACTB;CACNA1C
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3755740710295683,0.8829528390024385,0.6216216216216216,1.0,1.0,16/46,22.58%,INPP5A;PI4KA;PLCB1;PIK3CA;LRRK2;PPP3CA;PPP3CB;PLPPR4;CALM1;PTEN;LIMK2;TOP1;TAOK1;HK1;INPP4A;PPIP5K2
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.5109672647855579,-0.8825658148779738,0.6862745098039216,0.9309880399501134,1.0,1/9,0.85%,OMD
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5728362492371546,0.8815230210643445,0.7115384615384616,1.0,1.0,3/5,28.50%,SLC8A1;MEF2C;AKAP13
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.4019867611253351,0.8814284130406098,0.6888888888888889,1.0,1.0,12/37,18.99%,ACTG1;YES1;ACTB;CHN1;AP2B1;EPHA4;CDC42;PSEN1;TIAM1;RAC1;ROCK1;CRK
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.5619820582907276,-0.8812349675610752,0.6382978723404256,0.9328463444676708,1.0,2/6,13.84%,VSIR;PGK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.4600057926712338,0.8811073973789213,0.6122448979591837,1.0,1.0,4/11,21.25%,ATP2A2;CACNA1C;ANK2;RYR2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4567011733121147,0.8809220228504522,0.625,1.0,1.0,5/18,13.49%,ADGRB3;S1PR1;ADGRL4;CALCRL;ADGRL2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.5210217303404517,0.8807856508912252,0.5932203389830508,1.0,1.0,5/9,14.21%,RALA;DDHD1;PINK1;MARCHF5;MFF
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,0.4602342405426081,0.8807572687857664,0.660377358490566,1.0,1.0,5/14,11.77%,YWHAB;UIMC1;YWHAZ;YWHAQ;HERC2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.5660514010225901,0.8800795848636387,0.6744186046511628,1.0,1.0,3/6,24.12%,CEP290;SPIDR;GAPVD1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5624751491116923,0.8797852460262443,0.7021276595744681,1.0,1.0,1/6,3.03%,HSP90B1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.5525591393715514,-0.8796057484128218,0.6346153846153846,0.9353432042761007,1.0,1/6,8.37%,ACER2
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,-0.6007766769444731,-0.8795713512846428,0.7045454545454546,0.9348588076199951,1.0,1/5,4.57%,PATJ
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.5271725492223175,0.8793912938075156,0.7142857142857143,1.0,1.0,2/9,9.93%,ACTG1;ACTB
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.41274742201377096,0.8792170025187807,0.5909090909090909,1.0,1.0,7/29,12.08%,RNF217;UBQLN1;TAF1;COP1;PIAS1;RNF180;LRRK2
prerank,CellMarker_Augmented_2021__Neural Stem cell:Brain,0.4550914280135292,0.8791749581095941,0.6136363636363636,1.0,1.0,3/10,21.70%,NCAM1;CD81;ADGRG1
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,0.4194922573980505,0.879055371892999,0.5625,1.0,1.0,7/21,18.57%,MCFD2;BET1;ANKRD28;TFG;CD59;PPP6R3;PPP6C
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,-0.4808846808565172,-0.8786795653710752,0.6481481481481481,0.9360232602318741,1.0,3/17,9.67%,TPM1;ITGB5;MYL12A
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,0.3631635169515879,0.8785626316848594,0.675,1.0,1.0,5/71,7.46%,PRPF8;U2SURP;NUP58;HNRNPR;RANBP2
prerank,CellMarker_Augmented_2021__M1 macrophage:Brain,0.604433024133209,0.8785026303899195,0.6862745098039216,1.0,1.0,2/5,32.03%,MGAT1;TAGLN2
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5081256155171395,-0.8784609860392959,0.6730769230769231,0.9358347043532625,1.0,6/16,18.96%,YTHDC1;USP39;SRPK1;SRSF5;LUC7L;GCFC2
prerank,CellMarker_Augmented_2021__Neural Crest cell:Undefined,0.5521122148170401,0.878269542128826,0.6046511627906976,1.0,1.0,1/6,6.11%,CHD7
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.5582385827742371,-0.8781128197825031,0.625,0.935815225666205,1.0,2/8,7.73%,CXCL12;STK39
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5652356130181728,0.8780998999264922,0.6666666666666666,1.0,1.0,3/6,12.08%,TRAK1;TRAK2;LRRK2
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.44459452388605397,-0.8779825036448164,0.6792452830188679,0.9354883923556285,1.0,7/36,14.53%,PARP14;SLC5A6;SLC2A3;PARP9;GPC3;ENPP2;PDXK
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.5937307941637873,0.8777957037596917,0.7068965517241379,1.0,1.0,2/5,18.38%,PPM1F;ADARB1
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.5637818346848864,0.8777379282005915,0.7333333333333333,1.0,1.0,1/7,7.86%,LRRC7
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.4594853463864837,-0.8776238500636968,0.5849056603773585,0.9356438205573308,1.0,4/25,4.04%,TPM1;FN1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.4427688300212981,0.877566941076861,0.5185185185185185,1.0,1.0,7/22,20.98%,TUBB4B;PCM1;HSP90AA1;CLASP1;YWHAG;CEP290;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.5746982599159528,0.8775507382758847,0.7254901960784313,1.0,1.0,1/6,8.87%,REST
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.5514055712574943,0.8771368867598479,0.64,1.0,1.0,4/6,33.57%,NLGN1;KIF5B;RAB27A;SPG11
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.40095132005735346,-0.8768020934387754,0.6721311475409836,0.9367261364905566,1.0,4/48,5.39%,ZIC1;EML1;SMARCA1;CTNNA2
prerank,PanglaoDB_Augmented_2021__Microglia,-0.49586693298595014,-0.8762320517063825,0.6909090909090909,0.9371333454465556,1.0,4/14,8.15%,ITGB5;SLCO2B1;LCP2;FOS
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.4609770224408415,-0.8760970005565376,0.66,0.9367644156621768,1.0,6/27,11.61%,TPM1;ITGB5;DMD;MYL12A;ARHGEF11;VIM
prerank,CellMarker_Augmented_2021__Mucosal-associated Invariant T cell:Liver,0.4407828912275784,0.8760198134304913,0.6585365853658537,1.0,1.0,1/18,0.53%,PNP
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.4625614495591616,-0.8759735939284584,0.6379310344827587,0.9364139462016984,1.0,2/21,4.04%,CXCL12;LAMA4
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.4463184438640614,-0.8757356123320004,0.5740740740740741,0.9363101264803451,1.0,4/19,8.74%,TPM1;CARMIL1;LIMCH1;CD47
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.5250877763662322,0.875655195910736,0.5660377358490566,1.0,1.0,3/9,23.77%,ROCK1;ROCK2;ADD1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5615964798565207,0.8753554752614463,0.660377358490566,1.0,1.0,2/7,16.44%,CDH12;NLGN1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Muscle,0.38947446643190403,0.8753031408722964,0.7333333333333333,1.0,1.0,6/32,11.39%,COL4A2;HSPG2;IGFBP3;PARVA;ARHGAP23;ADGRL4
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.5290199962021546,-0.8751431217774025,0.6818181818181818,0.9367286304137614,1.0,2/9,15.43%,CST3;PDE3B
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.5735280343915645,-0.8749438028525883,0.675,0.9366367457201569,1.0,1/5,7.54%,RPL23
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.5515579139821731,0.8748641204769436,0.6590909090909091,1.0,1.0,4/7,22.90%,CACNA1C;SKI;CEP290;NF1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.3787210038135137,0.8746752876999105,0.675,1.0,1.0,7/43,7.44%,INPP5F;PITPNM2;PLEKHA1;PI4KA;PIK3CA;TTC7A;PIGU
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.4584353534329064,-0.8745019441364604,0.6851851851851852,0.9368687150355062,1.0,3/24,3.72%,RREB1;CARMIL1;CASS4
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.5119467108478085,0.8744115536982513,0.6346153846153846,1.0,1.0,1/9,3.08%,ACTG1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.49450616782908713,-0.874319639620617,0.5416666666666666,0.9366869787753815,1.0,2/12,5.60%,CD109;SERPINE1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5253706942662313,-0.8739338058284654,0.6428571428571429,0.9369306245475515,1.0,4/8,25.18%,DSP;LSR;LAMA3;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5533308916130771,0.8736906419850917,0.74,1.0,1.0,4/6,31.87%,CYFIP1;WASF2;GSN;NCKAP1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.4260557976300304,0.8736721801370003,0.6595744680851063,1.0,1.0,5/23,21.73%,NUP58;RANBP2;PSEN1;EP300;HDAC4
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.47006166955800865,-0.8735194599628372,0.6428571428571429,0.9371620163910376,1.0,2/15,8.98%,STAT1;STAT5B
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,0.39615942673543203,0.8731633306183095,0.72,1.0,1.0,11/39,17.64%,ERBB4;YY1;HSP90AA1;CBFB;PGR;NCOA3;NCOA2;SMC1A;CREBBP;EP300;NCOA1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.5266269689412877,0.8730768359270038,0.5813953488372093,1.0,1.0,2/6,31.45%,NLGN1;NDEL1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.5346444098592558,0.8729937441177129,0.6530612244897959,1.0,1.0,2/6,24.25%,CPT1A;ACACA
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,0.4019908909699533,0.872933983055448,0.627906976744186,1.0,1.0,11/29,22.97%,AHCTF1;RANBP2;WAPL;XPO1;CLASP1;PPP2CB;SMC1A;TAOK1;CLIP1;PPP2R5E;PPP2R5C
prerank,Reactome_2022__Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,0.5393067172946497,0.8722870462502896,0.627906976744186,1.0,1.0,3/7,17.42%,FOXO3;CREBBP;EP300
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.44828617097497203,0.8722341794738246,0.6923076923076923,1.0,1.0,6/21,18.99%,YES1;PIK3CA;YWHAZ;GRB2;PRKCA;CRK
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.5534276694973743,0.8720589036159526,0.6666666666666666,1.0,1.0,2/5,18.30%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.5534276694973743,0.8720589036159526,0.6666666666666666,1.0,1.0,2/5,18.30%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.43347153881069955,-0.8718969451244075,0.6792452830188679,0.9395284711514544,1.0,17/45,20.03%,YTHDC1;GEMIN5;RPL38;USP39;RPS28;RPS19;RPS14;RPS15;RPL10;SRPK1;SRSF5;RPL24;LUC7L;RPL11;GCFC2;DHX29;RPS27
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.43760178686805845,-0.8718385455744608,0.6730769230769231,0.9391005171602224,1.0,5/15,10.73%,CX3CL1;IRF1;SAMHD1;ERAP1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.4951630716409522,0.8716518515083109,0.673469387755102,1.0,1.0,2/12,12.14%,CLASP1;RAB7A
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.33684701242464044,0.8713838117812516,0.7209302325581395,1.0,1.0,6/85,9.69%,NOVA1;PRPF8;U2SURP;HNRNPR;NOVA2;RALY
prerank,KEGG_2021_Human__Cellular senescence,0.35256659721671063,0.8712649074013512,0.71875,1.0,1.0,12/58,13.31%,RRAS2;ITPR3;KRAS;BTRC;IGFBP3;PIK3CA;CAPN2;PPP1CB;ITPR2;PPP3CA;FOXO3;PPP3CB
prerank,CellMarker_Augmented_2021__Basal cell:Airway Epithelium,0.4486595709230936,0.8712351084668734,0.6274509803921569,1.0,1.0,3/20,9.03%,HSPG2;HSPB1;PARVA
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.5076886393339468,-0.8709779295952248,0.6326530612244898,0.9401547022157171,1.0,1/7,3.88%,MAP2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4311429433727185,0.870816384826874,0.7,1.0,1.0,9/28,22.47%,CDH2;MPDZ;PTPN21;ADGRL2;RAI14;FOXC1;MAGI1;BOC;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.536009518067777,-0.8707248108921006,0.6545454545454545,0.9400552802896545,1.0,3/8,20.27%,NFKB1;PDGFB;MAP2K5
prerank,KEGG_2021_Human__Spliceosome,0.42153962290424485,0.8705915810208632,0.6829268292682927,1.0,1.0,2/36,4.73%,PRPF8;U2SURP
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.4498724756078339,0.8705723032158562,0.62,1.0,1.0,7/27,15.96%,SLC2A13;LARP4;SAMD4A;CPEB3;EIF3E;EPHA4;NSMAF
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.49057233935302474,0.8702735351176125,0.66,1.0,1.0,5/11,21.25%,ATP2A2;CACNA1C;ANK2;CALM1;RYR2
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.49913987997174347,0.8702568775649924,0.64,1.0,1.0,1/10,5.66%,SYNE2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.6200812592758532,0.869926041652639,0.7551020408163265,1.0,1.0,2/5,17.77%,CD59;RAC1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.5599147390774527,0.8698961138221509,0.6170212765957447,1.0,1.0,3/5,14.98%,GLCE;EXT1;HS6ST3
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.5011295121339728,0.8693237259668138,0.6428571428571429,1.0,1.0,2/7,13.55%,ENTPD1;SND1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.44899971719764203,0.8685305795820747,0.7166666666666667,1.0,1.0,4/13,17.26%,HSP90AA1;NEK7;POT1;HMBOX1
prerank,Reactome_2022__RET Signaling R-HSA-8853659,0.42694438163314713,0.8685189692650096,0.6226415094339622,1.0,1.0,6/17,18.67%,PIK3CA;PIGU;GRB10;FRS2;GRB2;PRKCA
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,-0.32855062471741453,-0.8679066892927265,0.696969696969697,0.9445449093393571,1.0,37/223,14.93%,PSMA1;PSMB9;RPS12;RPL31;ATP6V1E1;RPL34;NR3C2;RPS8;RPL15;RPS6;RPL7A;MAP3K5;RPL38;ANAPC16;RPL23;NFKB1;FOS;RPL30;JUN;ERO1A;RPS28;RPS19;RPS7;RPS14;RPS15;UBC;UBE2D2;RPL28;RORA;NPLOC4;ATM;RPL9;EEF1A1;NUP54;RPL37;COX6C;PARN
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.4420438290810061,-0.8677399207707129,0.5789473684210527,0.9443774472705734,1.0,3/34,10.12%,PLCG2;VAV3;INPP5D
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.5305738188366218,-0.8677219564839149,0.5789473684210527,0.9438823538903981,1.0,2/10,10.12%,PLCG2;INPP5D
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.5826076034359791,0.8676957291535654,0.6949152542372882,1.0,1.0,2/5,22.10%,RALB;RAB3GAP2
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.5540093999394896,0.8676697966305391,0.7169811320754716,1.0,1.0,2/6,11.85%,MAP4;CLASP1
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,0.5208475958551579,0.8671251662161914,0.5882352941176471,1.0,1.0,3/9,15.56%,PIK3CA;BCL2L1;GRB2
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.5213439624204468,-0.866828022206947,0.6470588235294118,0.9451689815024475,1.0,3/6,17.88%,SPG7;MFN1;OPA1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.48414302944572785,0.8666959309544057,0.6590909090909091,1.0,1.0,2/9,10.41%,BACH2;XPO1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.37078034608666444,0.8665248658976321,0.6829268292682927,1.0,1.0,4/42,2.97%,HDAC9;TEAD4;RARB;TAF1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.45033716388298944,-0.8662805167865687,0.7017543859649122,0.9456146647258054,1.0,8/25,19.39%,HGSNAT;RNF213;ZNHIT6;SPAST;OPA1;MICU1;PKD2;FUS
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.49177713923327027,0.8659220057876622,0.6595744680851063,1.0,1.0,2/7,14.08%,LRRK2;PINK1
prerank,CellMarker_Augmented_2021__Stem cell:Fetal Liver,0.4073820645495245,0.8651273643189282,0.6170212765957447,1.0,1.0,4/27,5.07%,COL4A2;NREP;CDH2;NTM
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.3781169756743369,0.8651207515660523,0.7804878048780488,1.0,1.0,22/66,19.12%,SEMA3F;ALCAM;NCAM1;PIK3CA;ROBO2;NRXN1;KLF7;GRB10;FRS2;RANBP9;NRXN3;NPTN;CHN1;EPHA4;NRP1;RPS6KA5;GRB2;UNC5C;CYFIP1;RAC1;PRKCA;RYK
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.44643642865286337,0.8649697661617667,0.6666666666666666,1.0,1.0,3/21,10.41%,PRPF8;STT3B;XPO1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.5477453434851759,0.8649102376838879,0.660377358490566,1.0,1.0,5/6,38.70%,PSEN1;INSR;PRNP;ARF1;APP
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.33406439667903187,0.8646474144296477,0.813953488372093,1.0,1.0,6/77,9.69%,NOVA1;PRPF8;U2SURP;HNRNPR;NOVA2;RALY
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,-0.5185744617040866,-0.8645183533296608,0.6938775510204082,0.9482256670428668,1.0,1/6,10.62%,LBR
prerank,CellMarker_Augmented_2021__Megakaryocyte:Umbilical Cord Blood,0.42361392792242075,0.8643245176070294,0.5957446808510638,1.0,1.0,3/22,10.97%,MMRN1;ZEB2;TM6SF1
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.4198407453767059,-0.86411223660174,0.6612903225806451,0.9483003692454717,1.0,11/54,11.77%,PSMA1;PSMB9;PLCG2;VAV3;LCP2;NFKBIA;NFKB1;FOS;JUN;UBC;UBE2D2
prerank,KEGG_2021_Human__Cell cycle,0.395342464398226,0.8638364169646005,0.7045454545454546,1.0,1.0,9/37,18.91%,YWHAB;YWHAZ;ABL1;CDC14B;YWHAQ;SMC1A;CREBBP;EP300;YWHAG
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,-0.4346933618433493,-0.863720671781053,0.6226415094339622,0.9484581897511664,1.0,5/27,3.19%,PSMA1;PSMB9;HLA-F;HLA-B;HLA-C
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.5062182836409836,0.8635077736777149,0.6111111111111112,1.0,1.0,3/9,20.82%,CHD7;ANXA1;ADAM17
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.5114044466790114,-0.8634153792985174,0.6909090909090909,0.9485207912766818,1.0,3/15,6.56%,SLC16A2;SLCO1A2;SLCO2B1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.46458710818462284,0.8633773454749223,0.6458333333333334,1.0,1.0,3/12,21.14%,MAN1A2;UGGT1;EDEM3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.5177015103591591,-0.8630892101436786,0.6037735849056604,0.9486664289089607,1.0,3/12,15.91%,LIMA1;PAWR;SHROOM2
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,-0.46396697953288935,-0.8621575819611214,0.6078431372549019,0.9499213489717083,1.0,3/17,8.98%,STAT1;LRRFIP1;STAT5B
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.4295268553727502,-0.8621554710533024,0.6607142857142857,0.9493722614867536,1.0,3/24,7.04%,PSMA1;PSMB9;ANAPC16
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.5714801033790886,0.862132925807254,0.74,1.0,1.0,4/5,40.11%,SLC1A1;SLC1A2;SLC25A12;GJA1
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.48444362708085825,-0.8617145691278099,0.6153846153846154,0.9496830838723367,1.0,2/10,10.44%,LYPLA1;NOSTRIN
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.33486956752278707,0.8615059822047443,0.75,1.0,1.0,16/109,15.62%,UBQLN1;ATP2A2;PACS2;PCM1;WDPCP;YTHDF2;AMBRA1;PARVA;CDC14B;RAB7A;INO80;VMP1;G3BP1;ABCC4;ATG2B;NEK7
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,0.5406435150956734,0.8613727179367161,0.6557377049180327,1.0,1.0,1/6,6.14%,PKM
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.5553730929284595,-0.8610196681762299,0.5892857142857143,0.9503429816913556,1.0,1/5,16.31%,PDGFB
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5439869220601187,-0.8606959446759088,0.5818181818181818,0.9504220364841742,1.0,4/8,29.11%,KPNB1;PIBF1;EML4;RAB11A
prerank,Reactome_2022__HIV Infection R-HSA-162906,0.3642774020826105,0.8605225756695797,0.6944444444444444,1.0,1.0,13/68,12.70%,PSMD14;TAF1;NUP58;BTRC;AP1S2;SGIP1;RANBP2;TAF3;SEM1;ELMO1;XPO1;PSIP1;AP2B1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.4406070141363885,0.860330898183398,0.6086956521739131,1.0,1.0,4/14,22.02%,GXYLT1;GALNT2;GALNT10;C1GALT1
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,0.5504797798180613,0.8602533577110502,0.68,1.0,1.0,3/7,32.35%,DNMT3A;RBBP4;H3-3B
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.4607595997833322,-0.8601937658337762,0.6,0.9508855261169904,1.0,7/17,17.74%,ISG15;RFC3;TRIM25;UBC;PRIMPOL;RFC1;POLK
prerank,KEGG_2021_Human__Pertussis,-0.4723849619760544,-0.8599398354324869,0.5283018867924528,0.950709944937627,1.0,8/16,20.29%,IRF1;NFKB1;FOS;JUN;RHOA;MAPK14;CFL1;NOD1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.4411219542472669,-0.8598922135423137,0.6111111111111112,0.950280480350795,1.0,3/23,13.65%,PABPC1;SRSF5;SRRM1
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,-0.3803490929247808,-0.8598797489831385,0.7627118644067796,0.9497511156029418,1.0,18/102,15.43%,CX3CL1;CXCL12;GRK5;VAV3;RASGRF2;ARHGEF37;RGS6;LPAR6;DGKG;ARHGEF11;GNG4;MCF2L;GNA12;GNA14;PRKAR1A;RHOA;RAMP3;PDE3B
prerank,CellMarker_Augmented_2021__Ciliated Epithelial cell:Esophagus,0.38108274574489376,0.8598340212768975,0.6666666666666666,1.0,1.0,9/50,12.03%,NOVA1;ERBB4;RARB;TTLL7;CSMD1;STX2;USP24;MPDZ;FGF14
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.4174041253248613,0.859304495908549,0.6739130434782609,1.0,1.0,6/24,13.31%,ITPR3;SNAP25;REST;CACNA1C;ITPR2;PPP3CB
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.5368695364410287,0.8590696693391828,0.6140350877192983,1.0,1.0,1/5,22.28%,RC3H1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4963285094289921,-0.8590162062921032,0.5918367346938775,0.9509280870922849,1.0,1/9,2.58%,HMGN1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.3836843617178581,-0.8582338925527293,0.6923076923076923,0.9518618551552432,1.0,4/59,4.01%,SLC6A6;RREB1;SHLD1;PRKN
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.36751840346119125,0.8580050288770468,0.7692307692307693,1.0,1.0,8/63,12.56%,ARHGEF4;SRGAP1;BCR;FAM13B;TIAM2;ARHGAP31;ARHGAP23;CHN1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.5713204566500418,-0.8575682459360842,0.6666666666666666,0.9525410483366786,1.0,1/5,2.23%,PLCG2
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,0.49804567482663975,0.857382754254203,0.631578947368421,1.0,1.0,3/10,22.97%,PPP2CB;PPP2R5E;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.46104575624474087,0.8573163282159987,0.6595744680851063,1.0,1.0,4/12,9.22%,PRKD1;IL6R;HSPB1;PPM1F
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.48394923545031476,0.857312655771285,0.6923076923076923,1.0,1.0,4/8,36.81%,PHF14;KAT6A;LEF1;YEATS2
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.46187586875595343,0.8570701567710632,0.6666666666666666,1.0,1.0,6/18,18.67%,ITPR3;YES1;PRKX;ITPR2;CALM1;PRKCA
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.5353005616795142,-0.8569264646602545,0.7037037037037037,0.9532312452836836,1.0,2/6,8.74%,LGALS3;CD47
prerank,Reactome_2022__eNOS Activation R-HSA-203615,-0.5306477119845598,-0.8566870746753921,0.7021276595744681,0.9530432458533841,1.0,1/5,3.29%,LYPLA1
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.5074647629996699,0.8560037993306757,0.72,1.0,1.0,2/12,7.46%,NUP58;RANBP2
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,-0.35713135169620785,-0.8558498437029513,0.65,0.9540266246501208,1.0,4/109,1.51%,NR4A1;PPARG;PSMA1;PSMB9
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.444734609113192,0.8557890135855971,0.6410256410256411,1.0,1.0,5/15,17.24%,PLEKHA1;ABL1;SETX;STK24;ANXA1
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,-0.39395849875591804,-0.8555951699894907,0.6229508196721312,0.953920730847707,1.0,12/54,13.60%,PLCG2;NLRC5;MEF2A;NFKBIA;NFKB1;FOS;TANK;JUN;UBC;UBE2D2;TBK1;DNM3
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.47912332520011064,0.8553126443945115,0.6607142857142857,1.0,1.0,1/10,3.43%,GRIA2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.3443156501424305,-0.8550013733250336,0.7777777777777778,0.954408686254291,1.0,9/131,4.54%,KLHL20;PSMA1;PSMB9;IFI27;RNF213;RNF19A;ARIH2;PRKN;NUB1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.507287945728263,0.8548501302356439,0.6739130434782609,1.0,1.0,4/8,36.39%,LRRK2;GNPTAB;ARSB;ABCA1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.4938564472434943,-0.8547014987476557,0.6875,0.9543496959426442,1.0,3/8,20.56%,PATJ;RHOA;MSN
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,-0.4477882787199713,-0.8541662307331339,0.6086956521739131,0.9548251036571114,1.0,4/14,18.91%,STAM2;UBC;SH3GL1;PTPN2
prerank,KEGG_2021_Human__Purine metabolism,0.4252008984951864,0.8541574310214481,0.6938775510204082,1.0,1.0,5/26,13.33%,PNP;PKM;ENTPD1;AK3;PAPSS2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.3584400315687277,0.854058697195139,0.723404255319149,1.0,1.0,7/50,7.54%,CALR;HSPG2;INPP5F;HSP90B1;HSPH1;SGIP1;HSP90AA1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.45432545755494547,-0.8539562716797793,0.6440677966101694,0.9547072585697907,1.0,4/22,11.77%,PLCG2;TNIP1;UBC;UBE2D2
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.5228242544017588,0.8538423155630087,0.6666666666666666,1.0,1.0,3/9,14.48%,CDH2;PIK3CA;SLC8A1
prerank,CellMarker_Augmented_2021__Epithelial cell:Kidney,0.5541027184819137,0.8537422080536353,0.6862745098039216,1.0,1.0,1/7,2.55%,CDH2
prerank,CellMarker_Augmented_2021__Endometrial Stromal Stem cell:Endometrium Stroma,0.3833093414559011,0.8536247952828931,0.6585365853658537,1.0,1.0,3/33,2.18%,COL4A2;HSPG2;PRKG1
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,-0.3209158970533807,-0.8533509218730793,0.8472222222222222,0.9552464337537563,1.0,45/302,12.75%,PPARG;PSMA1;PSMB9;RPS12;FAM120B;CXCL12;DOK5;RPL31;VAV3;RPL34;PABPC1;RPS8;RPL15;CTNNA2;SCN3A;PLXND1;RPS6;RPL7A;RPL38;MEF2A;SMAD3;SCN2A;MAML3;RPL23;NFKB1;RPL30;JUN;ITGA10;RPS28;MYL12A;EBF1;RPS19;POLR2A;RPS7;RPS14;EFNB2;ARHGEF11;ARHGEF28;RPS15;UBC;UPF3A;RPL28;LAMA2;ITGAV;CLTA
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,-0.37044684713642795,-0.8533359514647278,0.734375,0.9547181637420854,1.0,19/109,15.43%,CX3CL1;CXCL12;GRK5;VAV3;RASGRF2;ARHGEF37;RGS6;LPAR6;DGKG;ARHGEF11;GNG4;MCF2L;FZD6;GNA12;GNA14;PRKAR1A;RHOA;RAMP3;PDE3B
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.554186236914472,-0.8532674279773885,0.6730769230769231,0.9542959474254462,1.0,2/7,17.66%,B2M;MAP3K3
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.43134970252884075,0.8532197895006407,0.6739130434782609,1.0,1.0,3/24,2.79%,BTBD10;INPP5A;PRKD1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.5162414449367404,-0.8530755177512845,0.7407407407407407,0.9541435433826013,1.0,5/10,29.38%,ATM;MDM2;KDM1A;XRCC5;WRN
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.4928066886855711,-0.8530755067528331,0.6578947368421053,0.9535992515723432,1.0,2/13,4.01%,OPTN;PRKN
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.5817487921602301,0.8530515518193382,0.6808510638297872,1.0,1.0,2/5,16.44%,BTRC;NLGN1
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,-0.30754972478480835,-0.8530129115033577,0.8157894736842105,0.9532193336359144,1.0,34/344,10.62%,NR4A1;BTG2;PPARG;PSMA1;ZNF43;PSMB9;STAT1;MLLT1;PLK2;CNOT8;NDRG1;LGALS3;RFC3;NR3C2;SERPINE1;SMAD3;TAF1D;ZKSCAN1;ANAPC16;LMO2;MAML3;BCL2L14;SLC2A3;NFKB1;ZNF33B;FOS;TOPBP1;JUN;CBX5;PMAIP1;POLR2A;ZNF248;MAPKAP1;LBR
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.49170396410678374,-0.852923251651493,0.5833333333333334,0.9528632286455326,1.0,6/11,28.45%,STAM2;UBC;SH3GL1;RPS27A;SH3KBP1;CTNNB1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.5229328442148671,-0.8526951431761909,0.6888888888888889,0.9527937710323514,1.0,1/10,0.13%,CD74
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4987175090081358,-0.8526132380635109,0.7222222222222222,0.9523799301634753,1.0,2/9,11.71%,TNIP1;UBC
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.538936286036606,-0.852558632967566,0.7017543859649122,0.9518790347525571,1.0,3/7,15.64%,ATM;DHX36;TNKS2
prerank,KEGG_2021_Human__Axon guidance,0.35635000709563436,0.852492802012028,0.7209302325581395,1.0,1.0,20/68,19.73%,SRGAP1;SEMA3F;KRAS;PIK3CA;ROBO2;ABL1;DPYSL2;PPP3CA;PPP3CB;EPHA4;NRP1;PARD3;CDC42;UNC5C;RAC1;PRKCA;ROCK1;RYK;LIMK2;FES
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.5453283859479623,0.8517868846730426,0.7090909090909091,1.0,1.0,4/6,22.50%,RTN1;RTN4;ROCK1;RTN3
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.48002982238139635,-0.851490179050569,0.7254901960784313,0.953134052414346,1.0,3/14,16.65%,TPM1;MSH2;DNAJC10
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.46896640419543323,-0.8514337242359383,0.7291666666666666,0.952668268080263,1.0,6/19,20.19%,TNIP1;GCNT1;CHST12;CSGALNACT1;SERP1;ST3GAL6
prerank,CellMarker_Augmented_2021__Adipose Multilineage-Differentiating Stress-Enduring cell:Adipose Tissue,0.4041448340104729,0.8513732223102248,0.6097560975609756,1.0,1.0,3/22,11.39%,COL4A2;NTM;ADGRL4
prerank,KEGG_2021_Human__Morphine addiction,-0.47510034130714407,-0.8511013099124625,0.6666666666666666,0.9527389203792158,1.0,4/20,16.23%,GRK5;GNG4;PDE3B;GNAS
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.5515169237035478,0.8506426948835574,0.68,1.0,1.0,4/6,22.55%,HSPA9;ZBTB16;CDC73;CDK6
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.568840500521193,0.8503928345862712,0.7321428571428571,1.0,1.0,1/5,2.68%,ATN1
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,0.47425207101874384,0.8503123674003737,0.6744186046511628,1.0,1.0,6/13,29.69%,PPP1CB;CDC42;CALM1;MYH9;MYH10;MYL6
prerank,KEGG_2021_Human__Bile secretion,-0.48900730734720027,-0.8500358275250652,0.6785714285714286,0.9542183625215228,1.0,1/15,3.75%,SLCO1A2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.5087502876593553,-0.8499677665845013,0.6666666666666666,0.9537585742248789,1.0,3/7,17.88%,SPG7;MFN1;OPA1
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.5067166587669142,-0.8494687409279189,0.6666666666666666,0.9541076167450518,1.0,2/8,10.44%,LYPLA1;NOSTRIN
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.33575329891811856,-0.8492439564276847,0.7692307692307693,0.9539622538094857,1.0,8/108,8.07%,KLHL20;PSMA1;PSMB9;IFI27;PRKN;UBR2;ANAPC16;TRIM25
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.5701620314941083,0.8490625465928894,0.6862745098039216,1.0,1.0,3/5,23.40%,PNPLA8;HADHB;PGS1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periosteum,0.37238801134537997,0.8488266939283251,0.7317073170731707,1.0,1.0,7/39,18.01%,COL4A2;IGFBP3;ALCAM;PARVA;EXT1;NECTIN3;PAM
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.4268531882083125,0.84879101337341,0.6739130434782609,1.0,1.0,2/17,1.25%,PDIA3;CALR
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,-0.4868442334404418,-0.8486235941897194,0.717391304347826,0.9546186410092724,1.0,1/9,9.85%,POLR2A
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.5336639207479044,0.8485379406243,0.7049180327868853,1.0,1.0,2/6,9.03%,PIK3CA;PARVA
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5242055903763,-0.8483864520055447,0.6170212765957447,0.9545021799170318,1.0,1/5,7.28%,DSP
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.47150744997188815,0.8481046092942629,0.6923076923076923,1.0,1.0,4/15,29.91%,PPP4R2;POT1;SPIDR;UBR5
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,0.48068588563424286,0.84771427611823,0.7090909090909091,1.0,1.0,3/12,5.26%,HSPG2;ITGA2;ITGA1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.4310929761466051,-0.8476069195707405,0.6842105263157895,0.9552561535468868,1.0,4/42,6.67%,MX1;PRKN;SPG7;MEF2A
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.43428905539954293,0.8470805034849627,0.75,1.0,1.0,8/21,15.30%,BAG3;HSPH1;STT3B;HSPB1;HSP90AA1;HSPD1;HSPA8;HSPA9
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.4014123512504987,-0.8468596023575058,0.631578947368421,0.9560846583679055,1.0,8/42,13.94%,KIAA1217;FN1;CXCL12;DSP;PKHD1L1;DUSP5;COBLL1;FBXO33
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.5479452589705807,-0.8467319677604953,0.6538461538461539,0.9552598031516991,1.0,1/5,11.29%,MTMR2
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.5479452589705807,-0.8467319677604953,0.6538461538461539,0.9552598031516991,1.0,1/5,11.29%,MTMR2
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.4308285658826986,-0.8466565022204713,0.6779661016949152,0.9548480737844673,1.0,3/25,9.69%,SLC6A6;SLC38A3;SLC25A26
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,0.3707069026858245,0.8462284780949882,0.75,1.0,1.0,12/53,13.31%,PSMD14;ITPR3;PRKG1;PLCB1;SEM1;NCOA3;GNB4;NLK;ITPR2;PPP3CA;AP2B1;PPP3CB
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.5660421721310969,0.8459800238034619,0.7021276595744681,1.0,1.0,2/6,11.18%,CACNA1C;GNB4
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.4385482550588504,0.8459355970783146,0.6785714285714286,1.0,1.0,3/15,9.16%,PLCB1;NRCAM;ABL1
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,-0.4234554800210585,-0.8454718526621654,0.6851851851851852,0.9564617890574997,1.0,8/29,15.19%,PSMA1;PSMB9;UBC;RORA;CLTA;FZD6;DAAM1;RHOA
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.4492197076865672,-0.8453608165259688,0.6507936507936508,0.9561192350714107,1.0,6/19,13.28%,TDRD7;YTHDC1;GEMIN5;PARP9;RPL10;ZC3H7A
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,0.3823035330442783,0.8451827467398897,0.75,1.0,1.0,6/28,14.61%,MAPK10;DUSP6;BTRC;TAB2;PPP2CB;RPS6KA5
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,0.3823035330442783,0.8451827467398897,0.75,1.0,1.0,6/28,14.61%,MAPK10;DUSP6;BTRC;TAB2;PPP2CB;RPS6KA5
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.4275666925670547,-0.8451788099097723,0.6666666666666666,0.9558406375868319,1.0,2/32,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.5095863337544733,-0.8451350518289676,0.7254901960784313,0.9553717496452393,1.0,1/9,1.57%,RIMS1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.4377342056738589,0.8450523388529934,0.6956521739130435,1.0,1.0,6/13,23.90%,GRM5;FOXO3;CYFIP1;ROCK1;PICALM;SAMD8
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.4522464535795015,-0.8450441978964991,0.6346153846153846,0.955013069484722,1.0,2/15,8.37%,SERPINE1;ACER2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.4405594007763157,-0.8449972665668041,0.5952380952380952,0.9545682519753144,1.0,2/19,7.62%,STAT1;B2M
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.45222878625230617,-0.8448506389339373,0.6666666666666666,0.9542450235768263,1.0,1/16,1.30%,IFIH1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex7:Brain,0.3974760070945026,0.8446106756742854,0.7391304347826086,1.0,1.0,16/34,21.59%,SNTG2;NOVA1;PRKG1;NTM;ROBO2;NRXN1;CACNA1C;PDZRN3;ANK2;PLPPR4;NLGN1;KCNT2;LSAMP;PREX2;BOC;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5516954692712353,0.844315231212181,0.7708333333333334,1.0,1.0,2/5,18.59%,CYFIP1;WASF2
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.5491786621882717,0.8441220787360448,0.7068965517241379,1.0,1.0,1/5,1.97%,INPP5F
prerank,Reactome_2022__SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,0.5373618503225931,0.8439559730520302,0.6595744680851063,1.0,1.0,4/6,33.20%,NRP1;FES;PLXNA2;FYN
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5213913834705505,-0.8434083909621004,0.6470588235294118,0.95607748487041,1.0,1/8,5.39%,CTNNA2
prerank,CellMarker_Augmented_2021__Neural Stem cell:Inferior Colliculus,-0.38067514115447154,-0.8428053469808674,0.6538461538461539,0.9566753191341796,1.0,12/37,25.02%,SMARCA1;PPP1R9A;DCLK1;SHROOM2;TJP1;ZNF423;ADGRL3;FARP1;PLP1;STOX2;PBX1;MID1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.47710540455901257,-0.8425405580997064,0.6078431372549019,0.9565356584649578,1.0,2/12,10.17%,PMAIP1;RPS7
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5242280153680161,0.842433676634554,0.6296296296296297,1.0,1.0,4/8,23.29%,SLC2A13;EPHA4;ROCK2;PICALM
prerank,KEGG_2021_Human__GABAergic synapse,-0.44396452311329626,-0.8422327724475455,0.66,0.9566032699669605,1.0,3/21,11.47%,GABARAPL1;SLC38A3;GNG4
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.5611156751403145,-0.8422045825022351,0.7,0.9560900573069114,1.0,2/5,13.63%,CAMKMT;NMT2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.5487546883015311,-0.8421508951360763,0.6976744186046512,0.955111304464327,1.0,1/5,14.00%,PRKAR1A
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.5487546883015311,-0.8421508951360763,0.6976744186046512,0.955111304464327,1.0,1/5,14.00%,PRKAR1A
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.5028050521785724,0.8421234969085212,0.6792452830188679,1.0,1.0,3/9,23.64%,PICALM;NEDD4L;HSP90AB1
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,-0.3753060217967674,-0.841689022791758,0.6896551724137931,0.9553804732673025,1.0,10/71,11.71%,PSMA1;PSMB9;IRF2;IRF1;TNFSF10;CDC37;TANK;PMAIP1;VIM;UBC
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.40216523770400675,-0.8415783795205278,0.6,0.9550067835121621,1.0,1/35,0.48%,NR4A1
prerank,Reactome_2022__Axon Guidance R-HSA-422475,-0.3320784356511087,-0.8413789614745977,0.8382352941176471,0.9548800697979578,1.0,36/208,13.60%,PSMA1;PSMB9;RPS12;CXCL12;DOK5;RPL31;VAV3;RPL34;PABPC1;RPS8;RPL15;SCN3A;PLXND1;RPS6;RPL7A;RPL38;SCN2A;RPL23;RPL30;ITGA10;RPS28;MYL12A;RPS19;RPS7;RPS14;EFNB2;ARHGEF11;ARHGEF28;RPS15;UBC;UPF3A;RPL28;ITGAV;CLTA;RPL9;DNM3
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.48056123325039285,0.8413715671253529,0.6727272727272727,1.0,1.0,2/8,9.83%,MRTFA;ITGA5
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5188840917467904,-0.8412705548615965,0.7307692307692307,0.9544956157080465,1.0,2/9,7.73%,DMD;STK39
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.4791474113812373,-0.841249124978253,0.6458333333333334,0.9539855857073382,1.0,3/12,5.55%,ULK4;CTNNA2;NTNG1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.5228086505067522,-0.840633834582756,0.7346938775510204,0.9547125768113915,1.0,1/6,3.88%,MAP2
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.4596303788117856,-0.840101645449533,0.7169811320754716,0.9551355375467716,1.0,2/18,8.92%,MAML3;JUN
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.43946888561656344,-0.8398788055045265,0.6956521739130435,0.9550662845491978,1.0,2/24,2.12%,PPARG;STAT1
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.4919246342033132,0.839601837832909,0.7222222222222222,1.0,1.0,3/9,18.43%,UIMC1;HERC2;RNF168
prerank,KEGG_2021_Human__Prolactin signaling pathway,-0.4595485891543667,-0.8393260274835299,0.6909090909090909,0.9555457244388343,1.0,5/27,8.98%,STAT1;IRF1;NFKB1;FOS;STAT5B
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,-0.4433219516145387,-0.8392872850317554,0.6896551724137931,0.9550765106068575,1.0,4/23,13.23%,ACSL4;NFKBIA;NFKB1;JAK2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.3884731311945591,0.8391245708555903,0.7547169811320755,1.0,1.0,6/36,12.54%,SLC25A37;HSPH1;LARP4;SAMD4A;CPEB3;EIF3E
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.46110723962880673,-0.839041561074826,0.6909090909090909,0.9550074060711271,1.0,2/8,10.57%,NFKB1;SPPL2A
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.5158250131056548,0.8389191426789193,0.7454545454545455,1.0,1.0,3/5,24.01%,DIAPH2;IHO1;USP9X
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.4764067135566927,-0.8387735827114592,0.6382978723404256,0.9549155575557704,1.0,6/10,28.31%,UBC;ATM;SMYD2;MDM2;RPS27A;EHMT1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.48658656042266957,-0.8387633613808694,0.673469387755102,0.9543904560624709,1.0,3/11,16.02%,CHKA;ENPP2;MFSD2A
prerank,CellMarker_Augmented_2021__PROM1High Progenitor cell:Large Intestine,-0.41086250715670625,-0.8387315611599281,0.6949152542372882,0.9539229267436631,1.0,4/33,4.99%,EML1;SLC16A2;FN1;COL8A1
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,0.35868625851462566,0.8384680725288546,0.6888888888888889,1.0,1.0,11/49,18.14%,CDH2;CADM2;SKAP2;PIK3CA;PARVA;DST;CDH12;PARD3;GRB2;NECTIN3;PALS1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.4612651200938351,-0.838440949884197,0.7450980392156863,0.9539571389663911,1.0,6/21,23.61%,CARMIL1;SSH1;HIP1R;KANK3;NCK1;CTTN
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.47970962712690457,0.838044451056848,0.6666666666666666,1.0,1.0,3/10,12.11%,ITPR3;PIK3CA;ITPR2
prerank,Reactome_2022__Inflammasomes R-HSA-622312,-0.4842594834208415,-0.8380277562542384,0.6296296296296297,0.9542190151291577,1.0,4/7,20.98%,NFKB1;SUGT1;NLRP1;TXNIP
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.5681774453980971,0.8376807914638449,0.7631578947368421,1.0,1.0,3/6,29.38%,SETX;SCAF8;PAPOLA
prerank,CellMarker_Augmented_2021__Neuron:Adipose Tissue,0.45164313759280317,0.8376700715871743,0.717391304347826,1.0,1.0,2/13,3.51%,GRIA2;SNAP25
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.40447637879888587,-0.8375448624520201,0.6779661016949152,0.9545033583646441,1.0,3/42,6.00%,EML1;PLK2;SPC25
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.4264232521253127,-0.8375273860894691,0.6444444444444445,0.9540424893485431,1.0,3/30,5.60%,PPARG;STAT1;SERPINE1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.5364286399571876,0.83698047962907,0.7115384615384616,1.0,1.0,3/6,23.64%,ENTPD1;ANO6;HSP90AB1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.3521080259617978,0.8369073353128927,0.7222222222222222,1.0,1.0,14/57,18.78%,RRAS2;PRKD1;RALA;PHACTR4;KRAS;ELMO1;HACE1;RALB;G3BP1;GRB2;CYFIP1;TIAM1;RAC1;ROCK1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.5181666223875663,0.8368116700144169,0.7241379310344828,1.0,1.0,1/6,8.61%,ERCC6
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,0.45800572306999837,0.8366773794529654,0.6923076923076923,1.0,1.0,1/12,1.73%,HSPG2
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,0.390542998530262,0.8366325559230666,0.6923076923076923,1.0,1.0,6/35,13.55%,YWHAB;TENT4A;DUSP6;TRAK1;PPP1CB;SND1
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,-0.33070568111079085,-0.8362640244839245,0.8405797101449275,0.9556962391639674,1.0,37/217,13.60%,PSMA1;PSMB9;RPS12;CXCL12;DOK5;RPL31;VAV3;RPL34;PABPC1;RPS8;RPL15;SCN3A;PLXND1;RPS6;RPL7A;RPL38;SCN2A;RPL23;RPL30;ITGA10;RPS28;MYL12A;RPS19;RPS7;RPS14;EFNB2;ARHGEF11;ARHGEF28;RPS15;UBC;UPF3A;RPL28;LAMA2;ITGAV;CLTA;RPL9;DNM3
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.5518122504308668,0.8361704767703388,0.7843137254901961,1.0,1.0,1/8,2.20%,UIMC1
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.45002572965153154,-0.8361597957814173,0.6382978723404256,0.9553090592296278,1.0,2/12,4.75%,SLC5A6;SLC38A3
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.5535688159842695,0.8354501672338506,0.7288135593220338,1.0,1.0,2/5,27.92%,ANK2;MDM4
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreatic Acinar Tissue,-0.49181429146906513,-0.8352462137822008,0.5882352941176471,0.9553862611961853,1.0,1/8,6.99%,LCP2
prerank,CellMarker_Augmented_2021__Definitive Endoderm cell:Germ,-0.49181429146906513,-0.8352462137822008,0.5882352941176471,0.9553862611961853,1.0,1/8,6.99%,LCP2
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreatic Acinar Tissue,-0.49181429146906513,-0.8352462137822008,0.5882352941176471,0.9553862611961853,1.0,1/8,6.99%,LCP2
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.48899300899221104,-0.8349969853746037,0.6792452830188679,0.9552608079849171,1.0,2/10,6.51%,UFL1;SRARP
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,-0.48980000846262917,-0.8349527953996266,0.65,0.954313997739397,1.0,1/12,2.39%,FN1
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.48980000846262917,-0.8349527953996266,0.65,0.954313997739397,1.0,1/12,2.39%,FN1
prerank,CellMarker_Augmented_2021__Granulosa cell:Undefined,0.37396219174174067,0.8344249391033529,0.8048780487804879,1.0,1.0,10/40,15.43%,COL4A2;HSPG2;NTM;PARVA;ADGRL4;MPDZ;DST;PTPN21;ADGRL2;RAI14
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.455122985142765,0.8343839308095227,0.6046511627906976,1.0,1.0,5/13,26.75%,BTRC;SPOPL;ITCH;TRAF3;ASPH
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,-0.3127256465708061,-0.8340051929717738,0.7941176470588235,0.9554850277091825,1.0,37/226,14.93%,PSMA1;PSMB9;RPS12;RPL31;ATP6V1E1;RPL34;NR3C2;RPS8;RPL15;RPS6;RPL7A;MAP3K5;RPL38;ANAPC16;RPL23;NFKB1;FOS;RPL30;JUN;ERO1A;RPS28;RPS19;RPS7;RPS14;RPS15;UBC;UBE2D2;RPL28;RORA;NPLOC4;ATM;RPL9;EEF1A1;NUP54;RPL37;COX6C;PARN
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.5639577536304555,0.8339195573821429,0.7045454545454546,1.0,1.0,1/7,14.26%,NRP1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.43058423879312596,0.8336286724959713,0.6808510638297872,1.0,1.0,4/14,9.93%,CLIC1;ACTG1;HSPB1;ACTB
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.32609040170230197,-0.8331852937865631,0.8166666666666667,0.9563380927164034,1.0,21/117,15.88%,HGSNAT;HLA-B;HLA-C;HEBP2;LGALS3;IGF2R;TMEM30A;B2M;SLC2A3;NFKB1;CDA;CD47;CST3;BST2;ITGAV;HLA-A;EEF1A1;PDXK;STOM;RHOA;SRP14
prerank,KEGG_2021_Human__VEGF signaling pathway,0.4140561923472045,0.8331836430731008,0.625,1.0,1.0,9/25,18.88%,KRAS;PIK3CA;HSPB1;PPP3CA;PPP3CB;CDC42;RAC1;PRKCA;PXN
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.4251683492478022,-0.8326514529107034,0.7192982456140351,0.9566363437849015,1.0,2/35,2.36%,SLC16A2;TPM1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.5370825987644963,0.8326168981990185,0.7916666666666666,1.0,1.0,2/8,6.45%,SLCO2A1;MAP7
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.5071341752857078,-0.8323037005890119,0.7169811320754716,0.9566857252328209,1.0,5/12,29.38%,ATM;MDM2;KDM1A;XRCC5;WRN
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.5067809861705352,0.8319905973691623,0.6862745098039216,1.0,1.0,2/7,17.24%,REST;ANXA1
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,0.44390419507070855,0.8318768407700001,0.7317073170731707,1.0,1.0,2/10,21.54%,SLC16A1;DEAF1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.5640278149186614,-0.8318501002845577,0.7222222222222222,0.9570794311027581,1.0,4/5,33.65%,APC;CTNNB1;GSK3B;LRP6
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.39720258542443543,0.8315502223663356,0.6545454545454545,1.0,1.0,9/28,17.80%,SMAD9;SMAD6;SMAD1;SMAD5;SKI;LEMD3;SMURF2;ATP2B4;ACVR2A
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.41115107992458316,-0.8312913909127133,0.7142857142857143,0.957619407510163,1.0,11/39,18.27%,RFC3;RPL23;TOPBP1;MAPKAP1;RPS15;ATM;BRD7;RPL37;SMYD2;RPL11;MAPK14
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.4853205431711089,-0.83110033084174,0.7407407407407407,0.9574031177924789,1.0,4/12,14.18%,ABCA5;SCARF1;LBR;LSS
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.4039539052687506,0.8305283106204918,0.6071428571428571,1.0,1.0,7/26,21.46%,CDH2;ACTG1;ACTB;CDH12;PRKCA;CTNND2;FSCN1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.5450253149609305,0.8302303183002664,0.7333333333333333,1.0,1.0,1/5,5.95%,CNOT2
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.5337237539617297,0.8300998907805006,0.7291666666666666,1.0,1.0,2/7,8.05%,UBE2B;PEX5L
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.353502125139945,0.8298865115172789,0.7954545454545454,1.0,1.0,9/50,15.83%,COL4A2;NTM;GULP1;PARVA;MPDZ;PTPN21;ADGRL2;PDZRN3;ANK2
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.4361408227073286,-0.8298272738987591,0.6875,0.9591597525077009,1.0,3/17,8.69%,MAP2;PRKN;GOSR1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.4980004031332374,-0.8287945346543207,0.7166666666666667,0.9604863383081615,1.0,3/9,15.64%,ATM;MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.48229902124607305,-0.8287391983633445,0.7254901960784313,0.9600267385908237,1.0,1/7,4.59%,RFC3
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,-0.38475861779592857,-0.8283676484054208,0.7192982456140351,0.9601415943055434,1.0,7/50,8.71%,PSMA1;PSMB9;NLRC5;SMAD3;NFKBIA;NFKB1;TANK
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,0.32754374854960994,0.8281902557401042,0.8292682926829268,1.0,1.0,9/68,12.06%,HDAC9;PSMD14;ATP2A2;YWHAZ;TLE4;SEM1;HDAC7;CCNC;CNTN1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.5071340873944381,-0.8277994240821468,0.6875,0.9601179918532118,1.0,1/5,4.01%,PRKN
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.5071340873944381,-0.8277994240821468,0.6875,0.9601179918532118,1.0,1/5,4.01%,PRKN
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,-0.43416254335341886,-0.8277651053573575,0.6976744186046512,0.9596483651934339,1.0,5/15,12.70%,ITGB5;LAMA4;SERPINE1;LAMA2;ITGAV
prerank,CellMarker_Augmented_2021__Stem cell:Adipose Tissue,-0.5049031936977676,-0.8267718081913475,0.6444444444444445,0.960841189930394,1.0,2/5,25.18%,CD34;ABCG2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.4573595442764037,-0.8267153258474944,0.6346153846153846,0.9604165741153213,1.0,1/18,2.34%,CENATAC
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.5520057234202445,0.826679805681319,0.7586206896551724,1.0,1.0,1/5,6.14%,PKM
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.4296812075584654,-0.8266687863517378,0.6222222222222222,0.9599868141015174,1.0,4/16,13.44%,HLA-B;UBC;UBE2D2;HLA-A
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.5196524715528457,-0.8265015565105889,0.775,0.9597873471672391,1.0,1/9,1.20%,RHOBTB1
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,0.47339493500738133,0.8261822046461632,0.6170212765957447,1.0,1.0,3/9,15.56%,ANGPT2;PIK3CA;GRB2
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.45312593280685665,0.8261818485595022,0.6792452830188679,1.0,1.0,3/13,23.64%,ITGA1;CALM1;HSP90AB1
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,-0.38320342033389704,-0.8261084092924869,0.7454545454545455,0.9599914699947188,1.0,9/43,15.48%,IRF2;IRF1;CARMIL1;CBX5;RCOR1;JAK2;PRKAR1A;MFN1;MAFK
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.375976059191348,0.8252402733402131,0.7307692307692307,1.0,1.0,2/24,2.82%,CDH2;CADM2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.34070253775630327,0.8251783712688787,0.8,1.0,1.0,27/82,19.12%,SEMA3F;NCAM1;PIK3CA;HSP90AA1;ROBO2;NRCAM;NRXN1;KLF7;ACTB;GRB10;FRS2;RANBP9;NRXN3;NPTN;PPP3CB;EPHA4;NRP1;RPS6KA5;PARD3;GRB2;UNC5C;PLPPR4;PTEN;CYFIP1;ANK3;PRKCA;RYK
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,0.3375238345412709,0.8251714050335217,0.85,1.0,1.0,19/64,20.37%,INPP5F;OSBPL10;PITPNM2;PLEKHA1;PI4KA;SBF2;PIK3CA;TNFAIP8;DDHD1;MIGA1;CHPT1;SLC44A1;PTEN;PNPLA8;HADHB;MTMR3;MBOAT2;PITPNB;MTMR10
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Bone Marrow,-0.5021487385899858,-0.8251464477030102,0.6862745098039216,0.9611752525921615,1.0,2/8,17.26%,LCP2;GIMAP8
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.3595419068866923,-0.8249619684291951,0.8235294117647058,0.9609642712116707,1.0,6/85,4.54%,KLHL20;PSMA1;PSMB9;FN1;SHISA5;NUB1
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.49892188911168034,-0.8249135396721121,0.673469387755102,0.9605465706554417,1.0,1/7,9.85%,POLR2A
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.5198442838507014,-0.8248991071820876,0.7317073170731707,0.9600622432587734,1.0,2/7,11.71%,RFC3;UBC
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.4222935717628593,-0.8246351282241212,0.7090909090909091,0.9598857356147391,1.0,4/24,9.88%,PRKN;SRGAP2C;TFRC;CST3
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,0.3994247889661398,0.8244188183651029,0.6829268292682927,1.0,1.0,9/19,33.20%,CDC42;UNC5C;ABLIM3;TRPC1;PTK2;DSCAM;WASL;DOCK1;FYN
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.5597259663021696,-0.8238207343871432,0.7647058823529411,0.9606531311459121,1.0,2/5,20.58%,RAPGEF2;ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.43065528810297826,-0.8236458569097365,0.7142857142857143,0.9604318456773523,1.0,4/18,12.54%,SERPINE1;B2M;AHI1;CLU
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.3540672945552389,-0.8236266605570651,0.7540983606557377,0.9599374780916382,1.0,4/65,7.09%,PSMA1;PSMB9;LGALS3;LMO2
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,-0.39445089482010126,-0.8232200977909905,0.7333333333333333,0.9602297206481324,1.0,2/43,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.5047139587254119,-0.8227516034187049,0.7111111111111111,0.9603600589964248,1.0,1/6,2.36%,TPM1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.5021372723006879,0.8222058807971833,0.7115384615384616,1.0,1.0,1/6,5.31%,PCM1
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.48428504322027544,0.8220802859598796,0.6610169491525424,1.0,1.0,2/8,13.65%,NAA50;SMC1A
prerank,KEGG_2021_Human__Apelin signaling pathway,0.35768662129471784,0.8219425028400694,0.8222222222222222,1.0,1.0,9/45,16.52%,RRAS2;ITPR3;KRAS;PLCB1;GNB4;ITPR2;SLC8A1;CALM1;KLF2
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,-0.3931488241812422,-0.821560630314253,0.7704918032786885,0.9620161429513445,1.0,5/37,11.71%,PSMA1;PSMB9;CDC14A;JUN;UBC
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.5369554836701378,0.8214093727143323,0.7708333333333334,1.0,1.0,3/5,37.10%,WASL;ASAP1;SH3GLB1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.4849770598126478,-0.8212368095120893,0.7090909090909091,0.9620563160056828,1.0,1/14,2.82%,OPTN
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.4052037757783487,-0.8211265448380037,0.6825396825396826,0.9617737978070486,1.0,6/28,13.81%,MAP2;PRKN;ATXN7;LIMA1;CLU;SSH1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.3586763391822464,0.8210618873490211,0.7567567567567568,1.0,1.0,4/47,2.97%,HDAC9;TEAD4;RARB;TAF1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.5241047245728019,-0.8209140583067727,0.6829268292682927,0.9616695018912942,1.0,1/6,3.96%,ARIH2
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.42829568334781587,0.8208830525637477,0.6938775510204082,1.0,1.0,3/17,10.36%,ARHGEF4;CCDC88A;S1PR1
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,0.4632694935906667,0.8204941850603613,0.7058823529411765,1.0,1.0,3/9,15.54%,YY1;INO80;RAD23B
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,-0.3733190896844689,-0.8204844756227447,0.7857142857142857,0.9618098209921517,1.0,7/51,13.09%,MAP3K5;ANAPC16;NFKB1;FOS;JUN;UBC;ATM
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,0.4889502738982758,0.8201793123974707,0.7272727272727273,1.0,1.0,2/9,13.12%,AP1S2;HSPA8
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,-0.3967087194252952,-0.820164133273654,0.7068965517241379,0.9618777880287805,1.0,6/39,8.71%,PSMA1;PSMB9;NLRC5;NFKBIA;NFKB1;TANK
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Ovary,0.5124124296477336,0.8199511403717897,0.6981132075471698,1.0,1.0,4/6,9.83%,CDH2;ZEB1;ZEB2;ITGA5
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.39502761807172165,-0.819827516797041,0.6935483870967742,0.9619179272571723,1.0,3/27,8.98%,PPARG;ACER2;STAT5B
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,-0.4108315344808355,-0.8196799054469217,0.7,0.9617527526891758,1.0,5/30,7.60%,CHKA;PLA1A;AGPAT3;GPD2;GPCPD1
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.4066830747085559,-0.8196607324778155,0.6896551724137931,0.9612606105826138,1.0,7/34,11.77%,PSMA1;PSMB9;PLCG2;NFKBIA;NFKB1;UBC;UBE2D2
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.49516051740980627,0.8195986773665421,0.6666666666666666,1.0,1.0,3/9,16.49%,PLCB1;GNB4;CALM1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.4910106657004629,0.8194165434917532,0.7090909090909091,1.0,1.0,3/8,12.08%,TRAK1;TRAK2;LRRK2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Embryo,0.4797993460879797,0.819100877133197,0.7777777777777778,1.0,1.0,3/7,26.22%,MAP7;ARFGEF3;VWA2
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.4589231552214463,-0.8190614657244347,0.660377358490566,0.9617554501841932,1.0,4/15,12.54%,MAP3K5;FOS;EFNB2;CLU
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.48424203889159984,-0.8178640694356415,0.7083333333333334,0.9633298333533863,1.0,3/12,12.70%,NFKB1;CLU;ITGAV
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.5037981371366752,-0.8173327591018018,0.7291666666666666,0.963762127577641,1.0,3/9,13.68%,GNG4;GNA12;GNA14
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.4246619204761576,0.8173250743776653,0.6976744186046512,1.0,1.0,1/13,3.03%,HSP90B1
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.40097009428531327,-0.8170129464881828,0.7222222222222222,0.9638343178587512,1.0,2/30,1.51%,PSMA1;PSMB9
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,0.4816751265768212,0.8169293582330984,0.7307692307692307,1.0,1.0,2/11,7.46%,NUP58;RANBP2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gastrointestinal Tract,-0.3664703468505902,-0.8168418082151685,0.7428571428571429,0.9626252436672302,1.0,6/50,12.93%,PLK2;FN1;TMEM30A;ARHGEF28;ITGAV;FZD6
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Intestine,-0.3664703468505902,-0.8168418082151685,0.7428571428571429,0.9626252436672302,1.0,6/50,12.93%,PLK2;FN1;TMEM30A;ARHGEF28;ITGAV;FZD6
prerank,CellMarker_Augmented_2021__Mucous Acinar cell:Salivary Gland,-0.3664703468505902,-0.8168418082151685,0.7428571428571429,0.9626252436672302,1.0,6/50,12.93%,PLK2;FN1;TMEM30A;ARHGEF28;ITGAV;FZD6
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.3664059963971018,-0.816692221114167,0.6923076923076923,0.9623555899838484,1.0,7/61,7.14%,PPARG;STAT1;SP100;TIE1;PLXND1;SERPINE1;WARS1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.42917515202139705,-0.8166171900970828,0.7540983606557377,0.9619979383282286,1.0,2/23,6.72%,ATP9A;TMEM30A
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,0.4637692166080726,0.8163337793174245,0.673469387755102,1.0,1.0,3/13,7.54%,PIK3CA;PIGU;HSP90AA1
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,0.4637692166080726,0.8163337793174245,0.673469387755102,1.0,1.0,3/13,7.54%,PIK3CA;PIGU;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.32551604227912445,0.8162711199359001,0.7560975609756098,1.0,1.0,12/71,9.88%,SOX5;BMP6;CDH2;PRKD1;IL6R;ZEB1;IGFBP3;PLCB1;NRCAM;REST;ABL1;WDFY2
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.4797374882059307,-0.8161772965340907,0.660377358490566,0.9622804156790901,1.0,2/13,10.60%,VAV3;MAPKAP1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5138420370823932,-0.8160872191832006,0.6808510638297872,0.9619562612315706,1.0,3/6,17.05%,RPL23;RPS7;RPL11
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.41637568185602725,0.8159915587097344,0.6862745098039216,1.0,1.0,5/15,25.21%,LRRC7;PARD3;CDC42;OPHN1;MARK2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.5141141707231334,0.815971717752414,0.7377049180327869,1.0,1.0,1/6,6.14%,PKM
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.5104254711699,-0.8159300290165893,0.76,0.9617150916796167,1.0,1/8,6.40%,SRGAP2C
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.3715942119301946,0.8159045156122975,0.7346938775510204,1.0,1.0,3/24,7.54%,PEX14;PPP1R10;HSP90AA1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.5197736675949323,-0.8158471781312949,0.7307692307692307,0.9614026009868551,1.0,1/5,15.67%,PLEC
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.43068837367244706,-0.8158336801129165,0.6792452830188679,0.9609033366694426,1.0,4/15,16.31%,MAP3K5;TAOK3;MAP3K4;PDGFB
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5196051740022962,0.8158147571088505,0.734375,1.0,1.0,1/5,8.61%,ERCC6
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,-0.412451767613778,-0.8157074581482955,0.7222222222222222,0.9606081171025392,1.0,10/32,22.58%,SNX2;IGF2R;TFRC;HOMER2;CLTA;FTH1;AP4S1;HIP1R;CLINT1;AP1G1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.3464755493504939,0.8155824148999374,0.7560975609756098,1.0,1.0,15/56,21.65%,ERBB4;PRKD1;TAF1;PRKX;ABL1;LRRK2;EPHA4;PINK1;STK24;OXSR1;FES;TAOK1;DYRK1A;CDK12;EIF2AK3
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.4248224914848254,-0.8150899262160888,0.6724137931034483,0.9611213177887358,1.0,4/26,10.12%,PLCG2;VAV3;LCP2;INPP5D
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,0.39191790523731923,0.8150841913522672,0.6938775510204082,1.0,1.0,6/20,24.30%,AEBP2;ATF7IP;SETD7;SETD3;KMT5B;MECOM
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.42239798338862505,-0.8148040677778806,0.7592592592592593,0.9611614537096291,1.0,5/29,12.75%,SNX2;IGF2R;TFRC;HOMER2;CLTA
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.3956950656905583,-0.8147722005288914,0.765625,0.9606908446706406,1.0,3/35,5.71%,FN1;RNF213;RPS6
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5367803454406107,-0.8146473932426038,0.7777777777777778,0.9603305088474227,1.0,3/7,18.43%,PRKAR1A;RAPGEF2;PKIG
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.41859594451557813,0.8146421135135896,0.7674418604651163,1.0,1.0,1/16,2.92%,COG6
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4762570875959268,0.8146192199317841,0.7288135593220338,1.0,1.0,4/10,14.08%,UBQLN1;HSP90AA1;ZMIZ1;PINK1
prerank,KEGG_2021_Human__Shigellosis,0.3094985871974318,0.8146063122394117,0.8285714285714286,1.0,1.0,23/99,18.99%,IL1R1;ITPR3;ACTG1;MAPK10;BTRC;PLCB1;PIK3CA;DIAPH1;TAB2;CAPN2;ELMO1;ITGA5;ACTB;ITPR2;FOXO3;RPS6KA5;BCL2L1;CDC42;RAC1;WASF2;ROCK1;PXN;CRK
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,0.4340184216439522,0.8142900602627943,0.6888888888888889,1.0,1.0,8/19,21.38%,DUSP6;REST;ID3;PPP2CB;RPS6KA5;EP300;ID1;TCF12
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.40444022314570827,0.8142891690273444,0.7142857142857143,1.0,1.0,4/18,11.85%,CCDC88A;PCM1;DST;CLASP1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.4148682126581847,-0.8140798019838302,0.7073170731707317,0.9607440204028881,1.0,6/20,12.70%,PRKN;LGALS3;BST2;MTMR2;NDFIP1;ITGAV
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,0.4375881657111257,0.8138763478502233,0.7358490566037735,1.0,1.0,2/14,7.46%,NUP58;RANBP2
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,0.3425289754307302,0.8138153326356338,0.8571428571428571,1.0,1.0,6/67,10.84%,ARHGEF4;SRGAP1;VAPB;DIAPH1;ARHGAP31;ARHGAP23
prerank,CellMarker_Augmented_2021__Germline Stem cell:Ovarian Cortex,-0.3821063390070035,-0.8137379482667831,0.6851851851851852,0.9603258295654894,1.0,3/38,2.82%,GBP1;IFI27;OPTN
prerank,CellMarker_Augmented_2021__Germinal Stem cell:Ovary,-0.3821063390070035,-0.8137379482667831,0.6851851851851852,0.9603258295654894,1.0,3/38,2.82%,GBP1;IFI27;OPTN
prerank,CellMarker_Augmented_2021__Brown Adipogenic Precursor cell:Adipose Tissue,-0.43850454252145266,-0.8136818509305404,0.7708333333333334,0.9594323074990571,1.0,5/25,7.12%,EML1;CXCL12;DOK5;LAMA4;HMCN1
prerank,CellMarker_Augmented_2021__Beige Adipogenic Precursor cell:Adipose Tissue,-0.43850454252145266,-0.8136818509305404,0.7708333333333334,0.9594323074990571,1.0,5/25,7.12%,EML1;CXCL12;DOK5;LAMA4;HMCN1
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.42312739141371425,0.8131984052964762,0.75,1.0,1.0,4/15,12.88%,ACAT1;TPST2;LRRK2;AK3
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Undefined,0.337554052236375,0.8131615662815145,0.9459459459459459,1.0,1.0,30/89,29.99%,PCM1;BRWD1;RANBP2;BDP1;ZNF644;SREK1;MDN1;RBM26;TTC3;HERC1;TAOK1;PHIP;CEP290;ZNF292;HELZ;BPTF;PPIP5K2;NIPBL;RALGAPA1;SCAF8;DMXL1;PIKFYVE;PHF3;MKLN1;ARFGEF1;ZMYM4;HECTD1;TNKS;UBR5;NHLRC2
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.5311860037068737,0.8130945372429981,0.75,1.0,1.0,1/5,9.22%,PPM1F
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.4687888277151989,-0.8126427934230734,0.74,0.9606439494148487,1.0,3/15,17.05%,FHIT;N4BP1;RPL11
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.4557135847753524,-0.8124442905334004,0.7884615384615384,0.9599373295030441,1.0,3/9,13.63%,MVB12B;UBC;NMT2
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,-0.4557135847753524,-0.8124442905334004,0.7884615384615384,0.9599373295030441,1.0,3/9,13.63%,MVB12B;UBC;NMT2
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,0.36945982441683933,0.812245336730795,0.725,1.0,1.0,11/44,12.70%,PSMD14;NUP58;BTRC;AP1S2;SGIP1;RANBP2;SEM1;ELMO1;XPO1;PSIP1;AP2B1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5142276260410678,-0.8122396012186746,0.7647058823529411,0.9598194576129522,1.0,3/5,24.99%,ATM;PIK3C3;SQSTM1
prerank,CellMarker_Augmented_2021__Adventitial cell:Skeletal Muscle,0.40643912998209575,0.8120835842007516,0.7674418604651163,1.0,1.0,4/17,10.68%,NCAM1;ZEB2;ELMO1;CELF2
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.5354268442193685,0.8119583826511989,0.7222222222222222,1.0,1.0,2/6,19.10%,WDR82;SETD3
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.43199099468202873,-0.8117383480311381,0.6666666666666666,0.9601712085324551,1.0,6/17,12.70%,ITGB5;LAMA4;DMD;ACTN1;LAMA2;ITGAV
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.5100693021186445,0.8114209816961889,0.6792452830188679,1.0,1.0,1/5,1.67%,COL4A2
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5105799426614174,0.8112071028670236,0.8214285714285714,1.0,1.0,2/7,2.07%,TRIM5;BMP6
prerank,KEGG_2021_Human__Chagas disease,0.3686234686744303,0.8111215598617818,0.7659574468085106,1.0,1.0,6/33,13.39%,CALR;MAPK10;PLCB1;PIK3CA;PPP2CB;PPP2R2B
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.41982171288619385,-0.8110631267590519,0.7169811320754716,0.9607026453800361,1.0,1/16,2.23%,PLCG2
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.48244381728613916,-0.8109388591972491,0.7321428571428571,0.960360962476807,1.0,5/10,22.50%,PRKN;CLU;OPA1;HERPUD1;RACK1
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.431677523171129,0.8107929890399226,0.7058823529411765,1.0,1.0,6/11,32.40%,ADAM15;GRAMD1A;SPIDR;CTNNA1;KLF9;ADCY2
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.38357715158508254,0.8097475792075617,0.76,1.0,1.0,3/27,7.28%,UBQLN1;HSP90B1;STT3B
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.4146770056732741,0.8092037887958098,0.6666666666666666,1.0,1.0,5/15,13.68%,CLIC1;ACTG1;HSPB1;ACTB;CD99
prerank,KEGG_2021_Human__IL-17 signaling pathway,0.4089785758673861,0.8091461615140627,0.6976744186046512,1.0,1.0,4/21,8.15%,HSP90B1;MAPK10;HSP90AA1;TAB2
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,0.43060174128010836,0.8089676314333542,0.6935483870967742,1.0,1.0,6/20,17.64%,XPO1;NCOA2;CRTC3;CREBBP;EP300;NCOA1
prerank,KEGG_2021_Human__Taste transduction,0.5325589923981031,0.808778060561665,0.7708333333333334,1.0,1.0,3/7,11.13%,ITPR3;PLCB1;CACNA1C
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.36696848123332826,-0.8082925226909543,0.7192982456140351,0.9641784269288572,1.0,6/63,9.27%,CX3CL1;ULK4;CTNNA2;NTNG1;KIDINS220;SCARF1
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,-0.3752307202954659,-0.8082196094653382,0.7906976744186046,0.9637644412958506,1.0,2/40,2.74%,PPARG;FAM120B
prerank,CellMarker_Augmented_2021__Sertoli cell:Fetal Gonad,-0.3299313708888902,-0.8079922826434648,0.7808219178082192,0.9636231342863896,1.0,17/150,10.52%,BTG2;SAT1;ITGB5;OPTN;IL32;SMARCA1;ACSL4;ARAP2;PPP1R9A;DSP;DMD;LIMCH1;TAOK3;DDX24;CST3;NOSTRIN;GLCCI1
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,-0.5034914671005808,-0.8076455507626138,0.7307692307692307,0.9635527218331338,1.0,1/12,3.13%,CLIC5
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.5124955086720925,0.8075819934651479,0.7843137254901961,1.0,1.0,1/5,19.36%,JARID2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.3549536895727064,0.8074457832369711,0.875,1.0,1.0,5/36,14.08%,UBQLN1;SLC38A9;PIK3CA;LRRK2;PINK1
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,0.4825323721397264,0.8073220670886594,0.8363636363636363,1.0,1.0,5/10,21.38%,REST;ID3;EP300;ID1;TCF12
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,-0.49450247973445566,-0.8072799823794866,0.7083333333333334,0.963585725220808,1.0,2/10,11.71%,PRKN;UBC
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,-0.40005455313788196,-0.8068859057281353,0.7962962962962963,0.9637111077828822,1.0,7/23,17.74%,HMGN1;RFC3;POLR2A;UBC;RNF111;XPC;POLK
prerank,KEGG_2021_Human__Gastric cancer,0.3725978478616858,0.8067822905833517,0.8636363636363636,1.0,1.0,3/41,7.01%,RARB;KRAS;PIK3CA
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,-0.5010692740029602,-0.8065325716321909,0.7083333333333334,0.963662493607329,1.0,2/5,33.09%,CABIN1;EP400
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.3747408008162285,-0.8064914889238707,0.7419354838709677,0.9632392352929567,1.0,8/51,9.11%,MAP2;GPM6A;CTNNA2;NTNG1;ZDHHC17;MEF2A;TAOK3;S100A6
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.4771150983149854,-0.8063853101092069,0.6415094339622641,0.9629032648380482,1.0,3/6,17.21%,BLCAP;ACIN1;KPNB1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.47969599566407517,0.8063573172028609,0.6545454545454545,1.0,1.0,2/6,12.88%,LRRK2;AK3
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.47969599566407517,0.8063573172028609,0.6545454545454545,1.0,1.0,2/6,12.88%,LRRK2;AK3
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.44910502281902254,-0.8063337202485832,0.7358490566037735,0.9620263624697503,1.0,2/13,4.01%,GABARAPL1;PRKN
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.44910502281902254,-0.8063337202485832,0.7358490566037735,0.9620263624697503,1.0,2/13,4.01%,GABARAPL1;PRKN
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.4652295459048694,0.8060389832145118,0.7543859649122807,1.0,1.0,4/9,28.45%,PTEN;PHLDB2;BCAS3;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.4652295459048694,0.8060389832145118,0.7543859649122807,1.0,1.0,4/9,28.45%,PTEN;PHLDB2;BCAS3;CORO1C
prerank,CellMarker_Augmented_2021__Liver Bud Hepatic cell:Liver,0.36554038928157023,0.8060369304098516,0.7380952380952381,1.0,1.0,10/47,10.54%,IL1R1;UGP2;NDUFAF2;MT2A;CD58;MBNL1;CPNE8;HSPB1;MT1M;KHDRBS3
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.3994129668498591,0.8059225721616018,0.7272727272727273,1.0,1.0,8/21,21.33%,NAV3;HSP90AA1;CLASP1;PINK1;RAC1;FES;CDK5RAP2;CLIP1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.38557772516606825,0.8058821168754174,0.7,1.0,1.0,8/28,17.66%,TAF1;ABL1;IDE;RALB;PPP2CB;LRRK2;PSEN1;TIAM1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.4105684670050621,-0.8058446597777462,0.7115384615384616,0.9622768059947963,1.0,2/17,2.26%,RIMS1;PLK2
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.3745617937229385,-0.8057590472893404,0.7954545454545454,0.9619203890914603,1.0,2/41,2.74%,PPARG;FAM120B
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3872942234324129,-0.805682501766483,0.7142857142857143,0.9615102165800544,1.0,2/39,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.41251529700998146,0.8056194022677163,0.7321428571428571,1.0,1.0,5/14,17.56%,SLC38A9;CAPN2;CPEB3;SESN1;CPEB4
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.5117104482884657,-0.8052670374757979,0.7021276595744681,0.9617875876741212,1.0,2/5,18.62%,RPL11;EPAS1
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,0.3404628429436103,0.8051803393337598,0.8048780487804879,1.0,1.0,3/56,6.27%,PRPF8;U2SURP;HNRNPR
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.536270418825903,0.8049381098210379,0.72,1.0,1.0,2/5,33.31%,RC3H1;DYNC1H1
prerank,Reactome_2022__NOTCH2 Intracellular Domain Regulates Transcription R-HSA-2197563,-0.5547928842863316,-0.8047712765401422,0.775,0.9620862962179779,1.0,1/5,7.22%,MAML3
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.5169732130077712,-0.8045919908643132,0.717391304347826,0.9617523493156059,1.0,2/5,21.54%,PARN;CHD1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5115235742959456,0.8043853199626672,0.8125,1.0,1.0,2/6,12.40%,HSP90AA1;HSPD1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.4957744569417144,-0.8043737876006531,0.7058823529411765,0.9615429949510599,1.0,1/9,5.50%,NGLY1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.32982053800123645,0.8043043330806237,0.9375,1.0,1.0,16/65,22.76%,VAPB;PRKD1;FAM174B;HACE1;ATP8B1;CLASP1;LRRK2;LEMD3;VMP1;CDC42;ANK3;TOR1AIP2;WASHC4;ATL2;EIF2AK3;TRAPPC8
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Salivary Gland,-0.39981704478613966,-0.8042968154848276,0.7166666666666667,0.9611287015373319,1.0,6/34,12.93%,FN1;CD109;SERPINE1;LIMA1;ITGAV;FZD6
prerank,CellMarker_Augmented_2021__Basal Progenitor cell:Breast,0.5099106843301157,0.8042434557166663,0.7272727272727273,1.0,1.0,1/5,4.83%,ITGA2
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,0.4885257171320999,0.8039192381966036,0.782608695652174,1.0,1.0,1/8,5.42%,BRWD1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.4386674783336226,-0.8039093768269251,0.6808510638297872,0.9611519274538125,1.0,4/14,17.53%,AGPAT3;CBR4;LSS;PDSS2
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.36177222100693146,0.8035698956698594,0.8604651162790697,1.0,1.0,12/50,20.11%,SLC25A37;HSP90AA1;LARP4;ZEB2;SAMD4A;CPEB3;EIF3E;STARD4;APPL1;KLF2;EDN1;RGCC
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.5435576075489352,-0.8034343661767862,0.7555555555555555,0.9613746793846109,1.0,4/5,28.58%,LARP1;RPTOR;CLEC16A;MTOR
prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.37670787112589066,0.8031823508912731,0.7333333333333333,1.0,1.0,7/36,15.56%,BCR;KRAS;CTBP2;PIK3CA;ABL1;BCL2L1;GRB2
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.5136612786181802,0.802899636177662,0.7254901960784313,1.0,1.0,2/6,25.76%,PARG;SETD5
prerank,CellMarker_Augmented_2021__Proximal Tubular cell:Kidney,0.4752385986031805,0.8025359776864832,0.7551020408163265,1.0,1.0,1/9,1.22%,MMRN1
prerank,"Reactome_2022__PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",0.4784750268071343,0.8022104673135839,0.6666666666666666,1.0,1.0,2/7,18.99%,ELMO1;CRK
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.42129720982083874,0.8021286583579997,0.7317073170731707,1.0,1.0,3/14,17.95%,CBFB;EP300;CNOT4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.4563827395959944,-0.801674536085011,0.734375,0.9638126602288585,1.0,2/12,9.85%,TAF1D;POLR2A
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.48386932930675297,-0.801583462420208,0.7241379310344828,0.9634842465662519,1.0,6/9,33.25%,UNC13B;RACK1;ZBTB20;GAS6;PCK1;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.4531628604109595,-0.8015468317545862,0.6491228070175439,0.9630215586514552,1.0,3/13,16.20%,PRKN;TMEFF2;TJP1
prerank,CellMarker_Augmented_2021__Endothelial cell:Adipose Tissue,-0.5436684876438698,-0.8013041884142633,0.8,0.9629253279304157,1.0,4/6,35.46%,CD34;ABCG2;PECAM1;PROM1
prerank,KEGG_2021_Human__Adherens junction,0.3554377803348624,0.8012202841494424,0.782608695652174,1.0,1.0,11/42,18.59%,ACTG1;YES1;ACTB;NLK;PARD3;CDC42;NECTIN3;CREBBP;EP300;RAC1;WASF2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Cartilage,0.34487587298409333,0.8005823574914477,0.8611111111111112,1.0,1.0,8/50,15.43%,COL4A2;ALCAM;PARVA;MPDZ;DST;PTPN21;ADGRL2;RAI14
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.5047715287803517,-0.8005005144576942,0.5952380952380952,0.9638404716352268,1.0,2/5,22.92%,FOXO1;RHEB
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.418275794923032,0.8004011175783077,0.6808510638297872,1.0,1.0,1/15,2.07%,BMP6
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.4415958758240075,-0.8003080917635507,0.6785714285714286,0.9635880000264891,1.0,3/16,6.99%,PLCG2;VAV3;LCP2
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.3596991980035097,-0.799883089064087,0.8032786885245902,0.9637710447106361,1.0,2/42,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Subcutaneous Adipose Tissue,-0.393844099873773,-0.799836696503349,0.7021276595744681,0.9633362711921638,1.0,3/26,8.53%,CLEC1A;CPQ;CDA
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.4371328603112263,-0.7993347059512255,0.6935483870967742,0.9636266131351612,1.0,2/16,2.23%,GBP1;PLCG2
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.45344210526427453,0.7992832790920993,0.7450980392156863,1.0,1.0,2/9,17.24%,REST;ANXA1
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,0.4220740843797969,0.799186740414247,0.7560975609756098,1.0,1.0,6/20,18.67%,PLCB1;AP2B1;SLC8A1;ATP2B4;ATP1A1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.41522645881782433,0.798900865842996,0.75,1.0,1.0,4/13,20.82%,PLCB1;ANXA1;RGCC;ADAM17
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.37606269775834344,-0.7987876260511788,0.7704918032786885,0.9640346824215328,1.0,5/43,7.68%,PSMA1;PSMB9;PLCG2;NFKBIA;NFKB1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.49203578915967117,0.7982496982373629,0.6808510638297872,1.0,1.0,4/7,40.11%,CDK5RAP2;NDEL1;ITGB1;GJA1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.360534366559629,0.7978100363338407,0.7674418604651163,1.0,1.0,5/39,7.54%,PSMD14;AVEN;TUBB4B;PCM1;HSP90AA1
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.3714870477557048,-0.7976338726699316,0.7575757575757576,0.9653646308988737,1.0,5/43,7.68%,PSMA1;PSMB9;PLCG2;NFKBIA;NFKB1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.498284791083077,-0.7974554516337224,0.6122448979591837,0.9651282327403548,1.0,1/6,1.54%,SOD2
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5001258106318285,0.7974295259982396,0.7708333333333334,1.0,1.0,1/6,16.84%,BAZ2A
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.45451050525580616,-0.7973247853493931,0.75,0.9647903052581958,1.0,1/10,1.57%,RIMS1
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.4231674999262417,0.7967647632466661,0.7115384615384616,1.0,1.0,2/15,6.85%,INPP5A;PLCB1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.4451522227544383,-0.7963332441877644,0.660377358490566,0.9659089769393189,1.0,2/7,6.56%,SLCO1A2;SLCO2B1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.448601686484277,-0.7962416707875953,0.7446808510638298,0.9655014310358438,1.0,6/20,12.96%,UFL1;NUB1;RPL23;RPS7;CLU;GNA12
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.441526186891171,-0.7961590360131652,0.7551020408163265,0.9651424444815845,1.0,1/12,0.56%,CYLD
prerank,CellMarker_Augmented_2021__Meiotic Prophase Fetal Germ cell:Fetal Gonad,-0.29576329600138634,-0.796148454371543,0.9577464788732394,0.9646555406091759,1.0,27/319,8.90%,KLHL20;LRPAP1;IFIH1;ABCA5;ZNF43;MAP3K2;PLK2;HLA-B;UFL1;ZRANB2;RNF19A;ARIH2;GIT2;NGLY1;ZDHHC17;MEF2A;ADSS2;PAXBP1;WARS1;FOXK1;EFCAB13;B2M;RANBP17;SCML1;SENP7;TANK;RUNDC3B
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,0.41744341304327626,0.7960976292202712,0.7111111111111111,1.0,1.0,5/12,26.93%,GALNT2;GALNT10;C1GALT1;ST6GALNAC3;GALNT18
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.5218836398724762,0.7960754722851404,0.74,1.0,1.0,2/5,17.24%,PPP3CA;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.45474891122854977,0.7957586908207249,0.6727272727272727,1.0,1.0,2/8,8.87%,PCM1;REST
prerank,CellMarker_Augmented_2021__Germ cell:Gonad,0.5253822155918774,0.7956180577305991,0.7735849056603774,1.0,1.0,1/7,6.03%,WDPCP
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,0.3440370052195861,0.7955801355386118,0.8888888888888888,1.0,1.0,2/45,3.53%,ANO5;ATP2A2
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.4392645733573318,-0.7954494551852391,0.7692307692307693,0.9652750814385839,1.0,5/19,12.62%,TPM1;MEF2A;DMD;NID1;LAMA2
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.3865933001051534,0.7954409750943513,0.7872340425531915,1.0,1.0,11/22,33.89%,CLASP1;INO80;SMC1A;NEK7;ZNF207;STARD9;TNKS;OFD1;STAG1;TOGARAM1;MAPRE2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.39825236350288906,-0.7948384822887552,0.6721311475409836,0.965733779886443,1.0,7/29,16.04%,LRPAP1;PRKN;ACER2;CLU;TBK1;RAMP3;NPAS2
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.48097543326868863,0.7947995462426295,0.6923076923076923,1.0,1.0,4/8,22.82%,PLCB1;GNB4;CDC42;AKT3
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,0.28780005333786934,0.7947166781878171,1.0,1.0,1.0,42/165,21.59%,PSMD14;MCPH1;YWHAB;UIMC1;TUBB4B;PCM1;NUP58;BTRC;AHCTF1;SYNE2;RANBP2;HSP90AA1;YWHAZ;WAPL;ABL1;SEM1;XPO1;PPP1CB;YWHAQ;HERC2;CLASP1;PPP2CB;LEMD3;ANKRD28;SMC1A;NEK7;SHQ1;TUBA1B;POT1;EP300;PPP6R3;RNF168;PPP6C;PRKCA;YWHAG;TAOK1;DYRK1A;CEP290;CDK5RAP2;CLIP1;PPP2R5E;FBXL7
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,0.4919271076901241,0.7939791199064004,0.6792452830188679,1.0,1.0,2/9,25.07%,ST8SIA4;ST6GALNAC3
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.4314604552967891,0.7939217228814958,0.75,1.0,1.0,6/18,16.57%,SNAP25;CTBP2;DNAJC5;TRIOBP;CAPZB;ATP2B4
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.4256167414752383,-0.7938180273020482,0.717391304347826,0.966811108538178,1.0,3/15,13.09%,NDRG1;ACER2;ATM
prerank,CellMarker_Augmented_2021__Thecal cell:Ovary,0.4594969951914069,0.79365163062719,0.813953488372093,1.0,1.0,2/15,9.83%,IL1R1;ITGA5
prerank,CellMarker_Augmented_2021__Zymogenic Chief cell:Gastric Epithelium,0.4594969951914069,0.79365163062719,0.813953488372093,1.0,1.0,2/15,9.83%,IL1R1;ITGA5
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.33499329453655335,0.7931338016730838,0.8717948717948718,1.0,1.0,7/71,9.93%,IL1R1;ACTG1;MAPK10;TUBB4B;TAB2;ABL1;ACTB
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.5261106635421917,0.7929990835492694,0.7884615384615384,1.0,1.0,4/6,37.72%,PTEN;MAP4K4;MAPRE2;IQSEC1
prerank,Reactome_2022__Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,0.44992877322912256,0.792816131608836,0.7543859649122807,1.0,1.0,1/6,8.15%,TAB2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.5359800634861217,-0.7927143581839539,0.7446808510638298,0.9681273628491124,1.0,2/5,21.33%,MICU1;TGM2
prerank,CellMarker_Augmented_2021__Villous Stromal cell:Placenta,0.4116200311226752,0.7917091930872527,0.7777777777777778,1.0,1.0,2/16,1.73%,COL4A2;HSPG2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.4843493170679205,-0.7916123996830141,0.7142857142857143,0.9694369173265064,1.0,2/7,5.92%,SP100;SUN1
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Brain,0.34447188268125145,0.7913709417977578,0.813953488372093,1.0,1.0,3/43,3.43%,GRIK2;ACTG1;GRIA2
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.4436973700913145,-0.791317985446638,0.7755102040816326,0.9694715241653481,1.0,2/12,5.60%,CD109;SERPINE1
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.4764519547075904,0.7911984313674532,0.7291666666666666,1.0,1.0,2/10,12.35%,GNB4;NPTN
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,-0.4949488220287762,-0.7911942277616479,0.7021276595744681,0.9691545758084842,1.0,2/8,6.80%,SCN3A;SCN2A
prerank,CellMarker_Augmented_2021__Pericyte:Brain,-0.41920826438645437,-0.7911701914784848,0.7272727272727273,0.9687048742699734,1.0,3/17,4.04%,FN1;CXCL12;LAMA4
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.43457952702056935,0.7910033799077821,0.7291666666666666,1.0,1.0,8/16,21.33%,NAV3;ABL1;CLASP1;RAC1;FES;DYRK1A;CDK5RAP2;CLIP1
prerank,KEGG_2021_Human__Colorectal cancer,0.36227218505321146,0.7900138487258214,0.8125,1.0,1.0,8/39,17.77%,RALA;MAPK10;KRAS;PIK3CA;RALB;GRB2;APPL1;RAC1
prerank,CellMarker_Augmented_2021__Platelet:Undefined,-0.5023581243989008,-0.7894044327945571,0.7307692307692307,0.9710435940305542,1.0,3/8,18.14%,ITGAV;LRRC32;BSG
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.37731961192177244,0.7893488753988307,0.7755102040816326,1.0,1.0,9/25,19.12%,NREP;NRCAM;KLF7;ACTB;RTN4;PARD3;PLPPR4;ANK3;RYK
prerank,CellMarker_Augmented_2021__Stem cell:Gastrointestinal Tract,0.32270701853824996,0.7886957057845353,0.875,1.0,1.0,8/52,16.71%,GOLM1;ALCAM;ZMYND11;FRS2;SMAD5;ADGRL2;GAREM1;MIB1
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.5075870872654573,0.7884029678777905,0.75,1.0,1.0,2/6,24.30%,SETD7;MECOM
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.5152458605150129,0.7881717446596768,0.8292682926829268,1.0,1.0,2/6,25.82%,USP22;FGFR1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.41758180881590473,0.7880692419410723,0.7619047619047619,1.0,1.0,4/19,16.39%,ACTG1;MICALL2;PARD3;ESAM
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.39036573564805704,0.7877343311775495,0.7291666666666666,1.0,1.0,8/26,11.13%,ACTG1;ATP2A2;ITGA2;ITGA1;TPM4;ITGA5;ACTB;CACNA1C
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.4221374790562492,0.7875253768397201,0.75,1.0,1.0,4/15,24.12%,PPM1F;HSPA8;PTPN1;GAPVD1
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.48471579858078967,-0.7872612963586957,0.717391304347826,0.9740286564743297,1.0,1/6,1.57%,RIMS1
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Small Intestine,-0.4012286803376627,-0.7867098430134083,0.8070175438596491,0.974310600032768,1.0,4/35,7.12%,TPM1;FN1;LAMA4;HMCN1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.37529607734901443,0.7865873799371444,0.775,1.0,1.0,9/20,22.55%,CBFB;HSPA9;CREBBP;EP300;CNOT4;FES;ZBTB16;CDC73;CDK6
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,0.3251299048492887,0.7865383801456646,0.813953488372093,1.0,1.0,3/57,6.27%,PRPF8;U2SURP;HNRNPR
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4702589730268306,0.7863365495331731,0.7291666666666666,1.0,1.0,2/8,10.60%,MED4;SETX
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.506804041417433,0.785950162038593,0.8113207547169812,1.0,1.0,1/6,14.21%,MFF
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.40888974939603095,0.785877207513923,0.7555555555555555,1.0,1.0,10/30,24.75%,HSPB1;ABL1;PPM1F;SH3BP5;SLC8A1;ADARB1;YWHAG;PTPN1;NF1;GNAQ
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.4616586470252102,-0.7858556102289168,0.7450980392156863,0.9753731535684379,1.0,3/11,20.19%,ALG11;ALG13;ST3GAL6
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.44886461449722614,-0.7856213626317369,0.7307692307692307,0.9752665152038786,1.0,1/6,8.07%,TRIM25
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.42082852272609417,0.7851370963244833,0.7804878048780488,1.0,1.0,4/21,7.04%,SLC26A3;NTM;ITGA1;SGIP1
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.39345464217449366,0.7851047101002255,0.7291666666666666,1.0,1.0,8/25,11.13%,ACTG1;ATP2A2;ITGA2;ITGA1;TPM4;ITGA5;ACTB;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.4736927788418459,0.7847528295220875,0.7647058823529411,1.0,1.0,2/11,3.13%,CALR;IL6R
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.5077181670114775,0.7846510886429948,0.8269230769230769,1.0,1.0,1/5,6.16%,MRTFA
prerank,Reactome_2022__Interleukin-6 Signaling R-HSA-1059683,-0.5077128894359737,-0.784504081946363,0.7619047619047619,0.9767095617026462,1.0,1/9,2.12%,STAT1
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,0.49954199903725527,0.7844480930255662,0.7962962962962963,1.0,1.0,2/7,25.07%,ST8SIA4;ST6GALNAC3
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone Marrow,0.3445142109901207,0.7843698758065217,0.8787878787878788,1.0,1.0,9/52,15.43%,COL4A2;HSPG2;PARVA;MAP4;ARHGAP23;MPDZ;PTPN21;ADGRL2;RAI14
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Adipose Tissue,0.3445142109901207,0.7843698758065217,0.8787878787878788,1.0,1.0,9/52,15.43%,COL4A2;HSPG2;PARVA;MAP4;ARHGAP23;MPDZ;PTPN21;ADGRL2;RAI14
prerank,CellMarker_Augmented_2021__Progenitor cell:Fetal Liver,0.3445142109901207,0.7843698758065217,0.8787878787878788,1.0,1.0,9/52,15.43%,COL4A2;HSPG2;PARVA;MAP4;ARHGAP23;MPDZ;PTPN21;ADGRL2;RAI14
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone,0.3445142109901207,0.7843698758065217,0.8787878787878788,1.0,1.0,9/52,15.43%,COL4A2;HSPG2;PARVA;MAP4;ARHGAP23;MPDZ;PTPN21;ADGRL2;RAI14
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Molar,0.3445142109901207,0.7843698758065217,0.8787878787878788,1.0,1.0,9/52,15.43%,COL4A2;HSPG2;PARVA;MAP4;ARHGAP23;MPDZ;PTPN21;ADGRL2;RAI14
prerank,CellMarker_Augmented_2021__Tumor-propagating cell:Undefined,0.3445142109901207,0.7843698758065217,0.8787878787878788,1.0,1.0,9/52,15.43%,COL4A2;HSPG2;PARVA;MAP4;ARHGAP23;MPDZ;PTPN21;ADGRL2;RAI14
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.4275926420736817,-0.7843251279169124,0.7254901960784313,0.9765227823359913,1.0,4/11,26.27%,LAMA2;PRX;UTRN;SREBF2
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,0.38023174084922523,0.7841546963516743,0.7894736842105263,1.0,1.0,4/29,5.76%,CDH2;GOLM1;HSP90B1;IGFBP3
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.38023174084922523,0.7841546963516743,0.7894736842105263,1.0,1.0,4/29,5.76%,CDH2;GOLM1;HSP90B1;IGFBP3
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.5270935614508852,0.7836135960504814,0.76,1.0,1.0,1/7,6.56%,SLC25A46
prerank,Reactome_2022__DNA Repair R-HSA-73894,-0.3289312557679294,-0.7834333220201509,0.8032786885245902,0.9774759705907086,1.0,13/65,15.38%,ISG15;HMGN1;RFC3;TRIM25;TOPBP1;BABAM2;POLR2A;MSH2;UBC;NPLOC4;ATM;RNF111;XPC
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.4621759789434089,-0.7826880395418396,0.7894736842105263,0.978120858896623,1.0,2/12,4.01%,OPTN;PRKN
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,-0.4201637159758442,-0.7824529045034405,0.7045454545454546,0.9779707108354277,1.0,4/16,8.31%,PLXND1;KIDINS220;FNBP1;TFRC
prerank,"Reactome_2022__TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",0.48064170572601905,0.7822612176182536,0.7708333333333334,1.0,1.0,1/5,8.15%,TAB2
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,0.48064170572601905,0.7822612176182536,0.7708333333333334,1.0,1.0,1/5,8.15%,TAB2
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,0.48064170572601905,0.7822612176182536,0.7708333333333334,1.0,1.0,1/5,8.15%,TAB2
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,0.48064170572601905,0.7822612176182536,0.7708333333333334,1.0,1.0,1/5,8.15%,TAB2
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,0.32050625253868614,0.7821163601466892,0.875,1.0,1.0,12/62,11.93%,PSMD14;YWHAB;UIMC1;AHCTF1;RANBP2;YWHAZ;SEM1;XPO1;YWHAQ;HERC2;CLASP1;PPP2CB
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.37647196429626767,0.7816807738087178,0.8043478260869565,1.0,1.0,6/23,13.33%,DSE;CHSY1;CHST15;MAT2A;GLCE;PAPSS2
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.46086500484118326,-0.781651526325986,0.75,0.978625264479507,1.0,2/8,15.75%,SMAD3;FOXO1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.3585321394496604,0.7815712948866569,0.7777777777777778,1.0,1.0,8/29,19.71%,FBXO7;TRAK1;TRAK2;MFF;PARD3;NLGN1;ZDHHC14;SEC63
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.4218917540362016,0.781437489712874,0.7894736842105263,1.0,1.0,2/15,8.15%,MAPK10;TAB2
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,-0.35917625104690076,-0.78040454901649,0.7647058823529411,0.9800462424163366,1.0,9/40,15.19%,TFRC;LBR;ARHGEF11;FMNL3;ARHGEF28;MCF2L;DAAM1;STOM;RHOA
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.3802847017908809,-0.7803283005978714,0.7719298245614035,0.9797472808858565,1.0,5/32,12.93%,PLCG2;CCDC88C;DIXDC1;UBC;FZD6
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3121848135055862,-0.7800420039504172,0.84375,0.9796494532169094,1.0,5/113,5.05%,PARP14;BTG2;CNOT8;PRKN;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.3690542007192519,0.7798701821304813,0.8541666666666666,1.0,1.0,12/30,27.78%,DIAPH1;CAPN2;ZEB2;CLIC4;PINK1;MFF;EP300;TAOK1;ARMH3;MARK2;RHOT1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.36420793931766954,-0.7797066455612015,0.8148148148148148,0.9797471665296326,1.0,2/37,4.01%,PLK2;PRKN
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.3700174769572737,-0.7796275578718604,0.7627118644067796,0.9793432315242582,1.0,10/34,13.23%,STAT1;SMAD3;NFKBIA;NFKB1;FOS;JUN;STAT5B;IFNGR2;RORA;JAK2
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,0.47531621162388876,0.7792755008826402,0.74,1.0,1.0,5/10,21.30%,NCOA2;CREBBP;EP300;NCOA1;CPT1A
prerank,KEGG_2021_Human__MAPK signaling pathway,0.29812681193211926,0.7785691692839339,0.9375,1.0,1.0,18/96,15.91%,IL1R1;RRAS2;ERBB4;MAPK10;ANGPT2;DUSP6;KRAS;HSPB1;TAB2;CACNA1C;NLK;RASA2;PPP3CA;HSPA8;PPP3CB;RPS6KA5;GRB2;CDC42
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.42333509084569887,0.7784833519911429,0.7592592592592593,1.0,1.0,2/14,6.85%,INPP5A;PLCB1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.42333509084569887,0.7784833519911429,0.7592592592592593,1.0,1.0,2/14,6.85%,INPP5A;PLCB1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.36792622284563553,0.7780707685113069,0.8,1.0,1.0,3/27,8.15%,MAPK10;BTRC;TAB2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.37771023801325954,-0.7778844810337584,0.8181818181818182,0.9815780791448844,1.0,9/29,13.49%,IFIH1;ISG15;HLA-B;EIF2AK2;CD47;BTNL9;AFAP1L2;SRGN;TBK1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Brain,0.490546936349068,0.7776195713334562,0.7619047619047619,1.0,1.0,2/10,8.45%,CHD7;SLC16A1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.41417746295090396,0.7775444200162073,0.8085106382978723,1.0,1.0,3/15,17.42%,MORF4L1;ZZZ3;EP300
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.5054354353067243,-0.777436717636146,0.8245614035087719,0.9811701924790236,1.0,1/6,14.42%,RAPGEF2
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.5054354353067243,-0.777436717636146,0.8245614035087719,0.9811701924790236,1.0,1/6,14.42%,RAPGEF2
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.4064385814006644,0.7769110039534742,0.8113207547169812,1.0,1.0,4/19,11.29%,FUT8;MAN1A2;STT3B;ST8SIA4
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.3700953225792934,0.776731115938423,0.8636363636363636,1.0,1.0,8/25,18.19%,AHCTF1;YTHDF2;SND1;BCL2L1;IHO1;CDC42;CALM1;UVRAG
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.5039286727226204,-0.7767283326900715,0.7115384615384616,0.9818780318024909,1.0,1/5,3.88%,MAP2
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,-0.3400597291326333,-0.7760788639655825,0.7966101694915254,0.9825008900087071,1.0,2/58,0.85%,CEMIP;OMD
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.412481928356386,-0.7760755452704932,0.7142857142857143,0.9820178376713192,1.0,1/12,2.12%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.44848298104823225,0.7760507606819653,0.7142857142857143,1.0,1.0,1/8,5.29%,CCDC88A
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.37307150620639007,0.7760028858327941,0.8048780487804879,1.0,1.0,3/26,7.01%,PLEKHA1;SBF2;PIK3CA
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.446984244160518,-0.775960635341968,0.717391304347826,0.9817562216884385,1.0,1/7,3.88%,MAP2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3662923082935644,-0.7756758044557504,0.819672131147541,0.9817157015633641,1.0,5/42,4.54%,UFL1;RNF19A;ARIH2;PRKN;NUB1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.4579835663423036,-0.775229526595868,0.6964285714285714,0.9813984270176734,1.0,4/9,23.51%,PABPC1;DHX36;ZFP36;ZFP36L1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.4579835663423036,-0.775229526595868,0.6964285714285714,0.9813984270176734,1.0,4/9,23.51%,PABPC1;DHX36;ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.4734866682161093,-0.775149928058497,0.7454545454545455,0.9810064203474019,1.0,1/11,5.60%,SERPINE1
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,0.4337486535440604,0.7747597335649852,0.8181818181818182,1.0,1.0,3/10,17.03%,ADAM10;MIB1;PSEN1
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,-0.3325755335416834,-0.7745426595703495,0.7758620689655172,0.9813756360936376,1.0,4/48,7.04%,PSMA1;PSMB9;SPC25;ANAPC16
prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.38395757529121355,-0.7744359942888922,0.7592592592592593,0.9809945306230002,1.0,6/41,10.89%,PLCG2;SERPINE1;RPS6;NFKB1;TFRC;IFNGR2
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.4389984930259505,-0.7743228867315107,0.723404255319149,0.9806871981756022,1.0,2/17,6.27%,PIGC;ZDHHC17
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,-0.3982048913287919,-0.7742794166011179,0.7777777777777778,0.9802753995600211,1.0,6/25,16.23%,GRK5;GNG4;PRKAR1A;RAMP3;PDE3B;GNAS
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.39843673027622145,-0.7739988493223164,0.7358490566037735,0.9802305644844715,1.0,1/16,2.42%,CNOT8
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.36789951452399483,-0.7739142606930239,0.8571428571428571,0.9798612883177685,1.0,4/25,10.97%,PPARG;NFKBIA;AHI1;RAB1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord,-0.4647884974461435,-0.7737670465856562,0.6904761904761905,0.97910818029816,1.0,1/5,18.03%,CD34
prerank,CellMarker_Augmented_2021__Urine-derived Stem cell:Urine,-0.4647884974461435,-0.7737670465856562,0.6904761904761905,0.97910818029816,1.0,1/5,18.03%,CD34
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.36005722164222803,-0.7735782316697981,0.8333333333333334,0.9788497791217748,1.0,6/33,14.26%,LGALS3;EIF2AK2;WARS1;TFRC;CLU;RIOK3
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.45312784654774496,-0.7735539960563779,0.6458333333333334,0.9783931671002664,1.0,3/6,28.98%,SUCLG2;ACOT9;ACACB
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.4651916081867863,0.7733101844781688,0.7547169811320755,1.0,1.0,2/6,13.55%,DIS3L2;SND1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.47517647487971204,-0.7731488772163616,0.8333333333333334,0.9785477997830314,1.0,3/10,13.07%,ABCA5;LBR;FAXDC2
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,0.3654461997164296,0.7730594233483083,0.8571428571428571,1.0,1.0,5/18,11.77%,UIMC1;ABL1;PPP4R2;SEM1;HERC2
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,0.3654461997164296,0.7730594233483083,0.8571428571428571,1.0,1.0,5/18,11.77%,UIMC1;ABL1;PPP4R2;SEM1;HERC2
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.3788813324277396,-0.7728810946454314,0.8275862068965517,0.9784309554754207,1.0,7/45,12.75%,POMP;SPAG1;RPL38;SMAD3;DMD;CLU;CLTA
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.40016003391212884,0.7727570475940156,0.8333333333333334,1.0,1.0,4/12,16.44%,RALA;NRP1;CDC42;NLGN1
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,-0.4367397936225851,-0.7726396252859039,0.9019607843137255,0.9783090149387836,1.0,2/12,11.71%,MVB12B;UBC
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.49975475693014104,-0.772627888280188,0.7291666666666666,0.9778119066994855,1.0,1/5,10.62%,LBR
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4398679244897329,-0.7725354318611368,0.82,0.9774611760160813,1.0,1/13,0.93%,KIAA1217
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,0.49113014907041114,0.7722872973536282,0.8461538461538461,1.0,1.0,2/6,25.07%,GCNT2;ST6GALNAC3
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,0.43793750429023115,0.772280669129558,0.813953488372093,1.0,1.0,3/12,12.70%,AP1S2;ELMO1;AP2B1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.4415923095960575,0.7721426636312495,0.75,1.0,1.0,4/11,32.51%,APPL1;C2CD5;INSR;PRKCI
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5007034172980215,-0.7714268884755168,0.7551020408163265,0.9786625148007517,1.0,4/8,21.12%,UBC;RNF111;XPC;CUL4A
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.3916473222606325,0.7712438794784846,0.8260869565217391,1.0,1.0,7/26,20.11%,CLASP1;GCNT2;PTEN;TIAM1;PHLDB2;FOXC1;RGCC
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.452583511709811,0.7712060390969832,0.7818181818181819,1.0,1.0,4/7,42.02%,AKAP12;ADCY2;ADCY9;GRM7
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.5445016703649702,-0.7711768042231913,0.8333333333333334,0.9786031576512988,1.0,2/5,9.19%,HLA-F;HLA-E
prerank,Reactome_2022__M Phase R-HSA-68886,0.2914770099994064,0.7711333929346287,0.9318181818181818,1.0,1.0,15/101,13.65%,PSMD14;MCPH1;TUBB4B;PCM1;NUP58;AHCTF1;RANBP2;HSP90AA1;WAPL;SEM1;XPO1;CLASP1;PPP2CB;LEMD3;SMC1A
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.31200652586249467,0.7709906829063277,0.9117647058823529,1.0,1.0,9/79,7.33%,PSMD14;RNF217;UBQLN1;TAF1;BTRC;FBXO7;FEM1C;RNF130;UBE2B
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.519078033277102,0.7707280802376245,0.8297872340425532,1.0,1.0,3/6,26.27%,ABL1;TOP1;TOP2B
prerank,KEGG_2021_Human__p53 signaling pathway,-0.3832786101896249,-0.7706482951935805,0.7843137254901961,0.9789339965198676,1.0,5/22,13.09%,SHISA5;SERPINE1;PMAIP1;ZMAT3;ATM
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,-0.3614735123289312,-0.7703970202098318,0.7457627118644068,0.9787809768020426,1.0,2/46,1.51%,PSMA1;PSMB9
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.31832059348445246,-0.7699394693687953,0.8793103448275862,0.979017852663081,1.0,11/104,9.38%,BTG2;UFL1;VAV3;RFC3;SAMHD1;ACER2;TAOK3;TOPBP1;TANK;BABAM2;CBX5
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,0.3783147888551139,0.7697971964221199,0.8292682926829268,1.0,1.0,5/37,7.65%,ITPR3;HSPG2;SNAP25;CTBP2;DNAJC5
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.3991365856100345,-0.7696840366124372,0.7241379310344828,0.9789324662656207,1.0,5/25,8.92%,STAT1;NFKBIA;NFKB1;FOS;JUN
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.42941100659548326,-0.7690285172537696,0.7884615384615384,0.9793974420698008,1.0,5/10,21.99%,MYCBP2;EFNB2;PDGFB;PTPN2;USP14
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreas,-0.3871839053994794,-0.7687981409693256,0.8032786885245902,0.9792548748433979,1.0,2/31,3.88%,ATP9A;MAP2
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.5218311058984115,-0.7684165611346787,0.6976744186046512,0.9793198930461392,1.0,1/5,4.01%,PRKN
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,-0.4667633661214467,-0.7682363633465689,0.8095238095238095,0.9791775090857678,1.0,1/12,2.12%,STAT1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.5081433894605071,0.7681858870872066,0.803921568627451,1.0,1.0,3/5,14.08%,UBQLN1;REST;PINK1
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Placenta,0.41284611824846196,0.7678072224298335,0.7317073170731707,1.0,1.0,7/22,13.49%,COL4A2;SEMA3F;SLCO2A1;PARVA;ARHGAP23;PTPN21;ADGRL2
prerank,KEGG_2021_Human__Endometrial cancer,0.36641949504436927,0.7678041962884676,0.7894736842105263,1.0,1.0,10/29,28.07%,KRAS;PIK3CA;FOXO3;GRB2;PTEN;AKT3;SOS2;CTNNA1;CTNNA3;TCF7L2
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,-0.3571317599143996,-0.7678001804427907,0.8,0.9792994894155599,1.0,3/49,2.23%,SLC16A2;STAT1;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.46284603410498026,0.7675794352833605,0.7547169811320755,1.0,1.0,1/5,9.22%,PPM1F
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.4764244852302085,0.7674480327849309,0.7450980392156863,1.0,1.0,2/6,18.30%,CLASP1;PHLDB2
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.3074689875175342,0.7669832047931043,0.9714285714285714,1.0,1.0,21/82,19.47%,ARHGEF4;RRAS2;ACTG1;ITGA2;ITGA1;KRAS;PIK3CA;DIAPH1;ITGA5;ACTB;PPP1CB;DIAPH2;CDC42;CYFIP1;TIAM1;RAC1;WASF2;ROCK1;PXN;CRK;LIMK2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.31198797865836503,-0.7668996667559753,0.8947368421052632,0.980058262519635,1.0,12/132,7.33%,KLHL20;IFIH1;ISG15;KLHL7;UFL1;RNF213;ARIH2;PRKN;NUB1;UBR2;ANAPC16;MYCBP2
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,-0.3744514380494712,-0.766676285526826,0.8113207547169812,0.9799726527593725,1.0,11/43,15.46%,NLRC5;MEF2A;NFKBIA;NFKB1;FOS;TANK;JUN;UBC;UBE2D2;TBK1;N4BP1
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,-0.49517503271222507,-0.7665566376119424,0.7346938775510204,0.9796646922486292,1.0,1/5,4.73%,PLA1A
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.30662745327964525,0.7657615682123717,0.9761904761904762,1.0,1.0,18/88,21.81%,ARHGEF4;CCDC88A;PCM1;WDPCP;PARVA;CDC14B;S1PR1;NRP1;ABCC4;ANO6;CYFIP1;ARF4;RAC1;CC2D2A;BBS9;CEP290;FSCN1;OPHN1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.481316152035719,0.7656411436408543,0.8333333333333334,1.0,1.0,2/6,8.58%,BCL6;CBFB
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.45542155055790634,0.7656045403074505,0.7777777777777778,1.0,1.0,1/6,7.76%,NFYC
prerank,CellMarker_Augmented_2021__Villous cytotrophoblast:Placenta,-0.40316637724278537,-0.7654321271107736,0.78,0.981099449573091,1.0,2/17,11.26%,RFC3;MSH2
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.47026045112740866,-0.7654295126118215,0.8043478260869565,0.9806051929234321,1.0,2/9,17.40%,DHX36;NUP98
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.46250972892046327,0.7652349615454949,0.8103448275862069,1.0,1.0,4/8,17.05%,MT2A;MT1M;MT1E;SLC39A10
prerank,KEGG_2021_Human__Homologous recombination,0.4480727297703267,0.7650476071902736,0.8292682926829268,1.0,1.0,3/7,16.23%,UIMC1;SEM1;SSBP1
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,-0.2904945312080647,-0.7649790416630569,0.9344262295081968,0.9807725721324649,1.0,17/175,11.29%,SLC22A5;PPARG;FAM120B;CHKA;SLCO1A2;PLA1A;ACSL4;AGPAT3;ESYT2;GPD2;GPCPD1;ACER2;INPP5D;PIK3C2B;LBR;CBR4;MTMR2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.4814594594365133,-0.7649713869151419,0.8076923076923077,0.9802944651074007,1.0,3/11,19.15%,CD47;AFDN;PTPRR
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Eye,0.35224389782072485,0.7648062434630319,0.8333333333333334,1.0,1.0,10/40,22.47%,COL4A2;MPDZ;PTPN21;ADGRL2;RAI14;ANK2;AKAP12;MAGI1;FBXL7;TEAD1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Spinal Cord,0.35224389782072485,0.7648062434630319,0.8333333333333334,1.0,1.0,10/40,22.47%,COL4A2;MPDZ;PTPN21;ADGRL2;RAI14;ANK2;AKAP12;MAGI1;FBXL7;TEAD1
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.416560417048325,0.7645534648814247,0.8043478260869565,1.0,1.0,6/19,16.57%,SNAP25;CTBP2;DNAJC5;TRIOBP;CAPZB;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.38008843330195674,-0.7644357427770408,0.8518518518518519,0.9806217905306208,1.0,5/28,13.89%,EIF2AK2;MAP3K5;TAOK3;SH3RF3;MAP3K4
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,0.36240828336270153,0.7644221069937033,0.7948717948717948,1.0,1.0,8/31,18.14%,CDH2;CADM2;PARVA;DST;CDH12;PARD3;NECTIN3;PALS1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.43913747609294584,-0.7642767331212554,0.6444444444444445,0.9804330517196361,1.0,1/6,3.88%,MAP2
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.49030905777107536,0.7642114027299312,0.8076923076923077,1.0,1.0,3/8,12.27%,MT2A;MT1M;MT1E
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.49030905777107536,0.7642114027299312,0.8076923076923077,1.0,1.0,3/8,12.27%,MT2A;MT1M;MT1E
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.3973268798413811,-0.764146042734604,0.8518518518518519,0.9801517169275684,1.0,2/35,2.79%,KIAA1217;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.41348616099190433,0.7639272686456917,0.8653846153846154,1.0,1.0,5/15,20.96%,GRM5;DOCK3;EPHA4;ADAM17;PTPN1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.4915506687339563,0.7635377750503043,0.7959183673469388,1.0,1.0,3/7,21.81%,ITGA2;NRP1;OPHN1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3192399792199989,-0.7634050736847015,0.967741935483871,0.9807877510592276,1.0,10/119,5.87%,KLHL20;PSMA1;PSMB9;IFI27;RNF213;RNF19A;ARIH2;PRKN;HERC6;UBR2
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,0.42206019742616385,0.763212488571804,0.7692307692307693,1.0,1.0,3/14,14.61%,DPYSL2;AP2B1;RPS6KA5
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.37762256877646255,-0.7630223612844006,0.803030303030303,0.9809133377972421,1.0,6/36,8.92%,PLCG2;PRKN;MEF2A;B2M;FOS;JUN
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.4002929139118785,0.7625632439835579,0.7333333333333333,1.0,1.0,1/11,4.81%,DUSP6
prerank,CellMarker_Augmented_2021__Intermediate Progenitor cell:Undefined,0.425406110186082,0.7624825861814707,0.8409090909090909,1.0,1.0,3/12,13.39%,PITPNC1;RTN1;PPP2R2B
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,0.40639333301405767,0.7624515264900229,0.6808510638297872,1.0,1.0,4/11,23.64%,HSP90AA1;HSPA8;PLIN2;HSP90AB1
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.37452547643239475,-0.7622851016166295,0.8076923076923077,0.9815380575127685,1.0,11/42,15.46%,NLRC5;MEF2A;NFKBIA;NFKB1;FOS;TANK;JUN;UBC;UBE2D2;TBK1;N4BP1
prerank,CellMarker_Augmented_2021__Stem cell:Dental Pulp,0.47343150825134656,0.7622014996038441,0.7966101694915254,1.0,1.0,1/5,6.43%,ALCAM
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.4296101528858868,0.7620565476579773,0.8113207547169812,1.0,1.0,4/9,24.94%,NLGN1;CANX;OPHN1;RAB5A
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.4040753069906539,0.7619614477901858,0.7843137254901961,1.0,1.0,9/19,35.43%,FOXC1;ROCK1;ROCK2;FGFR1;MEF2C;FBXL17;RBPJ;TGFBR3;LEF1
prerank,CellMarker_Augmented_2021__Stem cell:Liver,0.45120585758408166,0.7618809918405228,0.8333333333333334,1.0,1.0,1/7,6.75%,NCAM1
prerank,CellMarker_Augmented_2021__Paneth cell:Undefined,0.42918638280943244,0.7614763203517023,0.7659574468085106,1.0,1.0,3/11,19.18%,ACAT1;MLEC;SCP2
prerank,CellMarker_Augmented_2021__Progenitor cell:Corneal Epithelium,-0.3770058210302253,-0.761245671819139,0.7704918032786885,0.9826714480911062,1.0,6/26,12.93%,CD109;SERPINE1;PRSS23;LIMA1;ITGAV;FZD6
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.44345960785892063,-0.7610554088127626,0.8679245283018868,0.982435972956972,1.0,1/8,7.28%,DSP
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.4224023696870365,0.7608382487999492,0.8,1.0,1.0,4/11,17.24%,PLEKHA1;ABL1;SETX;ANXA1
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,0.4362495564425447,0.7608292692152908,0.7692307692307693,1.0,1.0,2/9,15.56%,PPP2CB;GRB2
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.36244256667941954,0.7607260887616114,0.82,1.0,1.0,8/26,17.74%,COG6;BET1;CD59;ANK2;CAPZB;COG5;ARF4;ANK3
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.4458984115517466,-0.7606995768209885,0.782608695652174,0.9824628362381043,1.0,1/8,2.31%,KLF3
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.4141599824487029,0.7602975262867728,0.7592592592592593,1.0,1.0,7/16,28.45%,ACTG1;CLASP1;ROCK1;ROCK2;EFNA5;PTK2;CORO1C
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.41618492514475597,-0.7601918994233858,0.7884615384615384,0.9827208236921866,1.0,7/18,9.19%,HLA-F;HLA-B;HLA-C;TAP1;B2M;ERAP1;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.4353001746295832,0.7600326590818576,0.7735849056603774,1.0,1.0,1/7,5.52%,BTRC
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.4805235168239307,-0.7600135577925787,0.7857142857142857,0.9825832256856244,1.0,1/8,8.74%,CD47
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.5074587581272794,0.7598615199954527,0.7843137254901961,1.0,1.0,1/5,14.21%,MFF
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.42943073354523087,0.7598550144956524,0.76,1.0,1.0,1/9,7.04%,SGIP1
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Lung,0.3955423600642843,0.7598381875380108,0.813953488372093,1.0,1.0,10/21,24.83%,NREP;SKAP2;SLC16A1;HSPD1;ADAM10;ANXA1;ATP11C;GRAMD1A;FMNL2;NAV1
prerank,CellMarker_Augmented_2021__Brush Cell (Tuft cell):Lung,0.3955423600642843,0.7598381875380108,0.813953488372093,1.0,1.0,10/21,24.83%,NREP;SKAP2;SLC16A1;HSPD1;ADAM10;ANXA1;ATP11C;GRAMD1A;FMNL2;NAV1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.482703984118611,0.759614152104735,0.8070175438596491,1.0,1.0,2/6,16.10%,SEMA3F;UNC5C
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,0.341806157212328,0.7595771273651745,0.8541666666666666,1.0,1.0,10/47,14.93%,SMAD9;SMAD6;XPO1;PPP1CB;SMAD1;SMAD5;CCNC;SKI;PARD3;SMURF2
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.4930559635311478,-0.7591798781447235,0.7924528301886793,0.9833027344181122,1.0,1/5,19.73%,ACTR3
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.3935664180125911,-0.7589580041182208,0.8,0.9831598540686388,1.0,7/18,18.91%,UFL1;RPS19;RPS14;JAK2;ACIN1;CDIN1;PTPN2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.4245345958113759,-0.757741369003283,0.8148148148148148,0.9843653656045197,1.0,1/10,1.20%,RHOBTB1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Mammary Gland,0.3327573201339683,0.757722432175925,0.8285714285714286,1.0,1.0,11/37,18.88%,DUSP6;CTDSP2;CAPN2;ITGA5;HDAC7;RALB;PHC2;TRIOBP;BCL2L1;ANXA1;PXN
prerank,KEGG_2021_Human__Pancreatic cancer,0.3682569230204758,0.7574075789299999,0.8666666666666667,1.0,1.0,8/32,17.77%,RALA;MAPK10;KRAS;PIK3CA;RALB;BCL2L1;CDC42;RAC1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.37805216794777075,-0.7573638560872746,0.7708333333333334,0.9844680425691251,1.0,6/20,16.31%,RFC3;ATM;MAP3K4;PARN;TNKS2;PDGFB
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,0.38725840059276084,0.7572812521691608,0.8431372549019608,1.0,1.0,2/17,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.4557535323061931,-0.7572349505645268,0.72,0.9842121257585833,1.0,1/7,4.01%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.41158605329322645,-0.7569938049652131,0.78,0.9840230080788048,1.0,7/14,23.05%,PRKN;LIMA1;SSH1;TJP1;HIP1R;KANK3;SHANK3
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,-0.47200285800143893,-0.7560287795825889,0.7735849056603774,0.9850619658612345,1.0,3/12,13.23%,PLCG2;STAT5B;JAK2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.3291691065512274,0.7555526490109754,0.8205128205128205,1.0,1.0,22/48,23.64%,BCL6;NREP;TRPS1;CBFB;REST;PLEKHB2;CLASP1;NLGN1;CREBBP;TIAM1;PHLDB2;ROCK1;CCN2;YWHAG;FES;MBOAT2;CDK5RAP2;BIRC2;NR1D2;CDK6;NF1;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.44663962076351926,0.7554745270159802,0.782608695652174,1.0,1.0,1/9,4.81%,DUSP6
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.40564976196488933,0.7554039696797655,0.7735849056603774,1.0,1.0,3/12,11.85%,NAV3;PIK3CA;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3690724070707065,-0.7548911006704816,0.864406779661017,0.9862021606858541,1.0,4/29,4.54%,RNF19A;ARIH2;PRKN;NUB1
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,0.3349213240424706,0.7548531264187464,0.8260869565217391,1.0,1.0,5/26,11.77%,UIMC1;ABL1;PPP4R2;SEM1;HERC2
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.4610727987377752,-0.7539553310145288,0.72,0.9872287751646507,1.0,2/7,15.56%,CAPRIN1;DHX36
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,-0.48537739663759094,-0.7539291858788755,0.75,0.9867984299844483,1.0,2/7,12.75%,UBC;CLTA
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,-0.3061019940776603,-0.7538772251047138,0.9701492537313433,0.9864297853237477,1.0,27/192,12.19%,EPSTI1;RHOBTB1;VAV3;IL32;RASGRF2;ARAP2;GIT2;CDC37;PLXND1;NHS;KCTD3;KIDINS220;FNBP1;TFRC;TAOK3;ARHGAP17;ARHGAP15;LBR;ACTN1;ARHGEF11;ANKFY1;STAM2;FMNL3;ARHGEF28;VIM;HOMER2;MCF2L
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.39330847251430284,0.7535683136003501,0.7608695652173914,1.0,1.0,1/16,1.09%,IL1R1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.42649310695580817,0.7535541729348907,0.803921568627451,1.0,1.0,1/10,2.92%,COG6
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.42983434148683464,0.753402091890238,0.7727272727272727,1.0,1.0,2/9,13.12%,RAB7A;HSPA8
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3907368485380933,-0.7531634122292086,0.7962962962962963,0.9869801317521504,1.0,1/19,2.26%,PLK2
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.4768890705418637,-0.753065927126841,0.7021276595744681,0.9865607540613428,1.0,1/5,2.07%,TMSB4X
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.32417906625991594,0.7527337338219593,0.9130434782608695,1.0,1.0,8/57,10.41%,PSMD14;YWHAB;FASTKD1;HSPB1;YTHDF2;YWHAZ;SAMD4A;XPO1
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,0.45945134291008427,0.7527010207166772,0.8461538461538461,1.0,1.0,3/9,14.61%,DUSP6;PPP2CB;RPS6KA5
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.3472678619344379,0.7524691090996662,0.8148148148148148,1.0,1.0,6/23,20.82%,NAA50;HSPD1;GALNT2;ADAM10;PSEN1;ADAM17
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.37467225505672175,0.7523711758555628,0.8269230769230769,1.0,1.0,2/21,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.43375694436266676,0.7523123509957121,0.7446808510638298,1.0,1.0,2/9,14.08%,CCDC88A;PINK1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.4220170216889137,-0.7520440959484235,0.8269230769230769,0.9876152294550946,1.0,1/11,2.42%,CNOT8
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.36092685462174706,0.7519757613531555,0.7906976744186046,1.0,1.0,3/28,5.98%,YWHAB;TENT4A;TRAK1
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,0.36391274842921806,0.7519179124700269,0.7708333333333334,1.0,1.0,9/28,20.98%,TUBB4B;PCM1;HSP90AA1;CLASP1;CC2D2A;PRKCA;YWHAG;CEP290;CDK5RAP2
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryo,0.43161139617567357,0.7516944520531866,0.7391304347826086,1.0,1.0,6/12,28.07%,CTBP2;CYYR1;RBPMS;TEK;ARAP3;TCF7L2
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.49076585249376825,-0.7515790788053895,0.7777777777777778,0.9878533191914365,1.0,1/6,1.57%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.47883403599917507,0.7512773600888917,0.8363636363636363,1.0,1.0,2/6,16.47%,RPS6KA5;DIP2A
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.44788597585365014,-0.7511221683704686,0.75,0.9879587458551222,1.0,2/8,16.20%,DSP;TJP1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.40647588144582913,0.750730668195152,0.8596491228070176,1.0,1.0,3/14,13.86%,GRM5;SH3BP5;EPHA4
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.31408204419457736,0.7506417033549906,0.925,1.0,1.0,9/53,12.22%,SOX5;TAF1;MED4;IVNS1ABP;TAF3;CBFB;ERCC6;SETX;FOXO3
prerank,Reactome_2022__PECAM1 Interactions R-HSA-210990,0.4938165648342048,0.750145521319783,0.8846153846153846,1.0,1.0,1/7,4.14%,YES1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.4937993362261074,0.7501057176028577,0.8,1.0,1.0,1/5,5.42%,BRWD1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.4937993362261074,0.7501057176028577,0.8,1.0,1.0,1/5,5.42%,BRWD1
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,-0.39707064842852097,-0.749747790817956,0.8461538461538461,0.9897134885417707,1.0,1/18,1.62%,ATP9A
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,0.404220243699153,0.7497419491968558,0.84,1.0,1.0,3/17,7.46%,KPNA3;NUP58;RANBP2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3450495786626486,-0.7496362468855414,0.7818181818181819,0.9894057372875116,1.0,8/51,11.71%,PSMA1;PSMB9;CDC14A;ANAPC16;CEP57;CEP70;APPL2;UBC
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.46895717296615064,-0.7493113292618826,0.7755102040816326,0.9894237796145811,1.0,1/5,1.81%,HGSNAT
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.3723979816840286,0.7492525176315251,0.7543859649122807,1.0,1.0,2/20,8.61%,UIMC1;ERCC6
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.4968655980765247,0.7488003670717815,0.875,1.0,1.0,2/5,26.40%,LRRK2;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.419317392695641,-0.7485605864122868,0.7818181818181819,0.9901280409779133,1.0,2/14,8.10%,MAP2;ATXN7
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,0.41234962714205425,0.748363576707169,0.875,1.0,1.0,4/13,18.67%,KRAS;PIK3CA;ATP1A1;PRKCA
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.48567301593805334,0.7480649465242082,0.7592592592592593,1.0,1.0,2/5,20.64%,BDP1;SNAPC3
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,-0.42456582779846785,-0.7478663394277941,0.84,0.9906537795519578,1.0,2/15,9.85%,RFC3;POLR2A
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.3639757261992302,-0.7478461831143045,0.75,0.9901836697028921,1.0,8/41,11.71%,NLRC5;MEF2A;NFKBIA;NFKB1;FOS;TANK;JUN;UBC
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.4013691040519447,-0.7471060799042946,0.8076923076923077,0.9907849958379337,1.0,2/16,9.85%,MLLT1;POLR2A
prerank,CellMarker_Augmented_2021__Side-population cell:Undefined,0.3999497756604807,0.7461793817092376,0.76,1.0,1.0,4/19,10.89%,ITGA2;BACE2;CAPN2;ANXA2
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3705164922585436,0.74614602072986,0.86,1.0,1.0,4/16,17.26%,HSP90AA1;NEK7;POT1;HMBOX1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.3907090363072281,-0.7460823058285273,0.7627118644067796,0.9917966548155217,1.0,6/22,24.99%,LGALS3;RAMP3;DLG1;RACK1;SPTBN1;SQSTM1
prerank,Reactome_2022__Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation R-HSA-8948700,0.44036534824171264,0.7458641141043529,0.78,1.0,1.0,4/8,41.59%,AGO2;VAPA;TNRC6B;TNRC6A
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.37641773099470643,0.7457393533809415,0.88,1.0,1.0,2/20,7.46%,NUP58;RANBP2
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,0.4176639492056815,0.7456293015249752,0.8292682926829268,1.0,1.0,5/13,26.93%,GALNT2;GALNT10;C1GALT1;ST6GALNAC3;GALNT18
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.4716933744143337,0.745426304789361,0.7924528301886793,1.0,1.0,2/6,22.79%,ROCK1;ROCK2
prerank,Reactome_2022__Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,-0.5259556869385931,-0.7451928294057434,0.7843137254901961,0.9925030732668875,1.0,2/5,15.67%,VIM;PLEC
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.473753417997554,-0.7450266192247702,0.7843137254901961,0.9923015916858576,1.0,5/10,24.14%,GRB14;APPL2;PTPN2;NCK1;TNS2
prerank,CellMarker_Augmented_2021__Neural Tube cell:Germ,0.4705003733563887,0.7450195665810683,0.75,1.0,1.0,1/5,17.34%,CD81
prerank,CellMarker_Augmented_2021__Epithelial cell:Blood,0.46936726032421733,0.7448744083400535,0.8269230769230769,1.0,1.0,1/5,4.94%,SEMA3F
prerank,CellMarker_Augmented_2021__Cancer cell:Lung,0.46936726032421733,0.7448744083400535,0.8269230769230769,1.0,1.0,1/5,4.94%,SEMA3F
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.3717323212987422,-0.7447154501638451,0.7777777777777778,0.9922320163823678,1.0,8/40,11.71%,NLRC5;MEF2A;NFKBIA;NFKB1;FOS;TANK;JUN;UBC
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.30061085012312,-0.7444546212160297,0.9824561403508771,0.9921473202680574,1.0,12/76,15.38%,BTG2;RFC3;TOPBP1;BABAM2;PARP9;MSH2;UBC;PWWP3A;ATM;PDS5B;PRIMPOL;XPC
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.30982248898708875,0.7442510067559905,0.925,1.0,1.0,3/42,3.37%,VAPB;PRKD1;KDSR
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.461619723908259,0.7440031796897816,0.7857142857142857,1.0,1.0,4/7,24.25%,ACAT1;PAM;FAR2;ACACA
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.33646556090400837,-0.7437409644263903,0.7884615384615384,0.9927054123743596,1.0,8/59,12.03%,BTG2;CNOT8;EIF2AK2;GEMIN5;CAPRIN1;VIM;UPF3A;RPL10
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,0.46560161960533836,0.7435478952282734,0.7818181818181819,1.0,1.0,1/6,1.41%,BCL6
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.4830933510666497,0.7430137066132831,0.7948717948717948,1.0,1.0,3/7,17.69%,ATP2B4;ATP1A1;KCNT2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.3016265737532467,0.7429881199759638,0.9285714285714286,1.0,1.0,11/90,12.40%,ARHGEF4;BCL6;DUSP6;IGFBP3;TNFAIP8;REST;TIAM2;ABL1;LRRK2;FOXO3;HSPD1
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,0.3852523739275061,0.7429878548653589,0.7272727272727273,1.0,1.0,2/17,5.76%,BCL6;IGFBP3
prerank,PanglaoDB_Augmented_2021__Neurons,-0.31746928010595576,-0.7429045747215381,0.8870967741935484,0.9934551645980004,1.0,9/61,13.60%,ZIC1;ACSL4;CTNNA2;PPP1R9A;SCN2A;NOL4;RORA;RNPC3;DNM3
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.4769385887114174,-0.7428650487962937,0.8163265306122449,0.99301609340357,1.0,6/7,28.37%,RPL10;RPL24;RPL11;RPL3;RPL23A;RPL5
prerank,KEGG_2021_Human__Lysine degradation,-0.3757561837967646,-0.742836787653126,0.7777777777777778,0.9925673484161195,1.0,2/22,9.16%,TMLHE;CAMKMT
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.44907098197116596,0.7427856431838912,0.8076923076923077,1.0,1.0,6/10,23.88%,CACNA1C;SLC8A1;ANK2;CALM1;RYR2;AKAP6
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.3699383274053549,-0.7423009747051847,0.8775510204081632,0.9928817009803995,1.0,3/40,3.88%,SLC16A2;DOK5;MAP2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.3593695363654457,-0.7422155443439644,0.8947368421052632,0.9925394763057961,1.0,8/39,15.75%,PLK2;PRKN;NFKBIA;RAB1A;GPC3;CLU;HECW2;FOXO1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.4152421921998788,-0.7416992081485564,0.7446808510638298,0.9927021614001724,1.0,1/10,1.57%,RIMS1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.46438343649470154,-0.7415854373997433,0.8125,0.9923805345000867,1.0,4/10,19.28%,PRKN;PMAIP1;OPA1;HERPUD1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.39237976247358786,-0.7413239345681031,0.8363636363636363,0.992265895349045,1.0,3/24,9.85%,TOPBP1;DDX24;POLR2A
prerank,CellMarker_Augmented_2021__CD141+CLEC9A+ Dendritic cell:Blood,0.35352734197021884,0.741145783392126,0.9512195121951219,1.0,1.0,2/33,1.41%,DSE;BCL6
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.36888890509190936,-0.7408849602109652,0.7872340425531915,0.992413360213728,1.0,3/22,9.56%,PPARG;JUN;RCOR1
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,-0.45224154688208085,-0.7408122838062919,0.7567567567567568,0.9920268830718446,1.0,2/9,12.62%,LAMA4;LAMA2
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.46929415843982425,-0.7408086847859594,0.7659574468085106,0.9915552182191741,1.0,1/5,12.32%,VSIR
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.37262893432798155,-0.7408076257220225,0.7962962962962963,0.9896179200302578,1.0,8/39,11.71%,NLRC5;MEF2A;NFKBIA;NFKB1;FOS;TANK;JUN;UBC
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.37262893432798155,-0.7408076257220225,0.7962962962962963,0.9896179200302578,1.0,8/39,11.71%,NLRC5;MEF2A;NFKBIA;NFKB1;FOS;TANK;JUN;UBC
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.37262893432798155,-0.7408076257220225,0.7962962962962963,0.9896179200302578,1.0,8/39,11.71%,NLRC5;MEF2A;NFKBIA;NFKB1;FOS;TANK;JUN;UBC
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.37262893432798155,-0.7408076257220225,0.7962962962962963,0.9896179200302578,1.0,8/39,11.71%,NLRC5;MEF2A;NFKBIA;NFKB1;FOS;TANK;JUN;UBC
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.4226145371490857,0.7405769593017908,0.8793103448275862,1.0,1.0,3/9,17.74%,ANO6;ANK2;ANK3
prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.3656446135189214,-0.7404687761845535,0.8125,0.9895904395853082,1.0,6/40,8.92%,VAV3;LCP2;NFKBIA;NFKB1;FOS;JUN
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.48416629158872987,0.7403997357971519,0.8,1.0,1.0,1/5,3.11%,WRNIP1
prerank,CellMarker_Augmented_2021__Oocyte:Embryo,-0.37884503823897225,-0.7402539448785717,0.8367346938775511,0.9894274844539218,1.0,3/30,13.28%,ABCA5;SNX25;ZC3H7A
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.4371443829592918,-0.740229078147677,0.7755102040816326,0.9889938180610831,1.0,2/12,9.88%,MAP2;CST3
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.40904137453268696,-0.7402258435808307,0.7916666666666666,0.98851043887337,1.0,1/11,1.57%,RIMS1
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,0.3835629691078539,0.740139421459696,0.7894736842105263,1.0,1.0,2/15,7.54%,ACTG1;HSP90AA1
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,-0.3918086088325631,-0.739745129833365,0.75,0.9886188561435659,1.0,1/17,1.57%,RIMS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.4343836858453046,-0.7397031887521007,0.7450980392156863,0.9881611759674944,1.0,3/9,26.51%,UBC;UGGT2;RPS27A
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.3779779788220742,-0.7395889532776188,0.75,0.9878841704231007,1.0,3/28,4.04%,TPM1;CXCL12;LAMA4
prerank,CellMarker_Augmented_2021__Hepatocyte:Fetal Liver,0.32813817996634503,0.7387581025419692,0.9583333333333334,1.0,1.0,4/32,9.03%,TEAD4;ITGA2;SEMA3F;PARVA
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.44867733970375956,-0.7386953717842921,0.7857142857142857,0.9885581739138112,1.0,2/7,19.07%,DMD;PKD2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.29207416575161815,-0.73849581544228,1.0,0.9879146036424681,1.0,15/118,10.20%,HGSNAT;HLA-B;HLA-C;HEBP2;LGALS3;IGF2R;TMEM30A;DSP;B2M;SLC2A3;NFKB1;CDA;CD47;CST3;BST2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.29207416575161815,-0.73849581544228,1.0,0.9879146036424681,1.0,15/118,10.20%,HGSNAT;HLA-B;HLA-C;HEBP2;LGALS3;IGF2R;TMEM30A;DSP;B2M;SLC2A3;NFKB1;CDA;CD47;CST3;BST2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4964502129802384,-0.7384287393391427,0.8035714285714286,0.9875233366557828,1.0,1/5,7.46%,DMD
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.41173777497239444,-0.738375003956927,0.7377049180327869,0.9871024857875562,1.0,2/15,3.24%,ISG15;UFL1
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.3752056913826113,-0.7381734322663445,0.8095238095238095,0.9869166550380157,1.0,8/40,12.19%,VAV3;RASGRF2;ARHGEF37;NFKBIA;NFKB1;ARHGEF11;UBC;MCF2L
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.28913227615536224,-0.738081731478945,1.0,0.9865513907775533,1.0,15/120,10.20%,HGSNAT;HLA-B;HLA-C;HEBP2;LGALS3;IGF2R;TMEM30A;DSP;B2M;SLC2A3;NFKB1;CDA;CD47;CST3;BST2
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,-0.42796705034424276,-0.7380223349166775,0.8275862068965517,0.9861715210796533,1.0,1/14,2.39%,FN1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.35032804836940606,0.7377753820265697,0.8157894736842105,1.0,1.0,4/32,9.03%,ATRNL1;MICALL2;YTHDF2;PARVA
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4963764760924123,-0.737609155891965,0.7777777777777778,0.9863452930399609,1.0,1/5,7.46%,DMD
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.40739277753345937,-0.7373527366012085,0.7454545454545455,0.9861801191142114,1.0,6/19,24.99%,LGALS3;RAMP3;DLG1;SPTBN1;EPB41;SQSTM1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.4193999107126677,-0.73710013148864,0.8545454545454545,0.9859802483681136,1.0,3/20,10.07%,PRKN;TFRC;PARP9
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.4720151424290907,-0.7368655442271018,0.8372093023255814,0.9858552292999101,1.0,1/5,5.63%,CALCOCO2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.46300511975358416,-0.7368654823569727,0.7346938775510204,0.9853771229811419,1.0,1/5,2.07%,TMSB4X
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,0.2815579090239391,0.736716100326947,0.8809523809523809,1.0,1.0,12/66,13.65%,PSMD14;TUBB4B;NUP58;AHCTF1;RANBP2;WAPL;SEM1;XPO1;CLASP1;PPP2CB;LEMD3;SMC1A
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,0.2815579090239391,0.736716100326947,0.8809523809523809,1.0,1.0,12/66,13.65%,PSMD14;TUBB4B;NUP58;AHCTF1;RANBP2;WAPL;SEM1;XPO1;CLASP1;PPP2CB;LEMD3;SMC1A
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.3585516522630022,0.7366748010570215,0.8431372549019608,1.0,1.0,8/26,20.98%,TUBB4B;PCM1;HSP90AA1;CLASP1;CC2D2A;YWHAG;CEP290;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3592136551013266,-0.7365884103732626,0.9344262295081968,0.985277379249377,1.0,4/29,4.54%,RNF19A;ARIH2;PRKN;NUB1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.46595818398814937,-0.7362072075717435,0.8333333333333334,0.9853616202165114,1.0,1/9,4.01%,PRKN
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.4020364592468867,-0.7361112423938948,0.8043478260869565,0.9850533438956974,1.0,3/12,14.87%,HEBP2;PMAIP1;PPA2
prerank,CellMarker_Augmented_2021__Liver Stem cell:Fetal Liver,-0.3641457445880845,-0.7358601018013577,0.875,0.9848794246768234,1.0,3/37,4.06%,TPM1;FN1;SMARCA1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3865913568756034,0.7354839937189286,0.7555555555555555,1.0,1.0,6/15,17.80%,BMP6;ANKH;S1PR1;SLC8A1;ANO6;ACVR2A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone Marrow,-0.48362532979065764,-0.7352865498436632,0.8,0.9852217980723006,1.0,1/5,18.03%,CD34
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.3494172994307335,-0.7350174048965905,0.8703703703703703,0.985092608604031,1.0,2/48,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Stem cell:Pancreas,0.36359784199791134,0.734871569196148,0.8275862068965517,1.0,1.0,8/23,25.87%,LRRTM4;WDPCP;CNTNAP2;KPNA5;RPAP2;PREX2;PTBP2;PCDH11X
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.402213777695879,-0.7347569489875696,0.8035714285714286,0.9849585860800952,1.0,5/14,14.13%,ISG15;CD47;VSIR;HLA-A;IL18R1
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,-0.3576298105581074,-0.7347498422271307,0.896551724137931,0.9844877162177909,1.0,7/30,13.09%,PSMA1;PSMB9;RFC3;TOPBP1;BABAM2;UBC;ATM
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.38351012703625775,0.734698994934736,0.8043478260869565,1.0,1.0,2/20,8.15%,EIF4G3;TAB2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.2924117527387715,-0.7341352736283394,0.9838709677419355,0.9848890552666699,1.0,15/174,8.07%,KLHL20;PSMA1;PSMB9;ISG15;KLHL7;RNF213;RNF19A;ARIH2;PRKN;HERC6;NUB1;UBR2;ANAPC16;MYCBP2;TRIM25
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,0.3332593290306673,0.7338959236998,0.8666666666666667,1.0,1.0,12/46,22.63%,TUBB4B;PCM1;HSP90AA1;CLASP1;ARF4;CC2D2A;PRKCA;YWHAG;BBS9;CEP290;CDK5RAP2;KIFAP3
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.3742039275095328,0.7337836494476099,0.8409090909090909,1.0,1.0,5/17,14.26%,ACTG1;ACTB;LRRK2;PINK1;NRP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.455188498123193,0.7336317205714175,0.8727272727272727,1.0,1.0,5/8,21.25%,CACNA1C;SLC8A1;ANK2;CALM1;RYR2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Peripheral Blood,0.33020977618972347,0.7335751133970294,0.925,1.0,1.0,2/41,1.73%,IL1R1;HSPG2
prerank,CellMarker_Augmented_2021__Stem cell:Placenta,-0.40679281367740633,-0.7331990954796752,0.8035714285714286,0.9853738760632587,1.0,3/28,5.60%,FN1;LAMA4;SERPINE1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Breast,-0.40679281367740633,-0.7331990954796752,0.8035714285714286,0.9853738760632587,1.0,3/28,5.60%,FN1;LAMA4;SERPINE1
prerank,CellMarker_Augmented_2021__Endothelial cell:White Adipose Tissue,0.32640318447651706,0.7330883586255478,0.96875,1.0,1.0,7/49,12.99%,COL4A2;SLCO2A1;TM4SF18;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreatic Islet,-0.3675007749259444,-0.7330342282682066,0.8431372549019608,0.985071877564118,1.0,3/27,9.67%,HLA-C;SHISA5;MYL12A
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.29392714397477615,0.732950691904803,0.9473684210526315,1.0,1.0,3/58,4.12%,COG6;MAN1A2;KIF26B
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.47366356599674886,-0.7327741102737866,0.8076923076923077,0.9850321809762165,1.0,2/5,5.60%,TPM1;SERPINE1
prerank,CellMarker_Augmented_2021__Cancer cell:Esophagus,0.3310477303857952,0.732600750870163,0.8809523809523809,1.0,1.0,8/43,15.46%,IL1R1;HSPG2;PARVA;SAMD4A;FNDC3B;PAPSS2;NRP1;CD59
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.36388492833791763,0.7321933312114104,0.84,1.0,1.0,6/15,26.11%,FOXO3;SESN1;CPEB4;MTMR3;EIF2AK3;IFI16
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.498089941481238,0.7321912002953161,0.7708333333333334,1.0,1.0,1/5,16.92%,POT1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.42652227119196506,-0.7321845263466663,0.8333333333333334,0.9852889957851202,1.0,1/19,2.39%,FN1
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.362311304124782,-0.7318365014858796,0.8490566037735849,0.9853134378103062,1.0,3/33,4.91%,PSMA1;PSMB9;PABPC1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.42983407436048326,0.7316717281361571,0.7647058823529411,1.0,1.0,1/8,5.31%,PCM1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.3827794200407738,-0.7314547447773444,0.8095238095238095,0.9853082375300499,1.0,4/19,4.01%,SOD2;HLA-F;SNX6;PRKN
prerank,KEGG_2021_Human__Protein digestion and absorption,0.385023318951811,0.7313402354938127,0.8571428571428571,1.0,1.0,1/13,1.67%,COL4A2
prerank,"Reactome_2022__WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",-0.5107741558077954,-0.7303485935944294,0.8478260869565217,0.9863638713956242,1.0,2/5,12.75%,RORA;CLTA
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,-0.3735286094794963,-0.7298691277669898,0.8363636363636363,0.9864765323046043,1.0,6/20,18.62%,PRKN;UBC;ATM;MFN1;ATG12;EPAS1
prerank,CellMarker_Augmented_2021__Plasma cell:Salivary Gland,-0.3867822953732403,-0.72956918735009,0.8627450980392157,0.9864165577927948,1.0,2/23,7.28%,KIAA1217;DSP
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,0.2533422854239167,0.7294684190923284,1.0,1.0,1.0,35/216,19.79%,YWHAB;UBQLN1;RALA;COG6;MCFD2;MAN1A2;KIF26B;AP1S2;SBF2;SGIP1;RALGAPB;YWHAZ;YWHAQ;RAB7A;BET1;DENND5B;AP2B1;GALNT2;HSPA8;TPD52L1;ANKRD28;TFG;CD59;GRB2;ANK2;CAPZB;COG5;CALM1;ARF4;ANK3;PPP6R3;PPP6C;YWHAG;DENND1A;RALGAPA2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.35202294597398404,-0.7294627888071039,0.847457627118644,0.9861053649440114,1.0,4/25,15.19%,PLK2;CDC14A;SPAST;RHOA
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.3916192208716438,0.7293568653622842,0.8163265306122449,1.0,1.0,2/17,7.46%,NUP58;RANBP2
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.3916192208716438,0.7293568653622842,0.8163265306122449,1.0,1.0,2/17,7.46%,NUP58;RANBP2
prerank,KEGG_2021_Human__Viral myocarditis,0.3865672974128921,0.7292022357585499,0.85,1.0,1.0,5/17,9.93%,ABL2;EIF4G3;ACTG1;ABL1;ACTB
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.4223934008279248,-0.7288798415513349,0.7446808510638298,0.9864395953314691,1.0,1/10,3.96%,ARIH2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4351357165187441,0.7288461957951866,0.8909090909090909,1.0,1.0,1/7,4.78%,UGCG
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.36263078445050295,-0.7285795719153743,0.7755102040816326,0.9863600358753548,1.0,7/26,18.22%,PATJ;TFRC;TRPM6;COBLL1;NEBL;FGD4;THRB
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.32908422628810885,-0.7285260148262415,0.8421052631578947,0.9859066410785031,1.0,2/50,1.51%,PSMA1;PSMB9
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Small Intestine,0.4553380058425189,0.7283188784274095,0.8,1.0,1.0,5/7,28.42%,ZNF608;TRIQK;FBXL7;RASA1;RHBDD1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.34388526169382205,0.7281469637746639,0.8048780487804879,1.0,1.0,8/32,15.64%,CRY1;UBQLN1;IVNS1ABP;HSP90AA1;SPOPL;LRRK2;PINK1;UBE3A
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.3913429677186566,-0.7277445053769921,0.7954545454545454,0.9866978165023563,1.0,5/21,13.84%,NDRG1;SCN2A;PMAIP1;RORA;PGK1
prerank,CellMarker_Augmented_2021__Muscle cell:Embryoid Body,0.3503042608250656,0.7276459575850461,0.8666666666666667,1.0,1.0,7/24,17.69%,COL4A2;PRKG1;RBFOX1;ADGRL2;PDZRN3;ANK2;KCNT2
prerank,CellMarker_Augmented_2021__Liver Progenitor cell:Fetal Liver,-0.3727394711228992,-0.7275104808802009,0.8596491228070176,0.9865936718050575,1.0,1/32,0.93%,KIAA1217
prerank,CellMarker_Augmented_2021__Cancer cell:Brain,-0.3641184890716712,-0.7273121278121534,0.7083333333333334,0.9864011960777862,1.0,3/18,9.99%,RFC3;GEMIN5;CAPRIN1
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.28869738488266405,-0.7268420906590446,1.0,0.9866950411218559,1.0,17/177,11.71%,NR4A1;PSMA1;PSMB9;STAT1;FN1;RNF213;ZC3HAV1;CDC37;RPS6;SMAD3;MAML3;LRRFIP1;STAT5B;POLR2A;MAPKAP1;NRG3;UBC
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.41912651267511436,0.7267332863672129,0.75,1.0,1.0,3/8,21.81%,NLGN1;CANX;OPHN1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.4045096498188158,0.7267240277593792,0.8636363636363636,1.0,1.0,4/13,23.61%,ADGRB3;CSMD3;CAMK1D;NEDD4L
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Uterus,-0.3324021083601393,-0.7266983033427863,0.9166666666666666,0.9863407331149252,1.0,3/62,4.97%,KIAA1217;LAMA4;MMRN2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.35766210553313665,-0.7265952329857385,0.8909090909090909,0.9859769524507943,1.0,6/24,18.25%,RNF213;PRKN;UBE2D2;SH3RF3;NFX1;KLHL24
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,-0.45221422634503056,-0.72618075758628,0.8,0.9855592023331899,1.0,2/7,13.63%,CAMKMT;NMT2
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.45221422634503056,-0.72618075758628,0.8,0.9855592023331899,1.0,2/7,13.63%,CAMKMT;NMT2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.42746770979658505,0.7257225990930902,0.7777777777777778,1.0,1.0,4/7,31.47%,DICER1;AGO2;TUT7;TUT4
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,-0.3668103268264856,-0.7255856071399359,0.8301886792452831,0.9858282541169804,1.0,7/41,10.62%,VAV3;GIT2;NHS;TFRC;TAOK3;ARHGAP17;LBR
prerank,CellMarker_Augmented_2021__FOXN4+ cell:Lung,0.3878987575475826,0.725027748005502,0.8409090909090909,1.0,1.0,1/18,1.51%,INSIG1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.47670454120721295,-0.724811086227253,0.7777777777777778,0.9863859370186296,1.0,1/7,4.01%,PRKN
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.37586985408543033,-0.7244003300478797,0.84,0.9864585748316912,1.0,7/20,22.79%,RFC3;TOPBP1;ATM;RFC1;ORC2;NAP1L1;REV3L
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4121085128475378,-0.7243781550627637,0.8076923076923077,0.9860028358419429,1.0,5/14,15.64%,ATM;MAP3K4;PARN;DHX36;TNKS2
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.38154618919383154,0.7241302638677767,0.8461538461538461,1.0,1.0,5/20,15.56%,PIK3CA;PIGU;GRB10;FRS2;GRB2
prerank,KEGG_2021_Human__RNA transport,0.3184242247088369,0.7237494212427119,0.975,1.0,1.0,6/39,12.54%,EIF4G3;NUP58;EIF5;RANBP2;XPO1;EIF3E
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.4268943802745558,0.7236101268861302,0.7446808510638298,1.0,1.0,4/10,15.88%,YWHAZ;ABL1;EPHA4;IL1RAPL1
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,0.29751282544506824,0.7235527380591786,0.9487179487179487,1.0,1.0,17/66,18.99%,ITPR3;ACTG1;YES1;PRKX;ENTPD1;ABL1;ELMO1;GNB4;ITPR2;CALCRL;GRB2;CDC42;CALM1;CYFIP1;WASF2;PRKCA;CRK
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.3491283412683003,0.7230461959217797,0.9111111111111111,1.0,1.0,4/31,9.16%,ABL2;CCDC88A;PIK3CA;ABL1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.4247813332624762,-0.7230333269701513,0.7884615384615384,0.9873517216460558,1.0,2/5,22.90%,MSN;JAM2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.3888577350097411,-0.72293504536679,0.8301886792452831,0.9870230553480759,1.0,3/17,15.67%,FN1;ACTN1;PLEC
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,-0.39478115374756917,-0.7225660426641671,0.8333333333333334,0.9869926717026187,1.0,4/17,11.71%,PRKN;B2M;CST3;UBC
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3421872949180512,-0.7224422374920316,0.8837209302325582,0.9866937837050666,1.0,5/39,9.24%,PPARG;SNX6;CD109;SMAD3;SNX25
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.39062499431171266,0.7223067002770411,0.7843137254901961,1.0,1.0,5/15,16.68%,LRRK2;EPHA4;TANC2;NLGN1;PTEN
prerank,KEGG_2021_Human__ECM-receptor interaction,-0.39786442315722426,-0.7219576144138306,0.8163265306122449,0.9868587896330293,1.0,7/21,12.70%,FN1;ITGB5;LAMA4;CD47;ITGA10;LAMA2;ITGAV
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestinal Crypt,0.36441810087975945,0.7216453102609002,0.8076923076923077,1.0,1.0,6/23,10.89%,ITGA2;BACE2;IGFBP3;ALCAM;ATP8B1;ANXA2
prerank,KEGG_2021_Human__Small cell lung cancer,0.33269638529529444,0.7206063341949224,0.8636363636363636,1.0,1.0,4/35,7.01%,COL4A2;RARB;ITGA2;PIK3CA
prerank,Reactome_2022__Signal Amplification R-HSA-392518,-0.4033942034851553,-0.7202856885173708,0.8076923076923077,0.9885845282016491,1.0,3/11,18.27%,GNG4;GNA14;MAPK14
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4078556541053932,0.7200982062869115,0.8695652173913043,1.0,1.0,4/13,17.42%,ABL1;FNIP2;BCL2L1;EP300
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.38098785043106587,-0.7197709171086563,0.84,0.9887972332525902,1.0,5/17,17.05%,RPL23;RPS7;FHIT;N4BP1;RPL11
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.4379670758355398,0.7197003522956571,0.7894736842105263,1.0,1.0,2/6,21.99%,RNF168;CDC73
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,0.3397223295817369,0.7195501329897522,0.8979591836734694,1.0,1.0,6/31,11.85%,TUBB4B;PCM1;BTRC;HSP90AA1;PPP1CB;CLASP1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.3992683591852745,0.7191332072128523,0.8269230769230769,1.0,1.0,3/13,10.49%,NRCAM;ABL1;RTN4
prerank,KEGG_2021_Human__Yersinia infection,-0.33897570774187347,-0.7186124278747503,0.8787878787878788,0.9898479172207737,1.0,8/59,8.92%,FN1;VAV3;GIT2;LCP2;NFKBIA;NFKB1;FOS;JUN
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.46066660832868755,0.7184255172374794,0.8333333333333334,1.0,1.0,4/7,31.29%,ANK2;AKAP6;KIF5B;KCNMB4
prerank,KEGG_2021_Human__Ether lipid metabolism,0.43868278653044956,0.7181933391562624,0.8679245283018868,1.0,1.0,2/7,18.11%,CHPT1;AGPS
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.42654642330028003,0.7176584620879543,0.8596491228070176,1.0,1.0,3/10,18.78%,LRRK2;EPHA4;ROCK1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.47612269205968294,0.7171387563219933,0.88,1.0,1.0,4/6,30.39%,BCL2L1;FGFR1;HSPA1A;EYA3
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.3770886107392006,0.7170912753872739,0.7924528301886793,1.0,1.0,8/14,21.25%,UGCG;SLC8A1;ANK2;ANXA1;YWHAG;CRK;PTPN1;RYR2
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,0.4399644372462548,0.7160854626442533,0.8085106382978723,1.0,1.0,2/7,7.52%,UPP1;ENTPD1
prerank,Reactome_2022__IRF3-mediated Induction Of Type I IFN R-HSA-3270619,-0.4755876604052404,-0.7159930620718764,0.8113207547169812,0.9924331451510551,1.0,1/5,13.49%,TBK1
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.4755876604052404,-0.7159930620718764,0.8113207547169812,0.9924331451510551,1.0,1/5,13.49%,TBK1
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.4566541732466096,-0.7157926417216374,0.8333333333333334,0.992273788891985,1.0,3/7,17.21%,LBR;VRK2;KPNB1
prerank,Reactome_2022__G2/M Transition R-HSA-69275,-0.32824589918687797,-0.7156816341379092,0.8333333333333334,0.9914936777397774,1.0,3/54,2.82%,PSMA1;PSMB9;OPTN
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,-0.32824589918687797,-0.7156816341379092,0.8333333333333334,0.9914936777397774,1.0,3/54,2.82%,PSMA1;PSMB9;OPTN
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.3261205078006312,0.7150710184124349,0.8695652173913043,1.0,1.0,9/44,14.50%,ABL2;PRKX;YTHDF2;FRMD5;ABL1;PPP1CB;PPP3CA;EPHA4;ADAM10
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.3922143485137851,-0.7150617932028142,0.875,0.9919521234073496,1.0,1/12,4.01%,PRKN
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.2911763559824007,0.7146070872789151,0.9629629629629629,1.0,1.0,15/95,17.66%,ARHGEF4;BCL6;DUSP6;IGFBP3;TNFAIP8;REST;TIAM2;ABL1;FOXO3;HSPD1;TPD52L1;ANO6;SHQ1;PSEN1;TIAM1
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.4184638645654208,0.7145951238077065,0.8260869565217391,1.0,1.0,3/8,17.74%,LRRK2;PDZRN3;ANK3
prerank,KEGG_2021_Human__Nucleotide excision repair,-0.4438737484287714,-0.7144688678329135,0.7959183673469388,0.9923032810750393,1.0,4/8,21.12%,RFC3;XPC;RFC1;CUL4A
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.4697143401393898,0.7144565182049849,0.7884615384615384,1.0,1.0,4/5,29.77%,EDN1;RGCC;PHIP;INSR
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4453410949525026,-0.7141112190726949,0.7647058823529411,0.992440499772464,1.0,1/6,4.73%,PLA1A
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.3793520878758049,-0.7139320400942506,0.8771929824561403,0.9922233635368636,1.0,5/23,12.62%,CXCL12;LAMA4;HMCN1;ADAMTS1;LAMA2
prerank,Reactome_2022__Establishment Of Sister Chromatid Cohesion R-HSA-2468052,0.4248125926872823,0.7137711751863319,0.8301886792452831,1.0,1.0,2/7,13.65%,WAPL;SMC1A
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.35527746339088645,-0.7133506128620316,0.8656716417910447,0.9925253938172097,1.0,8/53,12.62%,TPM1;FN1;CXCL12;LAMA4;HMCN1;NOSTRIN;ACTN1;LAMA2
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.40709798247269424,-0.7131542915100286,0.7346938775510204,0.9922502489450818,1.0,3/13,11.71%,PRKN;VIM;UBC
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.3636334025289036,-0.7131254085900454,0.8679245283018868,0.9918154617692784,1.0,7/34,15.59%,GABARAPL1;PRKN;VPS36;STAM2;STX17;MFN1;ATG12
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.46762541735794416,0.7130085500407333,0.864406779661017,1.0,1.0,2/5,29.88%,MDM4;BMPR2
prerank,KEGG_2021_Human__Tight junction,0.3025352974161491,0.7126439246113813,0.9210526315789473,1.0,1.0,14/60,18.78%,ACTG1;MAPK10;MICALL2;ACTB;MPDZ;PPP2CB;PPP2R2B;PARD3;CDC42;TUBA1B;TIAM1;RAC1;PALS1;ROCK1
prerank,CellMarker_Augmented_2021__Fibroblast:Heart,-0.35929049781231676,-0.7125875318630362,0.8833333333333333,0.9919816462610741,1.0,2/34,10.70%,ITGB5;ACTN1
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.38736755510852244,-0.7118983682672604,0.8913043478260869,0.9923267890171839,1.0,3/23,4.38%,OPTN;HEBP2;LGALS3
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.4556903030800091,-0.711622784168634,0.8636363636363636,0.9921248369521015,1.0,2/8,13.09%,MSH2;ATM
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.4205565363210274,-0.7115972021500948,0.88,0.9916957652556975,1.0,4/13,20.58%,ZDHHC17;FOXO1;ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.44182915729178684,-0.7115263929789627,0.75,0.9912912684881069,1.0,3/5,26.91%,GSPT1;MRPL33;PTCD3
prerank,CellMarker_Augmented_2021__Stromal Vascular Fraction cell:Adipose Tissue,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Bone Marrow,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Dendritic cell:Umbilical Cord Blood,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Umbilical Cord Blood,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Submandibular Gland Stem cell:Submandibular Gland,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Blood,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Endothelial cell:Corpus Luteum,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Endothelial cell:Bladder,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Progenitor-like Angiogenesis-Promoting cell:Blood,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Keratinocyte:Epithelium,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Cardiomyocyte Progenitor cell:Myocardium,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Adipose Tissue,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Peripheral Blood,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Periodontal Ligament,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,CellMarker_Augmented_2021__Monocyte:Umbilical Cord Blood,0.31248025312848243,0.71148169386807,0.9230769230769231,1.0,1.0,6/40,12.99%,MMRN1;ANGPT2;CYYR1;ADGRL4;SHROOM4;CALCRL
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.3474453264332584,-0.7114567393421991,0.8596491228070176,0.9909161437507538,1.0,3/42,7.62%,LRPAP1;PRKN;B2M
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,-0.3987408887808633,-0.711294064951778,0.8541666666666666,0.9906089859837456,1.0,1/11,6.83%,TAF1D
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,0.3092931791309358,0.7110711493303598,0.92,1.0,1.0,9/36,19.68%,SLC38A9;ATG4C;HSP90AA1;AMBRA1;HSPA8;PINK1;PLIN2;UVRAG;MTMR3
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.44120116323164554,0.7109296082230524,0.8928571428571429,1.0,1.0,1/7,8.23%,SLTM
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.3752466537445946,0.7108761661301253,0.9322033898305084,1.0,1.0,6/16,14.21%,RALA;FBXO7;DDHD1;PINK1;MARCHF5;MFF
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.42325231247396067,-0.7106033791097999,0.8076923076923077,0.9909586274574324,1.0,1/10,4.89%,RASGRF2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.4800567019012425,-0.7104581364345315,0.8461538461538461,0.9906758637108272,1.0,1/6,10.39%,NNT
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.43600541850048213,0.7103469086620013,0.8076923076923077,1.0,1.0,2/6,12.22%,CAPN2;FOXO3
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.43600541850048213,0.7103469086620013,0.8076923076923077,1.0,1.0,2/6,12.22%,CAPN2;FOXO3
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.39742133942826163,-0.7102299140145508,0.8571428571428571,0.9905332253472401,1.0,1/10,9.88%,CST3
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.39845892390611665,-0.7101886827607019,0.8363636363636363,0.990120774434111,1.0,2/12,9.46%,STAT5B;PMAIP1
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,-0.4267175575546548,-0.7100772117481944,0.82,0.9898195298325617,1.0,2/7,16.23%,PRKAR1A;GNAS
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.4164792372039364,-0.710070242634982,0.8421052631578947,0.9893740896234569,1.0,1/15,2.39%,FN1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.4479671184437891,0.709937711293629,0.8571428571428571,1.0,1.0,3/6,33.23%,LRRK2;MEF2C;INSYN2A
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.4479671184437891,0.709937711293629,0.8571428571428571,1.0,1.0,3/6,33.23%,LRRK2;MEF2C;INSYN2A
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.3492116453037625,-0.7097295585201977,0.9298245614035088,0.9892900941415499,1.0,4/38,7.22%,PSMA1;PSMB9;SMAD3;MAML3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.4749252247561785,0.7090769924949805,0.8372093023255814,1.0,1.0,2/5,14.26%,DOCK4;NRP1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.4037946181825163,-0.7088805556618534,0.8372093023255814,0.9899038349644715,1.0,2/11,6.99%,IL32;LCP2
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.3716342842151593,-0.7084983064660553,0.88,0.9900553194778793,1.0,3/14,10.57%,NFKB1;ERAP1;SPPL2A
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.4244324017149207,0.7083174304238127,0.7758620689655172,1.0,1.0,2/6,15.56%,PLCB1;GRB2
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.4244324017149207,0.7083174304238127,0.7758620689655172,1.0,1.0,2/6,15.56%,PLCB1;GRB2
prerank,CellMarker_Augmented_2021__Muller cell:Retina,0.34135789866888006,0.7077334253292982,0.851063829787234,1.0,1.0,6/21,19.68%,RNF130;RTN1;TM6SF1;FOXO3;NCOA1;MTMR3
prerank,Reactome_2022__Retrograde Neurotrophin Signaling R-HSA-177504,-0.4809830379209854,-0.7072994805865712,0.8695652173913043,0.9913266747970847,1.0,2/6,13.60%,CLTA;DNM3
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.40077686789047434,0.7068194613690232,0.8727272727272727,1.0,1.0,1/15,0.96%,CRY1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.38952112044251896,-0.7067204422288043,0.875,0.9915686397049785,1.0,2/17,2.79%,TPM1;CXCL12
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,0.4111432400639013,0.7064121399760995,0.8679245283018868,1.0,1.0,7/12,29.69%,PPP1CB;ROCK1;LIMK2;ROCK2;MYH9;MYH10;MYL6
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.41353596004199034,0.706198381556054,0.8695652173913043,1.0,1.0,1/10,1.89%,AGTPBP1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.39154969610192375,-0.7061496765024474,0.8653846153846154,0.9917479465818593,1.0,4/17,11.71%,PRKN;B2M;CST3;UBC
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.35794026453369704,0.7057341258349696,0.8367346938775511,1.0,1.0,2/20,7.01%,SLC38A9;PIK3CA
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.38835366877233085,0.7054542775655371,0.8518518518518519,1.0,1.0,5/15,26.40%,CBFB;ROCK1;ROCK2;SETD5;MEF2C
prerank,Reactome_2022__RUNX3 Regulates NOTCH Signaling R-HSA-8941856,-0.43928156913974237,-0.7053934265403227,0.8125,0.9917654042130475,1.0,1/7,7.22%,MAML3
prerank,Reactome_2022__Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,-0.43928156913974237,-0.7053934265403227,0.8125,0.9917654042130475,1.0,1/7,7.22%,MAML3
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.4250662604777895,-0.7045569074781938,0.8409090909090909,0.9924670973292162,1.0,3/8,18.27%,GNG4;GNA14;MAPK14
prerank,CellMarker_Augmented_2021__Chondrocyte:Cartilage,-0.36950671352965764,-0.7042333019974525,0.9074074074074074,0.9924347376575148,1.0,2/29,2.39%,SLC16A2;FN1
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,0.4056933957761741,0.7041213521794913,0.9090909090909091,1.0,1.0,2/11,7.46%,NUP58;RANBP2
prerank,Reactome_2022__Free Fatty Acids Regulate Insulin Secretion R-HSA-400451,-0.46841023870975695,-0.704093718117253,0.8103448275862069,0.9921341007028572,1.0,2/5,13.68%,ACSL4;GNA14
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4658307364732476,-0.7039948604078081,0.8571428571428571,0.9918002216735684,1.0,4/8,26.51%,UBC;XPC;CUL4A;RPS27A
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.3803767393051643,0.7038738985896361,0.8863636363636364,1.0,1.0,2/11,7.52%,IL1R1;ENTPD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.38954934627608917,-0.7038492572990673,0.8048780487804879,0.9915001613824168,1.0,2/12,14.24%,MEF2A;PDE9A
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,-0.39745088861570954,-0.7036295609547555,0.7735849056603774,0.9908913155877718,1.0,3/14,13.09%,MAPKAP1;UBC;ATM
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.39745088861570954,-0.7036295609547555,0.7735849056603774,0.9908913155877718,1.0,3/14,13.09%,MAPKAP1;UBC;ATM
prerank,KEGG_2021_Human__Non-small cell lung cancer,0.32546696701885397,0.7034234375353977,0.8636363636363636,1.0,1.0,3/31,7.01%,RARB;KRAS;PIK3CA
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3577030368694575,0.7031979034146806,0.8823529411764706,1.0,1.0,4/23,15.91%,ITGA1;CCDC88A;GRB2;CDC42
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.415899602409774,-0.7031944994220738,0.8275862068965517,0.991070102546362,1.0,3/10,22.52%,NFKB1;PDGFB;ZBTB20
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.4298004909435206,0.7030043536281934,0.8245614035087719,1.0,1.0,3/9,22.97%,CALM1;PPP2R5E;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.3783503673186578,-0.7029347918737011,0.8666666666666667,0.9904720587057559,1.0,3/12,15.19%,CDC14A;SPAST;RHOA
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3783503673186578,-0.7029347918737011,0.8666666666666667,0.9904720587057559,1.0,3/12,15.19%,CDC14A;SPAST;RHOA
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.3927957611903573,0.7024547965812503,0.9047619047619048,1.0,1.0,3/12,31.10%,PTPN1;NF1;HYAL2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.31644058505250383,0.7021581121016148,0.9803921568627451,1.0,1.0,10/41,18.67%,CALR;PRKD1;ABL1;PPM1F;RTN4;CLASP1;NRP1;RAC1;EDN1;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3548692765319004,0.7020862551090918,0.9333333333333333,1.0,1.0,6/26,22.90%,ABL1;SLC8A1;HEG1;PTEN;PTPN1;NF1
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,0.3921988099643966,0.7019966312562281,0.8461538461538461,1.0,1.0,7/14,31.42%,CTBP2;PPP2CB;PPP2R5E;PPP2R5C;TCF7L2;TNKS;FZD4
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3069634470552802,0.7015823441148457,0.9534883720930233,1.0,1.0,14/48,21.59%,TUBB4B;PCM1;BTRC;PLCB1;HSP90AA1;PPP1CB;CLASP1;TPD52L1;KHDRBS1;YWHAG;TAF2;CEP290;CDK5RAP2;FBXL7
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.3039683481714631,0.7015723546845524,0.9215686274509803,1.0,1.0,14/39,21.81%,CDH2;ACTG1;NRCAM;NRXN1;ACTB;CDH12;VMP1;CDC42;NLGN1;PTEN;RYK;CTNND2;FSCN1;OPHN1
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,0.39306416112232595,0.7015281492587543,0.8125,1.0,1.0,4/14,14.61%,MAPK10;DUSP6;PPP2CB;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3662488209234671,-0.7009385214824011,0.88,0.9924933118087926,1.0,4/29,16.31%,FN1;JAK2;PPP1R16B;PDGFB
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreas,0.33270457824412886,0.7009125700677761,0.94,1.0,1.0,5/29,11.87%,CYYR1;ROBO2;NRXN1;CNTNAP2;SHROOM4
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Kidney,0.3051667516024759,0.7009041702567659,0.9347826086956522,1.0,1.0,6/36,13.15%,GOLM1;ATP2A2;CTBP2;DNAJC5;PHC2;FNDC3B
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Lymph,0.3051667516024759,0.7009041702567659,0.9347826086956522,1.0,1.0,6/36,13.15%,GOLM1;ATP2A2;CTBP2;DNAJC5;PHC2;FNDC3B
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Liver,0.3051667516024759,0.7009041702567659,0.9347826086956522,1.0,1.0,6/36,13.15%,GOLM1;ATP2A2;CTBP2;DNAJC5;PHC2;FNDC3B
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.41396529658996617,0.7007809553618434,0.8444444444444444,1.0,1.0,1/9,7.01%,PIK3CA
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.3906237080665676,-0.7004611201247146,0.9,0.9925803691882465,1.0,1/12,2.23%,PLCG2
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,-0.4206484192786577,-0.7000268303877182,0.8723404255319149,0.9926578077592492,1.0,1/9,6.83%,TAF1D
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.44495290990061176,-0.699723921366698,0.8478260869565217,0.9924634715949338,1.0,2/6,19.18%,PCCA;CD320
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,0.47989914230441144,0.6994472393498189,0.8653846153846154,1.0,1.0,2/5,15.91%,GNB4;CDC42
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.3289306130553403,-0.6993397661129137,0.9076923076923077,0.9924598960050371,1.0,11/50,14.77%,STAT1;NDRG1;PRKN;BCL2L14;ACER2;PMAIP1;ACTN1;CLU;ATM;JAK2;CHM
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.3761988496725357,0.6993002748582792,0.7619047619047619,1.0,1.0,2/13,9.30%,UIMC1;CDC14B
prerank,CellMarker_Augmented_2021__Ionocyte cell:Lung,0.28078992926449836,0.6986266076124321,0.975,1.0,1.0,18/87,14.42%,GOLM1;RALA;BCR;DUSP6;MGAT5;FAM174B;DOCK4;CHST15;ZNF704;PALM2AKAP2;KHDRBS3;CELF2;ID3;ITPR2;ANKRD6;INO80;MTHFD1L;TFG
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.4148318678923051,0.6983363584136714,0.8461538461538461,1.0,1.0,1/6,7.25%,PRKX
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.4732649298669269,-0.6978545353954044,0.8536585365853658,0.9937230926836663,1.0,1/6,8.92%,JUN
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,0.39067739363625886,0.6977231716142844,0.6938775510204082,1.0,1.0,3/9,20.82%,ADAM10;MIB1;ADAM17
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.34531293023355625,0.6976854113716354,0.8793103448275862,1.0,1.0,9/17,28.76%,HSP90AA1;PGR;HSPA8;CAPZB;HSP90AB1;CAPZA1;FKBP5;NR3C1;HSPA1A
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.3550129137111676,-0.6969590555809695,0.86,0.9943044256676002,1.0,1/20,1.57%,RIMS1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.3765932308026038,0.6965083287339047,0.7884615384615384,1.0,1.0,4/11,20.82%,BACE2;ADAM10;PSEN1;ADAM17
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.37396173031488106,-0.6964834076528046,0.8771929824561403,0.9944665266832426,1.0,8/25,21.12%,HMGN1;MSH2;UBC;PWWP3A;XPC;SAFB;TCF7L1;CUL4A
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.39463966455672167,0.6961000718142194,0.8,1.0,1.0,1/11,2.52%,VAPB
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.4229494609448046,0.6955821836135567,0.9318181818181818,1.0,1.0,1/11,4.70%,YAF2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.4229494609448046,0.6955821836135567,0.9318181818181818,1.0,1.0,1/11,4.70%,YAF2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.40252032908825297,0.6953836063055763,0.7804878048780488,1.0,1.0,1/9,1.09%,IL1R1
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.39131280602792406,0.6951934376809813,0.8035714285714286,1.0,1.0,3/13,18.67%,RAB11FIP2;GNB4;PRKCA
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,0.39131280602792406,0.6951934376809813,0.8035714285714286,1.0,1.0,3/13,18.67%,RAB11FIP2;GNB4;PRKCA
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,-0.3094502647395956,-0.695102377287933,0.9666666666666667,0.9956366785441613,1.0,13/66,13.33%,VAV3;RASGRF2;ARAP2;GIT2;KCTD3;FNBP1;TFRC;ARHGAP17;LBR;ARHGEF11;FMNL3;MCF2L;DAAM1
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.38207134841088897,-0.6945053673943618,0.8727272727272727,0.9959929039159654,1.0,5/13,13.09%,RFC3;TOPBP1;BABAM2;UBC;ATM
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.46897614403220805,-0.6941781578816568,0.8461538461538461,0.9954886056057044,1.0,4/6,26.51%,UBC;XPC;CUL4A;RPS27A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.46897614403220805,-0.6941781578816568,0.8461538461538461,0.9954886056057044,1.0,4/6,26.51%,UBC;XPC;CUL4A;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.3793166930485011,0.6940661403383669,0.8780487804878049,1.0,1.0,3/11,18.59%,CLASP1;PHLDB2;WASF2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.4503118114092301,-0.6939378807184621,0.88,0.9953364906202975,1.0,3/6,20.74%,ATP2B1;ZDHHC21;ECE1
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,-0.47142562914689323,-0.6937370636891177,0.84,0.9950991123370152,1.0,1/5,6.77%,SMAD3
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.41449874489861016,-0.6929989382205638,0.7804878048780488,0.9955685821591128,1.0,1/7,4.38%,LGALS3
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.44728078350833234,-0.6929418373461887,0.8863636363636364,0.995193847823539,1.0,1/6,9.75%,RPS19
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.32722809108942885,0.6928227047075711,0.9591836734693877,1.0,1.0,2/19,7.12%,BACH2;PPP1R10
prerank,CellMarker_Augmented_2021__Progenitor cell:Prostate,0.4624182482445955,0.6925811607323147,0.9166666666666666,1.0,1.0,1/5,4.83%,ITGA2
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,0.3813453162897583,0.6924856999034651,0.8936170212765957,1.0,1.0,4/12,29.48%,ARF4;BBS9;EXOC5;ASAP1
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.33873467666821405,0.692187389320483,0.9318181818181818,1.0,1.0,1/21,4.25%,TENT4A
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,0.3250749256668145,0.692049046314614,0.8627450980392157,1.0,1.0,9/27,22.97%,AHCTF1;RANBP2;XPO1;CLASP1;PPP2CB;TAOK1;CLIP1;PPP2R5E;PPP2R5C
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.3540591030540533,0.6918795135155495,0.9387755102040817,1.0,1.0,6/19,28.02%,EP300;NCOA1;NCOR2;AGO2;KDM3A;NRIP1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.34936200585618055,0.691622284000737,0.8571428571428571,1.0,1.0,4/20,19.71%,PEX14;PARD3;ZDHHC14;SEC63
prerank,KEGG_2021_Human__Focal adhesion,0.30018710177269536,0.6913076450433535,0.9354838709677419,1.0,1.0,20/84,18.99%,COL4A2;ACTG1;MAPK10;ITGA2;ITGA1;PIK3CA;DIAPH1;CAPN2;PARVA;ITGA5;ACTB;PPP1CB;GRB2;CDC42;PTEN;RAC1;PRKCA;ROCK1;PXN;CRK
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.3767681185814235,-0.690903094792236,0.8913043478260869,0.997174291829894,1.0,2/12,10.09%,TANK;NET1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.3702923943085912,-0.6908761626424036,0.9215686274509803,0.9967612749412832,1.0,6/24,23.16%,SEPTIN11;SPAST;RHOA;APC;SEPTIN2;SPTBN1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.40044515115331525,-0.6899522232681438,0.8771929824561403,0.9973663890274755,1.0,3/9,18.73%,DGKG;MGLL;DGKE
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.34526152884467587,-0.6899484448920333,0.9111111111111111,0.9969063491801382,1.0,4/26,16.65%,PRKN;WARS1;PRKRIP1;DNAJC10
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.4171121451669352,-0.6895945210605825,0.8,0.9969953387142849,1.0,3/14,13.23%,STAT1;NFKB1;JAK2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.44045285640190296,0.6889369627075944,0.8571428571428571,1.0,1.0,1/8,4.94%,SEMA3F
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.3647994367791595,0.6889328210473548,0.9074074074074074,1.0,1.0,5/13,22.90%,SBF2;SKI;PARD3;PLLP;NF1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3019479926939987,0.688669474761188,0.9777777777777777,1.0,1.0,9/30,22.55%,PLCB1;INO80;APPL1;PTEN;ANXA1;RGCC;ADAM17;CDC73;CDK6
prerank,CellMarker_Augmented_2021__Basal cell:Epithelium,-0.4032147795798451,-0.6883209709795873,0.8235294117647058,0.9982329499077082,1.0,1/10,2.55%,ITGB5
prerank,Reactome_2022__Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,-0.4193164631092054,-0.6878398751940752,0.8333333333333334,0.9983543213939385,1.0,1/6,5.37%,CDC37
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.3981081754854713,-0.6872292859266179,0.8888888888888888,0.9985228093479986,1.0,2/11,11.71%,NFKB1;UBC
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.347751479903508,-0.6871688433696639,0.82,0.9981388262501661,1.0,2/25,5.63%,OPTN;CALCOCO2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.43382504730627897,0.6870530528920612,0.8846153846153846,1.0,1.0,1/5,11.55%,ACOX1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.3501434690129555,0.6869165695847227,0.9512195121951219,1.0,1.0,6/20,17.64%,URI1;ROBO2;NCOA3;NCOA2;ATP1A1;NCOA1
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.43280471405098464,-0.685779259360092,0.8571428571428571,0.9992179245737939,1.0,1/6,4.89%,RASGRF2
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.32250404522842274,0.6856159013502754,0.9285714285714286,1.0,1.0,8/41,17.42%,IL6R;IFNAR1;PIAS1;PIK3CA;BCL2L1;GRB2;CREBBP;EP300
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.3515181037481249,0.68554378944381,0.9024390243902439,1.0,1.0,3/23,9.03%,ATRNL1;MICALL2;PARVA
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.320093066526438,0.6853295430774958,0.9333333333333333,1.0,1.0,6/25,18.43%,UIMC1;COP1;INO80;GRB2;ANXA1;RNF168
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.3424334961999663,-0.6851392640427371,0.9193548387096774,0.9995225560198743,1.0,5/35,16.44%,DENND3;DENND2C;RAB1A;RIN2;DENND6A
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.437821526234523,0.6850248446704823,0.7966101694915254,1.0,1.0,2/5,19.10%,SETD7;SETD3
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.4170894915347335,-0.6849611791573257,0.8979591836734694,0.9992329256908005,1.0,3/10,13.23%,STAT1;STAT5B;JAK2
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.31923940206482365,0.6844194896516966,0.8888888888888888,1.0,1.0,4/17,15.64%,PGR;ZMIZ1;ARID1A;UBE3A
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.4605819829219581,-0.6836271590280553,0.7962962962962963,1.0,1.0,4/6,32.32%,RIMKLB;DGLUCY;GLUD1;GLUL
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.44278793334619876,-0.6834213314777254,0.8541666666666666,1.0,1.0,2/7,23.11%,MAP3K4;GADD45B
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.41234148541181703,-0.6829998465449691,0.8,1.0,1.0,1/9,4.01%,PRKN
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.39134678180054716,-0.6828363670147903,0.9016393442622951,0.9999169086453951,1.0,5/14,13.81%,GEMIN5;NFKBIA;NFKB1;RPL10;SSH1
prerank,CellMarker_Augmented_2021__Bulge Stem cell:Scalp,-0.3394869494310532,-0.6828345671329913,0.9107142857142857,0.9994631448042509,1.0,4/31,10.04%,DOK5;CTNNA2;ARMCX4;ITM2A
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.3587536313670873,-0.6822201833324268,0.9074074074074074,0.9996726630227647,1.0,3/29,4.04%,TPM1;CXCL12;LAMA4
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,0.3456212542979361,0.6821191396305454,0.8571428571428571,1.0,1.0,5/14,17.42%,CNTN1;ADAM10;MIB1;PSEN1;EP300
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.38455578237528176,0.68211714184927,0.8372093023255814,1.0,1.0,1/12,0.90%,INPP5A
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Adipose Tissue,-0.3172342008532767,-0.6820618367442768,0.9166666666666666,0.9994167858329805,1.0,6/47,9.61%,TPM1;FN1;ITGB5;SERPINE1;PRSS23;LIMA1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.3093977144809173,-0.6818348009746861,0.9,0.9991940210754992,1.0,7/53,11.29%,PLCG2;CHKA;AGPAT3;DGKG;INPP5D;PIK3C2B;MTMR2
prerank,KEGG_2021_Human__FoxO signaling pathway,-0.3213888418617062,-0.6811801052657865,0.9433962264150944,0.999473795649034,1.0,5/53,6.77%,SOD2;PLK2;GABARAPL1;TNFSF10;SMAD3
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.41313863353026153,0.6809306792322576,0.8333333333333334,1.0,1.0,2/8,11.26%,WAPL;PPHLN1
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,-0.37256512640780204,-0.6801254055637083,0.9285714285714286,1.0,1.0,3/14,17.45%,STAM2;UBC;SH3GL1
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.32268866937928997,-0.6800506262179857,0.9830508474576272,0.9998824834687343,1.0,6/50,8.92%,PLCG2;MAP3K5;NFKBIA;NFKB1;KIDINS220;JUN
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,-0.42871641587514375,-0.6799836852300994,0.8653846153846154,0.9994958230862753,1.0,3/11,13.23%,STAT1;STAT5B;JAK2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.4246242503314291,-0.6791551608377401,0.9423076923076923,1.0,1.0,3/8,13.23%,STAT1;STAT5B;JAK2
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.40531509067243365,-0.6790329326008304,0.8163265306122449,0.9997399907657113,1.0,2/7,15.19%,UBC;RHOA
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,-0.441257669543218,-0.6788475967804122,0.8043478260869565,0.9995224720691515,1.0,1/5,8.42%,COL18A1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.35097492786291346,0.6777397647168193,0.9148936170212766,1.0,1.0,5/14,16.57%,ITPR3;ITPR2;SLC8A1;SLC24A2;ATP2B4
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.37869462335849036,-0.6775320718230092,0.8518518518518519,1.0,1.0,1/9,4.73%,PLA1A
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.36258769502324656,0.6772827866831534,0.8867924528301887,1.0,1.0,4/18,18.67%,PRKX;GNB4;CALCRL;PRKCA
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.45503436629975935,-0.6770238342912661,0.82,1.0,1.0,2/7,13.23%,STAT5B;JAK2
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.40144708283378,-0.6769842009770825,0.8148148148148148,0.9997946730572811,1.0,1/10,1.78%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.40144708283378,-0.6769842009770825,0.8148148148148148,0.9997946730572811,1.0,1/10,1.78%,ISG15
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,-0.3992531076490327,-0.6768053914028108,0.88,0.9995636110992739,1.0,1/10,4.59%,RFC3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Liver,0.4295784023766305,0.6759767345401557,0.8392857142857143,1.0,1.0,1/5,6.75%,NCAM1
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.4166648577291619,-0.6755848349608353,0.8727272727272727,1.0,1.0,1/10,1.59%,SLC16A2
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.30713738041399075,0.6755341950603179,1.0,1.0,1.0,14/47,21.59%,TUBB4B;PCM1;BTRC;PLCB1;HSP90AA1;PPP1CB;CLASP1;TPD52L1;KHDRBS1;YWHAG;TAF2;CEP290;CDK5RAP2;FBXL7
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.40266168489182097,-0.6752219780099248,0.7346938775510204,1.0,1.0,1/8,1.54%,SOD2
prerank,CellMarker_Augmented_2021__Stem cell:Periodontal Ligament,0.4062077512353586,0.6751152487962131,0.82,1.0,1.0,1/8,6.43%,ALCAM
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.43952725716291463,-0.6750727334622489,0.8936170212765957,1.0,1.0,2/5,6.56%,SLCO1A2;SLCO2B1
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Fetal Liver,-0.325811189899657,-0.6750057715400389,0.8923076923076924,0.9996812490839093,1.0,3/44,4.86%,CXCL12;DOK5;TIE1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4127653952688129,0.6745842401093503,0.88,1.0,1.0,3/6,14.08%,FBXO7;REST;PINK1
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,-0.3753544734650558,-0.6743205504147173,0.9230769230769231,0.9999727502781369,1.0,2/21,9.85%,RFC3;POLR2A
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,0.3040551564736448,0.6742478767312713,0.9428571428571428,1.0,1.0,10/39,19.47%,ACTG1;YES1;AP2B1;EPHA4;ADAM10;CDC42;PSEN1;TIAM1;ROCK1;LIMK2
prerank,Reactome_2022__Regulation Of PTEN Localization R-HSA-8948747,-0.3916571844007777,-0.6742399336918931,0.88,0.9996211165879185,1.0,1/7,11.71%,UBC
prerank,CellMarker_Augmented_2021__Stem cell:Esophagus,-0.33065393990935577,-0.674165543149507,0.9433962264150944,0.9992372075775054,1.0,2/40,4.06%,MAP2;SMARCA1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.335218068512265,-0.6741198606542971,0.92,0.9988210671788219,1.0,6/32,12.59%,MAP2;SMAD3;CDA;BST2;GNG4;SMARCA2
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Skin,-0.4347810549461668,-0.6738331726597433,0.8478260869565217,0.9986565198507644,1.0,1/5,18.03%,CD34
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,0.34016951144901864,0.6734619755290163,0.8703703703703703,1.0,1.0,2/16,11.93%,ABL1;PPP2CB
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.34340675329055836,0.6734522777376587,0.8292682926829268,1.0,1.0,3/18,15.91%,TPM4;DST;CDC42
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.3596233426822461,0.6731617029491456,0.9545454545454546,1.0,1.0,5/17,26.08%,EP300;NCOA1;NCOR2;AGO2;KDM3A
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.4361336111376094,-0.6726273539835809,0.7924528301886793,0.9994500283446872,1.0,1/7,1.78%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.39795597716261666,0.6720467401477883,0.8048780487804879,1.0,1.0,3/9,32.51%,APPL1;INSR;PRKCI
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.3321740944673131,0.6720025966233075,0.8666666666666667,1.0,1.0,3/22,7.41%,GRM5;CCDC88A;HSPB1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.3987766456727227,0.6718793093198672,0.8679245283018868,1.0,1.0,1/8,4.78%,UGCG
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.32508444675560455,-0.6718321209885811,0.9038461538461539,0.9998709837322316,1.0,5/36,12.01%,CDK14;PRKN;APCDD1;GPC3;SULF2
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.40125890043767964,0.6715962401651785,0.8775510204081632,1.0,1.0,3/9,16.84%,DNMT3A;ATF7IP;BAZ2A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.40125890043767964,0.6715962401651785,0.8775510204081632,1.0,1.0,3/9,16.84%,DNMT3A;ATF7IP;BAZ2A
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.40125890043767964,0.6715962401651785,0.8775510204081632,1.0,1.0,3/9,16.84%,DNMT3A;ATF7IP;BAZ2A
prerank,Reactome_2022__Signal Regulatory Protein Family Interactions R-HSA-391160,0.453747951221606,0.6709457335091363,0.8867924528301887,1.0,1.0,2/5,15.56%,SKAP2;GRB2
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.3886736864121615,-0.6706558481036855,0.9285714285714286,1.0,1.0,3/13,29.38%,PRIMPOL;BOD1L1;WRN
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.37745169874711193,-0.6705364378857143,0.8333333333333334,1.0,1.0,4/12,16.23%,GNG4;FZD6;RAMP3;GNAS
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.3948019599945988,-0.6704352643180602,0.96,1.0,1.0,2/10,6.88%,GMPS;ADSS2
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,0.38570423882866867,0.6703722256975541,0.8245614035087719,1.0,1.0,3/9,18.83%,XPO1;MDN1;WDR43
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,-0.42646655573554826,-0.6702873219753518,0.8536585365853658,0.9997601440629792,1.0,1/5,5.58%,PLXND1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3790955528704904,0.6699066061242703,0.8076923076923077,1.0,1.0,2/9,9.30%,UIMC1;CDC14B
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.35547657575624436,0.6691885912349798,0.9298245614035088,1.0,1.0,5/17,16.04%,ITGA1;RAB7A;GRB2;CDC42;CBLB
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.3931488856172944,-0.6691089966997283,0.8780487804878049,1.0,1.0,2/9,14.24%,MEF2A;PDE9A
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Undefined,0.4297174929571055,0.6689573625536557,0.8541666666666666,1.0,1.0,1/8,15.46%,CD59
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.43611734171343164,-0.6689554408887337,0.8928571428571429,1.0,1.0,4/6,26.83%,UBC;SQSTM1;RPS27A;MAPK8
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,-0.3500953384689333,-0.6678435413774313,0.9622641509433962,1.0,1.0,4/28,11.71%,MAP3K5;FOS;JUN;UBC
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.27442022057541715,0.6677815187116342,0.9777777777777777,1.0,1.0,4/52,8.92%,MMRN1;CDH2;TET2;ELF1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.35539945023154274,0.6677720806836104,0.9454545454545454,1.0,1.0,5/15,16.49%,ACTB;GNB4;YWHAQ;CDC42;CALM1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.35702702894326316,0.6677105415198388,0.9302325581395349,1.0,1.0,1/18,0.72%,PSMD14
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.3423041805177329,0.6672862582035132,0.9090909090909091,1.0,1.0,6/16,17.66%,YES1;AP2B1;EPHA4;ADAM10;PSEN1;TIAM1
prerank,CellMarker_Augmented_2021__Pancreatic Endoderm cell:Embryonic Stem Cell,-0.3006273123000165,-0.6670564689859458,0.9830508474576272,1.0,1.0,1/34,2.26%,PLK2
prerank,KEGG_2021_Human__mTOR signaling pathway,0.2865784642180327,0.6668168097558852,1.0,1.0,1.0,8/49,18.67%,SLC38A9;KRAS;PIK3CA;GRB10;FNIP2;GRB2;PTEN;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.4429274272386737,0.6665975675072415,0.8666666666666667,1.0,1.0,1/5,16.52%,KLF2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.3802036962814145,0.6665631189998122,0.875,1.0,1.0,2/10,20.98%,CLASP1;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.38216566551648123,-0.6664624562169792,0.8269230769230769,1.0,1.0,2/15,10.44%,LYPLA1;NOSTRIN
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.3172175496155337,-0.6661241326517955,0.9473684210526315,1.0,1.0,2/33,2.26%,PLCG2;PLK2
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.3816079362091005,-0.665519036755357,0.8979591836734694,1.0,1.0,1/9,1.81%,HGSNAT
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.35283709824581144,-0.6654359724625574,0.8620689655172413,1.0,1.0,6/33,12.19%,VAV3;RASGRF2;ARHGEF37;ARHGEF11;UBC;MCF2L
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.4229991470833582,-0.6650600168377092,0.8163265306122449,1.0,1.0,1/7,7.46%,DMD
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.35830297003496725,0.6648072018780341,0.9523809523809523,1.0,1.0,9/29,23.64%,ITGA1;HSP90AA1;DPYSL2;NRP1;ROCK1;LIMK2;FES;ROCK2;HSP90AB1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.357354216690723,-0.6643115679487103,0.8909090909090909,1.0,1.0,2/15,8.66%,PRKN;CCDC88C
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,0.42461643624140993,0.6640813919271281,1.0,1.0,1.0,1/10,4.70%,YAF2
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.44584133954737387,0.6631898220647786,0.8627450980392157,1.0,1.0,1/5,7.89%,ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.44584133954737387,0.6631898220647786,0.8627450980392157,1.0,1.0,1/5,7.89%,ACAT1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.32424613540134584,0.6627995148544193,0.9347826086956522,1.0,1.0,5/21,21.25%,CACNA1C;CALCRL;SLC8A1;PSEN1;RYR2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.3789910731484738,0.6627676159979228,0.8936170212765957,1.0,1.0,3/11,20.03%,NAV3;CLASP1;TAOK1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.42616900645026307,-0.6627285810319749,0.8653846153846154,1.0,1.0,1/9,5.26%,GRB14
prerank,CellMarker_Augmented_2021__AXL+SIGLEC6+ Dendritic cell:Blood,-0.3535829333086029,-0.6624571803819767,0.8867924528301887,1.0,1.0,5/20,18.54%,NDRG1;BHLHE40;KLF12;GPR146;MGLL
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,-0.3443536286315503,-0.6615217789890292,0.8727272727272727,1.0,1.0,1/13,3.51%,ATP6V1E1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.4174105006107016,-0.6609794537894911,0.8723404255319149,1.0,1.0,2/6,5.60%,CD109;SERPINE1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.3670862201123358,-0.6606476193664358,0.84,1.0,1.0,6/17,19.76%,SERPINE1;NFKB1;VIM;RHOA;MAPK14;ZFP36
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,0.3371906325833739,0.6605389402315371,0.8666666666666667,1.0,1.0,2/20,7.01%,COL4A2;PIK3CA
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.4156057117541029,0.6604856258927064,0.8867924528301887,1.0,1.0,2/5,19.47%,CLASP1;LIMK2
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.3670880343022629,0.6603425568100004,0.8604651162790697,1.0,1.0,4/14,17.24%,RAD23B;SSBP1;POT1;ANXA1
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,-0.39572358956771037,-0.6599705377631796,0.8235294117647058,1.0,1.0,1/6,6.69%,GPD2
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.3680230718070695,0.6599318250264601,0.92,1.0,1.0,5/11,29.77%,EDN1;RGCC;PHIP;CDC16;INSR
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,0.40701902259293304,0.6599126993887396,0.8775510204081632,1.0,1.0,1/7,4.78%,UGCG
prerank,CellMarker_Augmented_2021__MKI67+ Progenitor cell:Large Intestine,0.2658418233867478,0.6598228270530281,1.0,1.0,1.0,10/55,20.11%,MMRN1;SLCO2A1;CYYR1;CALCRL;NRP1;DIPK2B;ESAM;HEG1;FOXC1;RGCC
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.29319480723057095,0.6594870219359277,1.0,1.0,1.0,9/57,15.99%,BCL6;CCDC85B;URI1;RTN4;CHPT1;INO80;ADAM10;CDC42;ST7L
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.4131849940155868,-0.6594539901762125,0.8333333333333334,1.0,1.0,1/5,11.95%,CLYBL
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.4131849940155868,-0.6594539901762125,0.8333333333333334,1.0,1.0,1/5,11.95%,CLYBL
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Liver,0.4271771914555293,0.6594238852170095,0.8947368421052632,1.0,1.0,1/5,6.75%,NCAM1
prerank,CellMarker_Augmented_2021__Cytokine Induced Killer cell:Blood,0.4271771914555293,0.6594238852170095,0.8947368421052632,1.0,1.0,1/5,6.75%,NCAM1
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,-0.38236274593393604,-0.6592257701529357,0.9183673469387755,1.0,1.0,1/12,6.83%,TAF1D
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.3894604960509803,0.6588797972372691,0.8936170212765957,1.0,1.0,3/8,13.12%,PIK3CA;ABL1;HSPA8
prerank,CellMarker_Augmented_2021__Mesoderm cell:Undefined,-0.39231467853864527,-0.6581166999028697,0.8604651162790697,1.0,1.0,1/9,2.20%,MLLT1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.33477928567364046,0.6580869294284759,0.9322033898305084,1.0,1.0,2/19,3.13%,BAG3;IL6R
prerank,CellMarker_Augmented_2021__Retinal Progenitor cell:Retina,0.3093409280146649,0.657883236054028,0.9,1.0,1.0,10/37,16.15%,SGIP1;CYYR1;ROBO2;NRXN1;ADGRB3;CELF2;CACNA1C;BAALC;EPHA4;PLPPR4
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Periodontal Ligament,0.3093409280146649,0.657883236054028,0.9,1.0,1.0,10/37,16.15%,SGIP1;CYYR1;ROBO2;NRXN1;ADGRB3;CELF2;CACNA1C;BAALC;EPHA4;PLPPR4
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,0.33308763987474166,0.6577078602315319,0.9642857142857143,1.0,1.0,4/17,18.99%,ITGA2;PIGU;GRB2;CRK
prerank,CellMarker_Augmented_2021__Luminal cell:Prostate,-0.35550514738387945,-0.6576645386072477,0.9111111111111111,1.0,1.0,2/25,7.28%,KIAA1217;DSP
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.4500299333581444,0.6576431973004617,0.8541666666666666,1.0,1.0,3/5,33.57%,KIF5B;RAB27A;SPG11
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.40091565960814324,0.6576254304692717,0.8723404255319149,1.0,1.0,3/8,29.77%,PSEN1;ARNT;INSR
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.40091565960814324,0.6576254304692717,0.8723404255319149,1.0,1.0,3/8,29.77%,PSEN1;ARNT;INSR
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.3660952080629859,0.6574868732544952,0.8392857142857143,1.0,1.0,4/8,34.13%,MYO1E;WASL;MYO1B;FNBP1L
prerank,Reactome_2022__Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,0.4159531133916008,0.6570831672584871,0.8596491228070176,1.0,1.0,1/5,9.03%,PARVA
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.4478920827254459,0.6567371213182658,0.8823529411764706,1.0,1.0,1/5,7.01%,PIK3CA
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.3872586013498328,-0.6567161063602984,0.7678571428571429,1.0,1.0,2/6,19.89%,MAPK14;PIK3C3
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.37017416032920525,0.6562968894391956,0.9523809523809523,1.0,1.0,3/15,25.15%,ANXA1;CANX;ARFGAP3
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",-0.26208167554549444,-0.6559372059910662,1.0,1.0,1.0,19/132,14.56%,PSMA1;PSMB9;OPTN;RFC3;SPC25;CDC14A;ANAPC16;CEP57;CEP70;LBR;RAB1A;UBC;USO1;KANSL1;JAK2;SPAST;PDS5B;NUP54;PPP1R12B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3852848182738878,0.6557851132262602,0.8478260869565217,1.0,1.0,2/7,7.49%,PRKG1;DOCK4
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.312678170754053,0.6555742476727876,0.94,1.0,1.0,7/31,17.48%,VAPB;DOCK4;DOCK3;RAB7A;LEMD3;CDC42;CYFIP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.3812070855880377,0.6555140593746822,0.8076923076923077,1.0,1.0,1/12,2.34%,MCC
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.3856208526295549,-0.6554010137749601,0.8490566037735849,1.0,1.0,1/12,1.78%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.40835009079760476,-0.6549030537457022,0.8809523809523809,1.0,1.0,3/8,21.33%,ITGAV;JAK2;TGM2
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,-0.3436883743915741,-0.6547740316968323,0.8490566037735849,1.0,1.0,9/33,16.92%,VAV3;RASGRF2;ARHGEF37;ARHGEF11;GNG4;MCF2L;GNA12;RHOA;FGD4
prerank,KEGG_2021_Human__Mitophagy,-0.3413181830327455,-0.6547401801822267,0.8571428571428571,1.0,1.0,8/30,14.85%,OPTN;GABARAPL1;PRKN;CALCOCO2;JUN;UBC;TBK1;MFN1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Bone Marrow,-0.3647745511855789,-0.654505460493067,0.94,1.0,1.0,3/26,5.60%,FN1;LAMA4;SERPINE1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Breast,-0.31428384390214287,-0.6540747561921961,0.9454545454545454,1.0,1.0,9/42,18.03%,ITIH5;CXCL12;TIE1;APCDD1;ENPP2;GNA14;RAMP3;ZNF423;CD34
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Corneal Endothelium,-0.31428384390214287,-0.6540747561921961,0.9454545454545454,1.0,1.0,9/42,18.03%,ITIH5;CXCL12;TIE1;APCDD1;ENPP2;GNA14;RAMP3;ZNF423;CD34
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,-0.354769659433514,-0.6540547316827995,0.8571428571428571,1.0,1.0,2/12,11.71%,MVB12B;UBC
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,0.3575035767906447,0.6535477069551338,0.9285714285714286,1.0,1.0,1/9,7.76%,NFYC
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.3991961517977962,0.6532722263943074,0.864406779661017,1.0,1.0,3/8,17.77%,SEMA3F;NRP1;RAC1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.2878688552517073,0.6530324619194705,0.9787234042553191,1.0,1.0,15/46,24.41%,ZBTB1;KDM4C;BRWD1;KDM5A;INO80;ARID1A;BAZ1B;BAZ2A;SETD7;JARID2;TOP1;HDAC4;BPTF;MECOM;PBRM1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.3664552526642929,0.6529791550528921,0.851063829787234,1.0,1.0,4/12,16.68%,PCM1;REST;RTN4;PTEN
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3809782429709626,0.6529683673081651,0.9047619047619048,1.0,1.0,2/11,9.93%,CCNI;ACTB
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,-0.3572747545759264,-0.652587032929148,0.864406779661017,1.0,1.0,5/27,12.19%,VAV3;RASGRF2;ARHGEF37;ARHGEF11;MCF2L
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.3870441852238717,0.6525351241180127,0.9019607843137255,1.0,1.0,3/6,26.77%,PINK1;DYRK1A;PIKFYVE
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Plasma,0.40034334129111104,0.6523015698803993,0.8653846153846154,1.0,1.0,1/6,3.80%,SLC25A37
prerank,CellMarker_Augmented_2021__Erythroblast:Fetal Liver,0.40034334129111104,0.6523015698803993,0.8653846153846154,1.0,1.0,1/6,3.80%,SLC25A37
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,0.3839217042136074,0.6516588007002291,0.8936170212765957,1.0,1.0,1/9,9.03%,PARVA
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4122104481199456,0.6512044097805331,0.890625,1.0,1.0,1/7,18.78%,ROCK1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.3807495998269842,-0.6502764339818936,0.9056603773584906,1.0,1.0,1/17,5.26%,GRB14
prerank,KEGG_2021_Human__Cardiac muscle contraction,0.37026364545079216,0.6502198550964642,0.8863636363636364,1.0,1.0,5/14,17.18%,ATP2A2;TPM4;CACNA1C;SLC8A1;ATP1A1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.4092401777527279,-0.6492285641994757,0.9090909090909091,1.0,1.0,1/12,2.12%,STAT1
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.3479649740609163,0.6490998808478936,0.9183673469387755,1.0,1.0,3/15,20.85%,ELL2;SNAPC3;RPAP2
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,0.2956870862161258,0.6488064169041956,0.9818181818181818,1.0,1.0,7/33,20.96%,ITGA2;PIK3CA;PIGU;RANBP9;GRB2;CRK;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.36360237544315344,-0.6488055129483192,0.9433962264150944,1.0,1.0,4/12,15.64%,ATM;MAP3K4;PARN;TNKS2
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.40154764305249535,-0.6485168962353832,0.8936170212765957,1.0,1.0,4/11,21.33%,SULF2;GNAS;SLC10A7;TGM2
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.3664071233703568,0.6483205211443533,0.88,1.0,1.0,3/13,17.42%,SMAD6;CDC42;EP300
prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.27286440916389526,0.6483075742592534,1.0,1.0,1.0,12/57,22.82%,ACTG1;KRAS;PIK3CA;ACTB;BCL2L1;ARID1A;GRB2;PTEN;PRKCA;MGST2;CDK6;AKT3
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,0.40398831003483815,0.6482464750305279,0.8863636363636364,1.0,1.0,2/5,23.85%,SEM1;SPIDR
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,0.40398831003483815,0.6482464750305279,0.8863636363636364,1.0,1.0,2/5,23.85%,SEM1;SPIDR
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.44643917155725515,-0.6481456312337698,0.8461538461538461,1.0,1.0,1/5,12.24%,RORA
prerank,KEGG_2021_Human__MicroRNAs in cancer,0.27350320794776856,0.6477981081373867,1.0,1.0,1.0,16/64,18.99%,ZEB1;KRAS;PIK3CA;ZEB2;ABL1;ITGA5;DNMT3A;DICER1;RPS6KA5;GRB2;PTEN;CREBBP;EP300;PRKCA;ROCK1;CRK
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.34693692643345836,-0.6469783383436108,0.9090909090909091,1.0,1.0,4/19,13.09%,RFC3;TOPBP1;UBC;ATM
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.43143609107641373,0.646527640147189,0.82,1.0,1.0,3/5,27.09%,GCH1;SCP2;FDFT1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.386446142640891,-0.646510253813676,0.8823529411764706,1.0,1.0,4/14,23.51%,STAT5B;EEF1A1;ZFP36;ZFP36L1
prerank,Reactome_2022__Apoptosis R-HSA-109581,-0.2914267500485363,-0.6464763535839342,1.0,1.0,1.0,7/59,11.71%,PSMA1;PSMB9;TNFSF10;TANK;PMAIP1;VIM;UBC
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.410586777310413,-0.6464536100208732,0.8367346938775511,1.0,1.0,3/5,34.29%,MAPK14;WWC2;VGLL4
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.32211796794480435,0.6463494861894505,0.8571428571428571,1.0,1.0,5/16,22.82%,IGFBP3;KLF7;PTPN1;CDK6;AKT3
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4187797399705154,-0.6463102407268513,0.8181818181818182,1.0,1.0,1/7,7.46%,DMD
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Parotid Gland,-0.33240448738156975,-0.6460629144883955,0.8653846153846154,1.0,1.0,2/25,2.97%,CXCL12;DOK5
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.2869155139051909,-0.6459177873534578,0.9836065573770492,1.0,1.0,5/72,8.82%,PLK2;CDK14;OPTN;CEP57;CEP70
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.38020905290730206,0.6459097500273492,0.9791666666666666,1.0,1.0,3/10,20.03%,NAV3;CLASP1;TAOK1
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.42678279693257903,-0.6447727391891113,0.875,1.0,1.0,2/5,16.23%,GNG4;GNAS
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,-0.42678279693257903,-0.6447727391891113,0.875,1.0,1.0,2/5,16.23%,GNG4;GNAS
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.4164814987944317,0.6446475937387407,0.9090909090909091,1.0,1.0,2/6,19.10%,SETD7;SETD3
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.3720424846379137,-0.6445350523210566,0.8541666666666666,1.0,1.0,2/17,5.58%,STAT1;PLXND1
prerank,Reactome_2022__Mitotic Telophase/Cytokinesis R-HSA-68884,0.37523262709037153,0.6444810476171122,0.9285714285714286,1.0,1.0,3/8,22.66%,WAPL;SMC1A;NIPBL
prerank,Reactome_2022__Cohesin Loading Onto Chromatin R-HSA-2470946,0.37523262709037153,0.6444810476171122,0.9285714285714286,1.0,1.0,3/8,22.66%,WAPL;SMC1A;NIPBL
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.3371532449796871,-0.6444356452289824,0.8936170212765957,1.0,1.0,6/16,19.07%,SMAD3;CD47;CLU;JAK2;CD34;PKD2
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.40984304713138464,0.644357292545434,0.9272727272727272,1.0,1.0,1/5,23.88%,AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.40984304713138464,0.644357292545434,0.9272727272727272,1.0,1.0,1/5,23.88%,AKAP6
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.42415967366670404,-0.6440051050147029,0.84,1.0,1.0,1/5,8.37%,ACER2
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.2690170676138447,0.6437578658574289,1.0,1.0,1.0,17/78,23.82%,TUBB4B;PCM1;WDPCP;HSP90AA1;PARVA;CDC14B;CLASP1;ABCC4;ARF4;CC2D2A;YWHAG;BBS9;CEP290;CDK5RAP2;KIFAP3;GSN;NUDCD3
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.3364856356192641,0.6437106195518242,0.9545454545454546,1.0,1.0,7/17,31.47%,YTHDF2;DIS3L2;RC3H1;TUT7;XRN2;HSPA1A;TUT4
prerank,KEGG_2021_Human__Propanoate metabolism,0.37686527621717414,0.6427772716509924,0.9090909090909091,1.0,1.0,2/9,11.55%,ACAT1;ACOX1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.41945008613069545,0.6426299977187802,0.9454545454545454,1.0,1.0,3/6,23.85%,ATP2B4;ROCK2;SPIDR
prerank,CellMarker_Augmented_2021__Testis Somatic cell:Testis,-0.3269398645401811,-0.6424910419443258,0.9056603773584906,1.0,1.0,2/30,2.97%,CXCL12;DOK5
prerank,CellMarker_Augmented_2021__Fibroblast:Synovium,-0.3269398645401811,-0.6424910419443258,0.9056603773584906,1.0,1.0,2/30,2.97%,CXCL12;DOK5
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Blood Vessel,-0.3269398645401811,-0.6424910419443258,0.9056603773584906,1.0,1.0,2/30,2.97%,CXCL12;DOK5
prerank,CellMarker_Augmented_2021__Retinal Ganglion cell:Embryonic Stem Cell,-0.3269398645401811,-0.6424910419443258,0.9056603773584906,1.0,1.0,2/30,2.97%,CXCL12;DOK5
prerank,CellMarker_Augmented_2021__Fibroblast:Embryonic Stem Cell,-0.3269398645401811,-0.6424910419443258,0.9056603773584906,1.0,1.0,2/30,2.97%,CXCL12;DOK5
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Embryo,-0.3269398645401811,-0.6424910419443258,0.9056603773584906,1.0,1.0,2/30,2.97%,CXCL12;DOK5
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Pancreas,-0.3269398645401811,-0.6424910419443258,0.9056603773584906,1.0,1.0,2/30,2.97%,CXCL12;DOK5
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.38968425801259776,-0.6424726536888861,0.9166666666666666,1.0,1.0,4/10,26.91%,EEF1A1;MRPL33;RACK1;PTCD3
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.374177780932896,-0.6424526039989984,0.8541666666666666,1.0,1.0,3/11,16.23%,GNG4;PRKAR1A;GNAS
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.3752905949388926,0.642072849619484,0.8636363636363636,1.0,1.0,2/12,15.56%,PIK3CA;GRB2
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.41159244401052053,-0.6420255982524968,0.8867924528301887,0.9999488313619395,1.0,2/5,26.00%,GSPT1;CLEC16A
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.43055865271100946,0.6420142747037489,0.9038461538461539,1.0,1.0,2/5,16.20%,BCL2L1;APPL1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.39074294770198387,0.6416296981619966,0.8448275862068966,1.0,1.0,1/5,16.52%,KLF2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.363121750292163,-0.6411641594021146,0.96,1.0,1.0,5/14,20.24%,BRD7;PRMT2;PKD2;DLG1;APC
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Skin,-0.30967418788690737,-0.6408690091028173,0.9298245614035088,1.0,1.0,5/43,8.42%,FN1;ITGB5;PLXND1;SERPINE1;COL18A1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3080189544064478,0.6406540339739101,0.9523809523809523,1.0,1.0,7/23,30.25%,PLCB1;ANXA1;RGCC;ADAM17;BRD4;CDC16;KMT2E
prerank,Reactome_2022__G-protein Activation R-HSA-202040,-0.41791212526188337,-0.6403181425271459,0.8979591836734694,1.0,1.0,2/6,13.68%,GNG4;GNA14
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.3408028448971835,-0.6403012994154814,0.9215686274509803,0.9998048376644395,1.0,2/24,4.38%,LRPAP1;LGALS3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.3808882807971412,0.6402865048517402,0.9019607843137255,1.0,1.0,4/8,17.03%,CPEB3;TANC2;NLGN1;PSEN1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.38069003343247615,-0.640180747835533,0.9,0.9994600519746122,1.0,1/10,3.88%,MAP2
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,-0.3957864645035002,-0.6388297201834844,0.7551020408163265,1.0,1.0,1/5,6.69%,GPD2
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3703718081449918,0.6383802191148769,0.88,1.0,1.0,5/12,30.94%,ACAT1;NOS3;HIBADH;AUH;GLS
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.3552483508431598,-0.6383320203027272,0.9285714285714286,0.999956214067085,1.0,4/20,12.99%,GRB14;NNT;GPC3;ATP7B
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,-0.3728437377334796,-0.6374946300982957,0.8333333333333334,1.0,1.0,2/11,12.75%,UBC;CLTA
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.30755059833652715,0.6374652321593237,1.0,1.0,1.0,3/17,15.38%,UBE2B;UBE2Q2;UBE2R2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.35612153318098394,0.6364363714857911,0.9361702127659575,1.0,1.0,3/14,20.85%,ELL2;SNAPC3;RPAP2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.35612153318098394,0.6364363714857911,0.9361702127659575,1.0,1.0,3/14,20.85%,ELL2;SNAPC3;RPAP2
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.3957033967863738,-0.6351169759461415,0.9148936170212766,1.0,1.0,4/6,28.26%,MRPL33;RARS2;PTCD3;LARS2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3553765047977613,-0.6349130389574656,0.9333333333333333,1.0,1.0,2/10,14.24%,MEF2A;PDE9A
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.35805503516561626,0.6345630760948898,0.9387755102040817,1.0,1.0,2/11,9.30%,UIMC1;CDC14B
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.41367885633138246,0.6336142514978464,0.875,1.0,1.0,2/5,23.40%,PNPLA8;PGS1
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,0.3946946168173133,0.633511535059594,0.8928571428571429,1.0,1.0,1/6,14.69%,KPNA1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Lung,-0.30171630098215324,-0.6332225288322814,0.9824561403508771,1.0,1.0,5/50,9.88%,FN1;ITGB5;SERPINE1;PRSS23;CST3
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3753730397642243,-0.6331636665541195,0.9,1.0,1.0,1/7,5.87%,UBR2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.40523546282037537,-0.6329272182649236,0.9387755102040817,1.0,1.0,3/5,23.61%,ATP2B1;ZDHHC21;CTTN
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.34669133545435576,-0.6326594683480424,0.9444444444444444,1.0,1.0,6/17,18.65%,B2M;TFRC;NDFIP1;IREB2;ACO1;FTH1
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,-0.3381791194881943,-0.632561603766734,0.8958333333333334,1.0,1.0,2/15,13.65%,SRSF5;SRRM1
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,-0.3381791194881943,-0.632561603766734,0.8958333333333334,1.0,1.0,2/15,13.65%,SRSF5;SRRM1
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.4140222908946599,-0.631597226487014,0.9361702127659575,1.0,1.0,2/7,13.68%,GNG4;GNA14
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.40080185268524576,0.6311446845718119,0.8793103448275862,1.0,1.0,1/5,15.35%,SLC24A2
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.3632347055490872,-0.6310682509605718,0.8793103448275862,1.0,1.0,2/10,10.60%,RPS6;MAPKAP1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.33441437964971465,0.6307420879531009,0.9607843137254902,1.0,1.0,3/11,17.66%,ROBO2;TIAM2;TIAM1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.28910902976192615,0.6306350327008741,0.96,1.0,1.0,4/22,18.22%,CLASP1;INO80;SMC1A;ZNF207
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.39864218250802697,0.6304375500128978,0.8771929824561403,1.0,1.0,1/7,16.68%,PTEN
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.3501496644318789,-0.6302799744787924,0.8936170212765957,1.0,1.0,3/15,12.40%,GABARAPL1;RPL23;STX17
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.39534435828132286,-0.6302624936164654,0.875,1.0,1.0,2/6,25.02%,ZIC2;MID1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.3306164543200275,-0.6291490021346536,0.9491525423728814,1.0,1.0,6/26,14.26%,CARMIL1;LGALS3;MTMR2;CLU;TMEFF2;RIOK3
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.36985728956595515,-0.6289650769388329,0.9111111111111111,1.0,1.0,3/10,25.31%,ATM;CABIN1;CDKN1B
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,0.35141741752806493,0.6289180371429465,0.9215686274509803,1.0,1.0,3/12,17.42%,ERCC6;BAZ1B;EP300
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.2888572313519388,-0.6286939329293557,0.9814814814814815,1.0,1.0,9/30,23.51%,YTHDC1;SRSF5;SRRM1;NUP54;NUP98;ZFP36;POM121C;NUP214;ZFP36L1
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.35922844290803985,0.6266671789670841,0.9166666666666666,1.0,1.0,9/12,35.78%,CDC42;DIP2A;PTEN;CTNND2;WASL;INSR;FYN;PRNP;ARF1
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.29849816569966425,-0.6266217204876644,0.9824561403508771,1.0,1.0,7/42,15.19%,FN1;CTNNA2;SEPTIN11;CD2AP;CLTA;DNM3;RHOA
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,-0.33501746317635017,-0.6261683070815088,0.8275862068965517,1.0,1.0,1/19,2.12%,STAT1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.400410180398483,-0.6261236082371513,0.9215686274509803,1.0,1.0,2/8,8.37%,TFRC;ACER2
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.41675266472973704,0.6258635741639476,0.9347826086956522,1.0,1.0,2/5,21.17%,EXT1;NDST1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.3149860222855644,-0.6258247896322333,0.9791666666666666,1.0,1.0,6/24,24.01%,TANK;NET1;ATM;MAPK14;MDM2;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.3311808515378053,-0.6256732541318348,0.9387755102040817,1.0,1.0,3/20,10.92%,ACSL4;MYRIP;CD2AP
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.35092387776793477,0.6252062924990308,0.8958333333333334,1.0,1.0,4/11,14.71%,SETX;CELF2;PSIP1;SFSWAP
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.3404698909217654,0.624804844260065,0.9591836734693877,1.0,1.0,3/20,16.39%,ACTG1;ACTB;ESAM
prerank,CellMarker_Augmented_2021__Dopaminergic neuron:Midbrain,0.3949181847182518,0.6247482142037348,0.9464285714285714,1.0,1.0,1/9,4.94%,SEMA3F
prerank,CellMarker_Augmented_2021__Epithelial cell:Uterus,0.3949181847182518,0.6247482142037348,0.9464285714285714,1.0,1.0,1/9,4.94%,SEMA3F
prerank,Reactome_2022__WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,0.4033056567960711,0.6243765002132132,0.9347826086956522,1.0,1.0,2/6,18.67%,AP2B1;PRKCA
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.3805595259315694,0.6243595324991564,0.88,1.0,1.0,2/8,21.57%,DICER1;AGO2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.3920484595962387,0.6239861513210542,0.9583333333333334,1.0,1.0,2/10,25.15%,CANX;ARFGAP3
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.37046039271118236,-0.6235958438118421,0.9565217391304348,1.0,1.0,3/15,15.75%,SMAD3;RORA;FOXO1
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.32407090358047547,0.6227726031295574,0.9333333333333333,1.0,1.0,7/27,19.12%,UGCG;PBX3;ERCC6;DTNB;IL1RAPL1;WNK1;RYK
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.3752258722028381,0.6226191673718056,0.9090909090909091,1.0,1.0,1/8,3.59%,PRAG1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.39813829787234045,-0.6224675753344521,0.8666666666666667,1.0,1.0,5/5,60.27%,PPP2R5A;PIK3R1;RBL2;PIK3R3;RB1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.36981537530872044,-0.6222413483545424,1.0,1.0,1.0,2/9,9.08%,PLCG2;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.36981537530872044,-0.6222413483545424,1.0,1.0,1.0,2/9,9.08%,PLCG2;ERO1A
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.39048283547739365,-0.6220186525558297,0.88,1.0,1.0,2/5,20.58%,ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.39048283547739365,-0.6220186525558297,0.88,1.0,1.0,2/5,20.58%,ZDHHC20;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.3085577619631369,0.6219154193815107,0.9545454545454546,1.0,1.0,14/33,20.11%,ACTG1;CCDC88A;ABL1;PPM1F;CLASP1;NRP1;CDC42;RAC1;PHLDB2;WASF2;ROCK1;CCN2;PXN;RGCC
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.3944462520150639,-0.6214438746196813,0.88,1.0,1.0,1/6,6.77%,SMAD3
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.37611755306245764,0.6209760998347056,0.8571428571428571,1.0,1.0,2/7,30.76%,MIS18BP1;RBBP4
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.4298283185789722,-0.620969814634478,0.875,1.0,1.0,1/5,13.09%,ATM
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.4014930104615576,0.6208475701702182,0.9591836734693877,1.0,1.0,3/6,26.91%,SLC1A1;SLC23A2;SLC1A2
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.3694958066058537,-0.6207742919383665,0.8888888888888888,1.0,1.0,2/6,13.84%,FOXK1;PGK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.3694958066058537,-0.6207742919383665,0.8888888888888888,1.0,1.0,2/6,13.84%,FOXK1;PGK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.3694958066058537,-0.6207742919383665,0.8888888888888888,1.0,1.0,2/6,13.84%,FOXK1;PGK1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.41621658566216646,-0.6199350917585258,0.9444444444444444,1.0,1.0,2/6,18.27%,APPL2;MAPK14
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.404618558125732,0.619558425865039,0.9387755102040817,1.0,1.0,2/6,10.89%,INPP5F;ANXA2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.2908683176067307,0.6190105296450471,0.9767441860465116,1.0,1.0,7/27,16.57%,ATP2A2;MICU3;CACNA1C;SLC8A1;ANO6;SLC24A2;ATP2B4
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.4015922292773952,0.6189741807630813,0.9016393442622951,1.0,1.0,1/5,10.33%,NCOA3
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.30743114940146854,0.6189116555304613,0.9555555555555556,1.0,1.0,1/16,4.12%,KIF26B
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.42011406112542027,0.6188604934025248,0.9302325581395349,1.0,1.0,2/5,20.56%,ACOX1;MGST2
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,0.3939369759656157,0.618741146538989,0.9245283018867925,1.0,1.0,4/7,16.49%,FGF12;CACNA1C;FGF14;CALM1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.369956494056688,-0.6186339755385157,0.9230769230769231,1.0,1.0,1/6,10.33%,AHI1
prerank,Reactome_2022__Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,0.39430426300740984,0.6181084066010492,0.9122807017543859,1.0,1.0,2/6,17.42%,CREBBP;EP300
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.43536242970773875,0.6176692996647773,0.9583333333333334,1.0,1.0,3/5,30.39%,BCL2L1;HSPA1A;EYA3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.43536242970773875,0.6176692996647773,0.9583333333333334,1.0,1.0,3/5,30.39%,BCL2L1;HSPA1A;EYA3
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.3576734559850292,-0.6173325254081293,0.9361702127659575,1.0,1.0,3/18,12.83%,SMARCA1;SMARCA2;SMARCAD1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.3251249261598113,0.6171590283857309,0.9807692307692307,1.0,1.0,5/19,24.75%,HSPB1;PPM1F;YWHAG;NF1;GNAQ
prerank,CellMarker_Augmented_2021__Erythroid cell:Umbilical Cord Blood,-0.3166193976392097,-0.6170926711195226,0.9347826086956522,1.0,1.0,7/24,19.55%,TFRC;TOPBP1;DPY19L1P1;BMP2K;NUP98;OPA1;PSME4
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Germ,-0.3841447193402501,-0.6165468003311831,0.8958333333333334,1.0,1.0,6/6,61.67%,ABCG2;PROM1;CD9;ITGA6;PODXL;ITGB1
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,-0.3037942257175379,-0.6162043911849729,0.9827586206896551,1.0,1.0,8/39,18.27%,RFC3;TOPBP1;MAPKAP1;UBC;ATM;BRD7;SMYD2;MAPK14
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,0.3333461805738801,0.6161443769980991,0.9302325581395349,1.0,1.0,3/18,15.56%,PIK3CA;BCL2L1;GRB2
prerank,CellMarker_Augmented_2021__Trophectoderm cell:Embryo,-0.2927198756988989,-0.6157793438577643,1.0,1.0,1.0,4/32,10.70%,LRRFIP1;TFRC;S100A6;ACTN1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.3425936534935041,0.6156786528615568,0.9607843137254902,1.0,1.0,7/16,26.19%,PDZD8;LARP4;ZRANB1;CAPZB;PHIP;FMNL2;EFNA5
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.36229268753838284,-0.6151825505267724,0.9183673469387755,1.0,1.0,1/11,4.97%,MMRN2
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,0.3135052240206545,0.6148385935855519,0.9615384615384616,1.0,1.0,4/16,20.21%,NCOA2;CREBBP;NCOA1;NCOR2
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.332864060907367,0.6144501909900051,0.9107142857142857,1.0,1.0,2/11,9.16%,CDH2;ABL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.3623651009374307,0.6138392761857306,0.9310344827586207,1.0,1.0,1/8,7.41%,HSPB1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.3415924261182113,0.6138182689921673,0.9423076923076923,1.0,1.0,5/9,24.83%,CLASP1;ZNF207;CDK5RAP2;CLIP1;NAV1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.3623411419123652,-0.613657614315776,0.9411764705882353,1.0,1.0,4/12,17.40%,LBR;SPAST;KPNB1;NUP98
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.3623411419123652,-0.613657614315776,0.9411764705882353,1.0,1.0,4/12,17.40%,LBR;SPAST;KPNB1;NUP98
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.3623411419123652,-0.613657614315776,0.9411764705882353,1.0,1.0,4/12,17.40%,LBR;SPAST;KPNB1;NUP98
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.37631034965050836,0.6130612525831636,0.9411764705882353,1.0,1.0,2/6,24.62%,UGGT1;VCP
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.2650635185983641,0.6127100861750462,1.0,1.0,1.0,9/46,18.91%,IGFBP3;HSPB1;SMAD6;PPM1F;LRRK2;PARD3;CALM1;PTEN;YWHAG
prerank,CellMarker_Augmented_2021__Colonic Stem cell:Colon,0.2900994464924192,0.6121542941686451,0.9607843137254902,1.0,1.0,6/28,22.47%,SEMA3F;PTPN21;PARD3;RAI14;MAGI1;TEAD1
prerank,Reactome_2022__Autophagy R-HSA-9612973,0.2596683764866767,0.6115314853345276,1.0,1.0,1.0,9/44,19.68%,SLC38A9;ATG4C;HSP90AA1;AMBRA1;HSPA8;PINK1;PLIN2;UVRAG;MTMR3
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.36310665436454226,0.6110021161175406,0.8507462686567164,1.0,1.0,5/10,25.18%,SMAD6;ROBO2;ROCK1;ROCK2;NOS3
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,-0.3042669571540643,-0.6109854218070935,0.9411764705882353,1.0,1.0,5/27,16.25%,HLA-B;UBC;UBE2D2;HLA-A;OTULIN
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,0.3546347253791228,0.6107070945162817,0.9423076923076923,1.0,1.0,2/11,15.56%,PIK3CA;GRB2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.4017228063975651,-0.6106716700393038,0.8723404255319149,1.0,1.0,1/5,10.73%,APPL2
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.3456002366587162,0.6096140962441579,0.9636363636363636,1.0,1.0,2/11,17.24%,POT1;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.33919609261265393,0.6095647995599595,0.9482758620689655,1.0,1.0,1/13,2.97%,TAF1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.3649094285241728,-0.6095149637173518,0.92,1.0,1.0,1/8,8.37%,ACER2
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,-0.3011523158317549,-0.608671050535908,0.9491525423728814,1.0,1.0,2/20,11.34%,GIT2;STAM2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.35224005051971785,-0.6086233474551311,0.94,1.0,1.0,1/12,7.73%,STK39
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,0.3863553625814178,0.6078982321780777,0.9487179487179487,1.0,1.0,4/10,18.67%,RPS6KA5;CREBBP;EP300;PRKCA
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.35207763923129254,-0.6077854856389502,0.9361702127659575,1.0,1.0,2/12,10.73%,PLCG2;APPL2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.29174013298468493,0.6076650715550709,0.975,1.0,1.0,3/29,8.15%,IFNAR1;SMAD6;TAB2
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.3101768255851085,0.6073259033588041,0.9183673469387755,1.0,1.0,4/16,15.54%,PIAS1;YY1;INO80;RAD23B
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.3526244406103989,-0.6070177775994458,0.9803921568627451,1.0,1.0,1/19,1.54%,SOD2
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.3812922659888273,0.6070017848087778,0.9069767441860465,1.0,1.0,2/8,23.69%,RSRC1;RBM17
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,0.34692644335860034,0.6058596279164569,0.9743589743589743,1.0,1.0,3/15,12.22%,CAPN2;DNMT3A;FOXO3
prerank,KEGG_2021_Human__Glioma,-0.30246703898181904,-0.6055857648600635,1.0,1.0,1.0,1/31,2.23%,PLCG2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4057997747389935,0.6053040473744452,0.8775510204081632,1.0,1.0,2/5,14.26%,SEMA3F;NRP1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.3799212735623244,-0.6052706305484831,0.9545454545454546,1.0,1.0,3/6,28.18%,ATM;TENT2;XRN1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.3799212735623244,-0.6052706305484831,0.9545454545454546,1.0,1.0,3/6,28.18%,ATM;TENT2;XRN1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.26180030111517083,0.605054427512997,0.9787234042553191,1.0,1.0,8/40,19.73%,ERBB4;YES1;FRS2;EPHA4;ROR1;ACVR2A;RYK;FES
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,0.3570282382537818,0.6041571190008644,0.9574468085106383,1.0,1.0,2/8,12.70%,AP1S2;AP2B1
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,0.2768724182747551,0.60414166758559,0.9791666666666666,1.0,1.0,4/32,15.56%,UBQLN1;SGIP1;AP2B1;GRB2
prerank,Reactome_2022__PKA Activation R-HSA-163615,0.3514704980033357,0.6020816255086444,0.9649122807017544,1.0,1.0,2/8,18.67%,CALM1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.3967122677651683,-0.6020183992710176,0.9183673469387755,1.0,1.0,2/6,15.64%,MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.33047867899275024,-0.6015777859927299,0.896551724137931,1.0,1.0,3/16,12.48%,PABPC1;POLR2A;SRPK1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.32756814156142033,-0.6012842403882039,0.9818181818181818,1.0,1.0,1/15,4.01%,PRKN
prerank,KEGG_2021_Human__mRNA surveillance pathway,-0.28967539115697716,-0.6010904431377606,0.9615384615384616,1.0,1.0,7/30,19.39%,PABPC1;UPF3A;SRRM1;PPP2R3A;ACIN1;GSPT1;FUS
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.32940080629376717,0.601037973434541,0.9347826086956522,1.0,1.0,6/15,19.12%,CDH2;NRCAM;NRXN1;NLGN1;PTEN;RYK
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.40809014002405447,0.6003454367918515,0.9347826086956522,1.0,1.0,1/5,11.74%,DST
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.2796628833442673,-0.6002156063079892,1.0,1.0,1.0,5/29,17.40%,YTHDC1;SRSF5;SRRM1;NUP54;NUP98
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.393213557672465,-0.6001259543353182,0.9454545454545454,1.0,1.0,1/6,8.74%,CD47
prerank,Reactome_2022__Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,0.38842077031746725,0.5998122423443174,0.9122807017543859,1.0,1.0,1/6,3.98%,MAPK10
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.30779875819911356,0.599132765556617,0.918918918918919,1.0,1.0,11/23,34.02%,ROBO2;ZMIZ1;CREBBP;EP300;NOS3;STAT3;AAK1;TSPAN14;RBPJ;PRKCI;YAP1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.4282131684480501,0.5988310222239281,0.9791666666666666,1.0,1.0,3/5,37.72%,MAP4K4;MAPRE2;IQSEC1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.4075521907509102,-0.5984919614737939,0.9302325581395349,1.0,1.0,1/6,15.56%,DHX36
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.3769880678133259,-0.5984593133500893,0.9318181818181818,1.0,1.0,1/5,5.87%,UBR2
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.2723055435047818,-0.59828789074953,1.0,1.0,1.0,5/60,9.38%,PPARG;SP100;NR3C2;NFKBIA;CBX5
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,-0.3304210689077535,-0.5982783621712419,0.9661016949152542,1.0,1.0,3/20,13.23%,STAT1;STAT5B;JAK2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.3614532625637642,-0.598224893199363,0.9545454545454546,1.0,1.0,1/5,13.39%,SERBP1
prerank,Reactome_2022__Prolactin Receptor Signaling R-HSA-1170546,0.4150790313881263,0.5982187745423657,0.8918918918918919,1.0,1.0,1/5,5.52%,BTRC
prerank,CellMarker_Augmented_2021__Neural Crest Stem cell:Hair Follicle,0.3225373249251134,0.5968355797041345,0.9183673469387755,1.0,1.0,1/10,6.75%,NCAM1
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,0.33112927250557755,0.5965375880664145,0.8913043478260869,1.0,1.0,2/11,15.54%,PIAS1;RAD23B
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.33228386318887193,-0.5963719222592136,0.9411764705882353,1.0,1.0,4/17,15.64%,ATM;MAP3K4;PARN;TNKS2
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.31599114731126154,0.5961070157617154,0.9772727272727273,1.0,1.0,3/15,18.22%,CLASP1;SMC1A;ZNF207
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.3471027679507248,0.5954711889925741,0.9375,1.0,1.0,2/12,8.10%,SMAD6;ROBO2
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.28026846421897256,-0.5954710220811331,1.0,1.0,1.0,5/28,17.40%,YTHDC1;SRSF5;SRRM1;NUP54;NUP98
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.28026846421897256,-0.5954710220811331,1.0,1.0,1.0,5/28,17.40%,YTHDC1;SRSF5;SRRM1;NUP54;NUP98
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.3829953578249357,0.5953558890262176,0.9166666666666666,1.0,1.0,2/5,16.92%,SSBP1;POT1
prerank,Reactome_2022__Myogenesis R-HSA-525793,0.3101449529027935,0.5947035069563175,0.9259259259259259,1.0,1.0,8/14,28.07%,CDH2;ABL1;CDC42;TCF12;BOC;CTNNA1;MEF2C;TCF7L2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.35503131160293266,-0.5943695630865583,0.8775510204081632,1.0,1.0,1/6,11.26%,MSH2
prerank,CellMarker_Augmented_2021__Pit Progenitor cell:Stomach,-0.3303037419955623,-0.5937515150077223,0.8846153846153846,1.0,1.0,2/11,10.25%,MVB12B;DIXDC1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.3514899403283758,0.5922119647053712,0.9791666666666666,1.0,1.0,4/9,37.29%,MIS18BP1;RBBP4;POGZ;CENPC
prerank,Reactome_2022__Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,-0.38882436800497044,-0.5919427231999754,0.9074074074074074,1.0,1.0,2/5,13.44%,B2M;HLA-A
prerank,CellMarker_Augmented_2021__Natural Killer cell:Liver,0.3618306176405374,0.5917572544804838,0.9215686274509803,1.0,1.0,1/6,6.75%,NCAM1
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.3297896787378605,0.5913459019786002,1.0,1.0,1.0,7/16,32.35%,ERCC6;BAZ1B;EP300;MYO1E;MTA3;RBBP4;H3-3B
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,0.31918592547116176,0.5912004046499428,0.9375,1.0,1.0,3/15,18.67%,ITGA5;GNB4;PRKCA
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.33232526698178816,-0.5906364770159107,0.94,1.0,1.0,2/20,8.74%,SOD2;CD47
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.36723807015089543,-0.5905268179201789,0.8703703703703703,1.0,1.0,1/7,9.85%,POLR2A
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,0.28605674903428757,0.589505428295266,1.0,1.0,1.0,4/23,21.57%,ATP2A2;CREBBP;EP300;AGO2
prerank,CellMarker_Augmented_2021__Naive CD8+ T cell:Peripheral Blood,0.2598217057499805,0.5894450289537855,0.96,1.0,1.0,3/28,12.54%,BACH2;PSIP1;EIF3E
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.3274557147209128,0.5889503920228044,0.9333333333333333,1.0,1.0,4/14,20.98%,LRRK2;PINK1;LIMK2;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.3620271886613903,0.5887554203624225,0.9038461538461539,1.0,1.0,4/7,42.36%,HSPA1A;DYNC1H1;HNRNPU;CLTC
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.34749023348068186,-0.5887368533927394,0.94,1.0,1.0,2/11,12.75%,SNX25;CLTA
prerank,Reactome_2022__SUMOylation R-HSA-2990846,-0.2700448315666503,-0.5884867206809291,0.9818181818181818,1.0,1.0,5/62,9.38%,PPARG;SP100;NR3C2;NFKBIA;CBX5
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.33225782819900707,0.586828555843416,0.9302325581395349,1.0,1.0,2/12,16.20%,GRB10;APPL1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.32258452994331843,-0.5865077925760587,0.9622641509433962,1.0,1.0,7/19,24.41%,APPL2;JAK2;GNAS;EPAS1;APC;KDM1A;LEPR
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.3083168403345261,-0.5863606915326167,0.9454545454545454,1.0,1.0,3/28,10.46%,VAV3;PLXND1;ARHGAP15
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.3675849255919971,0.5859248601329813,0.9411764705882353,1.0,1.0,2/7,19.10%,SETD7;SETD3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2761705961070359,-0.585672732212576,0.9591836734693877,1.0,1.0,6/38,14.32%,SNX6;CD109;SMAD3;SNX25;UBC;RNF111
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.3681395404888588,-0.585504275582954,0.9,1.0,1.0,2/8,20.16%,POLR2A;MTERF1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Pluripotent Stem Cell,-0.3054684357035848,-0.585314165179903,0.9649122807017544,1.0,1.0,5/22,15.03%,LMO2;CST3;IFNGR2;NID1;RIN2
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.3643183178271259,-0.584802373503899,0.9206349206349206,1.0,1.0,3/8,23.64%,NEBL;CCDC60;MYO5C
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,-0.26394311700829365,-0.5836124366759984,1.0,1.0,1.0,2/60,4.01%,RHOBTB1;PRKN
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,0.3140918062108375,0.582294013210269,1.0,1.0,1.0,3/13,16.92%,SYNE2;SMC1A;POT1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.2762923065434728,0.5811864676771573,1.0,1.0,1.0,8/35,17.80%,URI1;ROBO2;NCOA3;NCOA2;LRRK2;IL1RAPL1;NCOA1;ACVR2A
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.3776117000121963,-0.5806935420641368,0.9019607843137255,1.0,1.0,1/6,7.46%,DMD
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3652746228486349,-0.5804961723414573,0.9333333333333333,1.0,1.0,1/5,7.28%,DSP
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",0.3669196371535258,0.5799067069474734,0.9166666666666666,1.0,1.0,4/7,29.06%,ACAT1;HADHB;HIBADH;AUH
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.39398441046550947,-0.5797359363086396,0.9375,1.0,1.0,2/6,15.38%,MSH2;XPC
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,-0.38167751577545916,-0.579592652614801,0.9433962264150944,1.0,1.0,2/6,13.76%,CAMKMT;EEF1A1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.30834307564110586,0.5795724579888145,0.9607843137254902,1.0,1.0,4/15,20.11%,GCNT2;TIAM1;FOXC1;RGCC
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryoid Body,-0.3520195628735836,-0.5795424172607115,0.9111111111111111,1.0,1.0,3/11,16.36%,COL18A1;SULF2;TECPR2
prerank,CellMarker_Augmented_2021__Osteoblast:Bone Marrow,-0.3520195628735836,-0.5795424172607115,0.9111111111111111,1.0,1.0,3/11,16.36%,COL18A1;SULF2;TECPR2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.34511279228918484,-0.579279534485793,0.8571428571428571,1.0,1.0,5/12,31.82%,CABIN1;NAP1L1;NPM1;MACROH2A1;NASP
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.3056925316825567,-0.5779646666551845,1.0,1.0,1.0,1/19,2.90%,CAVIN2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.3844852065757176,0.5774449993192219,0.9574468085106383,1.0,1.0,1/6,11.85%,CLASP1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.33942349610389205,-0.5764990314092687,0.9459459459459459,1.0,1.0,1/8,7.28%,DSP
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tooth,0.37182402404433446,0.5763404600132569,0.9655172413793104,1.0,1.0,2/6,17.34%,ALCAM;CD81
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3229655685666047,-0.576038627387713,0.9803921568627451,1.0,1.0,5/15,20.24%,BRD7;PRMT2;PKD2;DLG1;APC
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,0.3378055889438455,0.5753720317390698,0.9433962264150944,1.0,1.0,2/9,12.22%,XPO1;FOXO3
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.3668998668829083,0.5752850704511498,0.9622641509433962,1.0,1.0,3/7,17.03%,CPEB3;NLGN1;PSEN1
prerank,Reactome_2022__Interleukin-15 Signaling R-HSA-8983432,-0.3690777058219662,-0.5752812759132002,0.926829268292683,1.0,1.0,1/8,8.98%,STAT5B
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.2881055101489238,-0.5751119134210753,0.9830508474576272,1.0,1.0,3/28,7.46%,PRKN;WARS1;DMD
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.39112586285240114,-0.5751061180436183,0.9534883720930233,1.0,1.0,2/6,15.19%,CD47;RHOA
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.3509571240248567,0.5748782928453527,0.8809523809523809,1.0,1.0,1/6,12.86%,DICER1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.3480668664699677,-0.5746312266683057,0.9565217391304348,1.0,1.0,3/12,17.77%,MSH2;TNKS2;RAD21
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.4018164363603672,0.5744310161733347,0.9444444444444444,1.0,1.0,4/5,20.82%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.4018164363603672,0.5744310161733347,0.9444444444444444,1.0,1.0,4/5,20.82%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.4018164363603672,0.5744310161733347,0.9444444444444444,1.0,1.0,4/5,20.82%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.3208903602840226,-0.574163229973991,0.92,1.0,1.0,1/11,8.37%,ACER2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.3092171412390111,-0.5740848160076318,0.95,1.0,1.0,5/21,20.24%,PATJ;RHOA;AFDN;DLG1;APC
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,-0.3564735620578636,-0.5737693162976988,0.9245283018867925,1.0,1.0,2/10,15.75%,MAML3;FOXO1
prerank,Reactome_2022__STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,-0.3680081405472013,-0.5729042702588826,0.9791666666666666,1.0,1.0,1/6,8.98%,STAT5B
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,-0.32762000107884726,-0.5706645604753136,0.9818181818181818,1.0,1.0,4/14,16.20%,VIM;PLEC;ACIN1;TJP1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.35789888767970945,0.570224500513387,1.0,1.0,1.0,2/6,13.92%,GLCE;EXT1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.335754296298627,-0.5699418797756877,0.9661016949152542,1.0,1.0,4/11,15.64%,ATM;MAP3K4;DHX36;TNKS2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3188017324943138,-0.5696570398577683,0.9591836734693877,1.0,1.0,2/15,13.28%,SMAD3;ZC3H7A
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,0.37553611180762403,0.5670288923204503,0.9661016949152542,1.0,1.0,1/5,22.55%,CDK6
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Blood,-0.33800976422921036,-0.5668065656040624,0.9545454545454546,1.0,1.0,2/11,8.92%,SMAD3;JUN
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.36675531914893617,-0.5666032446963019,0.9230769230769231,1.0,1.0,5/5,63.40%,KDM1A;N4BP2L2;FERMT2;GJA1;HNRNPU
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.3498741156872579,0.5662616075495902,0.9795918367346939,1.0,1.0,1/6,15.09%,ARID1A
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.3221763441765795,0.5657002487826285,0.9818181818181818,1.0,1.0,2/7,21.81%,CDC42;OPHN1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.3477340936312895,-0.565354352690483,0.8666666666666667,1.0,1.0,3/7,24.36%,SHROOM2;AP1G1;KIF13A
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.2713363380605854,0.5652865339561114,1.0,1.0,1.0,8/21,29.03%,GALNT2;GALNT10;THSD7A;C1GALT1;ADAMTS6;ST6GALNAC3;GALNT18;THSD1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.31210586972998733,0.564863937702526,0.875,1.0,1.0,3/8,20.00%,DGKI;PLPPR4;MBOAT2
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,-0.341449602923689,-0.5646378479029422,0.8888888888888888,1.0,1.0,2/7,15.27%,ADAMTS1;THSD4
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,-0.341449602923689,-0.5646378479029422,0.8888888888888888,1.0,1.0,2/7,15.27%,ADAMTS1;THSD4
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.35116069840478437,-0.5639482283555532,0.8846153846153846,1.0,1.0,2/7,18.01%,SMYD2;PRMT2
prerank,KEGG_2021_Human__Protein export,-0.37531855949003473,-0.5638999686029524,0.9607843137254902,1.0,1.0,2/7,15.88%,IMMP2L;SRP14
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.33698140250094044,-0.5635413084895619,0.9215686274509803,1.0,1.0,3/12,14.42%,CAPRIN1;HECW2;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.3416025727326763,-0.5619789695250539,0.9777777777777777,1.0,1.0,2/11,12.96%,APPL2;GNA12
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.2933657467137729,0.5618890203283343,1.0,1.0,1.0,4/17,21.57%,CALM1;PRKCA;NCOR2;AGO2
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,0.36053939695471693,0.5618625395215219,0.9787234042553191,1.0,1.0,1/6,17.05%,SLC39A10
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.34135705176437225,-0.5617490552861655,0.8958333333333334,1.0,1.0,1/7,6.77%,SMAD3
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Undefined,0.3618392760773089,0.5612588424705921,0.9302325581395349,1.0,1.0,2/7,11.71%,SMAD1;SMAD5
prerank,Reactome_2022__Suppression Of Phagosomal Maturation R-HSA-9637687,0.32736993991538155,0.5611343440135544,0.9347826086956522,1.0,1.0,2/8,14.69%,RAB7A;KPNA1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.36272421093298735,0.5608391761835205,0.9433962264150944,1.0,1.0,3/6,23.64%,HSP90AA1;PTEN;HSP90AB1
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.3607069008521305,0.5603555040114417,0.9245283018867925,1.0,1.0,1/6,11.18%,GNB4
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.2958496214850057,-0.5602120803628747,0.9508196721311475,1.0,1.0,4/17,20.24%,PATJ;AFDN;DLG1;APC
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.28037877492046837,0.5595810911786031,1.0,1.0,1.0,7/22,26.77%,PARD3;NECTIN3;ZDHHC14;SEC63;RAB3GAP2;RFTN1;PIKFYVE
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.33182846021334517,0.5591391117223861,0.9818181818181818,1.0,1.0,1/10,7.41%,HSPB1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.29056326579867636,-0.5587701598533348,0.9821428571428571,1.0,1.0,6/25,17.85%,GRK5;GNA12;GNA14;RAMP3;GNAS;ADGRL3
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.33444974702050456,-0.5585232594074353,0.9019607843137255,1.0,1.0,2/6,18.27%,EFNB2;MAPK14
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.36808510638297876,-0.5581972297922236,0.918918918918919,1.0,1.0,5/5,63.27%,SH3D19;SNX9;ADAM9;TNFRSF1B;NRDC
prerank,CellMarker_Augmented_2021__Myotube:Muscle,-0.3659992968347459,-0.5581702031487313,0.9166666666666666,1.0,1.0,1/5,14.61%,ZNF106
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,-0.3198642787840128,-0.5557851232064089,0.9666666666666667,1.0,1.0,2/14,10.92%,ACTN1;CD2AP
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.3366253945275072,0.5554235381273697,0.9807692307692307,1.0,1.0,4/9,26.80%,EPHA4;ROCK2;PICALM;STAT3
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,0.3772866756657674,0.5550325757828787,0.9523809523809523,1.0,1.0,1/6,11.18%,GNB4
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.2740827262222405,-0.5549672907514032,0.9830508474576272,1.0,1.0,2/22,9.85%,CEP57;POLR2A
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,0.3110041569352005,0.5546932568392031,0.9454545454545454,1.0,1.0,6/15,24.62%,RAB7A;TUBA1B;ROCK1;ROCK2;RALGAPA1;VCP
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.3510562303578786,-0.5534034388115104,0.9069767441860465,1.0,1.0,3/8,10.97%,RPL23;RPS7;RAB1A
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.33003913792504885,-0.5529241179546445,0.9272727272727272,1.0,1.0,3/9,16.57%,DMD;RORA;NEBL
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3481159655065585,-0.5526638572477359,0.9215686274509803,1.0,1.0,3/5,29.11%,NPM1;MECP2;RAB11A
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.30062440271781643,0.5525116169097962,1.0,1.0,1.0,3/12,19.44%,HSPA8;HSPA9;UGGT1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.34815616682640826,0.5523531971162842,0.9607843137254902,1.0,1.0,1/8,2.79%,PRKD1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.3191609078771138,-0.5522065066077456,0.9387755102040817,1.0,1.0,2/11,14.42%,PDE9A;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.2560169809297712,0.551512592224473,1.0,1.0,1.0,3/35,9.22%,HSPB1;TAB2;PPM1F
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.28201288860100815,0.550307962962084,1.0,1.0,1.0,5/21,20.82%,CCNI;ACTB;PTEN;RGCC;ADAM17
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.34532005155099765,0.5502042483770518,0.9183673469387755,1.0,1.0,2/6,17.34%,CD59;CD81
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.34532005155099765,0.5502042483770518,0.9183673469387755,1.0,1.0,2/6,17.34%,CD59;CD81
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.34532005155099765,0.5502042483770518,0.9183673469387755,1.0,1.0,2/6,17.34%,CD59;CD81
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.3532826178339225,-0.5499392824122217,0.9387755102040817,1.0,1.0,2/6,18.73%,DGKG;DGKE
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.372469373082847,-0.5490744070969023,0.9361702127659575,1.0,1.0,2/6,15.19%,GNG4;RHOA
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.2671198369684716,-0.5479075887999119,0.9782608695652174,1.0,1.0,2/22,12.48%,YTHDC1;SRPK1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.3516643114840108,-0.5477414739388609,0.9607843137254902,1.0,1.0,2/5,31.82%,CABIN1;NASP
prerank,KEGG_2021_Human__Fatty acid degradation,-0.32086887972765693,-0.5444765392196023,0.9230769230769231,1.0,1.0,1/8,4.94%,ACSL4
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,-0.3098806201893991,-0.5444138200892712,0.96,1.0,1.0,3/10,26.51%,UBC;UGGT2;RPS27A
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.3410523978518496,0.5442190351419042,0.9824561403508771,1.0,1.0,2/7,17.42%,REST;EP300
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.34750796371675335,-0.5441929006333015,0.9565217391304348,1.0,1.0,1/5,15.56%,DHX36
prerank,Reactome_2022__Reproduction R-HSA-1474165,-0.2934539293681365,-0.5435303488372323,1.0,1.0,1.0,7/17,24.49%,SUN1;ATM;RAD21;SMC3;SUN2;DIDO1;SYCP2
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,0.3316933786177252,0.5418357377508571,0.9411764705882353,1.0,1.0,2/8,17.34%,CD59;CD81
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.30146061838786653,0.5414970448100349,0.9795918367346939,1.0,1.0,2/12,14.69%,PPP4R2;KPNA1
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,0.3502266300553628,0.5407600305147912,0.8846153846153846,1.0,1.0,2/5,24.20%,HADHB;DECR1
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.31364019567819973,0.539661200120878,1.0,1.0,1.0,5/10,32.40%,ROCK2;ADAM15;NR3C1;KLF9;ADCY2
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.33297185163081733,-0.5396246043184076,0.9285714285714286,1.0,1.0,4/7,34.29%,MAPK14;IQCJ-SCHIP1;WWC2;VGLL4
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.2896647930680189,-0.5385469174616354,0.9696969696969697,1.0,1.0,2/17,11.69%,MAP2;GPC3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.30958570678846253,0.5383822609871182,0.9782608695652174,1.0,1.0,4/14,17.74%,FGF12;FGF14;WNK1;ANK3
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,-0.3287239994994306,-0.5364924841363405,0.9565217391304348,1.0,1.0,1/6,13.23%,JAK2
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.33491110149308656,-0.5358013190695721,0.9411764705882353,1.0,1.0,2/7,20.37%,BMP2K;HIP1R
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,0.2902599373587402,0.535072859902891,1.0,1.0,1.0,3/15,20.21%,REST;PHF21A;NCOR2
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.31375797147876144,-0.5350528899496095,1.0,1.0,1.0,2/12,20.08%,UBC;FANCL
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.32658861384914706,0.534404655498691,1.0,1.0,1.0,4/6,36.57%,PTEN;LATS2;LATS1;IPO7
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.2770086319632036,-0.533729833095907,0.9811320754716981,1.0,1.0,3/21,13.36%,MAP3K5;TAOK3;SH3RF3
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.3411206918172535,0.5337212424814902,0.8909090909090909,1.0,1.0,2/5,22.28%,CPEB3;RC3H1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.3243718920113141,0.5320379693984482,0.9655172413793104,1.0,1.0,2/6,21.81%,CDC42;OPHN1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.29532950714079964,-0.5312763678980819,0.9827586206896551,1.0,1.0,2/18,6.40%,GPM6A;SRGAP2C
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.26786632242022235,-0.5305077304361719,1.0,1.0,1.0,1/21,4.44%,GPM6A
prerank,Reactome_2022__Meiosis R-HSA-1500620,-0.29911269115522,-0.5302807221866812,0.9814814814814815,1.0,1.0,7/15,24.49%,SUN1;ATM;RAD21;SMC3;SUN2;DIDO1;SYCP2
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.297474917239353,-0.5293620097771619,0.9302325581395349,1.0,1.0,2/7,19.26%,FMNL3;DLG1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.32904268276246124,-0.5281945799542426,0.9411764705882353,1.0,1.0,4/5,27.84%,CBR4;PKD2;CPSF6;GRIN2B
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,0.33178173390729243,0.5281143793791796,0.9375,1.0,1.0,1/8,11.18%,GNB4
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,-0.239349594609215,-0.5269642195009562,1.0,1.0,1.0,11/54,20.37%,IGF2R;FNBP1;TFRC;STAM2;UBC;CLTA;DNM3;SH3GL1;SYNJ2;ACTR3;HIP1R
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.2829283158106983,-0.5262369939698803,0.98,1.0,1.0,2/16,10.07%,TFRC;PARP9
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.34091407500990245,0.5259514648341488,1.0,1.0,1.0,1/5,17.61%,PNPLA8
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.3571035952390572,0.5249994253579593,0.98,1.0,1.0,1/5,16.49%,CALM1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.2653364174023995,-0.5233566031024819,0.9795918367346939,1.0,1.0,6/23,23.51%,SRSF5;SRRM1;ZFP36;POM121C;NUP214;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.32737865071341365,0.5219037328129664,0.9047619047619048,1.0,1.0,1/8,24.70%,ARMH3
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.25359683249187587,0.5213441454950606,1.0,1.0,1.0,1/19,3.59%,PRAG1
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.33295541203058765,-0.5209930937006626,0.9433962264150944,1.0,1.0,3/5,20.98%,NFKB1;SUGT1;TXNIP
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.2865389766002112,-0.5199433836698348,1.0,1.0,1.0,1/17,6.03%,AGPAT3
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,-0.2794739050961478,-0.519913585972078,1.0,1.0,1.0,5/19,17.21%,VIM;PLEC;ACIN1;TJP1;KPNB1
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,0.29764410614590137,0.5196582662619851,0.9791666666666666,1.0,1.0,2/10,15.09%,DNMT3A;ARID1A
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.30180317181452654,-0.519490611861563,0.9629629629629629,1.0,1.0,1/11,4.57%,PATJ
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3236990368695376,0.5192433147199137,0.9811320754716981,1.0,1.0,3/8,23.64%,RGCC;ADAM17;HSP90AB1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.30395299766343786,-0.5179543529634967,0.9375,1.0,1.0,2/11,14.42%,KIDINS220;RAPGEF2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.26763152856656564,0.5176481828731945,1.0,1.0,1.0,5/20,22.79%,PHACTR4;CDC42;ROCK1;ADGRG1;ROCK2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.302840553216943,-0.516885622503195,1.0,1.0,1.0,5/12,22.50%,STAT5B;PDGFB;ACVRL1;MAP2K5;RACK1
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.27863305163143987,-0.516398099786207,1.0,1.0,1.0,2/15,11.71%,SMAD3;UBC
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Eye,-0.2877119136995888,-0.5154339582936189,0.9795918367346939,1.0,1.0,5/20,17.85%,DOK5;GPC3;DCLK1;ZNF423;ADGRL3
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.3156504596599763,0.5143983578189031,0.9649122807017544,1.0,1.0,3/8,24.99%,IDE;UVRAG;SMURF1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.30921929408249865,0.5111540222662414,1.0,1.0,1.0,3/8,26.40%,KLF2;MTSS1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3212452322686662,0.5093442215146315,1.0,1.0,1.0,4/7,36.57%,PTEN;LATS2;LATS1;IPO7
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.32102469174254017,0.5077152286702705,0.9423076923076923,1.0,1.0,2/5,22.66%,RPS6KA5;NIPBL
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.2664739997176539,-0.5071330489095928,0.9838709677419355,1.0,1.0,4/15,24.99%,SRGN;CD34;ALS2;SQSTM1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.3282367647181691,-0.5066153239751574,0.9302325581395349,1.0,1.0,2/5,23.51%,DHX36;ZFP36L1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.3016873906452218,-0.5050108809595307,0.9347826086956522,1.0,1.0,2/8,19.47%,RHOA;ACVRL1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.33452404121037893,-0.5043904544145115,0.9803921568627451,1.0,1.0,3/6,32.32%,RIMKLB;GLUD1;GLUL
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Bone Marrow,-0.3334581855493759,-0.5039034023097202,0.9736842105263158,1.0,1.0,2/6,26.56%,CD34;ALPL
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.30794402344636185,-0.502967251139844,1.0,1.0,1.0,1/9,7.46%,DMD
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.2678685363189369,-0.5026009063411463,0.9787234042553191,1.0,1.0,3/17,16.20%,TIE1;RAPGEF2;TJP1
prerank,Reactome_2022__RHO GTPases Activate KTN1 R-HSA-5625970,-0.3010224694360203,-0.5017717684467929,0.9523809523809523,1.0,1.0,2/6,17.34%,RHOA;KLC1
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.2688970925175561,-0.5007647359534979,1.0,1.0,1.0,2/18,12.75%,UBC;CLTA
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.31358099999099964,-0.49951685162868437,0.9622641509433962,1.0,1.0,4/7,25.60%,SRP14;SPCS3;MAN1A1;RAB3GAP1
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,0.31089906717622756,0.4992616388246383,0.9166666666666666,1.0,1.0,1/6,12.70%,AP2B1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.3073638324294584,0.49902576467793525,0.9591836734693877,1.0,1.0,2/8,22.90%,ANXA1;NF1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.3307599841638813,0.49901571452812926,0.9772727272727273,1.0,1.0,3/7,23.88%,LRRK2;AKAP12;AKAP6
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.3339128591658015,0.49659401421303817,0.9795918367346939,1.0,1.0,2/5,36.65%,HSPA1A;HNRNPU
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.29906953797956826,0.4965879716600166,0.9767441860465116,1.0,1.0,4/9,32.30%,EP300;AKT3;RBBP4;KAT6A
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.27517860873749617,0.4961070587078795,1.0,1.0,1.0,2/10,15.30%,HSPA8;HSPA9
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.2976063829787234,-0.4944027586549349,0.9622641509433962,1.0,1.0,5/5,70.31%,PKD2;GALNT11;NOTCH1;OFD1;RFX3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.24358654578647515,-0.49299037930626133,0.9830508474576272,1.0,1.0,5/24,17.77%,CDC14A;SPAST;RHOA;PDGFB;RAD21
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,0.29213731442691737,0.49283388338060335,0.9777777777777777,1.0,1.0,3/10,29.48%,ARF4;EXOC5;ASAP1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3017121257590551,0.4901408578948304,1.0,1.0,1.0,1/6,20.21%,NCOR2
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.233272303861493,-0.4896661305823765,1.0,1.0,1.0,5/33,16.31%,TAOK3;MAPKAP1;JAK2;PRKAR1A;PDGFB
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,0.20674240397723714,0.48935325453986117,1.0,1.0,1.0,9/33,27.94%,KIF26B;GALNT2;CAPZB;ARF4;RAB3GAP2;KIFAP3;ARFGAP3;CAPZA1;KIF5B
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.2218165871438751,-0.4882896061768443,1.0,1.0,1.0,6/58,11.24%,CDC14A;RTTN;SCLT1;AHI1;RAB1A;SPAG16
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.2996604303673272,0.48678599419270446,1.0,1.0,1.0,3/8,37.29%,MIS18BP1;RBBP4;CENPC
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.2996604303673272,0.48678599419270446,1.0,1.0,1.0,3/8,37.29%,MIS18BP1;RBBP4;CENPC
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.2996604303673272,0.48678599419270446,1.0,1.0,1.0,3/8,37.29%,MIS18BP1;RBBP4;CENPC
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.2996604303673272,0.48678599419270446,1.0,1.0,1.0,3/8,37.29%,MIS18BP1;RBBP4;CENPC
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.28229122633882103,-0.48676503059225995,1.0,1.0,1.0,2/10,12.54%,SMAD3;CLU
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.28229122633882103,-0.48676503059225995,1.0,1.0,1.0,2/10,12.54%,SMAD3;CLU
prerank,Reactome_2022__Complement Cascade R-HSA-166658,0.28458472744459107,0.48304047792218696,0.9629629629629629,1.0,1.0,2/9,17.34%,CD59;CD81
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.32288061109401217,-0.48294299783244526,0.9807692307692307,1.0,1.0,1/5,10.97%,RAB1A
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.28867862152404805,0.4824310850990006,1.0,1.0,1.0,2/6,31.37%,RYR2;RBPJ
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.2611323093596054,0.4819329017548714,1.0,1.0,1.0,7/17,34.45%,ANK3;ROCK1;ROCK2;RASA1;MYH10;ECT2;TTC19
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.2833814540994245,-0.48062911102993544,1.0,1.0,1.0,2/9,21.46%,HECW2;ANAPC5
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,-0.26725345859918753,-0.4783881068869003,1.0,1.0,1.0,2/12,16.23%,GNG4;GNAS
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.2790488221005319,-0.47817909295717687,1.0,1.0,1.0,1/10,13.71%,PPP1R16B
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.28448342835007784,0.4780338600968767,1.0,1.0,1.0,3/7,31.45%,MYH9;KIF5B;NDEL1
prerank,CellMarker_Augmented_2021__Hemangioblast:Germ,-0.29260146654403046,-0.4773898515004092,0.9333333333333333,1.0,1.0,1/6,18.03%,CD34
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.26151085247894296,-0.47734273190054843,0.9782608695652174,1.0,1.0,1/15,7.73%,STK39
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.311436170212766,-0.4763627648262134,0.9777777777777777,1.0,1.0,5/5,68.92%,ACVR1;SMAD7;TGFBR2;TGFBR3;USP15
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.2750574310018489,-0.47511734148202295,0.98,1.0,1.0,1/6,19.20%,SYTL4
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.28713167056543193,-0.4690902224275026,1.0,1.0,1.0,2/7,18.41%,SRGN;BCOR
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.29388297872340424,-0.464955863253183,0.98,1.0,1.0,5/5,70.68%,CSTF3;CPSF6;WDR33;PCF11;PAPOLA
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.29388297872340424,-0.464955863253183,0.98,1.0,1.0,5/5,70.68%,CSTF3;CPSF6;WDR33;PCF11;PAPOLA
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,0.2990147545044168,0.46137257012456917,1.0,1.0,1.0,1/5,20.56%,MGST2
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.3011755687574912,0.4605458184427475,0.9782608695652174,1.0,1.0,3/5,27.78%,PXN;STAT3;PTK2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.2304825471130812,-0.45997901289000165,1.0,1.0,1.0,6/35,19.71%,SLC38A3;SHROOM2;TJP1;KIAA1549L;STXBP1;FARP1
prerank,CellMarker_Augmented_2021__Leydig cell:Testis,0.30998336036418983,0.45989710984565574,1.0,1.0,1.0,2/5,25.87%,JARID2;PCDH11X
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.29801427814762305,0.4593739712781139,0.9782608695652174,1.0,1.0,1/6,15.41%,ATG2B
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.31382978723404253,-0.45771640760905796,0.9761904761904762,1.0,1.0,5/5,68.69%,ACVR1;DLL4;GALNT11;NOTCH1;RBPJ
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,-0.2792184229908543,-0.4568606162174107,1.0,1.0,1.0,2/12,15.27%,ADAMTS1;THSD4
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.2741720974030727,-0.4555012639688601,1.0,1.0,1.0,2/11,15.19%,ARHGEF11;RHOA
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,-0.2641189615882924,-0.4536922630039102,0.9767441860465116,1.0,1.0,2/14,15.19%,ARHGEF11;RHOA
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.2782654961425911,-0.4527054788088345,0.9787234042553191,1.0,1.0,6/6,72.24%,ANAPC5;NSMCE2;CDC27;RB1;CUL3;CDC16
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.2782654961425911,-0.4527054788088345,0.9787234042553191,1.0,1.0,6/6,72.24%,ANAPC5;NSMCE2;CDC27;RB1;CUL3;CDC16
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.2782654961425911,-0.4527054788088345,0.9787234042553191,1.0,1.0,6/6,72.24%,ANAPC5;NSMCE2;CDC27;RB1;CUL3;CDC16
prerank,Reactome_2022__Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,-0.28690416516171424,-0.4512703092374182,1.0,1.0,1.0,1/5,11.71%,UBC
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.26531699520511454,-0.45125679280302117,1.0,1.0,1.0,11/11,73.57%,FBXL3;KIF13A;DCAF7;FBXW4;FBXL5;ARFGEF2;FBXW7;FBXW2;LONP2;STAT3;XRN2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.2874108035442392,-0.45121458261945363,0.98,1.0,1.0,4/7,26.61%,SEPTIN2;GLI3;KIAA0586;HIPK2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.2519957424161788,-0.451042089495012,1.0,1.0,1.0,7/7,74.87%,ACVRL1;ACVR1;NOTCH1;SMAD2;ENG;MDM4;NOS3
prerank,GO_Biological_Process_2021__morphogenesis of an endothelium (GO:0003159),0.304641022224996,0.4510318605788634,1.0,1.0,1.0,1/5,18.09%,CCM2
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.31382978723404253,-0.4505129078338565,0.9791666666666666,1.0,1.0,5/5,68.69%,ACVRL1;DLL4;ENG;ADAMTS9;RBPJ
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,-0.2415539997921408,-0.4504093925677539,1.0,1.0,1.0,3/23,13.68%,RGS6;GNG4;GNA14
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.24082040962675982,-0.450096399593942,0.9803921568627451,1.0,1.0,7/23,24.41%,APPL2;JAK2;GNAS;EPAS1;APC;KDM1A;LEPR
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.29743619371046065,0.4494129978077234,1.0,1.0,1.0,2/5,25.18%,PRKCA;NOS3
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.24624628113598412,0.448534728890364,0.9629629629629629,1.0,1.0,1/8,19.36%,JARID2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2531114785825606,-0.44787809979128174,0.9565217391304348,1.0,1.0,5/14,32.54%,CARD8;MAP2K5;GAS6;XIAP;CAST
prerank,Reactome_2022__Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,-0.2862170493810312,-0.4472428862187682,0.9761904761904762,0.9998743804375348,1.0,2/5,25.66%,TBL1X;MECP2
prerank,Reactome_2022__Protein Folding R-HSA-391251,-0.23070168333474733,-0.4458758195007432,1.0,0.9996734778936747,1.0,3/25,13.68%,RGS6;GNG4;GNA14
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.2519957424161788,-0.44585084570262185,0.9772727272727273,0.999269732547191,1.0,7/7,74.87%,ACVRL1;ACVR1;NOTCH1;TGFBR2;ENG;MDM4;NOS3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.2918102372956184,-0.44480175995344257,1.0,0.999011258286512,1.0,4/6,31.39%,BCOR;KDM1A;MTF2;MACROH2A1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.2551824935667733,-0.4433526641791043,1.0,0.9988440642166879,1.0,2/11,15.30%,STAT5B;RAMP3
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.2706446457112413,-0.44033821603410916,1.0,0.9988466608703992,1.0,11/11,73.04%,NAP1L1;NPM1;MACROH2A1;EZH1;RSF1;ATRX;SIRT1;SMARCA5;KAT6B;RBBP4;NAP1L4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.27588575509738733,0.43961486127074273,0.9591836734693877,1.0,1.0,2/5,26.40%,ANXA1;MEF2C
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.24849137539530386,0.43760251314696325,1.0,1.0,1.0,2/12,22.52%,DST;AP3B1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.2686591227831302,0.4374730040007816,0.9791666666666666,1.0,1.0,3/7,30.09%,ITCH;IFI16;MAPKBP1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.2817691479428571,-0.43681981296644623,0.9782608695652174,0.9989402535608483,1.0,2/7,19.07%,PDGFB;PKD2
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.28791910590739755,-0.4365026601337694,0.9795918367346939,0.9985748289282115,1.0,7/7,71.29%,SENP6;TPR;CHMP4B;PDCD6IP;HNRNPU;DYNC1H1;HSPA1A
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.2630772984873919,0.43419291777475244,0.9803921568627451,1.0,1.0,2/7,22.90%,NIPBL;NF1
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.2632344570948856,0.43362413970519065,0.9787234042553191,1.0,1.0,1/7,21.57%,AGO2
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.2632344570948856,0.43362413970519065,0.9787234042553191,1.0,1.0,1/7,21.57%,AGO2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.2866039364749618,0.4330646498817241,1.0,1.0,1.0,2/6,35.91%,MYO1E;BASP1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.2681564245810056,-0.4320515227700376,0.9622641509433962,0.9987676464184987,1.0,6/6,73.25%,ZFP36;PUM1;DHX9;PUM2;FXR1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.273133944692295,0.4313862726794854,0.9615384615384616,1.0,1.0,2/5,29.75%,SPEN;RFX3
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.2538690304567126,0.42927128814802906,0.9787234042553191,1.0,1.0,2/7,24.57%,ITCH;TRAF3
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.2520628160766569,-0.4262006858525429,0.9787234042553191,0.9989768337233081,1.0,8/8,74.87%,ACVRL1;FOXF1;ACVR1;NOTCH1;ENG;BMPR2;MDM4;NOS3
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.2791379826785384,0.42583700204038283,1.0,1.0,1.0,3/6,28.23%,NDUFS4;NDUFA12;UQCRC2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2791379826785384,0.42583700204038283,1.0,1.0,1.0,3/6,28.23%,NDUFS4;NDUFA12;UQCRC2
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,0.2444143453347502,0.4249390274487308,1.0,1.0,1.0,4/11,29.69%,PPP1CB;MYH9;MYH10;MYL6
prerank,Reactome_2022__Activation Of RAC1 R-HSA-428540,0.25712244562533415,0.421509864908611,1.0,1.0,1.0,1/6,25.44%,SOS2
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.24500665778961384,-0.42068276597665283,1.0,0.9992560561063215,1.0,10/10,75.59%,SLC3A2;SLC36A4;SLC25A29;SLC38A5;SLC25A13;SLC7A1;SLC7A5;SLC25A12;SLC1A2;SLC1A1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.24940047961630696,-0.41985398872075314,1.0,0.9989612678539072,1.0,12/12,75.17%,MAP2K5;GAS6;XIAP;DNAJB6;PAK2;DDX3X;KLF4;CSNK2A1;RAF1;USP47;RPS6KA3;YWHAE
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Tooth,-0.25877659574468087,-0.41703621322212064,1.0,0.9988028845182789,1.0,5/5,74.18%,POU2F1;ATXN3;NASP;PODXL;PCDH11X
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.22602030572743137,-0.41620119016410084,1.0,0.9984755184529227,1.0,4/17,21.09%,DIXDC1;FZD6;APC;TCF7L1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.2473270748034599,-0.4087165355939001,1.0,0.9989317815045303,1.0,2/10,19.47%,ZNF423;ACVRL1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.22076800154689535,0.4066796119911062,1.0,1.0,1.0,5/13,29.88%,POT1;HMBOX1;RGCC;TNKS;BMPR2
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,-0.22741669927716546,-0.4049729338993549,1.0,0.9988725126498154,1.0,5/14,29.11%,RAB1A;RAB14;RAB2A;RAB8B;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.21615138592750532,-0.4024453168342859,1.0,0.998718539057021,1.0,13/13,78.49%,ZFP36;DDX5;EGFR;DDX6;RIPK1;PUM1;DHX9;MAP2K1;TNRC6B;PUM2;FXR1;STAT3;AGO2
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.252447416878012,0.39943540073876416,0.9803921568627451,1.0,1.0,2/7,25.76%,RPS6KA5;SETD5
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,-0.20691204189587817,-0.38904718930674365,1.0,0.999219453201543,1.0,1/16,11.71%,UBC
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.2267526781455858,0.3838782809939356,1.0,1.0,1.0,4/9,37.48%,POT1;BMPR2;HNRNPU;DCP2
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,0.24241617881852057,0.3766594728759821,1.0,1.0,1.0,7/7,75.80%,KIFAP3;IFT140;TTC21B;DYNC2I1;DYNC2H1;TNPO1;TRIP11
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.23787959509856152,-0.3764361485758488,1.0,0.9994729836803823,1.0,11/11,76.31%,CABIN1;NPM1;NASP;RSF1;UBN1;ATRX;SMARCA5;CENPP;CENPC;RBBP4;MIS18BP1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gall Bladder,0.21583307752271697,0.37460379260978444,1.0,1.0,1.0,3/13,32.40%,PREX2;PCDH11X;ADCY2
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.2202920811149709,0.374278074459291,1.0,1.0,1.0,4/10,32.40%,PDE7B;AKAP6;PDE7A;ADCY2
prerank,Reactome_2022__AKT Phosphorylates Targets In Cytosol R-HSA-198323,-0.24290069147870583,-0.37384040181228484,1.0,0.9991790543844241,1.0,3/5,31.26%,MDM2;CDKN1B;GSK3B
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.20948827292110875,-0.368714939298015,1.0,0.9990252048303774,1.0,13/13,79.15%,CLCN3;ALS2;SQSTM1;HOOK3;USP8;TMCC1;ARFGEF2;SNX3;EEA1;RAB27A;CORO1C;DNAJC13;WASHC4
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.2171078996498299,0.35847226731217124,1.0,1.0,1.0,3/7,35.94%,POT1;TNKS;ATR
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,0.23427183013091218,0.3564900875799554,1.0,1.0,1.0,3/6,32.70%,RTN3;GRIA4;PTPRD
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.21373575989985055,0.33565012406835093,1.0,0.9999334138286161,1.0,4/7,37.48%,POT1;TNKS;HNRNPU;DCP2
